Molecule ChEMBL ID,Molecule Name,Smiles,Standard Type,pChEMBL Value,Assay ChEMBL ID,Assay Description,Cell Name,InChIKey
CHEMBL1224279,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCc6ccc7c(c6)OCO7)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.14,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,ZEAZBNWVIIXFJZ-JNLDGDHFSA-N
CHEMBL1224363,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCc6ccc7c(c6)OCO7)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.5,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,JFJDNAMZIYNXPC-CNHRZFDUSA-N
CHEMBL1269453,,COCOc1cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc(OC)c1C/C=C(\C)C/C=C/C(C)COC(=O)CCCC[C@H]1SC[C@H]2NC(=O)N[C@H]21,EC50,5.57,CHEMBL1273920,Cytotoxicity against human SF295 cells,SF295,MYAJMYWMOPXPGG-IYWZCBGFSA-N
CHEMBL1269454,,COCOc1cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc(OC)c1C/C=C(\C)C/C=C/C(C)CNC(=O)CCCC[C@H]1SC[C@H]2NC(=O)N[C@H]21,EC50,5.96,CHEMBL1273920,Cytotoxicity against human SF295 cells,SF295,NEFHRHHZCAEVPZ-IYWZCBGFSA-N
CHEMBL4062767,,C=C(c1ccc(OC)cc1)c1cc(C)cc2ccccc12,IC50,6.85,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,DBNFLZAGLUSXCU-UHFFFAOYSA-N
CHEMBL498271,,C=C(c1ccc(OC)c(O)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.11,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,CNGKIRSNRQSORA-UHFFFAOYSA-N
CHEMBL2164695,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3ccc(F)cc3)cc1n2Cc1ccc(F)cc1.[Br-],IC50,4.85,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,CHTGQWXZLQUCQI-UHFFFAOYSA-M
CHEMBL2164718,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,6.22,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,HDGXFFZEDXJLJV-UHFFFAOYSA-M
CHEMBL2164716,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,6.32,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,SEZZOMVRRQGVSJ-UHFFFAOYSA-M
CHEMBL1645544,,C=CCOc1ccc2c(c1)[nH]c1c(C)nccc12,IC50,4.5,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,JBSMSTGKQFHUBO-UHFFFAOYSA-N
CHEMBL1822932,,CCCCOc1c(OC)ccc2cc(C(=O)NCC(F)c3ccccc3)c(=O)[nH]c12,Ki,9.1,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,FNTMGRNAIKUGDA-UHFFFAOYSA-N
CHEMBL125395,,COc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.16,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,LSUJEFUOJJOYDR-UHFFFAOYSA-N
CHEMBL1164496,,COc1ccc(-c2nnn(CCCCCCCn3nnc(-c4ccc(OC)c(OC)c4)n3)n2)cc1OC,IC50,4.4,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,KKLBOXOFXWBVGV-UHFFFAOYSA-N
CHEMBL1163276,,O=C(OCc1cc(COC(=O)c2ccc(O)c(F)c2)cc(COC(=O)c2ccc(O)c(F)c2)c1)c1ccc(O)c(F)c1,IC50,4.43,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,FWATVAIBJMWBSG-UHFFFAOYSA-N
CHEMBL1163275,,COc1cc(C(=O)OCc2cc(COC(=O)c3ccc(O)c(OC)c3)cc(COC(=O)c3ccc(O)c(OC)c3)c2)ccc1O,IC50,4.55,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,SRTMPHPQVYKQHX-UHFFFAOYSA-N
CHEMBL1164563,,COc1cc(C(=O)OCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.25,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,HMQDKFDLCCFFNU-UHFFFAOYSA-N
CHEMBL253178,,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(O)c2)c(OC)c1,IC50,8.15,CHEMBL926537,Antitumor activity against human U87 cells by trypan blue exclusion assay,U-87MG ATCC,GHPUSRLWNSTQIK-BQYQJAHWSA-N
CHEMBL2419667,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,7.75,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XHBKQWXDUHRNOS-HASSKWOGSA-N
CHEMBL1171448,CIRENSENOSIDE O,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.86,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,QDUNASUIHMLOJM-VYEWMGKISA-N
CHEMBL2430034,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.76,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,ZPSFHHIZWMURAT-GSDJGKHLSA-N
CHEMBL2397982,,COc1ccc(NS(=O)(=O)/C=C/c2c(OC)cc(OC)cc2OC)cc1,IC50,6.64,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,CNXODVDGIBSDFK-MDZDMXLPSA-N
CHEMBL192687,,Oc1cc(-c2ccccc2)nc2c1ccc1[nH]ccc12,IC50,4.0,CHEMBL833357,Cytotoxic activity against human tumor A-172 cell line,A-172,UNOZBASOWIOTMS-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL240954,,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H]1C,IC50,5.32,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,SXOZSDJHGMAEGZ-IGKKHSBFSA-N
CHEMBL1091644,LINSITINIB,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,IC50,4.39,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,PKCDDUHJAFVJJB-VLZXCDOPSA-N
CHEMBL191384,,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,IC50,5.67,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,AVLYNJZZQYEFEA-XDJHFCHBSA-N
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,8.79,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,5.72,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.68,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,5.92,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL110525,,CCOC(=O)c1cnc2c(c1)-c1nc3ccccc3c3ccnc(c13)C2=O,IC50,7.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,NJGLKAOBESXCHS-UHFFFAOYSA-N
CHEMBL87506,,CCOC(=O)Cn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,RRACHVADVPJIDE-UHFFFAOYSA-N
CHEMBL87506,,CCOC(=O)Cn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,RRACHVADVPJIDE-UHFFFAOYSA-N
CHEMBL316130,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCN(C)C)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,GGCKHBAUSWWNEQ-UHFFFAOYSA-N
CHEMBL220172,,Cc1cc(N2CCC[C@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,5.19,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LBCGUKCXRVUULK-KRWDZBQOSA-N
CHEMBL220880,,CCc1cc(N2CCC[C@@H]2CC(=O)NCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.89,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,QZMBUROFNSSUCP-GOSISDBHSA-N
CHEMBL119,TRIMETREXATE,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,IC50,7.96,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,NOYPYLRCIDNJJB-UHFFFAOYSA-N
CHEMBL85742,,COc1cc(OC)c2cc(-c3ccc(OCc4ccccc4)cc3)c(O)nc2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,QPBWAIBGHJOAES-UHFFFAOYSA-N
CHEMBL110730,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1,IC50,8.19,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,NSNVDTQEDMRJDI-QCKNELIISA-N
CHEMBL2349385,(2-PHENYL-1H-INDOL-3-YL)METHANOL,OCc1c(-c2ccccc2)[nH]c2ccccc12,EC50,4.52,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,WWOMARKUBVSTBK-UHFFFAOYSA-N
CHEMBL1760592,,COc1cc(C[C@@H](CO)[C@](O)(CO)Cc2ccc(O)c(OC)c2)ccc1O,IC50,4.56,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,INPPVVSEQRZCLJ-MGPUTAFESA-N
CHEMBL2313472,,COc1cc(Sc2c(-c3ccncc3)[nH]c3ccccc23)cc(OC)c1OC,IC50,6.99,CHEMBL2321142,Cytotoxicity against human U87MG cells assessed as cell survival after 24 hrs by MTS conversion assay,U-87MG ATCC,SXKCLXVXENOBLF-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,6.72,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL4282544,,CCn1c2ccccc2c2cc(C(=O)c3cccc4ccccc34)ccc21,EC50,5.77,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,HQBBGYZHBSZKQC-UHFFFAOYSA-N
CHEMBL4292529,,CCn1c2ccccc2c2cc(C(=O)c3ccc(C)c4ccccc34)ccc21,EC50,7.06,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,JHYURZUKNMASQT-UHFFFAOYSA-N
CHEMBL4284603,,CCn1c2ccccc2c2cc(C(O)c3ccc(C)c4ccccc34)ccc21,EC50,6.25,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,WWVXNRZZDMWJNK-UHFFFAOYSA-N
CHEMBL3410531,,O=C1/C(=C/c2cccc([N+](=O)[O-])c2)CS(=O)(=O)C/C1=C\c1cccc([N+](=O)[O-])c1,IC50,6.12,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,OEBPTKPFIJYBCZ-BGPOSVGRSA-N
CHEMBL3410533,,COc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc([N+](=O)[O-])cc3)C2=O)cc1,IC50,5.68,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,NWUHGYXUFVOVSZ-OTYYAQKOSA-N
CHEMBL473087,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CCC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,4.56,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IBFHBKDCSZGUSP-UNZYHPAISA-N
CHEMBL4075572,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.51,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,MJUNOVRHVGCIDZ-RZPOAMPKSA-N
CHEMBL3347578,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.17,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,IAOFKRFVYOFYTI-KEQPWATNSA-N
CHEMBL4102380,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(C#N)c1)CC(C)(C)O2,IC50,4.85,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CJYMCBSCMOLHIE-UHFFFAOYSA-N
CHEMBL2069126,CORNUSALTERIN C,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)[C@@H]3CCC4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.75,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,AHAJUDPVPSLOAM-MCTQLSMQSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.75,CHEMBL1103642,Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4459518,,CN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1ccc(F)cc1,IC50,5.01,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RJGWWNVHLMPYEN-BUHFOSPRSA-N
CHEMBL4787717,,COc1cc(C(=O)NC2CCNCC2)ccc1Nc1ncc2scc(-c3ccccc3OC)c2n1,IC50,5.19,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,PAQTVICEMANNAC-UHFFFAOYSA-N
CHEMBL446591,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc(Cl)c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.08,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,IOFPYWWAVQTBSB-ALMBTRMVSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.88,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL229727,,COc1cc(OC)c2nc3c(nc2c1)C(=O)c1cnncc1C3=O,IC50,7.48,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,ONAIIUROHYQSCU-UHFFFAOYSA-N
CHEMBL5087462,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(Cl)c2C)cc1,IC50,5.32,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,FZEOLZCBYJQGGE-UHFFFAOYSA-N
CHEMBL5082822,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(C)c2C)cc1,IC50,4.13,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,VRMIGBQDTMKLPK-UHFFFAOYSA-N
CHEMBL5076815,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.38,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,YSEVIHSXDAOIMX-VZHCALMGSA-N
CHEMBL301982,CELASTROL,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C,IC50,5.64,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,KQJSQWZMSAGSHN-JJWQIEBTSA-N
CHEMBL5090187,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.5,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GAKKQBFYSNJTAZ-CDKFMWKUSA-N
CHEMBL5091306,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C(C)(C)C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.31,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,RVEWODMIOUUZJR-CHFKRMNXSA-N
CHEMBL301982,CELASTROL,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C,IC50,5.65,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,KQJSQWZMSAGSHN-JJWQIEBTSA-N
CHEMBL5080560,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(F)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.66,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,NSHNVMIURYQLAG-MCLIRCHUSA-N
CHEMBL4777873,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc(N3CCOCC3)n2)cc1,IC50,5.88,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,WPUHLJLOCQBRHP-YIXHJXPBSA-N
CHEMBL4758970,,CN(C)C(=O)c1ccc(NC(=O)Nc2ccc(Nc3nc(/C=C/c4ccccc4)nc(N4CCOCC4)n3)cc2)cc1,IC50,6.28,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,AVWRCFPHHWUSFI-CAOOACKPSA-N
CHEMBL244034,,CC(COc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O)N(C)C,IC50,7.0,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,LEFCTXDNQSIXLV-UHFFFAOYSA-N
CHEMBL575196,,COC(=O)[C@H](Cc1ccc(O)cc1)N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@@H](Cc3ccc(O)cc3)C(=O)OC)C(=O)C(O)=C4C(C)C)c(O)c21,IC50,4.49,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AFCGYIWULPMWPT-ZXRMINHTSA-N
CHEMBL4436062,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1NC(=O)/C=C/C=C(C)\C=C\[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,6.14,CHEMBL4430445,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability by Alamar blue assay,SF295,ZONXPAWDWNRZKV-VEDKGFTPSA-N
CHEMBL3262852,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cccc(Cl)c3Cl)cc2F)ccn1,IC50,4.88,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WAXOCTYMPSZMGB-AMVVHIIESA-N
CHEMBL3262861,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(O)cc3O)cc2F)ccn1,IC50,4.81,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GBBGXHSEQRXIMO-CCVNUDIWSA-N
CHEMBL3262867,,COc1ccc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)c(OC)c1,IC50,4.9,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DIRAYSYIKRPJSE-OKCVXOCRSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.82,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL4450269,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.04,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,XHHHLVOLGLLDQG-QRDFGAMCSA-N
CHEMBL229004,,O=C1c2cnncc2C(=O)c2nc3cc(C(F)(F)F)ccc3nc21,IC50,6.94,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,JUMAJRYRBLTOKZ-UHFFFAOYSA-N
CHEMBL229680,,O=C1C(=O)c2c(nc3ncccn23)-c2ncccc21,IC50,6.86,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,ANQNFFOSXIYUIE-UHFFFAOYSA-N
CHEMBL229678,,CCc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.89,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,JNVMLBLPMYUGCM-UHFFFAOYSA-N
CHEMBL65633,,COc1cc(N2C(=O)C(O)C2c2ccc3c(c2)OCO3)cc(OC)c1OC,IC50,6.1,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,RVUVVQHETFFQKU-UHFFFAOYSA-N
CHEMBL2338397,CRENIGACESTAT,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)c2ncccc2-c2ccccc21,IC50,9.55,CHEMBL2344616,Inhibition of gamma-secretase mediated cleavage of Notch 1 in human U-87-MG cells assessed as nuclear accumulation of Notch 1 intracellular domain (N1ICD) after 24 hrs by ELISA,U-87MG ATCC,YCBAQKQAINQRFW-UGSOOPFHSA-N
CHEMBL4519381,,N#Cc1cccc(/C=C/C(=O)c2ccc(F)c(O)c2)c1,IC50,4.78,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,WHPARJMPPFCLBF-QPJJXVBHSA-N
CHEMBL4460678,,N#Cc1cccc(/C=C/C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)c1,IC50,4.54,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,YOHPFXYRYBLWTK-NTEUORMPSA-N
CHEMBL4584988,,CCCCN(CCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.17,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,PZRIKWNOAQZQDI-XNTDXEJSSA-N
CHEMBL4550951,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)c(F)c2)cc1,IC50,4.54,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,KWEGBFABGINGLE-FNORWQNLSA-N
CHEMBL4459949,,CCCCCN(CCCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,5.25,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,KSVZDKHRYOARAP-SFQUDFHCSA-N
CHEMBL2237333,,COc1cc(/C=C(\C(=O)O)c2ccccc2)cc(OC)c1OC,IC50,4.06,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,YITBDTHDPPLHMZ-ZROIWOOFSA-N
CHEMBL2237334,,COc1cccc(/C=C(\C(=O)O)c2ccccc2)c1OC,IC50,5.41,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,MVBILHILDTUHOK-KAMYIIQDSA-N
CHEMBL2172478,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccc(-c4cnn(C(C)C)c4)cn23)nc(C)n1,IC50,6.16,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,QNSXRDAUAHBZSB-UHFFFAOYSA-N
CHEMBL2172474,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3cccnn23)nc(C)n1,IC50,5.91,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CWCIJIQAVFNXDY-UHFFFAOYSA-N
CHEMBL2172630,,Cc1nc(Nc2cnccn2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,7.18,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,ABQRVDGZZXHLLT-UHFFFAOYSA-N
CHEMBL2172629,,CC(=O)Nc1cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)nc(C)n1,IC50,7.35,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CCXBYTLKYILHRE-UHFFFAOYSA-N
CHEMBL2172628,,Cc1nccc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,5.66,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CWYLZDNXUUUUJJ-UHFFFAOYSA-N
CHEMBL575456,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(=O)C(O)=C2C(C)C,IC50,4.88,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,FVNKIYDSILCLGI-BDXXZCQXSA-N
CHEMBL4079155,,Cc1cc(=O)n(-c2ccccc2F)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.31,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CDOXNDLQNWWSNK-UHFFFAOYSA-N
CHEMBL4088695,,Cc1cc(=O)n(-c2cccc(C(F)(F)F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.03,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NTRGHCZYFVEYHO-UHFFFAOYSA-N
CHEMBL496556,,CNC(=O)c1ccccc1SC/C=C(\C)CC/C=C(\C)CCC=C(C)C,IC50,4.75,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,UATVIEUDDKLRJY-YEFHWUCQSA-N
CHEMBL4439979,,CC(C)(C)OC(=O)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1Cn1cc(CNc2ccn([C@@H]3O[C@H](CO)[C@@H](O)C3(F)F)c(=O)n2)nn1,IC50,5.33,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,PRCCOEONMPKMOZ-ZLIPZANWSA-N
CHEMBL444437,,C=C(C)[C@@H]1CC[C@]2(COC3CCCCO3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.68,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,COQXEBGTMOMMEH-XIYJGOOFSA-N
CHEMBL941,IMATINIB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.42,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,KTUFNOKKBVMGRW-UHFFFAOYSA-N
CHEMBL475796,,Cc1ccc(NCc2ccc(C(=O)Nc3ccccc3N)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.8,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,JLIZHCYTSUGKKN-UHFFFAOYSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,6.02,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL1095626,,COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1,IC50,6.22,CHEMBL1104677,Antiproliferative activity against human U87MG cells,U-87MG ATCC,OFIHBQUKIUHAHV-UHFFFAOYSA-N
CHEMBL4535437,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4ccncc4)o3)C2=O)cc1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,OHCVPSMPLCUVNE-MORMLQEESA-N
CHEMBL4566955,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ncc[nH]1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,OIBPYKJPDLXDIT-NCUFVCKSSA-N
CHEMBL4442904,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ccc(Br)cc1,IC50,5.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,ULBOWKXOFOTCMU-NLDKGBHCSA-N
CHEMBL3301610,ABEMACICLIB,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,EC50,6.92,CHEMBL4387155,Antiproliferative activity against human U87MG assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,U-87MG ATCC,UZWDCWONPYILKI-UHFFFAOYSA-N
CHEMBL4440980,,C[C@@H]1CCCCn2ncc(-c3nc(Nc4ccc(N5CCN(C)CC5)cn4)ncc3F)c21,EC50,6.46,CHEMBL4387155,Antiproliferative activity against human U87MG assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,U-87MG ATCC,UHCMUGYUWQCODZ-MRXNPFEDSA-N
CHEMBL514389,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(Br)cc1,IC50,5.74,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,YLDUQUOZOMZQEQ-UHFFFAOYSA-N
CHEMBL2180728,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1c(C)nc2ccccc21)c1cccc(F)c1,IC50,6.62,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,QGBXSUVTQOBSQO-UHFFFAOYSA-N
CHEMBL2180730,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,IC50,6.72,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,SPSSOXNPEUCMPB-UHFFFAOYSA-N
CHEMBL597550,,COc1cc(CCc2cc(O)c(CCC(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.55,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,VRQABKBYQHWBDG-YCVRVPNXSA-N
CHEMBL599633,,COc1cc(/C=C/c2cc(O)c3ccoc3c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.32,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,CHOAALBWVLPKBQ-WPCAQGITSA-N
CHEMBL597175,,COc1cc(/C=C/c2cc(O)c(CCCO)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.6,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,NRMPJPAJOFYRHT-RPYFTWFOSA-N
CHEMBL597174,,CCCc1c(O)cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,EC50,6.05,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,ZVLHXOXBQCYIGF-RSOHHRNFSA-N
CHEMBL1760591,,COc1cc([C@@H](O)[C@@H](CO)Oc2ccc(CCCO)cc2OC)ccc1O,IC50,4.58,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,DBIKJXXBCAHHMC-WOJBJXKFSA-N
CHEMBL3967430,,CC1c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S(=O)(=O)N1CCS(N)(=O)=O,IC50,6.51,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,ASNVRAUVNPTTIK-UHFFFAOYSA-N
CHEMBL3898090,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCCCNC(=O)c1cccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)c1)[C@@H]3C,EC50,6.42,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,QNIIODKUCXZOMU-RPWWTVJQSA-N
CHEMBL4877280,,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(C(F)(F)F)c2)ccc1O,IC50,4.05,CHEMBL4810781,Neurotoxicity in human U87 MG cells assessed as cell viability for 24 hrs by MTT assay,U-87MG ATCC,AUSDOGATGBZSJY-XVYDYJIPSA-N
CHEMBL3612320,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.98,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UWYTUSAPPUVSIF-UHFFFAOYSA-N
CHEMBL170937,,CCNCCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC,IC50,7.07,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,ZSBHNAMMFVRBAT-UHFFFAOYSA-N
CHEMBL3343364,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QOBYLORHSHBOAP-UHFFFAOYSA-N
CHEMBL3343393,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.94,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BSPWNQRKZFSVIY-UHFFFAOYSA-N
CHEMBL301393,,COCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CCl)OCCO3,IC50,7.54,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,NDTNRXBJYADVNN-UHFFFAOYSA-N
CHEMBL300396,,CC(=O)O.CCOCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,IC50,5.26,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,ADVSJECXSHTRHA-UHFFFAOYSA-N
CHEMBL5083386,,CCN(C(=O)[C@H](Cc1ccccc1)NS(=O)(=O)c1cccc2nsnc12)c1ccccc1,IC50,4.18,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,AJDKKWMQQBSNBG-FQEVSTJZSA-N
CHEMBL1165205,,O=C(OCc1cc(COC(=O)c2ccc(O)c(Cl)c2)cc(COC(=O)c2ccc(O)c(Cl)c2)c1)c1ccc(O)c(Cl)c1,IC50,4.6,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,MKXWHCDJKDVLAD-UHFFFAOYSA-N
CHEMBL502860,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc(Cl)c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.51,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,YHRBSJUMRRQWAQ-GVQBMFDGSA-N
CHEMBL5220389,,COc1ccc(-c2ncccc2CNc2ccc(Cl)cc2)cc1OC,IC50,4.36,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,RKDQLJLYASYZAO-UHFFFAOYSA-N
CHEMBL5219943,,COc1ccc(NCc2cccnc2-c2cc(OC)c(OC)c(OC)c2)cc1,IC50,4.71,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,KGWSULVXWYWPRK-UHFFFAOYSA-N
CHEMBL1822938,,CCCCOc1c(OC)ccc2cc(C(=O)NCCc3cn(CCF)nn3)c(=O)[nH]c12,Ki,5.62,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,UUDSOVGGCULQFR-UHFFFAOYSA-N
CHEMBL575446,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C)C)C(=O)C(O)=C3C(C)C)/C(=C/NC(C)C)C(=O)C(O)=C2C(C)C,IC50,4.61,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,SSSPNLJUJBETHQ-GACBQCINSA-N
CHEMBL334217,,COc1ccc2c(n1)C(=O)c1ncc(OC)c3ccnc-2c13,IC50,6.16,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,VADKSBGLASVELY-UHFFFAOYSA-N
CHEMBL558927,,C=C1C(=O)O[C@@H]2C3=C(C)C(=O)C=C[C@]3(C)CC[C@@H]12,IC50,5.57,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SOEFILJAGJAINE-XEGUGMAKSA-N
CHEMBL1683544,ERIBULIN MESYLATE,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O,IC50,7.55,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,QAMYWGZHLCQOOJ-WRNBYXCMSA-N
CHEMBL443885,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,6.18,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,BKQUQGAKNSXOHH-PLDABBGUSA-N
CHEMBL474038,,CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC(=O)[C@H](C(C)C)NC1=O,IC50,8.4,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,CXMBFUMTPNXCMT-HDHGSYJOSA-N
CHEMBL474037,,CC[C@H](C)[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC1=O,IC50,8.3,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,ZWHILRBVKJAMNY-FELOTHHLSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,7.44,CHEMBL801266,Compound was evaluated for in vitro activity against SF-295 CNS cell lines (Human tumor cells ),SF295,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL3290919,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.89,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WFFFXRJVCFPXNE-UHFFFAOYSA-N
CHEMBL3290916,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.86,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,AZBIXVOPJHAERT-UHFFFAOYSA-N
CHEMBL3290915,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)c(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.85,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,GBUGDGGIILOEGB-UHFFFAOYSA-N
CHEMBL3290923,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5Cl)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.75,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MKIUQQULMXHCND-UHFFFAOYSA-N
CHEMBL3290935,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.71,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,ZJCUQDMGHWMKKH-UHFFFAOYSA-N
CHEMBL3290930,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.7,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HECDTLBFMUFDFS-UHFFFAOYSA-N
CHEMBL342137,,Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1,IC50,8.84,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,UMOFYSFQZJYWNT-RXVVDRJESA-N
CHEMBL4585178,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccccc1)O2,IC50,6.96,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,IWMAWSKAKALHJM-UHFFFAOYSA-N
CHEMBL511104,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CO)nn1,IC50,5.47,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,REMSSOCTCKAZGO-UHFFFAOYSA-N
CHEMBL3401523,,NC(=O)c1cc(O)cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1,IC50,5.49,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UZCPYNPIIHNPQA-UHFFFAOYSA-N
CHEMBL3401525,,NC(=O)c1cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc(C(F)(F)F)c1,IC50,4.95,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VZDKMEUDDGIPDW-UHFFFAOYSA-N
CHEMBL3401532,,CN(c1nc(-c2cc(C(N)=O)cc(C(F)(F)F)c2)nc(N2CCOCC2)n1)C1CCN(S(C)(=O)=O)CC1,IC50,5.33,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WKGPDSVLACYRJW-UHFFFAOYSA-N
CHEMBL236780,,COCc1cn(-c2ncc(F)c3c(S(=O)(=O)N4CCN(C(=O)c5ccccc5)CC4C)c[nH]c23)nn1,IC50,6.24,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DRVFDOLVHIQECA-UHFFFAOYSA-N
CHEMBL239424,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)ncc(F)c12,IC50,8.15,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,UWEPTEGNPCLLAE-CQSZACIVSA-N
CHEMBL238266,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)ncc(F)c12,IC50,7.44,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RASBPZQXUFEKOD-OAHLLOKOSA-N
CHEMBL238111,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)nccc12,IC50,7.1,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ARHPJYQUPRCXQA-MRXNPFEDSA-N
CHEMBL235969,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(Cl)nccc12,IC50,4.96,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LXWTXPDNOXWULE-UHFFFAOYSA-N
CHEMBL235966,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)ccc(F)c12,IC50,6.82,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OZBFRVOUNCCDAV-OAHLLOKOSA-N
CHEMBL235964,,COc1cccc2[nH]cc(S(=O)(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,IC50,5.38,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BPXPAHHGBSRISR-OAHLLOKOSA-N
CHEMBL392342,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(F)c(F)c(F)c(F)c12,IC50,5.33,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,IMXHQIHAYMWELJ-LLVKDONJSA-N
CHEMBL429809,,Cc1csc(C(=O)N2CCN(S(=O)(=O)c3c[nH]c4ncccc34)[C@H](C)C2)c1,IC50,5.72,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,UWPGHMBUNAKEOQ-CYBMUJFWSA-N
CHEMBL240049,,C[C@@H]1CN(C(=O)c2csc(N)n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,6.28,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,CTFBUNZARCVBPA-SNVBAGLBSA-N
CHEMBL390452,,O=C(/C=C/c1cccc(C(=O)c2cc3ccccc3o2)c1)NO,IC50,5.96,CHEMBL895813,Cytotoxicity against human U87MG cells,U-87MG ATCC,KMVDSQMVUNRCNZ-CMDGGOBGSA-N
CHEMBL210065,,CCN(CC)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1,IC50,6.68,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,UJOQSHCJYVRZKJ-UHFFFAOYSA-N
CHEMBL385325,,O=C(CC1CN(c2cccc(F)n2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.55,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZYJJCOLCHBJORK-UHFFFAOYSA-N
CHEMBL375404,,CC(C)CCN1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,SRHJPUAVXACAOL-UHFFFAOYSA-N
CHEMBL373623,,CN1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.32,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,GSOOHDJMKOKFNJ-UHFFFAOYSA-N
CHEMBL223614,,COc1ccc(NC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1OC,IC50,7.18,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,AYNOIPXHVJCQGG-UHFFFAOYSA-N
CHEMBL215803,,C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2,IC50,8.44,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,PAXKGQZKOJPPEG-OLZOCXBDSA-N
CHEMBL443999,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1,IC50,8.85,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,GXJXVSDXVMSAIP-QCWLDUFUSA-N
CHEMBL519575,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3cccs3)cc1OC2(C)C,EC50,5.7,CHEMBL964510,Cytotoxicity against human LN229 cells assessed as cell death after 18 hrs,LN-229,HBOZOOYIOXJZFX-IAGOWNOFSA-N
CHEMBL106209,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1,IC50,7.92,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,FMNMLKWJLFYSMF-UHFFFAOYSA-N
CHEMBL302778,,O=C(OCCS(=O)(=O)c1ccccc1)N1c2ccc(OCCO)cc2[C@@]23O[C@]24CCC[C@H]3C#C/C=C\C#C[C@H]14,IC50,6.11,CHEMBL873998,Cytotoxic activity against U-87 UG astrocytoma tumor cell lines.,U-87MG ATCC,ZNWSAFOOCBOGNX-GCAOFRLQSA-N
CHEMBL357557,,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,8.92,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,QWZMAQRSGSBPHQ-RXVVDRJESA-N
CHEMBL416673,,COc1ccc(C2C(O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1N,IC50,6.96,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,DWPCTWGZTVHWRA-UHFFFAOYSA-N
CHEMBL2172487,,CC(=O)Nc1cccc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)c1,IC50,7.54,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,ZOHYOLFOCULNKX-UHFFFAOYSA-N
CHEMBL2172484,,Cc1cc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)ccn1,IC50,7.64,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,JLLAMEOULOFCQI-UHFFFAOYSA-N
CHEMBL2172636,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccnc4)cn23)n1,IC50,7.92,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,TVEHRMCNBMAAEH-UHFFFAOYSA-N
CHEMBL2172639,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccc(F)c4)cn23)n1,IC50,7.14,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,ZTOKQSUVJJWFOD-UHFFFAOYSA-N
CHEMBL2172638,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccccc4F)cn23)n1,IC50,7.19,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,UUUGUCCOXDAVOY-UHFFFAOYSA-N
CHEMBL2172487,,CC(=O)Nc1cccc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)c1,IC50,6.94,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,ZOHYOLFOCULNKX-UHFFFAOYSA-N
CHEMBL315414,,COc1cc(OC)c2cc(-c3ccc(O)cc3)c(=O)n(C)c2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,ZDDUTRUNORAGJX-UHFFFAOYSA-N
CHEMBL82808,,COc1cc(OC)c2cc(-c3ccc(O)cc3)c(O)nc2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,GPCBCTZRCDKMOS-UHFFFAOYSA-N
CHEMBL112299,,Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1,IC50,8.4,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,DCQTZTFWQIEXHS-VXKWHMMOSA-N
CHEMBL409,BICALUTAMIDE,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,IC50,4.14,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,LKJPYSCBVHEWIU-UHFFFAOYSA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,6.33,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,5.06,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL6067492,BLEOMYCIN,,IC50,4.4,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,
CHEMBL1927610,,CN(C)CCN1C(=O)c2cccc3c2c(cc2nnn(C)c23)C1=O,IC50,6.35,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AEOMJRRZAWZFQF-UHFFFAOYSA-N
CHEMBL1081831,,N[C@H](CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.2,CHEMBL1102927,Cytotoxicity against human U87MG cells after 3 days by alamar blue assay,U-87MG ATCC,XPPKIHZJFAAJLB-INIZCTEOSA-N
CHEMBL316168,,CCN(CC)C(=O)Cn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,CNUXSSQGSIPTFQ-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.91,CHEMBL1955142,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL599424,,C#CCc1c(O)cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,EC50,5.89,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,RQPZMGVXRCJPRD-RSOHHRNFSA-N
CHEMBL598811,,C=CCc1c(O)cc(/C=C/c2cc3c(c(OC)c2)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,EC50,5.77,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,HBUUYTBAEDPLTF-RSOHHRNFSA-N
CHEMBL189584,PD-173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,IC50,5.77,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,DXCUKNQANPLTEJ-UHFFFAOYSA-N
CHEMBL106790,,CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.36,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,AKFKVWRGZGPBHW-PJJLUWSFSA-N
CHEMBL112760,,CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.55,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,VCJCJIKWNXQAAJ-BXVZCJGGSA-N
CHEMBL324671,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.92,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,VCJCJIKWNXQAAJ-URGPHPNLSA-N
CHEMBL1822053,,O=S(=O)(Nc1cc(-c2ccc3ncsc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.11,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,KUFZSPXXONLZCF-UHFFFAOYSA-N
CHEMBL1914712,,O=S(=O)(Nc1cc(-c2ccc3ncccc3n2)cnc1Cl)c1ccc(F)cc1,IC50,6.11,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,WYYOJVMTMUWNGA-UHFFFAOYSA-N
CHEMBL1914716,,O=S(=O)(Nc1cc(-c2ccc3ncncc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.64,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,FDCNRCBAXUDBRG-UHFFFAOYSA-N
CHEMBL1914734,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCCc4ccccc4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.62,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,NISINSDPCKGKBV-UHFFFAOYSA-N
CHEMBL324780,,CC(=O)Nc1ccnc2c1C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,7.22,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,HOHZUMHEHJGFEE-UHFFFAOYSA-N
CHEMBL103807,,O=C1c2cccnc2C(=O)c2ncc(CO)cc21,IC50,6.52,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,ZKEHMUGJKIDIOH-UHFFFAOYSA-N
CHEMBL1170263,,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,IC50,5.71,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,ZFGTXXFHVWNYLH-IBGZPJMESA-N
CHEMBL406863,,NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.23,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,QOZMRRGNAZNWDN-UHFFFAOYSA-N
CHEMBL236390,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)[C@@]4(F)CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.94,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,VJJYWDCQJZRPAN-XJGQKTCCSA-N
CHEMBL2146208,"cis-Dichloro[(2S,3R,4S)-2-aminomethyl-3,4-dihydroxypyrrolidine]platinum (II)",,IC50,4.83,CHEMBL822894,In vitro cytotoxicity against CNS cancer XF 498 cell lines,XF 498,
CHEMBL1165315,,COc1cc(C(=O)O[C@@H]2CCCC[C@H]2OC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.16,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CJJVDYUOTKHCBA-QZTJIDSGSA-N
CHEMBL1164769,,COc1cc(C(=O)OCC#CCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.14,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,XKOVVSUTLGCEFP-UHFFFAOYSA-N
CHEMBL1163850,,COc1ccc(C(=O)OCCCCCCCOC(=O)c2ccc(OC)c(O)c2)cc1O,IC50,4.51,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,WBYUPSSWONGLLF-UHFFFAOYSA-N
CHEMBL1163848,,COc1cc(C(=O)OCCCCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.5,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,JBWXEGPMCYLSHT-UHFFFAOYSA-N
CHEMBL239423,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)ncc(F)c12,IC50,7.1,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,IAXDMWLLSCYANC-UHFFFAOYSA-N
CHEMBL439564,,C[C@@H]1CN(C(=O)c2ccn(C)n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.62,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DYNYBLGPTLDVGR-GFCCVEGCSA-N
CHEMBL3092911,,Cn1c2cnc1ONC(=O)CCCCCCCCCOc1ccccc1-2,IC50,4.19,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,SDJYAZMSSOETBA-UHFFFAOYSA-N
CHEMBL1224208,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.4,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,HCDMYGHVGDBONW-SJOMWMNGSA-N
CHEMBL1097312,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)NCC(=O)OCCOCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.13,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,RLWAAPCVGFLZKM-ZIDCOHPLSA-N
CHEMBL139942,,Cc1ccc2c(O)nc(-c3ccccc3C)cc2c1,IC50,5.7,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,JFNDUQYQBKMAEG-UHFFFAOYSA-N
CHEMBL141254,,Cc1ccc(-c2cc3cc(C)ccc3c(O)n2)cc1,IC50,4.95,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,KYDUBVYKIUREAK-UHFFFAOYSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.7,CHEMBL3297406,Antiproliferative activity against human U87 cells after 72 hrs,U-87MG ATCC,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL3291067,,CCC1=C[C@@H]2CN(C1)C[C@H](CN1CCC[C@H]1C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.6,CHEMBL3297406,Antiproliferative activity against human U87 cells after 72 hrs,U-87MG ATCC,UJSDIMPPELQZCW-TZZICCFCSA-N
CHEMBL223782,,O=C(CC1CN(C(=O)c2ccco2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.17,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LODDVTSCZXYADZ-UHFFFAOYSA-N
CHEMBL223384,,CNC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PIQCDPVLMAIZFH-UHFFFAOYSA-N
CHEMBL3343382,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.96,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OIIPGLWIAWFBQK-UHFFFAOYSA-N
CHEMBL3343383,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.6,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WRHLIOGWJHQBHX-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,5.14,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL515416,,Cc1ccc(-c2c(C(=O)CCl)n(CCCO)c3ncnc(N)c23)cc1,IC50,4.5,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,PELFTNQHGSITLB-UHFFFAOYSA-N
CHEMBL379300,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,IC50,6.94,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,YWTBGJGMTBHQTM-IBGZPJMESA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,6.52,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL412142,LADUVIGLUSIB,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,IC50,4.32,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AQGNHMOJWBZFQQ-UHFFFAOYSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,4.49,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,7.49,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,6.17,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL1023,BEXAROTENE,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,IC50,4.97,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NAVMQTYZDKMPEU-UHFFFAOYSA-N
CHEMBL191384,,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,IC50,5.28,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AVLYNJZZQYEFEA-XDJHFCHBSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,5.29,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,4.55,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,RDSACQWTXKSHJT-UHFFFAOYSA-N
CHEMBL521686,OLAPARIB,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,IC50,4.32,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,FDLYAMZZIXQODN-UHFFFAOYSA-N
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,5.0,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,RITAVMQDGBJQJZ-FMIVXFBMSA-N
CHEMBL189584,PD-173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,IC50,4.32,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,DXCUKNQANPLTEJ-UHFFFAOYSA-N
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,5.24,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,CEGSUKYESLWKJP-UHFFFAOYSA-N
CHEMBL505699,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,5.78,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,XYNAVBNWRSKIDD-RNBUTDDUSA-N
CHEMBL1782906,,CCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.37,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,LOWADNGIIGYMOB-QNMIOERPSA-N
CHEMBL563437,,CC(=O)Oc1ccc(/C=C/c2cc(F)cc(F)c2)cc1,IC50,4.22,CHEMBL1053287,Anticancer activity against human SNB75 cells,SNB-75,DZZTWCXKYNKNQY-NSCUHMNNSA-N
CHEMBL3359305,,C=C(CCCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.61,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,LWABSVMRKSAHOW-LWXWOMNKSA-N
CHEMBL3359306,,C=C(CCCC(C)(C)OC(=O)CCl)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,5.0,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,UPLCUOLYACCTIC-LWXWOMNKSA-N
CHEMBL1652079,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccccc3O)[nH]c21,IC50,5.41,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PXQACXGBBNTXJM-UHFFFAOYSA-N
CHEMBL155771,,CC(C)CCC1=C(O)C(=O)c2ccccc2C1=O,IC50,4.69,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CBIBTBSDPZSTOE-UHFFFAOYSA-N
CHEMBL1652067,,C=C1C2=C(CCCC2)C(=O)C(OC2(CCC(C)C)C(=O)C(=O)C3=C(CCCC3)C2=O)=C1CCC(C)C,IC50,5.0,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QOOFFZTYUAIZLG-UHFFFAOYSA-N
CHEMBL1652074,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccccc3F)[nH]c21,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HBMPNWGFWNUSJV-UHFFFAOYSA-N
CHEMBL1652078,,Cc1cccc(-c2nc3ccc4c(c3[nH]2)C(=O)c2ccccc2C4=O)c1,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZPORFQBPMNEZCQ-UHFFFAOYSA-N
CHEMBL383961,,O=c1c2cccc3c2sn1CCNCCOc1cccc2nc(O)c-3nc12,IC50,6.22,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,DZSJECNZKMWWQI-UHFFFAOYSA-N
CHEMBL448434,,C=CCN(C)CCCCC[C@H]1CC[C@H](N(C)C(=O)Oc2ccc(C(F)(F)F)cc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O,IC50,5.08,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,MUWQVRLDCKDCPR-URGWDIIDSA-N
CHEMBL324162,,C=CCN(C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1.O=C(O)/C=C/C(=O)O,IC50,5.06,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,XCYAYLWZCRGKDS-WLHGVMLRSA-N
CHEMBL2172486,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncnc4C)cn23)n1,IC50,7.24,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,FEKALHVHQQPGPI-UHFFFAOYSA-N
CHEMBL514869,,CC1(C)CNC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1,IC50,5.46,CHEMBL989183,Antiproliferative activity against human U87-MG cells,U-87MG ATCC,ZCCMLCRXWWFYEG-HNNXBMFYSA-N
CHEMBL121802,,COc1ccnc2c1C(=O)c1nc3ccccc3c3ccnc-2c13,IC50,6.3,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,NPMBMAQAWUDHLX-UHFFFAOYSA-N
CHEMBL166487,,COCCOCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.39,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,AUEXEZJNTMMGJV-UHFFFAOYSA-N
CHEMBL1164847,,CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl,IC50,5.9,CHEMBL1169191,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NKLGZZXEURDTLU-UHFFFAOYSA-N
CHEMBL1095627,,CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1,IC50,7.92,CHEMBL1104677,Antiproliferative activity against human U87MG cells,U-87MG ATCC,OHKRUKRKVNWNNT-UHFFFAOYSA-N
CHEMBL1823147,,COc1cc(C(=O)c2c(C)oc3c(O)c(OC)ccc23)cc(OC)c1OC,IC50,9.39,CHEMBL1828312,Antiproliferative activity against human U87MG after 48 hrs by spectrophotometry,U-87MG ATCC,RADMJHVVIZTENA-UHFFFAOYSA-N
CHEMBL51483,GOSSYPOL,Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,IC50,4.52,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QBKSWRVVCFFDOT-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.1,CHEMBL2061954,Antiproliferative activity against human U87MG cells after 48 hrs by XTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL124315,,O=C1c2cccnc2-c2nccc3c2c1nc1cc(Br)ccc13,IC50,6.3,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,CPXBDTZAJSRIKJ-UHFFFAOYSA-N
CHEMBL1080569,,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,EC50,6.42,CHEMBL1104227,Cytotoxicity against human U87MG cells after 3 days by alamar blue staining,U-87MG ATCC,WZOVTPHXONVIIJ-SFHVURJKSA-N
CHEMBL1224359,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(N)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.92,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,NUMDCZFKPVPXKE-SJOMWMNGSA-N
CHEMBL1927616,,CCCCn1nnc2cc3c4c(cccc4c21)C(=O)N(CCCN(C)C)C3=O,IC50,5.2,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CDIILIISLKWYOH-UHFFFAOYSA-N
CHEMBL561281,LUMISANTONIN,C[C@@H]1C(=O)O[C@H]2[C@H]1CC[C@]1(C)C3(C)C(=O)C=CC231,IC50,4.16,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DAGAGXCQQYCLAE-VADQIUEASA-N
CHEMBL61102,,COc1ccc(C2C(OC(C)=O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1N,IC50,6.84,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,URXLBKJEOVKBRG-UHFFFAOYSA-N
CHEMBL3659990,,O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F,IC50,5.1,CHEMBL4220076,Antiproliferative activity against human U87 cells,U-87MG ATCC,PVMIBRDKTVSNOE-UHFFFAOYSA-N
CHEMBL4225608,,CCCC(=O)Nc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)sc2n1,IC50,5.64,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,OCZKWWSNGOLFQE-UHFFFAOYSA-N
CHEMBL324643,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.96,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KFNRGFZWGOCXDB-TVKQRKNISA-N
CHEMBL1095527,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(-c3ccc(F)cc3)nn2)[C@H]1Br,IC50,5.75,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NRONRYWDUHRKEF-PGRDOPGGSA-N
CHEMBL1095548,,COc1ccc(-c2cn([C@H]3C4=C(OC(C)(C)[C@@H]3Br)c3ccccc3C(=O)C4=O)nn2)cc1,IC50,5.52,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WMMRPQPHXVNHGI-WMZHIEFXSA-N
CHEMBL1095549,,CC(C)=CCC1=C(OC2(CC=C(C)C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.99,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VJAAOWAHJDQBCD-UHFFFAOYSA-N
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,5.39,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL5220190,,CCOC(=O)c1c(NC(=O)CC#N)sc(C(=O)Nc2ccc(Cl)cc2)c1-c1ccccc1,IC50,6.37,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,UTBGHGVZAUCAKQ-UHFFFAOYSA-N
CHEMBL5220279,,CCOC(=O)c1c(N)sc(C(=O)Nc2ccccc2)c1-c1ccccc1,IC50,5.13,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,BAUNUTNFPSWYHZ-UHFFFAOYSA-N
CHEMBL5270178,,C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)cc2)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261885,Cytotoxicity against human T98G cells measured after 8 days,T98G,JGOZUFGBTSAWEI-NSCUHMNNSA-N
CHEMBL1643048,,CCNC(=O)OCc1c(COC(=O)NCC)c(-c2ccc(OC)cc2)n2c1Cc1ccccc1C2,IC50,4.77,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,DPYIEPVHRLMFQA-UHFFFAOYSA-N
CHEMBL321413,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1,IC50,8.68,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XBGWFPDHOIKUGB-YQCHCMBFSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.85,CHEMBL813198,In vitro cytotoxicity expressed as concentration that inhibits 50% of U87 (glioblastoma) resistant variant cell proliferation,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1807797,,CC(=O)N1CCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@H](C)C1)CC(C)(C)CC3=O,IC50,7.62,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,JNXQZEQTCNUMCM-WBVHZDCISA-N
CHEMBL1807803,,COCCC(=O)N1CCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@H](C)C1)CC(C)(C)CC3=O,IC50,7.27,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,YCWFAWGWYOUCKZ-MJGOQNOKSA-N
CHEMBL1807809,,Cc1c2c(n3c1CCN(C(=O)C1(N)CCCC1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.36,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,OQCZXOJFRLBCCF-QUCCMNQESA-N
CHEMBL313230,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC(=O)OCc3ccccc3)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,RPVDOUORCPXFHC-UHFFFAOYSA-N
CHEMBL1087476,,Cn1cc(NC(=O)CCCCCCCCCCCN)c(-c2ccccn2)n1,IC50,4.05,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,JMEQPFASHHJIDA-UHFFFAOYSA-N
CHEMBL109158,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1,IC50,9.3,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,SIGNOFGQWWUQJS-QCWLDUFUSA-N
CHEMBL323454,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1,IC50,7.12,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,IYUGABYSRYTCQT-UHFFFAOYSA-N
CHEMBL3093025,,Cn1c2cnc1OCCCCCCCCOc1cc3ccccc3cc1-2,IC50,4.5,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,QGVMDYASGGDBIO-UHFFFAOYSA-N
CHEMBL3093030,,Cn1c2cnc1OCCCCCCCCOc1ccccc1-2,IC50,4.08,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GOQRJMXCBGQPQO-UHFFFAOYSA-N
CHEMBL3114587,,CC1(C)CC(Nc2ccc(I)cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.04,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,BYEGKHWKKSCKSO-UHFFFAOYSA-N
CHEMBL373751,GSK-319347A,COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC,IC50,4.08,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,LDTAHRLHGHFHKP-UHFFFAOYSA-N
CHEMBL1090771,AVAGACESTAT,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,IC50,4.45,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,XEAOPVUAMONVLA-QGZVFWFLSA-N
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,6.1,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,PQAPVTKIEGUPRN-UHFFFAOYSA-N
CHEMBL1173055,RUCAPARIB,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.86,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,HMABYWSNWIZPAG-UHFFFAOYSA-N
CHEMBL2144069,,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,IC50,5.01,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,ZGBGPEDJXCYQPH-UHFFFAOYSA-N
CHEMBL572878,TOZASERTIB,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,IC50,5.0,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,GCIKSSRWRFVXBI-UHFFFAOYSA-N
CHEMBL325041,BORTEZOMIB,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,IC50,9.04,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,GXJABQQUPOEUTA-RDJZCZTQSA-N
CHEMBL1673039,,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,IC50,5.13,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,DDTPGANIPBKTNU-UHFFFAOYSA-N
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,4.01,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,CTESJDQKVOEUOY-UHFFFAOYSA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,6.13,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,7.08,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,PQAPVTKIEGUPRN-UHFFFAOYSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.72,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.26,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,6.25,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,4.39,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JWQOJVOKBAAAAR-UHFFFAOYSA-N
CHEMBL191384,,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,IC50,4.85,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AVLYNJZZQYEFEA-XDJHFCHBSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.42,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL443684,NAVITOCLAX,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,IC50,4.73,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JLYAXFNOILIKPP-KXQOOQHDSA-N
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,5.05,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,GFMMXOIFOQCCGU-UHFFFAOYSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,6.61,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,7.46,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,5.7,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AHJRHEGDXFFMBM-UHFFFAOYSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.07,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL4066144,,O=C(O)c1cc2nc(N3CCOCC3)nc(N3CCOCC3)c2s1,IC50,5.61,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,LYAOGFDLXPWLNU-UHFFFAOYSA-N
CHEMBL2165005,,COc1ccc(Nc2ncc(CN3CCS(=O)(=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.92,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,NYHQXLSMSMLVGN-UHFFFAOYSA-N
CHEMBL2165028,,COCCNCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1,IC50,6.82,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,JRWLTKDVIINVLC-UHFFFAOYSA-N
CHEMBL2165006,,COc1ccc(Nc2ncc(Cc3ccccc3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.16,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,CGJYZCCLUUIRAJ-UHFFFAOYSA-N
CHEMBL2165010,,COc1ccc(Nc2ncc(CN3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.89,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,OIPZJHZMJMKKBK-UHFFFAOYSA-N
CHEMBL2164704,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](Cc3ccc(F)cc3)c(C)c21.[Br-],IC50,5.24,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,SIVFFLFLAHGUGB-UHFFFAOYSA-M
CHEMBL2164702,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](Cc3ccccc3)c(C)c21.[Br-],IC50,5.77,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FWTWQWOYZONKGF-UHFFFAOYSA-M
CHEMBL23293,SALIRASIB,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O,IC50,4.27,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WUILNKCFCLNXOK-CFBAGHHKSA-N
CHEMBL2165012,,COc1ccc(Nc2ncc(CN3CC[C@@H](CO)C3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.41,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,NOEYFOUOAVCIAX-CQSZACIVSA-N
CHEMBL2165008,,COc1ccc(Nc2ncc(CN3CCCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.66,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,KPKRMMWVCSAMKZ-UHFFFAOYSA-N
CHEMBL2164703,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](Cc3ccccc3F)c(C)c21.[Br-],IC50,5.75,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,VJJUFPUKYWKJQJ-UHFFFAOYSA-M
CHEMBL2164719,,Cc1c2c(cc[n+]1CCc1ccccc1)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,5.62,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DNGGRJSXRCAZDO-UHFFFAOYSA-M
CHEMBL2164717,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,6.43,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,QFZTVBUSKCUSJG-UHFFFAOYSA-M
CHEMBL2164715,,Cc1c2[nH]c3cc(OCc4ccccc4)ccc3c2cc[n+]1Cc1ccccc1.[Br-],IC50,5.25,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,GYPXDFJYZGSDLJ-UHFFFAOYSA-N
CHEMBL2164710,,Cc1nccc2c3ccc(OCc4cccc(F)c4)cc3n(Cc3cccc(F)c3)c12,IC50,4.57,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,YLPZZFNUBHIQQA-UHFFFAOYSA-N
CHEMBL2164707,,Cc1nccc2c1[nH]c1cc(OCc3cccc4ccccc34)ccc12,IC50,4.92,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,UDUMVLIVSFJGGL-UHFFFAOYSA-N
CHEMBL1645553,,Cc1nccc2c1[nH]c1cc(OCc3ccncc3)ccc12,IC50,5.44,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,JAZIJXBWEKKRAM-UHFFFAOYSA-N
CHEMBL1645552,,Cc1nccc2c1[nH]c1cc(OCc3cccnc3)ccc12,IC50,4.54,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DBVRCFMRLBRLQE-UHFFFAOYSA-N
CHEMBL1645549,,Cc1nccc2c1[nH]c1cc(OCc3ccccc3)ccc12,IC50,4.77,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,CGOCGPOAPLNJFM-UHFFFAOYSA-N
CHEMBL1645548,,Cc1nccc2c1[nH]c1cc(OCC3CCCCC3)ccc12,IC50,5.14,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,XPNBZXYLKBNCSU-UHFFFAOYSA-N
CHEMBL1645545,,Cc1nccc2c1[nH]c1cc(OCC(C)C)ccc12,IC50,4.66,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,VRVCIYIVKIFEPH-UHFFFAOYSA-N
CHEMBL1089308,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3OC(=O)CCCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)CCCC(=O)O[C@H]3[C@H](O[C@@H]5c6cc7c(cc6[C@@H](c6cc(OC)c(OC(=O)CN(C)C)c(OC)c6)[C@H]6C(=O)OC[C@@H]65)OCO7)O[C@@H]5CO[C@@H](C)O[C@H]5[C@@H]3O)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCNC(=O)CCCC(=O)O[C@H]3[C@H](O[C@@H]5c6cc7c(cc6[C@@H](c6cc(OC)c(OC(=O)CN(C)C)c(OC)c6)[C@H]6C(=O)OC[C@@H]65)OCO7)O[C@@H]5CO[C@@H](C)O[C@H]5[C@@H]3O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC(=O)CN(C)C,IC50,6.48,CHEMBL1103642,Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay,U-87MG ATCC,XFDBHMKNWWTEFD-KBLHWHQNSA-N
CHEMBL1807790,,Cc1c2c(n3c1CCCN[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.21,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,NPICSXCYDBJDTM-HOTGVXAUSA-N
CHEMBL1807795,,Cc1c2c(n3c1CCN(CCO)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.26,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KVCRXCKHFUBLBP-AEFFLSMTSA-N
CHEMBL1807800,,Cc1c2c(n3c1CCCN(C(=O)CO)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.96,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,GUYAKTTZJAARFK-IRXDYDNUSA-N
CHEMBL1738703,,Cc1c2c(n3c1CCCNC[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.44,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,DGOVAFNEOBXFEF-AWEZNQCLSA-N
CHEMBL1801525,,NCCC(=O)Nc1csc2c1C(=O)c1ccccc1C2=O.O=C(O)C(F)(F)F,IC50,5.55,CHEMBL1803379,Antitumor activity against human SF295 cells after 24 to 48 hrs by MTT assay,SF295,WBFRIIZROPKMQJ-UHFFFAOYSA-N
CHEMBL318721,,CCC(CC)n1ccc2c3c(N)nc(N)nc3ccc21,IC50,8.1,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,GCPJCLJGTVTGRF-UHFFFAOYSA-N
CHEMBL2164402,,Cc1c2c(cc[n+]1CCC(C)C)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,5.92,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,LORBSHDWYPHBDQ-UHFFFAOYSA-M
CHEMBL2164720,,CCC[n+]1ccc2c3ccc(OCc4ccccc4)cc3n(Cc3ccccc3)c2c1C.[Br-],IC50,4.96,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,XEXWDDVPJQEIJG-UHFFFAOYSA-M
CHEMBL3358285,,Cc1nc(N)nc(-c2cc(C(C)(C)O)cnc2Nc2cncc(S(C)(=O)=O)c2)n1,IC50,5.94,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,RFOXDJCJLFNLBY-UHFFFAOYSA-N
CHEMBL3357868,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.89,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JTIBGKGGRQKKJP-UHFFFAOYSA-N
CHEMBL3357865,,COc1ncc(Nc2ncc([C@@H](C)O)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.7,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,RFMMTRCKHHKIJM-MRVPVSSYSA-N
CHEMBL3343372,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FLHSLGFLDYONEF-UHFFFAOYSA-N
CHEMBL1096180,,O=C(CCCCCCCCCCS)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.05,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,DAPWSEDEJZAZHD-UHFFFAOYSA-N
CHEMBL85989,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCCC#N)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,QCKSYPIYXKRMJG-UHFFFAOYSA-N
CHEMBL314863,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC#N)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,FLSXZIXQFOPKOC-UHFFFAOYSA-N
CHEMBL5416410,DASATINIB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O,IC50,4.26,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,XHXFZZNHDVTMLI-UHFFFAOYSA-N
CHEMBL300389,,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,IC50,5.42,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,IYNDTACKOAXKBJ-UHFFFAOYSA-N
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,4.95,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,RDSACQWTXKSHJT-UHFFFAOYSA-N
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,4.82,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,GFMMXOIFOQCCGU-UHFFFAOYSA-N
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,4.66,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,AHJRHEGDXFFMBM-UHFFFAOYSA-N
CHEMBL244452,,CC(COc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O)N(C)C,IC50,6.85,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,MHLDFTSFDRBGTQ-UHFFFAOYSA-N
CHEMBL941,IMATINIB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.01,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,KTUFNOKKBVMGRW-UHFFFAOYSA-N
CHEMBL213100,,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1,IC50,5.76,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,NBTNHSGBRGTFJS-UHFFFAOYSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.92,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL337547,,Cc1ccc2c(S)nc(-c3ccccc3)cc2c1,IC50,5.04,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,RRJXVVWHJOHBHM-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,6.85,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL15192,LAPACHONE,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.04,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QZPQTZZNNJUOLS-UHFFFAOYSA-N
CHEMBL572083,,COc1ccc(NC2C3C(=O)C(=O)c4ccccc4C3OC2(C)C)c([N+](=O)[O-])c1,IC50,5.75,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,LPJIUFZAZCYEPO-UHFFFAOYSA-N
CHEMBL263664,,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,5.3,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,RZIDZIGAXXNODG-UHFFFAOYSA-N
CHEMBL259998,,NC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,5.33,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,ZYRDOEVRNXUXJJ-UHFFFAOYSA-N
CHEMBL550042,,CCc1c(CO)c(CO)c2n1-c1ccccc1C2,IC50,4.74,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,TXHCNERZHOYNLK-UHFFFAOYSA-N
CHEMBL497610,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)OCc1ccccc1,IC50,4.52,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,QFZPEVVEVPCUQT-JYPYDPOKSA-N
CHEMBL407718,,Fc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,IC50,7.12,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,MYTFOQDJGMLDRY-UHFFFAOYSA-N
CHEMBL608114,,C[C@@]12CCC[C@H]1[C@@H]1CCc3cc(O)c(NC=O)cc3[C@H]1CC2,IC50,4.37,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,DYFCAFGQZNSPOB-MVWRLGRASA-N
CHEMBL5435752,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(S(=O)(=O)c3ccc(/C=C/C(=O)NO)cc3)CC1)C2,IC50,4.77,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,JPKJGEMGVPIVPZ-VMPITWQZSA-N
CHEMBL5423994,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3cccc(NC(=O)CCCCCCC(=O)NO)c3)CC1)C2,IC50,5.31,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,WCCIPIPPRWMNTJ-UHFFFAOYSA-N
CHEMBL3115967,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4ccccc4)nn3)[C@@H]2CC1,IC50,4.68,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,FERFPBUFCCVQNY-VMAZJTETSA-N
CHEMBL568180,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCNC(=O)CC[C@H](NC(=O)CC[C@H]3O[C@@H]4O[C@]5(C)CC[C@H]6[C@H](C)CCC([C@H]3C)[C@@]46OO5)C(=O)NCC[C@H]3O[C@@H]4O[C@]5(C)CC[C@H]6[C@H](C)CCC([C@H]3C)[C@@]46OO5)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,4.94,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,XGNWNLOBVKYAFF-FLSZHKJKSA-N
CHEMBL469099,,CC1(C)CC(=O)c2sc(N3CCOCC3)nc2C1,IC50,4.96,CHEMBL989183,Antiproliferative activity against human U87-MG cells,U-87MG ATCC,DZXMARZBAUMWLK-UHFFFAOYSA-N
CHEMBL5435760,,O=C(C#Cc1ccccc1)Nc1cc(-c2ccsc2)ccc1F,IC50,5.22,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,WIRSQLGKCLDYSJ-UHFFFAOYSA-N
CHEMBL2311578,,Cc1cc(OCc2nnc(SC3CCCC3)n2-c2cccnc2)ccc1-c1ccc(S(C)(=O)=O)cc1,IC50,5.21,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,UJGTUKMAJVCBIS-UHFFFAOYSA-N
CHEMBL5396390,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCCCN1CCOCC1,IC50,7.82,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,CMRWPDQPAFWOQN-UHFFFAOYSA-N
CHEMBL5281194,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],IC50,4.01,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,YBQNXTFBUCVWQQ-NBTZWHCOSA-M
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.0,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1673039,,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,IC50,4.8,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,DDTPGANIPBKTNU-UHFFFAOYSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,5.03,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,4.73,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,6.4,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL38,TRETINOIN,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,IC50,4.68,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,SHGAZHPCJJPHSC-YCNIQYBTSA-N
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,4.32,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,JAMULYFATHSZJM-UHFFFAOYSA-N
CHEMBL269277,BETULINIC ACID,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.21,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,QGJZLNKBHJESQX-FZFNOLFKSA-N
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,4.73,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL1673039,,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,IC50,4.63,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,DDTPGANIPBKTNU-UHFFFAOYSA-N
CHEMBL259181,,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,IC50,4.49,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,DOKZLKDGUQWMSX-HKBQPEDESA-N
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,6.77,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,PHXJVRSECIGDHY-UHFFFAOYSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,5.5,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,5.27,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,5.81,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL1164847,,CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl,IC50,4.96,CHEMBL1169194,Growth inhibition of human SNB75 cells after 48 hrs by sulforhodamine B assay,SNB-75,NKLGZZXEURDTLU-UHFFFAOYSA-N
CHEMBL4079222,,COc1cc(CO)c(Br)c(Br)c1OCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IC50,4.95,CHEMBL4026219,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,HVZPIWMCNYUSFV-DSPGLSBSSA-N
CHEMBL136737,NIMUSTINE,Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1,IC50,6.08,CHEMBL1111856,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VFEDRRNHLBGPNN-UHFFFAOYSA-N
CHEMBL255592,,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21,EC50,7.89,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ISHNPDWTQUXPSY-UHFFFAOYSA-N
CHEMBL565162,,C=C1C(=O)O[C@H]2[C@H]1CC[C@]1(C)C3(C)C(=O)C=CC231,IC50,5.67,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JQWAZWQLERJUJH-TZGSXBKUSA-N
CHEMBL5265884,,C[C@@H]1CC[C@H]2[C@@H](C)C(CCC(=O)NCCCN3CCN(CCCNC(=O)CCC4O[C@H]5O[C@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)CC3)O[C@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4,IC50,6.34,CHEMBL5257547,Antiproliferative activity against human XF498 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,XF 498,JVHGAAKZMCRLRS-OAZVRWERSA-N
CHEMBL3884836,,CCOC(=O)c1nc2ccccc2nc1C#Cc1cccc(F)c1,IC50,5.72,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QAOFJXKFKLDPCB-UHFFFAOYSA-N
CHEMBL2164398,,Cc1c2c(cc[n+]1CCO)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,5.58,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,KYNZIQWDVRSPNB-UHFFFAOYSA-M
CHEMBL1782895,,CCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.44,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,KFYBQAPIMYJCGR-LVEBQJTPSA-N
CHEMBL1782903,,CCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.32,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZPULXJOUYVMUSV-AZIXLERZSA-N
CHEMBL1782896,,CCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.09,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,MKGOTFINSHWUCP-QNMIOERPSA-N
CHEMBL1782910,,CCCCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.89,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,GEKFEXNIOALNSW-QIXIFPRPSA-N
CHEMBL15192,LAPACHONE,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.04,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QZPQTZZNNJUOLS-UHFFFAOYSA-N
CHEMBL210618,,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,IC50,4.67,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,KQMPRSZTUSSXND-UHFFFAOYSA-N
CHEMBL2134202,,CCc1cncnc1N1CCN(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)CC1,IC50,4.44,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,FBLPQCAQRNSVHB-UHFFFAOYSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,6.16,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,5.71,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.68,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,6.48,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,CTESJDQKVOEUOY-UHFFFAOYSA-N
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,4.59,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.56,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL259181,,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,IC50,4.2,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,DOKZLKDGUQWMSX-HKBQPEDESA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,7.61,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL412142,LADUVIGLUSIB,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,IC50,5.42,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,AQGNHMOJWBZFQQ-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.89,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL3794344,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCCC1,IC50,4.75,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,DWXHGPSLYBTJRB-UHFFFAOYSA-N
CHEMBL5290709,,Cn1nccc1NC(=O)Nc1ccc(-c2nc(-c3ccc(CN4CCN(S(C)(=O)=O)CC4)s3)nc(N3CCOCC3)n2)cc1,IC50,5.07,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,VXFIQWFKZBLWIN-UHFFFAOYSA-N
CHEMBL4551635,BAY-069,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1Cl,IC50,5.7,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,UNSHMXUHOHBLIQ-UHFFFAOYSA-N
CHEMBL5191892,,C[C@H](NC(=O)c1ccc2cc1OCCOCCNc1ccn3ncc-2c3n1)c1ccncc1,EC50,5.63,CHEMBL5167608,Antiproliferative activity against human T98G cells assessed as reduction in cell viability measured after 1 to 7 days by resazurin dye based fluorimetric analysis,T98G,FFVXISWLYSJERX-INIZCTEOSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,7.72,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL3343411,,CCCC[P@@]1(=O)O[C@H]([C@H]2COC(C)(C)O2)[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O,IC50,5.21,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,BASPGTBXGXQYJJ-XJPKVNQNSA-N
CHEMBL3343414,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](OS(C)(=O)=O)[C@H]2O1,IC50,5.2,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,SEURMQYJQTWTQJ-NYBGZPCFSA-N
CHEMBL3343646,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](N)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,5.53,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,YSSBDFDKGKVQQL-KLIJIXSESA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,6.26,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL3343368,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.93,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XXKOUGFWCFKCQQ-UHFFFAOYSA-N
CHEMBL3343373,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.0,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HHXLIMZXZVZKGQ-UHFFFAOYSA-N
CHEMBL3343375,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.57,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZRHBIYUNDWMKDW-UHFFFAOYSA-N
CHEMBL3343376,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.94,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZVOYCTHEUYIRPQ-UHFFFAOYSA-N
CHEMBL3343392,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.91,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UVKUURMGKLVPAN-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.04,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL2180746,,Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,IC50,6.24,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,FMROPZMGAOICAF-UHFFFAOYSA-N
CHEMBL2180740,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1c[nH]c2ccccc12)c1cccc(F)c1,IC50,6.44,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,GJJOEFRKCTWCTH-UHFFFAOYSA-N
CHEMBL4099523,,CCN1C/C(=C\c2ccc(S(F)(F)(F)(F)F)cc2)C(=O)/C(=C/c2ccc(S(F)(F)(F)(F)F)cc2)C1,IC50,6.03,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UVJVSGRLDKINCE-JYFOCSDGSA-N
CHEMBL4074549,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2Cl)ccc1OCCCCN1CCCCC1,IC50,5.21,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,JXAMDDJTHWVNQP-YRNVUSSQSA-N
CHEMBL4063094,,COc1ccc(C(=O)/C=C/c2ccc(OCCCn3nc(C)cc3C)c(OC)c2)cc1,IC50,5.16,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AXDBXRWTHYFXCA-WUXMJOGZSA-N
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,5.01,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,HVXBOLULGPECHP-WAYWQWQTSA-N
CHEMBL344607,,Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,8.74,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,QHHGCBRDJMDQEW-DHLKQENFSA-N
CHEMBL5418007,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CSCc2cccc(c2)CSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.84,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,KXMGMIKAPPHCEJ-ZBLPZKBESA-N
CHEMBL478526,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1O,IC50,5.33,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VDCLTZXJJLMWQH-UHFFFAOYSA-N
CHEMBL584338,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(F)c([N+](=O)[O-])c1,IC50,5.98,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HMKIICIVRKQVLD-UHFFFAOYSA-N
CHEMBL479011,,COc1ccc(NC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.96,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ULSOSJFIPXSKPO-UHFFFAOYSA-N
CHEMBL50418,,O=C1OCc2c(cc3n(c2=O)Cc2c-3nc3cc4c(cc3c2CCl)OCCO4)C1(O)CCO,IC50,6.41,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,HOVUHWKJLVMZLY-UHFFFAOYSA-N
CHEMBL299613,2-METHOXYESTRADIOL,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,IC50,5.07,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,CQOQDQWUFQDJMK-SSTWWWIQSA-N
CHEMBL4070551,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,8.7,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,FDGDLSJCAGGYLQ-HXVQJGFHSA-N
CHEMBL4072725,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc(C(F)(F)F)cc1)CC(C)(C)O2,IC50,4.82,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CUTXNWJTGUIISR-UHFFFAOYSA-N
CHEMBL3353051,,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,IC50,9.0,CHEMBL3383785,Antiviral activity against HIV1 isolate Hxbc2 pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,VBVXAAKYUMLCAV-UHFFFAOYSA-N
CHEMBL568150,,O=C1NC(=O)/C(=C/c2ccc3nccnc3c2)S1,IC50,6.5,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,SQWZFLMPDUSYGV-POHAHGRESA-N
CHEMBL1080569,,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.6,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,WZOVTPHXONVIIJ-SFHVURJKSA-N
CHEMBL1171647,,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,IC50,6.51,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,MOZRQQTUYAYCQT-FQEVSTJZSA-N
CHEMBL3765204,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccccc2)nn1,IC50,5.16,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MKCYQHHEJKSONF-UHFFFAOYSA-N
CHEMBL3735979,,O=C(c1ccc(I)cc1)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,IC50,8.13,CHEMBL3738637,Inhibition of PARP1 in human T98G cells incubated for 60 mins by immunofluorescence assay,T98G,QOCIPUHZHXLQMK-UHFFFAOYSA-N
CHEMBL222364,,CCOC(=O)CN1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.03,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HDVFZTUOHYYUBQ-UHFFFAOYSA-N
CHEMBL220834,,CC(C)OC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PUXXMEUMZYBGLD-UHFFFAOYSA-N
CHEMBL373919,,O=C(CC1CN(Cc2cccc3ccccc23)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.16,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HSHZHZBGDQDOAU-UHFFFAOYSA-N
CHEMBL220270,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(OC(F)(F)F)cc1,IC50,7.72,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MPMCKFDENKJOQC-UHFFFAOYSA-N
CHEMBL222362,,Cc1cc(N2CCN(C(=O)C(C)C)[C@H](CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,9.12,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BNKGEZQUYVVMBA-HXUWFJFHSA-N
CHEMBL255592,,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21,IC50,7.48,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,ISHNPDWTQUXPSY-UHFFFAOYSA-N
CHEMBL270639,,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,IC50,7.11,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,SUCAWRZDHHYRQV-UHFFFAOYSA-N
CHEMBL270640,,CCc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,EC50,6.4,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,PPMVOOTZFOABKA-UHFFFAOYSA-N
CHEMBL385786,TUBEIMOSIDE V,C[C@@H]1O[C@H]2O[C@@H]3[C@H](OC[C@@H](O)[C@H]3O)OC(=O)[C@]34CCC(C)(C)CC3C3=CCC5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@H]7O[C@@H](COC(=O)C[C@](C)(O)CC(=O)O[C@@H]1[C@@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]7O)[C@@](C)(CO)C6CC[C@@]5(C)[C@]3(C)CC4,IC50,5.44,CHEMBL910864,Antiproliferative activity against human U87MG cell line by MTT assay,U-87MG ATCC,LSUWFJVHSNDVLV-LRTBEYQQSA-N
CHEMBL5274469,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccc(OC(F)(F)F)cc4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,MCSXNLKTLHQAJJ-LBGRBXAQSA-N
CHEMBL5268246,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccccc4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,XNJGWZUITNZAMR-ZQXPYOPKSA-N
CHEMBL261342,,CC(C)n1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.85,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,OGGJXGGVMPYMPS-UHFFFAOYSA-N
CHEMBL2172489,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cnn(C5CC5)c4)cn23)n1,IC50,8.1,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,XODHFMOZHXRSNF-UHFFFAOYSA-N
CHEMBL2172485,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncnc4)cn23)n1,IC50,8.3,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,VLUBDPDZETYNRC-UHFFFAOYSA-N
CHEMBL2172481,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccccc4C)cn23)n1,IC50,7.27,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,ADTCCVMJGTXFQL-UHFFFAOYSA-N
CHEMBL2172480,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccnc4C)cn23)n1,IC50,8.0,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,LFOJPPGMFCXNEE-UHFFFAOYSA-N
CHEMBL2172640,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccncc4)cn23)n1,IC50,7.58,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,LDNZOZBLULAYOM-UHFFFAOYSA-N
CHEMBL5220279,,CCOC(=O)c1c(N)sc(C(=O)Nc2ccccc2)c1-c1ccccc1,IC50,5.13,CHEMBL5326861,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth,U-87MG ATCC,BAUNUTNFPSWYHZ-UHFFFAOYSA-N
CHEMBL5284457,,COc1cc(Nc2ccc3nnc(-c4nccs4)n3c2)cc(OC)c1OC,IC50,4.31,CHEMBL5224863,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth,T98G,IMTOIRJXYCGONG-UHFFFAOYSA-N
CHEMBL4551635,BAY-069,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1Cl,IC50,5.75,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,UNSHMXUHOHBLIQ-UHFFFAOYSA-N
CHEMBL5273682,,Cc1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.69,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,PDEPOPSZQUSURL-UHFFFAOYSA-N
CHEMBL5283623,,Brc1cccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)c1,IC50,4.83,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,ZLSBTTYHBILXSY-UHFFFAOYSA-N
CHEMBL473840,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC(=O)[C@H](C(C)C)NC1=O,IC50,8.26,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,DIDDMMTUXXHTQR-FELOTHHLSA-N
CHEMBL567524,,COC(=O)[C@@H](CS)N(Cc1ccccc1)C(=O)CC[C@H]1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CCC([C@H]1C)[C@@]24OO3,IC50,5.58,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,YTECTWXLJCDTEL-DOCXZMLISA-N
CHEMBL569027,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCNC(=O)CC[C@H]3O[C@@H]4O[C@]5(C)CC[C@H]6[C@H](C)CCC([C@H]3C)[C@@]46OO5)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,5.24,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,QDNYGRJDRIMPOK-BRHROXOMSA-N
CHEMBL478508,,Oc1ccc(CN(Cc2ccccc2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,6.6,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,LWPMUMIMHKHREW-UHFFFAOYSA-N
CHEMBL5437073,,COc1ccc([C@H]2[C@@H](C)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1/C=C/C(=O)NO,IC50,7.64,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,JFCXSUQGICXKPN-HVCBVEAFSA-N
CHEMBL551288,APOGOSSYPOL,Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O,IC50,4.45,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,PBJKWGWHZVXBGU-UHFFFAOYSA-N
CHEMBL220064,,O=C(CC1CCCCN1c1cc(-c2ccccc2)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.17,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,GBJQTVOLZGSIES-UHFFFAOYSA-N
CHEMBL600476,,O=C(Nc1nonc1NC(=O)c1ccc(C(F)(F)F)cc1)c1ccc(C(F)(F)F)cc1,IC50,4.84,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,KTXZEAQHXYYZGJ-UHFFFAOYSA-N
CHEMBL386467,,O=c1c2cccc(-c3nc4ccccc4nc3O)c2sn1C1CCCC1,IC50,6.51,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,IWNSRJDVPQNPCB-UHFFFAOYSA-N
CHEMBL5428666,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CCCC1,IC50,6.9,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RKBZFSLRVDPBOO-UHFFFAOYSA-N
CHEMBL464587,,C=C1C(=O)O[C@H]2[C@H]1C[C@@H](O)/C(C)=C/CC[C@@]1(C)O[C@@H]21,IC50,4.96,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,RZUCCKARTVHQBW-ZFDNOKKTSA-N
CHEMBL3393284,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CN)cc2)nc2nccn12,IC50,6.66,CHEMBL3395180,Inhibition of colony formation in human U87MG cells after 2 weeks by crystal violet staining-based assay,U-87MG ATCC,OERMTVRXFMLUOQ-UHFFFAOYSA-N
CHEMBL1224134,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.3,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,GSBQZUZJHLMNEB-IMKSHNIHSA-N
CHEMBL163078,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1,IC50,9.13,CHEMBL815089,Concentration required to inhibit the entry of HIV-1 reported virus (ADA) into U-87 cells,U-87MG ATCC,KRBMMTDOLHPSPA-UHFFFAOYSA-N
CHEMBL315088,,COC(=O)CCn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,ZTYRLNIVULKCEA-UHFFFAOYSA-N
CHEMBL2170099,,COc1ncc(Nc2ncc([C@H](C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.15,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,KUGIFHQBIIHRIZ-ZDUSSCGKSA-N
CHEMBL2170097,,Cc1nc(N)nc(-c2cc(CN3CCN(S(C)(=O)=O)CC3)cnc2Nc2cncc(F)c2)n1,IC50,7.64,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,MLKLYQDMHYWKGW-UHFFFAOYSA-N
CHEMBL2170094,,Cc1nc(N)nc(-c2cc(CN3CCN(S(C)(=O)=O)CC3)cnc2Nc2ccc(C(F)(F)F)nc2)n1,IC50,6.62,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,POILOEPNLLDHRQ-UHFFFAOYSA-N
CHEMBL3809213,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccccc4)n3)ccc21,IC50,4.85,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,ONFLBPIRWOZEJY-HZHRSRAPSA-N
CHEMBL168215,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(CCO)C(=O)OCc1ccccc1,IC50,5.72,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,YXPPZMUXQULDJR-UHFFFAOYSA-N
CHEMBL244396,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2C(F)(F)F)n1,IC50,6.66,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,LWYVGRHQPVLTAP-UHFFFAOYSA-N
CHEMBL244397,,c1cn(-c2ccc(Oc3cc(N4CCOCC4)nc(Cc4ccc5c(c4)OCO5)n3)cc2)cn1,IC50,6.08,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,WGFLIJQCXCLGRO-UHFFFAOYSA-N
CHEMBL243977,,Cc1c(F)c(Oc2ccc(-n3ccnc3)cc2)nc(Oc2ccc3c(c2)OCO3)c1F,IC50,6.35,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,CMSNMPXPGHEGBH-UHFFFAOYSA-N
CHEMBL1643027,,Cc1c(CO)c(CO)c2n1Cc1ccccc1C2,IC50,4.55,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,BVWJQOIYMKGOCN-UHFFFAOYSA-N
CHEMBL1643044,,CCNC(=O)OCc1c(COC(=O)NCC)c(-c2ccc(F)cc2)n2c1Cc1ccccc1C2,IC50,4.55,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,IVPXJJIXPOAQMQ-UHFFFAOYSA-N
CHEMBL43064,CINNARIZINE,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,IC50,4.87,CHEMBL1226546,Antiproliferative activity against human U87MG cells after 120 hrs by MTT assay,U-87MG ATCC,DERZBLKQOCDDDZ-JLHYYAGUSA-N
CHEMBL1448,NICLOSAMIDE,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,IC50,6.4,CHEMBL1226546,Antiproliferative activity against human U87MG cells after 120 hrs by MTT assay,U-87MG ATCC,RJMUSRYZPJIFPJ-UHFFFAOYSA-N
CHEMBL44,GENISTEIN,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,4.05,CHEMBL1647062,Cytotoxicity against human T98G cells after 72 hrs by SRB assay,T98G,TZBJGXHYKVUXJN-UHFFFAOYSA-N
CHEMBL1214141,,Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1,IC50,5.22,CHEMBL1217201,Antiproliferative activity against human U87 cells,U-87MG ATCC,SZNYUUZOQHNEKB-UHFFFAOYSA-N
CHEMBL1098108,,COc1ccc(C(=O)Nc2nc(-c3ccccc3)nc3nn(C)cc23)cc1,IC50,10.21,CHEMBL1120806,Antagonist activity at adenosine A3 receptor in human U87MG cells assessed as inhibition of Cl-IB-MECA-mediated ERK1/2 phosphorylation after 30 mins by ELISA,U-87MG ATCC,YEHUDYLWUFJTMH-UHFFFAOYSA-N
CHEMBL2297274,,COc1cc(OC)c2c(Nc3ccccc3)cc(-c3ccccc3)nc2c1,IC50,5.23,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,GTKIBDAQYUGPCT-UHFFFAOYSA-N
CHEMBL229627,,Cc1cccc2nc3c(n12)C(=O)C(=O)c1cccnc1-3,IC50,5.59,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,SSOREUPMLYAZHT-UHFFFAOYSA-N
CHEMBL1169623,,N[C@]1(CNC(=O)c2ccc(F)cc2F)CCN(c2ncnc3[nH]cc(Cl)c23)C1,IC50,6.55,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,NYXVMGDGFFQGFZ-SFHVURJKSA-N
CHEMBL1170445,,N[C@]1(CNC(=O)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,IC50,6.46,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,OSIJXFXWDRIUIH-SFHVURJKSA-N
CHEMBL293834,,COc1ccc(C2C(O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-],IC50,7.3,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,GSTOXUGHWJKGFJ-UHFFFAOYSA-N
CHEMBL1097309,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OC(C)CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.07,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BIZNEWHBFITJQR-YGMZGXMASA-N
CHEMBL232825,,c1cn(-c2ccc(OC3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,7.24,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HHOPJGKEAIIIDF-UHFFFAOYSA-N
CHEMBL233441,,CC1CCCCN1CCCNC(=O)CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2,IC50,5.8,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,NWNRAEPFIKOHBQ-UHFFFAOYSA-N
CHEMBL232819,,O=C(CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2)NCc1ccc2c(c1)OCO2,IC50,6.19,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,AGKVOYQQFKGLNS-UHFFFAOYSA-N
CHEMBL3335779,,N#Cc1cccc(-c2ccc(=O)n(C[C@@H]3CN(c4ncc(C5=CCNCC5)cn4)CCO3)n2)c1,IC50,5.01,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,WMCUXHSEYQTJIF-QFIPXVFZSA-N
CHEMBL272265,,N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,EC50,6.38,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,MBIMERRBQGQJIO-UHFFFAOYSA-N
CHEMBL5431344,,COc1ccc([C@H]2[C@H](C)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1OCC(=O)NO,IC50,7.25,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,GMAXMNJUVHIKOU-FKIZINRSSA-N
CHEMBL236387,,CC(=O)O[C@@H]1C=C2/C(=N/O)C[C@H]3[C@@H]4CC(C(C)=O)[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1,IC50,4.71,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,SBKHEVXAVZDYFH-CYBCVSRJSA-N
CHEMBL236425,,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]4[C@@H]3C/C(=N\O)[C@@]23O[C@@H]13,IC50,5.97,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,RTCRWUGRLHZHCG-NMKURSGASA-N
CHEMBL5219971,,COc1cc(-c2ncccc2CNc2ccc(C)cc2)cc(OC)c1OC,IC50,5.57,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MCPYDEUOPGPYCQ-UHFFFAOYSA-N
CHEMBL5218803,,COc1cc(-c2ncccc2NCc2ccc(C)cc2)cc(OC)c1OC,IC50,5.24,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,XPPLYXMRHDQZOO-UHFFFAOYSA-N
CHEMBL318311,,CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.74,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,MTHXVPHSKKLNEE-MHTZHOPKSA-N
CHEMBL3885217,,O=c1c2nc3ccccc3nc2cc(-c2ccccc2)n1-c1ccc(Cl)cc1,IC50,4.46,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TXKLQVPAWQXPLX-UHFFFAOYSA-N
CHEMBL2037136,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1C1CC1,IC50,4.13,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,YYCVSLJJJVOYHI-UHFFFAOYSA-N
CHEMBL2037147,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1C1CC1,IC50,4.34,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,RQFALKNLPBQTSO-UHFFFAOYSA-N
CHEMBL2035439,,O=C1SC(=Cc2c3ccccc3nc3ccccc23)C(=O)N1Cc1ccc(F)cc1,IC50,5.25,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,YNCXNVOUFHKLHL-UHFFFAOYSA-N
CHEMBL1590709,,O=C(CSc1ncnc2sccc12)N1CCN(C(=O)c2cccs2)CC1,IC50,4.47,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,XFGDIRCPGCBKKS-UHFFFAOYSA-N
CHEMBL394005,,Cc1ncn(-c2nccc3c(S(=O)(=O)N4CCN(C(=O)c5ccccc5)CC4C)c[nH]c23)n1,IC50,6.62,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RYIOKBONSZPVHX-UHFFFAOYSA-N
CHEMBL235971,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)nccc12,IC50,6.7,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DLNPHXOJDBJBBK-UHFFFAOYSA-N
CHEMBL392490,,CC1CN(C(=O)c2ccc3scnc3c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,4.9,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LJOKUTFVULXIIN-UHFFFAOYSA-N
CHEMBL238990,,C[C@@H]1CN(C(=O)c2cc3ccccc3o2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.52,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OIMRUVVSIWFMHE-CQSZACIVSA-N
CHEMBL397916,,CCOC(=O)CNC(=O)Cc1ccc2c(c1)OCO2,IC50,4.87,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,OCLIQPISHTXIJH-UHFFFAOYSA-N
CHEMBL1645547,,Cc1nccc2c1[nH]c1cc(OCCCC(F)(F)F)ccc12,IC50,4.07,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DTZUQYMIOUZBFU-UHFFFAOYSA-N
CHEMBL1078983,Ku-0063794,COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@@H](C)O[C@@H](C)C4)nc3n2)cc1CO,IC50,7.0,CHEMBL1107750,Inhibition of mTORC1 in human U87MG cells assessed as phosphorylated S6 ribosomal protein (Ser235/236) level after 2 hrs by Western blotting,U-87MG ATCC,RFSMUFRPPYDYRD-CALCHBBNSA-N
CHEMBL3113687,,Oc1cccc(/C=N/Nc2cnc3ccccc3n2)c1O,IC50,5.9,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,UNXJYUGXNLCILS-CAOOACKPSA-N
CHEMBL5624633,,O=C(CCl)N1CCN(Cc2ccccc2)C12COC2,IC50,4.94,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,RZTRFGKBSUIJJK-UHFFFAOYSA-N
CHEMBL5629923,,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc1,IC50,5.5,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,BKUHEMIKRWOYQA-CXUHLZMHSA-N
CHEMBL5630184,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1cccnc1,IC50,5.14,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,NANWLXDTOAZVSU-JLHYYAGUSA-N
CHEMBL5630029,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)s1)c1ccsc1,IC50,5.39,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,SFJBHUVZDYHTST-SOFGYWHQSA-N
CHEMBL125393,,CO[C@H]1Nc2cc3c(cc2C(=O)N2C=C(/C=C/C(=O)N(C)C)C[C@@H]12)OCO3,IC50,7.42,CHEMBL815849,In vitro cytotoxicity expressed as concentration that inhibits 50% of U87 (glioblastoma) resistant variant cell proliferation,U-87MG ATCC,TZWWXNMHPBLZFA-BYQXYHSISA-N
CHEMBL4535481,,Cc1cc2ncc(-c3ccc(OCc4ccccc4)c(O)c3)nc2cc1C,IC50,4.8,CHEMBL4342568,Antiangiogenic activity in human U87cells after 24 hrs by MTT assay,U-87MG ATCC,DAIWLKSJIGCCNJ-UHFFFAOYSA-N
CHEMBL322251,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,RQDGBNLSKUOAJD-SFTDATJTSA-N
CHEMBL5396585,,O=C(CSc1nc2ccccc2c(=O)n1-c1ccccc1)Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1,IC50,4.32,CHEMBL5386954,Cytotoxicity against human SNB-75 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,SNB-75,GQYAVMYYUMSGCM-UHFFFAOYSA-N
CHEMBL106813,,CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.29,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,YQCLAYRIYWYIKH-WGPBWIAQSA-N
CHEMBL480880,,CC(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.52,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,NBQKNTHBFZEQQO-AJNNAGPSSA-N
CHEMBL375563,,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.42,CHEMBL911410,Cytotoxicity against human U87MG cells after 24 hrs,U-87MG ATCC,PYXFVCFISTUSOO-HKUCOEKDSA-N
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,4.7,CHEMBL3783554,Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay,SF126,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CHEMBL3319521,,C[C@]12O[C@@H]1CC[C@@]1(C)O[C@@H]1[C@H]1OC(=O)[C@@H](CN3CCN(c4ccc(Cl)cc4)CC3)[C@@H]1C[C@H]2O,IC50,4.8,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,LATBPYVHKBKUNK-DACOWICCSA-N
CHEMBL2170081,,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.4,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,KUGIFHQBIIHRIZ-CYBMUJFWSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,6.88,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL11359,CISPLATIN,,IC50,4.79,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,
CHEMBL1090090,VX-702,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F,IC50,4.0,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,FYSRKRZDBHOFAY-UHFFFAOYSA-N
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.4,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,RAHBGWKEPAQNFF-UHFFFAOYSA-N
CHEMBL1081831,,N[C@H](CNc1ncc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.52,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,XPPKIHZJFAAJLB-INIZCTEOSA-N
CHEMBL450786,PHA-665752,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,IC50,4.26,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,OYONTEXKYJZFHA-SSHUPFPWSA-N
CHEMBL585517,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCC(=O)NCc3ccccc3)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,5.46,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,BHEURBJFAOJJHD-LDDWIZIVSA-N
CHEMBL568119,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCC(=O)N3CCC(Cc4ccccc4)CC3)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,5.71,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,DYFZAKQEEPCNLZ-JGOSJKENSA-N
CHEMBL2062866,,C=C(C)C(=O)O[C@H]1C[C@@H](C)[C@]2(O)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.04,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,YKIDGUZXBGGNBZ-GUNZAYKBSA-N
CHEMBL5270668,,Fc1ccccc1-n1c(SCCc2c[nH]c3ccccc23)nnc1-c1ccncc1,IC50,5.02,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,KAZUDXKVLLJMQV-UHFFFAOYSA-N
CHEMBL3121275,,CCc1nnc(NC(=O)c2ccoc2COc2ccccc2)s1,EC50,5.65,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KUBMSYDLEOLFPH-UHFFFAOYSA-N
CHEMBL3116234,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.12,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QYRPPRMBXWRGIN-HIXSDJFHSA-N
CHEMBL3116440,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.19,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZKQIRZBNHQBAND-YYADALCUSA-N
CHEMBL600041,,O=C(CCl)Nc1nonc1NC(=O)CCl,IC50,4.77,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,GCUTXDUNVVYCKK-UHFFFAOYSA-N
CHEMBL591752,,O=C(Nc1nonc1NC(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,4.75,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,VVMXINUGUXFATD-UHFFFAOYSA-N
CHEMBL1082016,,Cn1c(=O)[nH]c2ccc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc21,IC50,6.2,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,FLAQHSSOAXIOIA-HNNXBMFYSA-N
CHEMBL570552,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1OC1CCCCC1,IC50,5.64,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BETWCXJAIXKAOZ-UHFFFAOYSA-N
CHEMBL582830,,COc1ccc(OC)c(NC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)c1,IC50,6.41,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,GLAGCVLUFNSSLD-UHFFFAOYSA-N
CHEMBL1165314,,COc1cc(C(=O)OCc2cccc(COC(=O)c3ccc(O)c(OC)c3)c2)ccc1O,IC50,4.34,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,METXUACPHKWTLV-UHFFFAOYSA-N
CHEMBL1164313,,COc1cc(C(=O)OCCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.5,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,XCZJDUGEINJHHJ-UHFFFAOYSA-N
CHEMBL1163290,,CC(=O)c1ccccc1-c1ccc(-c2ccnc(NC(=O)Nc3cc(N4CCOCC4)cc(C(F)(F)F)c3)n2)cn1,IC50,5.27,CHEMBL1169194,Growth inhibition of human SNB75 cells after 48 hrs by sulforhodamine B assay,SNB-75,NGBOQLIIVBYICP-UHFFFAOYSA-N
CHEMBL1163290,,CC(=O)c1ccccc1-c1ccc(-c2ccnc(NC(=O)Nc3cc(N4CCOCC4)cc(C(F)(F)F)c3)n2)cn1,IC50,5.04,CHEMBL1169191,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NGBOQLIIVBYICP-UHFFFAOYSA-N
CHEMBL229401,,C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,IC50,6.64,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,QGUPDXLZKDANGO-SZNDQCEHSA-N
CHEMBL597549,,COc1cc(/C=C/c2cc(O)c3c(c2)OCC3)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.54,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,NATVWFRMTJXYMF-WPCAQGITSA-N
CHEMBL2385194,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)c(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.27,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FAGHBGHQYBASQO-UHFFFAOYSA-N
CHEMBL1910999,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,7.55,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,HQXHYGAANFLAOZ-UHFFFAOYSA-N
CHEMBL1911117,,COc1cc(N)cc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,8.06,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,GVCOXBXPKBZDEG-UHFFFAOYSA-N
CHEMBL566534,ARTEMETHER,CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,IC50,5.04,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,SXYIRMFQILZOAM-HVNFFKDJSA-N
CHEMBL324274,,C=C/C(C)=C/C[C@@]1(C)[C@@H](C)CCC23C(=C[C@@H](OC(=O)C(C)C)C[C@@H]21)[C@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,5.92,CHEMBL815854,In vitro cytotoxicity against parental and drug resistant glioblastoma human tumor cell line U87MG,U-87MG ATCC,ZORWLQPVCJDDHT-GMGUNDJRSA-N
CHEMBL5412398,,C[C@@H]1CC[C@H]2[C@@H](C)C(OCCOc3ccc(/C=C/S(=O)(=O)Nc4ccc(OC(F)(F)F)cc4)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,IC50,7.3,CHEMBL5355849,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,WSYNOMDLIDKXKP-PTSVAGJUSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,5.94,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,4.92,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL489474,,Cc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.87,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,SKABNCUDYKCTFK-UHFFFAOYSA-N
CHEMBL489269,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccc(N3CCOCC3)cc2)C1=O,IC50,5.77,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,RLRSGXCHTHBPMX-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.8,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5415375,,CCCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.68,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,BTVKSBMZVONCPT-UHFFFAOYSA-N
CHEMBL5401866,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(O)c1,IC50,6.62,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,FSNDECYIJRAGKA-UHFFFAOYSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.78,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,4.89,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.88,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL573107,,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,IC50,5.28,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,DTEKTGDVSARYDS-UHFFFAOYSA-N
CHEMBL379975,,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,IC50,4.41,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,DPEXRCOBPACFOO-UHFFFAOYSA-N
CHEMBL1614701,SELUMETINIB,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,IC50,4.01,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,CYOHGALHFOKKQC-UHFFFAOYSA-N
CHEMBL5630589,,COc1cc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)s2)cc(OC)c1OC,IC50,5.4,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,BIEISJXRFQWQNI-PKNBQFBNSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,5.71,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL2313862,CCHISANBICOLORIN A,COc1cc2c(c(O)c1OC)-c1c(cc3c(c1OC)CCC3)C[C@H](C)[C@H](C)C2,IC50,4.43,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UYCUEIUSIQQSOB-UONOGXRCSA-N
CHEMBL3348846,FEXAGRATINIB,COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1,IC50,4.59,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,VRQMAABPASPXMW-HDICACEKSA-N
CHEMBL1080569,,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.6,CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,U-87MG ATCC,WZOVTPHXONVIIJ-SFHVURJKSA-N
CHEMBL1822210,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2o1,IC50,5.96,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,QFGPLNAQFOAOAP-UHFFFAOYSA-N
CHEMBL5289444,,O=[N+]([O-])c1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.77,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,JJNCKTDZBWDREE-UHFFFAOYSA-N
CHEMBL228998,,COc1ccc(C[C@@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,IC50,8.5,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-KZULUSFZSA-N
CHEMBL229401,,C[C@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.8,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,QGUPDXLZKDANGO-SZNDQCEHSA-N
CHEMBL1652063,,CC(C)CC1=C(OC2(CC(C)C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.96,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QYDYSRCPCQQVAR-UHFFFAOYSA-N
CHEMBL1652064,,CC(C)CC1=C(O)C(=O)C2=C(CCCC2)C1=O,IC50,4.67,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,OIFDRMACNGIEQC-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.46,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4103914,,CSc1nc(Nc2ccccc2)c2ccn(CC(Cl)c3ccccc3)c2n1,IC50,4.56,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,FJQQPDTVQFJFJW-UHFFFAOYSA-N
CHEMBL5179338,,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N1CCN(c2cc(-c3cn(-c4ccccc4)nc3-c3cccc(O)c3)ccn2)CC1,IC50,5.82,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,XJAJDOWMQVDEOT-UHFFFAOYSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,7.0,CHEMBL4344200,Cytotoxicity against human U87 cells after 24 hrs by SRB method,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL5191703,,CCNCc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2,IC50,4.22,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,AAIHVZUDNKOBAV-UHFFFAOYSA-N
CHEMBL1683556,,C#CCN(C)C[C@H](C[C@H]1O[C@H]2C[C@H]3O[C@@H](CC[C@@H]4O[C@@H](CC[C@@]56C[C@H]7O[C@H]8[C@@H](O5)[C@H]5O[C@H](CC[C@@H]5O[C@H]8[C@H]7O6)CC(=O)C[C@@H]2[C@H]1OC)CC4=C)C[C@@H](C)C3=C)OC,IC50,9.39,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,REPKIIHCLQBBFO-LINFNXQUSA-N
CHEMBL222409,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccc(F)c1,EC50,7.52,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,HZSQCVIQVSEACA-UHFFFAOYSA-N
CHEMBL3092023,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(O)cc2)c(OC)c1,IC50,5.12,CHEMBL3096271,Cytotoxicity against human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,UBMQFEPVRWEBRN-UHFFFAOYSA-N
CHEMBL4642264,,CCCc1c(C)nc2c3ccccc3oc(=S)n12,IC50,4.96,CHEMBL4617329,Antimigratory activity against human U87MG cells assessed as inhibition of cell migration measured after 6 hrs by scratch wound healing assay,U-87MG ATCC,OEWGFBGGWFYYNM-UHFFFAOYSA-N
CHEMBL2042556,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccc(N(C)C)c2ccccc12,IC50,7.69,CHEMBL2044174,Antiproliferative activity against human U87 cells after 5 days by MTT assay,U-87MG ATCC,XWCSZMDVKNZVMD-UHFFFAOYSA-N
CHEMBL1241831,,CC(=O)Oc1ccccc1C(=O)Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,IC50,5.09,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,VDQXNBDUQMASBI-UHFFFAOYSA-N
CHEMBL166173,,O=C(Nc1ccccc1)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.22,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,XOEACJRWPRVYFO-UHFFFAOYSA-N
CHEMBL83286,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)/c2=N\Nc2ccccc2)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,AGFRIFGJACNPFZ-RFBIWTDZSA-N
CHEMBL83200,,COc1cc(OC)c2cc(-c3ccccc3)c(O)nc2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,ZWLSXHYTGYVCSY-UHFFFAOYSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,4.68,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL1097301,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OC(C)CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.69,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MVQBBYMHIJMDSV-FBCWVRNMSA-N
CHEMBL1097298,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OCCCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.58,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BGQCBRSBPIZVMD-QNKOPLAASA-N
CHEMBL3116218,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.17,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BKKCLSKIDFDDGH-FCDQGJHFSA-N
CHEMBL3114583,,O=C1C=C(n2cc(CNC3=C(Cl)C(=O)c4ccccc4C3=O)nn2)C(=O)c2ccccc21,IC50,5.26,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,RPUUVFLDXVKCTF-UHFFFAOYSA-N
CHEMBL3116438,,COc1cc(N2C(=O)NC(=O)/C(=C\Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)C2=O)c(OC)cc1Cl,IC50,5.47,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PYSDBKNKMBLVPA-NJNXFGOHSA-N
CHEMBL4789087,,Cc1ccc(Oc2c(/C=N\CCCCCOc3cc4oc(=O)cc(C)c4cc3Cl)c(C)nn2C)cc1,IC50,5.1,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UYTHBOSJITYGDH-LQNQUEJISA-N
CHEMBL4788103,,Cc1nn(C)c(Oc2ccc(F)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.78,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GHUACRRKNFSTRH-LJUMEUDFSA-N
CHEMBL4742104,,Cc1ccccc1Oc1c(/C=N\CCCCCCOc2cc3oc(=O)cc(C)c3cc2Cl)c(C)nn1C,IC50,5.02,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DOMDKSKJLQRCRN-MNBJERMJSA-N
CHEMBL118201,,O=C1c2nccc(O)c2-c2nccc3ccnc1c23,IC50,5.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,GQWRNDLEPKWUDO-UHFFFAOYSA-N
CHEMBL4794646,,CN(C)CCNC(=O)c1ccc(NC(=O)Nc2ccc(Nc3nc(/C=C/c4ccccc4)nc(N4CCOCC4)n3)cc2)cc1,IC50,5.61,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,OXIICGPNVHPDSH-CAOOACKPSA-N
CHEMBL1224209,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.1,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,NWTSKFFYRKGTAR-OGTXVEBCSA-N
CHEMBL118709,,COc1ccnc2c1C(=O)c1ncc(OC)c3ccnc-2c13,IC50,6.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,WZUNGQKHNMOASU-UHFFFAOYSA-N
CHEMBL125393,,CO[C@H]1Nc2cc3c(cc2C(=O)N2C=C(/C=C/C(=O)N(C)C)C[C@@H]12)OCO3,IC50,7.4,CHEMBL815850,In vitro cytotoxicity expressed as concentration that inhibits 50% of U87 (glioblastoma) sensitive variant cell proliferation,U-87MG ATCC,TZWWXNMHPBLZFA-BYQXYHSISA-N
CHEMBL5563749,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NCCCO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc34)[C@H]21,IC50,7.27,CHEMBL5548646,Antiproliferative activity against human U-87 MG cells measured after 72 hrs by CCK-8 cells,U-87MG ATCC,GIWIRTUVZIJPIP-KCGAXMGVSA-N
CHEMBL1914726,,O=S(=O)(Nc1cc(-c2ccc3nccc(-c4cccnc4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.92,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,RTXWPOABAGXULX-UHFFFAOYSA-N
CHEMBL609566,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)C=CC[C@@H]12,IC50,6.06,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,XYQNSUIMCBJUCF-MVWRLGRASA-N
CHEMBL601898,,O=C(Nc1nonc1NC(=O)c1ccc(I)cc1)c1ccc(I)cc1,IC50,6.0,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,DQBDTCPTGZFPEC-UHFFFAOYSA-N
CHEMBL4084013,,O=C1/C(=C/c2ccc(S(F)(F)(F)(F)F)cc2)CCC/C1=C\c1ccc(S(F)(F)(F)(F)F)cc1,IC50,5.5,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GKAZLAVJJMPWTP-UNZYHPAISA-N
CHEMBL167864,,CC(C)NC(=O)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,4.95,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,HRTHMRUFYMAULC-UHFFFAOYSA-N
CHEMBL1096754,,Cn1cc2c(NC(=O)c3ccccc3)nc(-c3ccccc3)nc2n1,IC50,9.13,CHEMBL1120806,Antagonist activity at adenosine A3 receptor in human U87MG cells assessed as inhibition of Cl-IB-MECA-mediated ERK1/2 phosphorylation after 30 mins by ELISA,U-87MG ATCC,QFBYVTZHJZITCY-UHFFFAOYSA-N
CHEMBL352383,,COCC(=O)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,4.75,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,NGWINTPSYNWYMP-UHFFFAOYSA-N
CHEMBL237676,,Cc1cn(-c2nccc3c(S(=O)(=O)N4CCN(C(=O)c5ccccc5)CC4C)c[nH]c23)nn1,IC50,6.07,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RCHLTRWNVMJCOU-UHFFFAOYSA-N
CHEMBL5575173,,N#CC1(C(=O)NCCC(=O)Nc2ccc(F)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.84,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,SAGAPWLCGLYIQT-UHFFFAOYSA-N
CHEMBL5595450,,CC(=O)C12CC(C#N)(C(=O)NCCc3ccc(F)cc3)C(c3ccccc31)c1ccccc12,IC50,4.53,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,NKMLQGUPJIWQQV-UHFFFAOYSA-N
CHEMBL5597987,,CN1CCN(C(=O)[C@@H]2[C@H](C(=O)O)[C@H]3CC[C@@H]2O3)CC1,IC50,4.59,CHEMBL5587080,Cytotoxicity against human U-87 MG cells incubated for 48 hrs by CCK8 assay,U-87MG ATCC,JUQMLSGOTNKJKI-ZRUFSTJUSA-N
CHEMBL465843,PIPLARTINE,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,IC50,4.79,CHEMBL4037663,Antiproliferative activity against human U87MG cells after 72 hrs in presence of ligustrazine by MTT assay,U-87MG ATCC,VABYUUZNAVQNPG-BQYQJAHWSA-N
CHEMBL4100831,,Cc1nc(C)c(/C=C/C(=O)N2CCC=C(I)C2=O)nc1C,IC50,5.14,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YTDONUVCMOZIEB-VOTSOKGWSA-N
CHEMBL5195215,,O=C(NCc1ccc(F)cc1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.47,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,NALIAYSLJPZACM-UHFFFAOYSA-N
CHEMBL4077885,,C=C(c1ccc(OC)c(F)c1)c1cc(C)nc2ccccc12,IC50,8.4,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,VWVGFUVQWMPTRY-UHFFFAOYSA-N
CHEMBL4078810,,C=C(c1ccc(OC)cc1)c1cc(C(=O)O)nc2ccccc12,IC50,7.12,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,BCDOTASWUFYEJI-UHFFFAOYSA-N
CHEMBL3353050,,COc1ncc(OC)c2c(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c[nH]c12,IC50,7.05,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,QGMJLQAXMOHHGW-UHFFFAOYSA-N
CHEMBL220472,SCHWEINFURTHIN E,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@H]1C2,IC50,7.66,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,IYHZCJNEODJYKB-DMCZWXATSA-N
CHEMBL1668101,CORNUSALTERIN H,CO[C@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.73,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,UDSUNACNDRCFFJ-QIBYADRPSA-N
CHEMBL2172626,,Cc1nc(N)cc(-c2c(Nc3cc[nH]n3)nc3ccccn23)n1,IC50,6.29,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CLXMPSJHRQXOQT-UHFFFAOYSA-N
CHEMBL3339356,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.38,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,DSPINUQBRPPQOY-QLQYKETESA-N
CHEMBL113387,,O=C1c2nccc(Cl)c2-c2nc3ccccc3c3ccnc1c23,IC50,7.7,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,LWXZWXHVVUIXRN-UHFFFAOYSA-N
CHEMBL386796,,O=c1c2cccc3c2sn1CCCCCOc1cccc2nc(O)c-3nc12,IC50,7.52,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,FJXIQAFPONNXHI-UHFFFAOYSA-N
CHEMBL320502,,CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.96,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,JOMKXVYAEOFACX-WGPBWIAQSA-N
CHEMBL3409458,,CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(C(=O)N4CCC(N5CCCCC5)CC4)cc3Cl)ncc21,EC50,5.43,CHEMBL3412560,Inhibition of IL6 secretion in LPS/IL-1beta-stimulated human U87 cells compound pretreated for 30 mins before stimulation measured after 24 hrs by ELISA,U-87MG ATCC,HVBMWPMWGDVORK-UHFFFAOYSA-N
CHEMBL3335772,,CN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nc(-c6ccc(F)c(Cl)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.82,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,CVZILHDMXKUPHK-QHCPKHFHSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.4,CHEMBL4119405,Cytotoxicity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5399070,,COc1ccc(-c2ccc3[nH]c(=O)c4cnn(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)c4c3c2)cn1,IC50,5.9,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,RSCTXUZWVYMQTL-UHFFFAOYSA-N
CHEMBL5406944,,COc1ccc(-c2ccc3[nH]c(=O)c4ncn(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)c4c3c2)cn1,IC50,5.35,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,FAXQWGUHCYAKEC-UHFFFAOYSA-N
CHEMBL5417476,,COc1ccc(-c2ccc3[nH]c(=O)c4ncc(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)n4c3c2)cn1,IC50,5.41,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,QXWITEPIWDRHEN-UHFFFAOYSA-N
CHEMBL4534595,,COc1cc(CNC(=O)Nc2ccc([N+](=O)[O-])cc2)ccc1O,IC50,4.01,CHEMBL4388788,Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,QTLCSBBNMYNBKP-UHFFFAOYSA-N
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,4.77,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,6.39,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL5523524,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)c4ccc5nccn5c4)cc3)cc2)n1,IC50,5.51,CHEMBL5509852,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,HENWOYNKEJWJFG-KDYSTLNUSA-N
CHEMBL5523524,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)c4ccc5nccn5c4)cc3)cc2)n1,IC50,5.49,CHEMBL5509853,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,HENWOYNKEJWJFG-KDYSTLNUSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,6.01,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL5523524,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)c4ccc5nccn5c4)cc3)cc2)n1,IC50,5.84,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,HENWOYNKEJWJFG-KDYSTLNUSA-N
CHEMBL5562174,,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccc(NC(=O)COc3cccnc3)cc2)cc1,IC50,6.5,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,NGXVQQDDOXHWSX-CUVVAGTFSA-N
CHEMBL5523524,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)c4ccc5nccn5c4)cc3)cc2)n1,IC50,5.49,CHEMBL5509851,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,HENWOYNKEJWJFG-KDYSTLNUSA-N
CHEMBL5562174,,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccc(NC(=O)COc3cccnc3)cc2)cc1,IC50,6.38,CHEMBL5509851,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,NGXVQQDDOXHWSX-CUVVAGTFSA-N
CHEMBL5620107,,CCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.01,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,ZWJZSZVFRGWKLP-BHVANESWSA-N
CHEMBL5618555,,CCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.72,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,RZJVZXFLQUKHCG-YTTGMZPUSA-N
CHEMBL1630322,,C=C1C(=O)O[C@@H]2/C(=C/CC(=O)O)C(=C(C)C)CC[C@@H]12,IC50,4.79,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MUEPVYYLPOSULF-XZWPSAHASA-N
CHEMBL3780205,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccc(O)cc5)cc4c32)cc1,IC50,4.53,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,OFZVYEGTPNVALW-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,9.49,CHEMBL4334155,Cytotoxicity against human LN229 cells after 48 hrs by CCK8 assay,LN-229,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL3780458,,O=c1oc2ccc(-c3ccncc3)cc2c2c1[nH]c(=O)n2-c1ccccc1,IC50,4.41,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,WXUKICABEMHKCO-UHFFFAOYSA-N
CHEMBL3779950,,CC(C)(C#N)c1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1,IC50,4.48,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,MZIDWHSBLDVVHO-UHFFFAOYSA-N
CHEMBL3357876,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1C(F)(F)F,IC50,6.84,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,DDKMFSTVGYJPSR-UHFFFAOYSA-N
CHEMBL3357866,,COc1ncc(Nc2ncc([C@H](C)O)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.58,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,RFMMTRCKHHKIJM-QMMMGPOBSA-N
CHEMBL2170081,,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.4,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,KUGIFHQBIIHRIZ-CYBMUJFWSA-N
CHEMBL353435,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNCCO,IC50,4.63,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,FQDACYMEFXKAFU-UHFFFAOYSA-N
CHEMBL3359308,,C/C(=C/CCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.46,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,PXLZXXWHUHFIPW-SXDXVQSQSA-N
CHEMBL3359310,,C/C(=C/CCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.78,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,IJBKYXUBTDMCDR-JOUREUQLSA-N
CHEMBL3359311,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.5,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,ZLXZHBUQHPKAMH-QUMRLDBXSA-N
CHEMBL1669124,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.56,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,VKYVIIIEJKSVBR-XHJPDDKBSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,4.42,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL4287065,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)c2cn(Cc3ccc(OC)c(OC)c3)nn2)cc1,IC50,6.01,CHEMBL4423095,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,HPNCRJJSTODGJI-UHFFFAOYSA-N
CHEMBL3400386,,CCCCc1ccc2nc3ccccc3c(NCc3nc4ccccc4[nH]3)c2c1,IC50,5.54,CHEMBL3407283,Antiproliferative activity against human A172 cells after 48 hrs by MTT assay,A-172,OUWVEIMVADFGIW-UHFFFAOYSA-N
CHEMBL50835,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,IC50,6.96,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,LNHWXBUNXOXMRL-UHFFFAOYSA-N
CHEMBL3360267,,O=S(=O)(Nc1ccc([O-])cc1)c1ccc(-c2ccccc2)cc1.[K+],IC50,4.9,CHEMBL3388460,Antitumor activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HKLWSXOMLXBWDQ-UHFFFAOYSA-M
CHEMBL3343365,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WRZNQISIWPZWOM-UHFFFAOYSA-N
CHEMBL3343366,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.07,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UZISGDYRMAXEPZ-UHFFFAOYSA-N
CHEMBL3343374,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WKCPOJBMNFSPJK-UHFFFAOYSA-N
CHEMBL487911,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)C=C(O)C(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.7,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,DHKMDDSMHOBYDQ-OSLPSIGMSA-N
CHEMBL464006,MORUSIN,CC(C)=CCc1c(-c2ccc(O)cc2O)oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,4.62,CHEMBL3802627,Cytotoxicity against human T98G cells assessed as reduction in cell viability after 24 hrs by MTT assay,T98G,XFFOMNJIDRDDLQ-UHFFFAOYSA-N
CHEMBL4454011,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N/OCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,4.85,CHEMBL4352916,Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay,U-87MG ATCC,IUYDZEFUPRODML-AWDRCZFNSA-N
CHEMBL3337799,,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)OCc1ccccc1)c1cc2ccc(O)cc2oc1=O,IC50,4.04,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,HCRCCVMNNUECQD-QXUSSCGESA-N
CHEMBL85538,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,WBXLVMDMTJKREJ-UHFFFAOYSA-N
CHEMBL3415684,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](CCC)c(C)c21.[Br-],IC50,5.92,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,IHMHMQUODBBECO-UHFFFAOYSA-M
CHEMBL3415680,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](CC)c(C)c21.[Br-],IC50,4.96,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,RAYVZVFRTKZJNC-UHFFFAOYSA-M
CHEMBL3415679,,CCCOc1ccc2c3cc[n+](CCC(C)C)c(C)c3n(CCC)c2c1.[Br-],IC50,5.4,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,IIMDYFGKRXUJCI-UHFFFAOYSA-M
CHEMBL418997,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1,IC50,8.24,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,RYDCEMWPUOVZIA-PJJLUWSFSA-N
CHEMBL4754210,,CCN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1cccc(C)c1,IC50,5.15,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ISQIHGOFCXLDAB-CCEZHUSRSA-N
CHEMBL590522,MAHANINE,CC(C)=CCC[C@H]1C=Cc2c(c(C)cc3c2[nH]c2cc(O)ccc23)O1,IC50,5.16,CHEMBL2405049,Cytotoxicity against human T98G cells assessed as growth inhibition after 48 hrs by MTT assay,T98G,UKLOEFBVUZOVRX-INIZCTEOSA-N
CHEMBL4757229,,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(OC)cccc2C3=O)[C@H]1C(=O)OC,IC50,5.05,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,WBMXRYALFPXLMA-UCPUWLPESA-N
CHEMBL4762286,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N(C)C)[C@H](O[C@H]2C[C@H](O)[C@H](O)[C@H](C)O2)[C@H](C)O1,IC50,6.22,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,JLYYHMATMXHAJD-MUSIKMTQSA-N
CHEMBL4757173,,CCC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N(C)CCN(C)C,IC50,4.28,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,CTEADNNPWMCNAC-UHFFFAOYSA-N
CHEMBL2441799,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,6.13,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZOOITGLKRZNSBM-UHFFFAOYSA-N
CHEMBL2441794,,COc1cc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,5.99,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,KJJFHHZWHXEKEA-UHFFFAOYSA-N
CHEMBL2441791,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.4,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,BMOBWMUJOHKEJL-UHFFFAOYSA-N
CHEMBL2441788,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4ccc(Cl)c(Cl)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.16,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,SPFUMQIYKBQJSC-UHFFFAOYSA-N
CHEMBL244395,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2Cl)n1,IC50,7.72,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,RUCJHTMNODDPBP-UHFFFAOYSA-N
CHEMBL243976,,c1cc(Oc2ccc(-n3ccnc3)cc2)nc(Oc2ccc3c(c2)OCO3)c1,IC50,7.11,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,QRKJIRHWSXRMDL-UHFFFAOYSA-N
CHEMBL390674,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2)n1,IC50,7.05,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,QQBNDYARFVOEGW-UHFFFAOYSA-N
CHEMBL1610540,,CCOC(=O)c1[nH]c(C)c(C(=O)c2ccc(C)cc2)c1C,EC50,6.28,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,RATCNKNLRDSESL-UHFFFAOYSA-N
CHEMBL3121284,,COc1ccc(Cl)cc1C(=O)N1CCN(c2cccc(Cl)c2)CC1,EC50,6.77,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,XBTHMXPSSTYETL-UHFFFAOYSA-N
CHEMBL1424468,,CCOC(=O)c1[nH]c2c(c1C)C(=O)CC(c1ccco1)C2,EC50,6.17,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,LAYLXGGTNSMQEK-UHFFFAOYSA-N
CHEMBL1448054,,COC(=O)c1[nH]c2c(c1C)C(=O)CC(c1cccs1)C2,EC50,6.39,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,JOTFIWPTFIQSLQ-UHFFFAOYSA-N
CHEMBL3121276,,NC(=O)c1ccccc1NC(=O)c1cccnc1N1CCCCC1,EC50,5.99,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,LUUYUIANPCXSFW-UHFFFAOYSA-N
CHEMBL1615189,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,8.2,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,YGBMCLDVRUGXOV-UHFFFAOYSA-N
CHEMBL1914718,,COCCNc1ccnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc12,IC50,5.99,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,FQTRTFZRCVMEKM-UHFFFAOYSA-N
CHEMBL1914722,,CC(C)N1CCN(c2ccnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc23)CC1,IC50,7.55,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,SHLRNAMEMGGTKI-UHFFFAOYSA-N
CHEMBL1914723,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCN(Cc5ccccc5)CC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.87,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,ANJMEARDENWYPS-UHFFFAOYSA-N
CHEMBL1914724,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCN(Cc5ccncc5)CC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.75,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,GHYIOUMBYNIERQ-UHFFFAOYSA-N
CHEMBL1914731,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCC4CCCCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.55,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,CFKJAZFCOSGTBJ-UHFFFAOYSA-N
CHEMBL1914741,,COC1CCN(c2cnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc3n2)CC1,IC50,7.34,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,AKUBJNKMQOIYPV-UHFFFAOYSA-N
CHEMBL4757158,,COC(=O)c1ccc(-c2cccc(C3N(C(=O)OC(C)(C)C)CCC34C(=O)Nc3ccccc34)c2)cc1S(C)(=O)=O,IC50,4.88,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,CSIIUZYJPVSIJG-UHFFFAOYSA-N
CHEMBL4797369,,CC(C)(C)OC(=O)N1CC[C@]2(C(=O)Nc3ccccc32)[C@H]1c1cccc(Nc2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.22,CHEMBL4686887,Antiproliferative activity against human A 172 cells measured after 7 days by CCK8 assay,A-172,YIKYKYFYFWNCSE-PDDLMNHVSA-N
CHEMBL5291472,,OC1CC2CC1CN2c1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,5.48,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,ZMOMHLVVLVGMBV-UHFFFAOYSA-N
CHEMBL163078,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1,IC50,8.29,CHEMBL815089,Concentration required to inhibit the entry of HIV-1 reported virus (ADA) into U-87 cells,U-87MG ATCC,KRBMMTDOLHPSPA-UHFFFAOYSA-N
CHEMBL5549872,,N[C@@H]1CN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C[C@H]1N,IC50,5.41,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,RKAHXFSNPPPOIR-HUUCEWRRSA-N
CHEMBL5566259,,CN1CCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)CC1,IC50,4.46,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,SCUPZUNLIPGWSZ-UHFFFAOYSA-N
CHEMBL5590031,,NC1CCCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C1,IC50,5.46,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,MBZPJHXHLMKCLE-UHFFFAOYSA-N
CHEMBL2037442,,C/C(=N/NC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.51,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PMHTWYVKIPHSFS-ZDLGFXPLSA-N
CHEMBL282346,,C/C(=N\NC(=S)Nc1ccccc1)c1ccccn1,IC50,8.17,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VHVSCHSQNUUXNS-GZTJUZNOSA-N
CHEMBL2037339,,CC(=NNC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.23,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,KRCPOZLWYUZVBS-UHFFFAOYSA-N
CHEMBL2037445,,C/C(=N/NC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.77,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,KRCPOZLWYUZVBS-ZDLGFXPLSA-N
CHEMBL2037439,,C/C(=N\NC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,7.16,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NPHJRKXEZJAUIL-LICLKQGHSA-N
CHEMBL2037437,,C/C(=N\NC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,8.0,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,RLHHYLRHRGHQLT-VCHYOVAHSA-N
CHEMBL2037337,,CC(=NNC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.75,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VCKFVZSNSWYSKQ-UHFFFAOYSA-N
CHEMBL2419669,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,8.01,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PSTHAQGLUUIJDB-CHSHITCJSA-N
CHEMBL2419656,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,7.72,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CBLOATFLKZWZOJ-QLQYKETESA-N
CHEMBL168896,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN1CCCCC1,IC50,4.29,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,PBHONWPIGUOEOK-UHFFFAOYSA-N
CHEMBL2144069,,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,IC50,4.71,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,ZGBGPEDJXCYQPH-UHFFFAOYSA-N
CHEMBL941,IMATINIB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.05,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,KTUFNOKKBVMGRW-UHFFFAOYSA-N
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,4.21,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.47,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,5.05,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.72,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL5186278,,CC(C)[C@@H]1[NH2+][B-](c2ccc(F)cc2F)(c2ccc(F)cc2F)OC1=O,IC50,4.31,CHEMBL5105180,Anticancer activity against human LN-229 cells assessed as cell growth inhibition by trypan blue exclusion assay,LN-229,HSYNFCMJBFKUBL-INIZCTEOSA-N
CHEMBL5202359,,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2-c1ccoc1)OCO3,IC50,7.72,CHEMBL5109659,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LQMZOEHJTWUPAV-VWLOTQADSA-N
CHEMBL4752065,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccccc2)n1,IC50,4.54,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,VOOMANZTSOAVDY-UHFFFAOYSA-N
CHEMBL4791731,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(OC)c(OC)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.9,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KZQXVJIAETXXPM-UHFFFAOYSA-N
CHEMBL4748897,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)nc(N)c2C#N)cc1,IC50,4.98,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,VVCBTDSTDBUAPK-UHFFFAOYSA-N
CHEMBL412142,LADUVIGLUSIB,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,IC50,4.1,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,AQGNHMOJWBZFQQ-UHFFFAOYSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,6.47,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL1023,BEXAROTENE,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,IC50,5.29,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,NAVMQTYZDKMPEU-UHFFFAOYSA-N
CHEMBL6067492,BLEOMYCIN,,IC50,7.67,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,5.97,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,7.22,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,6.37,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.34,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,RAHBGWKEPAQNFF-UHFFFAOYSA-N
CHEMBL106767,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1,IC50,8.4,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,JLFLNZCJUVHUGI-XLVZBRSZSA-N
CHEMBL5178989,,Cc1c2ccncc2c(/C=C/C(C)NC=O)c2c1[nH]c1ccccc12,IC50,5.9,CHEMBL5127175,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,GDXOPVJOVKTUOE-BQYQJAHWSA-N
CHEMBL4763211,,CC(=O)O[C@@H]1C[C@H](O)[C@@]23COC(O)[C@]1(C)[C@@H]2C[C@@H](O)[C@]1(C)[C@@H]3C(=O)C(O)[C@@]2(C)[C@H](c3ccoc3)C[C@H]3O[C@@]312,IC50,7.42,CHEMBL4712389,Cytotoxicity against human XF498 cells by SRB staining assay,XF 498,PUNWVWPDKCBXSA-GVRQUNDGSA-N
CHEMBL4789549,,CC(=O)OC1C(=O)[C@@H]2[C@@]34COC(O)[C@@](C)([C@H](OC(C)=O)C[C@@H]3O)[C@@H]4C[C@@H](O)[C@@]2(C)[C@@]23O[C@@H]2C[C@@H](c2ccoc2)[C@]13C,IC50,7.92,CHEMBL4712389,Cytotoxicity against human XF498 cells by SRB staining assay,XF 498,NAHTXVIXCMUDLF-XZEUDTBOSA-N
CHEMBL236603,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cc(CO)nn3)nccc12,IC50,6.6,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BDDVJFSVJBPFPK-OAHLLOKOSA-N
CHEMBL238108,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3nccn3)ccc(F)c12,IC50,6.7,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,AULYZZBYQNKBBN-OAHLLOKOSA-N
CHEMBL392491,,O=C(c1ccccc1)N1CCN(S(=O)(=O)c2c[nH]c3ncccc23)CC1,IC50,4.66,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LYBYVBOJVKMYLY-UHFFFAOYSA-N
CHEMBL240476,,Cc1ccc(C(=O)N2CCN(S(=O)(=O)c3c[nH]c4ncccc34)[C@H](C)C2)s1,IC50,5.64,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,FWSUSEHQAWXGOT-GFCCVEGCSA-N
CHEMBL106468,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1,IC50,8.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KCYWZQVQSDYWBO-XLVZBRSZSA-N
CHEMBL5572298,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccccc1,IC50,6.05,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,UCKRTNLJGZCCDX-UHFFFAOYSA-N
CHEMBL2282592,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(Cl)cc1,IC50,5.09,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,VTGDHSHQGSHPOQ-UHFFFAOYSA-N
CHEMBL3612312,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.44,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,NQYTWDAPGKHQPL-UHFFFAOYSA-N
CHEMBL3612316,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(C)cc4)c3)cc2s1,IC50,6.44,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DKBCPMBCYKHNCR-UHFFFAOYSA-N
CHEMBL3612317,,COc1ccc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cn1,IC50,5.14,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,BERLCZAODRNRRR-UHFFFAOYSA-N
CHEMBL1615189,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,6.36,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,YGBMCLDVRUGXOV-UHFFFAOYSA-N
CHEMBL4750472,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccc(Cl)c(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.19,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,NEGLWDUVROZELR-UHFFFAOYSA-N
CHEMBL4795290,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccccc4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.24,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,AVABUZCXDGOVNX-UHFFFAOYSA-N
CHEMBL4759883,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4cccc(OC)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.81,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,DXIRCPPLBMVXNK-UHFFFAOYSA-N
CHEMBL4751620,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(Cl)cc4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.34,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,CNNVTNOOYHRZTH-UHFFFAOYSA-N
CHEMBL4742679,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccc(Cl)cc2)n1,IC50,4.97,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,CMCDHSYDVQJOGE-UHFFFAOYSA-N
CHEMBL5567409,,NCCCNC(=O)C1Cc2c(O)c3c(c(O)c2C1)C(=O)c1ccccc1C3=O,IC50,5.41,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,JOYQHIYMPYOIJV-UHFFFAOYSA-N
CHEMBL229628,,O=C1C(=O)c2c(nc3c(C(=O)O)cccn23)-c2ncccc21,IC50,7.02,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,CYMAHFSGLPYKLW-UHFFFAOYSA-N
CHEMBL229726,,Cc1ccc2nc3c(nc2c1C)C(=O)c1cnncc1C3=O,IC50,7.89,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,WTCLTDFCKVIELS-UHFFFAOYSA-N
CHEMBL375723,,CCOc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.54,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,VAHWWNLOLGHDEX-UHFFFAOYSA-N
CHEMBL4450265,,CCOC(=O)C(=O)CSC(=S)N1CCN(C(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)CC1,IC50,5.94,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,SOJDTXKJCFQTHK-UHFFFAOYSA-N
CHEMBL229682,,Cc1cnc2nc3c(n2c1)C(=O)C(=O)c1cccnc1-3,IC50,6.42,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,PAMCROMTZDXCEV-UHFFFAOYSA-N
CHEMBL4472710,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(CO)c(Br)c2)c1,IC50,4.69,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,LFVVIVJGWWBLKR-VMPITWQZSA-N
CHEMBL4513992,,N#Cc1cccc(/C=C/C(=O)c2ccc(B(O)O)cc2)c1,IC50,4.7,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,TXAAMGTWMYWEKM-RUDMXATFSA-N
CHEMBL4289953,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccc(C)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.7,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VWFWRGHAKIARPG-FVNYYNFCSA-N
CHEMBL4281496,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(C(=O)N(C)C)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.45,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,WDLHBILECKVIQB-QRPJZNGTSA-N
CHEMBL563939,,C=C1C(=O)O[C@H]2[C@H]1CC/C(CO)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.2,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BAURYGOYSLZFPX-OOCKOLEWSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.8,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL331562,,COc1cc(OC)c2c(n1)C(=O)c1nccc3ccnc-2c13,IC50,5.3,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,LPXZPIDBMLWYEL-UHFFFAOYSA-N
CHEMBL4214832,,O=C(c1sc(N2CCOCC2)nc1-c1ccccc1)c1cnc2ccccn12,IC50,4.31,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,GBPLYOGNUSFBQU-UHFFFAOYSA-N
CHEMBL4213059,,CCOC(=O)c1c(Nc2ccccc2)sc(C(=O)c2cnc3ccc(Br)cn23)c1C,IC50,4.35,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,NZASTSOWNIDXGJ-UHFFFAOYSA-N
CHEMBL4636044,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccc(Cl)cc3)cc2)n1,IC50,4.81,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ABPYUTLLWASPRF-UHFFFAOYSA-N
CHEMBL84615,,COc1ccc(-c2cc3cccc(OC)c3nc2O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,HKAWJXBQZFSPAP-UHFFFAOYSA-N
CHEMBL512404,"6,7-DIHYDROPHOMOPSOLIDE B",C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CC[C@H](O)[C@H](C)O,IC50,4.77,CHEMBL4374033,Antiproliferative activity against human SNB75 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SNB-75,ZFVYHTGRRBKBJE-BUEHMHBYSA-N
CHEMBL3353050,,COc1ncc(OC)c2c(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c[nH]c12,IC50,6.72,CHEMBL3383785,Antiviral activity against HIV1 isolate Hxbc2 pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,QGMJLQAXMOHHGW-UHFFFAOYSA-N
CHEMBL5432753,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSCc2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC1=O,IC50,4.59,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,DVDRXPZWLYMDAV-RUZHBQKASA-N
CHEMBL3343380,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.95,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LSMQAIIXZQNXQM-UHFFFAOYSA-N
CHEMBL3353052,,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)C5=CCCCC5)CC4C3)c12,IC50,8.7,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,LKQWIKPNCGJODX-UHFFFAOYSA-N
CHEMBL1088479,,Oc1ccc(CN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.14,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,NQZPXVDZVBQIMG-UHFFFAOYSA-N
CHEMBL3765717,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2cccc3c2OCO3)nn1,IC50,4.87,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NKQQRAOWVIRWMW-UHFFFAOYSA-N
CHEMBL3764489,,COc1ccc(OC)c(Cn2cc(CN3C(=O)c4ccccc4Nc4ccccc43)nn2)c1,IC50,4.51,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GVXVAXXSEOPHNV-UHFFFAOYSA-N
CHEMBL3765034,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2cccc([N+](=O)[O-])c2)nn1,IC50,4.41,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,WPNXOFYHYZPMFX-UHFFFAOYSA-N
CHEMBL1727312,,O=C1Nc2ccccc2Nc2ccccc21,IC50,5.05,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KVVFXAAMMFTLGN-UHFFFAOYSA-N
CHEMBL589334,,O=C(Nc1nonc1NC(=O)c1ccc(Cl)c(Cl)c1)c1ccc(Cl)c(Cl)c1,IC50,4.62,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,DTRWBMYIPKRKIG-UHFFFAOYSA-N
CHEMBL590060,,O=C(Nc1nonc1NCc1ccc(C(F)(F)F)cc1)c1ccc(C(F)(F)F)cc1,IC50,4.74,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,PWTGEUJARMSQJL-UHFFFAOYSA-N
CHEMBL589654,,O=C(Nc1nonc1NC(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1,IC50,4.85,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,KMLMFVHYNPHSKD-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,5.63,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL3310803,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(C)=O)sc3n2)cc1C(N)=O,IC50,4.66,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CLWBLMPJCULBNA-UHFFFAOYSA-N
CHEMBL3310595,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(C)=O)sc3c2)cc1C(N)=O,IC50,5.32,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JOEINCOGUSOUGJ-UHFFFAOYSA-N
CHEMBL510689,,CCCCCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.08,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,CNHTXGFKRXLTSK-UHFFFAOYSA-N
CHEMBL455692,,O=C1NN(c2ccc(Cl)cc2)C(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.6,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,LQYHJDXUKCOVHT-UHFFFAOYSA-N
CHEMBL1095526,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(-c3ccc(Br)cc3)nn2)[C@H]1Br,IC50,5.63,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NZVSQWCKQJGRFR-PGRDOPGGSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.39,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3819467,,COC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C,IC50,6.81,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,ABYIXBHLPAQXPA-GMAHTHKFSA-N
CHEMBL3823904,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1cc(C)ccc1O,IC50,4.53,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JTPRTYHCGQWTIQ-UHFFFAOYSA-N
CHEMBL3822526,,Cl.O=C1C(O)=C(C(NCc2ccccn2)c2ccccc2)C(=O)c2ccccc21,IC50,4.87,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BUOKVJTXDXBLGW-UHFFFAOYSA-N
CHEMBL3818934,,CC[C@H](C)[C@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)N[C@H](C(=O)OC)C(C)C,IC50,7.11,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,SWTHVLJASKSMJY-RTFZILSDSA-N
CHEMBL3808804,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(Cl)cc4)n3)ccc21,IC50,5.24,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,QLNWHUKZRAWJTQ-OEAKJJBVSA-N
CHEMBL3819416,,CCOC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12,IC50,7.93,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,TXTXUJCZFZSISJ-SVBPBHIXSA-N
CHEMBL1927620,,COc1ccc(Nc2cc3c4c(cccc4c2)C(=O)N(CCN(C)C)C3=O)cc1,IC50,5.6,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SSEXKCGUQBIZQI-UHFFFAOYSA-N
CHEMBL4757657,,CC(=O)c1nc(C(=O)NCCc2ccccc2)cc2c3ccccc3n(C)c12,IC50,5.13,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,IXLQKNHMXNZJEX-UHFFFAOYSA-N
CHEMBL4791630,,COc1cc(/C=N/OCCc2ccccc2)nc(-c2ccccn2)c1,IC50,5.19,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,QYSCAYMWRYGKNI-PXLXIMEGSA-N
CHEMBL242273,SAFROLE,C=CCc1ccc2c(c1)OCO2,IC50,4.49,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,ZMQAAUBTXCXRIC-UHFFFAOYSA-N
CHEMBL3823206,,O=C1C(O)=C(C(NCc2ccccc2)c2ccccc2O)C(=O)c2ccccc21,IC50,4.64,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SXDWAISNZRQGAJ-UHFFFAOYSA-N
CHEMBL3824072,,O=C1C(O)=C(C(NCc2ccco2)c2ccccc2O)C(=O)c2ccccc21,IC50,4.63,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SZWJGUXSXYDHPK-UHFFFAOYSA-N
CHEMBL3823672,,O=C1C(O)=C(C(NCc2ccco2)c2ccccn2)C(=O)c2ccccc21,IC50,5.48,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PRKREBUEXHLVHP-UHFFFAOYSA-N
CHEMBL3823768,,Cl.O=C1C(O)=C(C(NCc2ccco2)c2ccccc2O)C(=O)c2ccccc21,IC50,5.75,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MXHHMVOMUIHVFM-UHFFFAOYSA-N
CHEMBL577771,,CC(C)COC1C2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.47,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZZLALCFNNDPTFZ-UHFFFAOYSA-N
CHEMBL576075,,CC1(C)OC2c3ccccc3C(=O)C(=O)C2C1Nc1ccc(Br)cc1Br,IC50,5.74,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WSVMBURZMWMWQM-UHFFFAOYSA-N
CHEMBL3765812,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccccc2)cc(OC)c1OC,IC50,5.77,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,QBILAUSHKIMZES-QGOAFFKASA-N
CHEMBL3618232,,CCOc1ccc(Nc2nc3ccccn3c2-c2nc(C)nc(N)n2)cn1,IC50,6.64,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,GGFHCTGTQGWFGO-UHFFFAOYSA-N
CHEMBL3618243,,COc1ncc(Nc2nc3ccc(N4CCN(C(=O)N(C)C)CC4)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,7.7,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,DSSCANDYWLGILC-UHFFFAOYSA-N
CHEMBL3765648,,C#CCN1C(=O)c2ccccc2Nc2ccccc21,IC50,4.65,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FGTQLWWGYPNADS-UHFFFAOYSA-N
CHEMBL4465698,,O=C(Nc1nc2ccc(Cl)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,5.17,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QXCIEDZGQFZJML-UHFFFAOYSA-N
CHEMBL4573769,,O=C(Nc1nc2ccc(F)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,5.11,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UKGBKCFHDNJRLB-UHFFFAOYSA-N
CHEMBL4562600,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccc(F)cc3s2)cc1,IC50,5.05,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AJOGVWDWLQQQOQ-UHFFFAOYSA-N
CHEMBL5630503,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccccn1,IC50,5.28,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,FWVDWLZTKCLROH-SDNWHVSQSA-N
CHEMBL5630721,,N#Cc1cccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)c1,IC50,5.21,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,SNEVTNDOJSNZIN-SDNWHVSQSA-N
CHEMBL5629880,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccsc1,IC50,5.07,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,TVQDBFXSSPGEQE-DHZHZOJOSA-N
CHEMBL593789,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](N)CC[C@@H]12,IC50,4.72,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,QZHNTBOWRLWTGQ-SSTWWWIQSA-N
CHEMBL2152488,,CCCC(=O)c1c(O)cc(O)cc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,IC50,5.41,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,WVNHYQZOJMNKPX-YMILTQATSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.03,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3588940,,CCC(=O)OC/C=C/c1ccc(OC(=O)CC)c(OC)c1,IC50,4.54,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,PSICOQVXYUXPFH-VOTSOKGWSA-N
CHEMBL2435996,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.75,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JHPYVZOWKUWFIK-UHFFFAOYSA-N
CHEMBL2435986,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.17,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HSAFYPRFIPETBQ-UHFFFAOYSA-N
CHEMBL509032,TAE-684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,IC50,4.59,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,QQWUGDVOUVUTOY-UHFFFAOYSA-N
CHEMBL515416,,Cc1ccc(-c2c(C(=O)CCl)n(CCCO)c3ncnc(N)c23)cc1,IC50,4.58,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,PELFTNQHGSITLB-UHFFFAOYSA-N
CHEMBL1224212,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](N)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,WCGACJRBLKTESN-ROUWMTJPSA-N
CHEMBL1224276,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.43,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,HIGZHNZNMNPJGR-VFUWXHBOSA-N
CHEMBL1224277,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,KSWVGOVMAMCCSP-CIKSYDIPSA-N
CHEMBL3114585,,CC1(C)CC(Nc2ccc([N+](=O)[O-])cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.22,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,XCOQGXREIJCFKD-UHFFFAOYSA-N
CHEMBL3116233,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)cc5F)C4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.8,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RHUAFKWPDLSXRB-HIXSDJFHSA-N
CHEMBL3116226,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.24,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MNIXGYJFGPTMQH-FCDQGJHFSA-N
CHEMBL3343408,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@@](=O)(c3ccccc3)[C@@H](O)[C@H]2O1,IC50,4.87,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,MAKXAOVRUMEYMV-DTNCKUBDSA-N
CHEMBL3116441,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5c(C)cccc5C)C4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.91,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DBSGJIPIKKIBIF-YYADALCUSA-N
CHEMBL3343416,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](Oc3ccc([N+](=O)[O-])cc3)[C@H]2O1,IC50,5.51,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,IHWLXVIGVQBSQG-KYGNLPSGSA-N
CHEMBL3116242,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccccc5)C4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.85,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZNTNQMVEAXDENP-HPNDGRJYSA-N
CHEMBL1668102,CORNUSALTERIN I,CO[C@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)C3=CC[C@@]12C,IC50,4.91,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WISSQECJGFKWLU-NBCACCRGSA-N
CHEMBL1668105,CORNUSALTERIN L,CC(C)=C[C@@H]1C[C@@H]([C@@H]2CC[C@]3(C)C4=CCC5C(C)(C)C(=O)CC[C@]5(C)[C@H]4CC[C@@]23C)CO1,IC50,5.24,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WAGHSYJXJAHWPX-DYRFBARISA-N
CHEMBL4760225,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CC(O)C3)n2)cc1,IC50,5.88,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,PLUFCDKZJSBUCF-YIXHJXPBSA-N
CHEMBL3339353,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(OC(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.35,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,APJOVJKWLATWSU-LALXJTNGSA-N
CHEMBL3339358,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.09,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MYCWVKJMXJUBHH-QLQYKETESA-N
CHEMBL3339359,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(OC(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.48,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OLLYZHAQVQRWOV-LALXJTNGSA-N
CHEMBL3339364,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccncc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.3,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MAQWJQFILIDGFF-XICOUIIWSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.99,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL5287724,,Cl.O=c1oc2ccc(Br)cc2c(Cl)c1-c1nc2cc(C3=NCCN3)ccc2[nH]1,IC50,4.39,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,RKAKZAJBOJDWAM-UHFFFAOYSA-N
CHEMBL5266539,,Cc1ccc2oc(=O)c(-c3nc4cc(C5=NCCN5)ccc4[nH]3)c(Cl)c2c1.Cl,IC50,5.04,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,DWBBQVKIFZYNLH-UHFFFAOYSA-N
CHEMBL5266313,,CCCCCCCC/C=C\CCCCCCCC(=O)OCC(O)COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],IC50,4.2,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,OJTTZZCPHGUDDM-KVVVOXFISA-M
CHEMBL374319,,O=C(CC1CN(C(=O)Nc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.06,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,FYPLQLJHWZUXDJ-UHFFFAOYSA-N
CHEMBL411343,,O=C(CC1CNCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.26,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVRGDTHDSIEZRY-UHFFFAOYSA-N
CHEMBL5400611,,O=[N+]([O-])c1ccccc1S(=O)(=O)N1c2ccccc2Sc2ccc(Cl)cc21,IC50,5.29,CHEMBL5345086,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,LADLBLLULGLYTQ-UHFFFAOYSA-N
CHEMBL5563702,,COc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1OC,IC50,5.31,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,NBCPRDXMNXGMJJ-UHFFFAOYSA-N
CHEMBL2037139,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1-c1ccc(F)cc1,IC50,4.27,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,MXLWCPNGFWKHOW-UHFFFAOYSA-N
CHEMBL591429,PAC-1,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,IC50,4.21,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,YQNRVGJCPCNMKT-LFVJCYFKSA-N
CHEMBL5275244,,C/C(=C\CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1)c1ccccc1,IC50,4.65,CHEMBL5225164,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,CCEWBVIQKCUYJV-WOJGMQOQSA-N
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,6.71,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,PHXJVRSECIGDHY-UHFFFAOYSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,4.57,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,4.71,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL477772,PAZOPANIB,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,4.35,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,CUIHSIWYWATEQL-UHFFFAOYSA-N
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,4.93,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,PLHJCIYEEKOWNM-HHHXNRCGSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,6.49,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL102714,SB-216763,Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21,IC50,4.63,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JCSGFHVFHSKIJH-UHFFFAOYSA-N
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,4.56,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,5.4,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,OGNYUTNQZVRGMN-UHFFFAOYSA-N
CHEMBL1173055,RUCAPARIB,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.25,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,HMABYWSNWIZPAG-UHFFFAOYSA-N
CHEMBL509032,TAE-684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,IC50,5.37,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,QQWUGDVOUVUTOY-UHFFFAOYSA-N
CHEMBL209148,,COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1,IC50,5.15,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,ZHXNIYGJAOPMSO-UHFFFAOYSA-N
CHEMBL1256459,TORIN1,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,IC50,7.2,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AKCRNFFTGXBONI-UHFFFAOYSA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,6.11,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL5422449,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc([N+](=O)[O-])ccc32)cc1,IC50,4.63,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,DFAFUDAUZSLLOV-UHFFFAOYSA-N
CHEMBL5396541,,Cc1cc(Cc2cn(C(=O)c3ccc(N4CCOCC4)cc3)c3ccccc23)cc(C)c1O,IC50,4.9,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,OPTKSQIHKUVTLN-UHFFFAOYSA-N
CHEMBL5275244,,C/C(=C\CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1)c1ccccc1,IC50,4.55,CHEMBL5225163,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,CCEWBVIQKCUYJV-WOJGMQOQSA-N
CHEMBL5409597,,Cc1cc(Cc2cn(C(=O)c3ccc(N4CCN(C)CC4)cc3)c3ccccc23)cc(C)c1O,IC50,5.25,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,UTYASBSXPIEEBV-UHFFFAOYSA-N
CHEMBL5277464,,C/C(=C\CN1CCN(C(=O)C2CCCC2)CC1)c1ccccc1,IC50,7.95,CHEMBL5225165,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,NRJLQONGQFSUJQ-GZTJUZNOSA-N
CHEMBL5274257,,c1ccc(Cn2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,5.09,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,TZZYVYSPVJUUAS-UHFFFAOYSA-N
CHEMBL5284548,,COc1cccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)c1,IC50,4.57,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,COGKKBFAXIHFCH-UHFFFAOYSA-N
CHEMBL5288388,,CCCCN(CCCC)c1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,4.83,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,UFPJMBOLQATAPQ-UHFFFAOYSA-N
CHEMBL4871938,,CC12CC3CC(C)(C1)CC(NCc1ccc(NC(=O)CCCCCCC(=O)NO)cc1)(C3)C2,IC50,5.53,CHEMBL5138196,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition,U-87MG ATCC,WLSVOCQBROCUNL-UHFFFAOYSA-N
CHEMBL5180973,,C[C@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](C6CCC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@@H](O)[C@@H]1O,IC50,4.3,CHEMBL5141038,Cytotoxicity against human T98G cells assessed as cell viability,T98G,JEFAXHDYQYKEJF-PCRCQVQCSA-N
CHEMBL259181,,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,IC50,4.61,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,DOKZLKDGUQWMSX-HKBQPEDESA-N
CHEMBL1091644,LINSITINIB,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,IC50,4.75,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,PKCDDUHJAFVJJB-VLZXCDOPSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,5.66,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,4.28,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,4.52,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,JAMULYFATHSZJM-UHFFFAOYSA-N
CHEMBL379975,,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,IC50,4.25,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,DPEXRCOBPACFOO-UHFFFAOYSA-N
CHEMBL1186585,,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,IC50,4.79,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,MIDUFIRTIFUTQA-UHFFFAOYSA-N
CHEMBL1923234,WP 1066,C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1,IC50,5.25,CHEMBL1925866,Antitumor activity against human U87MG cells after 24 to 72 hrs by MTT assay,U-87MG ATCC,VFUAJMPDXIRPKO-LQELWAHVSA-N
CHEMBL2180738,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cscn1)c1cccc(F)c1,IC50,6.54,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,RJMFNCWCWHLUKE-UHFFFAOYSA-N
CHEMBL2206921,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,IC50,7.62,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,KLMZZLVCEDUTEA-UHFFFAOYSA-N
CHEMBL4452490,,COc1ccc(CCn2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)nc3ccccc32)cc1,IC50,5.64,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,MFEBEVDFAFMXRL-UHFFFAOYSA-N
CHEMBL4078550,,CC(=O)Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1,EC50,5.8,CHEMBL4008906,Cytotoxicity against human A172 cells assessed as reduction in cell viability after 3 days by Alamar blue assay,A-172,PVFNDFZQGWYILU-UHFFFAOYSA-N
CHEMBL4096575,,Nc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1,EC50,5.8,CHEMBL4008906,Cytotoxicity against human A172 cells assessed as reduction in cell viability after 3 days by Alamar blue assay,A-172,ATXGVVQAUKKFAN-UHFFFAOYSA-N
CHEMBL456237,LXR-623,Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1,IC50,5.21,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,KYWWJENKIMRJBI-UHFFFAOYSA-N
CHEMBL4089188,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.38,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZRKCGJAPYRMUKR-UHFFFAOYSA-N
CHEMBL4076472,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(OC(F)(F)F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.91,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SFIKFXAMCYSROC-UHFFFAOYSA-N
CHEMBL2088440,,Clc1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,4.81,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,PQOPXVVBFWJXRY-RWPZCVJISA-N
CHEMBL179692,,Cc1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1,IC50,4.0,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,VWGSOKPABCWLQZ-UHFFFAOYSA-N
CHEMBL3980709,,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1cn(C2CCCCC2)nn1,IC50,7.38,CHEMBL4343297,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,HYTQLHJUBJETIG-UHFFFAOYSA-N
CHEMBL4285842,,COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5c4ccn5C)cc3)cc3cccnc32)cc1,IC50,5.29,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XZCWAWCAVJWZRC-UHFFFAOYSA-N
CHEMBL4785287,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N(C)C)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3CCC(=O)[C@H](C)O3)[C@H](C)O2)[C@H](C)O1,IC50,7.48,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,BUNNANZEUZITRL-KGLUEZTISA-N
CHEMBL480881,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.22,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,QOBGUGDUMKZVRC-ZLYZMSFYSA-N
CHEMBL2165024,,COc1ccc(Nc2ncc(C)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.51,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,SZCHCSAKGOOKBA-UHFFFAOYSA-N
CHEMBL106533,,CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.89,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XTHDDZXLYYZMNX-MHTZHOPKSA-N
CHEMBL109008,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1,IC50,8.77,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XEXZQYWUVMECQG-VEWQFJOQSA-N
CHEMBL4757519,,C#CCOc1ccc(/C=C/C(=O)c2cccc(C)c2)cc1OC,IC50,5.75,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,SBSQSTCPERSBLO-CSKARUKUSA-N
CHEMBL4788616,,C#CCOc1ccc(/C=C/C(=O)c2ccc(C(C)C)cc2)cc1CC=C,IC50,5.55,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,SZDSTOYHZATNIY-RIYZIHGNSA-N
CHEMBL3233842,,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,IC50,7.26,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,PUOOCZVRHBHJRS-NSHDSACASA-N
CHEMBL4640030,,CC(=O)NCC(=O)N1CCC[C@@H]1B(O)O,IC50,6.18,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,UUOZISWTWURDGU-SSDOTTSWSA-N
CHEMBL5432925,,O=C(Nc1ccc(OS(=O)(=O)c2ccc(F)cc2)cc1)C12CC3CC(CC(C3)C1)C2,IC50,5.74,CHEMBL5332775,Cytotoxicity against human SF-295 cells assessed as cell growth inhibition,SF295,LLXLLGJJXOHBLG-UHFFFAOYSA-N
CHEMBL534720,,Cl.Oc1cc2c(cc1O)C(Cc1ccc(-c3ccccc3)cc1)NCC2,IC50,4.99,CHEMBL913226,Cytotoxicity against human T98G cell line,T98G,KBMNQYDZBKKKPH-UHFFFAOYSA-N
CHEMBL505426,,N=C(N)NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCN)NC1=O,IC50,7.95,CHEMBL1021542,Displacement of [125I]c(RGDyK) form integrin alphaVbeta3 receptor in human U87MG cells,U-87MG ATCC,MFWXFNOXLDIPDQ-YSTOQKLRSA-N
CHEMBL2372257,,CSCC[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)CCCCCNC(=O)CC[C@H](NC(=O)COCCOCCOCCNC(=O)c1ccc(F)cc1)C(=O)NCCCC[C@H]1NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(C)C)C(N)=O,IC50,7.86,CHEMBL1021542,Displacement of [125I]c(RGDyK) form integrin alphaVbeta3 receptor in human U87MG cells,U-87MG ATCC,DOYWSGYUIHABGZ-ZKRQTGDMSA-N
CHEMBL2375478,,CCCCCCc1cn(C2C3=C(OC2(C)C)C(=O)c2ccccc2C3=O)nn1,IC50,4.95,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SJBRGTUWMZZBJW-UHFFFAOYSA-N
CHEMBL4862917,,O=C(CCCCCNC(=O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O)NO,IC50,5.1,CHEMBL4819318,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BWMRGOQFHBXKQR-UHFFFAOYSA-N
CHEMBL5276739,,CCN(CC)c1ccc2cc(-c3nc4ccc(C5=NCCCN5)cc4s3)c(=O)oc2c1.Cl,IC50,5.75,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,UKKQYSJWHJRPII-UHFFFAOYSA-N
CHEMBL3092921,,C=CCCCCOc1ncc(-c2cc(F)c(F)cc2OC)n1C,IC50,4.28,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,VVEQYBXCZNMQNX-UHFFFAOYSA-N
CHEMBL3092923,,C=CCCCCOc1ncc(-c2cccc(OC)c2OC)n1C,IC50,4.46,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,YQSRFHNQNFWUBY-UHFFFAOYSA-N
CHEMBL3092924,,C=CCCCCOc1ncc(-c2cc(Cl)ccc2OC)n1C,IC50,4.32,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,NKWGZVYZEXLKAP-UHFFFAOYSA-N
CHEMBL4635731,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CCCCC3)cc2)n1,IC50,4.39,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QYAOLXACVZFCGN-UHFFFAOYSA-N
CHEMBL4647086,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)c3)cc2)n1,IC50,4.94,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RQMVMSIAPOLUTD-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.16,CHEMBL3107274,Cytotoxicity against human SF295 cells by colorimetric method,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5177050,,O=C(NCc1ccccc1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.01,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,UGPZJVXEWINCSS-UHFFFAOYSA-N
CHEMBL5194390,,O=C(c1cc2c(F)cc(F)cc2[nH]1)N1CCN(C(=O)C23CC4CC(CC(C4)C2)C3)CC1,IC50,5.18,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,UDCDUUNSNJZOLI-UHFFFAOYSA-N
CHEMBL4556790,,Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1,IC50,5.03,CHEMBL4830056,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB method,U-87MG ATCC,WHVFOLXIIVBJTJ-ICCPGPOKSA-N
CHEMBL4759393,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(-c2ccccc2)c1,IC50,4.64,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,HNKXJPOYCMLZTF-UHFFFAOYSA-N
CHEMBL5517715,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCNCc1ccc(OCc2cccc(-c3ccccc3)c2C)c(C)c1,IC50,6.05,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,VHEDXODWNHMDGM-UHFFFAOYSA-N
CHEMBL4089730,,COc1nc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCNC(C)=O,IC50,5.43,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JEDPSOYOYVELLZ-UHFFFAOYSA-N
CHEMBL106982,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1,IC50,8.15,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,JYDQSSJQXSQYRG-UHFFFAOYSA-N
CHEMBL2206912,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)c3ccc(F)cc3)c2)n1,IC50,6.73,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,MUNMOKXVNKEMSH-UHFFFAOYSA-N
CHEMBL3116222,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.07,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BZKQEYSSBLBNPN-YYADALCUSA-N
CHEMBL2417829,,COc1ncc(-c2ccn3nc(NC(C)=O)nc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.62,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,SOQLTQJZRHAVGO-UHFFFAOYSA-N
CHEMBL2417825,,COc1ncc(-c2ccc3nc(NCC(N)=O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.24,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NKFBDFWZPCTYSY-UHFFFAOYSA-N
CHEMBL2417822,,COCCNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.19,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,DMJWWRFOIPKAKG-UHFFFAOYSA-N
CHEMBL2417832,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(C)cc4)c3)cn2n1,IC50,5.42,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OQCDYFGZHKFLRD-UHFFFAOYSA-N
CHEMBL4293675,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(Br)cc5F)c4=O)cc3F)ccnc21,IC50,5.19,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ABHROHNOIKXFRR-UHFFFAOYSA-N
CHEMBL3353410,OSIMERTINIB,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,IC50,5.35,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,DUYJMQONPNNFPI-UHFFFAOYSA-N
CHEMBL4785096,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCN(C)CC1,IC50,5.06,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,UZCSYQJYKYYMFC-UHFFFAOYSA-N
CHEMBL4743685,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1,IC50,5.44,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,GXMXPDYKQYFDRV-UHFFFAOYSA-N
CHEMBL4558324,LAZERTINIB,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,IC50,4.48,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,RRMJMHOQSALEJJ-UHFFFAOYSA-N
CHEMBL4755027,,C=CC(=O)Nc1ccc(OC)c(Nc2cc(-n3c(C)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,4.17,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,BKLRUEWKYUHYEW-UHFFFAOYSA-N
CHEMBL1652072,,CCCC1=C(OC2(CCC)C(=O)C(=O)C3=C(CCCC3)C2=O)C(=O)C2=C(CCCC2)C1=O,IC50,4.94,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FRQWJNQRFLUIDW-UHFFFAOYSA-N
CHEMBL1652076,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccc(F)cc3)[nH]c21,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VLIGWLHULWIRAT-UHFFFAOYSA-N
CHEMBL1652080,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3cccc(O)c3)[nH]c21,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JXSAPDKRKSXFLK-UHFFFAOYSA-N
CHEMBL3792614,,CCc1c2c(nc3ccc(B(O)O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,IC50,7.33,CHEMBL3795470,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by SRB assay,U-87MG ATCC,HYJCSFCPRVFVTP-QFIPXVFZSA-N
CHEMBL3410528,,O=C1/C(=C/c2ccc(Oc3ccccc3)cc2)CS(=O)(=O)C/C1=C\c1ccc(Oc2ccccc2)cc1,IC50,5.53,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,MDDJCAZXZQKGCV-FQHZWJPGSA-N
CHEMBL3793128,,CC(C)CCOC(=O)[C@H](CC(=O)OCc1ccccc1)NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1,EC50,4.36,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,UQEANUVGLTTYRD-KLSNLWCXSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.96,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.78,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL6067492,BLEOMYCIN,,IC50,5.79,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.61,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,8.42,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,6.38,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL3793546,,NCCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.29,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,PHLHGJXJLNVFHS-UHFFFAOYSA-N
CHEMBL4299292,,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@H]2C)c(N)c1=O,IC50,4.64,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,RJURFGZVJUQBHK-XXEICVIVSA-N
CHEMBL4754075,,CO[C@@]1(C)N(/C=C\c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,5.64,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,KQGIOFULIYUITH-XWDDPXMASA-N
CHEMBL4784386,,CC(=O)NC[C@H](OC(=O)c1cc2c3ccccc3n(C)c2c(=O)[nH]1)c1ccccc1,IC50,4.72,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,DPGAFACESYVFJH-FQEVSTJZSA-N
CHEMBL4787536,,C=CC(=O)Nc1cccc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,5.46,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,PDWKHLVZXHJEBJ-UHFFFAOYSA-N
CHEMBL4753387,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCC(N2CCOCC2)CC1,IC50,4.82,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,LGDFMQYYSVNPIA-UHFFFAOYSA-N
CHEMBL4798480,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)ccc1N(C)CCN(C)C,IC50,5.62,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,NUUYIUFDSIHSCZ-UHFFFAOYSA-N
CHEMBL2172483,,COc1ncccc1-c1ccc2nc(Nc3cc[nH]n3)c(-c3nc(C)nc(N)n3)n2c1,IC50,6.29,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,OEYUWZFJYRUVIQ-UHFFFAOYSA-N
CHEMBL2172481,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccccc4C)cn23)n1,IC50,6.19,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,ADTCCVMJGTXFQL-UHFFFAOYSA-N
CHEMBL2172640,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccncc4)cn23)n1,IC50,6.49,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,LDNZOZBLULAYOM-UHFFFAOYSA-N
CHEMBL2037443,,C/C(=N/NC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.92,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VCKFVZSNSWYSKQ-ZDLGFXPLSA-N
CHEMBL2037433,,C/C(=N\NC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.21,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NOHGJWJQBAAVFP-VCHYOVAHSA-N
CHEMBL1771488,,C/C(=N\NC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.51,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PMHTWYVKIPHSFS-VCHYOVAHSA-N
CHEMBL2037451,,C/C(=N/NC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.8,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PTOHINKLMXPSKL-YVLHZVERSA-N
CHEMBL2037444,,C/C(=N/NC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,8.0,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,RLHHYLRHRGHQLT-ZDLGFXPLSA-N
CHEMBL2037434,,C/C(=N\NC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.23,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NRNNRLWHLIPYQW-VCHYOVAHSA-N
CHEMBL593296,,CC1(C)CC(NC(=S)Nc2ccc([N+](=O)[O-])cc2)c2cc(Br)ccc2O1,IC50,5.3,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,WVQRNYQXPPQDMD-UHFFFAOYSA-N
CHEMBL3121280,,CCOc1ccccc1C1C(C#N)=C(N)Oc2cc(N(C)C)ccc21,EC50,6.85,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KJDUDNAIMFWPEI-UHFFFAOYSA-N
CHEMBL2170088,,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)C[C@@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,9.0,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-UONOGXRCSA-N
CHEMBL3114588,,CC1(C)CC(Nc2ccc(Cl)cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,7.16,CHEMBL4407636,Anticancer activity against human SF295 cells,SF295,MTKBKUDYIJQHSH-UHFFFAOYSA-N
CHEMBL3628030,,C/C=C(/C)C(=O)O[C@H]1C[C@@H](C)[C@]2(O)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.07,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,NPUVRWFJDAPMIA-IIHJLFQTSA-N
CHEMBL1241156,,CC(=O)Oc1ccccc1C(=O)Oc1ccc2ccccc2c1/C=N/NC(=O)c1cc(-c2ccc3ccccc3c2)n[nH]1,IC50,5.82,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,ICQQXCFFGHOVQV-JEPNHJGPSA-N
CHEMBL3622408,,Cl.O=C(CNCc1ccc(Cl)cc1)NC1(CO)CSC2=C1C(=O)c1ccccc1C2=O,IC50,5.9,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,NFYHBDUZAGMYBX-UHFFFAOYSA-N
CHEMBL3941850,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCNC(=O)c1ccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)cc1)[C@@H]3C,EC50,6.54,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,QWEQVKBMVKWEOC-KQNUSQPASA-N
CHEMBL2164399,,Cc1c2c(cc[n+]1CCC(C)C)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,6.37,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,LTUZKKASTPUPTL-UHFFFAOYSA-M
CHEMBL2165004,,COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)C3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.42,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,WGLLEJISTFRVBO-UHFFFAOYSA-N
CHEMBL2178606,,COC(C)(C)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1,EC50,6.42,CHEMBL2186327,Cytotoxicity against human A172 cells incubated for 4 days,A-172,BRCOIQMZYMWNIS-UHFFFAOYSA-N
CHEMBL2170083,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)C[C@@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.15,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SCIVONNAMHTUEH-ZDUSSCGKSA-N
CHEMBL2170096,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.22,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,HUIOREQGDCWTAK-UHFFFAOYSA-N
CHEMBL2165017,,COc1ccc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.8,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,RNTFRUPRTOCGJO-UHFFFAOYSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.99,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL4439727,,C=CC(=O)N1CC(OCc2ccc([C@H](C)Nc3ncc4c(n3)N(CC(C)C)C(=O)OC4)cc2)C1,IC50,5.89,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,CXBUALZPMGDWCK-KRWDZBQOSA-N
CHEMBL265129,,CC1(C)CC(NC(=O)Nc2ccccc2Cl)c2cc(F)ccc2O1,IC50,4.57,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,UVIYGERZPMGKKA-UHFFFAOYSA-N
CHEMBL2037446,,C/C(=N/NC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.09,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,JJPHEFXBDVUGNK-ZDLGFXPLSA-N
CHEMBL3775949,,COc1ccc(/C=C2/SC(=S)NC2=O)cc1,IC50,5.02,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,ORGCJYCWFZQEFX-RMKNXTFCSA-N
CHEMBL2164697,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,7.16,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,NLEJXNYUARRSPP-UHFFFAOYSA-M
CHEMBL229677,,COc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.19,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,JUNIDICBWWHAIV-UHFFFAOYSA-N
CHEMBL388108,,Cc1cccc2nc3c(nc12)C(=O)c1cnncc1C3=O,IC50,7.68,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,NNNYJMAMMVVSGX-UHFFFAOYSA-N
CHEMBL229725,,CN(C)c1ccc2nc3c(nc2c1)C(=O)c1cnncc1C3=O,IC50,7.16,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,YDLWGYKUXASPDB-UHFFFAOYSA-N
CHEMBL112210,,C=CCN(C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nsc2c1.O=C(O)/C=C/C(=O)O,IC50,5.28,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,JSJLJATXQGZYCY-WLHGVMLRSA-N
CHEMBL334470,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1,IC50,9.35,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,JWRNDENHFBRQCM-ROUUACIJSA-N
CHEMBL3359312,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,5.14,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,BNKPHPSLFQUVGS-QUMRLDBXSA-N
CHEMBL2163592,,CC(C)N(Cc1ccc2c(c1)C=CC(C)(C)O2)S(=O)(=O)c1ccccn1,IC50,4.0,CHEMBL2169673,Cytotoxicity against human LN229 cells transfected with V6R incubated for 3 days under normoxic condition by SRB assay,LN-229,WHQXEGKAFBEKSG-UHFFFAOYSA-N
CHEMBL2172635,,COc1cnnc(Nc2cc(-c3c(Nc4cc[nH]n4)nc4cccnn34)nc(C)n2)c1,IC50,7.07,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,UNITWMRQPUTNPC-UHFFFAOYSA-N
CHEMBL3263220,,OCCCC[C@@H]1[C@H]2CCCN3CCC[C@H](CN1Cc1ccc(Cl)cc1)[C@@H]23,IC50,5.34,CHEMBL3265609,Antiproliferative activity against human U87 cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,RRXAVFYUKAUFBY-NMIHRBCNSA-N
CHEMBL447283,,CC1(C)CC(NC(=S)Nc2ccc(Cl)cc2)c2cc(Br)ccc2O1,IC50,4.66,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,XGJJLDUNEIOCCW-UHFFFAOYSA-N
CHEMBL595929,,CC1(C)CC(NC(=S)Nc2cccc(C#N)c2)c2cc(F)ccc2O1,IC50,4.41,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,SVXRPXPNIGGEQX-UHFFFAOYSA-N
CHEMBL593820,,CC1(C)CC(NC(=S)Nc2cccc([N+](=O)[O-])c2)c2cc(Cl)ccc2O1,IC50,5.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,AXJORAYOMXRLIH-UHFFFAOYSA-N
CHEMBL608379,,CC1(C)CC(NC(=S)Nc2ccc([N+](=O)[O-])cc2)c2cc(Cl)ccc2O1,IC50,5.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,VGYSEYVWIATBOW-UHFFFAOYSA-N
CHEMBL1770165,,C/C(=N\NC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.18,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,MXWJIUNQTNDDFG-LICLKQGHSA-N
CHEMBL2037343,,CC(=NNC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.18,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,MXWJIUNQTNDDFG-UHFFFAOYSA-N
CHEMBL2037338,,CC(=NNC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,7.77,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,RLHHYLRHRGHQLT-UHFFFAOYSA-N
CHEMBL2037343,,CC(=NNC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.37,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,MXWJIUNQTNDDFG-UHFFFAOYSA-N
CHEMBL2037341,,CC(=NNC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.08,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NOHGJWJQBAAVFP-UHFFFAOYSA-N
CHEMBL2164692,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-],IC50,5.72,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,URPMXKMVEZFGEM-UHFFFAOYSA-M
CHEMBL4748534,,C=C(CC)C(=O)c1ccc(OCC(=O)NC2CCN(S(=O)(=O)c3cc(Cl)ccc3OC)CC2)c(Cl)c1Cl,IC50,6.51,CHEMBL4675763,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability by CellTiter Glo luminescent assay,U-87MG ATCC,PWCOCTJTFHMKLC-UHFFFAOYSA-N
CHEMBL5429646,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(C(=O)NO)cc3)CC1)C2,IC50,4.34,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,YCJALAWIBCRZMO-UHFFFAOYSA-N
CHEMBL5568994,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc34)[C@H]21,IC50,7.19,CHEMBL5548646,Antiproliferative activity against human U-87 MG cells measured after 72 hrs by CCK-8 cells,U-87MG ATCC,ZWQBUSIGZLXUII-ZFRLZFHFSA-N
CHEMBL5426295,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,5.29,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,OMRMOMGAFQHZAC-UHFFFAOYSA-N
CHEMBL5432732,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(OC)c(OC)c(OC)c3)ccc2NS(C)(=O)=O)c1,IC50,6.66,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,MJKBNKOQSZEVKD-UHFFFAOYSA-N
CHEMBL5398502,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.67,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,FVBRYQGAGKRSGL-UHFFFAOYSA-N
CHEMBL1613444,,Cc1cc2cc3c(N)[nH]nc3nc2cc1C,IC50,4.41,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,XSYYLQJMAAYYFC-UHFFFAOYSA-N
CHEMBL1688535,,COc1ccc2cc3c(N)n[nH]c3nc2c1,IC50,5.11,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,QLIPUPSGLWIGAQ-UHFFFAOYSA-N
CHEMBL1800960,,CC[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,7.75,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,KFRXJKMLZFERKO-KSSFIOAISA-N
CHEMBL1938594,,O=C(NCCCl)NCCN1c2nc3ccccc3cc2Sc2cc3ccccc3nc21,IC50,6.6,CHEMBL4140038,Cytotoxicity against human SF295 cells assessed as cell growth inhibition after 48 hrs by SRB assay,SF295,UHFHGUCGIVHXGO-UHFFFAOYSA-N
CHEMBL301311,,COCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.58,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,BTAPSFTYZPKJCW-UHFFFAOYSA-N
CHEMBL5279289,,C=C(C)[C@@H]1CC[C@]2(COCC(O)COC(=O)CCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.[Br-],IC50,5.39,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,KFHYSMGJXBTWHM-HJZPKLIKSA-M
CHEMBL5192457,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccc(Br)cc1)O2,IC50,6.82,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,BVTMADNSDGGGHL-UHFFFAOYSA-N
CHEMBL4594201,,CC1(C)O[C@H]2O[C@H](COC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)[C@@H](OCc3ccccc3)[C@H]2O1,IC50,6.8,CHEMBL5104528,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability by MTT assay,SF295,LIRLLGKTZVCTNS-XTNHUWDISA-N
CHEMBL3116445,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5c(C)cccc5C)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.92,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QKLVIKMIZOEFFF-HPNDGRJYSA-N
CHEMBL5179999,,O=C(/C(Cl)=N/Nc1ccc(Cl)cc1Cl)n1c(-c2cc3ccccc3oc2=O)nc2ccccc21,IC50,6.54,CHEMBL5126907,Anticancer activity against human U-87 MG cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,VDAFHRPMWNIKGP-OFWBYEQRSA-N
CHEMBL4644635,,Nc1nc2cc(-c3nn(C[C@@H]4CCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,NIIYHUNRXQLMBG-JTQLQIEISA-N
CHEMBL109479,,O=C1c2nccc(Cl)c2C(=O)c2c(-c3ccccc3NC(=O)C(F)(F)F)ccnc21,IC50,7.3,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,FLQFEOXZDIDKQJ-UHFFFAOYSA-N
CHEMBL1927621,,CN(C)CCN1C(=O)c2cccc3cc(Nc4ccc([N+](=O)[O-])cc4)cc(c23)C1=O,IC50,6.21,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XYCUZANBIMHLMM-UHFFFAOYSA-N
CHEMBL4866726,,COC(=O)N(C)/N=N/c1ccc(COC(=O)Nc2cc3c4c(cccc4c2)C(=O)N(CCN(C)C)C3=O)cc1,IC50,5.56,CHEMBL4831081,Cytotoxicity against human A 172 cells assessed as cell viability measured after 96 hrs by XTT assay,A-172,MWXZUPHVAMRLKE-QVIHXGFCSA-N
CHEMBL4871205,,COC(=O)N(C)/N=N/c1ccc(COC(=O)Nc2ccc3c4c(cccc24)C(=O)N(CCN(C)C)C3=O)cc1,IC50,5.13,CHEMBL4831081,Cytotoxicity against human A 172 cells assessed as cell viability measured after 96 hrs by XTT assay,A-172,ADBGAYOGSASRBL-QVIHXGFCSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.5,CHEMBL4832265,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL313545,,CCN(CC)C(=O)CCn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,KQLZYIAOSLOOPH-UHFFFAOYSA-N
CHEMBL322816,,Nc1ccnc2c1-c1nc3ccccc3c3ccnc(c13)C2=O,IC50,7.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,CTMGEBRFAKYRJS-UHFFFAOYSA-N
CHEMBL325556,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,8.57,CHEMBL815093,Inhibition of the entry of HIV-1 reporter virus (JrF1) into U-87 cells,U-87MG ATCC,LEFAKKLOKFYYJX-QFIPXVFZSA-N
CHEMBL4634881,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccc(F)cc3)c12,IC50,4.18,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,ZSYPSJVKCHZRCX-MIGQKNRLSA-N
CHEMBL4647532,,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccc(OCCCN3CCN(C(=S)Nc4ccc5c(c4)C(=O)OC54c5ccc(O)cc5Oc5cc(O)ccc54)CC3)cc12,IC50,5.82,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,QDRXRSYKXXJICW-MHZLTWQESA-N
CHEMBL5426666,,C#CCN(C)CCCOc1ccc(N(CC)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.05,CHEMBL5371253,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,A-172,UGMCCVYCFXAQTN-UHFFFAOYSA-N
CHEMBL143637,,Cc1ccc(-c2cc3cc(C)ccc3c(N3CCN(C)CC3)n2)cc1,IC50,5.35,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,TUODPWDNYPDJGL-UHFFFAOYSA-N
CHEMBL355166,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNCCOC(C)=O,IC50,6.13,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,ZCASKJBLWLEZOT-UHFFFAOYSA-N
CHEMBL352762,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNCc1ccccc1,IC50,6.55,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,NWJPFGDQFLWPFI-UHFFFAOYSA-N
CHEMBL2087608,ISOJACAREUBIN,CC1(C)CCc2c(cc(O)c3c(=O)c4ccc(O)c(O)c4oc23)O1,IC50,5.02,CHEMBL2091818,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,NNWFEKLCJFLWGN-UHFFFAOYSA-N
CHEMBL84655,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC(=O)O)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,ZPHQIWXAIWECJH-UHFFFAOYSA-N
CHEMBL200735,,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(Cl)c3)c1C2,IC50,4.62,CHEMBL861474,Antiproliferative activity against human glioma tumor cell line U87MG,U-87MG ATCC,WVDRRFJDEHTKNN-UHFFFAOYSA-N
CHEMBL5404488,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)c(F)c3)ccc2NS(C)(=O)=O)c1,IC50,5.82,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,ZVDVPNBGOJLJEJ-UHFFFAOYSA-N
CHEMBL5422599,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(SC)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.04,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,JVKAPVVHNMBGTI-UHFFFAOYSA-N
CHEMBL5404834,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.68,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,IBISTZATJWFWJX-UHFFFAOYSA-N
CHEMBL2398339,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc4ccccc4c3)ccc2NS(C)(=O)=O)c1,IC50,7.17,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,DVARQTHXJDZWTD-UHFFFAOYSA-N
CHEMBL5394831,,CCCCCC(=O)Nc1ccc(NS(C)(=O)=O)c(OCc2cc(OC)ccc2OC)c1,IC50,5.69,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,MGSJFAMGQGTRTC-UHFFFAOYSA-N
CHEMBL300389,,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,IC50,6.11,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,IYNDTACKOAXKBJ-UHFFFAOYSA-N
CHEMBL513909,BI-2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,IC50,4.6,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,XQVVPGYIWAGRNI-JOCHJYFZSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.79,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,4.58,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL2088455,,Clc1ccc(Cn2c(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)nc3ccccc32)cc1,IC50,4.87,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OMXAMGVPMDXNHB-JFLMPSFJSA-N
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,4.75,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CHEMBL1544486,,CC1=CC(C)(C)N(S(=O)(=O)c2ccc(C)cc2)c2cc(C)ccc21,EC50,5.42,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,AVEDXUCTNRSAQE-UHFFFAOYSA-N
CHEMBL3121282,,CCOC(=O)c1[nH]c2c(c1C)C(=O)CC(c1ccccc1Cl)C2,EC50,6.35,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,CTDJJVSXAQPXCB-UHFFFAOYSA-N
CHEMBL3120176,,CCN(CC)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccccc1,EC50,6.77,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,VBWFHJWQMXTBJL-UHFFFAOYSA-N
CHEMBL142215,,Cc1ccc2c(O)nc(-c3ccccc3)cc2c1,IC50,6.12,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,SYYBWJAZROEWQF-UHFFFAOYSA-N
CHEMBL3092931,,CCCCCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.24,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GCEVVAXRBXSXKN-UHFFFAOYSA-N
CHEMBL3093019,,C=CCCCCOc1ccc(OC)cc1-c1cnc(OCCC=C)n1C,IC50,4.13,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DKDCXSIOOOQYBD-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,6.11,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL5415723,,CNc1ncc2c(C#CCN3CCCC(N(C)C)C3)nn(CC3CCCC3)c2n1,EC50,5.3,CHEMBL5330903,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by PrestoBlue reagent based fluorescence assay,U-87MG ATCC,CLBVQMOKUUQLEK-UHFFFAOYSA-N
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,5.92,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL3393268,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)nc2nccn12,IC50,5.38,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,PMQDLTHWOPLUQZ-UHFFFAOYSA-N
CHEMBL3289080,,COc1ccc(C(=O)/C=C/c2nccc3c2[nH]c2ccccc23)cc1OC,IC50,5.48,CHEMBL3295157,Cytotoxicity against human A172 cells after 48 hrs by SRB assay,A-172,ZWEQPXSQLZNQEM-CMDGGOBGSA-N
CHEMBL76,CHLOROQUINE,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,IC50,5.44,CHEMBL3424559,Cytotoxicity against human LN229 cells after 72 hrs by MTT assay,LN-229,WHTVZRBIWZFKQO-UHFFFAOYSA-N
CHEMBL3290927,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.1,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FQXLTRHUHXXAPR-UHFFFAOYSA-N
CHEMBL3343385,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.92,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YGRLBDZCAHOYME-UHFFFAOYSA-N
CHEMBL1224281,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.8,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,OHVYRRNDSVHUII-MOFGVCBJSA-N
CHEMBL1224282,,C=C(CNCCc1ccc(O)cc1)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.1,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,PANRNQMMBRCNTO-UJTBAKDQSA-N
CHEMBL3116243,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.04,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,STKSFFDICKIQPP-XAYXJRQQSA-N
CHEMBL3114421,,CC1(C)CC(Nc2cccc(Br)c2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.06,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,YBHFKMJUPJENGZ-UHFFFAOYSA-N
CHEMBL2375473,,CC1(C)CC(n2cc(C3CCCCC3)nn2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,4.95,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,BSUBEHCTPVPWOF-UHFFFAOYSA-N
CHEMBL8953,,COc1cc(C(=O)c2cc(Cl)ccc2N)cc(OC)c1OC,EC50,7.05,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,XNXGUYDYCYSOCU-UHFFFAOYSA-N
CHEMBL1587877,,COc1ccc(S(=O)(=O)N2CCOc3ccccc32)cc1,EC50,5.88,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,QXCCHJXFTBHROS-UHFFFAOYSA-N
CHEMBL3121286,,COc1cccc(N2CCN(C(=O)c3cc(C)ccc3OC)CC2)c1,EC50,6.57,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,RWRCJPVSRQMKLP-UHFFFAOYSA-N
CHEMBL225066,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccccc1,EC50,6.92,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,FONUMHBHOAHTAW-UHFFFAOYSA-N
CHEMBL3121277,,Cc1nc2sccn2c1-c1csc(Nc2ccc(N(C)C)nc2)n1,EC50,6.66,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,XSAVJZHRGLMFMA-UHFFFAOYSA-N
CHEMBL3609563,,CCSC1CC2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.73,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,JPXPYTUOLLHURR-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.55,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,4.91,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL591429,PAC-1,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,IC50,4.7,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,YQNRVGJCPCNMKT-LFVJCYFKSA-N
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,4.88,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,JWQOJVOKBAAAAR-UHFFFAOYSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,5.64,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,8.36,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.83,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,5.53,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.68,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,4.81,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.57,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,5.3,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL2088441,,Fc1ccccc1Cn1cc(/C=N/Nc2nc(N3CCOCC3)c3sccc3n2)c2ccccc21,IC50,4.65,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MDFJQBTXFHWRJT-RWPZCVJISA-N
CHEMBL2035485,,O=c1c2ccc(F)cc2[se]n1CCn1[se]c2cc(F)ccc2c1=O,IC50,4.9,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NVKLMJZXBQGXPP-UHFFFAOYSA-N
CHEMBL4286454,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(Br)cc5)c4=O)cc3F)ccnc21,IC50,5.59,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OPQWJKPTIPCBSL-UHFFFAOYSA-N
CHEMBL4286245,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(F)c(Cl)c2)c1=O,IC50,5.28,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JRXNQABRFABFMW-UHFFFAOYSA-N
CHEMBL4285130,,COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5[nH]ccc45)cc3)cc3cccnc32)cc1,IC50,5.63,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BGBQCPAAOWLCJT-UHFFFAOYSA-N
CHEMBL1224366,,C=C(CNCCc1ccc(O)cc1)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.22,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,MGTNLRRVXNVYSH-JEMCJYJNSA-N
CHEMBL3781565,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.49,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FBMOENFWKWSJIY-UHFFFAOYSA-N
CHEMBL1224280,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCOC)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.42,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,BVLCLVPVXUSVRE-WAEOCRLMSA-N
CHEMBL3780204,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5cnc6ccccc6c5)cc4c32)cc1,IC50,4.46,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LZKZPMTXIDEEQT-UHFFFAOYSA-N
CHEMBL4285631,,COc1ccc(Cn2cc(C(=O)c3cn(-c4ccccc4)nc3-c3ccc(F)cc3)nn2)cc1OC,IC50,6.07,CHEMBL4343250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,BASABKRMOALIDI-UHFFFAOYSA-N
CHEMBL4739941,,CN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1ccccc1F,IC50,5.08,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UPYOSHFKFXBBIV-BUHFOSPRSA-N
CHEMBL3793469,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,4.75,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,KVYCFVZPOXFXOY-VTYCOLDWSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.11,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL3983705,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2nncc2-c2ccccc2)[C@H]1Br,IC50,5.8,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,FWRWLRSWPAAQJB-PGRDOPGGSA-N
CHEMBL4649216,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccccc4Cl)cc3)n2)cn1,IC50,4.35,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RGSKRIMCTMBWCH-UHFFFAOYSA-N
CHEMBL221190,DIPHYLLIN,COc1cc2c(O)c3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,IC50,4.58,CHEMBL5258260,Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis,U-87MG ATCC,VMEJANRODATDOF-UHFFFAOYSA-N
CHEMBL4460678,,N#Cc1cccc(/C=C/C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)c1,IC50,4.31,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,YOHPFXYRYBLWTK-NTEUORMPSA-N
CHEMBL4470548,,CCCCCN(CCCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(O)c2)cc1,IC50,4.82,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,RYIJKZMXBBDLBU-SFQUDFHCSA-N
CHEMBL596991,,NC1(Cc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1,IC50,8.34,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,KOBAABHHGSLFGF-UHFFFAOYSA-N
CHEMBL597415,,NC1(Cc2c(Cl)cccc2Cl)CCN(c2ncnc3[nH]ccc23)CC1,IC50,7.85,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,XYWQNCIEXBPHRJ-UHFFFAOYSA-N
CHEMBL598194,,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,7.77,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,XQPFDQVEBGYLHB-UHFFFAOYSA-N
CHEMBL3092932,,CCCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.02,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,PEWMWQRZPWEVSB-UHFFFAOYSA-N
CHEMBL3093029,,Cc1ccc2c(c1)-c1cnc(n1C)OCCCCCCCCO2,IC50,4.2,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,ZJPOKDSLAIVQKM-UHFFFAOYSA-N
CHEMBL3093030,,Cn1c2cnc1OCCCCCCCCOc1ccccc1-2,IC50,4.04,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GOQRJMXCBGQPQO-UHFFFAOYSA-N
CHEMBL2037450,,C/C(=N/NC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NPHJRKXEZJAUIL-YVLHZVERSA-N
CHEMBL2037448,,C/C(=N/NC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.19,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NRNNRLWHLIPYQW-ZDLGFXPLSA-N
CHEMBL1987055,,C/C(=N/NC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,9.0,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,QJEQNMXYYQUOAY-ZDLGFXPLSA-N
CHEMBL1630580,,C/C(=N\NC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.23,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,KRCPOZLWYUZVBS-VCHYOVAHSA-N
CHEMBL2037435,,CC(=NNC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PTOHINKLMXPSKL-UHFFFAOYSA-N
CHEMBL2037447,,C/C(=N/NC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.08,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NOHGJWJQBAAVFP-ZDLGFXPLSA-N
CHEMBL2037344,,CC(=NNC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,7.16,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NPHJRKXEZJAUIL-UHFFFAOYSA-N
CHEMBL2037339,,CC(=NNC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.77,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,KRCPOZLWYUZVBS-UHFFFAOYSA-N
CHEMBL1867591,,CC(=NNC(=S)Nc1ccccc1)c1ccccn1,IC50,8.85,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VHVSCHSQNUUXNS-UHFFFAOYSA-N
CHEMBL586702,ZSTK-474,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,7.5,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,HGVNLRPZOWWDKD-UHFFFAOYSA-N
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,4.07,CHEMBL3879641,Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability measured after 24 hrs by CCK8 assay,SF126,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CHEMBL473417,VISMODEGIB,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,IC50,4.43,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,BPQMGSKTAYIVFO-UHFFFAOYSA-N
CHEMBL3954793,,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNc1c2ccccc2nc2ccccc12)NC(=O)[C@@H](N)CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNc1c2ccccc2nc2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCNC(=O)c1ccc(B(O)O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,IC50,5.14,CHEMBL3853427,Antiviral activity against HIV1 NL4-3 infected in human U87 cells transfected with CD4/CXCR4 assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24 assay,U-87MG ATCC,VULIYGLYBQXDJR-SHAJCIBYSA-N
CHEMBL5423568,,C#CCN(C)CCCOc1ccc(N(C)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.46,CHEMBL5371250,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,U-87MG ATCC,JHKZNXCXUMFEOS-UHFFFAOYSA-N
CHEMBL5423568,,C#CCN(C)CCCOc1ccc(N(C)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.4,CHEMBL5371252,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,LN-229,JHKZNXCXUMFEOS-UHFFFAOYSA-N
CHEMBL5426666,,C#CCN(C)CCCOc1ccc(N(CC)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.51,CHEMBL5371252,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,LN-229,UGMCCVYCFXAQTN-UHFFFAOYSA-N
CHEMBL5283179,,CCC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,IC50,5.77,CHEMBL5445554,"Affinity Phenotypic Cellular interaction: (ProQinase broad tumor cell line profiling (CellTiterGlo assay, antiproliferative activity in brain, LN229,cancer cell line)) EUB0001183a CSNK2A1",LN-229,YKDZIFFKQUNVHH-UHFFFAOYSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,5.0,CHEMBL3757073,Antiproliferative activity against human T98G cells after 24 hrs by EZ-Tox assay,T98G,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL2035460,ETHASELEN,O=c1c2ccccc2[se]n1CCn1[se]c2ccccc2c1=O,IC50,5.3,CHEMBL2039587,Inhibition of TrxR in human U87MG cells after 12 hrs by insulin-reducing method,U-87MG ATCC,SFFSGPCYJCMDJM-UHFFFAOYSA-N
CHEMBL3359307,,C=C(CCCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.64,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,DVVXEMSAISDIBT-WZXSUGGSSA-N
CHEMBL1224360,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCO)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.8,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,UJVDKTULBHBERS-NZVCPMBMSA-N
CHEMBL1224364,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCOC)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.55,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,SEIHBOJCUVUPAJ-FDDWVMGPSA-N
CHEMBL119592,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccccc3)cc1OC2(C)C,EC50,5.33,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,GZYXCXRHVALIJD-WOJBJXKFSA-N
CHEMBL2069125,CORNUSALTERIN B,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)[C@@H]3CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.54,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,VXRYSPWFQKBSPW-BDROBAENSA-N
CHEMBL1668098,CORNUSALTERIN E,CC(C)CCC[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.88,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,ZYAWSDGOPQRREN-VNYVIHJJSA-N
CHEMBL343002,,CCOc1ccc(-c2nc3cc(-c4nc5cc(N6CCN(C)CC6)ccc5[nH]4)ccc3[nH]2)cc1,IC50,5.38,CHEMBL1671231,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,PRDFBSVERLRRMY-UHFFFAOYSA-N
CHEMBL471122,,CCCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.5,CHEMBL964507,Cytotoxicity against human U87 cells by side flank model relative to control,U-87MG ATCC,MZOOIDJUCGIQIU-DHIUTWEWSA-N
CHEMBL3290910,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FRFNHPYRKFRMMZ-UHFFFAOYSA-N
CHEMBL3290931,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JYBQEMYHVMILOJ-UHFFFAOYSA-N
CHEMBL2042472,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccc2c(F)cccc12,IC50,7.68,CHEMBL2044176,Antiproliferative activity against human A172 cells after 5 days by MTT assay,A-172,YKVMJQBXOMKRHY-UHFFFAOYSA-N
CHEMBL521245,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.75,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,WXZMJXNGGUJSIL-AJNNAGPSSA-N
CHEMBL506074,,CC(C)[C@@H]1CC[C@]2(COC3CCCCO3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.35,CHEMBL975264,Antiproliferative activity against human LN229 cells after 72 hrs by MTS assay,LN-229,PKUKASRXVYELCK-AQOUXIAOSA-N
CHEMBL3353046,,O=C(Cc1cccc2ccccc12)N1CCN(C(=O)c2ccco2)CC1,IC50,4.1,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,VMJVAMPNMNAKLD-UHFFFAOYSA-N
CHEMBL3353052,,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)C5=CCCCC5)CC4C3)c12,IC50,9.22,CHEMBL3383785,Antiviral activity against HIV1 isolate Hxbc2 pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,LKQWIKPNCGJODX-UHFFFAOYSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.28,CHEMBL5155487,Antiproliferative activity against human U-87 MG cells incubated for 24 hrs followed by incubating in drug-free medium for 48 hrs and measured by SRB assay,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL373587,,CCN(CC)c1ccc2c(C#N)c(-c3nc4ccccc4o3)c(=O)oc2c1,IC50,5.75,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,QCQWADYRINMUHR-UHFFFAOYSA-N
CHEMBL5418475,,CC(=O)OC[C@H]1O[C@H](OC2=CC(=O)c3cccc(O)c3C2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,5.49,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,CSKWWVYJAXDCIP-MWFZDGHISA-N
CHEMBL4455327,,Oc1ccccc1-c1ccc2ccccc2c1,EC50,4.32,CHEMBL5217394,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,DYXBPOGHFMDEDL-UHFFFAOYSA-N
CHEMBL222760,,CC(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)Cc6nccnc6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.72,CHEMBL916479,Cytotoxicity against human U87-Mg cells after 72 hrs by MTT assay,U-87MG ATCC,VZYGKLAIQLFCPM-JOQCCHAVSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.05,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,7.96,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,HVXBOLULGPECHP-WAYWQWQTSA-N
CHEMBL5401775,,O=C1c2cc(F)ccc2N(c2cccc(F)c2)C2c3[nH]c4ccccc4c3CCN12,IC50,4.78,CHEMBL5339028,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,U-87MG ATCC,DZDTUGJLJYIASD-UHFFFAOYSA-N
CHEMBL244184,,Cc1cnc(Oc2ccc(-n3ccnc3)cc2)nc1Oc1ccc2c(c1)OCO2,IC50,6.89,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,WUDOWDUJLISJRD-UHFFFAOYSA-N
CHEMBL244182,,c1cn(-c2ccc(Oc3ccnc(Oc4ccc5c(c4)OCO5)n3)cc2)cn1,IC50,7.13,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,VEWOKEGQNVXJDK-UHFFFAOYSA-N
CHEMBL3885128,,CCOC(=O)c1nc2ccccc2nc1C#Cc1cccc(C)c1,IC50,5.26,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GANAGRMHJQTADC-UHFFFAOYSA-N
CHEMBL1822930,,CCCCOc1c(OC)ccc2cc(C(=O)NCCc3ccc(F)cc3)c(=O)[nH]c12,Ki,8.62,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,RMDYOOKUYKPFTH-UHFFFAOYSA-N
CHEMBL1822935,,CCCCOc1c(OC)ccc2cc(C(=O)NCCF)c(=O)[nH]c12,Ki,6.31,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,UTFVZMLLHUZJOB-UHFFFAOYSA-N
CHEMBL5275244,,C/C(=C\CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1)c1ccccc1,IC50,7.72,CHEMBL5225165,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CCEWBVIQKCUYJV-WOJGMQOQSA-N
CHEMBL119894,,COc1ccc2c(n1)-c1nccc3ccnc(c13)C2=O,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,YTZSQUDIWAXIIV-UHFFFAOYSA-N
CHEMBL1779547,,Cc1c2c(n3c1CCCN1CCC[C@@H](C1)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.17,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,PWJSZCCBSVIOCL-KRWDZBQOSA-N
CHEMBL4205181,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(C(F)(F)F)cc4Cl)c3=O)cc2)ccn1,IC50,4.7,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LRSSWCNWEFCZTP-UHFFFAOYSA-N
CHEMBL4207773,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4)c3=O)cc2)ccn1,IC50,5.82,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WSIJRYOXDPXZPL-UHFFFAOYSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.91,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL480041,,CCN(CC)C(=O)Cc1c(-c2ccc(OC)cc2)nn2c(C)cc(C)nc12,Ki,8.18,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,ILZWUAWCTNWSFZ-UHFFFAOYSA-N
CHEMBL3634876,,CCN(CC)C(=O)Cn1c(-c2ccc(OC)cc2)cc2c(C)cc(C)cc21,Ki,6.09,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,RKBQFQARDYWAHE-UHFFFAOYSA-N
CHEMBL3144390,,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc2ccccc2)N1c1ccc(-c2ccccc2)cc1.Cl.Cl,IC50,5.34,CHEMBL1272663,Cytotoxicity against human A172 cells by MTT assay,A-172,XXBHXAMUPKFGNW-UHFFFAOYSA-N
CHEMBL4285275,,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,IC50,5.25,CHEMBL5048136,Cytotoxicity against human U-87 MG cells assessed as cell viability using raw interpretation method,U-87MG ATCC,LNKLNUAMTRHBLB-CGJDGIRVSA-N
CHEMBL1557864,,COc1cc(C(c2cc3c(cc2O)OCO3)N2CCCC2)cc(OC)c1OC,IC50,4.62,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,QCXGNLZKUHBIHD-UHFFFAOYSA-N
CHEMBL591855,,CCc1ccc(C(Nc2ccccn2)c2ccc3cccnc3c2O)cc1,IC50,5.03,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GKKHBDOWRWTQKO-UHFFFAOYSA-N
CHEMBL3703650,,Cc1ccnc(NC(c2ccccc2Cl)c2ccc3cccnc3c2O)c1,IC50,5.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,BKOLRAXMMXDABH-UHFFFAOYSA-N
CHEMBL4753606,,Oc1c(C(c2ccncc2)N2CCCCC2)ccc2ccoc12,IC50,6.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GJSGJEFEHZQMOS-UHFFFAOYSA-N
CHEMBL4792039,,Oc1ccc2ncccc2c1C(c1ccc(F)cc1)N1CCCCC1,IC50,5.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,KOSAQWFJCWQDGG-UHFFFAOYSA-N
CHEMBL4758830,,Oc1cc2c(cc1C(c1ccccc1)N1CCCCC1)OCO2,IC50,4.77,CHEMBL4729816,Cytotoxicity against human A 172 cells assessed as growth inhibition measured after 72 hrs by MTT assay,A-172,WXERBCAJTBAWGU-UHFFFAOYSA-N
CHEMBL4778052,,CCOP(=O)(Cc1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1)OCC,IC50,5.89,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,VVFGHJSVCIICMO-UHFFFAOYSA-N
CHEMBL3793197,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccccc1Cl,IC50,5.82,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,YPKZCXHKFPTHFY-YNEHKIRRSA-N
CHEMBL184632,,CCC1(c2ccccc2)CC(=O)C(C(CC(=O)c2ccc(-c3ccc(Br)cc3)cc2)c2ccccc2)=C(O)O1,IC50,5.18,CHEMBL825052,Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 after 72 hr of incubation was determined,XF 498,BYCOHDXJANLRLB-UHFFFAOYSA-N
CHEMBL5081822,,Nc1nc2cc3c(cc2cc1C(=O)NCC1CC1)OCO3,IC50,4.11,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,HVQSOLYMHDDJMB-UHFFFAOYSA-N
CHEMBL2441798,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)Nc1cccc(C(F)(F)F)c1,IC50,6.02,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,HMZVXEPIWCERKW-UHFFFAOYSA-N
CHEMBL2441796,,COc1cc(-c2nn(-c3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.82,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,KDESCVAKXJMELW-UHFFFAOYSA-N
CHEMBL2441795,,COc1cc(-c2nn(-c3cccc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,5.86,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,RAYZPAZGZSNIPK-UHFFFAOYSA-N
CHEMBL1668698,,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6ccc(F)cc6F)[nH]c5c4)[nH]c3c2)CC1,IC50,5.26,CHEMBL1671231,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GOYTTZQBYVHZNE-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,6.3,CHEMBL1671231,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL2441790,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.08,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,PBHHNPADCVUAJW-UHFFFAOYSA-N
CHEMBL4762080,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc5c(c4)OCO5)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.18,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,SQHULIWFGOHDAJ-UHFFFAOYSA-N
CHEMBL4798872,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(N)c(C#N)c(-c4ccccc4)n3)s2)cc1,IC50,5.07,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,DEAYOTAXACGNDI-UHFFFAOYSA-N
CHEMBL3337789,,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCc1ccccc1)c1cc2ccc(O)cc2oc1=O,IC50,4.0,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,JSVQEFOTCCULDI-HEVIKAOCSA-N
CHEMBL3121272,,O=C(Nc1ccc(I)cn1)c1cccc(F)c1,EC50,6.35,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,PEZBITNWNCFBLF-UHFFFAOYSA-N
CHEMBL4100560,,C=C(c1ccc(OC)cc1)c1cc(C)nc2ccccc12,IC50,7.68,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,LPJFLJRKCGUKFU-UHFFFAOYSA-N
CHEMBL4076496,,C=C(c1ccc(OC)cc1)c1cc(CO)nc2ccccc12,IC50,6.41,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,HUFYAIZSUXZQDL-UHFFFAOYSA-N
CHEMBL4065521,,C=C(c1ccc(OC)c(O)c1)c1nc(C)nc2ccccc12,IC50,8.21,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,JSUMHLAGZVXBKB-UHFFFAOYSA-N
CHEMBL524102,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccccc2)C1=O,IC50,5.82,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,VQMSLWWFCNFOAR-UHFFFAOYSA-N
CHEMBL523801,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccncc2)C1=O,IC50,5.95,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,URKMVTNTRSBXHE-UHFFFAOYSA-N
CHEMBL1668100,CORNUSALTERIN G,CO[C@@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.69,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,UDSUNACNDRCFFJ-SMLRQZPUSA-N
CHEMBL1668103,CORNUSALTERIN J,CO[C@@H](C=C(C)C)C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.74,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,CMYFKSGATOJENB-LRTLWCEFSA-N
CHEMBL1652082,,CC1(C)OC2C(=O)c3ccccc3C(=O)C2[C@@H]([N-][N+]#N)[C@@H]1Br,IC50,4.86,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,COAMQTJABBZFQJ-DUHSPSEUSA-N
CHEMBL2041934,,O=[N+]([O-])c1ccc(NC(=S)NCc2cccc(Cl)c2)cc1,IC50,4.7,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,LGMWYLBNBHIUMI-UHFFFAOYSA-N
CHEMBL1087935,,Oc1ccc(CN(Cc2cccs2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.06,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,DCSLAAUFCGHSGE-UHFFFAOYSA-N
CHEMBL1080911,,Cc1n[nH]c2ccc(-c3nnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)cc12,IC50,6.45,CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,KRKDQSSYLDUOBP-HNNXBMFYSA-N
CHEMBL269277,BETULINIC ACID,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.54,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,QGJZLNKBHJESQX-FZFNOLFKSA-N
CHEMBL1097919,,CCC(CC[C@@H](C)[C@H]1[C@H](O[C@@H]2O[C@@H]([C@@H](O)COC)[C@H](O)[C@H]2O)CC2=C3[C@@H](O[C@@H]4O[C@@H]([C@@H](O)COC)[C@H](O)[C@H]4O)[C@@H](O)[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C,IC50,5.44,CHEMBL1111856,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MXFMHAVXAGVCGZ-QLDMGMRTSA-N
CHEMBL3963286,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1nnc(-c3ccccc3)c1-c1ccccc1)O2,IC50,5.84,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,FHNODQVETSSAOP-UHFFFAOYSA-N
CHEMBL3908949,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C3(O)CCCCC3)nn1)O2,IC50,4.96,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,NWGUAWJRTBYMNS-UHFFFAOYSA-N
CHEMBL3341777,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](Nc1ccc3ccccc3c1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,Ki,6.91,CHEMBL3374643,Antimigratory activity against human SNB75 cells on matrix containing fibronectin after 24 hrs by 2-D migration assay,SNB-75,FWHOARIZUBCNOV-JBNHJABESA-N
CHEMBL43,AMSACRINE,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12,IC50,6.3,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,XCPGHVQEEXUHNC-UHFFFAOYSA-N
CHEMBL4095235,,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4cc(N5CC6CCC(C5)O6)c5nccn5n4)cc3)cc2)CC1,IC50,5.37,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,LPJMRYIXYRUNRW-UHFFFAOYSA-N
CHEMBL2088461,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4cccc(F)c4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.11,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,UWIACCOQIIULOL-WCMJOSRZSA-N
CHEMBL87938,,CCOC(=O)N(C)/N=N\CCCl,IC50,4.75,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,USWACFKAYKLOCN-HJWRWDBZSA-N
CHEMBL1170447,,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,IC50,5.73,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,AUXJPQSJHPPESP-IBGZPJMESA-N
CHEMBL3358287,,COc1cc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cnc1OC,IC50,8.0,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,BGEXTJGOTZMOEE-UHFFFAOYSA-N
CHEMBL3358284,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1C(C)C,IC50,6.38,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JPHLCGRVFUCWIH-UHFFFAOYSA-N
CHEMBL3357877,,CCc1cc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cnc1OC,IC50,6.33,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,BQJPZFLREHORGE-UHFFFAOYSA-N
CHEMBL3357872,,COc1ncc(Nc2ncc(C(C)(C)CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.43,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,VWJMXEJPKWZLNL-UHFFFAOYSA-N
CHEMBL1224210,,C=C(C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.05,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,QTRBSYDTCOEJBJ-YPAMOFLTSA-N
CHEMBL4537633,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)c(C(F)(F)F)c2)cc1,IC50,4.58,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,REXXXBZPNYDIJX-FNORWQNLSA-N
CHEMBL2170086,,COc1ncc(Nc2ncc([C@@H](C)N3CCN(S(C)(=O)=O)C[C@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.92,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-ZIAGYGMSSA-N
CHEMBL2170082,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)C[C@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,9.0,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SCIVONNAMHTUEH-CYBMUJFWSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,4.06,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.73,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,5.06,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,5.17,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AHJRHEGDXFFMBM-UHFFFAOYSA-N
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.05,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,SUDAHWBOROXANE-SECBINFHSA-N
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,4.95,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,GFMMXOIFOQCCGU-UHFFFAOYSA-N
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,5.52,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,RITAVMQDGBJQJZ-FMIVXFBMSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,6.53,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL176544,,Cn1cc(/C=C2\C(=O)Nc3cccnc32)c2ccccc21,IC50,4.02,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,NXNQLECPAXXYTR-LCYFTJDESA-N
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,4.39,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,JAMULYFATHSZJM-UHFFFAOYSA-N
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,6.2,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,PQAPVTKIEGUPRN-UHFFFAOYSA-N
CHEMBL409,BICALUTAMIDE,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,IC50,4.38,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,LKJPYSCBVHEWIU-UHFFFAOYSA-N
CHEMBL2164713,,Cc1nccc2c3ccc(OCCC(C)C)cc3n(CCC(C)C)c12,IC50,4.46,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,CYNQFAAXQWCODJ-UHFFFAOYSA-N
CHEMBL1739368,,NCCNC(=O)C(CN)(Cc1ccc2ccccc2c1)Cc1ccc2ccccc2c1,IC50,5.6,CHEMBL2154650,Cytotoxicity against human SF295 cells after 4 hrs by MTT assay,SF295,ZOSLLLKFQJEPRK-UHFFFAOYSA-N
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,4.6,CHEMBL3783555,Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay in presence of O6-BG,SF126,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CHEMBL3805721,,O=C(/C=C\Nc1ccc(O)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,5.82,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OHQRSSZZOGZMSW-PFONDFGASA-N
CHEMBL2178608,,COC1(c2sc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3c2C)COC1,EC50,6.85,CHEMBL2186329,Cytotoxicity against human LN229 cells incubated for 4 days,LN-229,XOZLHJMDLKDZAL-UHFFFAOYSA-N
CHEMBL3781819,LP-184,CC1=C(CN(O)C(N)=O)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,IC50,7.3,CHEMBL3783415,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,VWMPVAZEBAKLFR-HNNXBMFYSA-N
CHEMBL5085481,,O=C1c2cc(Cl)ccc2N(c2cccc(F)c2)C2c3[nH]c4ccccc4c3CCN12,IC50,4.85,CHEMBL5339028,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,U-87MG ATCC,VONATDVATMYHAA-UHFFFAOYSA-N
CHEMBL2022334,,[N-]=[N+]=NC1=CC(=O)c2ccccc2C1=O,IC50,5.47,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,IYUOYLLVOZNGKW-UHFFFAOYSA-N
CHEMBL3955548,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C[Se]c3ccccc3)nn1)O2,IC50,6.66,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,SINWVHMPJIQVNR-UHFFFAOYSA-N
CHEMBL3939072,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1cccc(-c2cn(C[Se]c3ccccc3)nn2)c1,IC50,6.47,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,PBZDSFFVEZDVJK-UHFFFAOYSA-N
CHEMBL3980099,,CC1(C)CC(Nc2cccc(-c3cn(C[Se]c4ccccc4)nn3)c2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.73,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,RUFWBCRLCZBHGU-UHFFFAOYSA-N
CHEMBL2441133,,CC1(C)CC(N=[N+]=[N-])C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.69,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,HKJNKCAALJABOG-UHFFFAOYSA-N
CHEMBL3973814,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1nnc(-c2ccccc2)c1I,IC50,5.34,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,WUPZIJXCRARTKU-UHFFFAOYSA-N
CHEMBL3945406,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C3CCCCC3)nn1)O2,IC50,5.72,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,LJBKUXPERIFYEA-UHFFFAOYSA-N
CHEMBL5411549,,COc1ccc(-c2ccc(NC(=O)c3cn(-c4ccc(N5CCNCC5)c(C(F)(F)F)c4)nn3)cc2)cn1,IC50,5.38,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,IZPAMEQTJBTCKQ-UHFFFAOYSA-N
CHEMBL394956,,CN(C)CCCCCN(C)C1=Nc2ccccc2C(CC(=O)NCc2ccccc2)N1c1ccc(-c2ccccc2)cc1,IC50,5.32,CHEMBL1272663,Cytotoxicity against human A172 cells by MTT assay,A-172,QVXCZTNUVKNCGU-UHFFFAOYSA-N
CHEMBL5417058,,COc1ccc(-c2ccc3[nH]c(=O)c4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1,IC50,5.36,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,AUKAFZKIDXYAHI-UHFFFAOYSA-N
CHEMBL5416400,,COc1ccc(-c2ccc3[nH]c(=O)c4ccc(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)n4c3c2)cn1,IC50,5.42,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,RWVZOVTVZOCLKX-UHFFFAOYSA-N
CHEMBL180966,,CN(CC[C@@H](Oc1ccc(-c2ccccc2)cc1)c1ccc(F)cc1)CC(=O)O,IC50,8.32,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,FDORQEIHOKEJNX-HSZRJFAPSA-N
CHEMBL1643112,,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,IC50,5.51,CHEMBL1647173,Cytotoxicity against human U87 cells after 4 hrs by MTT assay,U-87MG ATCC,YZGGEWBAXPONBE-HAQBABLCSA-N
CHEMBL1643113,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)[C@H]5O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.78,CHEMBL1647173,Cytotoxicity against human U87 cells after 4 hrs by MTT assay,U-87MG ATCC,KSUDUUNNZFFEPI-IUMLOJQTSA-N
CHEMBL119700,,COc1ccnc2c1-c1nccc3c(OC)cnc(c13)C2=O,IC50,8.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,MAOQMONYODZXHW-UHFFFAOYSA-N
CHEMBL3924500,,S=C(NNc1nncc2ccccc12)Nc1ccccc1,IC50,8.02,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,BJKBZKFIXRDJFX-UHFFFAOYSA-N
CHEMBL3977192,,NC(=S)NNc1nncc2ccccc12,IC50,8.03,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,BRPCQCNGNFEDIO-UHFFFAOYSA-N
CHEMBL3978686,,O=S(=O)(Nc1ccccn1)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.08,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,DZQPJZWTLANTON-UHFFFAOYSA-N
CHEMBL353585,,COCCOCOCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.36,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,VKHQKJIIXMHWOW-UHFFFAOYSA-N
CHEMBL87240,,CC(=O)N(C)/N=N\CCCl,IC50,4.7,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,QEIMBUYAZCMEGX-FPLPWBNLSA-N
CHEMBL3290901,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.43,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WMQYCMRSTBMSOT-UHFFFAOYSA-N
CHEMBL3359309,,C/C(=C/CCC(C)(C)OC(=O)CCl)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.67,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,ZLAIBROJNOEYDX-JOUREUQLSA-N
CHEMBL3359313,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](OC(=O)CCl)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.05,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,RRKKHXNOPJWETM-BVLXKVINSA-N
CHEMBL3359314,,CC(C)(CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C)OC(=O)CCl,IC50,4.4,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,VVQMKIXOJQUCSK-BVLXKVINSA-N
CHEMBL3358288,,COc1cncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)c1,IC50,7.15,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,GIJFIWCYFZUZAA-UHFFFAOYSA-N
CHEMBL3357874,,Cc1nc(N)nc(-c2cc(C(C)(C)O)cnc2Nc2cncc(F)c2)n1,IC50,7.01,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,QTCHCGFCYOHSMS-UHFFFAOYSA-N
CHEMBL3357871,,COc1ncc(Nc2ncc([C@H](C)CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.6,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JCDSCTRINIXUJR-SECBINFHSA-N
CHEMBL3357870,,COc1ncc(Nc2ncc([C@@H](C)CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.51,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,JCDSCTRINIXUJR-VIFPVBQESA-N
CHEMBL3357867,,COc1ncc(Nc2ncc(C(O)C(F)(F)F)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.47,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,ZWLQCJDCCOOFJD-UHFFFAOYSA-N
CHEMBL3357864,,COc1ncc(Nc2ncc(CO)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.36,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,YEWABQMWBKESOQ-UHFFFAOYSA-N
CHEMBL3904493,,COc1ncc(-c2ccc3nccc(-c4ccc(Cn5ccnc5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.22,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CWZQCUWQHVFQEI-UHFFFAOYSA-N
CHEMBL3905333,,CNCCN(C)Cc1ccc(-c2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)cc1,IC50,6.59,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZZZGLALTAWYHHN-UHFFFAOYSA-N
CHEMBL2313555,,CCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.17,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GYXXUZDCLMAMKS-JCNFZPKBSA-N
CHEMBL2333592,WITHAMETELIN F,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3C[C@H]4O[C@]45CC=CC(=O)[C@]5(C)[C@H]3CC[C@]12C,IC50,6.25,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,TWSTVCZSHMUIOQ-ZPRSOMTPSA-N
CHEMBL2333167,WITHAMETELIN,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3CC=C4CC=CC(=O)[C@]4(C)[C@H]3CC[C@]12C,IC50,6.0,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,QUGZOXCXHGEACS-FIPVAASQSA-N
CHEMBL2037061,,OCc1c(CO)c2sc3ccccc3n2c1-c1ccc(F)cc1,IC50,4.81,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,WFPZKOMYUKONFM-UHFFFAOYSA-N
CHEMBL2037062,,OCc1c(CO)c2sc3ccccc3n2c1-c1ccc(Cl)cc1,IC50,4.68,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,PXJQXEQFTLKFQP-UHFFFAOYSA-N
CHEMBL2037066,,COc1ccc(-c2c(CO)c(CO)c3sc4ccccc4n23)cc1,IC50,4.74,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,PXNALHYUQFCUFP-UHFFFAOYSA-N
CHEMBL258837,,N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,IC50,7.3,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,PXAOTHLXABAQIT-UHFFFAOYSA-N
CHEMBL259163,,Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,IC50,6.91,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,ARIHYXITNVJHJL-UHFFFAOYSA-N
CHEMBL552425,,Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1cncc(C(N)=O)c1,EC50,7.0,CHEMBL1060001,Inhibition of ephrin-B1-induced autophosphorylation of EphB2 expressed in human U87 cells after 1 hr by Western blot analysis,U-87MG ATCC,SAAYRHKJHDIDPH-UHFFFAOYSA-N
CHEMBL1779540,,CC(=O)N[C@H]1C[C@@H]2CNc3cc(ccc3C(N)=O)-n3c(c(C)c4c3CC(C)(C)CC4=O)CCCN2C1,EC50,5.44,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,HZDWFQUZDJXVGH-AZUAARDMSA-N
CHEMBL1779545,,Cc1c2c(n3c1CCCN1CCCC[C@@H]1[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,6.25,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,ZDILAMLZSXMAPA-FDDCHVKYSA-N
CHEMBL1774417,CASEARUPESTRIN A,C=CC(=C)CC[C@]1(C)[C@H](C)[C@@H](O)[C@H](OC(=O)/C=C\C=C\CCCCC)[C@@]23C(=C[C@H](O)C[C@@H]12)[C@@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.44,CHEMBL1776150,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NWTYSAQBDRQWLF-WWRGVMLBSA-N
CHEMBL1807806,,Cc1c2c(n3c1CCN(C(=O)[C@@H](N)C(C)C)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.32,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,WPQWDLRSWWBTSS-QZXAKIBKSA-N
CHEMBL1806511,,Cc1c2c(n3c1CCN(C(=O)[C@@H]1C[C@H](F)CN1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.06,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KVSGQPCLHVYQMQ-LDQAXMLRSA-N
CHEMBL4096164,,CSc1nc(NCc2ccccc2)c2ccn(CC(Cl)c3ccccc3)c2n1,IC50,4.29,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,PWYVDKFGQPXXFX-UHFFFAOYSA-N
CHEMBL4088440,,CSc1nc(N2CCCC2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.29,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,BBTSLIHTQGHZBD-UHFFFAOYSA-N
CHEMBL4060227,,COc1cc(Nc2nnc(Cl)c(Nc3cccc(NS(C)(=O)=O)c3)n2)cc(OC)c1OC,IC50,4.9,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,LPANKDJQNNNOIR-UHFFFAOYSA-N
CHEMBL3779942,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.29,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,VSLMCBYJVLSIEE-UHFFFAOYSA-N
CHEMBL3781674,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.72,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,XFVRBLHJVSIYPX-UHFFFAOYSA-N
CHEMBL4083156,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,8.15,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BMPZYKBGNRHAGU-HKIQETCMSA-N
CHEMBL4068953,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@H](C)NC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.94,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,MRSHFEIBWJDWOB-PUKOBOIISA-N
CHEMBL15192,LAPACHONE,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.02,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,QZPQTZZNNJUOLS-UHFFFAOYSA-N
CHEMBL3975187,,O=C1C(Br)=C(NCc2cn(C[Se]c3ccccc3)nn2)C(=O)c2ccccc21,IC50,5.79,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,WCDKOIITNPZJON-UHFFFAOYSA-N
CHEMBL3905337,,CC1(C)CC(n2cc(C[Se]c3ccccc3)nn2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.38,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,CGPWNKWONXQXKF-UHFFFAOYSA-N
CHEMBL3941937,,C[C@H]1NS(=O)(=O)c2ccc(-c3c[nH]c4cc(F)ccc34)cc21,IC50,7.57,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,ZMCRNPLKPSLLOS-SECBINFHSA-N
CHEMBL3982092,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCNC(=O)c1cccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)c1)[C@@H]3C,EC50,6.24,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,WPYNMQXAUVJGQD-YDVZNJOFSA-N
CHEMBL2435999,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.09,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YEGSATWQBXVWBX-UHFFFAOYSA-N
CHEMBL3913964,,O=S1(=O)NC(CO)c2cc(-c3c[nH]c4cc(F)ccc34)ccc21,IC50,7.37,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,MUYZCDJFMYXXLU-UHFFFAOYSA-N
CHEMBL260223,,CCCCn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.72,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,BRBRLDFWAFXYNB-UHFFFAOYSA-N
CHEMBL3262848,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cccc(Br)c3)cc2F)ccn1,IC50,6.08,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JEHYCMOMKCTLTF-WKULSOCRSA-N
CHEMBL3262850,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(F)cc3F)cc2F)ccn1,IC50,5.72,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QNNAMPWNPKHROX-AMVVHIIESA-N
CHEMBL3262858,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccccc3O[N+](=O)[O-])cc2F)ccn1,IC50,5.15,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AGCAIFFALBJUIZ-RWPZCVJISA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,4.81,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,6.8,CHEMBL3807045,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Z2 coulter counter method,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL2435961,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5)n4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.04,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YXNVRITWXLFAIM-UHFFFAOYSA-N
CHEMBL2435980,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(C)cc5)n4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ADJFQXLFIAVQNS-UHFFFAOYSA-N
CHEMBL2435993,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SNYFYZCQCLHZGW-UHFFFAOYSA-N
CHEMBL2435989,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5F)ccn4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.52,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NVLKRTHPAPBBFA-UHFFFAOYSA-N
CHEMBL3793100,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,5.0,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QXYGSSDGMTTZIF-MQUPRSIOSA-N
CHEMBL3794299,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(/C=C/Br)c(=O)[nH]c2=O)C[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,4.89,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,ZZWBRSWYVABVFY-HPGFCBSRSA-N
CHEMBL3093024,,Cn1c2cnc1OCCCCCCCCCOc1ccccc1-2,IC50,4.13,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,YVXCOBYXMMGCJH-UHFFFAOYSA-N
CHEMBL1834954,,O=C(O)c1cc(C#Cc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,IC50,4.52,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,JJNQWYPLIWCKRB-UHFFFAOYSA-N
CHEMBL1822057,,CC(=O)Nc1cn2cc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,IC50,6.93,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,XNIJHVMYDIVRJQ-UHFFFAOYSA-N
CHEMBL3114582,,O=C1C=C(NCc2cn(C3=CC(=O)c4ccccc4C3=O)nn2)C(=O)c2ccccc21,IC50,5.42,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,HANIQUTYFSDFSY-UHFFFAOYSA-N
CHEMBL3263123,,COc1cc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)cc(OC)c1OC,IC50,4.65,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HZBAKOORAWVZFL-WCMJOSRZSA-N
CHEMBL3259853,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3c(O)ccc4ccccc34)cc2F)ccn1,IC50,6.21,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IDHJQISXCBJVOX-VTNSRFBWSA-N
CHEMBL4277900,CROZBACICLIB,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,IC50,7.82,CHEMBL4253572,Antiproliferative activity against human U87MG cells after 72 hrs by DAPI staining based assay,U-87MG ATCC,AEFFENQISAXIKE-UHFFFAOYSA-N
CHEMBL3301610,ABEMACICLIB,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,IC50,7.32,CHEMBL4253572,Antiproliferative activity against human U87MG cells after 72 hrs by DAPI staining based assay,U-87MG ATCC,UZWDCWONPYILKI-UHFFFAOYSA-N
CHEMBL3121287,,O=C(Nc1ccncc1)C1CCCN1S(=O)(=O)c1ccc2ccccc2c1,EC50,5.82,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,FNVOIHVALBDIKK-UHFFFAOYSA-N
CHEMBL1335117,,CCOc1ccc2c(c1)C(C)=CC(C)(C)N2S(=O)(=O)c1ccc(C)cc1,EC50,6.16,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,PAWMDFURAZONCN-UHFFFAOYSA-N
CHEMBL3121285,,COc1ccccc1C(=O)N1CCN(c2ccccc2OC)CC1,EC50,5.49,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,FFQQPUIDIKZXNZ-UHFFFAOYSA-N
CHEMBL468756,,Cc1ccn2c(-c3csc(Nc4ccc(N(C)C)cc4)n3)c(C)nc2c1,EC50,6.96,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,CJLBQZGTWTUBJP-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.84,CHEMBL1103642,Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay,U-87MG ATCC,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL3400567,,CCC1=CC2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccc(C)cc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.48,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,XLNNYMWEEGDJEE-KYOITVBSSA-N
CHEMBL5399572,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N3CCN(S(C)(=O)=O)CC3)CC2)n1,IC50,5.9,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,KOBDMZOFSXEFLG-UHFFFAOYSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.77,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL1091644,LINSITINIB,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,IC50,4.65,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,PKCDDUHJAFVJJB-VLZXCDOPSA-N
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,4.62,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,5.34,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,JAMULYFATHSZJM-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,5.09,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL5409171,,C[C@@H]1CC[C@H]2[C@@H](C)C(OCCNC(=O)c3ccc(COc4ccc(/C=C/S(=O)(=O)Nc5ccc(OC(F)(F)F)cc5)cc4)cc3)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,IC50,7.05,CHEMBL5355849,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,MCSXNLKTLHQAJJ-RYQWKLEYSA-N
CHEMBL2392950,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.98,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YCHICXJMFVCFQB-UHFFFAOYSA-N
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.79,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,8.04,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL473417,VISMODEGIB,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(-c3ccccn3)c2)c(Cl)c1,IC50,4.62,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,BPQMGSKTAYIVFO-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,6.16,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL1186585,,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,IC50,4.64,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,MIDUFIRTIFUTQA-UHFFFAOYSA-N
CHEMBL276820,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.54,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,VSJKWCGYPAHWDS-UHFFFAOYSA-N
CHEMBL1164872,,COc1cc(C(=O)OCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.35,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,NHQAWDYBHFPUKA-UHFFFAOYSA-N
CHEMBL1164564,,COc1cc(C(=O)OCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.24,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,LCXOWQVFSXNYSJ-UHFFFAOYSA-N
CHEMBL1163821,,COc1cc(C(=O)OCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.23,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,LQBNUOMEOUZICV-UHFFFAOYSA-N
CHEMBL2381444,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc8c(O)cccc78)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.6,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,LGQLUFPPSGZGDH-RKDXGVHHSA-N
CHEMBL572878,TOZASERTIB,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,IC50,6.02,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,GCIKSSRWRFVXBI-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.3,CHEMBL3757073,Antiproliferative activity against human T98G cells after 24 hrs by EZ-Tox assay,T98G,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL232255,,c1cn(-c2ccc(OCCNCc3ccc4c(c3)OCO4)cc2)cn1,IC50,6.62,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,AFOSWVDYMVIRPF-UHFFFAOYSA-N
CHEMBL3114588,,CC1(C)CC(Nc2ccc(Cl)cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,6.15,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,MTKBKUDYIJQHSH-UHFFFAOYSA-N
CHEMBL453687,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.11,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,ZGMSWLRPBHQCQX-ALMBTRMVSA-N
CHEMBL61,PODOFILOX,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,5.25,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,YJGVMLPVUAXIQN-XVVDYKMHSA-N
CHEMBL3121271,,N#Cc1c(NC(=O)CCc2cccs2)sc2c1CCCC2,EC50,6.82,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,MPEANORHCANUPJ-UHFFFAOYSA-N
CHEMBL3116230,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.5,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MSQYLNJZSXKBIN-HPNDGRJYSA-N
CHEMBL3116434,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.5,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LRTHSPZKWWSRPY-SZXQPVLSSA-N
CHEMBL242772,,CC(COc1cc2oc3c(c2cc1Cl)C(=O)c1ccccc1C3=O)N(C)C,IC50,6.26,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,DUZOVWTWAFRSTO-UHFFFAOYSA-N
CHEMBL390904,,CCN(CC)CCOc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O,IC50,6.85,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,RPXGBDKJYOGAIK-UHFFFAOYSA-N
CHEMBL244032,,CC(C)N(CCOc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O)C(C)C,IC50,6.03,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,GZOJTMSHFBQNAX-UHFFFAOYSA-N
CHEMBL2164234,,CCN(CCO)CCCC#C[C@H]1CC[C@H](N(C)C(=O)Oc2ccc(Cl)cc2)CC1.Cl,IC50,4.68,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,USHZOFAMBDBKIO-URGWDIIDSA-N
CHEMBL479464,,CCN(CCO)CCCCOc1ccc2c(-c3ccc(Br)cc3)nsc2c1.Cl,IC50,5.54,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,JXPRRQCJDYYJLX-UHFFFAOYSA-N
CHEMBL3093013,,C=CCCCCOc1ccccc1-c1cnc(OCCCCC=C)n1C,IC50,5.4,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,KYNHZQLXFMOHST-UHFFFAOYSA-N
CHEMBL3091479,,Cn1c2cnc1OCCCCCCCCCCOc1cc3ccccc3cc1-2,IC50,4.66,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,FBYSFKNNHHNVSZ-UHFFFAOYSA-N
CHEMBL3093028,,COc1ccc2c(c1)-c1cnc(n1C)OCCCCCCCCO2,IC50,4.17,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,JHFXITBLDXDDDM-UHFFFAOYSA-N
CHEMBL223442,,O=C(CC1CCCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,8.7,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,AVNPCOQLNCMCEC-UHFFFAOYSA-N
CHEMBL220558,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccccn1,IC50,6.27,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NOQHBAPFLBFZJH-UHFFFAOYSA-N
CHEMBL2164696,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,6.8,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,YHSNXFZJLMWETE-UHFFFAOYSA-M
CHEMBL2164694,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCc3ccc(F)cc3)cc1n2Cc1ccc(F)cc1.[Br-],IC50,6.37,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FLZOCSUEHOIXCV-UHFFFAOYSA-M
CHEMBL2164404,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-],IC50,6.01,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,QKCJTBIHCTYFCD-UHFFFAOYSA-M
CHEMBL2164706,,Cc1nccc2c1[nH]c1cc(OC(=O)c3ccccc3)ccc12,IC50,4.38,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,WNUVMMWVNIMADA-UHFFFAOYSA-N
CHEMBL1645550,,Cc1nccc2c1[nH]c1cc(OCCc3ccccc3)ccc12,IC50,4.68,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,HVODEZHVACXTKZ-UHFFFAOYSA-N
CHEMBL1645546,,COCCOc1ccc2c(c1)[nH]c1c(C)nccc12,IC50,4.21,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,HSBQAAURJDHACO-UHFFFAOYSA-N
CHEMBL223792,,O=C(CC1CN(C(=O)OCc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.1,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,JMRAUIYBGKHYPA-UHFFFAOYSA-N
CHEMBL373942,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NC(c1ccccc1)c1ccccc1,IC50,5.74,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,DXHWXZWNGYBULD-UHFFFAOYSA-N
CHEMBL2165032,,COc1ccc(Nc2ncc(-c3ccc(C)nc3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.54,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,LJLOTRKTBODGRQ-UHFFFAOYSA-N
CHEMBL4071083,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccn[nH]4)cc3n2)C[C@H](C)O1,IC50,6.37,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,CCDCSUFMDNCKDI-BETUJISGSA-N
CHEMBL2206907,,Cc1nc(N)nc(-c2cc(C3CCOCC3)cnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,8.85,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,FLBPZSHGOYHCPK-UHFFFAOYSA-N
CHEMBL2206922,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)c3cccnc3)c2)n1,IC50,6.42,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,ZANRJYMOJHGSLE-UHFFFAOYSA-N
CHEMBL110809,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1,IC50,7.39,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,INGBRKRPMVCKOQ-UHFFFAOYSA-N
CHEMBL2206920,,COc1ncc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cc1NS(C)(=O)=O,IC50,7.02,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,HXWDVFRJZSNMJG-UHFFFAOYSA-N
CHEMBL4280206,,C(=C/c1ccc(OCCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,7.22,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,YSFZVBYOLOCFOX-BXGDTPBJSA-M
CHEMBL4290427,,C(=C/c1ccc(OCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,7.05,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,BBQBTVXJWMOHMK-IRWWKPKRSA-M
CHEMBL3609555,,CC1(C)OC2=C(CC1[Se]c1ccc(Cl)cc1)C(=O)C(=O)c1ccccc12,IC50,5.58,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,XGDBTKWMCLPMFM-UHFFFAOYSA-N
CHEMBL3609556,,CC1(C)OC2=C(CC1[Se]c1ccc(Br)cc1)C(=O)C(=O)c1ccccc12,IC50,6.01,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,ZFLSERJFPOCJGJ-UHFFFAOYSA-N
CHEMBL2392955,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.83,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YVZRDYCKRBWYLQ-UHFFFAOYSA-N
CHEMBL3797512,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(=O)/C=C/C=C(C)\C=C\[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,7.2,CHEMBL3825128,Antiproliferative activity against human SF295 cells after 48 to 72 hrs by Alamar blue assay,SF295,AIIZZRMMCAVMCU-GXNNERPOSA-N
CHEMBL3793946,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCCCC1,IC50,5.16,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,ZOSPTFWMMQSWDG-UHFFFAOYSA-N
CHEMBL334029,,O=C1c2ncccc2-c2nccc3ccnc1c23,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,OPUPHQHVRPYOTC-UHFFFAOYSA-N
CHEMBL117616,,O=C1c2c(Cl)ccnc2-c2nccc3ccnc1c23,IC50,6.1,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,PRRCPGPQYCZMFC-UHFFFAOYSA-N
CHEMBL1782899,,CCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.6,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZAUJDNSJLGGEJJ-ALMBTRMVSA-N
CHEMBL2381458,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc(OC)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.5,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,MITHWKIKAGALMC-BJMSDPACSA-N
CHEMBL1738703,,Cc1c2c(n3c1CCCNC[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,6.44,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,DGOVAFNEOBXFEF-AWEZNQCLSA-N
CHEMBL1738705,,Cc1c2c(n3c1CCCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.06,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,WQTXERXALASGRT-GOSISDBHSA-N
CHEMBL209148,,COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1,IC50,4.7,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,ZHXNIYGJAOPMSO-UHFFFAOYSA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.97,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL6067492,BLEOMYCIN,,IC50,4.2,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.59,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.94,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL506871,VELIPARIB,C[C@]1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1,IC50,4.35,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JNAHVYVRKWKWKQ-CYBMUJFWSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,5.62,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL573107,,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,IC50,5.48,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,DTEKTGDVSARYDS-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,7.53,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL118218,IROFULVEN,CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,IC50,6.5,CHEMBL3783415,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NICJCIQSJJKZAH-AWEZNQCLSA-N
CHEMBL354031,,CC(=O)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.82,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,GDQVCIVWZYDXJN-UHFFFAOYSA-N
CHEMBL1614701,SELUMETINIB,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,IC50,4.23,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,CYOHGALHFOKKQC-UHFFFAOYSA-N
CHEMBL86892,,C/N=N\N(C)C(=O)NC,IC50,4.62,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,NEXBHNSUHRMPFL-SREVYHEPSA-N
CHEMBL2172475,,CC(=O)Nc1cc(-c2c(Nc3cc[nH]n3)nc3ccccn23)nc(C)n1,IC50,7.22,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,DVKPPCJTWPFHAT-UHFFFAOYSA-N
CHEMBL261294,,CC(C)Cn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.72,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,PCUUECDOHPWNCN-UHFFFAOYSA-N
CHEMBL3794553,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12,IC50,5.4,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,LKSPPCNHWCHCRG-XUVXKRRUSA-N
CHEMBL3794362,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)C(Cl)Cl,IC50,5.29,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,AWKSPMWHISBXEP-RRKCRQDMSA-N
CHEMBL3793820,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,5.15,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,YRYZCLZPZKWTEP-PWRNOJCPSA-N
CHEMBL3792832,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccc(Cl)cc1,IC50,6.38,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,KWNHGHKHLZMRLZ-YNEHKIRRSA-N
CHEMBL3609560,,CC1(C)OC2=C(CC1Sc1ccccc1)C(=O)C(=O)c1ccccc12,IC50,5.48,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,YPMRQCFLHXEFQA-UHFFFAOYSA-N
CHEMBL3618241,,COCCN1CCN(c2ccc3nc(Nc4cnc(OC)c(F)c4)c(-c4nc(C)nc(N)n4)n3c2)CC1,IC50,7.58,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,VVZXIPYMKVAZOT-UHFFFAOYSA-N
CHEMBL353644,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(C(=O)OCc1ccccc1)C(C)C,IC50,6.02,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,XLHLDCVJLJQLIL-UHFFFAOYSA-N
CHEMBL355556,,O=C1OCc2c(cc3n(c2=O)Cc2cc4ccccc4nc2-3)C1(O)CO,IC50,5.14,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,RFHJILZUQZQPSJ-UHFFFAOYSA-N
CHEMBL1821797,EUPHODENDRIANE A,CC1=C[C@@H]2[C@H](C1=O)[C@H](O)C(C)=C[C@H]1[C@@H]3C(C)(C)[C@]3(OC(=O)C(C)C)[C@H](OC(=O)c3ccccc3)[C@@H](C)[C@]21O,IC50,4.22,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,TUYMOSZNDXCMQM-GLPNJXFDSA-N
CHEMBL111998,,Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,8.49,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,MUZZKZIHYIHBGE-SFTDATJTSA-N
CHEMBL260577,,NC(c1ccc(Cl)cc1)C1CCN(c2ccnc3[nH]ccc23)CC1,IC50,5.46,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,PRPNDHHOYWARPB-UHFFFAOYSA-N
CHEMBL98350,LY-294002,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,IC50,5.09,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,CZQHHVNHHHRRDU-UHFFFAOYSA-N
CHEMBL104264,,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,IC50,4.82,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,ZKZXNDJNWUTGDK-NSCUHMNNSA-N
CHEMBL4865974,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(CCc7c[nH]c8ccccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.26,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,MFELGXXVSHQQHD-CTRMNHBPSA-N
CHEMBL4877575,,O=C1C[C@H]2O[C@@H](CI)[C@@H](O)[C@H]2O1,IC50,5.12,CHEMBL4836842,Antiproliferative activity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,CZOPNPBGJUPGBD-LCZOEFHHSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.73,CHEMBL4836842,Antiproliferative activity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3622407,,Cl.O=C(CNc1ccc(Cl)cc1)NC1(CO)CSC2=C1C(=O)c1ccccc1C2=O,IC50,5.91,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,XZKBTOISYXIPED-UHFFFAOYSA-N
CHEMBL515133,,O=C1NC(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.51,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,MYVFKQAHICRDPT-UHFFFAOYSA-N
CHEMBL489463,,CCCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.35,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,GMBQUBWBOHICIN-UHFFFAOYSA-N
CHEMBL453903,,CC(C)(C)c1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.07,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,YHJMEBQVHJJZMS-UHFFFAOYSA-N
CHEMBL454889,,O=C1NN(c2ccc([N+](=O)[O-])cc2)C(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.32,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,LSJRAXQSPRWLFJ-UHFFFAOYSA-N
CHEMBL1807802,,COCCC(=O)N1CCCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@@H]1C)CC(C)(C)CC3=O,IC50,7.1,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RBWHSVCFANTGQI-OALUTQOASA-N
CHEMBL1779531,,Cc1c2c(n3c1CCCN1CCC[C@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.06,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,WQTXERXALASGRT-SFHVURJKSA-N
CHEMBL1807804,,Cc1c2c(n3c1CCN(C(=O)[C@H](C)N)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.1,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,JSSUIPOIXFFFQU-NJAFHUGGSA-N
CHEMBL176381,,CC1(C)CC(NC(=S)NCc2ccccc2)c2cc(Br)ccc2O1,IC50,4.27,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,IQMRTGYHVNXAEP-UHFFFAOYSA-N
CHEMBL373788,,CC1(C)CC(NC(=O)Nc2ccc(Cl)cc2)c2cc(F)ccc2O1,IC50,4.52,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,KTDZECNPAAWQKH-UHFFFAOYSA-N
CHEMBL510164,,Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1,IC50,5.96,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,XXLAEKOWCYJOKK-UHFFFAOYSA-N
CHEMBL494921,,c1cc(-c2nc(N3CCOCC3)c3sccc3n2)c2cn[nH]c2c1,IC50,5.08,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,GXJBABITGPOFCK-UHFFFAOYSA-N
CHEMBL3780933,,Nc1nc(OCc2cccc(CNC(=O)N(CCCl)N=O)c2)c2nc[nH]c2n1,IC50,4.3,CHEMBL3783554,Cytotoxicity against human SF126 cells expressing low level of AGT assessed as cell survival after 24 hrs by CCK8 assay,SF126,GVMAIDVNRQTZES-UHFFFAOYSA-N
CHEMBL1164468,,O=C(OCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,4.35,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,KKMQNWAUGKFRNL-UHFFFAOYSA-N
CHEMBL1779538,,Cc1c2c(n3c1CCCN1C[C@H](O)C[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,6.17,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,IRRAGNCOBFDJHT-QZTJIDSGSA-N
CHEMBL1779539,,Cc1c2c(n3c1CCCN1C[C@@H](F)C[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.02,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,RWRRZRNJYYDDSN-FUHWJXTLSA-N
CHEMBL3426486,,C=C1C(=O)[C@@]23CC[C@@H]4[C@@](C)(CO)CCC[C@@]4(C)C2=CC[C@@H]1C3,IC50,4.69,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,OPSDBQPQYGWZJL-UYUBTLJZSA-N
CHEMBL478507,,Oc1ccc(CN(Cc2ccc(C(F)(F)F)cc2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.0,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,JZARXLRJMQKPON-UHFFFAOYSA-N
CHEMBL4758691,,C#CCOc1ccc(/C=C/C(=O)c2ccccc2C)cc1OC,IC50,5.68,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,XFLIJBVWDOJQLX-PKNBQFBNSA-N
CHEMBL4758544,,C=CCOc1ccc(C=O)cc1OC,IC50,5.12,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,DGWCHURQYFMBFC-UHFFFAOYSA-N
CHEMBL3621992,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(C(=O)/C=C/c2ccccc2)cc1,IC50,6.43,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,IZAYQOKSONRKCE-SFQUDFHCSA-N
CHEMBL2417820,,COc1ncc(-c2ccc3nc(N)nn3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,5.6,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,YJGBMSZABXWLMO-UHFFFAOYSA-N
CHEMBL2417818,,COc1ncc(-c2ccc3nc(N)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.4,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,CCPJHMRMRYWHNJ-UHFFFAOYSA-N
CHEMBL1823651,,O=C(NC(c1ccc(Cl)c(Cl)c1)C1CCNCC1)c1ccc2cnc(F)cc2c1,IC50,6.41,CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,U-87MG ATCC,QFMBYPBOVSGXGC-UHFFFAOYSA-N
CHEMBL2402943,,CC(C)=CCC[C@]1(C)C=Cc2c(c(C)cc3c2[nH]c2ccccc23)O1,IC50,4.6,CHEMBL2405050,Cytotoxicity against human A172 cells assessed as growth inhibition after 48 hrs by MTT assay,A-172,HTNVFUBCWIYPJN-HSZRJFAPSA-N
CHEMBL3092021,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(O[Si](C)(C)C(C)(C)C)cc2)c(OC)c1,IC50,4.72,CHEMBL3096271,Cytotoxicity against human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,PRLFQHHCWWXLCB-UHFFFAOYSA-N
CHEMBL388881,,c1cn(-c2ccc(OC[C@H]3CCCN3Cc3ccc4c(c3)OCO4)cc2)cn1,IC50,6.6,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,LJMQPVKSZNDSKH-LJQANCHMSA-N
CHEMBL232826,,c1cn(-c2ccc(O[C@@H]3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,5.77,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HHOPJGKEAIIIDF-HXUWFJFHSA-N
CHEMBL316130,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCN(C)C)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,GGCKHBAUSWWNEQ-UHFFFAOYSA-N
CHEMBL84655,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC(=O)O)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,ZPHQIWXAIWECJH-UHFFFAOYSA-N
CHEMBL3975545,,Cc1[nH]c2c(c1-c1nnc(-c3ccccc3)o1)Cc1ccccc1-2,IC50,7.22,CHEMBL3878557,Antiproliferative activity against human T98G cells after 72 hrs by XTT assay,T98G,ASVQGQLIXGMQDH-UHFFFAOYSA-N
CHEMBL111249,,O=C1c2nccc(Cl)c2C(=O)c2c(-c3ccccc3[N+](=O)[O-])ccnc21,IC50,5.7,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,HYARGZOCQYEIQS-UHFFFAOYSA-N
CHEMBL107092,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1,IC50,9.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,GZYLUVFSBIJQAU-UHFFFAOYSA-N
CHEMBL355569,,CCN(CCc1c2c(nc3cc4c(cc13)OCO4)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC)C(=O)OCc1ccccc1,IC50,5.55,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,SNJYBAJACUNLGR-UHFFFAOYSA-N
CHEMBL1630325,,C=C1C(=O)O[C@@H]2C3=C[C@H]4OO[C@]3(CC[C@@H]12)C(C)(C)C4=O,IC50,5.59,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NMXXTJXRQIYUIO-IGRCHAIXSA-N
CHEMBL1641650,,CC(=O)O[C@@H]1C=C[C@H](OCCCOc2cc(O)c3c(=O)c(-c4ccc(O)cc4)coc3c2)O[C@H]1C,IC50,4.78,CHEMBL1647062,Cytotoxicity against human T98G cells after 72 hrs by SRB assay,T98G,PDZLLRLDZPDGCT-HRCLSFSHSA-N
CHEMBL432949,,O=C1OCc2c(cc3n(c2=O)Cc2cc4ccccc4nc2-3)C1(O)CCO,IC50,5.35,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,CCBXXGSAGQNXHX-UHFFFAOYSA-N
CHEMBL103577,,Cc1cnc2c(c1)C(=O)c1cccnc1C2=O,IC50,6.6,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,XVXWDZYWGRHSJR-UHFFFAOYSA-N
CHEMBL3092927,,C=CCCCCOc1ncc(-c2ccccc2OC)n1C,IC50,5.3,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,UPLYWSQTJNMGKG-UHFFFAOYSA-N
CHEMBL392695,S-TRITYL-L-CYSTEINE,N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O,IC50,5.56,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,DLMYFMLKORXJPO-FQEVSTJZSA-N
CHEMBL300389,,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,IC50,7.55,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,IYNDTACKOAXKBJ-UHFFFAOYSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.31,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL446473,PHENYLBUTYL ISOTHIOCYANATE,S=C=NCCCCc1ccccc1,IC50,4.46,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,CCBQOLFAKKAMLD-UHFFFAOYSA-N
CHEMBL513097,PLAKORTIDE M,CC/C=C/[C@H](CC)C/C=C/[C@@]1(CC)C[C@H](CC)[C@H](CC(=O)O)OO1,IC50,5.75,CHEMBL982259,Cytotoxicity against human SF295 cells,SF295,APFBSUUYUMZERZ-ACISTPACSA-N
CHEMBL119592,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccccc3)cc1OC2(C)C,EC50,5.51,CHEMBL964507,Cytotoxicity against human U87 cells by side flank model relative to control,U-87MG ATCC,GZYXCXRHVALIJD-WOJBJXKFSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.52,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,8.45,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.48,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,7.66,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL575196,,COC(=O)[C@H](Cc1ccc(O)cc1)N/C=C1\C(=O)C(O)=C(C(C)C)c2cc(C)c(-c3c(C)cc4c(c3O)/C(=C/N[C@@H](Cc3ccc(O)cc3)C(=O)OC)C(=O)C(O)=C4C(C)C)c(O)c21,IC50,4.84,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AFCGYIWULPMWPT-ZXRMINHTSA-N
CHEMBL575446,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC(C)C)C(=O)C(O)=C3C(C)C)/C(=C/NC(C)C)C(=O)C(O)=C2C(C)C,IC50,4.54,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,SSSPNLJUJBETHQ-GACBQCINSA-N
CHEMBL446125,FASCAPLYSIN A,CC1=C(CC/C(C)=C/CC/C(C)=C/CCC(CC(=O)O)C(=O)[O-])C(C)(C)CCC1.O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,IC50,5.28,CHEMBL1000757,Antitumor activity against human SNB75 cells,SNB-75,LORHTOVIKVOXSY-YOEDIAEGSA-N
CHEMBL394882,NOR-BETA-LAPACHONE,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.8,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DMSVAEFGRLMACV-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.39,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL571623,,Cc1cc([N+](=O)[O-])ccc1NC1C2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.73,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QQRVFKSGDWMEIS-UHFFFAOYSA-N
CHEMBL571407,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccccc1[N+](=O)[O-],IC50,5.75,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AZERFNFOCUWMHL-UHFFFAOYSA-N
CHEMBL1910998,,Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,8.89,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,WFRUFWRKGZIARP-UHFFFAOYSA-N
CHEMBL1910999,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,7.26,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,HQXHYGAANFLAOZ-UHFFFAOYSA-N
CHEMBL1911114,,COc1ccc2c(nc(C(F)F)n2-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1O,IC50,6.23,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,JMCCNBLPWHIWCV-UHFFFAOYSA-N
CHEMBL476113,,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](C)NC1=O,IC50,5.22,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,RGRWKFDNYSQFBZ-JRBASJLZSA-N
CHEMBL565420,,C[C@@H]1CC[C@H]2[C@H](CBr)CO[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4,IC50,4.79,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,ICJKLGDDPGNBBS-BXPKWHOZSA-N
CHEMBL569090,,C[C@H]1[C@@H](CCSCC[C@H]2O[C@@H]3O[C@]4(C)CC[C@H]5[C@H](C)CCC([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@]3(C)CCC4[C@H](C)CC[C@@H]1[C@]42OO3,IC50,5.26,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,SONOEGJPRKBJAA-HDHWBIKTSA-N
CHEMBL2180727,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,IC50,7.16,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,FNYGWXSATBUBER-UHFFFAOYSA-N
CHEMBL421,SULFASALAZINE,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,IC50,4.52,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,NCEXYHBECQHGNR-QZQOTICOSA-N
CHEMBL2037445,,C/C(=N/NC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.23,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,KRCPOZLWYUZVBS-ZDLGFXPLSA-N
CHEMBL1630582,,C/C(=N\NC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,9.0,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,QJEQNMXYYQUOAY-VCHYOVAHSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.34,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL2037449,,C/C(=N/NC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.37,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,MXWJIUNQTNDDFG-YVLHZVERSA-N
CHEMBL1630581,,C/C(=N\NC(=S)Nc1ccccc1Cl)c1ccccn1,IC50,8.59,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,DIAIPLSVPPGTLG-VCHYOVAHSA-N
CHEMBL2037436,,C/C(=N\NC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.75,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VCKFVZSNSWYSKQ-VCHYOVAHSA-N
CHEMBL1771488,,C/C(=N\NC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.3,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PMHTWYVKIPHSFS-VCHYOVAHSA-N
CHEMBL2037435,,CC(=NNC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.8,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PTOHINKLMXPSKL-UHFFFAOYSA-N
CHEMBL1081853,,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)sc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.04,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,ACASJCMNZMOGPH-AWEZNQCLSA-N
CHEMBL49378,,CCOC(=O)[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)NC(=O)CCCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,IC50,4.68,CHEMBL805826,The compound was tested for cytotoxicity against SF-126 (human) Glioma cell lines,SF126,IDHGEFGDZPCYJX-GDLZYMKVSA-N
CHEMBL2098107,,O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2ccccc2[nH]1,IC50,6.48,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,YGUDSHJNJUBIHP-UHFFFAOYSA-N
CHEMBL5195215,,O=C(NCc1ccc(F)cc1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.36,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,NALIAYSLJPZACM-UHFFFAOYSA-N
CHEMBL5199446,,O=C(CC12CC3CC(CC(C3)C1)C2)Nc1nc2ccccc2[nH]1,IC50,5.19,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,HQTLILQUYCGKIQ-UHFFFAOYSA-N
CHEMBL5201756,,O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2c(Cl)ccc(Cl)c2c1=O,IC50,5.04,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,ANMPGAUFPGVOHG-UHFFFAOYSA-N
CHEMBL3092918,,COc1ccccc1-c1cnc(OCCCc2ccccc2)n1C,IC50,5.52,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,IJRQFMLSTLUNTK-UHFFFAOYSA-N
CHEMBL3093026,,Cn1c2cnc1OCCCCCCCCOc1cc(F)ccc1-2,IC50,4.16,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CFNQXEGOPRAOTL-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,6.85,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL125191,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(N(CCCl)CCCl)cc13,IC50,7.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,CDSDBTYEKSPYEZ-UHFFFAOYSA-N
CHEMBL523263,,CN(C)c1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.1,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,GFUQYTODWIEYAX-UHFFFAOYSA-N
CHEMBL455132,,O=C1NN(c2ccccc2)C(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.34,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,WGKFUFBYBCYABN-UHFFFAOYSA-N
CHEMBL3933347,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCCC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.8,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LGGXLUJMVMVVOQ-UHFFFAOYSA-N
CHEMBL84,TOPOTECAN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,IC50,6.8,CHEMBL3265609,Antiproliferative activity against human U87 cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,UCFGDBYHRUNTLO-QHCPKHFHSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.36,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL428725,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cc(CF)nn3)nccc12,IC50,6.62,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,HUZFIDHFHZMOAP-OAHLLOKOSA-N
CHEMBL238265,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3nccn3)ncc(F)c12,IC50,6.21,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ABWXAJAMZIXGLW-CQSZACIVSA-N
CHEMBL392758,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)nccc12,IC50,6.82,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DLNPHXOJDBJBBK-OAHLLOKOSA-N
CHEMBL393585,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ccc(F)cc12,IC50,5.44,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,PAQRKQUUKFOMSK-CQSZACIVSA-N
CHEMBL238074,,C[C@@H]1CN(S(=O)(=O)c2c[nH]c3ncccc23)CCN1C(=O)c1ccccc1,IC50,4.89,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,QGODFPZTUSIJQW-CQSZACIVSA-N
CHEMBL393400,,CC1CN(C(=O)c2cnc3ccccc3n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.27,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ANOLRYSIPZVGCW-UHFFFAOYSA-N
CHEMBL236997,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,6.07,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ICLFAMDXSMSQGX-CQSZACIVSA-N
CHEMBL3588942,,CCCC(=O)Oc1ccc(/C=C/COC(C)=O)cc1OC,IC50,4.98,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,HOQXDJJQJVPBRZ-FNORWQNLSA-N
CHEMBL3588939,,COc1cc(/C=C/COC(C)=O)ccc1OC(C)=O,IC50,5.97,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,KCODNVFFXXYJPA-SNAWJCMRSA-N
CHEMBL4099562,,O=C(Nc1ccncc1)Nc1ccc(-c2cc(N3CC4CCC(C3)O4)c3nccn3n2)cc1,IC50,4.93,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,AMGONPXTTMZQRC-UHFFFAOYSA-N
CHEMBL4089423,,C[C@H]1COCCN1c1cc(-c2ccc(NC(=O)Nc3ccc(N4CCN(C)CC4)cc3)cc2)nn2ccnc12,IC50,5.58,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,AAXLFXKVJQWRCB-NRFANRHFSA-N
CHEMBL4077736,,CCc1cnc2c(N3CCOC[C@@H]3C)cc(-c3ccc(NC(=O)Nc4ccncc4)cc3)nn12,IC50,5.29,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,OECGDPJSTMHVTP-KRWDZBQOSA-N
CHEMBL3290928,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.75,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OXESTPIQGJVUCC-UHFFFAOYSA-N
CHEMBL3290917,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.6,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,NORQIYMCKYRXOJ-UHFFFAOYSA-N
CHEMBL3612309,,COc1ncc(-c2ccc3nc(NC(=O)NC4CC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.28,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,SETOUQDIHCNCHQ-UHFFFAOYSA-N
CHEMBL3612318,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1C#N,IC50,5.08,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,CYWXKRWCESQIOB-UHFFFAOYSA-N
CHEMBL3612322,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3n2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.32,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,GCCYGPNWMFOFLT-UHFFFAOYSA-N
CHEMBL1241832,,O=C(N/N=C/c1c(O)ccc2ccccc12)c1cc(-c2ccc3ccccc3c2)n[nH]1,IC50,6.0,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,XOXCTLAKMCIWCF-CVKSISIWSA-N
CHEMBL4864941,,CC12CC3CC(C)(C1)CC(NCc1ccc(C(=O)NO)cc1)(C3)C2,IC50,4.34,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,ZGUUWDMEHPPEGH-UHFFFAOYSA-N
CHEMBL4871938,,CC12CC3CC(C)(C1)CC(NCc1ccc(NC(=O)CCCCCCC(=O)NO)cc1)(C3)C2,IC50,5.53,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,WLSVOCQBROCUNL-UHFFFAOYSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,5.59,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL521686,OLAPARIB,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,IC50,4.17,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,FDLYAMZZIXQODN-UHFFFAOYSA-N
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,4.15,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,RITAVMQDGBJQJZ-FMIVXFBMSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.99,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,6.64,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,4.66,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,OGNYUTNQZVRGMN-UHFFFAOYSA-N
CHEMBL1782902,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CO)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,5.68,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,VYEHKJZEGTZXEK-AZIXLERZSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,5.25,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL573107,,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,IC50,4.84,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,DTEKTGDVSARYDS-UHFFFAOYSA-N
CHEMBL1614701,SELUMETINIB,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,IC50,4.22,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,CYOHGALHFOKKQC-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,5.86,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.89,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,4.81,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,CEGSUKYESLWKJP-UHFFFAOYSA-N
CHEMBL399530,,CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,IC50,4.71,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,OWPMENVYXDJDOW-UHFFFAOYSA-N
CHEMBL2380760,,NS(=O)(=O)c1cccc2c1C(=O)c1cccc(O)c1C2=O,IC50,6.8,CHEMBL2383235,Cytotoxicity against human U87 cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,CQBHSRLUQDYPBU-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.78,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.88,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,6.18,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,5.63,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL223615,,COc1ccc(CCNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1OC,IC50,7.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PQRVHILYLCVPLT-UHFFFAOYSA-N
CHEMBL221320,,Cc1cc(N2CCNC(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NQPBHEDOJDMNSV-UHFFFAOYSA-N
CHEMBL2381456,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccccc7C#N)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.82,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,XOGYFHSVBPTAAE-RROBCMOASA-N
CHEMBL2381455,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc(CC#N)cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.89,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,VQCWBWUZOOXFSK-ICIQEZEZSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,8.18,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL456075,CASEARLUCIN A,C=C/C(C)=C/C[C@]1(C)[C@H]2C[C@H](OC(=O)C(C)CC)C=C3[C@H](OC(C)=O)O[C@H](OC(C)=O)[C@@]32[C@H](O)C[C@@H]1C,IC50,5.85,CHEMBL815854,In vitro cytotoxicity against parental and drug resistant glioblastoma human tumor cell line U87MG,U-87MG ATCC,FGGPIWICAGRSLN-UQSIVEBGSA-N
CHEMBL554,LAPATINIB,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,4.02,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,BCFGMOOMADDAQU-UHFFFAOYSA-N
CHEMBL1189501,,CN1CCOc2cccc3nc(O)c(nc23)-c2cccc3c(O)n(nc23)CC1,IC50,7.11,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,VHQSTBKAAYHLRM-UHFFFAOYSA-N
CHEMBL4852923,,C(=C/c1nc2ccccn2c1Sc1ccccc1)\c1ccccc1,IC50,4.23,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,QQUXYMHDLHUXOU-CCEZHUSRSA-N
CHEMBL4852797,,N#Cc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.18,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,PMQSQPJUDIFZFL-UHFFFAOYSA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.89,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,4.38,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,4.82,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,JWQOJVOKBAAAAR-UHFFFAOYSA-N
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,4.82,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,GFMMXOIFOQCCGU-UHFFFAOYSA-N
CHEMBL4864675,,COc1cc(C(=O)c2cn(-c3ccc(C)cc3)cc2-c2ccsc2)cc(OC)c1OC,IC50,7.71,CHEMBL4838790,Cytotoxicity against human U-87MG cells assessed as cell growth inhibition measured after 48 hrs by MTS colorimetric assay,U-87MG ATCC,IPVNWYTUTMCVEH-UHFFFAOYSA-N
CHEMBL2165013,,COc1ccc(Nc2ncc(CN3CCNCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.7,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,KEDQOULNSHVTKP-UHFFFAOYSA-N
CHEMBL2165034,,COc1ccc(Nc2ncc(CN3CCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.21,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,LOXQLWVHDSHBPP-UHFFFAOYSA-N
CHEMBL106369,,COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1,IC50,7.58,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,LKDCAIVJHAMVHC-UHFFFAOYSA-N
CHEMBL229365,,O=C1C(=O)c2c(nc3cnccn23)-c2ncccc21,IC50,7.04,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,SQKMJSZLUCXAHB-UHFFFAOYSA-N
CHEMBL229723,,O=C1c2cnncc2C(=O)c2nc3cc(OC(F)(F)F)ccc3nc21,IC50,7.01,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,BGEMJGUECGHJCV-UHFFFAOYSA-N
CHEMBL317476,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1,IC50,8.3,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XRUMZMCHUHDEQQ-UHFFFAOYSA-N
CHEMBL7064,,O=C1c2ccccc2-c2n[nH]c3cccc1c23,IC50,4.77,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,ACPOUJIDANTYHO-UHFFFAOYSA-N
CHEMBL5191468,,O=C(NCCCNc1cc(-c2cn(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)Nc1ccc(F)cc1,IC50,6.27,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,BCNMJLRKWYKBBZ-UHFFFAOYSA-N
CHEMBL606259,,CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,4.84,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,CPWFSOCJQNZDPU-LVIOGHJBSA-N
CHEMBL551288,APOGOSSYPOL,Cc1cc2c(C(C)C)c(O)c(O)cc2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)cc2c1O,IC50,4.54,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,PBJKWGWHZVXBGU-UHFFFAOYSA-N
CHEMBL51483,GOSSYPOL,Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,IC50,4.22,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QBKSWRVVCFFDOT-UHFFFAOYSA-N
CHEMBL5436017,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCCCC(=O)NO)CC1)C2,IC50,4.37,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,BNAJKXYRVNGASQ-UHFFFAOYSA-N
CHEMBL5425203,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)CC1)C2,IC50,5.24,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,DRKZKGNONHNGTB-UHFFFAOYSA-N
CHEMBL1777854,,CCC1=C(C)/C(=C/c2ccc(C(=O)NC(=N)N)cc2)CCC1(C)C,IC50,5.18,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,XSSNKBMVZGXBCU-FOWTUZBSSA-N
CHEMBL5412356,,O=C(C#Cc1ccccc1)Nc1cc(-c2nccs2)ccc1F,IC50,5.93,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,OFHSPEKSWQTWLL-UHFFFAOYSA-N
CHEMBL5430775,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CCC1,IC50,6.81,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,VJPUQDMXGSSMSV-UHFFFAOYSA-N
CHEMBL5402707,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCc1ccc(C(F)(F)F)cc1,IC50,6.77,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,KVBZBOFHPSXVJH-UHFFFAOYSA-N
CHEMBL5436721,,O=C(C#Cc1ccccc1)Nc1cccc(-c2ncc[nH]2)c1,IC50,6.91,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,XAQWDQFCIKPFCH-UHFFFAOYSA-N
CHEMBL5428972,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)/C=C/c1ccc(Cl)cc1,IC50,5.0,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,KKBBKKLTSASRPU-BJMVGYQFSA-N
CHEMBL5439553,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(OC)c1,IC50,7.25,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,BQYVIYBBGCUYOJ-UHFFFAOYSA-N
CHEMBL361946,,CC1(c2ccccc2)CC(=O)C(C2CC(c3ccc(-c4ccc(Br)cc4)cc3)Cc3ccccc32)=C(O)O1,IC50,5.87,CHEMBL825052,Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 after 72 hr of incubation was determined,XF 498,BOKGXPIFERMENI-UHFFFAOYSA-N
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,5.85,CHEMBL836449,In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr,U-87MG ATCC,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CHEMBL3216760,,CN(C)CCNCCC(=O)Nc1csc2c1C(=O)c1ccccc1C2=O.Cl.Cl,IC50,6.22,CHEMBL1803379,Antitumor activity against human SF295 cells after 24 to 48 hrs by MTT assay,SF295,HCNOLYNOZAOMMO-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.36,CHEMBL1803379,Antitumor activity against human SF295 cells after 24 to 48 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL261907,DIHYDRODEHYDRODICONIFERY ALCOHOL,COc1cc([C@H]2Oc3c(OC)cc(CCCO)cc3[C@@H]2CO)ccc1O,IC50,4.87,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,SBLZVJIHPWRSQQ-HNAYVOBHSA-N
CHEMBL1760596,,COc1cc(C(=O)CCO)cc(OC)c1O,IC50,4.61,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,UHOAHNLBCNGCHE-UHFFFAOYSA-N
CHEMBL485875,,COc1cc(C(=O)CCO)ccc1O,IC50,4.55,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,NXCPMSUBVRGTSE-UHFFFAOYSA-N
CHEMBL1289102,,COc1ccc(-c2cc(C(=O)N/N=C(\C)c3ccc(OC)c(OC)c3)[nH]n2)cc1,IC50,6.22,CHEMBL1291285,Cytotoxicity against human U87MG cells after 48 hrs by sulforhodamine B assay,U-87MG ATCC,GMFUWEBOUKIKRP-LPYMAVHISA-N
CHEMBL5563604,,CCCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.85,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZCJXMLPKKDIHSJ-CQSZACIVSA-N
CHEMBL385415,,Oc1nc2cccc3c2nc1-c1cccc2c(O)n(nc12)CCN1CC[C@@H](C1)O3,IC50,7.57,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,XKBVYQGZLBOXHF-LBPRGKRZSA-N
CHEMBL1778208,,Cc1c2c(n3c1CCCNC(=O)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.1,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,SRLFTYLZJAKYNU-AWEZNQCLSA-N
CHEMBL1779532,,Cc1c2c(n3c1CCCN1CCCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.54,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,VNNXUBVMSLWQDG-LJQANCHMSA-N
CHEMBL4080072,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccccc1Cl)CC(C)(C)O2,IC50,4.06,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,DEMWNIWYAZPRNO-UHFFFAOYSA-N
CHEMBL1652081,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccc(O)cc3)[nH]c21,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QNKQRHGAMGCRIT-UHFFFAOYSA-N
CHEMBL1098852,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(-c3ccccc3)nn2)[C@H]1Br,IC50,5.81,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JSNJUKIDLLBRQT-PGRDOPGGSA-N
CHEMBL394882,NOR-BETA-LAPACHONE,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.8,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DMSVAEFGRLMACV-UHFFFAOYSA-N
CHEMBL4088848,,COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(OC)cc45)c(F)c3)nc3ccccc32)c(OC)c1,IC50,4.79,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DNMHJEOHMSRAAL-UHFFFAOYSA-N
CHEMBL4072335,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.03,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MJSOEWYWKXULFD-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,4.9,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,4.36,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL513909,BI-2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,IC50,4.28,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,XQVVPGYIWAGRNI-JOCHJYFZSA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,6.66,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,5.47,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,PHXJVRSECIGDHY-UHFFFAOYSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.37,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,5.95,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,8.12,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL103667,DORAMAPIMOD,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,IC50,4.48,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,MVCOAUNKQVWQHZ-UHFFFAOYSA-N
CHEMBL1079175,MK-2206,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,IC50,4.64,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,ULDXWLCXEDXJGE-UHFFFAOYSA-N
CHEMBL333669,,Cc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.22,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,XQDQFRGZXXSQCO-UHFFFAOYSA-N
CHEMBL463602,,C=C1C(=O)O[C@@H]2C3=C(C)C(=O)C[C@H]3[C@](C)(O)CC[C@@H]12,IC50,4.99,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FAESSFVRXUTLPW-FMRSBHEDSA-N
CHEMBL1360494,,COc1cc(OC)c(C(c2cc3c(cc2O)OCO3)N2CCOCC2)c(OC)c1,IC50,4.87,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,CURGVCDXVHAOOH-UHFFFAOYSA-N
CHEMBL1450405,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCCC2)cc1,IC50,4.65,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,TUODYFDDFYVYBP-UHFFFAOYSA-N
CHEMBL4764456,,Oc1c(C(Nc2ccccn2)c2c(Cl)cccc2Cl)ccc2cccnc12,IC50,5.16,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,WOPDKGYYANFDPZ-UHFFFAOYSA-N
CHEMBL2178606,,COC(C)(C)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1,EC50,6.54,CHEMBL2186332,Cytotoxicity against human U87MG cells incubated for 4 days,U-87MG ATCC,BRCOIQMZYMWNIS-UHFFFAOYSA-N
CHEMBL1760593,(-)-ISOLARICIRESINOL,COc1cc([C@@H]2c3cc(O)c(OC)cc3C[C@H](CO)[C@H]2CO)ccc1O,IC50,4.64,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,OGFXBIXJCWAUCH-WAWZGNHOSA-N
CHEMBL3793126,,Brc1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCOCC1,IC50,4.64,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,RWEPXLQRLRYFSK-UHFFFAOYSA-N
CHEMBL3794277,,CON(C)CCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.44,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,VRBJHYXYYJVWFK-UHFFFAOYSA-N
CHEMBL3792414,,CCN(CC)CCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.77,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,BORYBNQNXCBXDX-UHFFFAOYSA-N
CHEMBL554997,,Cc1c(CO)c(CO)c2n1-c1ccccc1C2,IC50,4.71,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,PLJQHKWMUDHDEF-UHFFFAOYSA-N
CHEMBL3794215,,CONCCCCCCN1c2ccccc2Sc2cccnc21,IC50,4.55,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,DEKITJMQIIOWLZ-UHFFFAOYSA-N
CHEMBL597378,,COc1cc(/C=C/c2cc(O)c(CCC(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,6.4,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,SDPGTYZDUFQIRL-HLULBIOLSA-N
CHEMBL1081029,,N[C@H](CNc1ncc(-c2ccc3c(c2)CNC3=O)s1)Cc1ccc(C(F)(F)F)cc1,IC50,5.22,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,UFEUMFPFVBUZRR-INIZCTEOSA-N
CHEMBL590061,,FC(F)(F)c1ccc(CNc2nonc2NCc2ccc(C(F)(F)F)cc2)cc1,IC50,4.69,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,MWVJBONVTITVIC-UHFFFAOYSA-N
CHEMBL591033,,O=C(Nc1nonc1NC(=O)c1ccc(Br)cc1)c1ccc(Br)cc1,IC50,4.85,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,OHBCJOHNVMVQIG-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.22,CHEMBL813199,In vitro cytotoxicity expressed as concentration that inhibits 50% of U87 (glioblastoma) sensitive variant cell proliferation,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL140730,,COc1ccc(-c2cc3c(N(C)C)cccc3c(N3CCN(C)CC3)n2)cc1,IC50,4.97,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,CUXVREHOPMDBBI-UHFFFAOYSA-N
CHEMBL5277445,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccncc5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,5.9,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,PVCHFDQWRQFBTJ-UHFFFAOYSA-N
CHEMBL553205,ROLLOAMIDE A,CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2CC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,6.14,CHEMBL1055507,Antiproliferative activity against human U87MG cells after 3 days by MTS assay,U-87MG ATCC,LVEJXBHPAHVYAJ-ZTTRGGFUSA-N
CHEMBL5410875,,O=C1NC(O)(c2ccc(Cl)cc2)C(c2ccc(Cl)cc2)=C1c1ccc(Cl)cc1,IC50,6.03,CHEMBL5333084,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth by CCK-8 assay,U-87MG ATCC,QVGDWGHPYVXRFO-UHFFFAOYSA-N
CHEMBL5282240,,C/C=C/Cn1cc(-c2ccc(C(C)(C)O)cc2OC)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261844,Cytotoxicity against human LN-229 cells measured after 8 days,LN-229,GVJYOLRRZZUUOE-AATRIKPKSA-N
CHEMBL111300,,O=C1c2nccc(O)c2C(=O)c2c(-c3ccccc3[N+](=O)[O-])ccnc21,IC50,6.1,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,SQGQTACESPGMNK-UHFFFAOYSA-N
CHEMBL1224362,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.5,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,MAWLSILLWAABOI-CNHRZFDUSA-N
CHEMBL594568,,CC[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)c(OC)cc4[C@H]3CC[C@]12C,IC50,4.89,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,OIKLWYPNJDWKNL-DQSYDGHTSA-N
CHEMBL595647,,CNc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)CCC[C@@H]12,IC50,4.65,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,CSUBNOHVQCLNET-MVWRLGRASA-N
CHEMBL595667,,CN(C)c1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)CCC[C@@H]12.Cl,IC50,4.47,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,VGFLJNZLWXAPCR-ZVSWTSNUSA-N
CHEMBL107154,,C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,9.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,ZPSNELIJNCRWKW-UHFFFAOYSA-N
CHEMBL391846,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2cccc(F)c12,IC50,6.7,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,WCWCDFCBGJVWBT-CQSZACIVSA-N
CHEMBL240688,,CC1CN(C(=O)c2cccs2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.34,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OUYKEJFBGBJLIL-UHFFFAOYSA-N
CHEMBL85641,,Cn1c(=O)c(-c2ccc(O)cc2)cc2c(O)cc(O)cc21,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,PUEMVFSBPADQCN-UHFFFAOYSA-N
CHEMBL85641,,Cn1c(=O)c(-c2ccc(O)cc2)cc2c(O)cc(O)cc21,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,PUEMVFSBPADQCN-UHFFFAOYSA-N
CHEMBL411515,,Clc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12,IC50,7.19,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,YLRSPXDEXXKFBG-UHFFFAOYSA-N
CHEMBL449964,,Clc1ccc2c(c1)C1(CCNCC1)CN2c1ncnc2[nH]ccc12,IC50,7.29,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,SYJAQTIUQWZRLK-UHFFFAOYSA-N
CHEMBL3780761,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.07,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OJSDVUBZLAMEFI-UHFFFAOYSA-N
CHEMBL1081105,,N[C@H](CCc1cc(-c2ccc3cnccc3c2)no1)Cc1ccc(C(F)(F)F)cc1,IC50,5.42,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,HZEDOBNROFBZAQ-HXUWFJFHSA-N
CHEMBL1081295,,Nc1cc2cc(-c3cnc(NC[C@@H](N)Cc4ccc(C(F)(F)F)cc4)s3)ccc2cn1,IC50,6.05,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,XLMDNKMMDBSPSJ-SFHVURJKSA-N
CHEMBL1081829,,N[C@H](CNc1ncc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.14,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,JEJKZRXWJBUNLT-INIZCTEOSA-N
CHEMBL574976,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NC1CC1)C(=O)C(O)=C3C(C)C)/C(=C/NC1CC1)C(=O)C(O)=C2C(C)C,IC50,4.49,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,USMHSUMBECSGPI-GACBQCINSA-N
CHEMBL3774448,,O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1,IC50,6.7,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,ZFGAUFCQRUSRCF-XFFZJAGNSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.12,CHEMBL1104099,Cytotoxic activity against human SF295 cells after 69 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3765479,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccc(C)cc2)cc(OC)c1OC,IC50,5.69,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,XVQGQUSOBZXZFW-CPNJWEJPSA-N
CHEMBL3763772,,COc1ccc(/C(=C\c2cc(OC)c(OC)c(OC)c2)C(=O)N2CCC=CC2=O)cc1,IC50,6.07,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,GXAWBZCBBVCHHX-CPNJWEJPSA-N
CHEMBL3805290,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5ccccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.34,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FVACZTPWZHJRTQ-RIWGJCQISA-N
CHEMBL3781819,LP-184,CC1=C(CN(O)C(N)=O)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,IC50,7.5,CHEMBL3783418,Cytotoxicity against human SNB75 cells after 48 hrs by sulforhodamine B assay,SNB-75,VWMPVAZEBAKLFR-HNNXBMFYSA-N
CHEMBL3785656,,COc1cc(/C=C/C(=O)OCCCc2cc(OC)c3c(c2)[C@@H](CO)[C@H](c2cc(OC)c(O[C@@H](CO)[C@H](O)c4ccc(O)c(OC)c4)c(OC)c2)O3)ccc1O,IC50,4.74,CHEMBL3792217,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TXCVWSBILJVFSH-PXQSDCCFSA-N
CHEMBL917,FLOXURIDINE,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,IC50,5.25,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,ODKNJVUHOIMIIZ-RRKCRQDMSA-N
CHEMBL3793573,,CC(C)(C)c1ccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc1,IC50,6.47,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,MYGBVGRQGYOQBF-ARFHVFGLSA-N
CHEMBL1699,MEMANTINE HYDROCHLORIDE,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl,IC50,4.63,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,LDDHMLJTFXJGPI-UHFFFAOYSA-N
CHEMBL3793447,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccc([N+](=O)[O-])cc1,IC50,6.4,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,QCIKSNAZLKDOMN-YNEHKIRRSA-N
CHEMBL3793774,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cncc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,4.97,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,XPGBBZUSOYAGMV-GRUVHVDGSA-N
CHEMBL119393,,COc1cnc2c3c(nccc13)-c1c(N(C)C)ccnc1C2=O,IC50,5.52,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,JJXIXCZCTTWZLB-UHFFFAOYSA-N
CHEMBL11359,CISPLATIN,,IC50,5.54,CHEMBL822894,In vitro cytotoxicity against CNS cancer XF 498 cell lines,XF 498,
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,8.0,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4873475,,O=C(NCCc1c[nH]c2ccccc12)c1ccccc1Nc1ccc(C(F)(F)F)cc1,IC50,4.45,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,KTWQLMKUUDQDDZ-UHFFFAOYSA-N
CHEMBL2372256,,CSCC[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)CCCCCNC(=O)CC[C@H](NC(=O)COCCOCCOCCN)C(=O)NCCCC[C@H]1NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O)C(C)C)C(N)=O,IC50,7.97,CHEMBL1021542,Displacement of [125I]c(RGDyK) form integrin alphaVbeta3 receptor in human U87MG cells,U-87MG ATCC,RNOUTIRQWZWSHX-RMCMQRDFSA-N
CHEMBL357518,,Cc1ccc2c(N3CCN(C)CC3)nc(-c3ccc(Cl)cc3)cc2c1,IC50,5.39,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,BGNUPPHAVDLYFT-UHFFFAOYSA-N
CHEMBL242533,,O=C(/C=C/c1cccc(C(=O)c2cc3ccccc3[nH]2)c1)NO,IC50,6.0,CHEMBL895813,Cytotoxicity against human U87MG cells,U-87MG ATCC,YONXIFHNDNWCKF-CMDGGOBGSA-N
CHEMBL4639932,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccc(Cl)cn3)cc2)n1,IC50,4.34,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GBMNARGJHFJMLX-UHFFFAOYSA-N
CHEMBL4648861,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ncccc3Cl)cc2)n1,IC50,4.34,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MDGSCYNTEHZLRR-UHFFFAOYSA-N
CHEMBL85742,,COc1cc(OC)c2cc(-c3ccc(OCc4ccccc4)cc3)c(O)nc2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,QPBWAIBGHJOAES-UHFFFAOYSA-N
CHEMBL1224135,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.54,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,ZFPAEAGOILUCEX-MHANECDQSA-N
CHEMBL1165328,,COc1cc(C(=O)OC2CCCC(OC(=O)c3ccc(O)c(OC)c3)C2)ccc1O,IC50,4.14,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,JUFXEAUUKULHLY-UHFFFAOYSA-N
CHEMBL1165327,,COc1cc(C(=O)O[C@H]2CCCC[C@H]2OC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.12,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CJJVDYUOTKHCBA-HDICACEKSA-N
CHEMBL1164467,,O=C(OCCCCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,IC50,4.51,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CNLXSCDIMLYWSJ-UHFFFAOYSA-N
CHEMBL1164100,,O=C(OCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,IC50,4.62,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,QYFNSLNMLBHCHL-UHFFFAOYSA-N
CHEMBL1163758,,COc1cc(C(=O)OCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.04,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,IXUAYZKUQBDYPL-UHFFFAOYSA-N
CHEMBL471988,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(Cl)cc3)cc1OC2(C)C,EC50,5.47,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,IRTQKPRGPXHPGU-WOJBJXKFSA-N
CHEMBL471123,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(F)cc3)cc1OC2(C)C,EC50,5.48,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,GXMKPONJLTZWSW-WOJBJXKFSA-N
CHEMBL471297,,CCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.49,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,FWCLETPIGPWXKI-FGZHOGPDSA-N
CHEMBL119592,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccccc3)cc1OC2(C)C,EC50,5.58,CHEMBL964510,Cytotoxicity against human LN229 cells assessed as cell death after 18 hrs,LN-229,GZYXCXRHVALIJD-WOJBJXKFSA-N
CHEMBL471123,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(F)cc3)cc1OC2(C)C,EC50,5.7,CHEMBL964510,Cytotoxicity against human LN229 cells assessed as cell death after 18 hrs,LN-229,GXMKPONJLTZWSW-WOJBJXKFSA-N
CHEMBL513924,,CC1(C)CC(=O)c2sc(N3CCOC[C@@H]3Cc3c[nH]c4ccccc34)nc2C1,IC50,6.1,CHEMBL989183,Antiproliferative activity against human U87-MG cells,U-87MG ATCC,UPQKAJYEZWCPJY-HNNXBMFYSA-N
CHEMBL522031,,OCCN1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1,IC50,6.1,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,PFNYDAIJXABZEY-UHFFFAOYSA-N
CHEMBL447062,LANTALUCRATIN A,C=C(C)C1CC2=C(O1)c1cccc(OC)c1C(=O)C2=O,IC50,5.33,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,ICDFLJCHILFMDR-UHFFFAOYSA-N
CHEMBL348667,,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1,IC50,8.74,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,KQHWUFNWNPCEGY-UGKGYDQZSA-N
CHEMBL1087801,,Oc1ccc(CN(Cc2cccc(C(F)(F)F)c2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,7.24,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,MNSWKXBKBFUHHI-UHFFFAOYSA-N
CHEMBL477958,,Oc1ccc(CN(Cc2ccccc2C(F)(F)F)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,6.68,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,LOMOLCXMSWGBDB-UHFFFAOYSA-N
CHEMBL1242367,,CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,IC50,4.57,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,YVXCDLCJCIDFHE-DKXQDJALSA-N
CHEMBL1081263,,N[C@H](CNc1ncc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.37,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,RUQPVADMLMMXDR-IBGZPJMESA-N
CHEMBL1081852,,N[C@H](CNc1ncc(-c2ccc3[nH]c(=O)oc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.3,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,NIKDKNHGEBMTNT-AWEZNQCLSA-N
CHEMBL454888,,Cc1ccc(N2NC(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.42,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,DJMAZMQCAGJMQH-UHFFFAOYSA-N
CHEMBL497812,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)OC(C)C,IC50,4.28,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,ANDHAMDHAMHCNK-BRAPJGFWSA-N
CHEMBL85761,,CC(=O)Oc1ccc(-c2cc3c(OC(C)=O)cc(OC(C)=O)cc3n(C)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,FPPHNMULMXCJGO-UHFFFAOYSA-N
CHEMBL78535,ANCRIVIROC,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,9.22,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,ZGDKVKUWTCGYOA-URGPHPNLSA-N
CHEMBL4088257,,Cc1nc(C)c(/C=C/C(=O)N2CCC=CC2=O)nc1C,IC50,5.06,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LAYWHPVNALSHFB-BQYQJAHWSA-N
CHEMBL3823726,,O=C1C(O)=C(C(NCc2ccccc2)c2cc(Br)ccc2O)C(=O)c2ccccc21,IC50,4.76,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WOHVVTQDLLOQNU-UHFFFAOYSA-N
CHEMBL3823458,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1cc(C)ccc1O.Cl,IC50,5.26,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CBWIHNBOQUVPNA-UHFFFAOYSA-N
CHEMBL3618244,,COc1ccc(Nc2nc3ccc(C(C)(C)O)cn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.35,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,DEOGGEOLSMKCSC-UHFFFAOYSA-N
CHEMBL313545,,CCN(CC)C(=O)CCn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,KQLZYIAOSLOOPH-UHFFFAOYSA-N
CHEMBL82808,,COc1cc(OC)c2cc(-c3ccc(O)cc3)c(O)nc2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,GPCBCTZRCDKMOS-UHFFFAOYSA-N
CHEMBL314002,,COc1ccc(-c2cc3c(OC)ccc(OC)c3nc2O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,KXHHAFDFPJBSKE-UHFFFAOYSA-N
CHEMBL445564,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCC#N)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,UWUBRPDSQCUZOQ-UHFFFAOYSA-N
CHEMBL5171674,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCOCC2)cc1)OCc1cccnc1,IC50,6.05,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,ZEVISJFSMWKSMN-UHFFFAOYSA-N
CHEMBL5180838,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(C3COC3)CC2)cc1)OCc1cccnc1,IC50,6.31,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,WHZPXXBWOIWRBY-UHFFFAOYSA-N
CHEMBL27759,ENTINOSTAT,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,5.36,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,INVTYAOGFAGBOE-UHFFFAOYSA-N
CHEMBL5177034,,COCCN1CCN(c2ccc(C(F)(F)F)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.07,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,CNCYHYVBWHVTRF-UHFFFAOYSA-N
CHEMBL3092023,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(O)cc2)c(OC)c1,IC50,5.16,CHEMBL3096270,Cytotoxicity against p53-knockdown human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,UBMQFEPVRWEBRN-UHFFFAOYSA-N
CHEMBL3092023,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(O)cc2)c(OC)c1,IC50,5.16,CHEMBL3096272,Cytotoxicity against human U87MG cells expressing sh-GFP after 5 days by methylene blue staining assay,U-87MG ATCC,UBMQFEPVRWEBRN-UHFFFAOYSA-N
CHEMBL3116223,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5c(C)cccc5C)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.15,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DTHZTZLQTJVRSH-YYADALCUSA-N
CHEMBL3116239,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(F)c(Cl)c5)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.0,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OXQHEWOTAZXICR-HIXSDJFHSA-N
CHEMBL395498,,O=C(CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2)NCc1ccc(C(F)(F)F)cc1,IC50,5.75,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,SFGIHMAJHAGGRH-UHFFFAOYSA-N
CHEMBL396273,,CCOC(=O)CN(CCOc1ccc(-n2ccnc2)cc1)Cc1ccc2c(c1)OCO2,IC50,5.92,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,QKBJVYOXPPHUJY-UHFFFAOYSA-N
CHEMBL1779543,,Cc1c2c(n3c1CCCCN1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,5.81,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,RPEZFJINCXMCIT-LJQANCHMSA-N
CHEMBL85691,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCc3nnn[nH]3)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,VFDUYXFWEKLFIY-UHFFFAOYSA-N
CHEMBL4092858,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.19,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LDPSTPXLWVVSEJ-UHFFFAOYSA-N
CHEMBL298669,,Nc1nc(S)c2ncn([C@H]3S[C@@H](CO)[C@H](O)[C@@H]3O)c2n1,IC50,4.21,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,MLMHTQZFUSSXMA-GIMIYPNGSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.52,CHEMBL4407616,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL228133,,Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1,IC50,5.72,CHEMBL919353,Inhibition of GSK3-beta phosphorylation in U87MG cells by ELISA,U-87MG ATCC,HPWBHQIUIBFTQC-UHFFFAOYSA-N
CHEMBL3985009,,COc1ncc(-c2ccc3nccc(-c4ccc(Cn5ccnc5C)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.4,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OUVJFIJCTWGJEX-UHFFFAOYSA-N
CHEMBL1779536,,Cc1c2c(n3c1CCCN1CC[C@H](CNc4cc-3ccc4C(N)=O)C1)CC(C)(C)CC2=O,EC50,6.38,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,HIBZKCZRHCXVEZ-QGZVFWFLSA-N
CHEMBL1813656,,COc1ccc(/C=C(NC=O)/C(=C/c2ccc(OC)cc2)NC=O)cc1,IC50,6.16,CHEMBL1816300,Cytotoxicity against human SF295 cells,SF295,ZRAIRHSUKMHHQT-YZLQMOBTSA-N
CHEMBL121911,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(NCc2ccccc2)cc13,IC50,7.16,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,JPFZPGSRDXAQRE-UHFFFAOYSA-N
CHEMBL1615189,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,7.17,CHEMBL1775774,Antiproliferative activity against PTEN-deficient human U87MG cells by ATP-based cell viability assay,U-87MG ATCC,YGBMCLDVRUGXOV-UHFFFAOYSA-N
CHEMBL332240,,CN(C)c1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.52,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,YJPSFNBCJFAVCP-UHFFFAOYSA-N
CHEMBL451169,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCC(C)=O)NC(=O)[C@H]2CCCCN2C1=O,IC50,7.14,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,SLNRKQPBCJPWHD-DVORCMKRSA-N
CHEMBL1269013,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(Br)cc1,EC50,4.9,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,KFHJWWYSIYEQTP-FNORWQNLSA-N
CHEMBL4061960,,Cc1cccc(C(=O)/C=C/c2ccc([N+](=O)[O-])o2)c1,EC50,5.48,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,WVUKPAXSYYBWGE-FNORWQNLSA-N
CHEMBL575179,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCO)C(=O)C(O)=C3C(C)C)/C(=C/NCCCO)C(=O)C(O)=C2C(C)C,IC50,4.92,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,IUQOLNRSKATKPJ-MPKYGIEOSA-N
CHEMBL3780556,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.19,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JGYPLELRFFNBJT-UHFFFAOYSA-N
CHEMBL3781197,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.8,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SUBPIGJEMSEJIK-UHFFFAOYSA-N
CHEMBL3780813,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.5,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KUQGSEZEDTXRKC-UHFFFAOYSA-N
CHEMBL3780676,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.28,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,HBQMROYUNHRFSB-UHFFFAOYSA-N
CHEMBL3780337,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccc(C)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.97,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,HSMHBKPGNYWETC-UHFFFAOYSA-N
CHEMBL518421,LARICIRESINOL,COc1cc(C[C@H]2CO[C@H](c3ccc(O)c(OC)c3)[C@H]2CO)ccc1O,IC50,4.93,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,MHXCIKYXNYCMHY-AUSJPIAWSA-N
CHEMBL301311,,COCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.58,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,BTAPSFTYZPKJCW-UHFFFAOYSA-N
CHEMBL258765,FASCAPLYSIN CHLORIDE,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-],IC50,5.41,CHEMBL1000754,Antitumor activity against human SF295 cells,SF295,PWUOOJVYZQILBG-UHFFFAOYSA-N
CHEMBL258765,FASCAPLYSIN CHLORIDE,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-],IC50,5.27,CHEMBL1000757,Antitumor activity against human SNB75 cells,SNB-75,PWUOOJVYZQILBG-UHFFFAOYSA-N
CHEMBL470052,,O=C1c2ccc(Br)cc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-],IC50,5.42,CHEMBL1000757,Antitumor activity against human SNB75 cells,SNB-75,OCNFGKRSWOZYBV-UHFFFAOYSA-N
CHEMBL573336,,COc1cc([C@@H]2OC[C@@H]3[C@H]2CO[C@H]3c2ccc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)c2)ccc1O,IC50,4.6,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,QLJNETOQFQXTLI-JKUDBEEXSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.76,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL442020,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(NCCCl)cc13,IC50,8.22,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,DNYPVNJKBKBXEJ-UHFFFAOYSA-N
CHEMBL267616,,COc1ccc(CC2CCc3nc(N)nc(N)c3C2)cc1OC,IC50,6.6,CHEMBL801267,Compound was tested for the growth inhibition of SF-295 CNS tumor cell line,SF295,XVXBYTNVUPDKPO-UHFFFAOYSA-N
CHEMBL4280638,,C#CCOc1ccc(-c2noc(-c3nnn(-c4cccc(/C(C)=N/O)c4)c3N)n2)cc1,IC50,5.48,CHEMBL5227635,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by XTT assay,U-87MG ATCC,IGQKYFPXTAJJLB-DHRITJCHSA-N
CHEMBL2088450,,CC(C)(C)c1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,4.95,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QXRQXPBVPSBMGN-FDAWAROLSA-N
CHEMBL2088449,,Cc1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,5.3,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ICIKDUZNAHFGKF-LQKURTRISA-N
CHEMBL2088444,,N#Cc1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,5.01,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GTULBBSHIUDCMY-MUFRIFMGSA-N
CHEMBL1096171,,CCCCCCCCCCCC(=O)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.09,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,IRFFYKLEZMTNDZ-UHFFFAOYSA-N
CHEMBL118845,,CN(C)c1cc(Cl)nc2c1-c1nccc3ccnc(c13)C2=O,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,XFCAQNNNTPNSHA-UHFFFAOYSA-N
CHEMBL109640,,O=C1c2nc(O)ccc2C(=O)c2c(-c3ccccc3NC(=O)C(F)(F)F)ccnc21,IC50,7.4,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,AOLNSOSEKLYMGN-UHFFFAOYSA-N
CHEMBL316168,,CCN(CC)C(=O)Cn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,CNUXSSQGSIPTFQ-UHFFFAOYSA-N
CHEMBL167656,,O=C(Nc1ccccc1)OCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.56,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,SGZFZFJELKXJQX-UHFFFAOYSA-N
CHEMBL255273,PLAKORTIDE N,CC/C=C/[C@H](CC)C/C(=C/[C@@]1(CC)C[C@H](CC)[C@H](CC(=O)O)OO1)CC,IC50,6.52,CHEMBL982259,Cytotoxicity against human SF295 cells,SF295,HGRUNRAUYWALHI-XICUHNIJSA-N
CHEMBL352708,,CNC(=S)N(C)CCNc1c2ccccc2nc2ccccc12,IC50,5.74,CHEMBL836449,In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr,U-87MG ATCC,LZXUHHGAOZIYPO-UHFFFAOYSA-N
CHEMBL611449,Acridinylthiourea derivative and platinum conjugate,,IC50,6.12,CHEMBL836449,In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr,U-87MG ATCC,
CHEMBL11359,CISPLATIN,,IC50,6.31,CHEMBL836449,In vitro inhibitory concentration against growth of U87MG glioblastoma cell line in clonogenic survival assay after 24 hr,U-87MG ATCC,
CHEMBL505354,,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,4.5,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,ZUXYTKOTAAEJOQ-NPVSZXFSSA-N
CHEMBL364880,,CC1(c2ccccc2)CC(=O)C(C(CC(=O)c2ccc(-c3ccc(Br)cc3)cc2)c2ccccc2)=C(O)O1,IC50,5.17,CHEMBL825052,Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 after 72 hr of incubation was determined,XF 498,LHCOZKWTLBDTFM-UHFFFAOYSA-N
CHEMBL608104,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)CCC[C@@H]12,IC50,5.12,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,ZAKWVBZLRDHTMB-MVWRLGRASA-N
CHEMBL3942320,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCN(C)CC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.47,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LZTXLXNESZHMGZ-UHFFFAOYSA-N
CHEMBL3914319,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCCCC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.5,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VGGJCBAGAPLUTL-UHFFFAOYSA-N
CHEMBL3915419,,CCN(CC)Cc1ccc(-c2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)cc1,IC50,5.31,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CFNRSEZJUZDEPX-UHFFFAOYSA-N
CHEMBL3985191,,COc1ncc(-c2ccc3nccc(-c4ccc(C)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,4.17,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MAMRHDZUBGCTFM-UHFFFAOYSA-N
CHEMBL1963575,,C/C(=C\CN1CCC(Cc2ccccc2)CC1)c1ccc2ccccc2c1,IC50,4.22,CHEMBL3877506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay,U-87MG ATCC,MIAFBZYKYDZOOH-FYJGNVAPSA-N
CHEMBL1963575,,C/C(=C\CN1CCC(Cc2ccccc2)CC1)c1ccc2ccccc2c1,IC50,4.98,CHEMBL3877507,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs in absence of 10% fetal calf serum by MTS assay,U-87MG ATCC,MIAFBZYKYDZOOH-FYJGNVAPSA-N
CHEMBL5408037,,CCC1=C(C)/C(=C/c2ccc(C3=NOB(c4ccccc4)N3)cc2)CCC1(C)C,IC50,4.22,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,IPRHEPMPQFDJAX-HEHNFIMWSA-N
CHEMBL3414623,,Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12,IC50,5.23,CHEMBL5676190,Antiproliferative activity against human T98G cells after 10 days,T98G,PNYRDVBFYVDJJI-UHFFFAOYSA-N
CHEMBL3809493,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(Cl)cc4Cl)n3)ccc21,IC50,4.43,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,HHUHKGMXFBBNPB-WSDLNYQXSA-N
CHEMBL535,SUNITINIB,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,4.22,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,WINHZLLDWRZWRT-ATVHPVEESA-N
CHEMBL1643030,,OCc1c(CO)c(-c2ccc(F)cc2)n2c1Cc1ccccc1C2,IC50,4.63,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,AZPVOZPYNPBHHA-UHFFFAOYSA-N
CHEMBL4873418,,CC1CCN(CCCN2/C(=C/c3cc(/C=C/c4ccc(N(C)C)cc4)[n+](C)c4ccccc34)Sc3ccccc32)CC1.[I-],IC50,4.83,CHEMBL4834608,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,QXZRPPRUYIDRQX-UHFFFAOYSA-M
CHEMBL4283509,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)([O-])Oc1ccc[n+](Cc2ccccc2)c1)c1ccccc1,IC50,5.58,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,FGHKFVXFDAGVOZ-ISJGIBHGSA-N
CHEMBL4281560,,C[N+]1(C)CCC(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)CC1,IC50,5.17,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,VCGBTSXCGBGKNS-XUVXKRRUSA-N
CHEMBL4286859,,CCOC(=O)C[n+]1cccc2cc(OP(=O)([O-])OC[C@H]3O[C@@H](n4cc(F)c(=O)[nH]c4=O)C[C@@H]3OC(=O)c3ccccc3)ccc21,IC50,6.28,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,PTGXRXANBUIEOI-ISJGIBHGSA-N
CHEMBL4278613,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3ccc4ncccc4c3)O2)cc1F,IC50,4.97,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,GEUOSZWLJLGCAR-ARFHVFGLSA-N
CHEMBL2311028,PLERIXAFOR OCTAHYDROCHLORIDE,Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,IC50,6.16,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,UEUPDYPUTTUXLJ-UHFFFAOYSA-N
CHEMBL1802333,,Fc1cnc(Cl)nc1NCc1ccc(CNc2ccnc(NCCN3CCOCC3)n2)cc1,IC50,9.1,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,GYIWMFHGPQGUIL-UHFFFAOYSA-N
CHEMBL2037441,,C/C(=N/NC(=S)Nc1ccccc1)c1ccccn1,IC50,8.17,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VHVSCHSQNUUXNS-BOPFTXTBSA-N
CHEMBL2037438,,C/C(=N\NC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.09,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,JJPHEFXBDVUGNK-VCHYOVAHSA-N
CHEMBL2035437,,O=C1SC(=Cc2c3ccccc3nc3ccccc23)C(=O)N1Cc1ccc(Br)cc1,IC50,5.14,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,CLVMUFNPZQJGKR-UHFFFAOYSA-N
CHEMBL259778,,Cn1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.46,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,CBLUYKNIXJXUAT-UHFFFAOYSA-N
CHEMBL530333,,COc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.19,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,RWWHHCTYSWQXOA-UHFFFAOYSA-N
CHEMBL523939,,CCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.92,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,PFNRWTLIQMEHPQ-UHFFFAOYSA-N
CHEMBL524101,,O=C1NNC(=O)C2(CSC3=C2C(=O)c2ncccc2C3=O)N1,IC50,5.3,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,WTDZQIBHGGRTSN-UHFFFAOYSA-N
CHEMBL460702,BMS-777607,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,IC50,6.8,CHEMBL963606,Antiproliferative activity against Met-driven human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,VNBRGSXVFBYQNN-UHFFFAOYSA-N
CHEMBL324671,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.85,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,VCJCJIKWNXQAAJ-URGPHPNLSA-N
CHEMBL153117,,COC(=O)[C@@]12CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)C1=C(C(C)C)C(=O)C2=O,IC50,4.13,CHEMBL916479,Cytotoxicity against human U87-Mg cells after 72 hrs by MTT assay,U-87MG ATCC,SQNAVENFPQWCIW-YHXGQZGQSA-N
CHEMBL2333166,WITHAMETELIN L,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3CC=C4CC=CC(=O)[C@]4(C)[C@H]3C[C@@H](O)[C@]12C,IC50,6.24,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,IZNYGGIUGIZTBU-MCMIQRFLSA-N
CHEMBL399623,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.62,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,OHVJEOXDVIFIPO-KLVPPCHUSA-N
CHEMBL235552,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=C(O)C(=O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.63,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,SVLBCFOVBXXWGQ-PGUJVLSBSA-N
CHEMBL441133,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=C[C@@H](O)C[C@H](O)[C@]4(C)[C@H]3CC[C@]12C,IC50,4.63,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,YCACVYNVSOIKQK-HQCBQJEKSA-N
CHEMBL672,FENOFIBRATE,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,IC50,4.13,CHEMBL1226546,Antiproliferative activity against human U87MG cells after 120 hrs by MTT assay,U-87MG ATCC,YMTINGFKWWXKFG-UHFFFAOYSA-N
CHEMBL269671,ARTEMISININ,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@]32OO4,IC50,4.79,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.46,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL519575,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3cccs3)cc1OC2(C)C,EC50,5.74,CHEMBL964507,Cytotoxicity against human U87 cells by side flank model relative to control,U-87MG ATCC,HBOZOOYIOXJZFX-IAGOWNOFSA-N
CHEMBL471988,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(Cl)cc3)cc1OC2(C)C,EC50,5.54,CHEMBL964510,Cytotoxicity against human LN229 cells assessed as cell death after 18 hrs,LN-229,IRTQKPRGPXHPGU-WOJBJXKFSA-N
CHEMBL2385190,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.14,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,XUQSXACLGZWVAU-UHFFFAOYSA-N
CHEMBL2417830,,COc1ncc(-c2ccn3nc(N)nc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.75,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NCYIPUPGKOLGPL-UHFFFAOYSA-N
CHEMBL2417827,,COc1ncc(-c2ccn3nc(NC(C)=O)nc3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.67,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,YQNNUPLNGSZSSB-UHFFFAOYSA-N
CHEMBL3290912,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.77,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,RGVRGSUCXNJFEX-UHFFFAOYSA-N
CHEMBL3290925,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.65,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,DBLRBWBNPSEDCB-UHFFFAOYSA-N
CHEMBL3290909,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.53,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HCMHGGVUBAQHQZ-UHFFFAOYSA-N
CHEMBL3290903,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.84,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,CIPWVHJQNZNVAN-UHFFFAOYSA-N
CHEMBL461455,PHENYLHEXYL ISOSELENOCYANATE,[Se]=C=NCCCCCCc1ccccc1,IC50,4.64,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,XPNZXCHCPXLBOM-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.43,CHEMBL1112256,Cytotoxicity against human SF295 cells after 69 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1096221,,CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN(C(=O)OCc3ccc(O[C@@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)c([N+](=O)[O-])c3)[C@H]1[C@H]2C,IC50,4.68,CHEMBL1105585,Cytotoxicity against human U87 cells assessed as viability in presence of beta glucuronidase,U-87MG ATCC,SWQHSMHFXZXJJZ-CTDLUEAJSA-N
CHEMBL85726,,COc1ccc(-c2cc3c(OC)cc(OC)c4c3n(c2=O)CCC4=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,IDBLOWQDUQJYDQ-UHFFFAOYSA-N
CHEMBL1822052,,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,7.36,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,NCRYSHBHDZWERB-UHFFFAOYSA-N
CHEMBL1823655,,O=C(N[C@@H](c1ccc(Cl)c(Cl)c1)C1CNC1)c1ccc2cnccc2c1,IC50,6.62,CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,U-87MG ATCC,TWAIYMKBHKNSRO-IBGZPJMESA-N
CHEMBL461242,PHENYLHEXYL ISOTHIOCYANATE,S=C=NCCCCCCc1ccccc1,IC50,4.58,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,VJNWEQGIPZMBMA-UHFFFAOYSA-N
CHEMBL94990,,N[C@H](C(=O)O)c1ccc(C(=O)O)cc1,IC50,4.82,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,VTMJKPGFERYGJF-ZETCQYMHSA-N
CHEMBL471988,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(Cl)cc3)cc1OC2(C)C,EC50,5.49,CHEMBL964507,Cytotoxicity against human U87 cells by side flank model relative to control,U-87MG ATCC,IRTQKPRGPXHPGU-WOJBJXKFSA-N
CHEMBL504590,,CC(C)C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,5.06,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,JFMPKUDKNYENDN-JCXJWVNZSA-N
CHEMBL4786701,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCCN(C)CC1,IC50,5.16,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,HKHJHRUYPCHLAP-UHFFFAOYSA-N
CHEMBL4764241,,COc1cc(N(C)CCN(C)C)ccc1Nc1cc(-n2c(SC)nnc2-c2ccc(F)cc2)ccn1,IC50,4.72,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,SYDRWCHBDRZZIX-UHFFFAOYSA-N
CHEMBL331140,,CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1,IC50,8.04,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KFNRGFZWGOCXDB-QVTSOHHYSA-N
CHEMBL4792536,,CN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1ccc(F)c(F)c1,IC50,5.15,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,YMNSSLGTRPIRCK-VAWYXSNFSA-N
CHEMBL261406,,C[C@@]12CCC[C@H]1[C@@H]1CCc3cc(O)ccc3[C@H]1CC2,IC50,4.66,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,HJKVPZJVBHWFCQ-BDXSIMOUSA-N
CHEMBL323172,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1,IC50,9.3,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,YZDKZEBRKKYLLA-QCWLDUFUSA-N
CHEMBL106299,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1,IC50,7.64,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,CHLLENYTSNHZGS-UHFFFAOYSA-N
CHEMBL106247,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1,IC50,8.0,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,ZVCMZXYHBQKEGX-UHFFFAOYSA-N
CHEMBL141699,,Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.05,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,QVDCSAIULQECDK-VXKWHMMOSA-N
CHEMBL111383,,O=C1c2nccc(Br)c2-c2nc3ccccc3c3ccnc1c23,IC50,6.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,ASOVTXPXTGIJGF-UHFFFAOYSA-N
CHEMBL314461,,COc1ccc2cc(-c3ccccc3)c(O)nc2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,AJLACADSVJJPJH-UHFFFAOYSA-N
CHEMBL1822053,,O=S(=O)(Nc1cc(-c2ccc3ncsc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.11,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,KUFZSPXXONLZCF-UHFFFAOYSA-N
CHEMBL311795,,Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.3,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,HMBFXHIQISYDKM-RXVVDRJESA-N
CHEMBL112938,,Nc1ccnc2c1C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,6.52,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,XSXOEAKXDLVRHU-UHFFFAOYSA-N
CHEMBL262185,,CC(C)NC(=O)OCc1cnc2c(c1)C(=O)c1cccnc1C2=O,IC50,7.0,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,KXKUQHADQCKIQT-UHFFFAOYSA-N
CHEMBL327101,MERIDINE,O=C1c2nccc(O)c2-c2nc3ccccc3c3ccnc1c23,IC50,7.0,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,QSJNAFJALFWFMT-UHFFFAOYSA-N
CHEMBL1807794,,Cc1c2c(n3c1CCCN(CCO)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.73,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,HGNIKZYVUYNHHF-ROUUACIJSA-N
CHEMBL1807796,,CC(=O)N1CCCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@@H]1C)CC(C)(C)CC3=O,IC50,7.54,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,MMJUEHBYHKCNKW-IRXDYDNUSA-N
CHEMBL1807810,,Cc1c2c(n3c1CCN(C(=O)[C@@H]1CCCN1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.22,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KRHCYUXPGWYNDE-LZNRXBQRSA-N
CHEMBL235658,,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,EC50,6.22,CHEMBL5227813,Antiproliferative activity against human A-172 cells assessed as cell growth inhibition,A-172,ODYAQBDIXCVKAE-UHFFFAOYSA-N
CHEMBL111359,,Nc1ccnc2c1C(=O)c1c(-c3ccccc3[N+](=O)[O-])ccnc1C2=O,IC50,5.57,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,CJSJGUVEESPREB-UHFFFAOYSA-N
CHEMBL355355,,COCOCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.08,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,FNSKSIHLYYLLCL-UHFFFAOYSA-N
CHEMBL5418077,,C[C@H]1[C@@H](OCCCN=C=S)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,5.13,CHEMBL5355864,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,U-87MG ATCC,MLDQCUOFTGHGFK-YRPRCUQKSA-N
CHEMBL3220497,,COc1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)ccc1N1CCOCC1,EC50,7.64,CHEMBL3226845,Inhibition of JNK in human U87MG cells overexpressing EGFR V3 mutant assessed as inhibition of c-jun phosphorylation after 6 hrs by ELISA,U-87MG ATCC,VWMWJCYJXWZIIP-UHFFFAOYSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,7.66,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL4798177,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N(C)CCN(C)C,IC50,5.55,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,XLUPXFVZMAQDMF-UHFFFAOYSA-N
CHEMBL2313430,,CCCCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,5.34,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,SFOKZRCSHDMJIN-UHFFFAOYSA-M
CHEMBL394882,NOR-BETA-LAPACHONE,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.8,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DMSVAEFGRLMACV-UHFFFAOYSA-N
CHEMBL1668772,TETRANGOMYCIN,C[C@]1(O)CC(=O)c2c(ccc3c2C(=O)c2cccc(O)c2C3=O)C1,IC50,4.92,CHEMBL3636048,Cytotoxicity against human SF295 cells after 72 hrs by MTS assay,SF295,UGEKKXLEYACFTD-LJQANCHMSA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,6.27,CHEMBL3636048,Cytotoxicity against human SF295 cells after 72 hrs by MTS assay,SF295,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL4088600,,OCc1cc2nc(N3CCOCC3)nc(N3CCOCC3)c2s1,IC50,4.76,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,GLFPUHMSENBNSW-UHFFFAOYSA-N
CHEMBL502620,ACLARUBICIN,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,IC50,6.86,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,USZYSDMBJDPRIF-SVEJIMAYSA-N
CHEMBL3290918,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,HRQBMMWXFQEHJT-UHFFFAOYSA-N
CHEMBL3290914,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.84,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FUGCLUZTVAAXJZ-UHFFFAOYSA-N
CHEMBL3290906,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.81,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,LWLZJKLPPDVLAK-UHFFFAOYSA-N
CHEMBL3290897,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)c(C)cc2=O)cc1,IC50,5.55,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,VGRKYDDEIPUXGN-UHFFFAOYSA-N
CHEMBL517080,WITHAFERIN A,CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1,IC50,5.96,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,DBRXOUCRJQVYJQ-CKNDUULBSA-N
CHEMBL211146,,CC1(C)CC(NC(=O)Nc2ccccc2Cl)c2cc(Cl)ccc2O1,IC50,4.7,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,IKNQZHCMDQZSRM-UHFFFAOYSA-N
CHEMBL377467,,CC1(C)CC(NC(=O)Nc2cccc(Cl)c2)c2cc(Cl)ccc2O1,IC50,4.6,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YTCPAIDEHJAZKD-UHFFFAOYSA-N
CHEMBL2041938,,O=[N+]([O-])c1ccc(NC(=S)NC2CCOc3ccc(Cl)cc32)cc1,IC50,4.92,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,SQWYPEJSOVZQSZ-UHFFFAOYSA-N
CHEMBL1164920,ORIDONIN,C=C1C(=O)[C@]23[C@H](O)[C@H]1CC[C@H]2[C@@]12CO[C@]3(O)[C@@H](O)[C@@H]1C(C)(C)CC[C@@H]2O,IC50,4.85,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,SDHTXBWLVGWJFT-XKCURVIJSA-N
CHEMBL3114420,,CC1(C)CC(Nc2cccc([N+](=O)[O-])c2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.82,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,FTSMYZOOTBACTI-UHFFFAOYSA-N
CHEMBL3114580,,CC(=O)OC[C@H]1OC(n2cc(CNC3=C(Br)C(=O)c4ccccc4C3=O)nn2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,5.55,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,QTTGRWDUISDAAB-ZZSHGKAPSA-N
CHEMBL111490,,COc1ccnc2c1C(=O)c1c(-c3ccccc3[N+](=O)[O-])ccnc1C2=O,IC50,8.05,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,LTRFHRPVICTOEZ-UHFFFAOYSA-N
CHEMBL5427348,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSCc2cccc(c2)CSC[C@H](NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.24,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,YXYFFJSLHXKPMN-NQAOGTSWSA-N
CHEMBL5421388,,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)CSCc2cccc(c2)CSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O,IC50,4.93,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,CNKSUTIROBOIQG-RZAATYBRSA-N
CHEMBL5420985,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CC1,IC50,7.29,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,XPNXLSWGWUOGGX-UHFFFAOYSA-N
CHEMBL3774830,,O=C1NC(=S)S/C1=C\c1ccc2c(c1)CCO2,IC50,5.25,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,DMARRXYRWLAEFB-POHAHGRESA-N
CHEMBL3775393,,O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1,IC50,6.25,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,TWNKLQGDXMYCCB-WTKPLQERSA-N
CHEMBL424062,,CCOC(=O)c1cnc2c(c1)C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,7.1,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,DXQRWLHHNFKEIY-UHFFFAOYSA-N
CHEMBL1956940,,CC1(C)C=C2[C@H]3CC[C@@H]4[C@@]5(C)[C@@H](O)C[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C)CC1,IC50,5.88,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,KDVPRLJVCKYSQH-VTNDHLKMSA-N
CHEMBL486400,HEDERAGENIN,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.44,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,PGOYMURMZNDHNS-MYPRUECHSA-N
CHEMBL2430030,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)C[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.59,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,GROQHEZXWUJYNW-ITUQRZNASA-N
CHEMBL2435994,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.25,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RUUVFPINVYGROZ-UHFFFAOYSA-N
CHEMBL5625099,,COc1ccc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)cc1OC,IC50,5.36,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,WIQORLYRHMAZDT-ACCUITESSA-N
CHEMBL118218,IROFULVEN,CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1,IC50,6.7,CHEMBL3783418,Cytotoxicity against human SNB75 cells after 48 hrs by sulforhodamine B assay,SNB-75,NICJCIQSJJKZAH-AWEZNQCLSA-N
CHEMBL3092917,,COc1ccc(C)cc1-c1cnc(OCCCCc2ccccc2)n1C,IC50,4.36,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,QEHBKBVTBLVVFM-UHFFFAOYSA-N
CHEMBL3091478,,C=CCCCCOc1ncc(-c2ccc(Cl)cc2OC)n1C,IC50,4.17,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CYEGDZWVJCBGKM-UHFFFAOYSA-N
CHEMBL3093020,,C=CCCCCOc1ccccc1-c1cnc(OCCC=C)n1C,IC50,4.54,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,LLGUTQDLVOAKNI-UHFFFAOYSA-N
CHEMBL1096754,,Cn1cc2c(NC(=O)c3ccccc3)nc(-c3ccccc3)nc2n1,IC50,9.77,CHEMBL1120799,Inhibition of Cl-IB-MECA-mediated human U87MG cell proliferation after 48 hrs by trypan blue exclusion assay,U-87MG ATCC,QFBYVTZHJZITCY-UHFFFAOYSA-N
CHEMBL1098108,,COc1ccc(C(=O)Nc2nc(-c3ccccc3)nc3nn(C)cc23)cc1,IC50,10.24,CHEMBL1120800,Inhibition of IBMECA-mediated human U87MG cell proliferation after 48 hrs by trypan blue exclusion assay,U-87MG ATCC,YEHUDYLWUFJTMH-UHFFFAOYSA-N
CHEMBL449662,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc([N+](=O)[O-])c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.17,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,DTONGMYGEYJMOI-ALMBTRMVSA-N
CHEMBL1914730,,COCCN(C)c1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,7.25,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,FUCFMCKCHUSEOG-UHFFFAOYSA-N
CHEMBL4649419,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccccc1F)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.34,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,CNFOIYQXNYBPAV-CDGBYUCFSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,4.73,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL4780138,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccc3c(c2)OCO3)c(C#N)c(=O)[nH]1,IC50,4.47,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,HQDOZLBOPMIXJO-UHFFFAOYSA-N
CHEMBL4779518,,COc1cccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)[nH]c(=O)c2C#N)c1,IC50,4.39,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KKPNBRPRPDPLGU-UHFFFAOYSA-N
CHEMBL4755715,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)[nH]c(=O)c2C#N)cc1,IC50,4.45,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KUFVWOZIJULUNL-UHFFFAOYSA-N
CHEMBL4754798,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(N)c(C#N)c(-c4ccc(OC)cc4)n3)s2)cc1,IC50,5.81,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,BGDAILDJTKTVIH-UHFFFAOYSA-N
CHEMBL2441792,,COc1cc(-c2nn(-c3cccc(NC(=O)c4ccccc4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.47,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NHSFILSFIDLRNH-UHFFFAOYSA-N
CHEMBL5413645,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(N)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.68,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,PXQGWUYSXHQDIU-UHFFFAOYSA-N
CHEMBL5432897,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc2NS(C)(=O)=O)c1,IC50,5.98,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,OBOCKVNQRVNBRB-UHFFFAOYSA-N
CHEMBL5428612,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)c([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,6.24,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,FIZYZDVSEWXTLH-UHFFFAOYSA-N
CHEMBL5399985,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)c(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,5.62,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,YPWHWQRROPQOSJ-UHFFFAOYSA-N
CHEMBL5433188,,COc1ccc(OC)c(COc2cc(NC(=O)OCCOC(=O)Nc3ccc(NS(C)(=O)=O)c(OCc4cc(OC)ccc4OC)c3)ccc2NS(C)(=O)=O)c1,IC50,5.64,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,YXAGTWTXTAUDDC-UHFFFAOYSA-N
CHEMBL593102,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)/C(=N/O)CC[C@@H]12,IC50,5.03,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,UMLKYOVSAWJPRN-GHMDYAQKSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,7.39,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.55,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,6.27,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL412142,LADUVIGLUSIB,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,IC50,4.87,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AQGNHMOJWBZFQQ-UHFFFAOYSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,4.97,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,8.93,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,5.38,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.25,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,RAHBGWKEPAQNFF-UHFFFAOYSA-N
CHEMBL379975,,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,IC50,4.09,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,DPEXRCOBPACFOO-UHFFFAOYSA-N
CHEMBL1079175,MK-2206,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,IC50,5.09,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,ULDXWLCXEDXJGE-UHFFFAOYSA-N
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,6.22,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,PQAPVTKIEGUPRN-UHFFFAOYSA-N
CHEMBL6067492,BLEOMYCIN,,IC50,5.51,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.3,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,4.75,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,6.56,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,8.71,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL413,SIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,5.88,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,QFJCIRLUMZQUOT-HPLJOQBZSA-N
CHEMBL401930,,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,IC50,4.12,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,ZWVZORIKUNOTCS-OAQYLSRUSA-N
CHEMBL379300,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,IC50,4.73,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,YWTBGJGMTBHQTM-IBGZPJMESA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,7.02,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,7.83,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL6067492,BLEOMYCIN,,IC50,5.31,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,4.56,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,PLHJCIYEEKOWNM-HHHXNRCGSA-N
CHEMBL443684,NAVITOCLAX,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,IC50,4.88,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,JLYAXFNOILIKPP-KXQOOQHDSA-N
CHEMBL2385191,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ZVBZTMFYJLZTIL-UHFFFAOYSA-N
CHEMBL233032,,c1cn(-c2ccc(OC3CCCN(Cc4ccc5c(c4)OCO5)C3)nn2)cn1,IC50,7.28,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,QYDFDUCNHWMTCI-UHFFFAOYSA-N
CHEMBL388205,,c1cn(-c2ccc(OC3CCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,5.38,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,WZGVPRAMPUCENN-UHFFFAOYSA-N
CHEMBL232827,,c1cn(-c2ccc(O[C@H]3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,8.05,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HHOPJGKEAIIIDF-FQEVSTJZSA-N
CHEMBL2417826,,CNC(=O)CNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.14,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,QTECVRYSLYWJJR-UHFFFAOYSA-N
CHEMBL2402943,,CC(C)=CCC[C@]1(C)C=Cc2c(c(C)cc3c2[nH]c2ccccc23)O1,IC50,4.6,CHEMBL2405049,Cytotoxicity against human T98G cells assessed as growth inhibition after 48 hrs by MTT assay,T98G,HTNVFUBCWIYPJN-HSZRJFAPSA-N
CHEMBL5647204,,CNC(=O)c1ccsc1Nc1nc(Nc2cccc(N3CCOCC3)c2)ncc1C(F)(F)F,IC50,4.72,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,MKBIQORJBNIRLJ-UHFFFAOYSA-N
CHEMBL5639183,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(CCN3CCOCC3)cc2)ncc1C(F)(F)F,IC50,5.08,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,BOBPOIDIKAENTO-UHFFFAOYSA-N
CHEMBL368347,(+)-SECOISOLARICIRESINOL,COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O,IC50,4.73,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,PUETUDUXMCLALY-HOTGVXAUSA-N
CHEMBL1643045,,CCNC(=O)OCc1c(COC(=O)NCC)c(-c2ccc(Cl)cc2)n2c1Cc1ccccc1C2,IC50,4.47,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,QLPYMGMVXHHGBU-UHFFFAOYSA-N
CHEMBL1643054,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c(-c2ccc(F)cc2)n2c1Cc1ccccc1C2,IC50,4.43,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,RAXFEHNXHDODMX-UHFFFAOYSA-N
CHEMBL1643055,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c(-c2ccc(Cl)cc2)n2c1Cc1ccccc1C2,IC50,4.64,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,JNCBRJVOHSEOEE-UHFFFAOYSA-N
CHEMBL3621416,,CCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,5.24,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,CKJGDRTWQYHBIU-UHFFFAOYSA-M
CHEMBL3621997,,CC(C)c1ccc(/C=C/C(=O)c2ccc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)cc2)cc1,IC50,5.79,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MZRQTEJEOVDTGI-WOJGMQOQSA-N
CHEMBL5208456,,c1c(CN2CCC2)c(-c2cc3ccc4c(c3cn2)OCO4)cc2c1OCO2,IC50,4.0,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,YKQMGFLWYMLIGV-UHFFFAOYSA-N
CHEMBL2088460,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4ccccc4F)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.41,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QJAWHITZMMIWOZ-WCMJOSRZSA-N
CHEMBL3113684,,Oc1ccccc1/C=N/Nc1cnc2ccccc2n1,IC50,5.64,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,NLKMOIDNHNAMNW-RQZCQDPDSA-N
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,6.1,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.48,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.54,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL307261,ARTENIMOL,C[C@H]1[C@@H](O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.27,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,BJDCWCLMFKKGEE-ISOSDAIHSA-N
CHEMBL1630581,,C/C(=N\NC(=S)Nc1ccccc1Cl)c1ccccn1,IC50,8.96,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,DIAIPLSVPPGTLG-VCHYOVAHSA-N
CHEMBL2037344,,CC(=NNC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NPHJRKXEZJAUIL-UHFFFAOYSA-N
CHEMBL2037340,,CC(=NNC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.09,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,JJPHEFXBDVUGNK-UHFFFAOYSA-N
CHEMBL589653,,O=C(Nc1nonc1NC(=O)c1ccc(F)cc1)c1ccc(F)cc1,IC50,5.22,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,FCKWSGYBASHDGM-UHFFFAOYSA-N
CHEMBL4103455,,Cc1cc(=O)n(-c2ccc(Cl)cc2Cl)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.03,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HIHRRZMJJHACOC-UHFFFAOYSA-N
CHEMBL4098102,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccccc1C#N)CC(C)(C)O2,IC50,4.17,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,SHACTFQJZVRJCP-UHFFFAOYSA-N
CHEMBL4103408,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccccc1[N+](=O)[O-])CC(C)(C)O2,IC50,4.66,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,OPURGIRJJYDWKL-UHFFFAOYSA-N
CHEMBL4095651,,COc1ccccc1NC(=O)NC1CC(C)(C)Oc2ccc(NC(=O)OC(C)(C)C)cc21,IC50,4.41,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,OYCICINCMXZKDR-UHFFFAOYSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,5.83,CHEMBL1817194,Cytotoxicity against human U87MG cells after 3 days by MTT assay,U-87MG ATCC,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,4.66,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL4571168,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC(C=O)C(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.51,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,XCSPRISAUMCZTK-FPEHZDRDSA-N
CHEMBL1652066,,C=C1C(CCC(C)C)=C(OC2(CCC(C)C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc21,IC50,4.99,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QGMKFDWGONDNEK-UHFFFAOYSA-N
CHEMBL1652069,,CCCC1=C(O)C(=O)c2ccccc2C1=O,IC50,4.64,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,YLXBHRSUAARBCT-UHFFFAOYSA-N
CHEMBL1652073,,CC1=C(OC2(C)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DXQUZSASIDQOJP-UHFFFAOYSA-N
CHEMBL4447630,,CC1(C)O[C@@H]2O[C@@H](COC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)[C@H]3OC(C)(C)O[C@H]3[C@@H]2O1,IC50,6.64,CHEMBL4407644,Anticancer activity against human SF295 cells by MTT assay,SF295,GYARFLWMYFKNBZ-ADFNPOGKSA-N
CHEMBL2152332,,COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,5.23,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,BDUHCSBCVGXTJM-IZLXSDGUSA-N
CHEMBL4090785,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.26,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,WQEJHLGNLCVSNT-LRYQAZMXSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.35,CHEMBL4046338,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1604428,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCCCC2)cc1OC,IC50,4.61,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,IVAFIHXRSKJQPF-UHFFFAOYSA-N
CHEMBL4752105,,CN(C)c1ccc(C(c2cc3c(cc2O)OCO3)N2CCCCC2)cc1,IC50,4.61,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,IWOZRLGQTHWMKK-UHFFFAOYSA-N
CHEMBL600752,,Cc1cc(C)c(C(Nc2ccccn2)c2ccc3cccnc3c2O)c(C)c1,IC50,5.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,JEXROXHHDBQUAA-UHFFFAOYSA-N
CHEMBL4066684,,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,6.12,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OBFGRWOUNPRHNH-UHFFFAOYSA-N
CHEMBL4084417,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc([N+](=O)[O-])c1)CC(C)(C)O2,IC50,5.16,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,GZAYOKRLLIKITK-UHFFFAOYSA-N
CHEMBL4060881,,COc1ccc(NC(=O)NC2CC(C)(C)Oc3ccc(NC(=O)OC(C)(C)C)cc32)cc1,IC50,4.31,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CUDQHCMXHDSLLN-UHFFFAOYSA-N
CHEMBL4094692,,CC1(C)CC(NC(=O)Nc2cccc(C#N)c2)c2ccccc2O1,IC50,4.5,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,PHNOCAJDMIWLQZ-UHFFFAOYSA-N
CHEMBL1669589,CORNUSALTERIN A,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.76,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,XQBDRFMUTUDWCI-SXQODDTDSA-N
CHEMBL1669592,CORNUSALTERIN D,C=C(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.75,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,SPMYJZJNYRWSFW-ICRZDDGFSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.76,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL4472807,,O=C(/C=C/c1ccc(-n2cnc3ccccc32)cc1)c1cccc(O)c1,IC50,4.97,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,OFWLIONWWZAJBY-JLHYYAGUSA-N
CHEMBL4464788,,O=C(/C=C/c1ccc(-c2cccnc2)cc1)c1cccc(O)c1,IC50,4.96,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,STIQSWSUIPGZMK-DHZHZOJOSA-N
CHEMBL4483086,,COC(=O)c1cccc(/C=C/C(=O)c2cccc(O)c2)c1,IC50,4.71,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,VMGKJSSPDGSNLN-CMDGGOBGSA-N
CHEMBL4537633,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)c(C(F)(F)F)c2)cc1,IC50,4.47,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,REXXXBZPNYDIJX-FNORWQNLSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,7.61,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL1824706,,N=C(N)NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCNC(=O)CCCC(=O)Nc2ccc(C3=NN=C(c4ccccn4)[C@@H]4CCC[C@@H](OCC[19F])CC[C@@H]34)nc2)NC1=O,IC50,6.71,CHEMBL1828410,Displacement of [125]I-echistatin from alphaVbeta3 integrin expressed in human U87MG cells by competitive binding assay,U-87MG ATCC,IJBAFUUBLIYJHQ-CZFZYNMESA-N
CHEMBL1081296,,N[C@H](CNc1ncc(-c2ccc3cncnc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,5.89,CHEMBL1102924,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,UKXIKQXJARSCKC-KRWDZBQOSA-N
CHEMBL3410525,,Cc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(C)cc3)C2=O)cc1,IC50,5.32,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,GIPGGNDYQHJDEB-AYKLPDECSA-N
CHEMBL3410524,,O=C1/C(=C/c2ccccc2)CS(=O)(=O)C/C1=C\c1ccccc1,IC50,5.29,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IYAJZHOOMHWDGK-JYFOCSDGSA-N
CHEMBL3410529,,N#Cc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(C#N)cc3)C2=O)cc1,IC50,5.87,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,XGNJMOWMCZCOSF-LQGKIZFRSA-N
CHEMBL3410538,,CCOC(=O)C1C/C(=C\c2ccc([N+](=O)[O-])cc2)C(=O)/C(=C/c2ccc([N+](=O)[O-])cc2)C1,IC50,5.61,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,OTVIWKDZSAWVIQ-JYFOCSDGSA-N
CHEMBL348877,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CNC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.15,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,YUYPWAMLWZVHAE-KAVGSWPWSA-N
CHEMBL3410540,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CSC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,4.94,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,JFBLEOXWBXYUCR-KAVGSWPWSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.32,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1643041,,CCNC(=O)OCc1c(COC(=O)NCC)c2n(c1C)Cc1ccccc1C2,IC50,4.86,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,RTMHDNWDEYRLSD-UHFFFAOYSA-N
CHEMBL5268484,,C/C=C/Cn1cc(-c2cc(OC)c(C(=O)N3CCOCC3)cc2OC)c2cc(C)[nH]c2c1=O,IC50,5.3,CHEMBL5262595,Cytotoxicity against human T98G cells measured after 3 days,T98G,FWTDDBIMDSVPTR-AATRIKPKSA-N
CHEMBL5574581,,COc1ccc(-c2snnc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,6.72,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,OCKCVMKASHLWDW-UHFFFAOYSA-N
CHEMBL5562675,,CNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.69,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UTAMAXPWOHAKSY-SNVBAGLBSA-N
CHEMBL5561771,,Cc1ccc(S(=O)(=O)N[C@H](CCC(N)=O)C(=O)O)cc1,IC50,4.7,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,YDNYEJZZJXFADP-SNVBAGLBSA-N
CHEMBL1683552,,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@@H](CN4CC(C)CC(C)C4)OC)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C,IC50,10.0,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,FVFOJNUMEBZYQA-IMUPSJILSA-N
CHEMBL1668106,DEOXYFLINDISSONE,CC(C)=C[C@H]1C[C@@H]([C@@H]2CC[C@]3(C)C4=CCC5C(C)(C)C(=O)CC[C@]5(C)[C@H]4CC[C@@]23C)CO1,IC50,5.29,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WAGHSYJXJAHWPX-XZXIZOHXSA-N
CHEMBL5431418,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N(C)C)CC2)n1,IC50,5.96,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,PWNNFZVPGJMZEG-UHFFFAOYSA-N
CHEMBL586702,ZSTK-474,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,6.89,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,HGVNLRPZOWWDKD-UHFFFAOYSA-N
CHEMBL2398330,,COc1ccc(C(=O)Nc2ccc(N(C)S(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.5,CHEMBL4713866,Antiproliferative activity against human A 172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,LNDXEXUTQMQCLA-UHFFFAOYSA-N
CHEMBL4788798,,CCS(=O)(=O)N(C)c1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,8.09,CHEMBL4713866,Antiproliferative activity against human A 172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,FIQDGCIYCNETRN-UHFFFAOYSA-N
CHEMBL1956924,,CO[C@@H]1O[C@@]2(CO)CC[C@@]13CC[C@]1(C)[C@H](C[C@@H](O)[C@@H]4[C@@]5(C)CC[C@H](O)[C@](C)(CO)[C@@H]5CC[C@]41C)[C@@H]3[C@]2(C)O,IC50,5.48,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,MECPBJHFIZSOAJ-IZSUBYBESA-N
CHEMBL513909,BI-2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,IC50,6.72,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,XQVVPGYIWAGRNI-JOCHJYFZSA-N
CHEMBL514499,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,IC50,7.01,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,JSKUWFIZUALZLX-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.83,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,4.76,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,5.04,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,PLHJCIYEEKOWNM-HHHXNRCGSA-N
CHEMBL11359,CISPLATIN,,IC50,4.32,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.03,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.09,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1822052,,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,7.36,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,NCRYSHBHDZWERB-UHFFFAOYSA-N
CHEMBL1914729,,COCCNc1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,7.27,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,CCTIPTYZBUJCCE-UHFFFAOYSA-N
CHEMBL1914733,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCC4CCCNC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,5.57,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,NMRMRRLTZFLVMO-UHFFFAOYSA-N
CHEMBL1914947,,O=S(=O)(Nc1cc(-c2ccc3ncc(-c4ccncc4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.62,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,URZNQWWEAQTUIM-UHFFFAOYSA-N
CHEMBL3335770,,CN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nc(-c6cc(F)c(F)c(F)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.04,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,DAMPDFDFNFIDMJ-QFIPXVFZSA-N
CHEMBL584746,,CC1(C)OC2c3ccccc3C(=O)C(=O)C2C1Nc1ccc(Cl)c(Cl)c1,IC50,5.31,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QVEMLFNIOZASOI-UHFFFAOYSA-N
CHEMBL561201,,C=C1C(=O)O[C@@H]2C3=C(C)C(=O)C[C@H]3[C@](C)(OC(C)=O)CC[C@@H]12,IC50,5.51,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NEBROCOVJBQSTF-IUPKNAOTSA-N
CHEMBL2178606,,COC(C)(C)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1,EC50,6.4,CHEMBL2186329,Cytotoxicity against human LN229 cells incubated for 4 days,LN-229,BRCOIQMZYMWNIS-UHFFFAOYSA-N
CHEMBL343482,,CN1CCN(c2nc(-c3ccccc3)cc3ccccc23)CC1,IC50,4.73,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,IWNXRLLJQNKLRQ-UHFFFAOYSA-N
CHEMBL2012805,,CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CS)NC1=O,IC50,5.22,CHEMBL2016103,Antiviral activity against Human immunodeficiency virus type 1 SF162 pseudovirus expressing envelope glycoprotein 160 infected in human U87 cells after 48 hrs by luminometric analysis,U-87MG ATCC,OAGGTYVPCYVCMS-POFDKVPJSA-N
CHEMBL509514,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5Cl)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,6.0,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,ALGAIOAAAOKMBW-GVGYXHIPSA-N
CHEMBL4094631,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(C(F)(F)F)c1)CC(C)(C)O2,IC50,4.68,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,ISDJDFNLNBGKFY-UHFFFAOYSA-N
CHEMBL3774518,,O=C(Nc1cc(-c2cccnc2)nc(NCCCN2CCOCC2)n1)c1cc(Br)cc(C(F)(F)F)c1,IC50,5.82,CHEMBL3777262,Cytotoxicity against human SNB75 cells after 24 hrs by SRB assay,SNB-75,SWGHSHOUMNMZNI-UHFFFAOYSA-N
CHEMBL4466566,,CC(C)[C@@H]1CC[C@]2(C)C1=CC[C@]1(C)[C@H]3CC[C@@]4(C)O[C@H]([C@H]4O)[C@]3(C)[C@@H](O)C[C@H]12,IC50,4.79,CHEMBL4393484,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,NLVZPTYDJZNGCY-OVZDKSCUSA-N
CHEMBL238100,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ccccc12,IC50,6.37,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,XZADTAXOFGSUFI-OAHLLOKOSA-N
CHEMBL3262851,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(F)cc3Cl)cc2F)ccn1,IC50,5.92,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ASXICJDAFDMINP-AMVVHIIESA-N
CHEMBL3262853,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(Cl)cc3Cl)cc2F)ccn1,IC50,5.63,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RXRDEPGMDFYQTQ-AMVVHIIESA-N
CHEMBL333225,,CN(C)CCNc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.52,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,QJOCISBWQLZIJK-UHFFFAOYSA-N
CHEMBL121878,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(Cl)cc13,IC50,6.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,RDOBSVYAIZUPAY-UHFFFAOYSA-N
CHEMBL1976714,,CC1=CC2=C(C=O)C(=O)[C@](C)(O)[C@@H](O)C2=CO1,IC50,4.55,CHEMBL3107274,Cytotoxicity against human SF295 cells by colorimetric method,SF295,QVMUHZHZYCDMAI-RYUDHWBXSA-N
CHEMBL1366503,,COc1ccc(CC(=O)NCc2ccccc2)cc1,EC50,5.5,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,AODURBKQPXZTLP-UHFFFAOYSA-N
CHEMBL3104959,,CC(=O)O[C@H]1C2=COC(C)=CC2=C(C=O)C(=O)[C@]1(C)OC(C)=O,IC50,4.58,CHEMBL3107274,Cytotoxicity against human SF295 cells by colorimetric method,SF295,QVXVIOCTOACBNT-HOTGVXAUSA-N
CHEMBL3093021,,C=CCCCCOc1ccc(C)cc1-c1cnc(OCCC=C)n1C,IC50,4.03,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DWYSYKYKDCSKNC-UHFFFAOYSA-N
CHEMBL4175621,,O=C1c2ccccc2C(=O)c2c(-c3cccc4c3OCO4)coc21,IC50,5.43,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,CBLDQKDCGPUTCM-UHFFFAOYSA-N
CHEMBL5410443,,COc1ccc(SC2=CC(=O)c3cccc(O)c3C2=O)cc1,IC50,4.78,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,OVZPYFOIGDYLFC-UHFFFAOYSA-N
CHEMBL3121278,,CCOc1ccc(Nc2nc(-c3c(C)nc4sccn34)cs2)cc1,EC50,7.52,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,GFBWFHBEQJJBIU-UHFFFAOYSA-N
CHEMBL3121273,,COc1ccc(Cl)cc1C(=O)N1CC(=O)Nc2ccccc21,EC50,6.19,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,GHDXFDQEPFAWSR-UHFFFAOYSA-N
CHEMBL4438947,,O=C(/C=C/c1ccc(B(O)O)cc1)c1ccccc1,IC50,4.49,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,GJEUTIGMSWDODK-DHZHZOJOSA-N
CHEMBL4459949,,CCCCCN(CCCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,5.05,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,KSVZDKHRYOARAP-SFQUDFHCSA-N
CHEMBL4464788,,O=C(/C=C/c1ccc(-c2cccnc2)cc1)c1cccc(O)c1,IC50,4.97,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,STIQSWSUIPGZMK-DHZHZOJOSA-N
CHEMBL4520670,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(O)c(C(F)(F)F)c2)c1,IC50,4.94,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IRTWUJOEIWQCHP-FNORWQNLSA-N
CHEMBL4483086,,COC(=O)c1cccc(/C=C/C(=O)c2cccc(O)c2)c1,IC50,4.78,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,VMGKJSSPDGSNLN-CMDGGOBGSA-N
CHEMBL5565051,,COc1cc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,IC50,5.4,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DRGUAWBWMQFXCR-UHFFFAOYSA-N
CHEMBL5566977,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCNC(=O)CN(C)Cc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.29,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KMROOFNFVYWIQS-UHFFFAOYSA-N
CHEMBL98745,NARCICLASINE,O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(c(O)c21)OCO3,IC50,7.01,CHEMBL998497,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,LZAZURSABQIKGB-AEKGRLRDSA-N
CHEMBL1802329,,CCOCCN1CCN(C(=O)c2cnc(NCc3ccc(CNc4ncc(F)cn4)cc3)nc2C(F)(F)F)CC1,IC50,8.27,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,HKDAUWBQNJQYOP-UHFFFAOYSA-N
CHEMBL2418954,,CC(=O)Nc1cn2cc(-c3cnc(N)c(C(F)(F)F)c3)ccc2n1,EC50,7.3,CHEMBL2423270,Inhibition of PI3 kinase in human U87MG cells assessed as inhibition of AKT phosphorylation at ser473,U-87MG ATCC,TVUPSIBSWDXJGQ-UHFFFAOYSA-N
CHEMBL4440980,,C[C@@H]1CCCCn2ncc(-c3nc(Nc4ccc(N5CCN(C)CC5)cn4)ncc3F)c21,EC50,6.14,CHEMBL4387157,Antiproliferative activity against human A172 assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,A-172,UHCMUGYUWQCODZ-MRXNPFEDSA-N
CHEMBL4545456,,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,EC50,6.28,CHEMBL4387158,Antiproliferative activity against human T98G assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,T98G,KMRYRPPWJDYHAL-QGZVFWFLSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.58,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL2064814,,CC(=O)O[C@@H]1C[C@@H]2[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@@]2(C)[C@]2(C)CC[C@H]([C@](C)(O)CCCC(C)(C)O)[C@@H]12,IC50,4.46,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,NHBPWNBEBHAAIP-ADZWRMKASA-N
CHEMBL342647,,Oc1nc(-c2ccc3c(c2)OCO3)cc2ccccc12,IC50,5.57,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,REBBEBMIHXXSMZ-UHFFFAOYSA-N
CHEMBL124546,,O=C1c2cccnc2-c2nccc3c2c1nc1ccc(Br)cc13,IC50,6.3,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,IEMDEAMHQYKMCM-UHFFFAOYSA-N
CHEMBL122076,,Nc1ccc2nc3c4c(nccc4c2c1Br)-c1ncccc1C3=O,IC50,7.1,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,VRNDCSQPEDETKM-UHFFFAOYSA-N
CHEMBL1807791,,Cc1c2c(n3c1CCNC[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.4,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,BDFNVHFLLPLTRV-ZBFHGGJFSA-N
CHEMBL1807792,,Cc1c2c(n3c1CCCN(C)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.88,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,XXAWNLULHYRRBI-IRXDYDNUSA-N
CHEMBL1807793,,Cc1c2c(n3c1CCN(C)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.31,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,UYHYKUQARKBKHF-WBVHZDCISA-N
CHEMBL1807807,,Cc1c2c(n3c1CCN(C(=O)C(C)(C)N)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.41,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RXKNSFZSSAIGRV-AEFFLSMTSA-N
CHEMBL1807808,,Cc1c2c(n3c1CCN(C(=O)C1(N)CC1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.07,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RENRGENBCMHTBB-AEFFLSMTSA-N
CHEMBL1807811,,Cc1c2c(n3c1CCN(C(=O)[C@H]1CCCN1)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.57,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KRHCYUXPGWYNDE-ZWCUEREDSA-N
CHEMBL1807812,,Cc1c2c(n3c1CCN(C(=O)[C@H](C)O)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.06,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,WGTWKBHDMIJGNZ-NJAFHUGGSA-N
CHEMBL1807813,,Cc1c2c(n3c1CCN(C(=O)[C@@H](O)C(C)C)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.12,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ZRAYVGSXRWTSBW-QZXAKIBKSA-N
CHEMBL340160,ASCIDIDEMIN,O=C1c2cccnc2-c2nccc3c2c1nc1ccccc13,IC50,7.16,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,BTAIBIXHXSXUFN-UHFFFAOYSA-N
CHEMBL2024160,,Oc1ccc2[nH]cc(C(c3ccc(C(c4c[nH]c5ccc(O)cc45)c4c[nH]c5ccc(O)cc45)cc3)c3c[nH]c4ccc(O)cc34)c2c1,IC50,5.56,CHEMBL2027285,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,JDESIJRAHSFINB-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.96,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL1956190,,Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)[O-])cc1.Cn1cc(NC(=O)CC[S+](C)C)cc1-c1nc2cc(C(=O)Nc3ccc(N(CCCl)CCCl)cc3)ccc2[nH]1,IC50,6.15,CHEMBL1958537,Growth inhibition of human SF295 cells,SF295,FGDAMRJAQQORJV-UHFFFAOYSA-N
CHEMBL1956190,,Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)[O-])cc1.Cn1cc(NC(=O)CC[S+](C)C)cc1-c1nc2cc(C(=O)Nc3ccc(N(CCCl)CCCl)cc3)ccc2[nH]1,IC50,6.15,CHEMBL1958539,Growth inhibition of human SNB75 cells,SNB-75,FGDAMRJAQQORJV-UHFFFAOYSA-N
CHEMBL163078,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1,IC50,7.32,CHEMBL815089,Concentration required to inhibit the entry of HIV-1 reported virus (ADA) into U-87 cells,U-87MG ATCC,KRBMMTDOLHPSPA-UHFFFAOYSA-N
CHEMBL1949931,,C=C1CCC(=O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.3,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KZCDZBRUJRDWLZ-RVYHWVNWSA-N
CHEMBL2430031,,CC[C@H]1O[C@@H](O[C@H]2CO[C@@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,IC50,5.23,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,YVZJSSFXXNLBHY-LNBDOPGKSA-N
CHEMBL2430029,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)O)CC[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,IC50,5.65,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,YMUVECXYJPPWBW-ZQPXAOBSSA-N
CHEMBL2430032,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)[C@@H](O)[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.54,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LKXSEJWOAPOCIO-SIOYIREESA-N
CHEMBL565966,SCHISANTHERIN A,COc1cc2c(c(OC)c1OC)-c1c(cc3c(c1O)OCO3)C[C@H](C)[C@](C)(O)[C@H]2OC(=O)c1ccccc1,IC50,4.0,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VJGNXZQPNWMFAQ-SSEZWIOCSA-N
CHEMBL2313858,,CCCCCCCCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.16,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VOPUILLVARXVAT-LUXASXKVSA-N
CHEMBL5279512,,N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)C(NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(c1ccccc1)c1ccccc1)C(N)=O,IC50,4.88,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,HLTROIQLCAEASX-HLKALLPASA-N
CHEMBL3578214,,Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1,IC50,7.13,CHEMBL3580215,Anticancer activity against human U87 cells assessed as cell growth inhibition after 20 to 70 hrs by Real-time RTCA iCELLgence system,U-87MG ATCC,VMTZCKPMAFGPEN-UHFFFAOYSA-N
CHEMBL141075,,CN1CCN(c2nc(-c3ccccc3)cc3c(N(C)C)cccc23)CC1,IC50,5.02,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,LVIPDHQIBOMSFK-UHFFFAOYSA-N
CHEMBL1928601,,COc1c2c(c(OC)c3ccccc13)[C@H]1Oc3ccccc3[C@H]1CO2,IC50,4.65,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,ADFKBBNAHGKEAQ-BEFAXECRSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,5.09,CHEMBL3096271,Cytotoxicity against human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL2037140,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1-c1ccc(Cl)cc1,IC50,4.54,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,JJWCPJDPEMMMMR-UHFFFAOYSA-N
CHEMBL2037141,,CC(C)NC(=O)OCc1c(COC(=O)NC(C)C)c2sc3ccccc3n2c1-c1ccc(F)c(F)c1,IC50,4.13,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,SLNLXKMQVSYVRR-UHFFFAOYSA-N
CHEMBL2037447,,C/C(=N/NC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.21,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NOHGJWJQBAAVFP-ZDLGFXPLSA-N
CHEMBL2037440,,C/C(=N\NC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PTOHINKLMXPSKL-LICLKQGHSA-N
CHEMBL2037439,,C/C(=N\NC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NPHJRKXEZJAUIL-LICLKQGHSA-N
CHEMBL2037434,,C/C(=N\NC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.19,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NRNNRLWHLIPYQW-VCHYOVAHSA-N
CHEMBL2037342,,CC(=NNC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.19,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NRNNRLWHLIPYQW-UHFFFAOYSA-N
CHEMBL534423,,CC(=NNC(S)=Nc1ccccc1Cl)c1ccccn1,IC50,8.96,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,DIAIPLSVPPGTLG-UHFFFAOYSA-N
CHEMBL1987055,,C/C(=N/NC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,7.51,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,QJEQNMXYYQUOAY-ZDLGFXPLSA-N
CHEMBL2037441,,C/C(=N/NC(=S)Nc1ccccc1)c1ccccn1,IC50,8.85,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VHVSCHSQNUUXNS-BOPFTXTBSA-N
CHEMBL2037440,,C/C(=N\NC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.8,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PTOHINKLMXPSKL-LICLKQGHSA-N
CHEMBL2037438,,C/C(=N\NC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.21,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,JJPHEFXBDVUGNK-VCHYOVAHSA-N
CHEMBL1725990,,CC(=NNC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,7.51,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,QJEQNMXYYQUOAY-UHFFFAOYSA-N
CHEMBL534423,,CC(=NNC(S)=Nc1ccccc1Cl)c1ccccn1,IC50,8.59,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,DIAIPLSVPPGTLG-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.33,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL478110,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(Cl)cc1,IC50,5.88,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SDMKQOWHXHPBLL-UHFFFAOYSA-N
CHEMBL569228,,C[C@@H]1CCC2[C@@H](C)[C@@H](CCC(=O)NCCCN3CCN(CCCNC(=O)CC[C@H]4O[C@@H]5O[C@]6(C)CC[C@H]7[C@H](C)CCC([C@H]4C)[C@@]57OO6)CC3)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4,IC50,6.34,CHEMBL1041736,Anticancer activity against human XF498 cells by sulforhodamine B assay,XF 498,JVHGAAKZMCRLRS-APGVTMGHSA-N
CHEMBL586702,ZSTK-474,FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,6.96,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,HGVNLRPZOWWDKD-UHFFFAOYSA-N
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,5.8,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL4458861,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1C,IC50,6.55,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,GMHBADQJCABDJH-UHFFFAOYSA-N
CHEMBL4590434,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1OC,IC50,5.79,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,JIORUMFDOIOVJQ-UHFFFAOYSA-N
CHEMBL603675,,CC(C)(C)c1ccc(CC2(N)CCN(c3ccnc4[nH]ncc34)CC2)cc1,IC50,8.19,CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,U-87MG ATCC,ZSPYHLIIAPFXSZ-UHFFFAOYSA-N
CHEMBL4438250,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1F,IC50,6.16,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,WXNYEPSDUHRGAY-UHFFFAOYSA-N
CHEMBL4560662,,O=C(Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1)OCc1cn(C[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2O)nn1,IC50,5.12,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,LZPJQBTUNHVIHV-HOINCJJXSA-N
CHEMBL2164700,,Cc1c2c(cc[n+]1CCC(C)C)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,6.39,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FNEBMMOEXCTUNT-UHFFFAOYSA-M
CHEMBL2165020,,COc1ccc(Nc2ncc(CC3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.27,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,IMXXTFKFHMPFMA-UHFFFAOYSA-N
CHEMBL2165019,,COc1ccc(Nc2ncc(CN3CCC(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.34,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,UZUPOMTXPRNVLO-UHFFFAOYSA-N
CHEMBL493083,,Cc1cc2nc(-c3cccc(O)c3)nc(N3CCOCC3)c2s1,IC50,6.0,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,IAAWZHBLOYYROY-UHFFFAOYSA-N
CHEMBL4126709,,Nc1n[nH]c2nc3cc(Cl)ccc3cc12,IC50,4.23,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,SAPWXFJDVCRSKW-UHFFFAOYSA-N
CHEMBL4127746,,Nc1n[nH]c2nc3c(ccc4ccccc43)cc12,IC50,4.26,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,KPDJPPWWQTYBRP-UHFFFAOYSA-N
CHEMBL15192,LAPACHONE,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.7,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,QZPQTZZNNJUOLS-UHFFFAOYSA-N
CHEMBL448558,LANTALUCRATIN B,C=C(C)C1CC2=C(O1)c1cccc(O)c1C(=O)C2=O,IC50,5.72,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,WKLGYQWVPPIRFC-UHFFFAOYSA-N
CHEMBL493290,,COCCN(C)Cc1cc2nc(-c3cccc(O)c3)nc(N3CCOCC3)c2s1,IC50,6.38,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,HAUSIZJQROQUOS-UHFFFAOYSA-N
CHEMBL447293,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5C)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.02,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,GRYDWYKJDXLYKW-MHTDFPPDSA-N
CHEMBL4763301,,CO[C@@]1(C)N(/C=C/c2ccccc2)C(=O)C2=C[C@@]3(C(=O)N(C)c4ccccc43)C(=O)N21,IC50,5.14,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,PLQBGVIHNRFEKK-FGTQWKHKSA-N
CHEMBL4166594,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(OC3CCOCC3)c2n1,IC50,6.6,CHEMBL4150398,Cytotoxicity against human U87MG cells after 96 hrs by MTT assay,U-87MG ATCC,IEDGFXCUFJCEAP-UHFFFAOYSA-N
CHEMBL514351,,Cc1ccc(NCc2ccc(/C=C/C(=O)NO)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,5.0,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,HIRRHXZKTMZOHN-PKNBQFBNSA-N
CHEMBL4529472,,COc1ccc(C2CC(c3ccc4ccccc4c3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(OC)cc43)S2)cc1,EC50,6.17,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,SXHQACGBIOZRKH-ZIADKAODSA-N
CHEMBL337547,,Cc1ccc2c(S)nc(-c3ccccc3)cc2c1,IC50,4.12,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,RRJXVVWHJOHBHM-UHFFFAOYSA-N
CHEMBL4440176,,CCOP(=O)(OCC)C(N(OC(C)c1nccn1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,INXHFCOUUUGHJG-UHFFFAOYSA-N
CHEMBL4871838,,O=S(=O)(Nc1cc(-c2ccc3nncc(-c4cnc(N5CCOCC5)nc4)c3c2)cnc1Cl)c1ccccc1,IC50,6.58,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,JDQJRYKTFFQLMZ-UHFFFAOYSA-N
CHEMBL3780278,,O=c1oc2ccc(-c3cnc4ccccc4c3)cc2c2c1[nH]c(=O)n2-c1ccccc1,IC50,4.45,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LVSBOXRWFDUGKX-UHFFFAOYSA-N
CHEMBL3780267,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccncc5)cc4c32)cc1,IC50,4.44,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,ALCXWEWOCSHWQS-UHFFFAOYSA-N
CHEMBL3780660,,CC(C)(C#N)c1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5cccnc5)cc4c32)cc1,IC50,4.59,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LSNCVXRDSDKEFL-UHFFFAOYSA-N
CHEMBL3781715,,CC(C)(C#N)c1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccncc5)cc4c32)cc1,IC50,4.54,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,GBZAAXXFXRMRAP-UHFFFAOYSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,5.44,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL3764611,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccccc2F)nn1,IC50,4.32,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RKLRFKNYTRWJAM-UHFFFAOYSA-N
CHEMBL3763427,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccc([N+](=O)[O-])cc2)nn1,IC50,4.48,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RBTLETQAAVLDLV-UHFFFAOYSA-N
CHEMBL4437426,,CO/C1=C\CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@H](C)C[C@@H]2C[C@H](OCc3cn(C[C@@H]4O[C@H](O)[C@@H](O)[C@H](O)[C@H]4O)nn3)O[C@@H]12,IC50,4.9,CHEMBL4432289,Cytotoxicity against human U87 cells assessed as reduction in cell survival after 72 hrs by sulforhodamine B assay,U-87MG ATCC,KUMDGGQDLPKBIB-ASWBBHMMSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.4,CHEMBL1776150,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4760262,,Cc1nn(C)c(Oc2cccc(F)c2)c1/C=N\CCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.01,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,LYZWYIFVGJYHFM-UHBFCERESA-N
CHEMBL4751883,,Cc1nn(C)c(Oc2ccc(Br)cc2)c1/C=N\CCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.82,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GWDBAGVHQLBYBE-UHBFCERESA-N
CHEMBL4756515,,Cc1nn(C)c(Oc2ccc(Cl)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.42,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VTCBPYADQWPZMH-LJUMEUDFSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,5.37,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL4593656,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(CNc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(N)nc2=O)C1(F)F,IC50,5.34,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,YOROBEOGIMLFGN-YFYJLLRASA-N
CHEMBL917,FLOXURIDINE,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,IC50,5.21,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,ODKNJVUHOIMIIZ-RRKCRQDMSA-N
CHEMBL43612,JUGLONE,O=C1C=CC(=O)c2c(O)cccc21,IC50,5.13,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,KQPYUDDGWXQXHS-UHFFFAOYSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,6.44,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,5.77,CHEMBL5509857,Synergistic antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs in presence of IDH305 by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL1782898,,CCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.0,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZUNBZSJIGSBNJN-GVQBMFDGSA-N
CHEMBL1782907,,CCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.75,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,GPLLOVYREUOHFC-ULBKPHCJSA-N
CHEMBL1782897,,CCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.62,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,PKYDWSNOPPOHAE-ULBKPHCJSA-N
CHEMBL5267325,,CCOC(=O)[C@H]1[C@@H](NO)[C@@H]2c3ccccc3OC(C)(C)[C@H]2[C@H](O)[C@]12C(=O)Nc1ccc(F)cc12,IC50,4.38,CHEMBL5235657,Anticancer activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,IVDOKEMXWIICJE-XNZMQEADSA-N
CHEMBL5289048,,COc1ccc(/C(C)=C/CN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1,IC50,7.69,CHEMBL5225165,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,PTGWAAKNSYOHMB-WOJGMQOQSA-N
CHEMBL5560649,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.97,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DMOOGJIRMQGHML-UHFFFAOYSA-N
CHEMBL5555620,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.47,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,FRCYUJLTCPHQMY-UHFFFAOYSA-N
CHEMBL4285772,,CC[N+](CC)(CC)CCCCCCCCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,6.96,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,JPHZPBLJNRODIE-LTRPLHCISA-M
CHEMBL4176771,,COc1ncc(-c2cc(O[C@@H]3CCOC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.55,CHEMBL4150401,Cytotoxicity against human T98G cells after 96 hrs by MTT assay,T98G,YLPQMLSKPUQHLB-QGZVFWFLSA-N
CHEMBL4166144,,COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.92,CHEMBL4150398,Cytotoxicity against human U87MG cells after 96 hrs by MTT assay,U-87MG ATCC,FEHPMLVVSQNYOF-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.76,CHEMBL3792217,Cytotoxicity against human XF498 cells by SRB assay,XF 498,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL3793543,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCSCC1,IC50,4.6,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,USUALIZBISSRTB-UHFFFAOYSA-N
CHEMBL3793099,,CN1CCN(CCCCCCN2c3ccccc3Sc3cccnc32)CC1,IC50,4.8,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,FKGCIKNEJVJXTO-UHFFFAOYSA-N
CHEMBL3792772,,O=[N+]([O-])CCCCCCN1c2ccc(F)cc2Sc2cccnc21,IC50,4.5,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,PCSDEWNPQINATA-UHFFFAOYSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,9.0,CHEMBL3297406,Antiproliferative activity against human U87 cells after 72 hrs,U-87MG ATCC,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL3291068,,CCC1=C[C@@H]2CN(C1)C[C@H](CN1CCC[C@H]1C(=O)N[C@H](C(=O)OC)[C@@H](C)CC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.4,CHEMBL3297406,Antiproliferative activity against human U87 cells after 72 hrs,U-87MG ATCC,MCGMYWJVQYWGBF-WDOZCWQQSA-N
CHEMBL4204920,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1,IC50,6.02,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HFSWCNDZVPIIOF-UHFFFAOYSA-N
CHEMBL3609553,,Cc1ccc([Se]C2CC3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.02,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,CUAJPFMTSQUMCC-UHFFFAOYSA-N
CHEMBL3400565,,CCC1=CC2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccc(C=O)cc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.92,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,UBXMGYCFGXRKKK-KYOITVBSSA-N
CHEMBL3426484,,C=C1C(=O)[C@@]23CC[C@@H]4[C@@](C)(C=O)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,5.36,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,QUHOWUGRZVTLAK-CBFGRJNTSA-N
CHEMBL3810407,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(F)cc4)n3)ccc21,IC50,4.79,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,DGVVXRGLEZWRQX-OEAKJJBVSA-N
CHEMBL3808776,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(C(F)(F)F)cc4)n3)ccc21,IC50,4.59,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,OEYIHBVDTVJSJG-OEAKJJBVSA-N
CHEMBL169169,,CCOCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.86,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,GBYYUYBZZWBZIP-UHFFFAOYSA-N
CHEMBL3819416,,CCOC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12,IC50,5.58,CHEMBL3820289,Antiproliferative activity against human U87MG cells expressing wild type p53 after 48 hrs by MTS assay,U-87MG ATCC,TXTXUJCZFZSISJ-SVBPBHIXSA-N
CHEMBL4292222,,O=C(COc1ccc(/C=C/C(=O)c2ccc(F)cc2)cc1)Nc1ccc2c(c1)COC2=O,IC50,5.22,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,SAESZHBCOSRELJ-KGVSQERTSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,4.74,CHEMBL3807045,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Z2 coulter counter method,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL4286698,,Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1,IC50,6.04,CHEMBL4276487,Growth inhibition of human T98G cells after 72 hrs by ATPlite based assay,T98G,UGDKPWVVBKHRDK-UHFFFAOYSA-N
CHEMBL424549,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(Cc1ccccc1)C(=O)OCc1ccccc1,IC50,5.93,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,BXUCUCJMGQGAGS-UHFFFAOYSA-N
CHEMBL168489,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN(CCOC(C)=O)C(=O)OCc1ccccc1,IC50,4.73,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,FKFWJXGEBAKAOB-UHFFFAOYSA-N
CHEMBL4295010,,O=C(/C=C/c1ccc(Oc2cc(=O)oc3ccccc23)cc1)/C=C/c1cccnc1,IC50,4.43,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,FDNNBTZTUHPFMX-MKICQXMISA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.32,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4451749,,COc1cc(/C=C/C(=O)Nc2cccc(OCC3CCNCC3)c2)ccc1O.Cl,IC50,4.51,CHEMBL4315250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,NHIRLIGCPAUYLZ-WVLIHFOGSA-N
CHEMBL4453750,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.67,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BKHJEJHQMSABBI-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.37,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3113706,,O=[N+]([O-])c1ccc(O)c(/C=N/Nc2cnc3ccccc3n2)c1,IC50,5.68,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,PPXNOINSRNIZRH-CAOOACKPSA-N
CHEMBL2436000,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5C)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.69,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LKJFGAFEPSNWPJ-UHFFFAOYSA-N
CHEMBL2385188,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.92,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QABSXSLQFVTLTK-UHFFFAOYSA-N
CHEMBL2385202,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NCZHZMPXMHJOKE-UHFFFAOYSA-N
CHEMBL2385206,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Br)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.8,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QVRRVDVQZFLJPI-UHFFFAOYSA-N
CHEMBL2385176,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.83,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YRIRNSUDWILAQP-UHFFFAOYSA-N
CHEMBL2385198,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5c(Cl)cccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.9,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YXHJZCCPKMMPDW-UHFFFAOYSA-N
CHEMBL379300,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,IC50,6.51,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,YWTBGJGMTBHQTM-IBGZPJMESA-N
CHEMBL591429,PAC-1,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,IC50,4.44,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,YQNRVGJCPCNMKT-LFVJCYFKSA-N
CHEMBL477772,PAZOPANIB,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,5.61,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,CUIHSIWYWATEQL-UHFFFAOYSA-N
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,5.27,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,RDSACQWTXKSHJT-UHFFFAOYSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.31,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.14,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,RAHBGWKEPAQNFF-UHFFFAOYSA-N
CHEMBL189584,PD-173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,IC50,5.21,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,DXCUKNQANPLTEJ-UHFFFAOYSA-N
CHEMBL1079175,MK-2206,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,IC50,5.07,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,ULDXWLCXEDXJGE-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,6.05,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.37,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,SUDAHWBOROXANE-SECBINFHSA-N
CHEMBL1186585,,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,IC50,4.36,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,MIDUFIRTIFUTQA-UHFFFAOYSA-N
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,4.66,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,CEGSUKYESLWKJP-UHFFFAOYSA-N
CHEMBL2392824,,COc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)cc1,IC50,6.03,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ACLUFQYNCIXYPM-UHFFFAOYSA-N
CHEMBL2392942,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.04,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HJPZKRAXGGLLCM-UHFFFAOYSA-N
CHEMBL4060213,,CCCCNc1nc(SC)nc2c1ccn2Cc1ccc(F)cc1,IC50,4.68,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,FQVMTUKCTPYSEC-UHFFFAOYSA-N
CHEMBL2297275,,COc1cc(OC)c2c(NCc3ccccc3)cc(-c3ccccc3)nc2c1,IC50,5.15,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,ZCOHSLDTKONWKK-UHFFFAOYSA-N
CHEMBL2297272,,COc1cc(OC)c2c(N3CCN(C)CC3)cc(-c3ccccc3)nc2c1,IC50,5.76,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,PLIQXFGTHSMWHJ-UHFFFAOYSA-N
CHEMBL2297268,,CCCCNc1cc(-c2ccccc2)nc2cc(OC)cc(OC)c12,IC50,5.41,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,PDUABDJEEBIIKK-UHFFFAOYSA-N
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,EC50,7.39,CHEMBL3226845,Inhibition of JNK in human U87MG cells overexpressing EGFR V3 mutant assessed as inhibition of c-jun phosphorylation after 6 hrs by ELISA,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL3781720,,N#CCc1ccc(-n2c(=O)[nH]c3c(=O)oc4ccc(-c5ccccc5)cc4c32)cc1,IC50,4.5,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,LITPROVKGQYSLW-UHFFFAOYSA-N
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,4.19,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,CTESJDQKVOEUOY-UHFFFAOYSA-N
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,5.44,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,PHXJVRSECIGDHY-UHFFFAOYSA-N
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,4.98,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,JWQOJVOKBAAAAR-UHFFFAOYSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,9.48,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,5.84,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.44,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,4.91,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL1230020,PLX-4720,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,IC50,4.29,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,YZDJQTHVDDOVHR-UHFFFAOYSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,5.38,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,8.41,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,5.24,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,PLHJCIYEEKOWNM-HHHXNRCGSA-N
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,8.39,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL443684,NAVITOCLAX,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,IC50,4.89,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,JLYAXFNOILIKPP-KXQOOQHDSA-N
CHEMBL1090090,VX-702,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F,IC50,4.22,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,FYSRKRZDBHOFAY-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,5.62,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL2165052,,Cc1nc(N)nc(-c2cccnc2Nc2cccc(O)c2)n1,IC50,7.22,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,ITUBWSOGJQVWCJ-UHFFFAOYSA-N
CHEMBL2375552,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(C2CCCCC2)nn1,IC50,5.5,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,DNRCXULLPXOXGG-UHFFFAOYSA-N
CHEMBL2375476,,CCC(C)(O)c1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,IC50,5.38,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,ZFNUJYXVCGAIRX-UHFFFAOYSA-N
CHEMBL3262845,,Cn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccccc3)cc2F)ccn1,IC50,4.44,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GPPWMADCPAEKSN-DHRITJCHSA-N
CHEMBL3262860,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(O)cc3)cc2F)ccn1,IC50,5.11,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VUTCCEJQYPCNLA-RWPZCVJISA-N
CHEMBL3262865,,Cc1cc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)cc(C)c1O,IC50,5.11,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HSWWIQFCGIMTQE-FJEPWZHXSA-N
CHEMBL3262866,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cc(C(C)(C)C)cc(C(C)(C)C)c3O)cc2F)ccn1,IC50,6.28,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GTNVXSUZBLAROW-ODNPBWNPSA-N
CHEMBL3263122,,COc1ccc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)c(OC)c1OC,IC50,5.12,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FXSLJSRWXCSNNE-WCMJOSRZSA-N
CHEMBL3263125,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc4c(c3)OCO4)cc2F)ccn1,IC50,6.14,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JUKOZSDIACGIFL-IPPBACCNSA-N
CHEMBL2348724,,Nc1n[nH]c(=O)c2ccccc12,IC50,5.22,CHEMBL2351701,Cytotoxicity against human SF295 cells after 48 hrs by MTT assay,SF295,IUBSMBJKUKVEMK-UHFFFAOYSA-N
CHEMBL3986488,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1nnc(-c2ccccc2)c1I,IC50,5.55,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,UXBPRHGBARQXMO-UHFFFAOYSA-N
CHEMBL3911886,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1nncc1-c1ccccc1,IC50,5.55,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,CCTAXCDYRZFLMW-UHFFFAOYSA-N
CHEMBL3901778,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1nncc1-c1ccccc1)O2,IC50,5.11,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,GPKASGONNYIPKG-UHFFFAOYSA-N
CHEMBL3952951,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(C3=CCCCC3)nn1)O2,IC50,5.63,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,WOWMAWBIEUQPCI-UHFFFAOYSA-N
CHEMBL3806140,,O=C(/C=C\Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.94,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,MJCYXBGMYBXSHF-NXVVXOECSA-N
CHEMBL3793270,,BrCCCCCCN1c2ccc(Br)cc2Sc2cccnc21,IC50,5.05,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,ZFSLTURYGVDXIY-UHFFFAOYSA-N
CHEMBL3793661,,CC(=O)N1CCN(CCCCCCN2c3ccccc3Sc3cccnc32)CC1,IC50,4.68,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,ZXKPHFCJOIZGBZ-UHFFFAOYSA-N
CHEMBL3092925,,C=CCCCCOc1ncc(-c2cc(C(C)C)ccc2OC)n1C,IC50,5.22,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,XXAGNOIZVPRFLM-UHFFFAOYSA-N
CHEMBL3092928,,C=CCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.41,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,VOLSTGCHRLWGMM-UHFFFAOYSA-N
CHEMBL3092933,,C=CCCCCCOc1ncc(-c2ccccc2OCCCCC=C)n1C,IC50,4.2,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DMTIIWJTCDCVEM-UHFFFAOYSA-N
CHEMBL3093016,,C=CCCCCOc1cc2ccccc2cc1-c1cnc(OCCC=C)n1C,IC50,4.5,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,RUEBIOFSSXTYMQ-UHFFFAOYSA-N
CHEMBL180127,SALUBRINAL,O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl,IC50,4.29,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,LCOIAYJMPKXARU-VAWYXSNFSA-N
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.61,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,SUDAHWBOROXANE-SECBINFHSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.96,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL3416185,,COc1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2cc1OC,IC50,5.3,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QXZWVYUEPCJXSN-UHFFFAOYSA-N
CHEMBL3414588,,COc1cc2nc(-c3ccc(OC)c(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.72,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RRSGTZKCGTZSHE-UHFFFAOYSA-N
CHEMBL305942,FAGARIDINE,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1O,IC50,5.95,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,RSCIYYHIBVZXDI-UHFFFAOYSA-O
CHEMBL3121274,,COc1cc(OC)cc(C(=O)Nc2ccc(I)cn2)c1,EC50,5.88,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KPZBBEOAWINKFP-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,8.05,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,4.43,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,5.64,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL5416410,DASATINIB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O,IC50,6.45,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,XHXFZZNHDVTMLI-UHFFFAOYSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,5.92,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,4.88,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,RDSACQWTXKSHJT-UHFFFAOYSA-N
CHEMBL3262847,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(Cl)cc3)cc2F)ccn1,IC50,5.86,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JFZSKKWSBXCPGI-WKULSOCRSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,4.71,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL1256459,TORIN1,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,IC50,5.23,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,AKCRNFFTGXBONI-UHFFFAOYSA-N
CHEMBL379300,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,IC50,4.7,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,YWTBGJGMTBHQTM-IBGZPJMESA-N
CHEMBL401930,,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,IC50,5.61,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,ZWVZORIKUNOTCS-OAQYLSRUSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],EC50,6.41,CHEMBL4810919,Cytotoxicity against human U-87MG cells assessed as reduction in total cell count measured after 96 hrs by Hoechst staining analysis,U-87MG ATCC,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,6.82,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,JAMULYFATHSZJM-UHFFFAOYSA-N
CHEMBL573107,,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,IC50,6.29,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,DTEKTGDVSARYDS-UHFFFAOYSA-N
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,6.01,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,OGNYUTNQZVRGMN-UHFFFAOYSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.83,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL2381447,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc8c(c7)OCO8)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.75,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,LLYHHQGLZTYOIO-FEOXQYHVSA-N
CHEMBL4854987,,COc1cc(C(=O)c2cn(-c3ccc(F)cc3)cc2-c2ccncc2)cc(OC)c1OC,IC50,7.41,CHEMBL4838790,Cytotoxicity against human U-87MG cells assessed as cell growth inhibition measured after 48 hrs by MTS colorimetric assay,U-87MG ATCC,HSFUMBZPJRQQBQ-UHFFFAOYSA-N
CHEMBL1760588,BERBIKONOL,COc1ccc([C@H](O)[C@@H](CO)Oc2c(OC)cc([C@@H]3Oc4c(OC)cc(CCCO)cc4[C@H]3CO)cc2OC)cc1OC,IC50,4.71,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,ABIOAIYWIAGXDZ-JZQDODDWSA-N
CHEMBL1760589,FICUSESQUILIGNAN A,COc1cc([C@@H](O)[C@H](CO)Oc2ccc([C@@H]3OC[C@@H]4[C@H]3CO[C@H]4c3cc(OC)c(O)c(OC)c3)cc2OC)ccc1O,IC50,5.02,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,PFZFCRCFYYFTPE-RWMYVIIASA-N
CHEMBL1760594,,COc1cc([C@@H]2c3c(cc(OC)c(O)c3OC)C[C@H](CO)[C@H]2CO)cc(OC)c1O,IC50,4.58,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,ZDVZKBOFCHOPLM-LBTNJELSSA-N
CHEMBL455365,,COc1cc([C@H]2c3c(cc(OC)c(O)c3OC)C[C@@H](CO)[C@@H]2CO)cc(OC)c1O,IC50,5.15,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,ZDVZKBOFCHOPLM-SUNYJGFJSA-N
CHEMBL1760597,,COc1ccc(CC(=O)O)cc1,IC50,4.55,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,NRPFNQUDKRYCNX-UHFFFAOYSA-N
CHEMBL2392951,,COc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)cc1,IC50,5.96,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MRZXKRZICOTLCN-UHFFFAOYSA-N
CHEMBL4080532,,Cc1cc(=O)n(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.72,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YAHBWSUTJNPKIT-UHFFFAOYSA-N
CHEMBL4093275,,Cc1cc(=O)n(-c2ccccc2F)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,5.2,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TUJPISNEJSVWCB-UHFFFAOYSA-N
CHEMBL5592590,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N[C@H]1CCNC1)C3,IC50,5.29,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,PREHDGJVTUBHPV-NSHDSACASA-N
CHEMBL5555258,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N1CCC(N2CCCCC2)CC1)C3,IC50,5.55,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DOVUGJIPCTTWJH-UHFFFAOYSA-N
CHEMBL4575746,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.37,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VLELOJUMXNTMDJ-UHFFFAOYSA-N
CHEMBL4441090,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.27,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CGCPUDDQPHXYNV-UHFFFAOYSA-N
CHEMBL4098763,,CSc1nc(NCCc2ccc(Cl)cc2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.34,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,WIHTVIAVTFAFHD-UHFFFAOYSA-N
CHEMBL3621994,,Cc1ccc(/C=C/C(=O)c2ccc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)cc2)cc1,IC50,5.34,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZNUCWZNVXLGUSK-SFQUDFHCSA-N
CHEMBL441441,ALPHA-LAPACHONE,CC1(C)CCC2=C(O1)C(=O)c1ccccc1C2=O,IC50,4.73,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PJWHOPKRRBUSDH-UHFFFAOYSA-N
CHEMBL1652071,,CCCC1=C(O)C(=O)C2=C(CCCC2)C1=O,IC50,4.64,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CQUTYTUJYIFOMU-UHFFFAOYSA-N
CHEMBL1652075,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3cccc(F)c3)[nH]c21,IC50,4.84,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PKEVBAAYDGBCRS-UHFFFAOYSA-N
CHEMBL1652077,,Cc1ccccc1-c1nc2ccc3c(c2[nH]1)C(=O)c1ccccc1C3=O,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QVXHINYXGZQZKJ-UHFFFAOYSA-N
CHEMBL604471,,Cc1ccc(-c2nc3ccc4c(c3[nH]2)C(=O)c2ccccc2C4=O)cc1,IC50,4.83,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MRHQJLSJDVEZQP-UHFFFAOYSA-N
CHEMBL5624986,,COc1cc(C(=O)/C=C/c2ccccc2C(=O)N2CCN(Cc3ccccc3)C23COC3)cc(OC)c1OC,IC50,5.26,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,OBBXIDOCUKVRIY-BUHFOSPRSA-N
CHEMBL5624576,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccccc1,IC50,5.3,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,KMYZPKBNYTUWMF-DTQAZKPQSA-N
CHEMBL5624739,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1)c1ccncc1,IC50,5.28,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,PJEYCULHRXACRW-DHZHZOJOSA-N
CHEMBL5630408,,N#Cc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc1,IC50,5.2,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,BGUVZKJVWHVYIX-XNTDXEJSSA-N
CHEMBL4176771,,COc1ncc(-c2cc(O[C@@H]3CCOC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.58,CHEMBL4150398,Cytotoxicity against human U87MG cells after 96 hrs by MTT assay,U-87MG ATCC,YLPQMLSKPUQHLB-QGZVFWFLSA-N
CHEMBL498271,,C=C(c1ccc(OC)c(O)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.1,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,CNGKIRSNRQSORA-UHFFFAOYSA-N
CHEMBL1822055,,Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,IC50,6.38,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,FPJNXVCSICMXRJ-UHFFFAOYSA-N
CHEMBL1822056,,O=S(=O)(Nc1cc(-c2ccc3nccn3n2)cnc1Cl)c1ccc(F)cc1,IC50,7.3,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,WEIYGNUYMJRNTA-UHFFFAOYSA-N
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,8.59,CHEMBL1828312,Antiproliferative activity against human U87MG after 48 hrs by spectrophotometry,U-87MG ATCC,HVXBOLULGPECHP-WAYWQWQTSA-N
CHEMBL550986,,COc1ccc(-c2c(CO)c(CO)c3n2-c2ccc(OC)cc2C3)cc1,IC50,4.61,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,OKKFIOJHAIELBA-UHFFFAOYSA-N
CHEMBL561917,,CNC(=O)OCc1c(COC(=O)NC)c(-c2ccc(OC)cc2)n2c1Cc1ccccc1-2,IC50,4.46,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,FHWSLEBLQJUACW-UHFFFAOYSA-N
CHEMBL552053,,COc1ccc(-c2c(CO)c(CO)c3n2-c2ccccc2C3)cc1,IC50,4.34,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,SCNHIBOGDBGMJE-UHFFFAOYSA-N
CHEMBL4059832,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.93,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QQUWBQJOOWMYGO-UHFFFAOYSA-N
CHEMBL4071208,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.91,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OZCQMOAWZCBZGN-UHFFFAOYSA-N
CHEMBL3335759,,Cn1cc(-c2cnc(N3CCO[C@H](Cn4nc(-c5ccc(OCc6ccccc6)cc5)ccc4=O)C3)nc2)cn1,IC50,5.12,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,RBIQCGFCXSOQEO-MHZLTWQESA-N
CHEMBL3335763,,O=c1ccc(-c2cccc(C(F)(F)F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.6,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,BTGRTFFNHLVSJR-DEOSSOPVSA-N
CHEMBL3359304,,C=C(CCCC(C)(C)O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](OC(=O)CCl)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.85,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,GHKZTZQXOVCKSZ-LWXWOMNKSA-N
CHEMBL3359315,,CC(C)(CCC[C@@](C)(OC(=O)CCl)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C)OC(=O)CCl,IC50,4.72,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,QHPAQYVVVUEVBN-BVLXKVINSA-N
CHEMBL404024,,CC(C#N)c1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,IC50,6.86,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,JPILNANJKLSYFG-UHFFFAOYSA-N
CHEMBL53424,,Nc1nc(=O)n([C@H]2S[C@@H](CO)[C@H](O)[C@@H]2O)cc1F,IC50,4.08,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,QDVOFRWTPUEFTR-TYQACLPBSA-N
CHEMBL3808886,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4cccs4)n3)ccc21,IC50,5.14,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,SUZJMSQJZBKXBA-DEDYPNTBSA-N
CHEMBL2165021,,COc1ccc(Nc2nccnc2-c2cc(N)nc(C)n2)cn1,IC50,6.23,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,IFEHHBCJSIHKDR-UHFFFAOYSA-N
CHEMBL2165268,,Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ccc23)n1,IC50,6.82,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,LVUPFSONRUTLLF-UHFFFAOYSA-N
CHEMBL3905411,,CCCCNC(=S)NNc1nncc2ccccc12,IC50,8.2,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,NKPUKLSVXYDTLL-UHFFFAOYSA-N
CHEMBL1380839,,CCN=C(S)NNc1nncc2ccccc12,IC50,9.4,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,LNBNLTRDQFABLX-UHFFFAOYSA-N
CHEMBL3906533,,CCOC(=O)c1ccc(Nc2nncc3ccccc23)cc1,IC50,9.48,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,FZXFZHFLUJFRGT-UHFFFAOYSA-N
CHEMBL3116221,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccccc5)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.32,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PQNPOENKAKBBNV-NJNXFGOHSA-N
CHEMBL3116444,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccc(C)cc5)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.82,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RSJQQGAPVMIJRS-HPNDGRJYSA-N
CHEMBL3116446,,COc1cc2c(Oc3ccc(N/C=C4\C(=O)NC(=O)N(c5ccccc5)C4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.89,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZXTQQNYRMCOIST-XTCLZLMSSA-N
CHEMBL3121281,,Cc1c(C(=O)OC(C)C)[nH]c2c1C(=O)CC(c1cccs1)C2,EC50,6.62,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,SGRJCCAQTQWZDV-UHFFFAOYSA-N
CHEMBL3121279,,Cc1nc2ncccn2c1-c1csc(Nc2ccc(Cl)cc2)n1,EC50,5.61,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,NAIFKGCRLXUVSL-UHFFFAOYSA-N
CHEMBL1521217,,O=C(Cc1ccc(-c2ccccc2)cc1)NCc1ccccc1,EC50,6.36,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,HFZXKRVFJQSEJD-UHFFFAOYSA-N
CHEMBL84615,,COc1ccc(-c2cc3cccc(OC)c3nc2O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,HKAWJXBQZFSPAP-UHFFFAOYSA-N
CHEMBL4070665,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2Cl)ccc1OCCCN1CCc2ccccc21,IC50,4.7,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BPZIZFSBNOIBGP-YRNVUSSQSA-N
CHEMBL3319516,,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCN(C)CC3)[C@@H]2C[C@@H]1O,IC50,4.64,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,AJVKCEKWRIWUFN-KKKYIMSDSA-N
CHEMBL4468684,,C=CC[C@H]1C[C@]2([C@H](C)Cc3cc(O)c(OC)cc3F)OCOC2=CC1=O,IC50,5.02,CHEMBL4326187,Antiproliferative activity against taxane-resistant human SF295 cells after 72 hrs by CellTiter 96 aqueous nonradioactive cell proliferation assay,SF295,NBQLFTNZXOUHIO-MTJIALIYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,4.25,CHEMBL4326187,Antiproliferative activity against taxane-resistant human SF295 cells after 72 hrs by CellTiter 96 aqueous nonradioactive cell proliferation assay,SF295,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4634658,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1cc(OC)ccc1C4=O,EC50,7.68,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,RSXKWDSDUVYSQA-UMGCSLAASA-N
CHEMBL6067492,BLEOMYCIN,,IC50,4.96,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,
CHEMBL1615189,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,5.55,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YGBMCLDVRUGXOV-UHFFFAOYSA-N
CHEMBL5272213,,COc1cc(Nc2ccc3nnc(-c4ccco4)n3c2)cc(OC)c1OC,IC50,4.37,CHEMBL5224863,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth,T98G,KXLLUBZULSSKMD-UHFFFAOYSA-N
CHEMBL3339340,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.32,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,RUEPFGSLNFJPIU-FADJLKOXSA-N
CHEMBL3339342,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.99,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,IRZYUTJCYKVYJW-GOJREDGKSA-N
CHEMBL3415678,,CCCOc1ccc2c3cc[n+](CC)c(C)c3n(CCC)c2c1.[Br-],IC50,4.66,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,ZCEJWAQQAGRUKR-UHFFFAOYSA-M
CHEMBL3793774,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cncc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,5.19,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,XPGBBZUSOYAGMV-GRUVHVDGSA-N
CHEMBL4240179,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCOCC3)CC1)c1ccccc1S2,EC50,4.7,CHEMBL4232380,Induction of intracellular Ca2+ level in human U87MG cells by Fura-2 AM dye-based assay,U-87MG ATCC,DCOREAZQNUSYDA-UHFFFAOYSA-N
CHEMBL4248942,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCCCC3)CC1)c1ccccc1S2,IC50,5.66,CHEMBL4232384,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,DALKPQZIEUGGGK-UHFFFAOYSA-N
CHEMBL3609552,,CC1(C)OC2=C(CC1[Se]c1ccccc1)C(=O)C(=O)c1ccccc12,IC50,5.68,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,DNWGOVCPCLJUDO-UHFFFAOYSA-N
CHEMBL4757485,,C=C(CC)C(=O)c1ccc(OCC(=O)NC2CCN(S(=O)(=O)c3ccc(OC)cc3)CC2)c(Cl)c1Cl,IC50,6.62,CHEMBL4675763,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability by CellTiter Glo luminescent assay,U-87MG ATCC,IDBBJXCKCAYMLL-UHFFFAOYSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.5,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL3343363,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.8,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RJMBEUADUJYIEH-UHFFFAOYSA-N
CHEMBL3343378,,COc1ccc(-n2nnc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(OC)cc45)c(F)c3)c2C(F)(F)F)cc1,IC50,5.62,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WUTYCVPPFZPUPA-UHFFFAOYSA-N
CHEMBL3343387,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.67,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XHOMYTXWOSNFKJ-UHFFFAOYSA-N
CHEMBL3343389,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UZKBOLDIUXTTCC-UHFFFAOYSA-N
CHEMBL2313857,,CCCCCCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.23,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,LDAMDKYTTMERSL-FGFRBZMOSA-N
CHEMBL4286698,,Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1,IC50,6.04,CHEMBL4276444,Growth inhibition of human U87MG cells after 72 hrs by ATPlite based assay,U-87MG ATCC,UGDKPWVVBKHRDK-UHFFFAOYSA-N
CHEMBL4295220,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1cccnc1)c1ccccc1,IC50,5.89,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,BODLNGDCJGRVNV-RCCFBDPRSA-N
CHEMBL4291354,,CCOC(=O)C[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,5.8,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,WHXVUFUYVAMPKN-PWRODBHTSA-N
CHEMBL4293736,,CCCCCCCCCC[n+]1cccc(O)c1,IC50,4.25,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,NVKKMFKXRUVDJJ-UHFFFAOYSA-O
CHEMBL3318026,,COc1cc(-c2cnc3ccc(NC(=O)NC(C)(C)C)nc3c2)ccc1O,IC50,5.01,CHEMBL3367509,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ZCHJWXKREFTWSX-UHFFFAOYSA-N
CHEMBL4440176,,CCOP(=O)(OCC)C(N(OC(C)c1nccn1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,INXHFCOUUUGHJG-UHFFFAOYSA-N
CHEMBL4521917,,CCOP(=O)(OCC)C(N(OC(C)c1n(C)cc[n+]1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,VSIKVCAIEJWCGB-UHFFFAOYSA-N
CHEMBL3290908,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.96,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,PUWBEDGMRHQJNX-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,4.56,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL197603,,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,IC50,4.66,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,ZMNWFTYYYCSSTF-SOAUALDESA-N
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,4.5,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,RITAVMQDGBJQJZ-FMIVXFBMSA-N
CHEMBL3971437,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCNC(=O)c1ccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)cc1)[C@@H]3C,EC50,6.1,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,ZNXUSLMSNLSJII-YDVZNJOFSA-N
CHEMBL5291091,,CCN1CCN(CCC(=O)Nc2cccc(-n3cc(-c4ccncc4)c(-c4ccc(Cl)c(OC)c4)n3)c2)CC1,IC50,6.41,CHEMBL5231164,Anticancer activity against human SNB-75 cells assessed as cell growth proliferation,SNB-75,KYADEHTYBROPGP-UHFFFAOYSA-N
CHEMBL217092,SARACATINIB,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,IC50,4.12,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,OUKYUETWWIPKQR-UHFFFAOYSA-N
CHEMBL2392819,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.96,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VODLZXJWEDNALT-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,4.57,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,6.72,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL5274027,,CN1CCN(c2ccc3nc(-c4ccc(OCCCN5C(=O)c6cccc7cccc(c67)C5=O)cc4)[nH]c3c2)CC1,IC50,6.96,CHEMBL5245068,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B reagent assay,SNB-75,KNRGNAFDDSPVOF-UHFFFAOYSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,9.0,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL2407686,,C=CCNC(=O)/C1=C(\C(=O)OC)Cc2c([nH]c3ccccc23)[C@@](C(=O)OC)(c2cc3c(cc2OC)N(C)[C@H]2[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]32[C@@H]54)C[C@@H]2C=C(CC)CN1C2,IC50,5.52,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,BSQAKIMWPONUOF-HAIPHDKGSA-N
CHEMBL3092022,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(OC(C)=O)cc2)c(OC)c1,IC50,5.16,CHEMBL3096270,Cytotoxicity against p53-knockdown human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,GMAGLVPSKNBQKR-UHFFFAOYSA-N
CHEMBL3092022,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(OC(C)=O)cc2)c(OC)c1,IC50,5.16,CHEMBL3096272,Cytotoxicity against human U87MG cells expressing sh-GFP after 5 days by methylene blue staining assay,U-87MG ATCC,GMAGLVPSKNBQKR-UHFFFAOYSA-N
CHEMBL3393272,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)nc2nccn12,IC50,5.85,CHEMBL3395180,Inhibition of colony formation in human U87MG cells after 2 weeks by crystal violet staining-based assay,U-87MG ATCC,DYHJJLYLVDGULB-UHFFFAOYSA-N
CHEMBL3343407,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](O)[C@H]2O1,IC50,4.84,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,MAKXAOVRUMEYMV-MSXRDDOVSA-N
CHEMBL2385196,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.07,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,VDRLWKQXYDMXJW-UHFFFAOYSA-N
CHEMBL2385186,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5c(Cl)cccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.87,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,UNUOJJJJMNFSAC-UHFFFAOYSA-N
CHEMBL2385193,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5c(Cl)cccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.98,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,PAGRSZZWQKPHIC-UHFFFAOYSA-N
CHEMBL572878,TOZASERTIB,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,IC50,4.51,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,GCIKSSRWRFVXBI-UHFFFAOYSA-N
CHEMBL515325,MAPPAIN,CC(C)=CCC/C(C)=C/Cc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc(O)c1O,EC50,5.27,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,GJZKDVGLDGLPMB-ZVBRSKEYSA-N
CHEMBL376007,SCHWEINFURTHIN F,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,6.62,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,BUFNPAYKUGAAAO-HLULBIOLSA-N
CHEMBL4248529,,COc1ccc(-c2ccc3c(N4CCOCC4)nc(CC#N)nc3n2)cc1CO,IC50,7.04,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,LNGGLFWITGYQKY-UHFFFAOYSA-N
CHEMBL4240170,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C)nc3n2)cc1CO,IC50,7.04,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,UGJRAKREIVRFDR-ZDUSSCGKSA-N
CHEMBL4250280,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C(C)C)nc3n2)cc1CO,IC50,7.47,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,OYHFLRHRRAMMKF-HNNXBMFYSA-N
CHEMBL2163592,,CC(C)N(Cc1ccc2c(c1)C=CC(C)(C)O2)S(=O)(=O)c1ccccn1,IC50,4.09,CHEMBL2166125,Cytotoxicity against human LN229 cells transfected with V6R incubated for 14 days under normoxic condition by clonogenecity assay,LN-229,WHQXEGKAFBEKSG-UHFFFAOYSA-N
CHEMBL3354442,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,6.66,CHEMBL3376032,Cytotoxicity against human SF295 cells assessed as growth inhibition after 72 hrs by MTT assay,SF295,LVHKHLZPRPTQJG-BNLDXBMISA-N
CHEMBL2064825,,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](OC(C)=O)[C@@H]4[C@@H]([C@](C)(O)CCCC(C)(C)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,IC50,4.38,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,ZEZRUSOHKTZTBL-CNRRHNSPSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.31,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,6.26,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.39,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,5.22,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,AHJRHEGDXFFMBM-UHFFFAOYSA-N
CHEMBL477989,SB590885,CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1,IC50,4.06,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,MLSAQOINCGAULQ-QFMPWRQOSA-N
CHEMBL1208572,SALINOMYCIN,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C,IC50,4.41,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,KQXDHUJYNAXLNZ-XQSDOZFQSA-N
CHEMBL3116070,,C=CCn1c(C)nc2ccc(Nc3nc(Nc4ccc(F)cc4)nc4ccccc34)cc21,IC50,5.12,CHEMBL3118244,Cytotoxicity against human SNB75 cells after 48 hrs by SRB assay,SNB-75,NVBPDZFQQPGTRB-UHFFFAOYSA-N
CHEMBL3409956,,C/C(=N\O)c1cc(-c2ccc(O)cc2)ccc1O,IC50,4.46,CHEMBL3413577,Antiproliferative activity against human U87 cells assessed as reduction in cell growth after 96 hrs,U-87MG ATCC,JFJKNDANYYIWDV-OQLLNIDSSA-N
CHEMBL480420,,O/N=C/c1cc(-c2ccc(O)cc2)ccc1O,IC50,4.34,CHEMBL3413577,Antiproliferative activity against human U87 cells assessed as reduction in cell growth after 96 hrs,U-87MG ATCC,INQGQXOIWVULMW-RIYZIHGNSA-N
CHEMBL1914725,,O=S(=O)(Nc1cc(-c2ccc3nccc(-c4ccccc4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.9,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,DBCYFWOTALWDQJ-UHFFFAOYSA-N
CHEMBL1256616,NIMUSTINE HYDROCHLORIDE,Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1.Cl,IC50,6.14,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,KPMKNHGAPDCYLP-UHFFFAOYSA-N
CHEMBL447565,ALPHA-HEDERIN,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,IC50,4.76,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,KEOITPILCOILGM-LLJOFIFVSA-N
CHEMBL2430035,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)[C@@H](O)[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.36,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,FRALZQPZQJMQEK-MKSLBANYSA-N
CHEMBL2430033,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CCC(C)(C)[C@@H](O)[C@H]4C4=CC[C@@H]6[C@@]7(C)CC[C@H](O[C@@H]8OC[C@H](O)[C@H](O)[C@H]8O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O)C(C)(C)[C@@H]7CC[C@@]6(C)[C@]4(C)CC5)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O,IC50,4.46,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,ANZUJNAJUBXIKU-WFXPECHOSA-N
CHEMBL3353044,,O=C(c1ccccc1)N1CCN(C(=O)c2ccc3c4c(cccc24)CC3)CC1,IC50,4.88,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,CVPZIQHWFMJXFX-UHFFFAOYSA-N
CHEMBL3353049,,COc1cnc(Cl)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,IC50,4.78,CHEMBL3383785,Antiviral activity against HIV1 isolate Hxbc2 pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,OITFVXLQFVGROH-UHFFFAOYSA-N
CHEMBL3609558,,CCCC[Se]C1CC2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.48,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,TXTHGEBIRWTCGO-UHFFFAOYSA-N
CHEMBL5632812,,N#Cc1cncc(Cl)n1,IC50,4.74,CHEMBL5625423,Cytotoxicity against human LN-229 cells assessed as reduction in cell growth incubated for 72 hrs by Celltiter-Glo assay,LN-229,CZPOFSDHJNNWQL-UHFFFAOYSA-N
CHEMBL5619899,,CC(C)CCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.08,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,PVDOVVCNMDJUMN-XIFFEERXSA-N
CHEMBL5619811,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC[C@H]1CCCO1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.67,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,MJHSFRDACBYUCG-HEIROHQZSA-N
CHEMBL5618400,,CCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.79,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,ZSGFENIVWPHHNA-DHUJRADRSA-N
CHEMBL4063136,,CSc1nc(NCCc2ccccc2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.88,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,ROJDRHKTFQFHCV-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.29,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3954520,,O=C1C(Cl)=C(NCc2cn(C[Se]c3ccccc3)nn2)C(=O)c2ccccc21,IC50,5.53,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,DDPYCCFALDEDQC-UHFFFAOYSA-N
CHEMBL3805422,,COc1cc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(Cl)cc2)cc(OC)c1OC,IC50,5.49,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,XXVFADRKOFZSGV-YPKPFQOOSA-N
CHEMBL3793866,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCC(N2CCCC2)CC1,IC50,4.85,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,MCLOERVVCNFRGV-UHFFFAOYSA-N
CHEMBL917,FLOXURIDINE,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,EC50,4.74,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,ODKNJVUHOIMIIZ-RRKCRQDMSA-N
CHEMBL4095304,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.09,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PKYAUFYPURMQOL-UHFFFAOYSA-N
CHEMBL4584494,,C=C(c1ccc2c(c1)c1ccccc1n2C)c1cc(C)nc2ccccc12,IC50,8.72,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QFMFGYHKBRNDLH-UHFFFAOYSA-N
CHEMBL4517935,,C=C(c1ccc2c(ccn2C)c1)c1cc(C#N)nc2ccccc12,IC50,8.26,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,IGADDWJYYPETJI-UHFFFAOYSA-N
CHEMBL4100335,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccccc4O)cc3n2)C[C@H](C)O1,IC50,5.0,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,IPJAFJNXEKNDFO-GASCZTMLSA-N
CHEMBL4083106,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=[N+]3C(=C(c4ccccc4)c4ccc(Cl)n4[B-]3(F)F)C=C2)nn1,IC50,5.71,CHEMBL4046412,Cytotoxicity against human SF295 cells after 24 hrs in absence of GSH-OEt by MTT assay,SF295,CWTATMITRQBWAX-UHFFFAOYSA-N
CHEMBL4283745,,CCCCCCCCCc1ccc(OP(=O)(O)OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)cc1,IC50,5.17,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,KPQPXTTWNSJLOS-UPRLRBBYSA-N
CHEMBL4295220,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1cccnc1)c1ccccc1,IC50,6.15,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,BODLNGDCJGRVNV-RCCFBDPRSA-N
CHEMBL5194390,,O=C(c1cc2c(F)cc(F)cc2[nH]1)N1CCN(C(=O)C23CC4CC(CC(C4)C2)C3)CC1,IC50,5.3,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,UDCDUUNSNJZOLI-UHFFFAOYSA-N
CHEMBL5193570,,O=C(Cc1ccc(NC(=O)c2cc3c(F)cc(F)cc3[nH]2)cc1)NC12CC3CC(CC(C3)C1)C2,IC50,5.31,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,WSMNNVPMLSBLSH-UHFFFAOYSA-N
CHEMBL5201756,,O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2c(Cl)ccc(Cl)c2c1=O,IC50,5.54,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,ANMPGAUFPGVOHG-UHFFFAOYSA-N
CHEMBL5192764,,O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2c(Cl)c(Cl)ccc2c1=O,IC50,5.09,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,REUDJZPVCYIQID-UHFFFAOYSA-N
CHEMBL5170486,,CCCCN(C)Cc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2,IC50,4.24,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,BBFCAELXDZIWJB-UHFFFAOYSA-N
CHEMBL3915508,,N#Cc1ccc(Nc2nncc3ccccc23)cc1,IC50,9.49,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,LYKFUIDYYBNHOA-UHFFFAOYSA-N
CHEMBL3113705,,COc1ccc(/C=N/Nc2cnc3ccccc3n2)c(O)c1,IC50,4.8,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,AMYCQSIRLSVLNG-GIJQJNRQSA-N
CHEMBL3410526,,O=C1/C(=C/c2ccc(O)cc2)CS(=O)(=O)C/C1=C\c1ccc(O)cc1,IC50,5.17,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,XPAZXXUGNRNCAJ-KAVGSWPWSA-N
CHEMBL3410532,,O=C1/C(=C/c2ccc(O)cc2)CS(=O)(=O)C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.66,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,WGBPZGIYBGZHKX-KAVGSWPWSA-N
CHEMBL14762,SELICICLIB,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,IC50,4.14,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,BTIHMVBBUGXLCJ-OAHLLOKOSA-N
CHEMBL941,IMATINIB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.05,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,KTUFNOKKBVMGRW-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,4.57,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL5416410,DASATINIB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O,IC50,5.91,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,XHXFZZNHDVTMLI-UHFFFAOYSA-N
CHEMBL401930,,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,IC50,4.37,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,ZWVZORIKUNOTCS-OAQYLSRUSA-N
CHEMBL3951052,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCN(CCO)CC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.67,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PVMLGIUZPIXOHY-UHFFFAOYSA-N
CHEMBL1236962,OMIPALISIB,COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.27,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CGBJSGAELGCMKE-UHFFFAOYSA-N
CHEMBL4543075,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccccc2[N+](=O)[O-])cc(OC)c1OC,IC50,7.46,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,RTVPWMWCWOVESQ-UHFFFAOYSA-N
CHEMBL2417837,,COc1ncc(-c2ccc3nc(NC(=O)C4CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.31,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,UEKVQZJSGBXJFO-UHFFFAOYSA-N
CHEMBL2417831,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.16,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NVAPPQYBNBVKDJ-UHFFFAOYSA-N
CHEMBL2441789,,COc1cc(-c2nn(-c3cccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)ccc1Cl,IC50,6.51,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,YGSBVQPQFQEYSR-UHFFFAOYSA-N
CHEMBL2441800,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1,IC50,6.21,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,NCAOISCQJZUYIU-UHFFFAOYSA-N
CHEMBL4583587,,CC1(C)C(/C=C/C2=C(SCCC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccccc21.[Cl-],IC50,7.68,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,COFRJLZYSZMKJW-QLSQMBKKSA-N
CHEMBL4541564,,CC1(C)C(/C=C/C2=C(SCCC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)/C(=C/C=C3/N(CCCCS(=O)(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCS(=O)(=O)O)c2ccccc21.[Cl-],IC50,7.68,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,VPIHYTGLXWIJEG-NOOGLOLCSA-N
CHEMBL495641,SIARESINOLIC ACID,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@@H]1O,IC50,4.36,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,KFALHTDSQSJCFC-LLICELPBSA-N
CHEMBL168,OLEANOLIC_ACID,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.73,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,MIJYXULNPSFWEK-GTOFXWBISA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.96,CHEMBL4338636,Cytotoxicity against human U87 cells measured after 72 hrs by Celltiter-Glo assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3401524,,NC(=O)c1cc(OC(F)(F)F)cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1,IC50,5.82,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OOHISYGGXDTPAM-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.05,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,6.28,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,4.24,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,CTESJDQKVOEUOY-UHFFFAOYSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,9.13,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL1023,BEXAROTENE,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,IC50,4.39,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,NAVMQTYZDKMPEU-UHFFFAOYSA-N
CHEMBL288441,BOSUTINIB,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,IC50,4.05,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,UBPYILGKFZZVDX-UHFFFAOYSA-N
CHEMBL1230020,PLX-4720,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,IC50,4.39,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,YZDJQTHVDDOVHR-UHFFFAOYSA-N
CHEMBL393929,,O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1,IC50,5.86,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,XOLMRFUGOINFDQ-YBEGLDIGSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.7,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL1614701,SELUMETINIB,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,IC50,4.37,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,CYOHGALHFOKKQC-UHFFFAOYSA-N
CHEMBL1353474,,Cc1cc(C)c(S(=O)(=O)NCc2ccncc2)c(C)c1,EC50,5.38,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,LGKQKELVYYSUHI-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.06,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,6.27,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,6.53,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,PHXJVRSECIGDHY-UHFFFAOYSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,4.92,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,5.23,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,5.1,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL4278178,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(OC)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.84,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VCGDLHPPHXFKLT-GRCRCFNVSA-N
CHEMBL4294165,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc([N+](=O)[O-])cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.91,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UWJVPWYWBPTVLU-UVHRBFQASA-N
CHEMBL2381459,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cc(OC)c(OC)c(OC)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.57,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,ARINPQLYYUMHKA-IVDBYKEZSA-N
CHEMBL590522,MAHANINE,CC(C)=CCC[C@H]1C=Cc2c(c(C)cc3c2[nH]c2cc(O)ccc23)O1,IC50,5.16,CHEMBL2405052,Cytotoxicity against human LN229 cells assessed as growth inhibition after 48 hrs by MTT assay,LN-229,UKLOEFBVUZOVRX-INIZCTEOSA-N
CHEMBL4569743,,CCCOc1cccc2c1C(=O)c1c(OCCC)cc(NC(=O)CI)cc1C2=O,IC50,4.84,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,BEJHJNFDBJSEOG-UHFFFAOYSA-N
CHEMBL3622410,,O=C(NC1(C(=O)NCc2ccc(Cl)cc2)CSC2=C1C(=O)c1ccccc1C2=O)c1ccc(Cl)cc1,IC50,6.5,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,FJKLNTLROKNEJY-UHFFFAOYSA-N
CHEMBL3622409,,Cl.O=C(CN1CCCCC1)NC1(CO)CSC2=C1C(=O)c1ccccc1C2=O,IC50,6.29,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,UPJLJSZLZARAQV-UHFFFAOYSA-N
CHEMBL4075562,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.85,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZIEWBFVEFQUEHS-UHFFFAOYSA-N
CHEMBL4286339,,CCn1c2ccccc2c2cc(C(=O)c3cccc4ncccc34)ccc21,EC50,6.74,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,PVXVLICZYVCCKQ-UHFFFAOYSA-N
CHEMBL4281189,,CCn1c2ccccc2c2cc(C(=O)N3CCCc4ccccc43)ccc21,EC50,6.12,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,FCYOAJHMZOQTGU-UHFFFAOYSA-N
CHEMBL4276667,,Cc1ccc(C(=O)n2c3ccccc3c3ccccc32)c2ccccc12,EC50,6.02,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,LKFUAUSEGXTMHZ-UHFFFAOYSA-N
CHEMBL3339344,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.38,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JZEBTBLTIZKIAL-FADJLKOXSA-N
CHEMBL3339352,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(S(C)(=O)=O)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.17,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YTSHUBILDJXKTF-HPNXWYHWSA-N
CHEMBL325041,BORTEZOMIB,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,IC50,9.15,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,GXJABQQUPOEUTA-RDJZCZTQSA-N
CHEMBL14762,SELICICLIB,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,IC50,4.01,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,BTIHMVBBUGXLCJ-OAHLLOKOSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.98,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,8.46,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL11359,CISPLATIN,,IC50,4.92,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,6.16,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,8.48,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL288441,BOSUTINIB,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,IC50,4.76,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,UBPYILGKFZZVDX-UHFFFAOYSA-N
CHEMBL1090771,AVAGACESTAT,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,IC50,4.36,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,XEAOPVUAMONVLA-QGZVFWFLSA-N
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,7.24,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,PQAPVTKIEGUPRN-UHFFFAOYSA-N
CHEMBL399530,,CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,IC50,4.94,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,OWPMENVYXDJDOW-UHFFFAOYSA-N
CHEMBL1173055,RUCAPARIB,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.94,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,HMABYWSNWIZPAG-UHFFFAOYSA-N
CHEMBL5564960,,CCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.79,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JKULNQJWKJXVEF-LLVKDONJSA-N
CHEMBL5560959,,Cc1ccc(S(=O)(=O)N[C@H](CCC(=O)NC(C)C)C(=O)O)cc1,IC50,4.69,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,VKLSUDCNBZVPTF-CYBMUJFWSA-N
CHEMBL3343409,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](O)[P@@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,4.79,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,MAKXAOVRUMEYMV-MDBOQZRESA-N
CHEMBL3343415,,Cc1ccc(S(=O)(=O)O[C@H]2[C@H]3OC(C)(C)O[C@H]3[C@@H]([C@H]3COC(C)(C)O3)O[P@]2(=O)c2ccccc2)cc1,IC50,5.03,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,BGQCWCIRJUFYEA-PCCBZKKBSA-N
CHEMBL3343641,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](Oc3ccc([N+](=O)[O-])c([N+](=O)[O-])c3)[C@H]2O1,IC50,5.16,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,JDPPBAVDMURBSO-AHJGHJDGSA-N
CHEMBL3343645,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](NCc1ccccc1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,5.29,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,SFTOZIBEPGKZDW-RSERMMFASA-N
CHEMBL3341777,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](Nc1ccc3ccccc3c1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,Ki,7.22,CHEMBL3374650,Antimigratory activity against human SNB75 cells on matrix containing laminin after 24 hrs by 2-D migration assay,SNB-75,FWHOARIZUBCNOV-JBNHJABESA-N
CHEMBL5619176,,CC(C)CCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.77,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,QPVQMCCXYZJJHQ-YTTGMZPUSA-N
CHEMBL5618638,,CCCCCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.92,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,CHENBVQGLCJZOL-KDXMTYKHSA-N
CHEMBL5619176,,CC(C)CCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.9,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,QPVQMCCXYZJJHQ-YTTGMZPUSA-N
CHEMBL5620079,,CCCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.22,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,WMHNKAPHRPPRMJ-QNGWXLTQSA-N
CHEMBL5619209,,CC(C)CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.69,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,PWLTUGNQRLCODH-YTTGMZPUSA-N
CHEMBL3410541,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)C[S+]([O-])C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.75,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IJIZQHZXBYFAJE-KAVGSWPWSA-N
CHEMBL3823627,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(=O)/C=C/C=C(C)/C=C/[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,6.21,CHEMBL3825128,Antiproliferative activity against human SF295 cells after 48 to 72 hrs by Alamar blue assay,SF295,AIIZZRMMCAVMCU-SEFLVTODSA-N
CHEMBL3353051,,COc1cnc(-n2cnc(C)n2)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,IC50,9.1,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,VBVXAAKYUMLCAV-UHFFFAOYSA-N
CHEMBL332828,,Nc1cccc2c1nc1c3c(nccc32)-c2ncccc2C1=O,IC50,6.52,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,XDPPYVAWMGNABF-UHFFFAOYSA-N
CHEMBL4172942,,C=C(c1ccc(OC(F)F)c(N)c1)c1cc(OC)c(OC)c(OC)c1,IC50,9.22,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,CNNMSQTUVDFJKI-UHFFFAOYSA-N
CHEMBL4281560,,C[N+]1(C)CCC(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)CC1,IC50,5.89,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,VCGBTSXCGBGKNS-XUVXKRRUSA-N
CHEMBL27759,ENTINOSTAT,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,4.04,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,INVTYAOGFAGBOE-UHFFFAOYSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,9.91,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,6.14,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,6.72,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.88,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,5.56,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL1090090,VX-702,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F,IC50,4.8,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,FYSRKRZDBHOFAY-UHFFFAOYSA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,6.77,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,4.59,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL4284890,,c1cc(-c2cnco2)nc(-c2cnc(-c3cccc(-c4cccc(-c5ncc(-c6cccc(-c7cnco7)n6)o5)n4)n3)o2)c1,IC50,6.61,CHEMBL4261146,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,LMVRDHUJKDYIMS-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,6.0,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.79,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL4089146,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2)ccc1OCCCN1CCCc2ccccc21,IC50,4.79,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MYDFZQPERCVXKB-OQLLNIDSSA-N
CHEMBL4205819,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(OC)cc4)c3=O)cc2)ccn1,IC50,5.09,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XFDZUVJMQQXSSX-UHFFFAOYSA-N
CHEMBL4209961,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4)c3=O)cc2)ccn1,IC50,5.74,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RHJNVFIPNGUCGL-UHFFFAOYSA-N
CHEMBL2407563,,CCC1=C[C@@H]2CN(C1)/C(C(=O)NC(C)(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.6,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,WZZDEXUAXZLSNU-YQMZIVQWSA-N
CHEMBL2064799,,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@@H]4[C@@H]([C@](C)(O)CCCC(C)(C)O)CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,IC50,4.49,CHEMBL3386073,Antiproliferative activity against human U87 cells assessed as cell-growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,BOZXDFXOMFAOOW-ADZWRMKASA-N
CHEMBL2397980,,COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(NC(C)(C)C(=O)O)c2)c(OC)c1,IC50,7.05,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,RINOCMDJPRBIMQ-MDZDMXLPSA-N
CHEMBL59976,,O=C1C2=C(OCC=C2)C(=O)c2ccccc21,IC50,5.64,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,NMAATQFODBZYJW-UHFFFAOYSA-N
CHEMBL3358286,,Cc1nc(N)nc(-c2cc(C(C)(C)O)cnc2Nc2cncc(S(=O)(=O)c3ccccc3)c2)n1,IC50,6.12,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,IOYMOANGBJUQON-UHFFFAOYSA-N
CHEMBL3357869,,COc1ncc(Nc2ncc(C3(O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.75,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,LDEKSEIDMAEWQY-UHFFFAOYSA-N
CHEMBL3357863,,COc1ncc(Nc2ncccc2-c2nc(C)nc(N)n2)cc1F,IC50,7.38,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,MSQQWMIPDSCJOT-UHFFFAOYSA-N
CHEMBL408851,ACETYLBAKUCHIOL,C=C[C@@](C)(/C=C/c1ccc(OC(C)=O)cc1)CCC=C(C)C,IC50,5.1,CHEMBL1948695,Cytotoxicity against human SF295 cells after 48 hrs by sulpharhodamine B assay,SF295,KLWKVZWSRSGVHJ-UPTIQUDWSA-N
CHEMBL1085588,,Cn1c2cc([S+](C)[O-])sc2c2cnn(Cc3cccc(N)c3)c(=O)c21,IC50,4.06,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,ZWKJWVSEDISQIS-UHFFFAOYSA-N
CHEMBL5201895,,C=C1C(=O)[C@]23[C@H](OC(=O)/C=C/c4ccncc4)[C@H]1CC[C@H]2[C@]12CCCC(C)(C)[C@H]1C[C@@]3(O)OC2,IC50,6.05,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ATISONUWEZVDGA-IEJGXSRGSA-N
CHEMBL4438521,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.97,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,WTILQCQZUFSWFT-ZIGMMIRASA-N
CHEMBL4543609,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.89,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,YXQDTYWWQFSZQC-WWMJZJIFSA-N
CHEMBL4466655,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.13,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,GWPIZLOXKPAPCU-RXQFCVLDSA-N
CHEMBL4466655,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.13,CHEMBL4381766,Antiproliferative activity against human U87 cells transfected with lentivirus expressing shNC assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,GWPIZLOXKPAPCU-RXQFCVLDSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.27,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.13,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL3824027,,CC(C)(C)OC(=O)NCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.58,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SXKNYMHGZVLVMI-UHFFFAOYSA-N
CHEMBL3822533,,CCCCCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccn1,IC50,5.77,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,XZAKQUHBBCBSGG-UHFFFAOYSA-N
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,4.07,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,JWQOJVOKBAAAAR-UHFFFAOYSA-N
CHEMBL3823665,,Cl.O=C1C(O)=C(C(NCc2ccccc2)c2ccccc2O)C(=O)c2ccccc21,IC50,4.94,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FZCPDAWKNGSOMB-UHFFFAOYSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,7.77,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL3823211,,Cl.O=C1C(O)=C(C(NCc2ccccc2)c2cc(Br)ccc2O)C(=O)c2ccccc21,IC50,4.97,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SNHYFEXPAPEPCS-UHFFFAOYSA-N
CHEMBL3823380,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1cc(Br)ccc1O.Cl,IC50,4.67,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NBADPCNUKCZVFE-UHFFFAOYSA-N
CHEMBL3823588,,Cc1ccc(O)c(C(NCc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)c1.Cl,IC50,4.84,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,OPFQPAJXVJXPBM-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.62,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1938594,,O=C(NCCCl)NCCN1c2nc3ccccc3cc2Sc2cc3ccccc3nc21,IC50,6.6,CHEMBL4140037,Cytotoxicity against human SNB75 cells assessed as cell growth inhibition after 48 hrs by SRB assay,SNB-75,UHFHGUCGIVHXGO-UHFFFAOYSA-N
CHEMBL44,GENISTEIN,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,4.36,CHEMBL4185546,Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay,LN-229,TZBJGXHYKVUXJN-UHFFFAOYSA-N
CHEMBL3806194,,O=C(Nc1ccc(Nc2ccc(OC3CCNCC3)cc2)cc1)c1cccc(-n2nc(C(=O)Nc3ccc(Nc4ccc(OC5CCNCC5)cc4)cc3)c3c2C(=O)NCC3)c1,IC50,4.47,CHEMBL3807045,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Z2 coulter counter method,U-87MG ATCC,IJMDBRMQQXOTSY-UHFFFAOYSA-N
CHEMBL3343410,,CC[P@@]1(=O)O[C@H]([C@H]2COC(C)(C)O2)[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O,IC50,5.31,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,YDBHENJAGLBQMF-ZAHCLZMSSA-N
CHEMBL3343412,,CC(=O)O[C@H]1[C@H]2OC(C)(C)O[C@H]2[C@@H]([C@H]2COC(C)(C)O2)O[P@]1(=O)c1ccccc1,IC50,5.86,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,HMNHGADPRMRMRU-RKBDPEJBSA-N
CHEMBL3343642,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](Oc3ccc(N)cc3)[C@H]2O1,IC50,5.21,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,VOQLGBUZFMSHHR-VVRVBYJRSA-N
CHEMBL3343647,,CC(=O)N[C@@H]1[C@H]2OC(C)(C)O[C@H]2[C@@H]([C@H]2COC(C)(C)O2)O[P@@]1(=O)c1ccccc1,IC50,6.19,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,ZNQDHAKESODAIJ-VOLRFWRVSA-N
CHEMBL3600437,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(C)cc4)c3)cn2n1,IC50,6.17,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FBUYWHIWCGFGGE-UHFFFAOYSA-N
CHEMBL4228946,,COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.52,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,RGNZNWVPZKJPFW-UHFFFAOYSA-N
CHEMBL5436930,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(S(=O)(=O)c3cccc(/C=C/C(=O)NO)c3)CC1)C2,IC50,5.2,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,PLVJFQLTLNVOKN-VOTSOKGWSA-N
CHEMBL5431792,,Cc1ccc(COc2ccc(-c3ncc[nH]3)cc2NC(=O)C#Cc2ccccc2)cc1,IC50,7.36,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RRRDSGXKQKNURJ-UHFFFAOYSA-N
CHEMBL5400122,,CN(C)c1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,6.33,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,QIIJRYSAAUQNMF-UHFFFAOYSA-N
CHEMBL3804852,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(F)cc2)cc1,IC50,5.05,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,BHLSJTFSALJROM-NXVVXOECSA-N
CHEMBL3805548,,COc1ccc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2cc(OC)c(OC)c(OC)c2)cc1,IC50,4.89,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,UVDZSUIHYBIZLL-PFONDFGASA-N
CHEMBL3818299,,CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12,IC50,5.92,CHEMBL3820289,Antiproliferative activity against human U87MG cells expressing wild type p53 after 48 hrs by MTS assay,U-87MG ATCC,QXHBVJGLCMIHJL-UIOOFZCWSA-N
CHEMBL3819071,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C)C(=O)OC,IC50,7.82,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,OJGVAQYHHAIMOZ-RTFZILSDSA-N
CHEMBL3819001,,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)NC,IC50,8.01,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,NUROBXGZWIJWJT-OICBGKIFSA-N
CHEMBL3813842,PAXALISIB,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,EC50,6.13,CHEMBL3816998,Antiproliferative activity against human U87 cells after 4 days by CellTitre-Glo assay,U-87MG ATCC,LGWACEZVCMBSKW-UHFFFAOYSA-N
CHEMBL3947656,,CC1c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S(=O)(=O)N1CC(N)=O,IC50,7.58,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,VNZGFEKDXRDFKR-UHFFFAOYSA-N
CHEMBL141064,,CN1CCN(c2nc(-c3ccc(Cl)cc3)cc3c(N(C)C)cccc23)CC1,IC50,5.14,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,MCQUMVWUMGSPRV-UHFFFAOYSA-N
CHEMBL3335761,,O=c1ccc(-c2cc(F)cc(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.5,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,QDPRJEMEPAHBFN-DEOSSOPVSA-N
CHEMBL3335764,,O=c1ccc(-c2cc(F)c(F)c(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.82,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,PAOJJIBFZZVKMH-NRFANRHFSA-N
CHEMBL3927935,,[N-]=[N+]=NCC1CC2=C(O1)C(=O)c1ccccc1C2=O,IC50,6.46,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,AMDIHEAGTDRSSE-UHFFFAOYSA-N
CHEMBL3904272,,C#Cc1cccc(NC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)c1,IC50,5.59,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,GDWZPGDVJPMMQX-UHFFFAOYSA-N
CHEMBL5433894,,CCC1=C(C)/C(=C/c2ccc(C(=O)Nc3ccc(C(F)(F)F)cc3)cc2)CCC1(C)C,IC50,5.23,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,GAKUZJXPJNLERL-CAPFRKAQSA-N
CHEMBL5424731,,CCC1=C(C)/C(=C/c2ccc(-c3noc(-c4cccnc4)n3)cc2)CCC1(C)C,IC50,4.45,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,JAPQNNLEFMFBDO-HMMYKYKNSA-N
CHEMBL4633294,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCCCCC[n+]3ccc4ccccc4c3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,5.6,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,NGTBGPGGABSUAM-LZFLYAGFSA-M
CHEMBL260224,,CC(C)n1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.31,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,XYZISUWGALDUBA-UHFFFAOYSA-N
CHEMBL5647372,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1C(F)(F)F,IC50,5.62,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,QUPSSTNMTKCKSQ-UHFFFAOYSA-N
CHEMBL5399985,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)c(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,6.32,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,YPWHWQRROPQOSJ-UHFFFAOYSA-N
CHEMBL5422876,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)cc3C(F)(F)F)ccc2NS(C)(=O)=O)c1,IC50,5.63,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,QEXIPIGGYWEZII-UHFFFAOYSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,4.73,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL3339341,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.21,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WYYQCNCNUUTYNA-GMEAVFFOSA-N
CHEMBL3339343,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.86,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,VNAIQSATTCBFAH-PNEAAFPUSA-N
CHEMBL3339345,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.23,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,KDDAHMJSDNKWMA-GMEAVFFOSA-N
CHEMBL3339346,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccccc4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.01,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,WRKFZFVDYDEDIQ-GUBAARJWSA-N
CHEMBL3339347,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.83,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,SFOBMADEYUECEF-NHXQZRDHSA-N
CHEMBL5270178,,C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)cc2)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261759,Cytotoxicity against human A-172 cells measured after 8 days,A-172,JGOZUFGBTSAWEI-NSCUHMNNSA-N
CHEMBL325202,,O=C1c2cccnc2-c2nccc3ccnc1c23,IC50,6.3,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,PBFIHLLASGHCTR-UHFFFAOYSA-N
CHEMBL220632,,Cc1cc(N2CCC[C@@H]2CC(=O)NCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KGCBJOGQMCNHQZ-QGZVFWFLSA-N
CHEMBL220630,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccco1,IC50,7.2,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,IZHMORDLBSKBHC-UHFFFAOYSA-N
CHEMBL223045,,CN(C)c1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,7.18,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MCCURRRMYPISPD-UHFFFAOYSA-N
CHEMBL223788,,O=C(CC1CCCCN1c1cc(Cl)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.31,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BEVVGWOCTQZNGA-UHFFFAOYSA-N
CHEMBL316041,,C/N=N\N(C)C(C)=O,IC50,4.43,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,SQENJUQJJQSJMP-WAYWQWQTSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,7.1,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4634849,,CCCNC(=O)c1ccc(Oc2nc(-c3c(C)noc3C)cnc2N)cc1,IC50,4.32,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YLQOKEHNPHRXAA-UHFFFAOYSA-N
CHEMBL4647800,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCOCC3)cc2)n1,IC50,4.57,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ONWUZLTWJSDCTN-UHFFFAOYSA-N
CHEMBL4638925,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cc(Cl)ccn4)cc3)n2)cn1,IC50,4.32,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BHDQFKWHUIWPRF-UHFFFAOYSA-N
CHEMBL229728,,O=C1c2cnncc2C(=O)c2nc3cc4c(cc3nc21)OCO4,IC50,6.93,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,WOPAKMGWAKJGRN-UHFFFAOYSA-N
CHEMBL5220033,,COc1ccc(CNc2cccnc2-c2cc(OC)c(OC)c(OC)c2)cc1,IC50,4.1,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MRMBGKFJCKCWSE-UHFFFAOYSA-N
CHEMBL1951709,GYPENSAPOGENIN C,CC(C)=C1CC=C([C@H]2CC[C@]3(C)[C@@H]2CC[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)C1=O,IC50,6.24,CHEMBL1955142,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,PTTPQVVXFQBCKP-WDKNXSKUSA-N
CHEMBL4101265,,COc1ccc(C(=O)/C=C/c2ccc(OCCN3CCOCC3)c(OC)c2)cc1,IC50,5.15,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,OCKUBYMSWAAOSQ-YCRREMRBSA-N
CHEMBL3967244,,Oc1nc(-c2ccccc2)nc2sc3c(c12)CCCC3,IC50,4.74,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,CDFWRIZOSNAGCV-UHFFFAOYSA-N
CHEMBL315414,,COc1cc(OC)c2cc(-c3ccc(O)cc3)c(=O)n(C)c2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,ZDDUTRUNORAGJX-UHFFFAOYSA-N
CHEMBL1643031,,OCc1c(CO)c(-c2ccc(Cl)cc2)n2c1Cc1ccccc1C2,IC50,4.57,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,LPXDODBVOVEYLQ-UHFFFAOYSA-N
CHEMBL85691,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCc3nnn[nH]3)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,VFDUYXFWEKLFIY-UHFFFAOYSA-N
CHEMBL313958,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)c2=S)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,FWXPNVLRLORRJY-UHFFFAOYSA-N
CHEMBL5404518,,COc1ccc(SC2=C(c3ccc(O)cc3O)C(=O)c3c(O)cccc3C2=O)cc1,IC50,4.95,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,KRDUKFLZZKMMPR-UHFFFAOYSA-N
CHEMBL2398335,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Br)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.81,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,OVSPUTNOWQJAED-UHFFFAOYSA-N
CHEMBL5417589,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(OC(F)(F)F)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.6,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,ZHVKLCABOSDPPM-UHFFFAOYSA-N
CHEMBL5433188,,COc1ccc(OC)c(COc2cc(NC(=O)OCCOC(=O)Nc3ccc(NS(C)(=O)=O)c(OCc4cc(OC)ccc4OC)c3)ccc2NS(C)(=O)=O)c1,IC50,5.28,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,YXAGTWTXTAUDDC-UHFFFAOYSA-N
CHEMBL5407384,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc([N+](=O)[O-])cc3)ccc2NS(C)(=O)=O)c1,IC50,5.92,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,VPEHTALTXOOVOZ-UHFFFAOYSA-N
CHEMBL2398335,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Br)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.83,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,OVSPUTNOWQJAED-UHFFFAOYSA-N
CHEMBL5429683,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,7.19,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ZTGOFTUXWMUHPM-UHFFFAOYSA-N
CHEMBL5394831,,CCCCCC(=O)Nc1ccc(NS(C)(=O)=O)c(OCc2cc(OC)ccc2OC)c1,IC50,5.93,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,MGSJFAMGQGTRTC-UHFFFAOYSA-N
CHEMBL1236095,,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,IC50,5.74,CHEMBL5445015,"Affinity Phenotypic Cellular interaction: (CellTiter-Glo assay (Promega, cell proliferation assay using SF295 cell line, 72 h incubation)) EUB0000612a TTK",SF295,JFOAJUGFHDCBJJ-UHFFFAOYSA-N
CHEMBL51495,,CC(=O)O.CC(C)NCCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CCO,IC50,5.45,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,UMUBOSFRVJIHCA-UHFFFAOYSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,5.45,CHEMBL5509851,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,6.01,CHEMBL5509853,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL1927613,,CN(C)CCN1C(=O)c2cccc3c2c(cc2nnn(CCN(C)C)c23)C1=O,IC50,6.89,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OXMVKWSROJASQD-UHFFFAOYSA-N
CHEMBL1927615,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(C)c23)C1=O,IC50,5.94,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LZPAEFQRLQMXJF-UHFFFAOYSA-N
CHEMBL5287665,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4c(Cl)cccc4Cl)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,UPBDCVTUDJDRJV-DBTHSLHSSA-N
CHEMBL258838,,CN1CCC2(CC1)CN(c1ncnc3[nH]ccc13)c1ccccc12,IC50,6.87,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,PPQBKZIRDIWMOB-UHFFFAOYSA-N
CHEMBL5087988,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)CCCC[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.72,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,ALSGWVXTKBXFEL-JPJFXSLNSA-N
CHEMBL5422307,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)CC[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.75,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,LQYFBFLLULPDRN-ZMUWHQJZSA-N
CHEMBL5428624,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)N[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,10.4,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,WOPQERLLNMDXCO-JBJZENLMSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,4.34,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL4743128,,Cc1nn(C)c(Oc2ccc(Br)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.27,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ZKCZORFIEPVVRR-LJUMEUDFSA-N
CHEMBL244238,,CCN(CC)CCOc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O,IC50,6.4,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,QAOJLLDMCMPLFS-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.05,CHEMBL4675763,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability by CellTiter Glo luminescent assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1224278,,C=C(CO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](NCCc6ccc(O)c(O)c6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,AKVCSRSRJFVZDW-JNLDGDHFSA-N
CHEMBL5428348,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(I)c3)ccc2NS(C)(=O)=O)c1,IC50,6.68,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,CSGPCUWSIHSOMM-UHFFFAOYSA-N
CHEMBL5406903,,COc1cccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)c1,IC50,5.08,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,RCRFQZPPCAAFGM-UHFFFAOYSA-N
CHEMBL5406623,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C)c([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,5.58,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,MQOCVRWDRMZBHE-UHFFFAOYSA-N
CHEMBL5432732,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(OC)c(OC)c(OC)c3)ccc2NS(C)(=O)=O)c1,IC50,5.47,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,MJKBNKOQSZEVKD-UHFFFAOYSA-N
CHEMBL561956,,COc1ccc(S(=O)(=O)c2cc(OC)c(OC)c(OC)c2)cc1,IC50,5.09,CHEMBL1023710,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NYEDBTDROUDIGI-UHFFFAOYSA-N
CHEMBL3633269,,COc1cccc2c1C(=O)c1ccc3c(c1C2O)C(=O)C[C@](C)(O)C3,IC50,5.51,CHEMBL3636048,Cytotoxicity against human SF295 cells after 72 hrs by MTS assay,SF295,YRKOFHPWOUTOGA-GFOWMXPYSA-N
CHEMBL488458,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccc([N+](=O)[O-])cc2)C1=O,IC50,5.99,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,FFOLIJUFOTVDCR-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.46,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL4063923,,OCc1cc2nc(N3CCOc4ccccc43)nc(N3CCOCC3)c2s1,IC50,4.67,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,FDJMFUPBFCVPKM-UHFFFAOYSA-N
CHEMBL1742001,,O=C(O)/C(=C\c1ccccc1)c1ccccc1,IC50,4.07,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,BIDDLDNGQCUOJQ-KAMYIIQDSA-N
CHEMBL5282240,,C/C=C/Cn1cc(-c2ccc(C(C)(C)O)cc2OC)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261886,Cytotoxicity against human U-87 MG cells measured after 8 days,U-87MG ATCC,GVJYOLRRZZUUOE-AATRIKPKSA-N
CHEMBL374300,,CS(=O)(=O)c1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,7.77,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HAUORGHEYRCDAG-UHFFFAOYSA-N
CHEMBL374486,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc([N+](=O)[O-])cc1,IC50,6.78,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZZZBJPZLGWDOGF-UHFFFAOYSA-N
CHEMBL219896,,Nc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,6.57,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,VARXOJXJKFRUFG-UHFFFAOYSA-N
CHEMBL223043,,Cc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,7.64,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,RBGAQAAKQMYHIU-UHFFFAOYSA-N
CHEMBL220269,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccccc1,IC50,7.6,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,YDZKZOIFEBHVTR-UHFFFAOYSA-N
CHEMBL266768,,O=C(CC1CCCCN1c1cc(-n2ccnc2)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.46,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KDPIGDVECQEMIR-UHFFFAOYSA-N
CHEMBL222619,,COC(=O)N1CCN(c2cc(C)nc(-n3ccnc3)n2)CC1CC(=O)NCc1ccc2c(c1)OCO2,IC50,8.27,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BHPZTAGGZNBTOV-UHFFFAOYSA-N
CHEMBL220511,,COC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)[C@H](CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,7.47,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVYMEDQKBQMAKF-QGZVFWFLSA-N
CHEMBL4289867,,C=CCOc1ccc(C(c2oc(C)cc(=O)c2O)c2oc(C)cc(=O)c2O)cc1,IC50,4.51,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,YQRFAPQVWGCSLL-UHFFFAOYSA-N
CHEMBL3343386,,COc1ccc(-n2nnc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c2C(F)(F)F)cc1,IC50,5.55,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HAHHSTUUBWPNHV-UHFFFAOYSA-N
CHEMBL3343388,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5)c4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.91,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QMNMYAYUSXNUSZ-UHFFFAOYSA-N
CHEMBL3343395,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.85,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OPZFRGMIMMLJME-UHFFFAOYSA-N
CHEMBL3109413,,CC(=O)O[C@@]1(C)CCC(=O)[C@@H](C)CCC[C@]2(C)O[C@H]2C(=O)C(=C(C)C)CC1,IC50,4.64,CHEMBL3112362,Cytotoxicity against human A172 cells cells after 24 hrs by MTT assay,A-172,VLTIKKJYNDMBON-RWXMBLCBSA-N
CHEMBL307261,ARTENIMOL,C[C@H]1[C@@H](O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.3,CHEMBL5250675,Anticancer activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BJDCWCLMFKKGEE-ISOSDAIHSA-N
CHEMBL5288231,,c1ccc(-c2nc(CNc3nccc(N4CCCC4)n3)cs2)cc1,IC50,4.58,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,SWTLLAOPNTXGEU-UHFFFAOYSA-N
CHEMBL5275618,,c1ccc(-c2nc(CNc3nccc(N4CCCCC4)n3)cs2)cc1,IC50,5.08,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,AAVIEAVLIPLDKB-UHFFFAOYSA-N
CHEMBL5273678,,CCN(CC)c1ccc2cc(-c3nc4cc(C5=NCCCN5)ccc4[nH]3)c(=O)oc2c1.Cl,IC50,4.01,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,QDCMGWUZNQPGQU-UHFFFAOYSA-N
CHEMBL3290926,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,KXSCVFRVUWUVDK-UHFFFAOYSA-N
CHEMBL3290924,,Cc1cc(=O)n(-c2ccccc2)nc1C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCC(C)CC4)ccc23)c(F)c1,IC50,5.94,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YIJZSESZNCHBPL-UHFFFAOYSA-N
CHEMBL3290929,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.8,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FVPKNPIIGGEJGZ-UHFFFAOYSA-N
CHEMBL242557,,CC(C)N(CCOc1ccc2c3c(oc2c1)C(=O)c1ccccc1C3=O)C(C)C,IC50,5.5,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,OBPYWCNNZZRYSP-UHFFFAOYSA-N
CHEMBL396473,,CC(CN(C)C)Oc1ccc2c3c(oc2c1)C(=O)c1ccccc1C3=O,IC50,5.76,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,ZTIIATLEWCTJQL-UHFFFAOYSA-N
CHEMBL4449966,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)Cc4nccnc4C(C)(C)[C@@H]3CC[C@]12C,IC50,4.42,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,NFXWMPDHPCQECL-OJAFHGKASA-N
CHEMBL4460972,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)C=C(O)C(=O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.34,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,HBMZZQPIQVFJBU-OSLPSIGMSA-N
CHEMBL4562094,,Cc1ncc2c(n1)C(C)(C)[C@@H]1CC[C@]3(C)[C@H](C[C@@H](O)[C@@H]4[C@@H]([C@@]5(C)CCCC(C)(C)O5)CC[C@]43C)[C@@]1(C)C2,IC50,4.06,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,TXNUXKLJONJFDC-ZSYGMLCOSA-N
CHEMBL445938,,CC(CN(C)C)Oc1cc2oc3c(c2cc1Cl)C(=O)c1ccccc1C3=O,IC50,6.26,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,YZDUWZIPARTLNH-UHFFFAOYSA-N
CHEMBL4082724,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.83,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QODZCSPDZVDCSD-UHFFFAOYSA-N
CHEMBL427062,,O=C(NCCc1ccc2c(c1)OCO2)[C@H]1CCCN1c1ccnc(-n2ccnc2)n1,IC50,9.32,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVOJJTOWUAGHLE-MRXNPFEDSA-N
CHEMBL4068286,,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.36,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZPDXQLPRRAIZEG-UHFFFAOYSA-N
CHEMBL385324,,COC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)[C@@H](CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.62,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVYMEDQKBQMAKF-KRWDZBQOSA-N
CHEMBL3393280,,C=COC(=O)NCc1ccc(Nc2nc(Nc3ccccc3C(=O)NC)n3ccnc3n2)cc1,IC50,5.54,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,DIVBJWPQPWFSGQ-UHFFFAOYSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,9.0,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.46,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL3400568,,C#Cc1ccc2[nH]c3c(c2c1)C/C(C(=O)OC)=C\N1CC(CC)=CC(C1)C[C@]3(C(=O)OC)c1cc2c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]3(CC)C=CCN4CC[C@]21[C@@H]43,IC50,5.8,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,KBESTWONWPHFJI-YOGRKGKHSA-N
CHEMBL364713,NOSCAPINE,COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,IC50,4.16,CHEMBL3599618,Antiproliferative activity against human LN229 cells assessed as decrease in colony formation,LN-229,AKNNEGZIBPJZJG-MSOLQXFVSA-N
CHEMBL4279079,,CCn1c2ccccc2c2cc(C(=O)c3ccc(C)cc3)ccc21,EC50,6.0,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,XAOSAGCPDVOOIN-UHFFFAOYSA-N
CHEMBL4294001,,CCn1c2ccccc2c2cc(C(=O)c3ccc(Cl)cc3)ccc21,EC50,5.82,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,PVEHLRUSSIFJEZ-UHFFFAOYSA-N
CHEMBL3416004,,COc1cc2nc(-c3cccc(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.8,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UOBMKCYJPQWFNP-UHFFFAOYSA-N
CHEMBL263664,,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.18,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,RZIDZIGAXXNODG-UHFFFAOYSA-N
CHEMBL1224361,,C=C(CNCCO)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CCC(NCCc6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.85,CHEMBL1225662,Cytotoxicity against human LN229 cells after 72 hrs by MTS assay,LN-229,OPFARVHLHCUEBK-JEMCJYJNSA-N
CHEMBL2037446,,C/C(=N/NC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.21,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,JJPHEFXBDVUGNK-ZDLGFXPLSA-N
CHEMBL4289577,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(F)cc2)c1=O,IC50,6.21,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IXULLLZCNUKGBJ-UHFFFAOYSA-N
CHEMBL2037063,,OCc1c(CO)c2sc3ccccc3n2c1-c1ccc(F)c(F)c1,IC50,4.76,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,RFIAIOOIVGYGRQ-UHFFFAOYSA-N
CHEMBL2037071,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(F)cc1,IC50,4.53,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,DQAJBKDSVCOILV-UHFFFAOYSA-N
CHEMBL2037072,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(Cl)cc1,IC50,4.58,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,HRUGBLPNQAMDNO-UHFFFAOYSA-N
CHEMBL2037073,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(F)c(F)c1,IC50,4.42,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,SKXROXLGGWJOMV-UHFFFAOYSA-N
CHEMBL559398,,COc1cc(/C=C/c2cc(O)c(/C=C/c3cccc(O)c3)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.1,CHEMBL1053939,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,CSNGISUZVMQNJH-MLYJIWBTSA-N
CHEMBL538653,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)[C@@]4(F)C[C@H](O)[C@H](O)C[C@]4(C)[C@H]3CC[C@]12C,IC50,5.65,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,KLWOZTZXVGZOOI-LNDZPLTESA-N
CHEMBL488457,,O=C1C2=C(C(=O)c3ncccc31)C1(CS2)NC(=O)N(c2ccc(Cl)cc2)C1=O,IC50,6.23,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,VMHZPMBRTFQLHS-UHFFFAOYSA-N
CHEMBL489268,,CCN(CC)c1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.14,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,SEHVPBXORALIPC-UHFFFAOYSA-N
CHEMBL379715,,CC1(C)CC(NC(=O)Nc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.47,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,JEGXVJSJPRRLJM-UHFFFAOYSA-N
CHEMBL367287,,CC1(C)CC(NC(=O)NCc2ccccc2)c2cc(F)ccc2O1,IC50,4.31,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,HROJXDDLVYXAHT-UHFFFAOYSA-N
CHEMBL1076555,,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,IC50,4.97,CHEMBL1246432,Cytotoxicity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,ZFGXZJKLOFCECI-UHFFFAOYSA-N
CHEMBL3410534,,Cc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc([N+](=O)[O-])cc3)C2=O)cc1,IC50,5.86,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,VRIPMQKPFGIJOH-ODPUSEOTSA-N
CHEMBL4287953,,CCCCCCCCCC[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,6.4,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,CEVBXTPFVCEMSL-UPRLRBBYSA-N
CHEMBL4279183,,CCCOc1ccc(C(c2oc(C)cc(=O)c2O)c2oc(C)cc(=O)c2O)cc1,IC50,4.53,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,PESSYBNCGCYSIU-UHFFFAOYSA-N
CHEMBL4278116,,COc1ccc(COc2ccc(C(c3oc(C)cc(=O)c3O)c3oc(C)cc(=O)c3O)cc2)cc1,IC50,5.28,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,IRETWYAUKXXMAV-UHFFFAOYSA-N
CHEMBL3116220,,COc1cc(N2C(=O)NC(=O)/C(=C\Nc3ccc(Oc4ccnc5cc(OCCCN6CCCC6)c(OC)cc45)c(F)c3)C2=O)c(OC)cc1Cl,IC50,5.55,CHEMBL3118140,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CYVPZDFIJGYWLQ-BSYVCWPDSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,4.6,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL1165533,,O=C(OCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,4.42,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,MLDOJAWEIYORFI-UHFFFAOYSA-N
CHEMBL1165527,,O=C(OCCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1,IC50,4.96,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,GVNLJMMUFRRTAY-UHFFFAOYSA-N
CHEMBL1163780,,COc1cc(C(=O)OCCCCCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.52,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,SAFCXUZYFBMWGZ-UHFFFAOYSA-N
CHEMBL3310591,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(=O)C4CC4)sc3c2)cc1C(N)=O,IC50,5.54,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DEQPTLVHBFFNGH-UHFFFAOYSA-N
CHEMBL1097311,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OCCOCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.89,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WBEBANORPCGJMO-YXAZKUIBSA-N
CHEMBL233031,,c1cn(-c2ccc(NC3CCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,8.0,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,KYDUFQIZMRXXFB-UHFFFAOYSA-N
CHEMBL115716,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,GLPXKCDPFDUVQT-GOTSBHOMSA-N
CHEMBL113154,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,QCDDKNCWCRNPEP-OALUTQOASA-N
CHEMBL3634876,,CCN(CC)C(=O)Cn1c(-c2ccc(OC)cc2)cc2c(C)cc(C)cc21,EC50,4.83,CHEMBL3636927,Potentiation of antiproliferative activity of PK11195 against human T98G cells incubated for 48 hrs by BrdU enzyme-linked immunosorbent assay,T98G,RKBQFQARDYWAHE-UHFFFAOYSA-N
CHEMBL3612314,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCN(C)CC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.36,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,GADNWLMJPUJMIN-UHFFFAOYSA-N
CHEMBL3612319,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)C1CC1,IC50,5.78,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KMNHIBFNIBQIEX-UHFFFAOYSA-N
CHEMBL325276,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1,IC50,8.92,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,SWRITPDTBCAFCK-OALUTQOASA-N
CHEMBL302389,,COc1ccc(C2C(OC(C)=O)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1[N+](=O)[O-],IC50,6.84,CHEMBL817427,In vitro cytotoxicity against human glioblastoma (T-98G) tumor cell line,T98G,QGJLKHPPBNNBCA-UHFFFAOYSA-N
CHEMBL3747513,CB-5083,Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(c(NCc3ccccc3)n1)COCC2,IC50,7.12,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RDALZZCKQFLGJP-UHFFFAOYSA-N
CHEMBL5414874,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(Cl)c1,IC50,7.46,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,VQSRULQBCHLBDH-UHFFFAOYSA-N
CHEMBL2205662,,Cc1ccc(N(CCn2nnc3c(C(N)=O)ncn3c2=O)CCn2nnc3c(C(N)=O)ncn3c2=O)cc1,IC50,4.95,CHEMBL4423100,Antiproliferative activity against human T98G cells after 5 days by CyQuantGR dye-based fluorescence assay,T98G,SRFTZNAYQBILPX-UHFFFAOYSA-N
CHEMBL4071720,,O=C(CCCc1ccc(-c2cccnc2F)cc1)Nc1ccc(O)cc1,EC50,5.85,CHEMBL4423086,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by AlamarBlue assay,U-87MG ATCC,ULZGONBLGFFMKX-UHFFFAOYSA-N
CHEMBL4469689,,O=C1C=C(N[C@@H](Cc2ccccc2)C(=O)O)C(=O)c2ccccc21,IC50,5.7,CHEMBL4423116,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NKLMFCNSZRLCJX-INIZCTEOSA-N
CHEMBL3942123,,COc1ccc(/N=C/c2c(O)ccc3c2oc2cc(Cl)c(O)c(Cl)c23)cc1,IC50,4.6,CHEMBL4423113,Antiproliferative activity against human U87MG cells after 24 hrs by WST-1 assay,U-87MG ATCC,UWXKHLVNEQUSFY-NUGSKGIGSA-N
CHEMBL4169540,,N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NC(c2ccccc2)c2ccccc2)c1,IC50,6.94,CHEMBL4145085,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QKCFDPUKGKJIML-NRFANRHFSA-N
CHEMBL3824051,,Cc1ccc(O)c(C(NCc2ccccc2)C2=C(O)C(=O)c3ccccc3C2=O)c1,IC50,5.07,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,VFYYHNQZUSDYNE-UHFFFAOYSA-N
CHEMBL3823432,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccn1,IC50,5.02,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CNSGWJRTENMKET-UHFFFAOYSA-N
CHEMBL15221,,Cc1ccc2[nH]c3nnc(N)c-3cc2c1,IC50,4.21,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,RKOSJFGLKQAHTK-UHFFFAOYSA-N
CHEMBL4091786,,O=C1/C(=C/c2ccc(S(F)(F)(F)(F)F)cc2)CSC/C1=C\c1ccc(S(F)(F)(F)(F)F)cc1,IC50,5.68,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VPIODVANGKMJSC-KAVGSWPWSA-N
CHEMBL259804,,O=c1[nH]c(-c2cccc([N+](=O)[O-])c2)nc2sc3c(c12)CCCC3,IC50,5.08,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,PGKKSSRLXTZLGF-UHFFFAOYSA-N
CHEMBL506862,,COc1cc(N2CCC(N3CCCCC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,IC50,6.0,CHEMBL3882890,Cytotoxicity against human A172 cells after 3 days by InCell analyser assay,A-172,GYHFAWCGOCYIPE-UHFFFAOYSA-N
CHEMBL3604102,,COc1ccc(OC2=CC(=O)c3cccc(O)c3C2=O)cc1,IC50,4.9,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,VTTOUOKMZWJFAL-UHFFFAOYSA-N
CHEMBL254849,,COc1ccc(CS(=O)(=O)/C=C/c2c(OC)cc(OC)cc2OC)cc1,IC50,7.4,CHEMBL926537,Antitumor activity against human U87 cells by trypan blue exclusion assay,U-87MG ATCC,PKJIMDZRAFWKBI-MDZDMXLPSA-N
CHEMBL5282240,,C/C=C/Cn1cc(-c2ccc(C(C)(C)O)cc2OC)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261759,Cytotoxicity against human A-172 cells measured after 8 days,A-172,GVJYOLRRZZUUOE-AATRIKPKSA-N
CHEMBL5573600,,N#CC1=C(N)Oc2c(cc(Cl)c3cccnc23)C1c1ccc(Cl)c(Cl)c1,IC50,5.38,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,MBGZHUPYZCKGHI-UHFFFAOYSA-N
CHEMBL5575161,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(F)cc1,IC50,5.1,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,JVHAXSCWKMOCIX-UHFFFAOYSA-N
CHEMBL4102138,,C=C(c1ccc(OC)c(O)c1)c1cc(C)nc2ccccc12,IC50,8.82,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,UOHMIDHLKVSHEV-UHFFFAOYSA-N
CHEMBL3115965,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4ccc(C)c(C)c4)nn3)[C@@H]2CC1,IC50,4.92,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,FALDXBZLBIZXRG-IMPNOVIYSA-N
CHEMBL3314669,,O=C1/C(=C/c2ccc(F)cc2)CS(=O)(=O)C/C1=C\c1ccc(F)cc1,IC50,5.66,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,DDCLVAVYBCIVNX-KAVGSWPWSA-N
CHEMBL3410536,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CC2(C/C1=C\c1ccc([N+](=O)[O-])cc1)OCCO2,IC50,4.81,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,SQPUICXPDUIQQG-JYFOCSDGSA-N
CHEMBL3410537,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CC(O)C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,5.33,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,BCDOATJLGCTQBE-KAVGSWPWSA-N
CHEMBL3410539,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)COC/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,4.3,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,IDGWXKSDMBOSHH-KAVGSWPWSA-N
CHEMBL4251185,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C4CCOCC4)nc3n2)cc1CO,IC50,7.03,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,SSTJSROOZICEBQ-INIZCTEOSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.84,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL258844,,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,IC50,4.97,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,BIWGYFZAEWGBAL-UHFFFAOYSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,4.99,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL472940,,Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12,IC50,4.0,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,RFAXLXKIAKIUDT-UHFFFAOYSA-N
CHEMBL558642,GSK-650394,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,IC50,5.05,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,WVSBGSNVCDAMCF-UHFFFAOYSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,6.56,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.53,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,5.41,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,PLHJCIYEEKOWNM-HHHXNRCGSA-N
CHEMBL38,TRETINOIN,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,IC50,4.18,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,SHGAZHPCJJPHSC-YCNIQYBTSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.98,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,7.64,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL2041933,AZD-7762,NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,IC50,6.24,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,IAYGCINLNONXHY-LBPRGKRZSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,7.71,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.5,CHEMBL826592,Concentration required for inhibiting proliferation of human brain tumor cell line XF 498 by 50% after 72 hr of incubation was determined,XF 498,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL2385178,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(C)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.71,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NFGUCNQIGLKFJZ-UHFFFAOYSA-N
CHEMBL5416410,DASATINIB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O,IC50,4.51,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,XHXFZZNHDVTMLI-UHFFFAOYSA-N
CHEMBL515416,,Cc1ccc(-c2c(C(=O)CCl)n(CCCO)c3ncnc(N)c23)cc1,IC50,4.92,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,PELFTNQHGSITLB-UHFFFAOYSA-N
CHEMBL514499,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,IC50,4.75,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,JSKUWFIZUALZLX-UHFFFAOYSA-N
CHEMBL27759,ENTINOSTAT,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,5.52,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,INVTYAOGFAGBOE-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.46,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.57,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL104264,,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,IC50,4.82,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,ZKZXNDJNWUTGDK-NSCUHMNNSA-N
CHEMBL1081628,,N[C@H](CNc1nnc(-c2ccc3[nH]ncc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.35,CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,BRTIFMBVAUCZIX-HNNXBMFYSA-N
CHEMBL1080569,,N[C@H](CNc1nnc(-c2ccc3cnccc3c2)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.61,CHEMBL1104223,Inhibition of human AKT1 in human U87MG cells assessed as PRAS40 phosphorylation after 1 hr by ELISA,U-87MG ATCC,WZOVTPHXONVIIJ-SFHVURJKSA-N
CHEMBL2407564,,CCC1=C[C@@H]2CN(C1)C[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.15,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,QLRSUTPMRJVBOB-LGOXCPFQSA-N
CHEMBL2407571,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)NC(C)(C)C)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.1,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,NCXVCMMXIPFTAI-WUFFRZSXSA-N
CHEMBL2407569,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)NC(C)C)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.7,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,PZERHFHXOGNCIS-AIURUJAXSA-N
CHEMBL2407567,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)OC)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.82,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,WVLGMGBTBSCBCV-GFCHHHBMSA-N
CHEMBL575179,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/NCCCO)C(=O)C(O)=C3C(C)C)/C(=C/NCCCO)C(=O)C(O)=C2C(C)C,IC50,4.54,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,IUQOLNRSKATKPJ-MPKYGIEOSA-N
CHEMBL4293238,,CCCCCCC[N+]1(CCCC)CCN(CC(=O)O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)CC1.[I-],IC50,4.92,CHEMBL4267508,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,LZAUXCIOLOABFJ-IQIXNTFZSA-M
CHEMBL4288767,,CCCCCCCCCCCC[N+]1(CCCC)CCN(CC(=O)O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)CC1.[I-],IC50,4.71,CHEMBL4267508,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NAMAPGGJMXSNRB-NHYSMLRKSA-M
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,5.96,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.1,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL4279750,,COc1cc(OC)c2c(=O)c(OCCCOc3ccccc3/C=C/C(=O)/C=C/c3scnc3C)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.02,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,IDTUYXNRINXUIJ-SQIWNDBBSA-N
CHEMBL4467819,,COc1ccc(C2CC(c3cccs3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(Cl)cc43)S2)cc1,EC50,5.24,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,JCVDHJINKKLSQI-DQRAZIAOSA-N
CHEMBL4284568,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1ccc2ncccc2c1)c1ccccc1,IC50,6.06,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,DYQOTLNYCHIRDN-BHDDXSALSA-N
CHEMBL4280046,,C[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,6.23,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,JGMWIVXPWUUSHK-IPMKNSEASA-N
CHEMBL4282076,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3ccccc3)O2)cc1F,IC50,4.47,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,SNJLCEROIWROPY-YNEHKIRRSA-N
CHEMBL50,QUERCETIN,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,4.64,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,REFJWTPEDVJJIY-UHFFFAOYSA-N
CHEMBL50,QUERCETIN,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,IC50,4.92,CHEMBL4185546,Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay,LN-229,REFJWTPEDVJJIY-UHFFFAOYSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,4.82,CHEMBL4185546,Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay,LN-229,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL221895,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccs1,EC50,6.66,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KJGVNCPJDOKDLP-UHFFFAOYSA-N
CHEMBL2407628,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.14,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,MVGQVUFEKIVQTO-UHFFFAOYSA-N
CHEMBL4087882,,CN1CCN(CCOC(=O)N(c2cccc(Br)c2)c2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,5.28,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,ZPYFGEVWAWJEIR-UHFFFAOYSA-N
CHEMBL400211,,CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,4.76,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,ZSKSRKTYCCBGOO-UHFFFAOYSA-N
CHEMBL110185,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3Br)CC2)CC1,IC50,5.89,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,DOECUUJDDMDCMT-UHFFFAOYSA-N
CHEMBL5282379,,Cc1ccc(F)c(NS(=O)(=O)/C=C/c2ccc(OCc3ccc(C(=O)NCCO[C@@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)cc3)cc2)c1,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,PNNXMIZIJXWEIU-PKNYZBDWSA-N
CHEMBL5286086,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccc(Cl)cc3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,MFAAXNUFCCVXRZ-KFFRJZQJSA-N
CHEMBL465843,PIPLARTINE,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,IC50,5.0,CHEMBL5241671,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition,LN-229,VABYUUZNAVQNPG-BQYQJAHWSA-N
CHEMBL5618120,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1cn(C)c2ccccc12)c1cn(C)c2ccccc12,IC50,4.23,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,QAWJNXINUKRMKP-NDEPHWFRSA-N
CHEMBL5618865,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2c(F)cccc12)c1c[nH]c2c(F)cccc12,IC50,4.83,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,GVYYFFSSLUXDQY-SANMLTNESA-N
CHEMBL5620245,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2c(Br)cccc12)c1c[nH]c2c(Br)cccc12,IC50,5.13,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,FNKHUIDOILEMJD-SANMLTNESA-N
CHEMBL5619755,,CC(C)OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.63,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,HGFHWYQDTQWKRH-PMERELPUSA-N
CHEMBL5619566,,CCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.66,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,WPLFAFAPIXAWJP-HKBQPEDESA-N
CHEMBL5619171,,CCCCCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.26,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,MTPKQHRIZWOKLZ-KDXMTYKHSA-N
CHEMBL5618234,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2cc(Br)ccc12)c1c[nH]c2cc(Br)ccc12,IC50,5.18,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,IEVQQZKXBRVHGN-NDEPHWFRSA-N
CHEMBL5620250,,COCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.71,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,PPNXYNNTAAQBNK-HKBQPEDESA-N
CHEMBL3426485,,C=C1C(=O)[C@@]23CC[C@@H]4[C@](C)(CO)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,4.89,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,HCZYQWZXOMCLRO-JBCQCRMPSA-N
CHEMBL3426487,,C=C1C(=O)[C@@]23CC[C@@H]4C(C)(C)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,5.42,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,DGKNOMBMBJXZGO-DMSXTEQDSA-N
CHEMBL3121288,,COc1ccc(Cl)cc1NS(=O)(=O)c1ccc(N2CCCC2=O)cc1,EC50,6.29,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,RIIDUZTZWJNBAF-UHFFFAOYSA-N
CHEMBL3121283,,CCOC(=O)c1[nH]c2c(c1C)C(=O)CC(c1ccccc1)C2,EC50,6.96,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,JKCCBJPERVOVSS-UHFFFAOYSA-N
CHEMBL3334513,,O=c1ccc(-c2ccc(F)c(Cl)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.92,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,YTJGVIJQWQWUQU-QFIPXVFZSA-N
CHEMBL3335785,,CN1CCN(c2ccc(-c3cnc(N4CCO[C@H](Cn5nc(-c6cccc(C#N)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.8,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,RSHVSHQCLHTDJZ-SANMLTNESA-N
CHEMBL3818586,,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(C)C,IC50,7.61,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,DMOPRYXQRGZSPH-GMAHTHKFSA-N
CHEMBL5218457,,CCOC(=O)c1c(NC(=O)CC#N)sc(C(=O)Nc2ccccc2)c1-c1ccccc1,IC50,6.21,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,BPQSRLLFHGSCEN-UHFFFAOYSA-N
CHEMBL163078,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1,IC50,7.96,CHEMBL815089,Concentration required to inhibit the entry of HIV-1 reported virus (ADA) into U-87 cells,U-87MG ATCC,KRBMMTDOLHPSPA-UHFFFAOYSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,5.91,CHEMBL5680329,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth incubated for 72 hrs by 3H-thymidine incorporation assay,T98G,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL314002,,COc1ccc(-c2cc3c(OC)ccc(OC)c3nc2O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,KXHHAFDFPJBSKE-UHFFFAOYSA-N
CHEMBL3343377,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.95,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RXQZRDTUYYDUIN-UHFFFAOYSA-N
CHEMBL3343384,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5Cl)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.92,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BHCGVCIDYXFAEL-UHFFFAOYSA-N
CHEMBL3343399,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.86,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NSBBTNXMJRENKO-UHFFFAOYSA-N
CHEMBL496089,,CC1(C)CC(NC(=S)Nc2ccccc2Cl)c2cc(Br)ccc2O1,IC50,5.1,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,TUBPYFDYIFDFBD-UHFFFAOYSA-N
CHEMBL513524,,COc1cccc(NC(=S)NC2CC(C)(C)Oc3ccc(Br)cc32)c1,IC50,4.06,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,TVXILMSSFSASBV-UHFFFAOYSA-N
CHEMBL2041935,,O=[N+]([O-])c1cccc(NC(=S)NCc2cccc(Cl)c2)c1,IC50,4.21,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,GWMKLBRGUPIGNQ-UHFFFAOYSA-N
CHEMBL4068289,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(F)c1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,URLZKXFVTNTQAR-UHFFFAOYSA-N
CHEMBL4094715,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(Br)c1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,CBFYQYIFVNRVRR-UHFFFAOYSA-N
CHEMBL4076935,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(=O)N1CCC[C@H]1C(=O)O)[C@H](C)O,IC50,4.34,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,HWONCQFYVPJQAU-JVHWHSFSSA-N
CHEMBL4077042,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCOCC3)c(OC)c2)cc1,IC50,5.15,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,ALFHQRBQXLUACD-ONNFQVAWSA-N
CHEMBL4084821,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CC(C)OC(C)C3)c(OC)c2)cc1,IC50,5.25,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,XWLRUOAWOQYIMG-WUXMJOGZSA-N
CHEMBL4069958,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@@H](N)CC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.91,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,PNHQDLHJACAPEL-GYVXDGDLSA-N
CHEMBL4083106,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=[N+]3C(=C(c4ccccc4)c4ccc(Cl)n4[B-]3(F)F)C=C2)nn1,IC50,6.55,CHEMBL4046338,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,CWTATMITRQBWAX-UHFFFAOYSA-N
CHEMBL3799200,,O=c1c(Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(N[C@@H](c2ccccc2)C(O)(c2ccccc2)c2ccccc2)c1=O,IC50,4.22,CHEMBL3801363,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,SBQCJYMLXBPBIH-LJAQVGFWSA-N
CHEMBL3806194,,O=C(Nc1ccc(Nc2ccc(OC3CCNCC3)cc2)cc1)c1cccc(-n2nc(C(=O)Nc3ccc(Nc4ccc(OC5CCNCC5)cc4)cc3)c3c2C(=O)NCC3)c1,IC50,4.22,CHEMBL3806851,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by Z2 coulter counter method,U-87MG ATCC,IJMDBRMQQXOTSY-UHFFFAOYSA-N
CHEMBL4225819,,COc1ncc(-c2cc3c(C)nc(N)nc3n(C)c2=O)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.02,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,BKGXQRKGPFGJOA-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.0,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3794099,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(I)c(=O)[nH]c2=O)C[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,4.42,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QIKJEQMDFNCEEL-MQUPRSIOSA-N
CHEMBL3794354,,CC(C)CCOC(=O)C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1)C(=O)OCCC(C)C,EC50,4.36,CHEMBL3796054,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,OZQXINIQLALHEN-NZCVOGEZSA-N
CHEMBL4103684,,CSc1ccc(C(=O)/C=C/c2ccc([N+](=O)[O-])o2)cc1,EC50,5.41,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,YGKNAFRUJDSMIE-XBXARRHUSA-N
CHEMBL4059707,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(N2CCCC2)cc1,EC50,4.45,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,RMHUSSMRBNFSBA-VQHVLOKHSA-N
CHEMBL3612194,,COc1ncc(-c2ccc3nc(NC4CC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.82,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,BFHXGYPDVYFMJA-UHFFFAOYSA-N
CHEMBL3612311,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.31,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,FMBGGQZXHUMWCJ-UHFFFAOYSA-N
CHEMBL4782575,,CC(=O)c1c(C)c2cnc(Nc3ccc(C(=O)N4CCNCC4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.42,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,OSBNRKPPJHLDGI-UHFFFAOYSA-N
CHEMBL3914323,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@@H](n2cc(C[Se]c3ccccc3)nn2)[C@@H]1Br,IC50,5.82,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,IPDKQWJEDZNPSV-XXBNENTESA-N
CHEMBL5084959,,NC(=O)C1CCN(C(=O)c2ccc(CSc3nc4cccnc4n3Cc3ccccc3)cc2)CC1,IC50,4.22,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,PDIMNUOJFYPJNS-UHFFFAOYSA-N
CHEMBL574956,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](CO)Cc1ccccc1)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](CO)Cc1ccccc1)C(=O)C(O)=C2C(C)C,IC50,4.53,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,CKTQBCPTHBKRDI-GDKVXFNHSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.7,CHEMBL4670045,Cytotoxicity against human U87 cells assessed as reduction in cell viability by SRB assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL3416181,,COc1cc2nc(-c3cc(O)cc(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.74,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZEETVDFZYSVSGW-UHFFFAOYSA-N
CHEMBL258925,,CCCn1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.07,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,WFNPIJHYLBLJEH-UHFFFAOYSA-N
CHEMBL2392952,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(Cl)cc5Cl)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.98,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WTRKXSWNJPFRGC-UHFFFAOYSA-N
CHEMBL2392823,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.0,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LALAFGCPFSXPPR-UHFFFAOYSA-N
CHEMBL2392958,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.01,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NDHAEGOOGOUGQD-UHFFFAOYSA-N
CHEMBL2392818,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.09,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BYGPPINXSJTQLN-UHFFFAOYSA-N
CHEMBL2392948,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.16,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YSIIKSBQGZWJKP-UHFFFAOYSA-N
CHEMBL4162270,,C=C(c1ccc(OC)c(F)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.1,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,VOVPNYONAIMJOD-UHFFFAOYSA-N
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,8.52,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,HVXBOLULGPECHP-WAYWQWQTSA-N
CHEMBL3400562,,CCC1=CC2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccc(I)cc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,5.52,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,BKSFWWGISUGTFD-FHJQSJRSSA-N
CHEMBL3400569,,C#Cc1ccc2[nH]c3c(c2c1)C/C(C(=O)OC)=C(/C(=O)NC(C)C)N1CC(CC)=CC(C1)C[C@]3(C(=O)OC)c1cc2c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]3(CC)C=CCN4CC[C@]21[C@@H]43,IC50,5.7,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,QUDGKSCVTLGFEM-NYYDPSAMSA-N
CHEMBL3963403,,Fc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccccc2)cc1,IC50,9.24,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RZJRJEDTYIELCA-AGFWYPDZSA-N
CHEMBL3927914,,COc1ccc(NC(=S)NNc2nncc3ccccc23)cc1,IC50,8.14,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,MJDGWMQMQUKVMK-UHFFFAOYSA-N
CHEMBL300389,,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,IC50,6.87,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,IYNDTACKOAXKBJ-UHFFFAOYSA-N
CHEMBL118655,,COc1cnc2c3c(nccc13)-c1ncccc1C2=O,IC50,6.52,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,JOBZJDOSNDFONB-UHFFFAOYSA-N
CHEMBL3601923,,COc1ncc(-c2ccc3nc(NC(=O)NC4CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.27,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YVAOMSDQXISTTH-UHFFFAOYSA-N
CHEMBL3601924,,COc1ncc(-c2ccc3nc(NC(=O)NCCN(C)C)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.01,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KYFUXWQWFUDCNB-UHFFFAOYSA-N
CHEMBL3601926,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.25,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DIJARPLLNQUOIO-UHFFFAOYSA-N
CHEMBL3600440,,COc1ncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.13,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SCGUAQOLNATAPZ-UHFFFAOYSA-N
CHEMBL3600442,,COc1ncc(-c2ccc3nc(NC(=O)N(C)C)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.75,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NQQQYVBBWRJZAK-UHFFFAOYSA-N
CHEMBL4446669,,O=C(/C=C/c1ccc(-c2ccncc2)cc1)c1cccc(O)c1,IC50,4.95,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,GHKWSAXLDYCGJD-RMKNXTFCSA-N
CHEMBL4470548,,CCCCCN(CCCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(O)c2)cc1,IC50,4.95,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,RYIJKZMXBBDLBU-SFQUDFHCSA-N
CHEMBL4577143,,CCN(CC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(O)c2)cc1,IC50,4.51,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,WQJDLXODDONTGE-MDWZMJQESA-N
CHEMBL4446669,,O=C(/C=C/c1ccc(-c2ccncc2)cc1)c1cccc(O)c1,IC50,4.6,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,GHKWSAXLDYCGJD-RMKNXTFCSA-N
CHEMBL424928,,O=C(CC1CN(Cc2ccco2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.24,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZARLWMXTKBWNAF-UHFFFAOYSA-N
CHEMBL4239931,,COc1ccc(-c2ccc3c(N4CCOCC4)nc(C(N)=O)nc3n2)cc1CO,IC50,6.09,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,AUEZWXLCYWYYPN-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,7.67,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL436535,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(F)cc1,IC50,8.52,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PFQCCCKWAOJRHG-UHFFFAOYSA-N
CHEMBL432219,,COc1cc2c(cc1OC)-c1n[nH]c(Nc3ccccc3)c1C2,IC50,4.68,CHEMBL861474,Antiproliferative activity against human glioma tumor cell line U87MG,U-87MG ATCC,RWKBPANRHRUTJW-UHFFFAOYSA-N
CHEMBL4586974,,Cc1c(C)c2c(c(C)c1CCCCCCN)CCC(C)(COc1ccc(/C=C3\CC(=O)NC3=O)cc1)O2,IC50,5.06,CHEMBL4380121,Antiproliferative activity against human U87 cells in 10% FCS by crystal violet staining based assay,U-87MG ATCC,KCRDVAXWHFTBNS-JJIBRWJFSA-N
CHEMBL244240,,CC(CN(C)C)Oc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O,IC50,6.77,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,JTKGQAOAZSNXIC-UHFFFAOYSA-N
CHEMBL2017974,BUPARLISIB,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,IC50,5.79,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CWHUFRVAEUJCEF-UHFFFAOYSA-N
CHEMBL390312,,O=C1C(=O)c2c(nc3ccc(Cl)cn23)-c2ncccc21,IC50,6.91,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,XQLDSZMTBZNFBP-UHFFFAOYSA-N
CHEMBL392123,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N/O)[C@@H]4[C@@H](O)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,4.64,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,BUFTXAANMISQCF-DUTFGLQASA-N
CHEMBL3634878,,CCN(CC)C(=O)Cn1c(-c2ccc(OC)cc2)nc2c(C)cc(C)nc21,Ki,6.84,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,SGOGIXZBMCSNBW-UHFFFAOYSA-N
CHEMBL3634877,,CCN(CC)C(=O)Cn1c(-c2ccc(OC)cc2)nc2c(C)cc(C)cc21,Ki,6.4,CHEMBL3636925,Displacement of [3H]PK11195 from TSPO in human T98G cell membranes incubated for 90 mins by competition radioligand binding assay,T98G,SJPVZIDWKSNHDB-UHFFFAOYSA-N
CHEMBL3609554,,COc1ccc([Se]C2CC3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.3,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SGRWXWKASKMUOL-UHFFFAOYSA-N
CHEMBL3612196,,O=C(Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1)NC1CC1,IC50,5.76,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,WFCYKYWPNDNUOI-UHFFFAOYSA-N
CHEMBL2062865,,C/C=C(\C)C(=O)O[C@H]1C[C@@H](C)[C@]2(O)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.12,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,NPUVRWFJDAPMIA-BDPKFFACSA-N
CHEMBL237677,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3cc[nH]n3)nccc12,IC50,6.85,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BGBYYLQBZCCHMG-UHFFFAOYSA-N
CHEMBL238113,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cccn3)nccc12,IC50,6.52,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,KVIXYBWOZQTNIY-UHFFFAOYSA-N
CHEMBL392576,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnc3)nccc12,IC50,6.8,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ARHPJYQUPRCXQA-UHFFFAOYSA-N
CHEMBL391847,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(F)ccc(F)c12,IC50,6.43,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,MHLUAQVEUDGLSM-CYBMUJFWSA-N
CHEMBL240063,,C[C@@H]1CN(C(=O)c2cccc(Cl)c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.08,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RHSZSOYHPUMCPO-CYBMUJFWSA-N
CHEMBL239204,,C[C@@H]1CN(C(=O)c2ccccn2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.48,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,SVTUHBOSNIGMNL-CYBMUJFWSA-N
CHEMBL2012582,,COc1cc(C(=O)N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C,EC50,6.18,CHEMBL3412560,Inhibition of IL6 secretion in LPS/IL-1beta-stimulated human U87 cells compound pretreated for 30 mins before stimulation measured after 24 hrs by ELISA,U-87MG ATCC,IWMCPJZTADUIFX-UHFFFAOYSA-N
CHEMBL462949,,C=C1C(=O)O[C@H]2[C@H]1C[C@H](O)/C(C)=C/CC[C@@]1(C)O[C@@H]21,IC50,4.6,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,RZUCCKARTVHQBW-MPFAERRBSA-N
CHEMBL3337791,,O=C(CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)OCc1ccccc1,IC50,5.0,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,LVTJBMIJDJGFJV-PXLJZGITSA-N
CHEMBL4276776,,COc1cc(/C=C/c2ccc(OCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)cc(OC)c1.[I-],IC50,6.07,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,PKZQPSOKNDPKAZ-ANVLNOONSA-M
CHEMBL4288118,,C(=C/c1ccc(OCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,5.85,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,TVAJSTLSCVCRRZ-PGCQSHBKSA-M
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,5.06,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL4277119,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.9,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NIHUEMNHVRWWIR-RAKOKPLXSA-N
CHEMBL4281638,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(Br)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.72,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CVBXBPXINGAATK-UVHRBFQASA-N
CHEMBL4281536,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccccn3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.58,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,OFWLZTVJYKXFDY-VKWKXTMMSA-N
CHEMBL4280439,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCC)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.3,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BDKSMEQWIKWOSA-PFRVYOCJSA-N
CHEMBL4282880,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(COc4ccc([N+](=O)[O-])cc4)nn3)CC[C@@H]12,IC50,5.87,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,XXUFVBQJPSKENX-CJRDBDCPSA-N
CHEMBL4539915,,CC(=O)Oc1ccc(-c2cnc3cc(C)c(C)cc3n2)cc1O,IC50,4.37,CHEMBL4342568,Antiangiogenic activity in human U87cells after 24 hrs by MTT assay,U-87MG ATCC,HRZBIKZMLQFWBP-UHFFFAOYSA-N
CHEMBL4277691,,COc1ccc(Cn2cc(C(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)nn2)cc1OC,IC50,6.07,CHEMBL4343250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,FSJLTXIAYGJAJT-UHFFFAOYSA-N
CHEMBL4083202,,C=CC[C@H]1C[C@]2([C@@H](C)Cc3ccc(OC)c(OC)c3)OCOC2=CC1=O,IC50,6.6,CHEMBL4053635,Antiproliferative activity against human SF295 cells after 72 hrs by CellTiter96 AQueous nonradioactive cell proliferation assay,SF295,BHTLRQBVGVBCSE-WDUKFBBWSA-N
CHEMBL3597212,,COc1ccc2c(Sc3cc(OC)c(OC)c(OC)c3)c(-c3ccccc3)[nH]c2c1,IC50,7.82,CHEMBL3599943,Cytotoxicity against human T98G cells assessed as growth inhibition after 48 hrs by MTS conversion assay,T98G,JOWLYQJNJNGREB-UHFFFAOYSA-N
CHEMBL4282477,,CC1(C)[C@@H](OC(N)=O)C=C[C@]2(C=O)[C@H]3CC[C@]4(C)[C@@H](c5ccc(=O)oc5)[C@@H](Cl)C[C@]4(O)C3=CC[C@@H]12,EC50,8.24,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,LGQRKPYKYDALST-ZDQYYBRASA-N
CHEMBL2035489,,COc1ccc2[se]n(CCn3[se]c4ccc(OC)cc4c3=O)c(=O)c2c1,IC50,5.79,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,MZMQMEKKARSJNG-UHFFFAOYSA-N
CHEMBL1644111,TRANS-PHYTOL,C/C(=C\CO)CCC[C@H](C)CCC[C@H](C)CCCC(C)C,IC50,5.1,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,BOTWFXYSPFMFNR-PYDDKJGSSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.29,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4085110,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZWBDBKSODBXWAG-UHFFFAOYSA-N
CHEMBL4129767,,C[C@H]1[C@H](N2CCN(C(=O)Nc3ccc(F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.54,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,USJQDXYIXWEYAI-LWCHGPQXSA-N
CHEMBL4126612,,C[C@H]1[C@H](N2CCN(C(=O)Nc3ccc(OC(F)(F)F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.71,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,WGAVTWUAWXWHSK-LWCHGPQXSA-N
CHEMBL3912723,,O=C1CS/C(=N/Nc2nncc3ccccc23)N1c1ccc(Cl)cc1,IC50,8.89,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,VXXXFNQITZZUER-OQKWZONESA-N
CHEMBL3893698,,CCN1C(=O)CS/C1=N/Nc1nncc2ccccc12,IC50,8.46,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,HZSSTZXPAUWYIN-GHRIWEEISA-N
CHEMBL3774518,,O=C(Nc1cc(-c2cccnc2)nc(NCCCN2CCOCC2)n1)c1cc(Br)cc(C(F)(F)F)c1,IC50,5.71,CHEMBL3777259,Cytotoxicity against human SF295 cells after 24 hrs by SRB assay,SF295,SWGHSHOUMNMZNI-UHFFFAOYSA-N
CHEMBL2088451,,FC(F)(F)c1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,5.32,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,WFRXYTZMMUQYIJ-IBBHUPRXSA-N
CHEMBL4086663,,C=C(c1ccc(OC)cc1)c1cc(C#N)nc2ccccc12,IC50,9.0,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,NXQPEOJBNVLIDQ-UHFFFAOYSA-N
CHEMBL4074142,,COc1ccc(C(=O)c2cc(C)nc3ccccc23)cc1,IC50,7.6,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,YJPJWRJEDPGCAM-UHFFFAOYSA-N
CHEMBL2441804,,O=C(Nc1cccc(-n2cc(-c3ccncc3)c(-c3ccc(Cl)c(O)c3)n2)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1,IC50,5.77,CHEMBL2445302,Growth inhibition of human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,XGEXNJLMBQAOEX-UHFFFAOYSA-N
CHEMBL5641814,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2OC)ncc1C(F)(F)F,IC50,4.78,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,GFFVSBZSQJUZJY-UHFFFAOYSA-N
CHEMBL1097764,LUDARTIN,C=C1C(=O)O[C@H]2[C@H]1CCC(C)=C1C[C@H]3O[C@@]3(C)[C@@H]12,IC50,5.2,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,QXJYIGSXUBOSID-JZEMPJKHSA-N
CHEMBL3337790,,O=C(C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1)OCc1ccccc1,IC50,4.17,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,MDAGTEMXGXPCCE-SVWSIEHRSA-N
CHEMBL2037337,,CC(=NNC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.92,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VCKFVZSNSWYSKQ-UHFFFAOYSA-N
CHEMBL1770165,,C/C(=N\NC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.37,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,MXWJIUNQTNDDFG-LICLKQGHSA-N
CHEMBL4066913,,C=C(c1ccc(OC)cc1)c1nc2ccccc2nc1C,IC50,6.16,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,ITIITPSWAMLPJU-UHFFFAOYSA-N
CHEMBL411729,CYTOCHALASIN B,C=C1[C@@H](C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@H](O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,IC50,5.63,CHEMBL2019566,Cytotoxicity against human XF498 cells after 48 hrs by SRB assay,XF 498,GBOGMAARMMDZGR-TYHYBEHESA-N
CHEMBL2435976,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(C)cc5)n4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.62,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NJOWRKQMWSBOGC-UHFFFAOYSA-N
CHEMBL2435969,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.1,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VGMYZLMRKMRCLC-UHFFFAOYSA-N
CHEMBL2035491,,O=c1c2cc(O)ccc2[se]n1CCn1[se]c2ccc(O)cc2c1=O,IC50,5.18,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OZRKFNKYXQVVSD-UHFFFAOYSA-N
CHEMBL2034987,,O=c1c2cc(F)ccc2[se]n1CCn1[se]c2ccc(F)cc2c1=O,IC50,5.16,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,FRYLJQGCOCBGLG-UHFFFAOYSA-N
CHEMBL1725990,,CC(=NNC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,9.0,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,QJEQNMXYYQUOAY-UHFFFAOYSA-N
CHEMBL2037433,,C/C(=N\NC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.08,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NOHGJWJQBAAVFP-VCHYOVAHSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.21,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL2037336,,CC(=NNC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.3,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PMHTWYVKIPHSFS-UHFFFAOYSA-N
CHEMBL2165270,,Cc1nc(N)cc(-c2cccnc2Nc2cccc(O)c2)n1,IC50,6.52,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,OFOLNFFDYMUPIF-UHFFFAOYSA-N
CHEMBL2165053,,Cc1nc(N)nc(-c2cccnc2Nc2cccc3[nH]ncc23)n1,IC50,6.64,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,YCLSLKKTHSFLGB-UHFFFAOYSA-N
CHEMBL603669,,COc1cc(CCc2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,EC50,5.54,CHEMBL1070407,Cytotoxicity against human SF295 cells after 44 hrs by MTT assay,SF295,QMPBVDJIRSEKGB-YCVRVPNXSA-N
CHEMBL1822929,,COc1ccc2cc(C(=O)NCCc3ccc(F)cc3)c(=O)[nH]c2c1OC,Ki,8.3,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,VLNYVUQPQVEPDW-UHFFFAOYSA-N
CHEMBL1822931,,COc1ccc2cc(C(=O)NCC(F)c3ccccc3)c(=O)[nH]c2c1OC,Ki,7.66,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,RTTGKYVLNXUSQE-UHFFFAOYSA-N
CHEMBL1822933,,CCCCOc1c(OC)c([N+](=O)[O-])cc2cc(C(=O)NCCc3ccc(F)cc3)c(=O)[nH]c12,Ki,8.85,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,LIFKXJIIMHZEDS-UHFFFAOYSA-N
CHEMBL1822936,,CCCCOc1c(OC)ccc2cc(C(=O)NCCCF)c(=O)[nH]c12,Ki,7.24,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,JFSQXIGNGMVQLG-UHFFFAOYSA-N
CHEMBL2178608,,COC1(c2sc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3c2C)COC1,EC50,6.62,CHEMBL2186327,Cytotoxicity against human A172 cells incubated for 4 days,A-172,XOZLHJMDLKDZAL-UHFFFAOYSA-N
CHEMBL5091566,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.37,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,BZQJKEMXKXEHFN-WFVGHVPHSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.85,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5090018,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CCC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.92,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,BDWTWOVMVWJZNR-SUNMMQDUSA-N
CHEMBL5089977,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CCCCC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.6,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,XNZFUNKIEWOVAE-MCLIRCHUSA-N
CHEMBL5089631,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccccc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.67,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,CKQLOINPQOUXOW-MCLIRCHUSA-N
CHEMBL4764838,,COC(=O)c1ccc(-c2cccc([C@H]3N(C(=O)OC(C)(C)C)CC[C@]34C(=O)Nc3ccccc34)c2)cc1S(C)(=O)=O,IC50,5.12,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,CSIIUZYJPVSIJG-MXBOTTGLSA-N
CHEMBL84852,,CCOC(=O)N(C)/N=N\C,IC50,4.7,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,GESXCZVUZIBFRC-SREVYHEPSA-N
CHEMBL333433,,COc1ccnc2c1C(=O)c1nccc3ccnc-2c13,IC50,5.4,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,CGMJZZIYLGQIJU-UHFFFAOYSA-N
CHEMBL3976938,,COc1ncc(-c2ccc3nccc(-c4ccc(Cn5cccn5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.79,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MGJLRASXFUHARL-UHFFFAOYSA-N
CHEMBL1801706,,CCN(CC)CCC(=O)Nc1csc2c1C(=O)c1ccccc1C2=O.Cl,IC50,6.22,CHEMBL1803379,Antitumor activity against human SF295 cells after 24 to 48 hrs by MTT assay,SF295,WGDYDYRTFNYLSX-UHFFFAOYSA-N
CHEMBL3800138,,COC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OC,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,VEXIODYWKRBZER-UHFFFAOYSA-N
CHEMBL4642386,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)CCC(=O)n1cc(/C=C/c2cccnc2)c2ccccc21,IC50,6.12,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,JALDPRKSINWMRJ-LCPPQYOVSA-N
CHEMBL3621410,,CCCCCCCCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.49,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,NKUUIVLNNUOSEA-UHFFFAOYSA-M
CHEMBL810,TEMOZOLOMIDE,Cn1nnc2c(C(N)=O)ncn2c1=O,IC50,4.71,CHEMBL3625311,Cytotoxicity against human U87 cells assessed as growth inhibition after 72 hrs by SRB assay,U-87MG ATCC,BPEGJWRSRHCHSN-UHFFFAOYSA-N
CHEMBL2144069,,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,IC50,4.6,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,ZGBGPEDJXCYQPH-UHFFFAOYSA-N
CHEMBL483847,,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,IC50,4.42,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,WEVYNIUIFUYDGI-UHFFFAOYSA-N
CHEMBL1242367,,CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,IC50,4.26,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,YVXCDLCJCIDFHE-DKXQDJALSA-N
CHEMBL176544,,Cn1cc(/C=C2\C(=O)Nc3cccnc32)c2ccccc21,IC50,4.21,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NXNQLECPAXXYTR-LCYFTJDESA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,6.98,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL2381451,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc(I)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.36,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,UQIMIZMWCGHEED-WKZPCIAFSA-N
CHEMBL515416,,Cc1ccc(-c2c(C(=O)CCl)n(CCCO)c3ncnc(N)c23)cc1,IC50,4.93,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,PELFTNQHGSITLB-UHFFFAOYSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,8.15,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.35,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL9470,SHIKONIN,CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,6.11,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,NEZONWMXZKDMKF-SNVBAGLBSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,5.0,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL521686,OLAPARIB,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,IC50,4.57,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,FDLYAMZZIXQODN-UHFFFAOYSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,5.61,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL573107,,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,IC50,4.8,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,DTEKTGDVSARYDS-UHFFFAOYSA-N
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,5.08,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,OGNYUTNQZVRGMN-UHFFFAOYSA-N
CHEMBL4088635,,C[C@H]1COCCN1c1cc(-c2ccc3[nH]ccc3c2)nn2c(C3CCN(Cc4cccnc4)CC3)cnc12,IC50,5.1,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,YTASBTNTVMGSHW-NRFANRHFSA-N
CHEMBL4082724,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.18,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QODZCSPDZVDCSD-UHFFFAOYSA-N
CHEMBL2095003,,CC(C)(C)c1cc(C(c2ccccn2)N2CCOCC2)cc(C(C)(C)C)c1O,IC50,4.31,CHEMBL4390251,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability after 72 hrs by Cell Titer-Glo luminescent assay,U-87MG ATCC,FHIRILMXIWNDLT-UHFFFAOYSA-N
CHEMBL197603,,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C,IC50,6.47,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,ZMNWFTYYYCSSTF-SOAUALDESA-N
CHEMBL213100,,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1,IC50,6.45,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,NBTNHSGBRGTFJS-UHFFFAOYSA-N
CHEMBL401930,,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,IC50,5.46,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,ZWVZORIKUNOTCS-OAQYLSRUSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,7.43,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.91,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL409,BICALUTAMIDE,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,IC50,4.23,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,LKJPYSCBVHEWIU-UHFFFAOYSA-N
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,5.54,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,PHXJVRSECIGDHY-UHFFFAOYSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,5.32,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL1091644,LINSITINIB,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,IC50,4.85,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,PKCDDUHJAFVJJB-VLZXCDOPSA-N
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.63,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,8.52,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.76,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.24,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,5.21,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,RDSACQWTXKSHJT-UHFFFAOYSA-N
CHEMBL4072236,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.96,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BMCXPSDQXSBAHT-UHFFFAOYSA-N
CHEMBL464006,MORUSIN,CC(C)=CCc1c(-c2ccc(O)cc2O)oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,4.62,CHEMBL3802602,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,XFFOMNJIDRDDLQ-UHFFFAOYSA-N
CHEMBL3763919,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccc(Cl)cc2)nn1,IC50,4.61,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SMEYPLCWRNXDCK-UHFFFAOYSA-N
CHEMBL3609562,,CC1(C)OC2=C(CC1Sc1cccc(Cl)c1)C(=O)C(=O)c1ccccc12,IC50,5.96,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,VDJREMNYXGITNM-UHFFFAOYSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,4.44,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL191384,,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,IC50,4.96,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AVLYNJZZQYEFEA-XDJHFCHBSA-N
CHEMBL18155,,Nc1nc(N)c2nc(CNc3ccc(C(=O)NC(CCCNC(=O)c4ccccc4C(=O)O)C(=O)O)cc3)cnc2n1,IC50,9.29,CHEMBL801266,Compound was evaluated for in vitro activity against SF-295 CNS cell lines (Human tumor cells ),SF295,NYQPLPNEESYGNO-UHFFFAOYSA-N
CHEMBL4453479,,C=CC(=O)NC(c1ccccc1)C(C(=O)/C=C/c1cccc(O)c1)C(=O)/C=C/c1cccc(O)c1,IC50,6.42,CHEMBL4364468,Cytotoxicity against human U87MG Cells 48 hrs by MTS assay,U-87MG ATCC,SZHWVJARXUAHDW-YXLFCKQPSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,5.96,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,4.9,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,4.76,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,OGNYUTNQZVRGMN-UHFFFAOYSA-N
CHEMBL4290621,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3cccc([N+](=O)[O-])c3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.0,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,GSYMDOHZLCQWSN-YTEMWHBBSA-N
CHEMBL4521917,,CCOP(=O)(OCC)C(N(OC(C)c1n(C)cc[n+]1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,VSIKVCAIEJWCGB-UHFFFAOYSA-N
CHEMBL229614,,C[C@@H](Cc1cccc2ccccc12)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.92,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,QGUPDXLZKDANGO-QKKBWIMNSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,5.09,CHEMBL4026219,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL379849,,O=C1/C(=C/c2ccccc2F)CNC/C1=C\c1ccccc1F,IC50,5.85,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NIVYQYSNRUIFIF-KAVGSWPWSA-N
CHEMBL4068246,,O=C(O)CCC(=O)OCCOc1c(S(=O)(=O)c2ccccc2)no[n+]1[O-],IC50,4.49,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,VIIYJQVYKOHPLH-UHFFFAOYSA-N
CHEMBL4072672,,COc1cc(/C=C/C(=O)c2ccc(Br)cc2)ccc1OCCCCN1CCCCC1,IC50,5.4,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,ZXNZWXWTGKDQCQ-NTUHNPAUSA-N
CHEMBL2206908,,Cc1nc(N)nc(-c2cc(CN3CCOCC3)cnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,8.28,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,GNMXQROCYSRVEQ-UHFFFAOYSA-N
CHEMBL2206904,,COc1cnc(Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.2,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,BHEMPSVJQFJQIN-UHFFFAOYSA-N
CHEMBL3806194,,O=C(Nc1ccc(Nc2ccc(OC3CCNCC3)cc2)cc1)c1cccc(-n2nc(C(=O)Nc3ccc(Nc4ccc(OC5CCNCC5)cc4)cc3)c3c2C(=O)NCC3)c1,IC50,4.35,CHEMBL3806924,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by Z2 coulter counter method,U-87MG ATCC,IJMDBRMQQXOTSY-UHFFFAOYSA-N
CHEMBL5426666,,C#CCN(C)CCCOc1ccc(N(CC)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.34,CHEMBL5371254,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,T98G,UGMCCVYCFXAQTN-UHFFFAOYSA-N
CHEMBL3797512,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(=O)/C=C/C=C(C)\C=C\[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,7.18,CHEMBL3802921,Antiproliferative activity against human SF295 cells assessed as cell viability by Alamar Blue assay,SF295,AIIZZRMMCAVMCU-GXNNERPOSA-N
CHEMBL3310592,,COc1c(NS(=O)(=O)C2CC2)cc(-c2ccc3nc(NC(=O)C4CC4)sc3c2)cc1C(N)=O,IC50,5.08,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CPMLWFNIQIZNKF-UHFFFAOYSA-N
CHEMBL323280,,O=C1c2nccc([N+](=O)[O-])c2-c2nc3ccccc3c3ccnc1c23,IC50,7.16,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,YKRRMKBNPLZPKR-UHFFFAOYSA-N
CHEMBL2385205,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NZTZNGJHLDGDDB-UHFFFAOYSA-N
CHEMBL2385179,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cc(C)ccc5C)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.87,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,AZZAXSOMHADXBU-UHFFFAOYSA-N
CHEMBL140827,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1,IC50,9.52,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,CAZKDDQXONGRTE-ROUUACIJSA-N
CHEMBL3410530,,COc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(OC)c([N+](=O)[O-])c3)C2=O)cc1[N+](=O)[O-],IC50,5.94,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,UPRAHZCTKDUQPW-BGPOSVGRSA-N
CHEMBL1097302,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)NCC(=O)OCC#CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.83,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,MJXFAVYMJZHYAK-IVEJOGDBSA-N
CHEMBL1097300,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OCCOCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.74,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,JLKUKOUXEVPGQG-MYEUQPDOSA-N
CHEMBL1097299,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OCCCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.05,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,VGRCLALCXBLFSZ-JGFHVXTRSA-N
CHEMBL601719,CRIZOTINIB,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,IC50,4.16,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,KTEIFNKAUNYNJU-GFCCVEGCSA-N
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,7.19,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,CTESJDQKVOEUOY-UHFFFAOYSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.43,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL38,TRETINOIN,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,IC50,4.39,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,SHGAZHPCJJPHSC-YCNIQYBTSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,5.09,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,6.39,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.28,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,RAHBGWKEPAQNFF-UHFFFAOYSA-N
CHEMBL191334,NUTLIN-3,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,5.17,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,BDUHCSBCVGXTJM-WUFINQPMSA-N
CHEMBL4063172,,COc1cc(/C=C/C(=O)c2ccccc2OC)ccc1OCCCN1CC(C)OC(C)C1,IC50,5.3,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QUGACEDDVWEABX-ZRDIBKRKSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.5,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.03,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL1186585,,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,IC50,4.24,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,MIDUFIRTIFUTQA-UHFFFAOYSA-N
CHEMBL4093183,,C=C(c1ccc(OC)cc1)c1nc(C)nc2ccccc12,IC50,7.4,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,LHIIXZMSXRDIET-UHFFFAOYSA-N
CHEMBL4064087,,CC(O)c1cc2nc(N3C[C@@H](C)O[C@@H](C)C3)nc(N3CCOCC3)c2s1,IC50,5.48,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,KPYIICUHFXSFAD-FUNVUKJBSA-N
CHEMBL393220,ATORVASTATIN CALCIUM,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2],IC50,5.09,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,FQCKMBLVYCEXJB-MNSAWQCASA-L
CHEMBL4080590,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)nnc1Cl,IC50,5.77,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,BJYZYCDBIWVFEN-UHFFFAOYSA-N
CHEMBL3597223,,COc1cc(Sc2c(-c3ccccc3)[nH]c3c(Cl)c(Cl)ccc23)cc(OC)c1OC,IC50,7.79,CHEMBL3599943,Cytotoxicity against human T98G cells assessed as growth inhibition after 48 hrs by MTS conversion assay,T98G,NGOSBFUXHJANRG-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.87,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL1782905,,CCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.68,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,RFEUBQAKWNFXQN-LVEBQJTPSA-N
CHEMBL1807801,,Cc1c2c(n3c1CCN(C(=O)CO)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.33,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,ZNHZHSANEXQZND-WBVHZDCISA-N
CHEMBL278315,GELDANAMYCIN,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,7.05,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,QTQAWLPCGQOSGP-KSRBKZBZSA-N
CHEMBL237830,,c1ccc(NCc2ccc(CNc3ccccn3)cc2)nc1,IC50,8.74,CHEMBL1806025,Antagonist activity at human CXCR4 expressed in human U87 cells expressing CD4 assessed as inhibition of CXCL12-induced cAMP production pretreated for 15 mins before forskolin challenge by TR-FRET analysis,U-87MG ATCC,KBVFRXIGQQRMEF-UHFFFAOYSA-N
CHEMBL4641878,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccc(C)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.55,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,DRCZVSOYNQERJP-PXCOWHNISA-N
CHEMBL1807798,,Cc1c2c(n3c1CCCN(C(=O)CN)[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.32,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,RGXUGCVLZOLOQG-IRXDYDNUSA-N
CHEMBL1807799,,Cc1c2c(n3c1CCN(C(=O)CN)C[C@@H](C)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,6.42,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,QRUWUQGHACTCGO-WBVHZDCISA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,4.05,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL3400563,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(Br)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,5.52,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,AXCLHNCUQVHTDE-LUJDZOJYSA-N
CHEMBL3400564,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(C=O)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.64,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,XRDWUWZIBPDAJW-OXPDPLDSSA-N
CHEMBL505426,,N=C(N)NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCN)NC1=O,IC50,6.94,CHEMBL1828410,Displacement of [125]I-echistatin from alphaVbeta3 integrin expressed in human U87MG cells by competitive binding assay,U-87MG ATCC,MFWXFNOXLDIPDQ-YSTOQKLRSA-N
CHEMBL3415682,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](CC(C)C)c(C)c21.[Br-],IC50,5.42,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,OJSRECCJWPQHDA-UHFFFAOYSA-M
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.4,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3114423,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1Sc1ccccc1,IC50,5.04,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,CSKHKZLUBWGDKA-UHFFFAOYSA-N
CHEMBL3114589,,COc1ccc(NC2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)cc1,IC50,6.13,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SGUSEXOKZCOCFX-UHFFFAOYSA-N
CHEMBL3114586,,CC1(C)CC(Nc2ccc(Br)cc2)C2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.2,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,LVDWHNNSPPTBKQ-UHFFFAOYSA-N
CHEMBL2375477,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(-c2ccccc2)nn1,IC50,5.46,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,SKZPRPFMFVHUMQ-UHFFFAOYSA-N
CHEMBL1567256,,O=C(Cc1ccc(Br)cc1)NCc1ccccc1,EC50,5.63,CHEMBL3122444,Decrease in PrPc expression on human T98G cell surface after 2 days by ELISA,T98G,KXFWFGCNDQHKRZ-UHFFFAOYSA-N
CHEMBL4097578,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)nnc1Cl,IC50,4.88,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,NVINUJFUNDNKJI-UHFFFAOYSA-N
CHEMBL117185,,C=C/C(C)=C/C[C@@]1(C)[C@@H](C)C[C@@H](O)C23C(=C[C@@H](OC(=O)C(C)C)C[C@@H]21)[C@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.0,CHEMBL815854,In vitro cytotoxicity against parental and drug resistant glioblastoma human tumor cell line U87MG,U-87MG ATCC,PASSAFHUDJPXAL-UUCYYRGWSA-N
CHEMBL4284792,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3cccs3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.68,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,SVOFEUHLLHYNRJ-JLXBFWJWSA-N
CHEMBL2407568,,CCC1=C[C@@H]2CN(C1)[C@H](C(=O)NCc1ccccc1)[C@H](C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.16,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,BERPIXVXUHXNAJ-GIBQAPQMSA-N
CHEMBL4284998,,c1cc(-c2ncc(-c3ccc(-c4cnco4)cn3)o2)nc(-c2ncc(-c3ccc(-c4cnco4)cn3)o2)c1,IC50,6.36,CHEMBL4261146,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,FZMULGSCSMOHRS-UHFFFAOYSA-N
CHEMBL307261,ARTENIMOL,C[C@H]1[C@@H](O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.18,CHEMBL5250676,Anticancer activity against human A-172 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,A-172,BJDCWCLMFKKGEE-ISOSDAIHSA-N
CHEMBL5280101,,O=S(=O)(NC1CCCCC1)c1ccc2c(c1)C(=NO)c1cc(S(=O)(=O)NC3CCCCC3)ccc1-2,IC50,5.38,CHEMBL5250701,Induction of ferroptosis in human LN-229 cells assessed as GPX4 degradation,LN-229,JLCFMMIWBSZOIS-UHFFFAOYSA-N
CHEMBL5269497,,Clc1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.63,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,YUWNKSTXMKZSEK-UHFFFAOYSA-N
CHEMBL4097171,,Cc1cc(=O)n(-c2cccc(F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.05,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,URZMEUOWWYWJBV-UHFFFAOYSA-N
CHEMBL3617078,,CCCc1cc(=O)n2nc(NCc3c(F)cc(Cl)cc3F)c(C#N)c2[nH]1,IC50,5.28,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,SFUVDTPAOHEGCQ-UHFFFAOYSA-N
CHEMBL5267195,,COc1cc(C(=O)c2cn(-c3ncccn3)cc2-c2ccco2)cc(OC)c1OC,IC50,8.0,CHEMBL5238348,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth incubated for 48 hrs by trypan blue exclusion assay,U-87MG ATCC,IXBOSJOTMWEKPZ-UHFFFAOYSA-N
CHEMBL4206106,,O=c1c(-c2c(O)cc3c(c2O)C[C@@H](O)[C@H](c2ccc(O)cc2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.51,CHEMBL4187983,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,T98G,AMGHFASSLAHWBX-PBBNMVCDSA-N
CHEMBL4756703,,CO[C@@]1(C)N(C[C@H](O)c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,4.77,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,NSKGPNPTDFLIQO-RDPSFJRHSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.22,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5179292,,Br.Fc1ccc2c(c1)c(-c1nc(-c3c[nH]c4ncccc34)cs1)cn2CCCCN1CCOCC1,EC50,5.44,CHEMBL5122041,Cytotoxicity against human U-87 MG cells overexpressing GLS-1,U-87MG ATCC,OFXKPOFBKPYJJU-UHFFFAOYSA-N
CHEMBL5205920,,O=C(NCCCNc1cc(-c2cn(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)Nc1cccc(C(F)(F)F)c1,IC50,5.75,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,KEZRNSQBXOWDMI-UHFFFAOYSA-N
CHEMBL4238900,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCCC3)CC1)c1ccccc1S2,EC50,5.21,CHEMBL4232380,Induction of intracellular Ca2+ level in human U87MG cells by Fura-2 AM dye-based assay,U-87MG ATCC,CVFJHVCUQHZUDA-UHFFFAOYSA-N
CHEMBL4576165,,CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2n1,IC50,4.34,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,AWJAAKKEYXUCFY-UHFFFAOYSA-N
CHEMBL4127998,,C[C@H]1[C@H](N2CCN(C(=O)Nc3ccc(C(F)(F)F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.82,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,HVEMXAGNWZKCPE-LWCHGPQXSA-N
CHEMBL4286032,,Cc1cc(=O)c(O)c(C(c2ccc(OCc3ccccc3)cc2)c2oc(C)cc(=O)c2O)o1,IC50,5.34,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,NRCFTXZTBUYJRR-UHFFFAOYSA-N
CHEMBL4102004,,CCc1cnc2c(N3CCOC[C@@H]3C)cc(-c3ccc(NC(=O)Nc4cccnc4)cc3)nn12,IC50,5.08,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,VTCYYHFNVWXODK-KRWDZBQOSA-N
CHEMBL168888,,CC(C)NC(=O)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.28,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,RZTDQABOCFQUFV-UHFFFAOYSA-N
CHEMBL4760781,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(Nc2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.43,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,YIKYKYFYFWNCSE-UHFFFAOYSA-N
CHEMBL5433580,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSCc2ccccc2CSC[C@H](NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.94,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,VMIUNURGDIYHPA-NQAOGTSWSA-N
CHEMBL5395996,,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)CSCc2ccccc2CSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O,IC50,5.55,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,CJDQEJPOCUIGOI-RZAATYBRSA-N
CHEMBL5558244,,O=C(Nc1ccc(Oc2ccnc(C(=O)NCCCCNC(=O)C3CC4C=CC3C4)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1,IC50,4.2,CHEMBL5503291,Antiproliferative activity against human U87 cells assessed as inhibition of cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QPMWUPDBRJFZLI-UHFFFAOYSA-N
CHEMBL3401519,,NC(=O)c1cc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)ccc1OCc1ccc(F)cc1,IC50,5.4,CHEMBL3404849,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WYNDFDUHWUEWJF-UHFFFAOYSA-N
CHEMBL3780566,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.89,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BKMYJTORXVRSOY-UHFFFAOYSA-N
CHEMBL3339360,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.54,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,DQVUCDBOFDTXMU-LALXJTNGSA-N
CHEMBL3339371,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.29,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JFZPAVVJZJMWAJ-UUKRNIFRSA-N
CHEMBL373546,,C/N=C/N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,7.48,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HDWZRGPJHTWCSK-ZVHZXABRSA-N
CHEMBL373868,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(C(F)(F)F)cc1,IC50,6.82,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,GMACZBIWIXUAPQ-UHFFFAOYSA-N
CHEMBL220123,,Cc1cc(N2CCN(Cc3ccccc3)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.6,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,DVUZLCFDNOGYKM-UHFFFAOYSA-N
CHEMBL3327006,,COc1ncc(-c2cnc3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(C#N)cc1,IC50,5.61,CHEMBL3380580,Antiproliferative activity against human U87MG cells after 4 days by CellTiter-Glo assay,U-87MG ATCC,JFSMZTDNJFICOR-UHFFFAOYSA-N
CHEMBL1234354,PF-04691502,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,IC50,6.28,CHEMBL3380580,Antiproliferative activity against human U87MG cells after 4 days by CellTiter-Glo assay,U-87MG ATCC,XDLYKKIQACFMJG-WKILWMFISA-N
CHEMBL169,URSOLIC ACID,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.32,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,WCGUUGGRBIKTOS-GPOJBZKASA-N
CHEMBL4864509,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7cccc8[nH]ccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.33,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,RFNPZBPEUSTEIE-JDMHCBMBSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,8.09,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL3353045,,O=C(COc1cccc2ccccc12)N1CCN(C(=O)c2ccccc2)CC1,IC50,4.27,CHEMBL3383780,Antiviral activity against Human immunodeficiency virus type 1 (isolate YU2) pseudotyped virus expressed in human U87 cells after 48 hrs by cell-based luciferase reporter gene assay,U-87MG ATCC,XLZDOLVDLGNPEM-UHFFFAOYSA-N
CHEMBL1779533,,Cc1c2c(n3c1CCCN1CCOC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,7.52,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,WCKJSDUJHUSOFY-SFHVURJKSA-N
CHEMBL534720,,Cl.Oc1cc2c(cc1O)C(Cc1ccc(-c3ccccc3)cc1)NCC2,IC50,4.59,CHEMBL911522,Cytotoxicity against human U87 cell line,U-87MG ATCC,KBMNQYDZBKKKPH-UHFFFAOYSA-N
CHEMBL4441865,,COc1cc(/C=N/Nc2nc(-c3ccc(Br)cc3)cs2)cc(Br)c1OC,IC50,4.55,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,NKCFNFYCVRRXDU-ZVBGSRNCSA-N
CHEMBL4550807,,COc1ccccc1-c1csc(N/N=C/c2ccc(F)c(F)c2)n1,IC50,4.39,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,CEWAJXHLDDWARA-AWQFTUOYSA-N
CHEMBL2435965,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5)n4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.95,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OKJTTYWLYKAMBD-UHFFFAOYSA-N
CHEMBL2435975,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccccc5)n4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.87,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RBUJKCIMCCHILL-UHFFFAOYSA-N
CHEMBL2435985,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.89,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZFWMISSSYWICDR-UHFFFAOYSA-N
CHEMBL2435998,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.0,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NGTAHWHMGVUEDB-UHFFFAOYSA-N
CHEMBL3588941,,CCCC(=O)OC/C=C/c1ccc(OC(C)=O)c(OC)c1,IC50,4.73,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,UHANZZHYVNKKSW-FNORWQNLSA-N
CHEMBL3588938,,CCCCCCCCCCCCCCCCCCCCOC(=O)/C=C/c1ccc(O)c(OC)c1,IC50,5.28,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,UBNJQWYYWIBSGN-ZNTNEXAZSA-N
CHEMBL2435997,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5F)ccn4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.21,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZEXVKTFRFYFERV-UHFFFAOYSA-N
CHEMBL2375474,,CCCCCc1cn(C2CC(C)(C)OC3=C2C(=O)c2ccccc2C3=O)nn1,IC50,5.56,CHEMBL3118051,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,GQBURWAEKZKSAW-UHFFFAOYSA-N
CHEMBL452911,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.73,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,QUBNLZCADIYAFW-RITZIESXSA-N
CHEMBL444982,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6OC[C@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.8,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,HZLWUYJLOIAQFC-HRDZKRTASA-N
CHEMBL2430037,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CC[C@]6(C(=O)O)CC[C@]45C)[C@]3(C)CO)OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,IC50,4.53,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,GSOMSXJOAJCAIV-YFNOCVKUSA-N
CHEMBL4763389,,Cc1nn(C)c(Oc2ccc(Cl)cc2)c1/C=N\CCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.73,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DYSYRTYGHNZWOO-UHBFCERESA-N
CHEMBL4791408,,Cc1nn(C)c(Oc2ccccc2Br)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.66,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CUYOGGLYAOKVHD-LJUMEUDFSA-N
CHEMBL4762880,,Cc1nn(C)c(Oc2cccc(C(F)(F)F)c2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.63,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UZFLECKMFSQDKV-DLCNMLRHSA-N
CHEMBL4779312,,Cc1nn(C)c(Oc2ccc(OC(F)(F)F)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.02,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,JQMSUSQEEABTHG-DLCNMLRHSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.38,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4791226,,Cc1cccc(C(C(=O)NC2CCCCC2)N(C)CCOC(=O)/C=C/C(=O)c2ccc(F)cc2)c1,IC50,5.15,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CQTVFFHTFZUWRM-FOCLMDBBSA-N
CHEMBL223385,,O=C(CC1CN(C(=O)Oc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,8.85,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,CNWNPKTZNBJRTQ-UHFFFAOYSA-N
CHEMBL220156,,O=C(CC1CN(S(=O)(=O)c2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,8.57,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,UXEWUEZKRXQCGG-UHFFFAOYSA-N
CHEMBL223791,,O=C(CC1CN(C(=O)NCc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.02,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,TXDBPIRWDGSMJW-UHFFFAOYSA-N
CHEMBL3577925,,O=S(=O)(Nc1cc(-c2cc3c(-c4ccncc4)ncnc3s2)cnc1Cl)c1ccc(F)cc1F,IC50,5.35,CHEMBL3579772,Cytotoxicity against human U87MG cells harboring PTEN deletion mutant assessed as growth inhibition after 4 days by CellTiter-Glo luminescent cell viability assay,U-87MG ATCC,OGUIPHCQISNMKY-UHFFFAOYSA-N
CHEMBL5184425,,CO[C@@H]1O[C@H](COC2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)[C@H]2OC(C)(C)O[C@@H]12,IC50,6.8,CHEMBL5104528,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability by MTT assay,SF295,AMDWNEOUUQNSLQ-HDWZVLIESA-N
CHEMBL1652065,,CC(C)CC1=C(OC2(CC(C)C)C(=O)C(=O)C3=C(CCCC3)C2=O)C(=O)C2=C(CCCC2)C1=O,IC50,4.97,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AWUWZGUYHOFDNO-UHFFFAOYSA-N
CHEMBL307794,,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc4c(cc3nc2-1)OCO4,IC50,6.96,CHEMBL5109659,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,RPFYDENHBPRCTN-NRFANRHFSA-N
CHEMBL4082189,,CC(=O)OC[C@H]1O[C@@H](S[C@@H]2CC(=O)[C@@H]3OC[C@H]2O3)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,4.19,CHEMBL4611186,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 14 hrs by CCK8 assay,U-87MG ATCC,ILWHSILTMOSREC-OJWHBJTBSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,5.26,CHEMBL5509849,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL5562174,,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccc(NC(=O)COc3cccnc3)cc2)cc1,IC50,6.11,CHEMBL5509850,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,NGXVQQDDOXHWSX-CUVVAGTFSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,6.25,CHEMBL5509859,Synergistic antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs in presence of AG-120 by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL1910998,,Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,8.54,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,WFRUFWRKGZIARP-UHFFFAOYSA-N
CHEMBL1096181,,NCCCCCCCCCCCC(=O)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.11,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,MVUALRSRYHHUKP-UHFFFAOYSA-N
CHEMBL5272157,,CC1(C)CC(=O)C2=C(C1)OC(N)=C(C#N)C21C(=O)N(CCCCCCCCCCBr)c2ccccc21,IC50,5.6,CHEMBL5226671,Antiproliferative activity against human U87 cells,U-87MG ATCC,UJDUXBISCYQNNZ-UHFFFAOYSA-N
CHEMBL4643992,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(C(F)(F)F)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.76,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,RCKSXRJGPINTBA-AAKZOTGXSA-N
CHEMBL4644332,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccccc1F)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.49,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,IDURRGUUHPZZPT-CDGBYUCFSA-N
CHEMBL4646810,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)NCCCC)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.32,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,SIARFVBTBUCVJS-ZDBMLTPASA-N
CHEMBL4647700,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(CC)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.84,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,BAQCFXXHSYBPQT-HILUMYNGSA-N
CHEMBL4642264,,CCCc1c(C)nc2c3ccccc3oc(=S)n12,IC50,5.61,CHEMBL4617339,Antiinvasive activity against human U87MG cells assessed as reduction in cell invasion measured after 24 hrs using Diff-quick staining by light microscopy based Boyden chamber assay,U-87MG ATCC,OEWGFBGGWFYYNM-UHFFFAOYSA-N
CHEMBL4633299,,Cc1cc(C)c(CNC(=O)c2cc(C)n(-c3cccc(NC(=O)CCCCCCC(=O)NO)c3)c2C)c(=O)[nH]1,IC50,4.7,CHEMBL4616189,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter-Glo Luminescent cell viability assay,U-87MG ATCC,HQAHZUWVVKNTRB-UHFFFAOYSA-N
CHEMBL5291398,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4cccc(Cl)c4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,XXJNRYISGDIFRB-IZNAELAISA-N
CHEMBL574956,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](CO)Cc1ccccc1)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](CO)Cc1ccccc1)C(=O)C(O)=C2C(C)C,IC50,4.53,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,CKTQBCPTHBKRDI-GDKVXFNHSA-N
CHEMBL4647017,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccc(C(F)(F)F)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.6,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ROMCDQXUNLGMJO-AAKZOTGXSA-N
CHEMBL5418077,,C[C@H]1[C@@H](OCCCN=C=S)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,5.13,CHEMBL5355865,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,MLDQCUOFTGHGFK-YRPRCUQKSA-N
CHEMBL1822054,,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,IC50,7.89,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,FHOXICOTPQTJOQ-UHFFFAOYSA-N
CHEMBL1822059,,O=S(=O)(Nc1cc(-c2ccc3nccn3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.24,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,DNCWCPDSMUNNAM-UHFFFAOYSA-N
CHEMBL1822060,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2[nH]1,IC50,6.47,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,VMOWYZQEUZXDFM-UHFFFAOYSA-N
CHEMBL4239569,,COc1ccc(-c2ccc3c(N4CCOCC4)nc(C#N)nc3n2)cc1CO,IC50,6.04,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,YORDELGQXBGIHM-UHFFFAOYSA-N
CHEMBL4246481,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(CC(OC)OC)nc3n2)cc1CO,IC50,7.05,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,QENAZHNQLZMAPO-HNNXBMFYSA-N
CHEMBL4246121,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C4=CCOCC4)nc3n2)cc1CO,IC50,7.07,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,PQSRXIWKDZAALQ-INIZCTEOSA-N
CHEMBL425148,MATAIRESINOL,COc1cc(C[C@H]2COC(=O)[C@@H]2Cc2ccc(O)c(OC)c2)ccc1O,IC50,4.63,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,MATGKVZWFZHCLI-LSDHHAIUSA-N
CHEMBL5270178,,C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)cc2)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261844,Cytotoxicity against human LN-229 cells measured after 8 days,LN-229,JGOZUFGBTSAWEI-NSCUHMNNSA-N
CHEMBL4103284,,COc1cc(/C=C/C(=O)c2ccccc2O)ccc1OCCCN1CCCCC1,IC50,5.54,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,HZCOSEZBEUQJPH-ZRDIBKRKSA-N
CHEMBL3262849,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(F)cc3)cc2F)ccn1,IC50,5.64,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ASBJBQZTHWZUNT-WKULSOCRSA-N
CHEMBL3335768,,O=c1ccc(-c2cc(F)c(F)c(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCN(CCO)CC4)c3)cn2)CCO1,IC50,5.39,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,INWKTLVUGKCAMW-QHCPKHFHSA-N
CHEMBL3335769,,CN1CCC(n2cc(-c3cnc(N4CCO[C@H](Cn5nc(-c6cccc(F)c6)ccc5=O)C4)nc3)cn2)CC1,IC50,5.47,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,RDWKECAQTMHRSL-VWLOTQADSA-N
CHEMBL1822211,,Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2o1,IC50,7.0,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,SMTOUMSBNIEJMF-UHFFFAOYSA-N
CHEMBL3343381,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.94,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CODZLYDUWWEMOC-UHFFFAOYSA-N
CHEMBL3343391,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.55,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XHQYABUNYJJQNG-UHFFFAOYSA-N
CHEMBL3262856,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(O)c(Br)c3)cc2F)ccn1,IC50,4.91,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YVWVQRDRTYXJEJ-IPPBACCNSA-N
CHEMBL3263195,,COC(=O)CCC[C@@H]1[C@H]2CCCN3CCC[C@H](CN1Cc1ccc(Cl)cc1)[C@@H]23,IC50,4.9,CHEMBL3265609,Antiproliferative activity against human U87 cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,DBHCSAFZYROWFD-LPOZWGFCSA-N
CHEMBL1795857,,CCCCc1ccc(C#Cc2ccc(S(=O)(=O)N[C@H](Cc3ccc(OCc4ccccc4)cc3)C(=O)NO)s2)cc1,IC50,7.92,CHEMBL1799656,Antiinvasive activity against human U87MG cells after 24 hrs by Matrigel basement membrane transwell assay,U-87MG ATCC,VZNWQFCLBMVARX-SSEXGKCCSA-N
CHEMBL4101008,,Cc1ccccc1-n1nc(C(=O)Nc2ccc(Oc3ccnc4[nH]ccc34)cc2)c(C)cc1=O,IC50,5.49,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LUCCIHRGBDBWOV-UHFFFAOYSA-N
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,6.77,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL4068211,,CN1CCN(CCOC(=O)N(Cc2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,4.73,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,ONIFAJAFWHMUOA-UHFFFAOYSA-N
CHEMBL4060917,,CSc1nc(N(C(=O)OC(Cc2ccccc2)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.17,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,YZYCFZMIKGBFFD-UHFFFAOYSA-N
CHEMBL411043,,ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1,IC50,5.31,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,SEFWYTXTKMMUEF-UHFFFAOYSA-N
CHEMBL2407628,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.8,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,MVGQVUFEKIVQTO-UHFFFAOYSA-N
CHEMBL1098108,,COc1ccc(C(=O)Nc2nc(-c3ccccc3)nc3nn(C)cc23)cc1,IC50,10.04,CHEMBL1120799,Inhibition of Cl-IB-MECA-mediated human U87MG cell proliferation after 48 hrs by trypan blue exclusion assay,U-87MG ATCC,YEHUDYLWUFJTMH-UHFFFAOYSA-N
CHEMBL5620269,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.77,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LSCFMIBDVFNSCU-NDEPHWFRSA-N
CHEMBL5618234,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2cc(Br)ccc12)c1c[nH]c2cc(Br)ccc12,IC50,5.32,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,IEVQQZKXBRVHGN-NDEPHWFRSA-N
CHEMBL5619899,,CC(C)CCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.91,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,PVDOVVCNMDJUMN-XIFFEERXSA-N
CHEMBL5619566,,CCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.69,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,WPLFAFAPIXAWJP-HKBQPEDESA-N
CHEMBL1169766,,COc1ccc(/C=C/[C@](C)(/C=C/c2ccc(O)cc2)CCC=C(C)C)cc1,IC50,4.66,CHEMBL1948695,Cytotoxicity against human SF295 cells after 48 hrs by sulpharhodamine B assay,SF295,YUBDDAFYPBAOLK-NSDNEPAYSA-N
CHEMBL355004,,CCOCOCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,4.95,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,KFVUDTYOUWJVII-UHFFFAOYSA-N
CHEMBL5436787,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCN(C(=S)SCC(=O)N(C)C)CC2)n1,IC50,5.69,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,JXCSRHVITGYTRY-UHFFFAOYSA-N
CHEMBL5397031,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.13,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,DWMRSQUGHUXVSZ-UHFFFAOYSA-N
CHEMBL5433632,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCC1CCCCC1,IC50,6.84,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,QKZIZOZKBBOCAH-UHFFFAOYSA-N
CHEMBL4098035,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccccn4)cc3n2)C[C@H](C)O1,IC50,5.35,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,DSQSNLIGWUDVSQ-GASCZTMLSA-N
CHEMBL4634930,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1cc(O)ccc1C4=O,EC50,7.29,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,SRBWZZOBDMCFHB-XIQYBZFWSA-N
CHEMBL4633528,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1c(ccc(OC)c1O)C4=O,EC50,8.4,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,IEVSIHHPTPATHO-UOGOAWDKSA-N
CHEMBL1351,CARBOPLATIN,,IC50,4.87,CHEMBL822894,In vitro cytotoxicity against CNS cancer XF 498 cell lines,XF 498,
CHEMBL3793044,,c1ccc2c(c1)Sc1cccnc1N2CCCCCCN1CCOCC1,IC50,4.51,CHEMBL3795261,Cytotoxicity against human T98G cells assessed as cell viability after 24 hrs by MTT assay,T98G,UIEKSGGZBSOENC-UHFFFAOYSA-N
CHEMBL3793499,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cccnc1,IC50,6.18,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,UAQPYWINZIRBDY-QJPTWQEYSA-N
CHEMBL3792839,,O=C(CCCC[C@@H]1CCSS1)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO,IC50,6.48,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,AVEZQSILLDDILW-YXCITZCRSA-N
CHEMBL3793670,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccccc1,IC50,6.28,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,WINHOLWWINLHRE-YNEHKIRRSA-N
CHEMBL3793197,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccccc1Cl,IC50,6.19,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,YPKZCXHKFPTHFY-YNEHKIRRSA-N
CHEMBL3793499,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cccnc1,IC50,4.88,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,UAQPYWINZIRBDY-QJPTWQEYSA-N
CHEMBL3792429,,CC(=O)Oc1ccccc1C(=O)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO,IC50,5.45,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,XKWCELKXOXBVSR-RRFJBIMHSA-N
CHEMBL3764541,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccc(SC)cc2)cc(OC)c1OC,IC50,5.69,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,BSTXCPVIBADBRU-CPNJWEJPSA-N
CHEMBL3765252,,COc1cc(/C=C(/C(=O)N2CCC=CC2=O)c2ccc(F)cc2)cc(OC)c1OC,IC50,5.71,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,RHGMRAZDADDXKT-LDADJPATSA-N
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,7.96,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,HVXBOLULGPECHP-WAYWQWQTSA-N
CHEMBL352630,,COCC(=O)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.16,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,PUVLMZIGKJSEMS-UHFFFAOYSA-N
CHEMBL5572684,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CNC1)C3,IC50,5.54,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DQLTZXUTRHYPJH-UHFFFAOYSA-N
CHEMBL5569200,,N[C@H]1CCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C1,IC50,6.16,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DKTKUPGWANWPSS-NSHDSACASA-N
CHEMBL5589615,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CCCNC1)C3,IC50,5.46,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DJAPPFABCGXIHD-UHFFFAOYSA-N
CHEMBL4090663,,Cc1nc(C)c(/C=C/C(=O)N2CCC=C(Br)C2=O)nc1C,IC50,5.37,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QDSGKXLBOWDWHE-VOTSOKGWSA-N
CHEMBL465843,PIPLARTINE,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,IC50,4.76,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VABYUUZNAVQNPG-BQYQJAHWSA-N
CHEMBL4090082,,COc1cc(/C=C/C(=O)c2ccccc2)ccc1OCCCN1CCCc2ccccc21,IC50,4.7,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,VFOXCQNDDNLOKR-JQIJEIRASA-N
CHEMBL4100526,,CSc1nc(N2CCOCC2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.69,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,QGGIXKZOWARZOR-UHFFFAOYSA-N
CHEMBL4091022,,CSc1nc(NCc2ccccc2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,5.15,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,RENHBYHXMSFCBW-UHFFFAOYSA-N
CHEMBL4084146,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ISLMUWZWOABKBN-UHFFFAOYSA-N
CHEMBL3735270,,OC[C@H]1O[C@@H](Sc2c(F)c(F)c(/C3=C4\C=CC(=N4)C(c4c(F)c(F)c(F)c(F)c4F)C4=N/C(=C(/c5c(F)c(F)c(S[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(F)c5F)c5ccc([nH]5)/C(c5c(F)c(F)c(F)c(F)c5F)=C5/C=CC3=N5)C=C4)c(F)c2F)[C@H](O)[C@@H](O)[C@@H]1O,EC50,8.0,CHEMBL3737968,Photocytotoxicity against human U87 cells assessed as cell survival preincubated for 24 hrs followed by irradiation at 16 J/cm2 measured at 24 hrs by WST-8 assay,U-87MG ATCC,AYDRZTACVIBHHJ-ZBFLLVCBSA-N
CHEMBL4092999,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.92,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XDRRPCJJHJGRKX-UHFFFAOYSA-N
CHEMBL1164287,,COc1cc(C(=O)OCc2ccccc2COC(=O)c2ccc(O)c(OC)c2)ccc1O,IC50,4.19,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,CYTQDYWRDYAMTP-UHFFFAOYSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.7,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL4286698,,Nc1cc(C(F)F)c(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)cn1,IC50,6.04,CHEMBL4276443,Growth inhibition of human A172 cells after 72 hrs by ATPlite based assay,A-172,UGDKPWVVBKHRDK-UHFFFAOYSA-N
CHEMBL331163,,CN(C)c1ccnc2c1-c1nccc3ccnc(c13)C2=O,IC50,5.7,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,BLYPRRAUYLWDOD-UHFFFAOYSA-N
CHEMBL113436,,Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.7,CHEMBL815087,Compound was tested for inhibiting HIV (ADA) entry into cells; Range is 0.2-2.0 nM,U-87MG ATCC,DTKUANPECHGGBY-UNMCSNQZSA-N
CHEMBL288441,BOSUTINIB,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,IC50,5.26,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,UBPYILGKFZZVDX-UHFFFAOYSA-N
CHEMBL1186585,,O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12,IC50,4.43,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,MIDUFIRTIFUTQA-UHFFFAOYSA-N
CHEMBL3805762,,C[C@]12CC[C@H](OC(=O)Cn3cc(COc4ccc5ccc(=O)oc5c4)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.36,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YXTSDYROYUUFHX-ZYDPEMPTSA-N
CHEMBL85702,,CCOP(=O)(OCC)N(C)/N=N\C,IC50,4.85,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,BARCMKNJTPZIIK-FPLPWBNLSA-N
CHEMBL3793670,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccccc1,IC50,6.36,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,WINHOLWWINLHRE-YNEHKIRRSA-N
CHEMBL3793573,,CC(C)(C)c1ccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc1,IC50,5.96,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,MYGBVGRQGYOQBF-ARFHVFGLSA-N
CHEMBL3793372,,COc1ccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc1,IC50,6.41,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,FQPVJRDHGMKKQS-BFHYXJOUSA-N
CHEMBL3792429,,CC(=O)Oc1ccccc1C(=O)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO,IC50,5.01,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,XKWCELKXOXBVSR-RRFJBIMHSA-N
CHEMBL3793372,,COc1ccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc1,IC50,6.28,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,FQPVJRDHGMKKQS-BFHYXJOUSA-N
CHEMBL3792839,,O=C(CCCC[C@@H]1CCSS1)O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO,IC50,6.25,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,AVEZQSILLDDILW-YXCITZCRSA-N
CHEMBL3780698,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.32,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KXTZGBPADOSZJP-UHFFFAOYSA-N
CHEMBL3780522,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.88,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GUOHTHYECWTYKK-UHFFFAOYSA-N
CHEMBL313958,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)c2=S)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,FWXPNVLRLORRJY-UHFFFAOYSA-N
CHEMBL85734,,Oc1ccc(-c2cc3c(O)cc(O)cc3nc2O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,WWGWIVQHGAYORR-UHFFFAOYSA-N
CHEMBL85761,,CC(=O)Oc1ccc(-c2cc3c(OC(C)=O)cc(OC(C)=O)cc3n(C)c2=O)cc1,IC50,5.0,CHEMBL815083,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,FPPHNMULMXCJGO-UHFFFAOYSA-N
CHEMBL339527,,Nc1ccc2nc3c4c(nccc4c2c1)-c1ncccc1C3=O,IC50,7.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,QVCFIRMNSMMTLK-UHFFFAOYSA-N
CHEMBL3337794,,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.58,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,CUPKWSGZEKNROE-ODZSYRHHSA-N
CHEMBL442870,PHENETHYLISOSELENOCYANATE,[Se]=C=NCCc1ccccc1,IC50,4.62,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,CNMSUIBHTZHSEK-UHFFFAOYSA-N
CHEMBL115487,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.0,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,HMVJROBJYQFKLV-GOTSBHOMSA-N
CHEMBL1170448,,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12,IC50,6.51,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,BAYGQIFIHYGSEE-IBGZPJMESA-N
CHEMBL1170261,,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,IC50,6.19,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,MACTYDWFDZZTGD-FQEVSTJZSA-N
CHEMBL1096067,,CCCCC(C#CC(=O)OC)O/C=C/C(=O)OC,IC50,5.31,CHEMBL4378598,Antiproliferative activity against human U87 cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,UTONHELWURZURG-MDZDMXLPSA-N
CHEMBL98745,NARCICLASINE,O=C1N[C@@H]2C(=C[C@H](O)[C@@H](O)[C@H]2O)c2cc3c(c(O)c21)OCO3,IC50,7.32,CHEMBL998498,Antiproliferative activity against human T98G cells by MTT assay,T98G,LZAZURSABQIKGB-AEKGRLRDSA-N
CHEMBL5175707,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(CCF)CC2)cc1)OCc1cccnc1,IC50,6.39,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YLGCHBUJABEZPI-UHFFFAOYSA-N
CHEMBL5199657,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(C3CCC3)CC2)cc1)OCc1cccnc1,IC50,6.21,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,KOYLPNACSINQDI-UHFFFAOYSA-N
CHEMBL3343410,,CC[P@@]1(=O)O[C@H]([C@H]2COC(C)(C)O2)[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O,Ki,7.57,CHEMBL3374650,Antimigratory activity against human SNB75 cells on matrix containing laminin after 24 hrs by 2-D migration assay,SNB-75,YDBHENJAGLBQMF-ZAHCLZMSSA-N
CHEMBL4468971,,CC(=O)C(=NNc1ccccc1C#N)C(C)=O,IC50,4.06,CHEMBL4317180,Cytotoxicity against human LN229 cells assessed as reduction in cell proliferation measured after 48 hrs by trypan blue dye-based cell counting analysis,LN-229,FDMUFIZTSWLKSP-UHFFFAOYSA-N
CHEMBL3609559,,CC1(C)OC2=C(CC1SCc1ccccc1)C(=O)C(=O)c1ccccc12,IC50,5.41,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,RJMWHRTZXBLHNQ-UHFFFAOYSA-N
CHEMBL3609561,,Cc1ccc(SC2CC3=C(OC2(C)C)c2ccccc2C(=O)C3=O)cc1,IC50,5.22,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,VKFXKHDQMRJCPP-UHFFFAOYSA-N
CHEMBL50001,,COC(=O)c1ccccc1SC/C=C(\C)CC/C=C(\C)CCC=C(C)C,IC50,5.0,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,VSEDGUQFBMASFM-YEFHWUCQSA-N
CHEMBL496557,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(N)=O,IC50,5.0,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,GZTMFRUGZMZCRD-CFBAGHHKSA-N
CHEMBL524628,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N(C)C,IC50,4.7,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,LQDIKDAVLUSQPN-YHHVCGRHSA-N
CHEMBL1911117,,COc1cc(N)cc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,8.32,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,GVCOXBXPKBZDEG-UHFFFAOYSA-N
CHEMBL478414,,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,4.71,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,MXEIEIPFARBHKD-JQZXIOIQSA-N
CHEMBL326020,,Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,8.7,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,KFQDPQKXTSWQOC-SFTDATJTSA-N
CHEMBL4060227,,COc1cc(Nc2nnc(Cl)c(Nc3cccc(NS(C)(=O)=O)c3)n2)cc(OC)c1OC,IC50,7.16,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,LPANKDJQNNNOIR-UHFFFAOYSA-N
CHEMBL4090537,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5F)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.95,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IHLDUYHYMVUCMO-UHFFFAOYSA-N
CHEMBL4279607,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(C(F)(F)F)cc5Cl)c4=O)cc3F)ccnc21,IC50,4.99,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PSHVAMXWEGRSSC-UHFFFAOYSA-N
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.03,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL1097304,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)NCC(=O)OC(C)CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.81,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,PVRNBHHCMFPGTE-FBXQPAQYSA-N
CHEMBL5565786,,NCCN(CCN)C(=O)C1Cc2c(O)c3c(c(O)c2C1)C(=O)c1ccccc1C3=O,IC50,5.8,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,FCTNJSDNGJBGKT-UHFFFAOYSA-N
CHEMBL5590209,,N#CC1(C(=O)Nc2ccc3c(c2)OCO3)CC2c3ccccc3C1c1ccccc12,IC50,4.34,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,KKZYSGCIMXPESB-UHFFFAOYSA-N
CHEMBL4238656,,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C(C)(C)C)nc3n2)cc1CO,IC50,8.49,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,DZLWBRXUDBZZHQ-HNNXBMFYSA-N
CHEMBL4239712,,CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(C(C)(C)C)nc3n2)c1,IC50,7.49,CHEMBL4233146,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by CCK8 assay,U-87MG ATCC,VUWOZURKZJVAEV-HNNXBMFYSA-N
CHEMBL4572589,,CCN(CC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.58,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,PVIFYSUWLTVVKK-MDWZMJQESA-N
CHEMBL2385175,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.77,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NQSBULPZCGDNAY-UHFFFAOYSA-N
CHEMBL2385174,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.84,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ADAZJHGJWPAJRZ-UHFFFAOYSA-N
CHEMBL4162596,,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc(C/C=C(\C)CCC=C(C)C)c1O,EC50,5.16,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,MRXGJOGASBBDTM-FVFOHYRDSA-N
CHEMBL223046,VEDELIANIN,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)[C@H](O)C[C@@]2(C)O3)cc1O,EC50,7.52,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,OYMAGMAEFPAAGU-HKYLTJPLSA-N
CHEMBL4535709,,CCOc1cccc2c1C(=O)c1c(OCC)cc(NC(=O)CI)cc1C2=O,IC50,4.98,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,KAKKQFWHQUGART-UHFFFAOYSA-N
CHEMBL4452206,,CCCOc1cccc2c1C(=O)c1c(OCCC)cc(NC(=O)CN=[N+]=[N-])cc1C2=O,IC50,4.75,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,IHULAANGIJWQQE-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.6,CHEMBL4604072,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL85726,,COc1ccc(-c2cc3c(OC)cc(OC)c4c3n(c2=O)CCC4=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,IDBLOWQDUQJYDQ-UHFFFAOYSA-N
CHEMBL117784,,COc1ccnc2c1-c1nccc3ccnc(c13)C2=O,IC50,7.0,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,WCRIHVQLNYDYHQ-UHFFFAOYSA-N
CHEMBL87769,,CNC(=O)N(C)/N=N\CCCl,IC50,4.57,CHEMBL624724,Evaluated for the inhibitory concentration required to cause growth inhibition of A172Mer- cell line of central nervous system (CNS) using the MTT Cytotoxicity Assay,A-172,CJLYVUNRUJYSGI-HJWRWDBZSA-N
CHEMBL2435973,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C(F)(F)F)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JIRWVSFHXIEANN-UHFFFAOYSA-N
CHEMBL3109415,,CC(=O)O[C@@]1(C)CCC(=O)/C(C)=C/CC[C@]2(C)O[C@H]2C(=O)C(=C(C)C)CC1,IC50,4.43,CHEMBL3112362,Cytotoxicity against human A172 cells cells after 24 hrs by MTT assay,A-172,JNFYTEVLFJWCJH-VUWNFVCTSA-N
CHEMBL354150,,CC(=O)OCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,5.4,CHEMBL624722,In vitro cytotoxicity against A172 human tumor cell lines.,A-172,WOJJOSHDTGRKES-UHFFFAOYSA-N
CHEMBL314461,,COc1ccc2cc(-c3ccccc3)c(O)nc2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,AJLACADSVJJPJH-UHFFFAOYSA-N
CHEMBL119037,,COc1ccc2c(n1)C(=O)c1nccc3ccnc-2c13,IC50,5.22,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,NXHFYTNPRXAFAC-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,7.16,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL3805637,,O=C(/C=C\Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.99,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,KFRVRWSQDNDVJA-NXVVXOECSA-N
CHEMBL3805375,,O=C(/C=C\Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,4.74,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,CXYFPWNKXDCDRW-PFONDFGASA-N
CHEMBL1823630,,N[C@H](CNc1nnc(-c2ccc3c(c2)CC(=O)N3)s1)Cc1ccc(C(F)(F)F)cc1,IC50,6.52,CHEMBL1825376,Inhibition of AKT1-mediated PRAS40 phosphorylation in human U87MG cells after 1 hr in presence of 5% FBS by ELISA assay,U-87MG ATCC,ULPHTBRVXJBSIQ-HNNXBMFYSA-N
CHEMBL3965975,,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCNc1c2ccccc2nc2ccccc12)C(=O)N[C@@H](CCCCNc1c2ccccc2nc2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,IC50,4.99,CHEMBL3853427,Antiviral activity against HIV1 NL4-3 infected in human U87 cells transfected with CD4/CXCR4 assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24 assay,U-87MG ATCC,PBPCGYFTVDKXDD-OWBOGJPASA-N
CHEMBL3927147,,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCNc1c2ccccc2nc2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCNc1c2ccccc2nc2ccccc12)C(=O)N[C@@H](CCCCNC(=O)c1ccc(B(O)O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O,IC50,5.0,CHEMBL3853427,Antiviral activity against HIV1 NL4-3 infected in human U87 cells transfected with CD4/CXCR4 assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection for 24 hrs and subsequent compound wash out and addition of additional compound measured at 72 hrs post infection by p24 assay,U-87MG ATCC,PLFZZOMKOTYLDB-SHAJCIBYSA-N
CHEMBL2172488,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncn4C)cn23)n1,IC50,6.56,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,CTXUPZKYBBQLJM-UHFFFAOYSA-N
CHEMBL2172482,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cnccc4C)cn23)n1,IC50,7.31,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,NECBLBSHQGQKDS-UHFFFAOYSA-N
CHEMBL2172639,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccc(F)c4)cn23)n1,IC50,6.04,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,ZTOKQSUVJJWFOD-UHFFFAOYSA-N
CHEMBL272265,,N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,IC50,7.03,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,MBIMERRBQGQJIO-UHFFFAOYSA-N
CHEMBL2385200,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cc(C)ccc5C)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.61,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YECWSUXGTFLMNH-UHFFFAOYSA-N
CHEMBL2385177,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.98,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SLONUMXPVJUXEW-UHFFFAOYSA-N
CHEMBL4639291,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCCCCC[n+]3ccccc3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,4.95,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,AHEFQKUDCFDRAD-XARMMMSZSA-M
CHEMBL4642711,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCCCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,5.89,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,ACEHQLUTLAXHMS-ZTDYFSAPSA-M
CHEMBL4285411,,CCCCCCCCCCCC[N+]1(C)CCN(CC(=O)O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)CC1.[I-],IC50,5.12,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,ZOLGSVKCRDIUOJ-NCHIOQGESA-M
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.95,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL375920,,Cc1cccn2c3c(nc12)-c1ncccc1C(=O)C3=O,IC50,7.07,CHEMBL904567,Anticancer activity against human XF498 cells after 48 hrs by SRB assay,XF 498,VPBRLYVYYCPCCW-UHFFFAOYSA-N
CHEMBL4752354,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccc(Cl)cc2)n1,IC50,5.47,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,RHKHXSMWHHAZLL-UHFFFAOYSA-N
CHEMBL590522,MAHANINE,CC(C)=CCC[C@H]1C=Cc2c(c(C)cc3c2[nH]c2cc(O)ccc23)O1,IC50,5.16,CHEMBL2405050,Cytotoxicity against human A172 cells assessed as growth inhibition after 48 hrs by MTT assay,A-172,UKLOEFBVUZOVRX-INIZCTEOSA-N
CHEMBL1911114,,COc1ccc2c(nc(C(F)F)n2-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1O,IC50,6.42,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,JMCCNBLPWHIWCV-UHFFFAOYSA-N
CHEMBL3092922,,C=CCCCCOc1ncc(-c2cc(C(F)(F)F)ccc2OC)n1C,IC50,4.06,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,FVRGXLUIRGUICK-UHFFFAOYSA-N
CHEMBL2392949,,COc1cccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)c1,IC50,5.79,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HUJQXBZJKIRBCV-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.98,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL3104250,,C/C(=N\NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1)c1cc(Cl)ccc1O,IC50,5.94,CHEMBL3107689,Growth inhibition of human U87 cells after 96 hrs by ATPlite luminescence assay,U-87MG ATCC,NKUDGJUBIVEDTF-FYJGNVAPSA-N
CHEMBL1911002,,FC(F)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,6.38,CHEMBL1914068,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Thr308 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,PJLRZCKJQYTSNY-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,5.88,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL2417828,,COc1ncc(-c2ccn3nc(NC(C)=O)nc3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,5.69,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,GTKPTDFLYGQQPV-UHFFFAOYSA-N
CHEMBL2417824,,CCOC(=O)CNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.1,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,WNQIPKTTWSVBJF-UHFFFAOYSA-N
CHEMBL2417836,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(C2CC2)cc1,IC50,5.43,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,YFSUSZAVLPDOCY-UHFFFAOYSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,5.56,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL337820,,Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,10.0,CHEMBL815086,Tested for inhibiting HIV (ADA) entry into cells,U-87MG ATCC,KUOUHUKIBBTXEV-PXNSSMCTSA-N
CHEMBL2206919,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(C)c(NS(C)(=O)=O)c2)n1,IC50,7.02,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,RBXKFGUMEZSADC-UHFFFAOYSA-N
CHEMBL481608,,C=CCN(C)Cc1ccc(-c2ccc(C(=O)c3ccc(Br)cc3)cc2)cc1.Cl,IC50,4.75,CHEMBL2168459,Cytotoxicity against human LN229 cells assessed as reduction in cell survival after 72 hrs by MTT assay,LN-229,MCMDJJBPNGLKKM-UHFFFAOYSA-N
CHEMBL5394493,,COc1cccc(-c2ccc(F)c(NC(=O)C#Cc3ccccc3)c2)c1,IC50,4.93,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,XIGSSELZIPMFEM-UHFFFAOYSA-N
CHEMBL5415803,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cc(OC)c(OC)c(OC)c1,IC50,6.91,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,WCOJKQVBIGKRIH-UHFFFAOYSA-N
CHEMBL5423427,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(F)cc1,IC50,7.47,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,VFWLIXHERZWZAJ-UHFFFAOYSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.8,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL3889534,,Cl.FC(F)(F)c1cccc(-c2c[nH]c(C3CCN(c4ncnc5[nH]ncc45)CC3)n2)c1,IC50,4.84,CHEMBL3881188,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation after 72 hrs by Alamar Blue assay,U-87MG ATCC,KBPOPQFIGUANJS-UHFFFAOYSA-N
CHEMBL5430183,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,8.96,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,BVLMGTBJGDNQCI-MNVSKPNQSA-N
CHEMBL5394654,,C=CCc1c(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c(c1O)O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.34,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,WMKPMYWSMDYVJC-IZTRPBQQSA-N
CHEMBL411344,SCHWEINFURTHIN H,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)C(O)C3)cc2c1O[C@]1(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.18,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,RFLJGOACFXZRHJ-ZHIKFPNPSA-N
CHEMBL5413968,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc(C)ccc32)cc1,IC50,4.68,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,KBDSJUFIJNFEOV-UHFFFAOYSA-N
CHEMBL5396858,,CC(=O)n1cc(Cc2cc(C)c(O)c(C)c2)c2ccccc21,IC50,4.23,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WIWKDKJEINZEAT-UHFFFAOYSA-N
CHEMBL2163603,,CC(C)CN(Cc1cc(O)c2c(c1)C=CC(C)(C)O2)S(=O)(=O)c1ccncc1,IC50,4.04,CHEMBL2169673,Cytotoxicity against human LN229 cells transfected with V6R incubated for 3 days under normoxic condition by SRB assay,LN-229,NJOAQZNAGFIDRV-UHFFFAOYSA-N
CHEMBL1911002,,FC(F)Oc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCOCC2)n1,IC50,6.37,CHEMBL1914069,Inhibition of PIK3CA-mediated cell signaling in PTEN-deficient human U87MG cells assessed as inhibition of insulin-induced pAkt/PKB phosphorylation at Ser473 treated for 15 mins before insulin challenge measured after 5 mins by immunoblotting,U-87MG ATCC,PJLRZCKJQYTSNY-UHFFFAOYSA-N
CHEMBL237859,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3nccs3)nccc12,IC50,6.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,ZCBXKVDZSCIMDK-UHFFFAOYSA-N
CHEMBL393332,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3ncon3)nccc12,IC50,5.91,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,QSZNZPLBLSGDFR-UHFFFAOYSA-N
CHEMBL393331,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3ccnc(N)n3)nccc12,IC50,6.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BBKIJJQQYXXNIU-UHFFFAOYSA-N
CHEMBL238115,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)nccc12,IC50,7.27,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,WELZLTSZYGTAHI-UHFFFAOYSA-N
CHEMBL429087,,COc1cc2c(S(=O)(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c2cn1,IC50,5.04,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,LHMWTBKZSSXQOL-CQSZACIVSA-N
CHEMBL240477,,CC1CN(C(=O)c2ccc3[nH]ccc3c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.34,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,CJYOAVILJRQDKM-UHFFFAOYSA-N
CHEMBL238103,,COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c[nH]c12,IC50,7.58,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,DBPMWRYLTBNCCE-UHFFFAOYSA-N
CHEMBL337301,,COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c12,IC50,8.1,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,OKGPFTLYBPQBIX-CQSZACIVSA-N
CHEMBL442078,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1c[nH]c2ncccc12,IC50,7.52,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,CCGWWGUXCYXFJW-CQSZACIVSA-N
CHEMBL2206909,,Cc1nc(N)nc(-c2cc(CN3CCOCC3)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,IC50,8.41,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,ZMAXXRHYLSDAIN-UHFFFAOYSA-N
CHEMBL2206918,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,7.75,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,QNTWFBRDSGVBHE-UHFFFAOYSA-N
CHEMBL1042,CHOLECALCIFEROL,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.53,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QYSXJUFSXHHAJI-YRZJJWOYSA-N
CHEMBL1949933,,C=C1CC[C@@H](N)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.91,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KBTODVOGUWIIOU-YHJXBONMSA-N
CHEMBL1949934,,C=C1CC[C@@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.41,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QYSXJUFSXHHAJI-YHJXBONMSA-N
CHEMBL1949935,,C=C1CC[C@H](N)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.91,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KBTODVOGUWIIOU-YRZJJWOYSA-N
CHEMBL269277,BETULINIC ACID,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.66,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,QGJZLNKBHJESQX-FZFNOLFKSA-N
CHEMBL2172634,,Cc1nc(Nc2cnn(C3CCOC3)c2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.84,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,BODKINCAIVHOBM-UHFFFAOYSA-N
CHEMBL2172625,,Cc1nc(N)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.68,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,PQQNUIZZMSTORP-UHFFFAOYSA-N
CHEMBL388708,,Cc1cc(Oc2ccc3c(c2)OCO3)nc(Oc2ccc(-n3ccnc3)cc2F)n1,IC50,7.04,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,FDGPPDMWCPBMSY-UHFFFAOYSA-N
CHEMBL2163603,,CC(C)CN(Cc1cc(O)c2c(c1)C=CC(C)(C)O2)S(=O)(=O)c1ccncc1,IC50,4.52,CHEMBL2166126,Cytotoxicity against human LN229 cells transfected with V6R incubated for 1 hr under normoxic condition followed by 14 days under hypoxic condition by clonogenecity assay,LN-229,NJOAQZNAGFIDRV-UHFFFAOYSA-N
CHEMBL2163603,,CC(C)CN(Cc1cc(O)c2c(c1)C=CC(C)(C)O2)S(=O)(=O)c1ccncc1,IC50,4.64,CHEMBL2166125,Cytotoxicity against human LN229 cells transfected with V6R incubated for 14 days under normoxic condition by clonogenecity assay,LN-229,NJOAQZNAGFIDRV-UHFFFAOYSA-N
CHEMBL2163598,,COc1cc(CN(C(C)C)S(=O)(=O)c2ccccn2)cc2c1OC(C)(C)C=C2,IC50,4.16,CHEMBL2166125,Cytotoxicity against human LN229 cells transfected with V6R incubated for 14 days under normoxic condition by clonogenecity assay,LN-229,LREPTZOCUMWFMS-UHFFFAOYSA-N
CHEMBL4450512,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(C[Se]c3ccc(F)cc3)nn2)[C@H]1Br,IC50,5.83,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,OAOAYCGZHNXPAB-WMZHIEFXSA-N
CHEMBL454935,,CC(C)(O)c1cn(C2C3=C(OC2(C)C)c2ccccc2C(=O)C3=O)nn1,IC50,5.55,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,KQPBRFALEYFWBN-UHFFFAOYSA-N
CHEMBL1927618,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(CCN(C)C)c23)C1=O,IC50,6.43,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NLQVIEPODYFPBE-UHFFFAOYSA-N
CHEMBL428676,AMONAFIDE,CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O,IC50,5.55,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UPALIKSFLSVKIS-UHFFFAOYSA-N
CHEMBL475845,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](CS(=O)(=O)O)C(C)=O)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,7.9,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,YWMWRRNNRCIAAJ-WGPXQLEISA-N
CHEMBL515145,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@H](C)[C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,8.46,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,PCZVRCIZMAPKOI-HMHHHFJXSA-N
CHEMBL3290920,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.82,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,RVPSNYLJUHSZDC-UHFFFAOYSA-N
CHEMBL1170446,,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,IC50,6.04,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,XDBJHHAFLGPGOE-FQEVSTJZSA-N
CHEMBL259265,,c1ccc2c(c1)N(c1ncnc3[nH]ccc13)CC21CCNCC1,IC50,7.02,CHEMBL936669,Inhibition of AKT1 in human U87 cells after 2 hrs by ELISA,U-87MG ATCC,OMUNCTQJLGEHQC-UHFFFAOYSA-N
CHEMBL1914727,,O=S(=O)(Nc1cc(-c2ccc3nccc(-c4ccncc4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,8.43,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,LHLRTOZIMJUPET-UHFFFAOYSA-N
CHEMBL1914719,,CN(C)c1ccnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc12,IC50,6.65,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,RTHFARGKBRIFCM-UHFFFAOYSA-N
CHEMBL1914721,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCC(O)CC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.82,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,LGDWBXISXWXDQF-UHFFFAOYSA-N
CHEMBL1914742,,CC(C)N1CCN(c2cnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc3n2)CC1,IC50,7.77,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,MVPHPMFJESRQLE-UHFFFAOYSA-N
CHEMBL376632,,Cc1cc(N2CCC[C@@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.54,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LBCGUKCXRVUULK-QGZVFWFLSA-N
CHEMBL442041,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,YCVKPMKXQJEDIS-UHFFFAOYSA-N
CHEMBL376237,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc(Cl)cc1,IC50,8.24,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,QSGAUBIKGYULKQ-UHFFFAOYSA-N
CHEMBL223839,,COc1ccccc1CNC(=O)CC1CCCCN1c1ccnc(-n2ccnc2)n1,IC50,6.55,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MQLMLAGRRODONI-UHFFFAOYSA-N
CHEMBL374681,,COc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,9.1,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,RWQHNEZMEIPWJF-UHFFFAOYSA-N
CHEMBL223840,,O=C(CC1CCCCN1c1cc(C(F)(F)F)nc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,6.75,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,JDDBNIXQWYFIPL-UHFFFAOYSA-N
CHEMBL220824,,Cc1cc(N2CCN(C(=O)C(C)C)[C@@H](CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,6.52,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BNKGEZQUYVVMBA-FQEVSTJZSA-N
CHEMBL1369953,,Nc1[nH]nc2nc3ccccc3cc12,IC50,5.11,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,KEVOFPICRVTBPL-UHFFFAOYSA-N
CHEMBL3612310,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,6.41,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,YWFOHQFLGQVFIB-UHFFFAOYSA-N
CHEMBL3612315,,COc1ncc(-c2ccc3nc(NC(=O)NCCN(C)C)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.99,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,MMPNESYYANFTSJ-UHFFFAOYSA-N
CHEMBL3612321,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCOCC4)sc3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,6.28,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,GQEYRORRZYLMJY-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,5.85,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL270638,,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)C#N)cc1,IC50,7.35,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,HFNJWNHCEQNJQQ-UHFFFAOYSA-N
CHEMBL270638,,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)C#N)cc1,EC50,6.84,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,HFNJWNHCEQNJQQ-UHFFFAOYSA-N
CHEMBL4644076,,Cc1c(C(=O)N/N=C\c2c(O)cccc2F)oc2cccc(O)c12,IC50,5.03,CHEMBL4618024,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth,U-87MG ATCC,LLUZEJOXOPCQPJ-UWVJOHFNSA-N
CHEMBL2385201,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.31,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JUNYZZIFXGBUIR-UHFFFAOYSA-N
CHEMBL52910,,CC(=O)O.COCOCCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,IC50,4.92,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,SIUALZNIFSJUSF-UHFFFAOYSA-N
CHEMBL2418954,,CC(=O)Nc1cn2cc(-c3cnc(N)c(C(F)(F)F)c3)ccc2n1,EC50,5.7,CHEMBL2423268,Cytotoxicity against human U87MG cells,U-87MG ATCC,TVUPSIBSWDXJGQ-UHFFFAOYSA-N
CHEMBL110757,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1,IC50,9.05,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,XXBAQSKVZOMDJH-GKPLWNPISA-N
CHEMBL3093014,,C=CCCCCOc1cc2ccccc2cc1-c1cnc(OCCCCC=C)n1C,IC50,4.4,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,UCNOEJJVPVJYSN-UHFFFAOYSA-N
CHEMBL3093030,,Cn1c2cnc1OCCCCCCCCOc1ccccc1-2,IC50,4.12,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GOQRJMXCBGQPQO-UHFFFAOYSA-N
CHEMBL364713,NOSCAPINE,COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,IC50,4.7,CHEMBL3599619,Antiproliferative activity against human A172 cells assessed as decrease in colony formation,A-172,AKNNEGZIBPJZJG-MSOLQXFVSA-N
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,4.79,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,RDSACQWTXKSHJT-UHFFFAOYSA-N
CHEMBL521686,OLAPARIB,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,IC50,4.21,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,FDLYAMZZIXQODN-UHFFFAOYSA-N
CHEMBL3818951,,CC[C@H](C)[C@H](NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12)C(=O)N[C@H](C(=O)OC)[C@@H](C)CC,IC50,7.93,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,DSKXIRKCUGRZJR-MQQADFIWSA-N
CHEMBL493090,,CN1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.1,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,XXHROJHHXVCFML-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,7.35,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL601719,CRIZOTINIB,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,IC50,4.78,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,KTEIFNKAUNYNJU-GFCCVEGCSA-N
CHEMBL217092,SARACATINIB,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,IC50,5.44,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,OUKYUETWWIPKQR-UHFFFAOYSA-N
CHEMBL1242367,,CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,IC50,4.83,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,YVXCDLCJCIDFHE-DKXQDJALSA-N
CHEMBL213100,,COc1ccc(N(C(=O)Oc2c(C)cccc2C)c2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c(OC)c1,IC50,4.17,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,NBTNHSGBRGTFJS-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL2435959,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5F)n4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.11,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VHCBNYHCIPMGJM-UHFFFAOYSA-N
CHEMBL2435971,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,4.9,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XQLJHWGHYTTZRD-UHFFFAOYSA-N
CHEMBL5274151,,c1ccc(-c2nc(CNc3nccc(N4CCC4)n3)cs2)cc1,IC50,4.67,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,LUXJFZBHVLTCOX-UHFFFAOYSA-N
CHEMBL470052,,O=C1c2ccc(Br)cc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-],IC50,6.23,CHEMBL1000754,Antitumor activity against human SF295 cells,SF295,OCNFGKRSWOZYBV-UHFFFAOYSA-N
CHEMBL3394092,,ClC(Cn1ncc2c(Nc3cccc(Br)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1,IC50,4.76,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,TWWILBWAYDXBCM-UHFFFAOYSA-N
CHEMBL4087882,,CN1CCN(CCOC(=O)N(c2cccc(Br)c2)c2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,5.75,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,ZPYFGEVWAWJEIR-UHFFFAOYSA-N
CHEMBL4090317,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,5.59,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,PHZNEXIQOLYTSB-UHFFFAOYSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,7.34,CHEMBL980865,Inhibition of Akt Ser 473 phosphorylation in PTEN-null human U87MG cells,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL1652070,,CCCC1=C(OC2(CCC)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.93,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZYYHKDCWWXNTTA-UHFFFAOYSA-N
CHEMBL3622411,,Cl.O=C(CN1CCCCC1)NC1(C(=O)NCc2ccc(Cl)cc2)CSC2=C1C(=O)c1ccccc1C2=O,IC50,6.21,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,JEUNFIVMHNCMAB-UHFFFAOYSA-N
CHEMBL7492,PIRITREXIM,COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1,IC50,7.32,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,VJXSSYDSOJBUAV-UHFFFAOYSA-N
CHEMBL4794622,,CCOC(=O)[C@@H](N)CCCCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.98,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,QAQOLDHIHQCYBL-IKGHOSPCSA-N
CHEMBL7063,,COc1cc(CC2CCc3nc(N)nc(N)c3C2)cc(OC)c1OC,IC50,6.6,CHEMBL801267,Compound was tested for the growth inhibition of SF-295 CNS tumor cell line,SF295,CEJLKULOOMMHNK-UHFFFAOYSA-N
CHEMBL2172637,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccccn23)n1,IC50,6.79,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,OEQWYIZFUDGMEW-UHFFFAOYSA-N
CHEMBL4579634,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CCC(=O)[C@H](C)O,IC50,5.7,CHEMBL4374036,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SF295,DZUFXUWCLMAHIK-VOUBRIMZSA-N
CHEMBL512404,"6,7-DIHYDROPHOMOPSOLIDE B",C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CC[C@H](O)[C@H](C)O,IC50,4.77,CHEMBL4374036,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SF295,ZFVYHTGRRBKBJE-BUEHMHBYSA-N
CHEMBL5424990,,COc1ccc(OC)c(COc2cc(NC(=O)OCCOCCOCCOC(=O)Nc3ccc(NS(C)(=O)=O)c(OCc4cc(OC)ccc4OC)c3)ccc2NS(C)(=O)=O)c1,IC50,5.26,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,JBISAMZWMJFIRT-UHFFFAOYSA-N
CHEMBL4444630,,COc1cc2c(cc1OC)[C@H](O)[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C,IC50,5.85,CHEMBL4337234,Cytotoxicity against human SF295 cells assessed as inhibition of cell viability after 69 hrs by MTT assay,SF295,ZAVWGRCRKSHIMO-OALUTQOASA-N
CHEMBL4757761,,CC(C)(C)OC(=O)N1CC[C@]2(C(=O)Nc3ccccc32)[C@H]1c1cccc(-c2cc(F)c(CO)c(S(C)(=O)=O)c2)c1,IC50,5.11,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,HYQGRYRHNUHTJF-PDDLMNHVSA-N
CHEMBL1615189,,CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,8.2,CHEMBL1828261,Inhibition of PI3K-mediated Akt phosphorylation at Ser 473 in human U87MG cells after 2 hrs by alphascreen assay,U-87MG ATCC,YGBMCLDVRUGXOV-UHFFFAOYSA-N
CHEMBL5399967,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3ccccc32)cc1,IC50,5.14,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,FBLPWEPWFONTID-UHFFFAOYSA-N
CHEMBL5420275,,COc1ccc2c(Cc3cc(C)c(O)c(C)c3)cn(S(=O)(=O)c3ccc(C)cc3)c2c1,IC50,4.98,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WZZXMLBYQHQMME-UHFFFAOYSA-N
CHEMBL5413828,,Cc1cc(Cc2cn(Cc3ccc(Cl)cc3)c3ccccc23)cc(C)c1O,IC50,4.06,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,NHPSRZJEKIXTMN-UHFFFAOYSA-N
CHEMBL5417863,,Cc1cc(Cc2cn(C(=O)c3ccc(Cl)cc3)c3ccccc23)cc(C)c1O,IC50,4.38,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,OVKXLAMBGQHZFS-UHFFFAOYSA-N
CHEMBL5397688,,Cc1cc(Cc2cn(S(=O)(=O)c3ccc([N+](=O)[O-])c(Cl)c3)c3ccccc23)cc(C)c1O,IC50,5.45,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,ACOUUHGFPHAQCN-UHFFFAOYSA-N
CHEMBL110786,,Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1,IC50,7.42,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KXMNHKYDYLLZNM-UHFFFAOYSA-N
CHEMBL4467693,,CCOP(=O)(OCC)C(N(OC(C)n1cc[n+](C)c1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,BEBGZMBAAKJZSE-UHFFFAOYSA-N
CHEMBL5191468,,O=C(NCCCNc1cc(-c2cn(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)Nc1ccc(F)cc1,IC50,5.86,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,BCNMJLRKWYKBBZ-UHFFFAOYSA-N
CHEMBL5182819,,COc1cccc(-c2nn(-c3ccccc3)cc2-c2ccnc(NCCCNC(=O)Nc3ccc(F)cc3)c2)c1,IC50,5.38,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,BBDDFAGBJKUSTL-UHFFFAOYSA-N
CHEMBL178,DAUNORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.55,CHEMBL4352916,Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay,U-87MG ATCC,STQGQHZAVUOBTE-VGBVRHCVSA-N
CHEMBL4475868,,CCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCC)c4ccccc4C3(C)C)=C2SCCC(=O)Nc2ccn([C@H]3C[C@H](O)[C@@H](CO)O3)c(=O)n2)C(C)(C)c2ccccc21.[Cl-],IC50,5.47,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,CBUCLPBNOVAOCL-XRHWIWAFSA-N
CHEMBL4569800,,O=C(CCS)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,7.96,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,MODDLRRNEHNQAD-BDODKLCJSA-N
CHEMBL4475048,,CCCOc1cccc2c1C(=O)c1c(OCCC)cc(NC(=O)CCl)cc1C2=O,IC50,5.1,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,GZUAONCDQFICIN-UHFFFAOYSA-N
CHEMBL4553726,,[N-]=[N+]=NCCOc1cccc2c1C(=O)c1c(OCCN=[N+]=[N-])cc(NC(=O)CCl)cc1C2=O,IC50,5.32,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,OGZTZYVYGUMFAU-UHFFFAOYSA-N
CHEMBL4450413,,O=C(CI)Nc1cc(OCc2ccccc2)c2c(c1)C(=O)c1cccc(OCc3ccccc3)c1C2=O,IC50,4.86,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,ZFPGMRDWBXYKGL-UHFFFAOYSA-N
CHEMBL4455664,,[N-]=[N+]=NCCOc1cccc2c1C(=O)c1c(OCCN=[N+]=[N-])cc(NC(=O)CN=[N+]=[N-])cc1C2=O,IC50,4.86,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,YFVWLTXYBCBCPX-UHFFFAOYSA-N
CHEMBL4561562,,C=CC(=O)Nc1cc(OCc2ccccc2)c2c(c1)C(=O)c1cccc(OCc3ccccc3)c1C2=O,IC50,5.01,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,MIQLGXGHNNEPKZ-UHFFFAOYSA-N
CHEMBL4453643,,Cc1n[nH]c(=O)c2c1c1cc(F)ccc1n2Cc1cn(Cc2ccc(F)cc2)nn1,IC50,7.38,CHEMBL4343297,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,UPCFUUCRTSFTAE-UHFFFAOYSA-N
CHEMBL2381452,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccccc7CO)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.77,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,WXSHMRMCDVUCEU-RROBCMOASA-N
CHEMBL5590516,,Cc1c(I)c(C)n2c1C=C1C=C(I)C(CCC(=O)NCCCCCCNC(=O)c3ccc(S(N)(=O)=O)cc3)=[N+]1[B-]2(F)F,IC50,7.3,CHEMBL5576892,Photodynamic antitumor activity against human U87 cells assessed as inhibition of cell growth incubated for 60 mins followed by compound washout and light irradiation measured after 72 hrs by MTT assay,U-87MG ATCC,KTSLYWMADUYWFD-UHFFFAOYSA-N
CHEMBL5569643,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCC(=O)NCCCO[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc34)[C@H]21,IC50,7.31,CHEMBL5548646,Antiproliferative activity against human U-87 MG cells measured after 72 hrs by CCK-8 cells,U-87MG ATCC,QFMUFYJYPWNLNA-RJEGBZFXSA-N
CHEMBL1988478,,CC1=CC(=O)c2cccc(O)c2C1=O,IC50,5.62,CHEMBL5514332,Cytotoxicity against human U87 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis,U-87MG ATCC,ZMOIGGHUSNHCAB-UHFFFAOYSA-N
CHEMBL4174909,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(O[C@@H]3CCOC3)c2n1,IC50,6.39,CHEMBL4150401,Cytotoxicity against human T98G cells after 96 hrs by MTT assay,T98G,DVLVYFPEVHXTKT-GOSISDBHSA-N
CHEMBL223515,,O=C(CC1CCCCN1c1nccc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,7.28,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BVJMSWZNRPVGLJ-UHFFFAOYSA-N
CHEMBL219792,,CC(=O)N1CCN(c2cc(C)nc(-n3ccnc3)n2)CC1CC(=O)NCc1ccc2c(c1)OCO2,IC50,8.07,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PRXHAUDSZIOYDL-UHFFFAOYSA-N
CHEMBL220122,,Cc1cc(N2CCN(C)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,LIAQATNNEGXRGJ-UHFFFAOYSA-N
CHEMBL4871213,,O=S(=O)(Nc1cc(-c2ccc3nncc(-n4ccnc4)c3c2)cnc1Cl)c1ccccc1,IC50,4.78,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,QKUMTMOJNZWMQU-UHFFFAOYSA-N
CHEMBL3823820,,CC(C)(C)OC(=O)NCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.8,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HWJQKFLZTSDONP-UHFFFAOYSA-N
CHEMBL3822799,,CCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.48,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,GJXMVBYYKCTZSU-UHFFFAOYSA-N
CHEMBL3823544,,CCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.72,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,ZRHUOQGBOBKJOJ-UHFFFAOYSA-N
CHEMBL3822502,,CCCCCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccc1O,IC50,4.64,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,MRMKOFUCDNSWBG-UHFFFAOYSA-N
CHEMBL3823118,,O=C1C(O)=C(C(NCCCCl)c2cc(Br)ccc2O)C(=O)c2ccccc21,IC50,4.54,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,CBCISFONTTYOSV-UHFFFAOYSA-N
CHEMBL3823494,,O=C1C(O)=C(C(NCc2ccccc2)c2ccccn2)C(=O)c2ccccc21,IC50,5.89,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BMZQEWMGLOSUOR-UHFFFAOYSA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,7.94,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL1084546,PF-00562271,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,IC50,5.19,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,MZDKLVOWGIOKTN-UHFFFAOYSA-N
CHEMBL258844,,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,IC50,4.87,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,BIWGYFZAEWGBAL-UHFFFAOYSA-N
CHEMBL591429,PAC-1,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,IC50,4.71,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,YQNRVGJCPCNMKT-LFVJCYFKSA-N
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,4.58,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL189584,PD-173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,IC50,4.58,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,DXCUKNQANPLTEJ-UHFFFAOYSA-N
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,5.29,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,OGNYUTNQZVRGMN-UHFFFAOYSA-N
CHEMBL3415685,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](CC(C)C)c(C)c21.[Br-],IC50,6.16,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,PAUADKIMJMOVMB-UHFFFAOYSA-M
CHEMBL465843,PIPLARTINE,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,IC50,5.31,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,VABYUUZNAVQNPG-BQYQJAHWSA-N
CHEMBL83405,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCC(=O)OCc3ccccc3)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,TYXOBSPYAFYWGB-UHFFFAOYSA-N
CHEMBL2062868,,C/C=C(\C)C(=O)O[C@H]1C[C@@H](C)[C@]2(OC)CC[C@](C)(/C=C3/OC(=O)C(COC(C)=O)=C31)O2,IC50,5.09,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,CIBBPLMBWXKCDP-RRPNGBMBSA-N
CHEMBL298391,,Cc1cn([C@H]2S[C@@H](CO)[C@H](O)[C@@H]2O)c(=O)[nH]c1=O,IC50,4.17,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,CKHFVQVATAWGSH-AZRUVXNYSA-N
CHEMBL475216,,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,IC50,4.79,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,ZYVVXIHSTYIMGL-GSLJADNHSA-N
CHEMBL514318,,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)CC)NC1=O,IC50,7.67,CHEMBL1034791,Inhibition of [3H]glycine uptake in human T98G cells,T98G,ZRUGSOVQAHAWHC-GSLJADNHSA-N
CHEMBL4280053,,COc1cc(Sc2c[nH]c3c(-c4cccs4)cccc23)cc(OC)c1OC,IC50,6.68,CHEMBL4271597,Growth inhibition of human T98G cells after 48 hrs by MTS assay,T98G,HHIQFCHFPXQBND-UHFFFAOYSA-N
CHEMBL2237321,,O=C(O)/C(=C\c1ccc(Cl)cc1)c1ccccc1,IC50,4.47,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,VRWKAXRIXMCDDY-UVTDQMKNSA-N
CHEMBL5289050,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](Cc3ccccn3)c(C)c21.[Br-],IC50,6.7,CHEMBL5242229,Antiproliferative activity against human T98G cells incubated for 72 hrs by MTT assay,T98G,MYLAXHVFTIRMMF-UHFFFAOYSA-M
CHEMBL260541,,CCCCn1nnc2c1C(=O)c1cnncc1C2=O,IC50,6.74,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,PNAPCIDZFSMMAU-UHFFFAOYSA-N
CHEMBL261876,,CCn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.77,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,KGHAPBUPHIFEAH-UHFFFAOYSA-N
CHEMBL406853,,CCn1nnc2c1C(=O)c1cnncc1C2=O,IC50,7.47,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,IMMFHDPBBANZQP-UHFFFAOYSA-N
CHEMBL4075470,,Cc1cc(=O)n(-c2ccccc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.99,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UVSFRKXOKUPOTQ-UHFFFAOYSA-N
CHEMBL4089464,,Cc1cc(=O)n(-c2cccc(Br)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.25,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DRXUGBRWMOFPNF-UHFFFAOYSA-N
CHEMBL263664,,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.18,CHEMBL932652,Inhibition of PIK-PKB-mTOR pathway in human U87MG cells,U-87MG ATCC,RZIDZIGAXXNODG-UHFFFAOYSA-N
CHEMBL3618236,,Cc1nc(N)nc(-c2c(Nc3ccc4cccnc4c3)nc3ccccn23)n1,IC50,7.75,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,HEVFJNSHEIITJA-UHFFFAOYSA-N
CHEMBL4076153,,COc1cc(COC(C)C)c(Br)c(Br)c1OCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IC50,4.95,CHEMBL4026219,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,AWKZWYURJDYGJQ-VVHMCBODSA-N
CHEMBL4069584,,CCC(CN1CCN(C)CC1)OC(=O)N(c1cccc(Br)c1)c1nc(SC)nc2c1cnn2CC(C)c1ccccc1,IC50,5.11,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,VIWJZMBDSOVKQF-UHFFFAOYSA-N
CHEMBL400211,,CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,4.66,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,ZSKSRKTYCCBGOO-UHFFFAOYSA-N
CHEMBL1836680,,CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,4.79,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,JSXXDWHFXXQDDJ-UHFFFAOYSA-N
CHEMBL3394092,,ClC(Cn1ncc2c(Nc3cccc(Br)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1,IC50,5.17,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,TWWILBWAYDXBCM-UHFFFAOYSA-N
CHEMBL2397802,,ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccc(Br)cc1,IC50,4.85,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,FCRZBVJEMPDRTR-UHFFFAOYSA-N
CHEMBL4084444,,COc1ccc(C(=CC#N)c2cc(C)nc3ccccc23)cc1,IC50,9.6,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,FLNFVWURPNUCNM-UHFFFAOYSA-N
CHEMBL3186037,,CC(C)CNc1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,4.42,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,DGRJOOOHPBSAHD-UHFFFAOYSA-N
CHEMBL3357147,,C/C=C(/C)C(=O)O[C@H]1[C@H](O)[C@]2(COC(C)=O)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)OC)[C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C,IC50,5.08,CHEMBL3385800,Inhibition of cell proliferation of human U87MG cells assessed as cell viability after 72 hrs by sulforhodamine B assay,U-87MG ATCC,RGTNKIXWAOWJPX-IJNATDAXSA-N
CHEMBL5220644,,N#CCC(=O)Nc1sc(C(=O)Nc2ccc(Cl)cc2)c(-c2ccccc2)c1C#N,IC50,6.07,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,OXRZSZLXOGIFDP-UHFFFAOYSA-N
CHEMBL5191222,,O=C(O)C=Cc1ccc(-c2ccc(O)c(C34CC5CC(CC(C5)C3)C4)c2)cc1,IC50,6.28,CHEMBL5155487,Antiproliferative activity against human U-87 MG cells incubated for 24 hrs followed by incubating in drug-free medium for 48 hrs and measured by SRB assay,U-87MG ATCC,QAWBIEIZDDIEMW-UHFFFAOYSA-N
CHEMBL3612197,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,5.86,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KMPJGKNDCOTNMA-UHFFFAOYSA-N
CHEMBL3612199,,CNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,5.91,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JJPRVXVDVQMCOL-UHFFFAOYSA-N
CHEMBL3612313,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCCC4)sc3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.12,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UNUKYNBFUYDMTJ-UHFFFAOYSA-N
CHEMBL3618242,,COc1ccc(Nc2nc3ccc(N4CCN(C(=O)N(C)C)CC4)cn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.47,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,WXJHQJVEUDYPFR-UHFFFAOYSA-N
CHEMBL221208,,CCc1cc(N2CCC[C@@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,9.28,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BXVNHBCLUUHXBC-GOSISDBHSA-N
CHEMBL223634,,O=C(CC1CN(Cc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,IQVGYCFOQODFLE-UHFFFAOYSA-N
CHEMBL387348,,COc1ccc(CCNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1,IC50,8.46,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KRNSTVMZJJNREA-UHFFFAOYSA-N
CHEMBL220121,,COc1ccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)cc1OC,IC50,8.82,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,XBKKUUPXEKAGJX-UHFFFAOYSA-N
CHEMBL3735270,,OC[C@H]1O[C@@H](Sc2c(F)c(F)c(/C3=C4\C=CC(=N4)C(c4c(F)c(F)c(F)c(F)c4F)C4=N/C(=C(/c5c(F)c(F)c(S[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(F)c5F)c5ccc([nH]5)/C(c5c(F)c(F)c(F)c(F)c5F)=C5/C=CC3=N5)C=C4)c(F)c2F)[C@H](O)[C@@H](O)[C@@H]1O,EC50,8.0,CHEMBL3737970,Photocytotoxicity against human T98G cells assessed as cell survival preincubated for 24 hrs followed by irradiation at 16 J/cm2 measured at 24 hrs by WST-8 assay,T98G,AYDRZTACVIBHHJ-ZBFLLVCBSA-N
CHEMBL3735275,,CN1CC2C3=N/C(=C(/c4c(F)c(F)c(S[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(F)c4F)C4=N/C(=C(/c5c(F)c(F)c(F)c(F)c5F)c5ccc([nH]5)/C(c5c(F)c(F)c(S[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(F)c5F)=C5/C=CC(=N5)C3c3c(F)c(F)c(F)c(F)c3F)C=C4)C2C1,EC50,9.3,CHEMBL3737970,Photocytotoxicity against human T98G cells assessed as cell survival preincubated for 24 hrs followed by irradiation at 16 J/cm2 measured at 24 hrs by WST-8 assay,T98G,XLZXJTFDRJWXSX-SCIACSNLSA-N
CHEMBL3780662,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.85,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,IJTYJQYEMJCTLU-UHFFFAOYSA-N
CHEMBL38957,,CC(=O)Nc1ccc2[nH]c(C(=O)Nc3ccc4[nH]c(C(=O)N5CC(CCl)c6c5cc(O)c5ccccc65)cc4c3)cc2c1,IC50,8.58,CHEMBL798840,"Cytotoxicity against NCI tumor panel, SF-295 CNS cancer cell line",SF295,BIIZHPQOVMNVIQ-UHFFFAOYSA-N
CHEMBL4248942,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCCCC3)CC1)c1ccccc1S2,EC50,5.17,CHEMBL4232380,Induction of intracellular Ca2+ level in human U87MG cells by Fura-2 AM dye-based assay,U-87MG ATCC,DALKPQZIEUGGGK-UHFFFAOYSA-N
CHEMBL4238900,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCCC3)CC1)c1ccccc1S2,IC50,5.64,CHEMBL4232384,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,CVFJHVCUQHZUDA-UHFFFAOYSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,4.8,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL475796,,Cc1ccc(NCc2ccc(C(=O)Nc3ccccc3N)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.8,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,JLIZHCYTSUGKKN-UHFFFAOYSA-N
CHEMBL220472,SCHWEINFURTHIN E,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@H]1C2,EC50,6.7,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,IYHZCJNEODJYKB-DMCZWXATSA-N
CHEMBL269538,HARMINE,COc1ccc2c(c1)[nH]c1c(C)nccc12,IC50,5.14,CHEMBL3776530,Growth inhibition of human U87MG cells after 4 days by MTT assay,U-87MG ATCC,BXNJHAXVSOCGBA-UHFFFAOYSA-N
CHEMBL4559783,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCCCC4)CC3)cc2)ncc1Cl,IC50,6.55,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,DBZXJKBZMWSTGM-UHFFFAOYSA-N
CHEMBL4454063,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4ccccn4)CC3)cc2)ncc1Cl,IC50,5.6,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,RZMMXURVEVVUGK-UHFFFAOYSA-N
CHEMBL4593471,,O=C(Nc1nc2ccccc2s1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,4.97,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UVKDLRXKOGRONZ-UHFFFAOYSA-N
CHEMBL4476739,,Cc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)sc2c1,IC50,4.48,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,HAXZZJQOXVLTTC-UHFFFAOYSA-N
CHEMBL4545225,,CC1(C)CCC[C@@](C)(O)[C@H]2CC[C@]3(C)[C@@H]2[C@@H](C[C@@H]2[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.12,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,IWMOSQKFCLANLM-ZVHMLHRNSA-N
CHEMBL489014,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.05,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,ZGORCAMFPVLITP-ZVHMLHRNSA-N
CHEMBL2018715,,CC1=C(C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)/C=C/[C@H](O)CCC[C@@H](C)C/C=C/[C@H]3[C@@H]1O,IC50,4.91,CHEMBL2019566,Cytotoxicity against human XF498 cells after 48 hrs by SRB assay,XF 498,SEJHGGVKMSZDDH-ZQLHMVIYSA-N
CHEMBL4283745,,CCCCCCCCCc1ccc(OP(=O)(O)OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)cc1,IC50,5.17,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,KPQPXTTWNSJLOS-UPRLRBBYSA-N
CHEMBL4474426,,CC(C)=CCc1cccc2[nH]c3c(c12)C[C@@H]1CC[C@@]2(O)[C@@]45O[C@@H]4[C@H](O)[C@@H](C(C)(C)O)O[C@H]5CC[C@]2(C)[C@@]31C,IC50,4.79,CHEMBL4334155,Cytotoxicity against human LN229 cells after 48 hrs by CCK8 assay,LN-229,RQTDORUGVRDBLB-WQRLADHGSA-N
CHEMBL2441127,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=CC(=O)c3ccccc3C2=O)nn1,IC50,5.89,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FCMCLALNSGOKIL-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.32,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL521686,OLAPARIB,O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,IC50,8.8,CHEMBL3738637,Inhibition of PARP1 in human T98G cells incubated for 60 mins by immunofluorescence assay,T98G,FDLYAMZZIXQODN-UHFFFAOYSA-N
CHEMBL498271,,C=C(c1ccc(OC)c(O)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.09,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,CNGKIRSNRQSORA-UHFFFAOYSA-N
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,8.4,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,HVXBOLULGPECHP-WAYWQWQTSA-N
CHEMBL3612198,,O=C(NCCN1CCOCC1)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2s1,IC50,5.62,CHEMBL3616151,Antiproliferative activity against human U87MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DTDHIXBPCHJAML-UHFFFAOYSA-N
CHEMBL4072336,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5cccc(F)c5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.73,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CZQQNZKELSIAMN-UHFFFAOYSA-N
CHEMBL4081754,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.88,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VBLNZCDXYXXGTG-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.02,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL3310590,,NC(=O)c1cc(-c2ccc3nc(NC(=O)C4CC4)sc3c2)cc(NS(=O)(=O)c2ccc(F)cc2)c1Cl,IC50,4.75,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OLBXVIGQZSYVGL-UHFFFAOYSA-N
CHEMBL3337798,,O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)OCc1ccccc1)c1cc2ccc(O)cc2oc1=O,IC50,4.45,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,WGLWHAXXSHABCO-BJKOEGOMSA-N
CHEMBL4748065,,CO[C@@]1(C)N(/C=C/c2ccccc2)C(=O)c2cc3c([nH]c4ccccc43)c(=O)n21,IC50,4.37,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,SURJBUWWTULNRV-OTOIZHKDSA-N
CHEMBL4758385,,CO[C@@]1(C)N(C[C@@H](O)c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,4.54,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,NSKGPNPTDFLIQO-YKSBVNFPSA-N
CHEMBL313230,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC(=O)OCc3ccccc3)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,RPVDOUORCPXFHC-UHFFFAOYSA-N
CHEMBL4783568,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C(C)C)c(=O)c3=O)cc2)ncc1Cl,IC50,5.89,CHEMBL4704568,Cytotoxicity against human A172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,HKMFURWCSXCSMM-XSFVSMFZSA-N
CHEMBL5426666,,C#CCN(C)CCCOc1ccc(N(CC)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.44,CHEMBL5371250,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,U-87MG ATCC,UGMCCVYCFXAQTN-UHFFFAOYSA-N
CHEMBL5423568,,C#CCN(C)CCCOc1ccc(N(C)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,5.48,CHEMBL5371253,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,A-172,JHKZNXCXUMFEOS-UHFFFAOYSA-N
CHEMBL244033,,CC(CN(C)C)Oc1ccc2c3c(oc2c1)C(=O)c1ncccc1C3=O,IC50,6.92,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,WIBDGWKPTCDNFX-UHFFFAOYSA-N
CHEMBL4444824,,CC(C)COc1cccc2c1C(=O)c1c(OCC(C)C)cc(NC(=O)CCl)cc1C2=O,IC50,4.95,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,MOOQOLLQRXEKKT-UHFFFAOYSA-N
CHEMBL4539926,,[N-]=[N+]=NCC(=O)Nc1cc(OCc2ccccc2)c2c(c1)C(=O)c1cccc(OCc3ccccc3)c1C2=O,IC50,4.6,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,DNKTWHCBXNDZRJ-UHFFFAOYSA-N
CHEMBL5286232,,CC(=O)C(C(C)=O)=C1SC=C(n2c(CC#N)nc3ccccc32)N1c1ccccc1,IC50,6.6,CHEMBL5245308,Cytotoxicity against human U-87 MG cells,U-87MG ATCC,HBYFKBKJBFIPJY-UHFFFAOYSA-N
CHEMBL3290911,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.89,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,URGMUHQGYAUFID-UHFFFAOYSA-N
CHEMBL3290922,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.85,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,UBHHPJNVXBNFSL-UHFFFAOYSA-N
CHEMBL3290913,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCC6)c(OC)cc45)c(F)c3)c(C)cc2=O)cc1,IC50,5.53,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,IXQJSKIPBZCEJF-UHFFFAOYSA-N
CHEMBL4641170,,Nc1nc2cc(-c3nn(C[C@H]4CCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,NIIYHUNRXQLMBG-SNVBAGLBSA-N
CHEMBL4648575,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccccc3Cl)cc2)n1,IC50,4.22,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BGKCFKWVLYAQNL-UHFFFAOYSA-N
CHEMBL4643724,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cc(Cl)ccn3)cc2)n1,IC50,4.15,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GVCQDSDKCMAUKH-UHFFFAOYSA-N
CHEMBL4646357,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccccc4)cc3)n2)cn1,IC50,4.75,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,PYIBJGHLGTVZLN-UHFFFAOYSA-N
CHEMBL4646392,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccc(Cl)cn4)cc3)n2)cn1,IC50,4.65,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OQAJFASGBAFYQH-UHFFFAOYSA-N
CHEMBL572878,TOZASERTIB,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,IC50,4.84,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GCIKSSRWRFVXBI-UHFFFAOYSA-N
CHEMBL4636924,,Cc1c(C(=O)N/N=C\c2ccc(O)c(O)c2O)oc2cccc(O)c12,IC50,5.22,CHEMBL4618024,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth,U-87MG ATCC,LDELKHXVFGCHDM-WSVATBPTSA-N
CHEMBL595755,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C)CC[C@@H]12,IC50,5.03,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,QSDRFCWATFIFOD-HDCQOPJRSA-N
CHEMBL576322,,CC(C)OC1C2=C(OC1(C)C)c1ccccc1C(=O)C2=O,IC50,5.36,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DAWQESFNBIZODU-UHFFFAOYSA-N
CHEMBL516585,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc([N+](=O)[O-])cc1,IC50,6.09,CHEMBL1042594,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,XOXKVAOVWLVYET-UHFFFAOYSA-N
CHEMBL4453837,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.71,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,MZUFKJUBPJEFAS-UHFFFAOYSA-N
CHEMBL4441965,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.9,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,XAOHZUNBVXUMQM-UHFFFAOYSA-N
CHEMBL4551259,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.8,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UEPIUPUOHWLWEO-UHFFFAOYSA-N
CHEMBL4585178,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccccc1)O2,IC50,5.89,CHEMBL4407616,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,IWMAWSKAKALHJM-UHFFFAOYSA-N
CHEMBL4525662,,Cc1cc(C)n2c1C(c1ccc(OCc3cn(C4C5=C(OC4(C)C)c4ccccc4C(=O)C5=O)nn3)cc1)=C1C=CC=[N+]1[B-]2(F)F,IC50,6.47,CHEMBL4407636,Anticancer activity against human SF295 cells,SF295,NIABHJXOXNBEBS-UHFFFAOYSA-N
CHEMBL83405,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCC(=O)OCc3ccccc3)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,TYXOBSPYAFYWGB-UHFFFAOYSA-N
CHEMBL5618644,,CCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.09,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LWAKRXJTSPCTEM-UMSFTDKQSA-N
CHEMBL5618247,,CCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.12,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LJBFWTUMACMVTG-XIFFEERXSA-N
CHEMBL5619638,,CCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.97,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,IORSARDCFLNDGU-UMSFTDKQSA-N
CHEMBL3339349,,COc1ccc(/C=N/NC(=O)Cc2ccc(Oc3ccnc4cc(OCCCN5CCOCC5)c(OC)cc34)c(F)c2)cc1,IC50,5.58,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,CZJIPNAZFHAYCU-HPNXWYHWSA-N
CHEMBL5419197,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N3CCOCC3)CC2)n1,IC50,6.22,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,HGOVTMLLXZBSHZ-UHFFFAOYSA-N
CHEMBL3393280,,C=COC(=O)NCc1ccc(Nc2nc(Nc3ccccc3C(=O)NC)n3ccnc3n2)cc1,IC50,6.38,CHEMBL3395180,Inhibition of colony formation in human U87MG cells after 2 weeks by crystal violet staining-based assay,U-87MG ATCC,DIVBJWPQPWFSGQ-UHFFFAOYSA-N
CHEMBL3393284,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CN)cc2)nc2nccn12,IC50,6.43,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,OERMTVRXFMLUOQ-UHFFFAOYSA-N
CHEMBL3393272,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)nc2nccn12,IC50,5.64,CHEMBL3395105,Antiproliferative activity against human U87MG cells after 48 hrs by WST-1 assay,U-87MG ATCC,DYHJJLYLVDGULB-UHFFFAOYSA-N
CHEMBL5429899,,COc1ccc([C@H]2[C@H](C)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1OCCCC(=O)NO,IC50,5.36,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,JICILFJSGOUHAX-RCDICMHDSA-N
CHEMBL4473391,,COc1ccc(CCn2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)nc3ccccc32)cc1,IC50,5.8,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BUXHFMLQFQVHDW-UHFFFAOYSA-N
CHEMBL3400566,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(C)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.96,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,UEQSALAYTBZOKG-LGAKBANOSA-N
CHEMBL2164701,,Cc1c2c(cc[n+]1CCc1ccccc1)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,5.46,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,VPBPTPYEZGRHBG-UHFFFAOYSA-M
CHEMBL5195582,,CC(C)=CC[C@@H](OC(=O)/C=C/C(=O)N1CCc2ccccc2C1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.16,CHEMBL5138621,Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,U-87MG ATCC,RILGTTMDSJEPTB-UWHSVAFCSA-N
CHEMBL2058276,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)OC(Cc2cn(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCN3C(=O)C=CC3=O)nn2)c2ccc(O[C@@H]3O[C@H](CC(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c([N+](=O)[O-])c2)[C@H](O)[C@H](C)O1,IC50,6.07,CHEMBL2061955,Antiproliferative activity against human U87MG cells after 48 hrs by XTT assay in presence of beta glucuronidase,U-87MG ATCC,KQTGOPFGQCCEMM-MSAOKDIJSA-N
CHEMBL3426225,,CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21,IC50,6.13,CHEMBL3430071,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,BNRXMSGHPVYSDK-UHFFFAOYSA-N
CHEMBL5407500,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2NS(C)(=O)=O)c1,IC50,6.0,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,VSXIQVSRTXSVGU-UHFFFAOYSA-N
CHEMBL5394592,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(Cl)cc(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,7.01,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,NKVCJWYRWCQWSL-UHFFFAOYSA-N
CHEMBL1236095,,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,IC50,6.09,CHEMBL5444995,"Affinity Phenotypic Cellular interaction: (CellTiter-Glo assay (Promega, cell proliferation assay using SF295 cell line, 72 h incubation)) EUB0000612a TTK",SF295,JFOAJUGFHDCBJJ-UHFFFAOYSA-N
CHEMBL2172479,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccc(-c4cnco4)cn23)nc(C)n1,IC50,6.46,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,XSGOPXVWIFLLDO-UHFFFAOYSA-N
CHEMBL2172476,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccccn23)nc(C)n1,IC50,6.03,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,UVYODFKMMWFOEC-UHFFFAOYSA-N
CHEMBL5558842,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.99,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,OWSARESXAAVFSL-UHFFFAOYSA-N
CHEMBL5560076,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.97,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,OQYAYTWFLPMJAY-UHFFFAOYSA-N
CHEMBL595421,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)/C(=N/NS(=O)(=O)c3ccc(C)cc3)CC[C@@H]12,IC50,4.56,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,GAYYAIPFTSBIDH-BMFAISMBSA-N
CHEMBL604882,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](NC(C)C)CC[C@@H]12,IC50,4.31,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,PTAIDWOXJBPQKX-HIFDQRORSA-N
CHEMBL4280046,,C[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,5.46,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,JGMWIVXPWUUSHK-IPMKNSEASA-N
CHEMBL4291607,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1ccccc1)c1ccccc1,IC50,6.1,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,TVSGTBVPVITRGR-IPMKNSEASA-N
CHEMBL4289446,,C[N+](C)(CCOP(=O)([O-])OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1OC(=O)c1ccccc1)Cc1ccccc1,IC50,6.21,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,OWFIZODXJXOTEE-RBZQAINGSA-N
CHEMBL4286524,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3cccnc3)O2)cc1F,IC50,4.4,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,RRRLTAROEKGADT-QJPTWQEYSA-N
CHEMBL5566237,,Cc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1,IC50,5.21,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,IXNNWKMEEPNZAG-UHFFFAOYSA-N
CHEMBL5423780,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C#N)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.1,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,JPLZYVWUANYAPB-UHFFFAOYSA-N
CHEMBL5404488,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)c(F)c3)ccc2NS(C)(=O)=O)c1,IC50,5.32,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ZVDVPNBGOJLJEJ-UHFFFAOYSA-N
CHEMBL553871,,COc1ccc(Sc2cc(OC)c(OC)c(OC)c2)cc1,IC50,7.52,CHEMBL1023710,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WQRZZYOXMWAVJV-UHFFFAOYSA-N
CHEMBL561955,,COc1ccc([S+]([O-])c2cc(OC)c(OC)c(OC)c2)cc1,IC50,5.84,CHEMBL1023710,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,HTDALNILKMJESX-UHFFFAOYSA-N
CHEMBL2037341,,CC(=NNC(=S)Nc1cccc(I)c1)c1ccccn1,IC50,7.21,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,NOHGJWJQBAAVFP-UHFFFAOYSA-N
CHEMBL1867591,,CC(=NNC(=S)Nc1ccccc1)c1ccccn1,IC50,8.17,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VHVSCHSQNUUXNS-UHFFFAOYSA-N
CHEMBL343264,,COc1ccc(-c2cc3cc(C)ccc3c(N3CCN(C)CC3)n2)cc1,IC50,5.13,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,ONMCQORMNSLXRV-UHFFFAOYSA-N
CHEMBL4085248,,O=C(Nc1ccc(-c2cc(N3CCOCC3)c3nccn3n2)cc1)Nc1cccnc1,IC50,4.7,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,PELFYEIYHAVUKB-UHFFFAOYSA-N
CHEMBL5559557,,C[C@H](NC1=CC(=O)c2ccccc2C1=O)C(=O)O,IC50,5.59,CHEMBL5514115,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,SF295,LXNTYZVDQSHAMO-ZETCQYMHSA-N
CHEMBL5557274,,CC(C)=CCC1=C(NCCCCN(CCCN)Cc2ccccc2)C(=O)c2ccccc2C1=O,IC50,5.37,CHEMBL5514220,Cytotoxicity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,RNYIVYZOEUFKBP-UHFFFAOYSA-N
CHEMBL221630,DEHYDROISO-ALPHA-LAPACHONE,C=C(C)C1CC2=C(O1)C(=O)c1ccccc1C2=O,IC50,5.58,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,ZDMOREUAQLXRCQ-UHFFFAOYSA-N
CHEMBL510369,,C=C(C)C1CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.47,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,JXIGNVDGTOKIJS-UHFFFAOYSA-N
CHEMBL124551,,O=C1c2cccnc2-c2nccc3c2c1nc1c([N+](=O)[O-])cccc13,IC50,8.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,GYNPAJQTGVMZOH-UHFFFAOYSA-N
CHEMBL5420233,,CCc1ccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,5.73,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,SONNMBQXZLPXFI-UHFFFAOYSA-N
CHEMBL5408307,,CCOc1cccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)c1,IC50,5.42,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,GTTIKNCVGNBXMI-UHFFFAOYSA-N
CHEMBL1774418,CASEARUPESTRIN B,C=CC(=C)CC[C@]1(C)[C@H](C)[C@@H](OC(=O)/C=C\C=C\CCCCC)[C@H](O)[C@@]23C(=C[C@H](O)C[C@@H]12)[C@@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.1,CHEMBL1776150,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,WGHDGSZCVSIZQE-WWRGVMLBSA-N
CHEMBL523379,,CN1CCN(Cc2cc3nc(-c4cccc(O)c4)nc(N4CCOCC4)c3s2)CC1,IC50,6.0,CHEMBL967869,Antiproliferative activity against PTEN-null human U87MG cells after 4 days by alamar blue assay,U-87MG ATCC,OKWPNODGKOTLAT-UHFFFAOYSA-N
CHEMBL2165022,,COc1ccc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.41,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,FPDKFSHCGOROGZ-UHFFFAOYSA-N
CHEMBL1615182,,N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1,IC50,6.72,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,FEBJYEFFVIDUNF-UHFFFAOYSA-N
CHEMBL220559,,O=C(CC1CCCCN1c1ccnc(-n2ccnc2)n1)Nc1nc2ccccc2[nH]1,IC50,7.96,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KKOHDWOUQQFWIP-UHFFFAOYSA-N
CHEMBL223005,,CN(Cc1ccccc1)C(=O)CC1CCCCN1c1ccnc(-n2ccnc2)n1,IC50,6.05,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KVYHMAVXYYJCLV-UHFFFAOYSA-N
CHEMBL5569396,,CCOC(=O)C1=C(CCl)NC(=O)NC1c1ccc(S(N)(=O)=O)cc1,IC50,4.0,CHEMBL5542075,Antiproliferative activity against human U-87MG cells assessed as reduction in cell growth incubated for 72 hrs in the presence of hypoxic condition by cytofluorimetric analysis,U-87MG ATCC,QSFWINATQNXDQX-UHFFFAOYSA-N
CHEMBL3353048,,O=C(c1ccccc1)N1CC2CN(C(=O)c3ccc4c5c(cccc35)CC4)CC2C1,IC50,4.0,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,YGRNBIZGACQZHP-UHFFFAOYSA-N
CHEMBL3353049,,COc1cnc(Cl)c2[nH]cc(C(=O)C(=O)N3CC4CN(C(=O)c5ccccc5)CC4C3)c12,IC50,6.01,CHEMBL3383784,Antiviral activity against Human immunodeficiency virus type 1 (JRCSF ISOLATE) pseudotyped virus expressed in human U87 cells after 48 hrs by luciferase reporter gene assay,U-87MG ATCC,OITFVXLQFVGROH-UHFFFAOYSA-N
CHEMBL170758,,CCC(CC)n1c(C)cc2c3c(N)nc(N)nc3ccc21,IC50,8.68,CHEMBL815878,Cytotoxic activity was evaluated against U87MG tumor cells,U-87MG ATCC,YBHNZQJIFKDDHM-UHFFFAOYSA-N
CHEMBL38761,,O=[Se](=O)(CCCl)c1ccccc1,IC50,5.22,CHEMBL873122,"In vitro cytotoxicity was determined against SF-295, U251, SNB19 human CNS tumor cell line using NCI screen",SF295,AONQHFVNYDVVAC-UHFFFAOYSA-N
CHEMBL2172490,,Cc1cc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)on1,IC50,8.15,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,INKMULYTOXUNTN-UHFFFAOYSA-N
CHEMBL2172486,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncnc4C)cn23)n1,IC50,8.22,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,FEKALHVHQQPGPI-UHFFFAOYSA-N
CHEMBL2172489,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cnn(C5CC5)c4)cn23)n1,IC50,7.24,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,XODHFMOZHXRSNF-UHFFFAOYSA-N
CHEMBL2172480,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccnc4C)cn23)n1,IC50,7.39,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,LFOJPPGMFCXNEE-UHFFFAOYSA-N
CHEMBL2172638,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4ccccc4F)cn23)n1,IC50,7.17,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,UUUGUCCOXDAVOY-UHFFFAOYSA-N
CHEMBL5624452,,COc1cc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc(OC)c1OC,IC50,5.68,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,JVDABCHLQNLAEA-SDNWHVSQSA-N
CHEMBL5630874,,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc1OC,IC50,5.43,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,OHJFXZQUSCOORH-GXDHUFHOSA-N
CHEMBL5624511,,COc1cc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)o2)cc(OC)c1OC,IC50,4.83,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,HOPXJXBUIFQLHV-PKNBQFBNSA-N
CHEMBL5624808,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)s1)c1ccncc1,IC50,5.17,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,YVLPLKQDLFBCCM-SOFGYWHQSA-N
CHEMBL5630088,,COc1cc(/C=C/C(=O)c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)cc(OC)c1OC,IC50,5.43,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,FLFDMHULUNZTIB-NTEUORMPSA-N
CHEMBL2165007,,COc1ccc(Nc2ncc(Cc3ccc(S(C)(=O)=O)cc3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.96,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,AXVUBWYMDBEDQM-UHFFFAOYSA-N
CHEMBL594118,,CCC[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)c(OC)cc4[C@H]3CC[C@]12C,IC50,4.06,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,DWIATUOXMDFPNE-ARSFUWKMSA-N
CHEMBL5618867,,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(/C=C/C(=O)NO)cc2)ccc1O,IC50,5.27,CHEMBL5614768,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,VNSNXSBINKRROS-KZHHGSSRSA-N
CHEMBL5559224,,CCOC(=O)C(NC1=C(Cl)C(=O)c2ccccc2C1=O)C(C)=O,IC50,4.72,CHEMBL5514202,Cytotoxicity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by resazurin assay,U-87MG ATCC,VJLKDEPOPCQNHD-UHFFFAOYSA-N
CHEMBL5566563,,N#CC1(C(=O)NCCC2CCN(Cc3ccccc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.3,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,RZJZAWPSUBSTEJ-UHFFFAOYSA-N
CHEMBL4645988,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2nnc3c2C(=O)c2ccccc2C3=O)c1,IC50,6.28,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,GEEOCEZSANXNQQ-SEYXRHQNSA-N
CHEMBL4646521,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)c3cccc(Cn4nnc5c4C(=O)c4ccccc4C5=O)c3)nn2)c1,IC50,6.37,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,BYONMJRCXBUVGH-NXVVXOECSA-N
CHEMBL4648258,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2nnc3c2C(=O)c2ccccc2C3=O)c1,IC50,6.21,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,DVDXIQZRWHQODS-WYMLVPIESA-N
CHEMBL4644554,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)c3cccc(Cn4nnc5c4C(=O)c4ccccc4C5=O)c3)nn2)c1,IC50,6.43,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,WEWGBNLINSIYFL-BMRADRMJSA-N
CHEMBL4634071,,C(=N/Nc1cnc2ccccc2n1)\c1ccccn1,IC50,5.41,CHEMBL4604072,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,SF295,JXPKKVRUTJZIMP-RQZCQDPDSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,4.7,CHEMBL5509849,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL5523524,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)c4ccc5nccn5c4)cc3)cc2)n1,IC50,5.58,CHEMBL5509849,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,HENWOYNKEJWJFG-KDYSTLNUSA-N
CHEMBL5517720,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)COc4cccnc4)cc3)cc2)n1,IC50,6.05,CHEMBL5509850,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,KRQSJWTXUQGYKQ-KDYSTLNUSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,5.98,CHEMBL5509852,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL5562174,,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccc(NC(=O)COc3cccnc3)cc2)cc1,IC50,6.33,CHEMBL5509853,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,NGXVQQDDOXHWSX-CUVVAGTFSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,5.6,CHEMBL5509855,Synergistic antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs in presence of FK866 by CCK8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL2165736,,CCNC(=O)Nc1ccc(S(=O)(=O)Oc2ccccc2CC)cc1,IC50,6.12,CHEMBL4723429,Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition measured after 48 hrs by sulforhodamine B assay,SF295,BEQRKSLOFGBOPF-UHFFFAOYSA-N
CHEMBL4799617,,C#CCOc1ccc(/C=C/C(=O)c2ccc(OC)c(OC)c2)cc1OC,IC50,5.54,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,QSJSOTLGLXQWOT-RMKNXTFCSA-N
CHEMBL3319515,,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCCCC3)[C@@H]2C[C@@H]1O,IC50,4.77,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,RHKZDVNMLMFSCO-SVNMQMHNSA-N
CHEMBL2397805,,Clc1ccccc1CNc1ncnc2c1cnn2CC(Cl)c1ccc(Br)cc1,IC50,4.83,CHEMBL4423083,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,PYGLWXFBTJNWSQ-UHFFFAOYSA-N
CHEMBL4534087,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.44,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RBWIXWWPRYTMCH-UHFFFAOYSA-N
CHEMBL4472885,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.09,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AYSPBJARTFATSL-UHFFFAOYSA-N
CHEMBL514351,,Cc1ccc(NCc2ccc(/C=C/C(=O)NO)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,5.0,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,HIRRHXZKTMZOHN-PKNBQFBNSA-N
CHEMBL113042,,C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1,IC50,9.1,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,NIQFKQNWLGIKCV-PMACEKPBSA-N
CHEMBL3310805,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC4CC4)sc3n2)cc1C(N)=O,IC50,4.38,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VGIZKCFSSHOEIA-UHFFFAOYSA-N
CHEMBL4872845,,CC12CC3CC(C)(C1)CC(NS(=O)(=O)c1cccc(/C=C/C(=O)NO)c1)(C3)C2,IC50,5.66,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,AYRVIZARUCAIDJ-VOTSOKGWSA-N
CHEMBL3357875,,COc1ncc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cc1C,IC50,7.31,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,ZVLPCWDGIPHSSN-UHFFFAOYSA-N
CHEMBL2013119,RIGOSERTIB SODIUM,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)[O-])c2)c(OC)c1.[Na+],IC50,7.1,CHEMBL2015273,Cytotoxicity against human U87 cells after 96 hrs by trypan blue exclusion assay,U-87MG ATCC,VLQLUZFVFXYXQE-USRGLUTNSA-M
CHEMBL278315,GELDANAMYCIN,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,EC50,7.05,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,QTQAWLPCGQOSGP-KSRBKZBZSA-N
CHEMBL1760169,,Cc1nc(NCC#N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1,IC50,6.46,CHEMBL1763013,Antiproliferative activity against human U87MG harboring PTEN gene mutation/amplification at 1 uM after 72 hrs by Ambit assay in presence of 10% serum,U-87MG ATCC,XPLCDRVACNNQQT-UHFFFAOYSA-N
CHEMBL4755317,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(-c2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.15,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,WCOXMLFEWOILDZ-UHFFFAOYSA-N
CHEMBL142703,VILDAGLIPTIN,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2,IC50,4.1,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,SYOKIDBDQMKNDQ-XWTIBIIYSA-N
CHEMBL1422,SITAGLIPTIN,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,IC50,4.07,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,MFFMDFFZMYYVKS-SECBINFHSA-N
CHEMBL5180424,,C=C[C@]1(C)CC[C@@H]2C[C@H]1C(=C)CN1CCN(CC1)C(=O)CCCCCC(=O)N1CCN(CC1)CC2=C,IC50,4.36,CHEMBL5099146,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay relative to control,U-87MG ATCC,VLAUTMRUYKPPJW-HRHHFINDSA-N
CHEMBL5195533,,C=C[C@]1(C)CC[C@@H]2C[C@H]1C(=C)CN(CC)CCCCCCN(CC)CC2=C,IC50,4.41,CHEMBL5099146,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay relative to control,U-87MG ATCC,DCDFXXOJMPMSLZ-DSNGMDLFSA-N
CHEMBL941,IMATINIB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,IC50,4.4,CHEMBL1018041,Cytotoxicity against human U87MG cells after 72 hrs by alamar-blue cell viability assay,U-87MG ATCC,KTUFNOKKBVMGRW-UHFFFAOYSA-N
CHEMBL394882,NOR-BETA-LAPACHONE,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.8,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,DMSVAEFGRLMACV-UHFFFAOYSA-N
CHEMBL5174980,,CCCN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.38,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,PLCQLVRNMKSZQY-UHFFFAOYSA-N
CHEMBL5196611,,COCCN1CCN(c2ccc(F)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.54,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,UFJYPJJOQSPYBA-UHFFFAOYSA-N
CHEMBL5180109,,COCCN1CCN(c2ccc(Cl)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.0,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,MQQSWRJWBQGBGD-UHFFFAOYSA-N
CHEMBL5183886,,COCCN1CCN(c2cc(C)ccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.28,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YRVYXPGVIJBXNM-UHFFFAOYSA-N
CHEMBL446125,FASCAPLYSIN A,CC1=C(CC/C(C)=C/CC/C(C)=C/CCC(CC(=O)O)C(=O)[O-])C(C)(C)CCC1.O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,IC50,5.28,CHEMBL1000754,Antitumor activity against human SF295 cells,SF295,LORHTOVIKVOXSY-YOEDIAEGSA-N
CHEMBL405384,,NC(c1ccc(Cl)cc1)C1CCN(c2ncnc3[nH]ccc23)CC1,IC50,5.22,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,CUQIEUIMKDNKMI-UHFFFAOYSA-N
CHEMBL406863,,NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.28,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,QOZMRRGNAZNWDN-UHFFFAOYSA-N
CHEMBL260000,,NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.35,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,KCWPSUKJCKZEAO-UHFFFAOYSA-N
CHEMBL220213,,O=C(CC1CCCCN1c1cccc(-n2ccnc2)c1)NCc1ccc2c(c1)OCO2,IC50,7.11,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,YJJUDDTUAPFIMD-UHFFFAOYSA-N
CHEMBL220932,,O=C(CC1COCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,MQSBSZNNVXQJSJ-UHFFFAOYSA-N
CHEMBL374552,,O=C(CC1CCCCN1c1cc(-n2ccnc2)ncn1)NCc1ccc2c(c1)OCO2,IC50,8.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,XLIZPIPYSZBNFC-UHFFFAOYSA-N
CHEMBL374132,,CC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.0,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HJZJKRIOLQAAGX-UHFFFAOYSA-N
CHEMBL223838,,CN(C)c1cccc2c(S(=O)(=O)N3CCN(c4ccnc(-n5ccnc5)n4)C(CC(=O)NCc4ccc5c(c4)OCO5)C3)cccc12,IC50,8.96,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,PGJNLWRKGQTXCD-UHFFFAOYSA-N
CHEMBL376713,,O=C(CC1CN(C(=O)COCc2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,HPYBQXBLGMGFEK-UHFFFAOYSA-N
CHEMBL390905,,CC(C)N(CCOc1cc2oc3c(c2cc1Cl)C(=O)c1cccnc1C3=O)C(C)C,IC50,6.04,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TZWKRWADOOFEEP-UHFFFAOYSA-N
CHEMBL3609557,,CC1(C)OC2=C(CC1[Se]c1cccc(C(F)(F)F)c1)C(=O)C(=O)c1ccccc12,IC50,5.66,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,ATCYVHURVWBFGU-UHFFFAOYSA-N
CHEMBL392510,,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C/C(=N\O)C4=CC(=O)C(O)=C[C@]4(C)[C@H]3CC[C@]12C,IC50,5.63,CHEMBL898285,Cytotoxicity against human T98G ECACC 92090213 cells after 2 days by MTT dye reduction assay,T98G,AGHDZMKTPDANEA-HBEGYKGVSA-N
CHEMBL3588944,,COc1cc(/C=C/COC(=O)C(C)C)ccc1OC(=O)C(C)C,IC50,4.53,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,RWETVSSIRIMMBD-VOTSOKGWSA-N
CHEMBL3588943,,CC[C@H](C)C(=O)OC/C=C/c1ccc(OC(C)=O)c(OC)c1,IC50,4.82,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,ZLACIACJCLRKRE-SYTKJHMZSA-N
CHEMBL3785785,,COc1cc(/C=C\C(=O)OCCCc2cc(OC)c3c(c2)[C@@H](CO)[C@H](c2cc(OC)c(O[C@H](CO)[C@H](O)c4ccc(O)c(OC)c4)c(OC)c2)O3)ccc1O,IC50,4.71,CHEMBL3792217,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TXCVWSBILJVFSH-IEXSKJOKSA-N
CHEMBL443508,PHENYLBUTYL ISOSELENOCYANATE,[Se]=C=NCCCCc1ccccc1,IC50,4.57,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,NMPQIJIERCLTOG-UHFFFAOYSA-N
CHEMBL1643111,INDIOSIDE E,C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,IC50,5.61,CHEMBL1647173,Cytotoxicity against human U87 cells after 4 hrs by MTT assay,U-87MG ATCC,DQYACEDUQHWXQZ-QBHYPGBSSA-N
CHEMBL1630324,,C=C1C(=O)O[C@@H]2C3=C[C@@H]4OO[C@@]3(CC[C@@H]12)C(C)(C)C4=O,IC50,5.59,CHEMBL1639714,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,NMXXTJXRQIYUIO-UBOXLASSSA-N
CHEMBL2398339,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc4ccccc4c3)ccc2NS(C)(=O)=O)c1,IC50,7.64,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,DVARQTHXJDZWTD-UHFFFAOYSA-N
CHEMBL228363,,COc1cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc(OC)c1OC,IC50,8.28,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,QASRNVZBHIVOPA-UHFFFAOYSA-N
CHEMBL5176963,,CCCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,7.56,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,SWJIJEHBWVAUTG-UHFFFAOYSA-N
CHEMBL5188413,,C#CCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,8.28,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,OZIYMFFXZNGZRQ-UHFFFAOYSA-N
CHEMBL4649244,,C=C1/C=C/C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)O[C@@H]([C@H](C)C[C@@H](C)CCC)[C@H](OC)C(=O)N1,IC50,6.92,CHEMBL4611999,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs under hypoxia condition by MTT assay,U-87MG ATCC,KRASFEIPFGADRT-RHDNYFDQSA-N
CHEMBL2325741,CAPIVASERTIB,NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2nc[nH]c3nccc2-3)CC1,IC50,4.3,CHEMBL4830056,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB method,U-87MG ATCC,JDUBGYFRJFOXQC-KRWDZBQOSA-N
CHEMBL4854960,,C[C@H]1[C@@H](O[C@@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]5[C@@H]4C[C@H](O)[C@@H]3C2)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.38,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,ZIINWKOITYBTBX-QFXSOFMZSA-N
CHEMBL233236,,c1cn(-c2ccc(OCC3CCCCN3Cc3ccc4c(c3)OCO4)cc2)cn1,IC50,7.0,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,OGIDTPKJWIUESB-UHFFFAOYSA-N
CHEMBL3921710,,CCCCN1C(=O)CS/C1=N/Nc1nncc2ccccc12,IC50,8.34,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,GYWJHWLJQBKSEF-XDJHFCHBSA-N
CHEMBL3970399,,O=S(=O)(Nc1nccs1)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.19,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,CBTHRMSBBQSAPG-UHFFFAOYSA-N
CHEMBL179581,,COc1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1OC,IC50,4.84,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,AWEISDLYLCJIFV-UHFFFAOYSA-N
CHEMBL385334,,O=C(CC1CN(C(=O)c2ccccc2)CCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.3,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,QUWWIESFFMGIEG-UHFFFAOYSA-N
CHEMBL376733,,O=C(C[C@H]1CCCN1c1ccnc(-n2ccnc2)n1)NCc1ccc2c(c1)OCO2,IC50,9.55,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,ZOBAVNWRXCJDMM-MRXNPFEDSA-N
CHEMBL4240179,,FC(F)(F)c1ccc2c(c1)N(CCCCN1CCC(N3CCOCC3)CC1)c1ccccc1S2,IC50,5.15,CHEMBL4232384,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,DCOREAZQNUSYDA-UHFFFAOYSA-N
CHEMBL387349,,COc1cccc(CNC(=O)CC2CCCCN2c2ccnc(-n3ccnc3)n2)c1,IC50,8.43,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,JWXNMIUXCQSJPN-UHFFFAOYSA-N
CHEMBL455534,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5C)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,IC50,5.71,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,XYMUPCSZALEVRH-GEYQZXRLSA-N
CHEMBL346383,,Cc1ccc(-c2cc3ccccc3c(O)n2)cc1,IC50,5.15,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,GNXMJRCVKBVQMQ-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.24,CHEMBL5386954,Cytotoxicity against human SNB-75 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,SNB-75,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5397184,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)C(C)C,IC50,4.84,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,YLEVETUZPGFSKX-FOXFXTFKSA-N
CHEMBL5427057,,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)CSCc2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O,IC50,4.89,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,BZNXRRBWLFGHLA-RZAATYBRSA-N
CHEMBL4279728,,O=C(COc1cccc(C(=O)/C=C/c2ccccc2)c1)Nc1ccc2c(c1)COC2=O,IC50,5.4,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,JUMOSJFJWDXNTR-FMIVXFBMSA-N
CHEMBL393719,,O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2ncccc12,IC50,6.28,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,YOOZSXQWGPLESR-UHFFFAOYSA-N
CHEMBL391722,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3ccnn3)nccc12,IC50,7.57,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,WELZLTSZYGTAHI-OAHLLOKOSA-N
CHEMBL238109,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cncn3)ccc(F)c12,IC50,6.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,AVJXMYYTKYQQKC-OAHLLOKOSA-N
CHEMBL238107,,C[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(C#N)cc(F)cc12,IC50,5.0,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,BWYCZDBEUMMMLW-CQSZACIVSA-N
CHEMBL238574,,CC[C@@H]1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,4.8,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,YTXBGWLKIPICDW-MRXNPFEDSA-N
CHEMBL240064,,C[C@@H]1CN(C(=O)c2cnccn2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.04,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,JEICIUQZOHOSQV-GFCCVEGCSA-N
CHEMBL392147,,CC1CN(C(=O)c2ccc3occc3c2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,5.0,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,VAUYARZNYJPRLX-UHFFFAOYSA-N
CHEMBL471123,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3ccc(F)cc3)cc1OC2(C)C,EC50,5.59,CHEMBL964507,Cytotoxicity against human U87 cells by side flank model relative to control,U-87MG ATCC,GXMKPONJLTZWSW-WOJBJXKFSA-N
CHEMBL471297,,CCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.6,CHEMBL964507,Cytotoxicity against human U87 cells by side flank model relative to control,U-87MG ATCC,FWCLETPIGPWXKI-FGZHOGPDSA-N
CHEMBL519575,,CC1=CC[C@@H]2[C@@H](C1)c1c(O)cc(C(C)(C)c3cccs3)cc1OC2(C)C,EC50,5.66,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,HBOZOOYIOXJZFX-IAGOWNOFSA-N
CHEMBL471122,,CCCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.44,CHEMBL964509,Cytotoxicity against human T98G cells assessed as cell death after 18 hrs,T98G,MZOOIDJUCGIQIU-DHIUTWEWSA-N
CHEMBL471122,,CCCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.61,CHEMBL964510,Cytotoxicity against human LN229 cells assessed as cell death after 18 hrs,LN-229,MZOOIDJUCGIQIU-DHIUTWEWSA-N
CHEMBL471297,,CCc1ccc(C(C)(C)c2cc(O)c3c(c2)OC(C)(C)[C@@H]2CC=C(C)C[C@@H]32)cc1,EC50,5.78,CHEMBL964510,Cytotoxicity against human LN229 cells assessed as cell death after 18 hrs,LN-229,FWCLETPIGPWXKI-FGZHOGPDSA-N
CHEMBL270640,,CCc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,IC50,6.86,CHEMBL947151,Inhibition of phosphorylation of T308-PKB in human U87MG cells by ELISA,U-87MG ATCC,PPMVOOTZFOABKA-UHFFFAOYSA-N
CHEMBL404024,,CC(C#N)c1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1,EC50,6.35,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,JPILNANJKLSYFG-UHFFFAOYSA-N
CHEMBL270639,,Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1,EC50,6.56,CHEMBL947152,Antiproliferative activity against human U87MG cells,U-87MG ATCC,SUCAWRZDHHYRQV-UHFFFAOYSA-N
CHEMBL5647104,,CNC(=O)c1cc(-c2ccccc2)sc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C(F)(F)F,IC50,4.63,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,ALAFOINLMDDMOW-UHFFFAOYSA-N
CHEMBL5639490,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1Br,IC50,4.52,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,CYWYRDRLCGNGDO-UHFFFAOYSA-N
CHEMBL5270178,,C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)cc2)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261886,Cytotoxicity against human U-87 MG cells measured after 8 days,U-87MG ATCC,JGOZUFGBTSAWEI-NSCUHMNNSA-N
CHEMBL3088349,,CCN(CC)c1ncnc2sc(Nc3ccc(Cl)cc3)nc12,IC50,5.47,CHEMBL3090176,Antiproliferative activity against human T98G cells after 48 hrs by SRB assay,T98G,LCWHOXGVDBIAJN-UHFFFAOYSA-N
CHEMBL4646906,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)CCC(=O)n1cc(/C=C/c2cccnc2)c2ccccc21,IC50,5.79,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,NEWUWRCUPSARDJ-XGRKLIJNSA-N
CHEMBL4634290,,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)CCC(=O)n3cc(/C=C/c4cccnc4)c4ccccc43)nn2)c1,IC50,6.05,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,YHMDJSKBHCHCHZ-HWWDBJQCSA-N
CHEMBL3341777,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](Nc1ccc3ccccc3c1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,Ki,7.0,CHEMBL3374646,Antimigratory activity against human SNB75 cells on matrix containing vitronectin after 24 hrs by 2-D migration assay,SNB-75,FWHOARIZUBCNOV-JBNHJABESA-N
CHEMBL4536105,,COc1ncc(-c2cc(OCCCCCCC(=O)NO)c3ncnc(C)c3c2)cc1F,IC50,5.5,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,BQKQDMVFQZHPJZ-UHFFFAOYSA-N
CHEMBL4548558,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CNC(=O)[C@H](C)O,IC50,5.7,CHEMBL4374033,Antiproliferative activity against human SNB75 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SNB-75,XZYKRDKKCJVLNQ-SPJFXFQZSA-N
CHEMBL553,ERLOTINIB,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,IC50,4.5,CHEMBL4376496,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,AAKJLRGGTJKAMG-UHFFFAOYSA-N
CHEMBL3415473,,O=S(=O)(Cc1ccccc1)N1Cc2ccccc2[C@@H]1c1c[nH]c2ccccc12,IC50,5.02,CHEMBL3420474,Cytotoxicity against human T98G cells assessed as growth inhibition after 4 days by XTT assay,T98G,WCZRIPJXOMUAPT-HSZRJFAPSA-N
CHEMBL3343369,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.97,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXSOMTVQGIJIAW-UHFFFAOYSA-N
CHEMBL3343371,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.82,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AGSRPEMWMIUSDW-UHFFFAOYSA-N
CHEMBL3343390,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.1,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KKEHZDMMOKHTMG-UHFFFAOYSA-N
CHEMBL278315,GELDANAMYCIN,COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.09,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,QTQAWLPCGQOSGP-KSRBKZBZSA-N
CHEMBL4206106,,O=c1c(-c2c(O)cc3c(c2O)C[C@@H](O)[C@H](c2ccc(O)cc2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.45,CHEMBL4187982,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,AMGHFASSLAHWBX-PBBNMVCDSA-N
CHEMBL399680,BUFALIN,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O,EC50,7.85,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QEEBRPGZBVVINN-BMPKRDENSA-N
CHEMBL4277691,,COc1ccc(Cn2cc(C(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)nn2)cc1OC,IC50,6.07,CHEMBL4271208,Cytotoxicity in human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,FSJLTXIAYGJAJT-UHFFFAOYSA-N
CHEMBL470256,LANTALUCRATIN C,C=C(C)C1CC2=C(O1)c1ccc(O)cc1C(=O)C2=O,IC50,5.14,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,RFNIZIGETMKYEI-UHFFFAOYSA-N
CHEMBL487397,LANTALUCRATIN E,C=C(C)C(O)CC1=C(OC)C(=O)c2c(OC)ccc(O)c2C1=O,IC50,5.16,CHEMBL1002741,Cytotoxicity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,IGQHQXQDGDLBTH-UHFFFAOYSA-N
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.51,CHEMBL4153991,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL4161307,,COc1ccc(-n2cc(-c3ccc(Cl)cc3)c3c2C(=O)c2ccccc2C3=O)cc1,IC50,5.37,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,ONQQNMNDBOIKLW-UHFFFAOYSA-N
CHEMBL5559858,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.24,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ATJCPWGWLOZRGF-UHFFFAOYSA-N
CHEMBL1643034,,COc1ccc(-c2c(CO)c(CO)c3n2Cc2ccccc2C3)cc1,IC50,4.98,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,RKZDLGRDWVDWQR-UHFFFAOYSA-N
CHEMBL1643051,,Cc1c(COC(=O)NC(C)C)c(COC(=O)NC(C)C)c2n1Cc1ccccc1C2,IC50,4.58,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,MOJIYIRNBVHOJS-UHFFFAOYSA-N
CHEMBL1643058,,COc1ccc(-c2c(COC(=O)NC(C)C)c(COC(=O)NC(C)C)c3n2Cc2ccccc2C3)cc1,IC50,4.68,CHEMBL1646138,Cytotoxicity against human U87 cells after 72 hrs by Alamar blue assay,U-87MG ATCC,GJWLYONOXCRYMT-UHFFFAOYSA-N
CHEMBL297453,EPIGALOCATECHIN GALLATE,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,4.82,CHEMBL4185546,Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay,LN-229,WMBWREPUVVBILR-WIYYLYMNSA-N
CHEMBL443114,SOLAMARGINE,C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O[C@@H]6O[C@H](CO)[C@@H](O[C@@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@H](O)[C@@H](O)[C@H]6O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,IC50,5.5,CHEMBL1772719,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,MBWUSSKCCUMJHO-ZGXDEBHDSA-N
CHEMBL3393268,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)nc2nccn12,IC50,6.66,CHEMBL3395180,Inhibition of colony formation in human U87MG cells after 2 weeks by crystal violet staining-based assay,U-87MG ATCC,PMQDLTHWOPLUQZ-UHFFFAOYSA-N
CHEMBL4517078,,COC(C)(C)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1C(=O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.49,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,JEDMOEWELHTQOB-IIHYJMCISA-N
CHEMBL4585866,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)Cc5cnc(N)nc5C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.08,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,ZPMAIMHOUQQFQD-IUZFIUEISA-N
CHEMBL4582822,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC(C#N)=C(O)C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.38,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,OPEANCHMAFTYCL-OSRQYFBDSA-N
CHEMBL4580671,,CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)Cc5cn[nH]c5C(C)(C)[C@@H]4CC[C@]23C)O1,IC50,4.58,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,HKYOUQDPYNJOOO-OSRQYFBDSA-N
CHEMBL2417821,,COc1ncc(-c2ccc3nc(NCC(=O)O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.01,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OWPOAPSRFIECAC-UHFFFAOYSA-N
CHEMBL2417835,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(C)cc1,IC50,5.8,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,SWNBKCKYZFXETO-UHFFFAOYSA-N
CHEMBL2417833,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.74,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,QBNYBMSPQYXIKK-UHFFFAOYSA-N
CHEMBL4214671,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1,IC50,5.95,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZIHXGTPYCJAFNA-UHFFFAOYSA-N
CHEMBL4207763,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)c(Cl)c4)c3=O)cc2)ccn1,IC50,5.45,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DBIJPVPCWQXIGH-UHFFFAOYSA-N
CHEMBL269538,HARMINE,COc1ccc2c(c1)[nH]c1c(C)nccc12,IC50,4.62,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,BXNJHAXVSOCGBA-UHFFFAOYSA-N
CHEMBL3927439,,c1ccc(-c2nnc(-c3c[nH]c4c3Cc3ccccc3-4)o2)cc1,IC50,6.3,CHEMBL3878557,Antiproliferative activity against human T98G cells after 72 hrs by XTT assay,T98G,JKVNVOZGQYTLOK-UHFFFAOYSA-N
CHEMBL2164712,,Cc1nccc2c3ccc(OCC4CCCCC4)cc3n(CC3CCCCC3)c12,IC50,4.5,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,PHTXDKLUFFBKQI-UHFFFAOYSA-N
CHEMBL2164711,,Cc1nccc2c3ccc(OCc4ccc(F)cc4)cc3n(Cc3ccc(F)cc3)c12,IC50,4.85,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,DCRLKBATTHCECA-UHFFFAOYSA-N
CHEMBL14355,,Cc1nccc2c1[nH]c1cc(OCCO)ccc12,IC50,4.28,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,ANFGSACSROQTSO-UHFFFAOYSA-N
CHEMBL2172484,,Cc1cc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)ccn1,IC50,6.65,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,JLLAMEOULOFCQI-UHFFFAOYSA-N
CHEMBL4292872,,CCn1c2ccc(C(=O)c3ccc(C)c4ccccc34)cc2c2ccc(OC)cc21,EC50,5.58,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,FLOPIVXDSYCUEZ-UHFFFAOYSA-N
CHEMBL3937796,,CNC(=O)CCN1C(C)c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S1(=O)=O,IC50,7.15,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,CDNKQZRLGOBBHA-UHFFFAOYSA-N
CHEMBL50835,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCNC(C)C,IC50,6.78,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,LNHWXBUNXOXMRL-UHFFFAOYSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,4.1,CHEMBL5332778,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition,SNB-75,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL2178608,,COC1(c2sc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3c2C)COC1,EC50,6.6,CHEMBL2186332,Cytotoxicity against human U87MG cells incubated for 4 days,U-87MG ATCC,XOZLHJMDLKDZAL-UHFFFAOYSA-N
CHEMBL84,TOPOTECAN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,IC50,7.22,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,UCFGDBYHRUNTLO-QHCPKHFHSA-N
CHEMBL5086537,,CC1Oc2ccc(S(=O)(=O)Nc3ccc(CCC(=O)O)cc3)cc2NC1=O,IC50,4.32,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,DXWAOBZLNDDYFW-UHFFFAOYSA-N
CHEMBL5076259,,Cc1ccc(CNC(=O)Cn2c(CO)cnc2SCC(=O)Nc2ccc3c(c2)OCO3)cc1,IC50,4.42,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,MLPJLGQFCCOREW-UHFFFAOYSA-N
CHEMBL5630510,,O=C(/C=C/c1cccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)c1)c1ccccc1,IC50,5.51,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,PTKJRAVLHGNQKU-CCEZHUSRSA-N
CHEMBL5630226,,O=C(/C=C/c1cccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)c1)c1ccncc1,IC50,5.14,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,RYTDMJFCMVKMGD-MDZDMXLPSA-N
CHEMBL5624827,,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)cc2)c(OC)c1OC,IC50,5.46,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,GZFYOLNOQMFVEC-RVDMUPIBSA-N
CHEMBL5083629,,O=C(Nc1ccccc1)Oc1cc(OC(=O)Nc2ccccc2)c2c(c1)N(C(c1ccc(F)cc1)c1cccc(Cl)c1O)CC2,IC50,4.07,CHEMBL5031400,Cytotoxicity effect against human LN-229 cells assessed as cell growth inhibition incubated for 48 hrs by trypan blue exclusion assay,LN-229,NBSJTAILDXZBAL-UHFFFAOYSA-N
CHEMBL3805521,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc(OC)c1OC,IC50,5.63,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NSJGQQBFMNXEJU-PFONDFGASA-N
CHEMBL4633273,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCN(C)CC3)cc2)n1,IC50,4.67,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,LROSTRBOAUSAAK-UHFFFAOYSA-N
CHEMBL4648432,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)n3)cc2)n1,IC50,4.19,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MDFAOWZCJOIKMO-UHFFFAOYSA-N
CHEMBL4644226,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cccc(Cl)c4)cc3)n2)cn1,IC50,4.66,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,WEOGGUARIACEDQ-UHFFFAOYSA-N
CHEMBL3319514,,C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)[C@@H](CN3CCCC3)[C@@H]2C[C@@H]1O,IC50,4.82,CHEMBL3362236,Anticancer activity against human T98G cells assessed as growth inhibition after 72 hrs by MTT assay,T98G,JYDLHDBFEPZUPQ-BGPVHYFNSA-N
CHEMBL367333,,CC(C)NC(=S)NC1CC(C)(C)Oc2ccc(Cl)cc21,IC50,4.04,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,KUYZXQYDFLUTKL-UHFFFAOYSA-N
CHEMBL176290,,CC1(C)CC(NC(=O)NCc2ccccc2)c2cc(Br)ccc2O1,IC50,4.42,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,ZSFAFBUNKYKVAS-UHFFFAOYSA-N
CHEMBL177950,,CC1(C)CC(NC(=S)NCc2ccccc2)c2cc(F)ccc2O1,IC50,4.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,BFDJNFIUFOYSPC-UHFFFAOYSA-N
CHEMBL360709,,CC1(C)CC(NC(=S)NCc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,RHEPHFNLNYPAFY-UHFFFAOYSA-N
CHEMBL596383,,CC1(C)CC(NC(=S)Nc2cccc(C#N)c2)c2cc(Br)ccc2O1,IC50,5.05,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YWRHTJZCWMLTRN-UHFFFAOYSA-N
CHEMBL5405084,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSCc2ccc(cc2)CSC[C@H](NC(=O)CNC(C)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.28,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,WIPDZZDNGWPJCA-NQAOGTSWSA-N
CHEMBL5423251,,CC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H]1CSCc2ccc(cc2)-c2ccc(cc2)CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC1=O)C(C)C,IC50,5.04,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,GTNCABRKYIQBGL-BDXNKPMSSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,4.5,CHEMBL5623091,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL3290902,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.93,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,FSTYDHPHNAHVOZ-UHFFFAOYSA-N
CHEMBL3290932,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5OC(F)(F)F)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.89,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,BWVHLLZOTCLDJN-UHFFFAOYSA-N
CHEMBL3290898,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(Cl)cc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.87,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,JBJZYGZTNVVXMN-UHFFFAOYSA-N
CHEMBL3290933,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.7,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,GAOHMJDLFNCXGF-UHFFFAOYSA-N
CHEMBL3290900,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.67,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,XKTCLUMXLWSCMM-UHFFFAOYSA-N
CHEMBL4071720,,O=C(CCCc1ccc(-c2cccnc2F)cc1)Nc1ccc(O)cc1,EC50,5.77,CHEMBL4423087,Antiproliferative activity against human U87 cells over-expressing EGFRvIII assessed as reduction in cell viability after 72 hrs by AlamarBlue assay,U-87MG ATCC,ULZGONBLGFFMKX-UHFFFAOYSA-N
CHEMBL3544960,AT-13148,NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1,IC50,5.96,CHEMBL3881297,Inhibition of PKB in human U87MG cells assessed as reduction in Gsk3beta Ser9 phosphorylation incubated for 1 hr by time-resolved fluorescence based assay,U-87MG ATCC,IIRWNGPLJQXWFJ-KRWDZBQOSA-N
CHEMBL3588945,,CCCC(=O)OC/C=C/c1ccc(OC(=O)CCC)c(OC)c1,IC50,4.76,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,PEENEBPZOQREGJ-RMKNXTFCSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,5.96,CHEMBL4393484,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL3087010,,O=C1c2c(Cl)cccc2-n2c1nc1ccccc1c2=O,IC50,4.71,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,SXBMVQSPFHEBPB-UHFFFAOYSA-N
CHEMBL306946,TRYPTANTHRIN,O=C1c2ccccc2-n2c1nc1ccccc1c2=O,IC50,5.3,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,VQQVWGVXDIPORV-UHFFFAOYSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,4.81,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL3301610,ABEMACICLIB,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,IC50,6.15,CHEMBL4305840,Antiproliferative activity against human U87MG cells,U-87MG ATCC,UZWDCWONPYILKI-UHFFFAOYSA-N
CHEMBL3806016,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cc(Br)ccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.41,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,CHXKOYXTKFWSCN-RIWGJCQISA-N
CHEMBL3805597,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5c(Br)cccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.67,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NENOXQQCEZKXHZ-IUFQJPFESA-N
CHEMBL3806061,,Cc1cc(=O)oc2cc(OCc3cn(CC(=O)O[C@H]4CC[C@@]5(C)C(=CC[C@@H]6[C@@H]5CC[C@]5(C)C(=O)CC[C@@H]65)C4)nn3)ccc12,IC50,4.32,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YJLIRGNRJJEWAG-OIZIHFBPSA-N
CHEMBL4592660,,CCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCC)c4ccccc4C3(C)C)=C2Cl)C(C)(C)c2ccccc21.[Cl-],IC50,5.15,CHEMBL4322558,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by AlamarBlue assay,U-87MG ATCC,MRQQUMFCWVKRHK-UHFFFAOYSA-M
CHEMBL4442218,,Nc1ccn([C@@H]2O[C@H](Cn3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](O)C2(F)F)c(=O)n1,IC50,4.9,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,YYCQJCLXZOMYAD-LTYCNYMDSA-N
CHEMBL4473696,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ccc(Cl)cc1,IC50,4.6,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,FNPDVQLGCRLOSL-NLDKGBHCSA-N
CHEMBL2165038,,Cc1nc(-c2cccnc2Nc2cccc3[nH]ccc23)c2[nH]cnc2n1,IC50,6.14,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,OBMONDJKDAOWHR-UHFFFAOYSA-N
CHEMBL1762782,,Cc1nc(NCC#N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1,IC50,7.77,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,MOYOOFRKRSCAKY-UHFFFAOYSA-N
CHEMBL4779845,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCC5(CCNC5)C4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.14,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,RLSTVRSFIFFZGV-UHFFFAOYSA-N
CHEMBL4791259,,CC(=O)c1c(C)c2cnc(Nc3ccc4c(n3)CCNC4)nc2n2cc(C(C)C)nc12,IC50,5.43,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,HKKFFWNWVBAQRC-UHFFFAOYSA-N
CHEMBL5435725,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(C)c1,IC50,6.53,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,YKOKZQZLXVBCQH-UHFFFAOYSA-N
CHEMBL229477,,C[C@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,IC50,8.17,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-PIGZYNQJSA-N
CHEMBL4164754,,CCOC(=O)Cc1c(-c2ccc(OC)c(OC)c2)c2c(n1-c1ccc(Br)cc1)C(=O)c1ccccc1C2=O,IC50,5.19,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,WSTFOHKWMJBNKP-UHFFFAOYSA-N
CHEMBL228992,,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,IC50,9.77,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-XIKOKIGWSA-N
CHEMBL2165271,,Cc1nc(N)cc(-c2cccnc2Nc2cccc3[nH]ncc23)n1,IC50,6.09,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,WHJXPQMHEGTMAA-UHFFFAOYSA-N
CHEMBL4517739,,Cc1nc(=O)c2c(-c3ccccc3)c(C(=O)c3ccccc3)[nH]c2[nH]1,IC50,7.11,CHEMBL4818316,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,JAQDZDAZCCSBAX-UHFFFAOYSA-N
CHEMBL3805856,,O=C(/C=C\Nc1ccc(O)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.37,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,BQCOUJYYNSPSCH-NXVVXOECSA-N
CHEMBL3806062,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc(OC)c1OC,IC50,4.9,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,KVQBDMFCRQLCRE-YPKPFQOOSA-N
CHEMBL3805111,,COc1cc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(F)cc2)cc(OC)c1OC,IC50,5.32,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,IPFWJHPHVYDGLP-YPKPFQOOSA-N
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,5.31,CHEMBL3854566,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL1085588,,Cn1c2cc([S+](C)[O-])sc2c2cnn(Cc3cccc(N)c3)c(=O)c21,IC50,4.05,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,ZWKJWVSEDISQIS-UHFFFAOYSA-N
CHEMBL4591115,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.99,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,OVYRDRDOTZHHTI-CPLYJULGSA-N
CHEMBL4459552,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.64,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,SNPLUKLYEATAGX-JGKBFTOSSA-N
CHEMBL5173983,,C=C1C(=O)[C@]23[C@H](OC(=O)/C=C/c4ccncc4)[C@H]1CC[C@H]2[C@]12C=CCC(C)(C)[C@H]1[C@H](O)[C@@]3(O)OC2,IC50,5.94,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ZLITUQOOIXADIY-KLSHHCPLSA-N
CHEMBL5219349,,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1C#N,IC50,5.3,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,JBKRLZPXWNTYBD-UHFFFAOYSA-N
CHEMBL72165,,O=C1c2cc(Br)ccc2-n2c1nc1ccccc1c2=O,IC50,5.5,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,INPHXCCBDRGBRF-UHFFFAOYSA-N
CHEMBL312537,,Cc1ccc2c(c1)C(=O)c1nc3ccccc3c(=O)n1-2,IC50,4.66,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,DSZRZFCUYHAAAE-UHFFFAOYSA-N
CHEMBL5087558,,CC(C)(C)NC(=O)c1ccc2cc1OCCOCCNc1ccn3ncc-2c3n1,EC50,4.98,CHEMBL5167608,Antiproliferative activity against human T98G cells assessed as reduction in cell viability measured after 1 to 7 days by resazurin dye based fluorimetric analysis,T98G,YCFFONJEHNSECY-UHFFFAOYSA-N
CHEMBL3926164,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCNC(=O)c1cccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)c1)[C@@H]3C,EC50,6.82,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,LFDNGBFUZSXYRZ-KQNUSQPASA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.24,CHEMBL5138621,Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL4291410,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(CCCCC)nn3)CC[C@@H]12,IC50,5.24,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,QNQRAZPKMAHRCI-OMHGRDNWSA-N
CHEMBL4279674,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(C(C)=O)nn3)CC[C@@H]12,IC50,5.21,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,QJGCJLOTFNHKGA-BWKWREGDSA-N
CHEMBL4279410,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccc(OC)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.75,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,RHBCULMKUXUPLC-QFGYYXCTSA-N
CHEMBL4290751,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(COc4ccc(-c5ccccc5)cc4)nn3)CC[C@@H]12,IC50,6.0,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,MPVPEFOUWMRSHU-ZIMZEJNUSA-N
CHEMBL4294566,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCOC(=O)/C=C/c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.36,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,ZSWWBNCHZRUSOY-LSWJKHNWSA-N
CHEMBL3898261,,Nc1nc(OCc2ccccc2)c2ncn(CCNC(=O)N(CCCl)N=O)c2n1,IC50,4.28,CHEMBL3879641,Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability measured after 24 hrs by CCK8 assay,SF126,WFIOEKMZVNMZTQ-UHFFFAOYSA-N
CHEMBL3916732,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1nncc1-c1ccccc1,IC50,5.62,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,NJIVJKVAHNLXIJ-UHFFFAOYSA-N
CHEMBL3980519,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1cc(-c3ccccc3)nn1)O2,IC50,5.49,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,LTAVIWBELVODLJ-UHFFFAOYSA-N
CHEMBL394882,NOR-BETA-LAPACHONE,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.13,CHEMBL4262759,Cytotoxicity against human SF295 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay,SF295,DMSVAEFGRLMACV-UHFFFAOYSA-N
CHEMBL394882,NOR-BETA-LAPACHONE,CC1(C)CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,5.84,CHEMBL4262752,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,DMSVAEFGRLMACV-UHFFFAOYSA-N
CHEMBL3983586,,Cc1ccc(C(/C=C/c2ccc(F)cc2)=N\Nc2nncc3ccccc23)cc1,IC50,9.26,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,IGXWHXJCDUCSBX-GNVALWJASA-N
CHEMBL3974626,,COc1ccc(N2C(=O)CS/C2=N/Nc2nncc3ccccc23)cc1,IC50,8.62,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,WRXMYALXQGBBNT-RELWKKBWSA-N
CHEMBL3937949,,O=C(O)c1ccc(Nc2nncc3ccccc23)cc1,IC50,9.36,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,FGBWIPBEKQBXCP-UHFFFAOYSA-N
CHEMBL1739368,,NCCNC(=O)C(CN)(Cc1ccc2ccccc2c1)Cc1ccc2ccccc2c1,IC50,5.56,CHEMBL2154653,Cytotoxicity against human SNB75 cells after 4 hrs by MTT assay,SNB-75,ZOSLLLKFQJEPRK-UHFFFAOYSA-N
CHEMBL5437683,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(/C=C/C(=O)NO)cc3)CC1)C2,IC50,5.75,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,YDGCPLJSOWXJQC-BQYQJAHWSA-N
CHEMBL5425578,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCCC(=O)NO)CC1)C2,IC50,5.1,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,OSKOJXVSKYGIAD-UHFFFAOYSA-N
CHEMBL5439573,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCCCCC(=O)NO)CC1)C2,IC50,4.54,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,PXASOYWUFJQDQD-UHFFFAOYSA-N
CHEMBL502,DONEPEZIL,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,IC50,4.33,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,ADEBPBSSDYVVLD-UHFFFAOYSA-N
CHEMBL5420815,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(F)c1,IC50,7.55,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,ZERJPDQJQQFZDN-UHFFFAOYSA-N
CHEMBL5402810,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(Cl)cc1,IC50,7.72,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,ZHMBNIOIPWBHET-UHFFFAOYSA-N
CHEMBL5427428,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(C(F)(F)F)c1,IC50,7.3,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,USYCACRSMUSOQU-UHFFFAOYSA-N
CHEMBL5428726,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(Cl)cc1F,IC50,7.9,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,NLKWPAPHRJUWLZ-UHFFFAOYSA-N
CHEMBL4289759,,CCn1c2ccccc2c2cc(C(=O)c3ccc(F)cc3)ccc21,EC50,5.1,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,BCOJHFLANMVQSY-UHFFFAOYSA-N
CHEMBL4294230,,CCn1c2ccccc2c2cc(C(=O)c3cccc4cccnc34)ccc21,EC50,5.06,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,GPGKTWSQCNBODD-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.77,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4087882,,CN1CCN(CCOC(=O)N(c2cccc(Br)c2)c2nc(SCCN3CCOCC3)nc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,5.12,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,ZPYFGEVWAWJEIR-UHFFFAOYSA-N
CHEMBL2397802,,ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccc(Br)cc1,IC50,4.6,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,FCRZBVJEMPDRTR-UHFFFAOYSA-N
CHEMBL4084427,,CSc1nc(N(C(=O)OC(C)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.35,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,DAIZESMIDQCQRX-UHFFFAOYSA-N
CHEMBL2397802,,ClC(Cn1ncc2c(Nc3ccccc3)ncnc21)c1ccc(Br)cc1,IC50,4.76,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,FCRZBVJEMPDRTR-UHFFFAOYSA-N
CHEMBL4068211,,CN1CCN(CCOC(=O)N(Cc2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,4.82,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,ONIFAJAFWHMUOA-UHFFFAOYSA-N
CHEMBL4084427,,CSc1nc(N(C(=O)OC(C)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.75,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,DAIZESMIDQCQRX-UHFFFAOYSA-N
CHEMBL4060917,,CSc1nc(N(C(=O)OC(Cc2ccccc2)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.77,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,YZYCFZMIKGBFFD-UHFFFAOYSA-N
CHEMBL165,RESVERATROL,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,IC50,4.7,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,LUKBXSAWLPMMSZ-OWOJBTEDSA-N
CHEMBL4278554,,COc1cc(Sc2c[nH]c3cc(-c4ccsc4)ccc23)cc(OC)c1OC,IC50,7.58,CHEMBL4271597,Growth inhibition of human T98G cells after 48 hrs by MTS assay,T98G,YIPMYOQVBMPGMW-UHFFFAOYSA-N
CHEMBL4580864,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1COC(=O)[C@H](C)O,IC50,4.8,CHEMBL4374036,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SF295,FKBITCOIJAFLNT-SPJFXFQZSA-N
CHEMBL5083440,,COc1ccc(N2C(=O)C[C@H](C(=O)NC3CCCCC3)[C@H]2c2ccc(F)cc2)cc1,IC50,4.11,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,SODMCALIAXWOMI-JTHBVZDNSA-N
CHEMBL5091005,,Cc1ccc([C@H](O)CNC(=O)c2cccc(C)c2C)cc1,IC50,4.17,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,PTDPRGPUURVUJA-QGZVFWFLSA-N
CHEMBL5405263,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C)c3)ccc2NS(C)(=O)=O)c1,IC50,6.38,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ZWVFOQDPNKJXIG-UHFFFAOYSA-N
CHEMBL5283179,,CCC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,IC50,5.77,CHEMBL5445694,"Affinity Phenotypic Cellular interaction: (ProQinase broad tumor cell line profiling (CellTiterGlo assay, antiproliferative activity in brain, LN229,cancer cell line)) EUB0001183a CSNK2A2",LN-229,YKDZIFFKQUNVHH-UHFFFAOYSA-N
CHEMBL315088,,COC(=O)CCn1c(=O)c(-c2ccc(OC)cc2)cc2c(OC)cc(OC)cc21,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,ZTYRLNIVULKCEA-UHFFFAOYSA-N
CHEMBL5563057,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(Cl)c(Cl)c1,IC50,5.7,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,AGJXRCUZJGTRGD-UHFFFAOYSA-N
CHEMBL597211,,CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1,IC50,8.24,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,SNNUMARRAFQOGY-UHFFFAOYSA-N
CHEMBL599448,,NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1,IC50,8.14,CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,U-87MG ATCC,WPDHASUWSYKMLT-UHFFFAOYSA-N
CHEMBL597600,,NC1(C(=O)NCc2ccc(Cl)cc2F)CCN(c2ncnc3[nH]ccc23)CC1,IC50,7.7,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,PEMLYVADBMMTQF-UHFFFAOYSA-N
CHEMBL1782904,,CCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.64,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,SLMAQIZSYXKRPJ-QQJYNPJZSA-N
CHEMBL1782909,,CCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.24,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,FVBXFAPFRUROQX-ALMBTRMVSA-N
CHEMBL4447924,,COc1c(-c2ccccc2)cc(OC)c2c1oc1cc(O)c(OCC=C(C)C)cc12,IC50,4.99,CHEMBL4344200,Cytotoxicity against human U87 cells after 24 hrs by SRB method,U-87MG ATCC,AMGZEEWYBXDHSG-UHFFFAOYSA-N
CHEMBL448455,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccccc5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.16,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,NBOAYFKMDBWDLM-GVQBMFDGSA-N
CHEMBL4073713,,CSc1nc(N2CCCCC2)c2ccn(Cc3ccc(F)cc3)c2n1,IC50,4.29,CHEMBL3993695,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by coulter counter analysis,U-87MG ATCC,WCTJLMVSZAACPV-UHFFFAOYSA-N
CHEMBL4754687,,CCS(=O)(=O)Nc1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,8.31,CHEMBL4713864,Antiproliferative activity against human T98G cells overexpressing AR assessed as reduction in cell viability incubated for 48 hrs by MTT assay,T98G,FBNFIWKETUMPPR-UHFFFAOYSA-N
CHEMBL4754687,,CCS(=O)(=O)Nc1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,8.17,CHEMBL4713867,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,FBNFIWKETUMPPR-UHFFFAOYSA-N
CHEMBL1078983,Ku-0063794,COc1ccc(-c2ccc3c(N4CCOCC4)nc(N4C[C@@H](C)O[C@@H](C)C4)nc3n2)cc1CO,IC50,6.82,CHEMBL1107751,Inhibition of mTORC2 in human U87MG cells assessed as phosphorylated AKT (Ser473) level after 2 hrs by Western blotting,U-87MG ATCC,RFSMUFRPPYDYRD-CALCHBBNSA-N
CHEMBL141838,,Cc1ccc2c(O)nc(-c3ccc(Cl)cc3)cc2c1,IC50,4.95,CHEMBL822900,Tested for in vitro cytotoxicity against XF498 (human CNS) tumor cell line using sulforhodamine B (SRB) assay,XF 498,DNQYHWBDJNQUHG-UHFFFAOYSA-N
CHEMBL4788798,,CCS(=O)(=O)N(C)c1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,8.11,CHEMBL4713867,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,FIQDGCIYCNETRN-UHFFFAOYSA-N
CHEMBL4127432,,COc1ccc2nc3[nH]nc(N)c3cc2c1,IC50,4.03,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,XYBJZZAKAVVXDR-UHFFFAOYSA-N
CHEMBL1782900,,CCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,4.85,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,UKUWMCDJZBBMPC-VQCLQPKNSA-N
CHEMBL1782911,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CO)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.82,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,VRYBKUIEJIKFNC-QWIYEXKTSA-N
CHEMBL106406,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1,IC50,8.05,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,CPELYVWCRNINCS-UHFFFAOYSA-N
CHEMBL4128893,,C[C@H]1[C@H](NCc2ccc(OC(F)(F)F)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.75,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,DTMVQUYLGYAQDU-ZMJFZODZSA-N
CHEMBL4126483,,C[C@H]1[C@H](Nc2ccc(SC(F)(F)F)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.55,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,ZWIOXSUVMPVWTH-SZMJOESGSA-N
CHEMBL4789230,,Cn1c2ccccc2c2cc(C(=O)NCCc3ccccc3)[nH]c(=O)c21,IC50,4.96,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,BHVGVCZSTYUCEH-UHFFFAOYSA-N
CHEMBL141081,,Oc1nc(-c2ccccc2)cc2ccccc12,IC50,5.86,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,VZYRBVZOGGKAKY-UHFFFAOYSA-N
CHEMBL5597580,,O=C(O)[C@@H]1[C@H](C(=O)n2ccc3ccccc32)[C@H]2CC[C@@H]1O2,IC50,4.7,CHEMBL5587087,Synergistic antiproliferative activity against human U-87 MG cells in presence of TMZ,U-87MG ATCC,KZVHQCVKMCBKRP-RQJABVFESA-N
CHEMBL4649244,,C=C1/C=C/C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)O[C@@H]([C@H](C)C[C@@H](C)CCC)[C@H](OC)C(=O)N1,IC50,6.39,CHEMBL4611998,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs under normoxia condition by MTT assay,U-87MG ATCC,KRASFEIPFGADRT-RHDNYFDQSA-N
CHEMBL4278233,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccccc2)c1=O,IC50,5.9,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WSCIHXKETKCFDO-UHFFFAOYSA-N
CHEMBL4280004,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccc(F)cc2)c1=O,IC50,5.87,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CQCVNKBXWWKFDO-UHFFFAOYSA-N
CHEMBL4639420,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1c(ccc(O)c1O)C4=O,EC50,7.35,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,KPDKPRCLDGTNFK-UUNAQHPASA-N
CHEMBL4287656,,CC[N+](CC)(CC)CCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1.[I-],IC50,5.28,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,ZQOOZRXNZQVSIV-RRABGKBLSA-M
CHEMBL4790971,,C#CCOc1ccc(/C=C/C(=O)c2ccc(-n3ccnc3)cc2)cc1OC,IC50,5.85,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,VNMNPXUSEUDRAE-ONNFQVAWSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.0,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.1,CHEMBL4343297,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL150607,,Cc1c(CNc2ccc(C(=O)NC(CCCNC(=O)c3ccccc3C(=O)O)C(=O)O)cc2)cnc2nc(N)nc(N)c12,IC50,9.23,CHEMBL801266,Compound was evaluated for in vitro activity against SF-295 CNS cell lines (Human tumor cells ),SF295,IAVQJNSRTDVUJY-UHFFFAOYSA-N
CHEMBL4545128,,Fc1ccc(/C=N/Nc2nc(-c3cccc(Br)c3)cs2)cc1F,IC50,4.4,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,XLNLIDYPMSLHDI-DNTJNYDQSA-N
CHEMBL4434923,,Fc1ccc(/C=N/Nc2nc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cs2)cc1F,IC50,4.53,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,CYNOGIKKPGIECM-OAHLVZFQSA-N
CHEMBL254578,,O=C(O)/C(Cc1ccccc1[N+](=O)[O-])=N\Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1,IC50,4.12,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,KFRKRECSIYXARE-HMAPJEAMSA-N
CHEMBL1928598,,COc1ccc2c(c1)O[C@@H]1C3=C(OC[C@H]21)C(=O)c1ccccc1C3=O,IC50,4.75,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,XSQMOHMPRQZEHK-KUHUBIRLSA-N
CHEMBL4545456,,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,EC50,6.57,CHEMBL4387157,Antiproliferative activity against human A172 assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,A-172,KMRYRPPWJDYHAL-QGZVFWFLSA-N
CHEMBL4483778,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.82,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,HIHLTQCSRFBDDQ-QDJGCMBGSA-N
CHEMBL5428709,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C(C)C)c(O)c(C(C)C)c3)c3ccccc32)cc1,IC50,4.12,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,MMMLVOMCRQVEDO-UHFFFAOYSA-N
CHEMBL515325,MAPPAIN,CC(C)=CCC/C(C)=C/Cc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc(O)c1O,IC50,5.16,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,GJZKDVGLDGLPMB-ZVBRSKEYSA-N
CHEMBL3883573,,O=c1c2nc3ccccc3nc2cc(-c2ccccc2)n1-c1ccccc1,IC50,4.67,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AKDIWALMSBBMRJ-UHFFFAOYSA-N
CHEMBL3883472,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccccc1,IC50,5.48,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HEPDGKDHKDFTDK-UHFFFAOYSA-N
CHEMBL5408043,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCN(C(=S)SCC(=O)N3CCOCC3)CC2)n1,IC50,5.91,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,BRNCLSYLICSNRO-UHFFFAOYSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.8,CHEMBL4309536,Growth inhibition of human SF295 cells incubated for 48 hrs by sulforhodamine B assay,SF295,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL4474362,,Cc1cn([C@H]2C[C@H](O)[C@@H](Cn3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)c(=O)[nH]c1=O,IC50,4.87,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,ILQANIFPCKZLGQ-ZQLWZKNSSA-N
CHEMBL5428348,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(I)c3)ccc2NS(C)(=O)=O)c1,IC50,6.89,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,CSGPCUWSIHSOMM-UHFFFAOYSA-N
CHEMBL5429070,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(N(C)C)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.72,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,SIZXPYCVVXWDOK-UHFFFAOYSA-N
CHEMBL5407500,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2NS(C)(=O)=O)c1,IC50,6.37,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,VSXIQVSRTXSVGU-UHFFFAOYSA-N
CHEMBL5417589,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(OC(F)(F)F)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.05,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ZHVKLCABOSDPPM-UHFFFAOYSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,6.35,CHEMBL5509860,Synergistic antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs in presence of IDH305 by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL312537,,Cc1ccc2c(c1)C(=O)c1nc3ccccc3c(=O)n1-2,IC50,6.74,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,DSZRZFCUYHAAAE-UHFFFAOYSA-N
CHEMBL1098875,,O=C1c2cc(F)ccc2-n2c1nc1ccccc1c2=O,IC50,7.22,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,UXBGZQXHNVNPFT-UHFFFAOYSA-N
CHEMBL3087010,,O=C1c2c(Cl)cccc2-n2c1nc1ccccc1c2=O,IC50,6.64,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,SXBMVQSPFHEBPB-UHFFFAOYSA-N
CHEMBL5630349,,C#CCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.25,CHEMBL5621066,"Antiproliferative activity against human U87 cells incubated for 48 hrs in presence of 4-azido-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)butanamide by MTT assay",U-87MG ATCC,IJDJQTVSYXXWMT-UHFFFAOYSA-N
CHEMBL5624941,,[N-]=[N+]=NCCCC(=O)Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,IC50,5.25,CHEMBL5621068,Antiproliferative activity against human U87 cells incubated for 48 hrs in presence of 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(prop-2-yn-1-yl)picolinamide by MTT assay,U-87MG ATCC,IQDAUQZEUZNBJF-UHFFFAOYSA-N
CHEMBL5624529,,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCN=[N+]=[N-])C(C)(C)C)cc1,IC50,4.79,CHEMBL5621068,Antiproliferative activity against human U87 cells incubated for 48 hrs in presence of 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-(prop-2-yn-1-yl)picolinamide by MTT assay,U-87MG ATCC,ZTMPPRFQBBGAOO-ZFGGDYGUSA-N
CHEMBL4582766,,CC(C)COc1cccc2c1C(=O)c1c(OCC(C)C)cc(NC(=O)CBr)cc1C2=O,IC50,4.78,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,ZCSFDYYGXDRTEM-UHFFFAOYSA-N
CHEMBL1372036,,O=C(Nc1ccc(Cl)c([N+](=O)[O-])c1)Nc1nc2ccccc2s1,IC50,5.64,CHEMBL5506204,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition measured after 6 days by RealTime-Glow MT cell viability assay,LN-229,JOTYYZZVRLAFOZ-UHFFFAOYSA-N
CHEMBL4072504,,COc1cc(/C=C/C(=O)c2ccc(Cl)cc2)ccc1OCCCCN1CCCCC1,IC50,5.1,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QNUPDLGIOKVKMM-NTUHNPAUSA-N
CHEMBL4096453,,COc1cc(/C=C/C(=O)c2ccc(C)cc2)ccc1OCCCN1CC(C)OC(C)C1,IC50,5.38,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,RTOXDVTXDWFPKT-XYOKQWHBSA-N
CHEMBL4064878,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc([N+](=O)[O-])cc1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,RYIXKARLZZLQDP-UHFFFAOYSA-N
CHEMBL4066710,,Cc1cc(=O)n(-c2cccc(F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.47,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SKFNRSXADVNTQX-UHFFFAOYSA-N
CHEMBL4104755,,Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,IC50,5.26,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VYGQKAWFMNCRKR-UHFFFAOYSA-N
CHEMBL4102463,,Cc1cc(=O)n(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,5.49,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JEMUEMMIHBANKW-UHFFFAOYSA-N
CHEMBL4078189,,Cc1ccccc1-n1nc(C(=O)Nc2ccc(Oc3ccnc4[nH]ccc34)c(F)c2)c(C)cc1=O,IC50,5.58,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZAUITWXGIQXSFV-UHFFFAOYSA-N
CHEMBL4078622,,Cc1cc(=O)n(-c2ccc(F)c(Cl)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,4.9,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XQQSOOFPTZZWTH-UHFFFAOYSA-N
CHEMBL1096754,,Cn1cc2c(NC(=O)c3ccccc3)nc(-c3ccccc3)nc2n1,IC50,9.39,CHEMBL1120800,Inhibition of IBMECA-mediated human U87MG cell proliferation after 48 hrs by trypan blue exclusion assay,U-87MG ATCC,QFBYVTZHJZITCY-UHFFFAOYSA-N
CHEMBL211045,,COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,6.98,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,BDUHCSBCVGXTJM-UHFFFAOYSA-N
CHEMBL3983169,,O=C1C2=C(OC(Cn3cc(C[Se]c4ccccc4)nn3)C2)C(=O)c2ccccc21,IC50,6.01,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,GDSDFDXWWZQUBO-UHFFFAOYSA-N
CHEMBL3895357,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1Nc1cccc(-c2cn(C[Se]c3ccccc3)nn2)c1,IC50,5.97,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,LKZVCKKXFFRUOZ-UHFFFAOYSA-N
CHEMBL3936130,,O=C1C(=O)c2ccccc2C2=C1CC(Cn1nnc(-c3ccccc3)c1I)O2,IC50,5.43,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,CBEHSQUYTWTCBE-UHFFFAOYSA-N
CHEMBL4556971,,C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)[C@@H]1O,IC50,5.42,CHEMBL4416282,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 72 hrs by SRB assay,U-87MG ATCC,JZQFWTNEUBVJCY-JDMXSVICSA-N
CHEMBL4218338,,O=c1c(-c2c(O)cc3c(c2O)C[C@@H](O)[C@@H](c2ccc(O)c(O)c2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.56,CHEMBL4187983,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,T98G,LVGLBFQVAZMOBH-ONOMSOESSA-N
CHEMBL4468114,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.87,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QUDBXQWWBJDDOH-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.35,CHEMBL4611998,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs under normoxia condition by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5173319,,CC(C)(C)[Si](O[C@H]1[C@H](O)C[C@](O)(CO)C[C@H]1O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)(c1ccccc1)c1ccccc1,IC50,4.97,CHEMBL5141031,Cytotoxicity against human LN-229 cells assessed as cell viability measured after 48 hrs by countess-II FL Hemocytometer method,LN-229,LVKKRKKKISMYSS-RDKVZNNQSA-N
CHEMBL38434,BREQUINAR,Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O,IC50,6.62,CHEMBL4723429,Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition measured after 48 hrs by sulforhodamine B assay,SF295,PHEZJEYUWHETKO-UHFFFAOYSA-N
CHEMBL3087009,,O=C1c2cc(F)ccc2-n2c1nc1ccc(F)cc1c2=O,IC50,7.21,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,PNIGSYVPVQBQOJ-UHFFFAOYSA-N
CHEMBL2385204,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(C(F)(F)F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.79,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RIJAXDHUBFBQQH-UHFFFAOYSA-N
CHEMBL5619848,,COC(=O)c1nn2c(NC(C)(C)C)nc3cc(Cl)ccc3c2c1C(=O)OC,IC50,5.58,CHEMBL5614908,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,CWWYOYQQBVCVDC-UHFFFAOYSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,5.38,CHEMBL5614538,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL5523403,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.87,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,AFJGGZNITGUTBL-UHFFFAOYSA-N
CHEMBL2381461,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cc(C)cc(O)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.72,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,YEAGUSLHYRFJBW-BJMSDPACSA-N
CHEMBL2381457,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc(C#N)cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.32,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,OKKOOEZHSOJKTD-BJMSDPACSA-N
CHEMBL4287242,,CCCCCCCCCCCC[N+](C)(C)[C@H]1CC[C@H](O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)O[C@@H]1C.[I-],IC50,4.55,CHEMBL4267508,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,ASIORGZWKDNLSR-KHNSZOIESA-M
CHEMBL590522,MAHANINE,CC(C)=CCC[C@H]1C=Cc2c(c(C)cc3c2[nH]c2cc(O)ccc23)O1,IC50,5.16,CHEMBL2405051,Cytotoxicity against human U87MG cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,UKLOEFBVUZOVRX-INIZCTEOSA-N
CHEMBL4466655,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.52,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,GWPIZLOXKPAPCU-RXQFCVLDSA-N
CHEMBL4591115,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.51,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,OVYRDRDOTZHHTI-CPLYJULGSA-N
CHEMBL4577179,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.79,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,BFHHDNOGNZULGK-CKBBDEFZSA-N
CHEMBL4450269,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.7,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,XHHHLVOLGLLDQG-QRDFGAMCSA-N
CHEMBL4466655,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.75,CHEMBL4381764,Antiproliferative activity against human U87 cells transfected with lentivirus expressing shPKM2 assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,GWPIZLOXKPAPCU-RXQFCVLDSA-N
CHEMBL11359,CISPLATIN,,IC50,5.03,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,7.95,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL2088463,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4cccc(C#N)c4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.18,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OWIQELVAPAZAHH-VTNSRFBWSA-N
CHEMBL2088459,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4ccc(Cl)cc4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.13,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ODVYHDCENWVMPV-WCMJOSRZSA-N
CHEMBL2088443,,Fc1ccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)cc1,IC50,5.05,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,XEVSBQUGUYKTRS-RWPZCVJISA-N
CHEMBL2088442,,Fc1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,4.9,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GZATWFXSLUADDR-RWPZCVJISA-N
CHEMBL2088439,,Clc1cccc(Cn2cc(/C=N/Nc3nc(N4CCOCC4)c4sccc4n3)c3ccccc32)c1,IC50,5.22,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JVDTYHMYONBVAU-RWPZCVJISA-N
CHEMBL314455,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)/c2=N\Nc2ccccn2)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,VYPKYZTWZFRBOL-PNHLSOANSA-N
CHEMBL4450973,,COc1cc(/C=N/Nc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc(Br)c1OC,IC50,4.39,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,JTFPPLGYLNFXQV-PGGKNCGUSA-N
CHEMBL4475103,,COc1cc(/C=N/Nc2nc(-c3cccc(Br)c3)cs2)c(Br)c(Br)c1OC,IC50,4.56,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,YYMUAVBTOWHGMO-GZIVZEMBSA-N
CHEMBL4062301,,O=C(/C=C/c1ccc(S(F)(F)(F)(F)F)cc1)/C=C/c1ccc(S(F)(F)(F)(F)F)cc1,IC50,5.06,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NMHQTDFYUPBIBB-FACPPWRESA-N
CHEMBL317644,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1,IC50,8.77,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,HSAKOKPUPOVOFH-RMLRFSFXSA-N
CHEMBL3337793,,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.66,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,CTUZCHLJFUMBPX-IGMOWHQGSA-N
CHEMBL3337795,,CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.24,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,IFVIVIXQVQVFAL-UZGNFBRWSA-N
CHEMBL3337797,,C[C@@H](O)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc2ccc(O)cc2oc1=O)C(=O)OCc1ccccc1,IC50,4.2,CHEMBL3381976,Cytotoxicity against human A172 cells by MTT assay,A-172,GNTQQMKQEBDBQY-XGTQTKKKSA-N
CHEMBL2042556,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccc(N(C)C)c2ccccc12,IC50,7.9,CHEMBL2044173,Antiproliferative activity against human T98G cells after 5 days by MTT assay,T98G,XWCSZMDVKNZVMD-UHFFFAOYSA-N
CHEMBL810,TEMOZOLOMIDE,Cn1nnc2c(C(N)=O)ncn2c1=O,IC50,4.31,CHEMBL2044174,Antiproliferative activity against human U87 cells after 5 days by MTT assay,U-87MG ATCC,BPEGJWRSRHCHSN-UHFFFAOYSA-N
CHEMBL4564714,,CCOc1cccc2c1C(=O)c1c(OCC)cc(NC(=O)CCl)cc1C2=O,IC50,5.28,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,XJEWVCSTXGINMO-UHFFFAOYSA-N
CHEMBL4454437,,CCOc1cccc2c1C(=O)c1c(OCC)cc(NC(=O)CN=[N+]=[N-])cc1C2=O,IC50,4.45,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,ZJQHBRAJUNHHDZ-UHFFFAOYSA-N
CHEMBL4476404,,C=CC(=O)Nc1cc(OCCC)c2c(c1)C(=O)c1cccc(OCCC)c1C2=O,IC50,4.6,CHEMBL4350215,Cytotoxicity against p53 mutated human T98G cells asessed as reduction in cell viability incubated for 24 hrs by MTT assay,T98G,NPDZGZCRKKKLTL-UHFFFAOYSA-N
CHEMBL212242,,O=c1oc2c3c4c(cc2cc1-c1nc2ccccc2[nH]1)CCCN4CCC3,IC50,4.48,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,GPGSAESYFKTPBM-UHFFFAOYSA-N
CHEMBL113072,,Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1,IC50,9.3,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,IICSHLLWAXMCEQ-ZEQRLZLVSA-N
CHEMBL83200,,COc1cc(OC)c2cc(-c3ccccc3)c(O)nc2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,ZWLSXHYTGYVCSY-UHFFFAOYSA-N
CHEMBL85734,,Oc1ccc(-c2cc3c(O)cc(O)cc3nc2O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,WWGWIVQHGAYORR-UHFFFAOYSA-N
CHEMBL4085354,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCCCC3)c(OC)c2)cc1,IC50,5.2,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,SIIHRNDOOSWZJP-NTUHNPAUSA-N
CHEMBL3262846,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccccc3)cc2F)ccn1,IC50,5.65,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VUZGCTWESWLKJB-LQKURTRISA-N
CHEMBL120077,,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,IC50,4.89,CHEMBL861474,Antiproliferative activity against human glioma tumor cell line U87MG,U-87MG ATCC,ZDNURMVOKAERHZ-UHFFFAOYSA-N
CHEMBL4097280,,C[C@H]1COCCN1c1cc(-c2ccc3[nH]ccc3c2)nn2c(C3CCN(C(=O)c4cccnc4)CC3)cnc12,IC50,5.0,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,JVOVVCAGNVWRQW-FQEVSTJZSA-N
CHEMBL2361103,,Nc1nc2cc3c(cc2cc1C(=O)NCCc1c[nH]c2ccccc12)OCO3,IC50,4.34,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,WNBZIJXYKUPXDE-UHFFFAOYSA-N
CHEMBL5085922,,COc1cc2nc(N)c(C(=O)NCCc3c[nH]c4ccccc34)cc2c(Cl)c1OC,IC50,4.22,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,BCTNKASKUKYVNC-UHFFFAOYSA-N
CHEMBL4525323,,c1ccc(CNCCN(CCNCc2ccccn2)Cc2ccc3ccccc3c2)nc1,IC50,5.2,CHEMBL4381289,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 48 hrs by cell titer-glo assay,LN-229,JQZJBHLTWMYVSN-UHFFFAOYSA-N
CHEMBL111845,,O=C1c2nccc(-c3ccccc3NC(=O)C(F)(F)F)c2C(=O)c2c([N+](=O)[O-])ccnc21,IC50,5.33,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,RFSJCVJLNACMNQ-UHFFFAOYSA-N
CHEMBL4225722,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)sc2n1,IC50,5.68,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,SMVKAKYSTNLAPJ-UHFFFAOYSA-N
CHEMBL4173811,,COc1cccc(-c2nc3sc4c(c3c(=O)[nH]2)CCCC4)c1O,IC50,4.31,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,ZJKYMNBOQCAOEE-UHFFFAOYSA-N
CHEMBL4172390,,O=c1[nH]c(-c2ccc(Cl)cc2Cl)nc2sc3c(c12)CCCC3,IC50,4.05,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,YNFSDNHFYZXMKX-UHFFFAOYSA-N
CHEMBL4072683,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCC#CCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.07,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CSOYPFGNCFIXJG-HKIQETCMSA-N
CHEMBL4098675,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)c2ccccc2C(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.09,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,ZPXXFKDIYJIPRZ-BRAPIWAESA-N
CHEMBL4090941,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CNC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.76,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,IGHHYVSLRSHUME-SZZCUWPLSA-N
CHEMBL4083106,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=[N+]3C(=C(c4ccccc4)c4ccc(Cl)n4[B-]3(F)F)C=C2)nn1,IC50,5.01,CHEMBL4046408,Cytotoxicity against human SF295 cells after 24 hrs in presence of GSH-OEt by MTT assay,SF295,CWTATMITRQBWAX-UHFFFAOYSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,5.76,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,4.35,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,JAMULYFATHSZJM-UHFFFAOYSA-N
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,4.79,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,AHJRHEGDXFFMBM-UHFFFAOYSA-N
CHEMBL2172632,,Cc1nc(Nc2cccnn2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.56,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,RHLKAAGLEWHOFV-UHFFFAOYSA-N
CHEMBL1946507,,CC1C(C(C)(C)O)CCC1(C)/C=C/c1ccc(O)cc1,IC50,4.64,CHEMBL1948695,Cytotoxicity against human SF295 cells after 48 hrs by sulpharhodamine B assay,SF295,LCKVCMDFSAGHIF-PKNBQFBNSA-N
CHEMBL112659,,Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1,IC50,8.15,CHEMBL815093,Inhibition of the entry of HIV-1 reporter virus (JrF1) into U-87 cells,U-87MG ATCC,RYUYDSMTRQCJHP-VXKWHMMOSA-N
CHEMBL4100714,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.66,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TUNTWEBPNIIEQN-UHFFFAOYSA-N
CHEMBL4103060,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Br)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.93,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YXFZCAIVOGPFBI-UHFFFAOYSA-N
CHEMBL4074866,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5C(F)(F)F)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.75,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XUNIDUGFADGDTL-UHFFFAOYSA-N
CHEMBL4099282,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.82,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JGSPNDOPABPAES-UHFFFAOYSA-N
CHEMBL4782175,,O=C(Nc1ccc(Cl)cc1)Nc1cccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc(N3CCOCC3)n2)c1,IC50,5.66,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NWBPDMCNTURELD-KPKJPENVSA-N
CHEMBL3426483,,C=C1C(=O)[C@@]23CC[C@@H]4[C@@](C)(CO)CCC[C@@]4(C)C2=CC[C@]1(O)C3,IC50,5.36,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,HCZYQWZXOMCLRO-CBFGRJNTSA-N
CHEMBL3426505,,C=C1C(=O)[C@@]23CC[C@@H]4C(C)(C)CCC[C@@]4(C)[C@@H]2[C@@H](O)C[C@@H]1C3,IC50,5.5,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,CNFJKVOXPKJCBT-SPBSJPQISA-N
CHEMBL4593477,,COc1cc(/C=N/Nc2nc(-c3ccc(F)c(F)c3)cs2)c(Br)c(Br)c1OC,IC50,4.71,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,MGVARTUZLPAUJN-HCGXMYGOSA-N
CHEMBL237675,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-n3cc(CN(C)C)nn3)nccc12,IC50,5.96,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,VLWKVXAOJONEGL-UHFFFAOYSA-N
CHEMBL392281,,Cc1ccc(C(=O)N2CCN(S(=O)(=O)c3c[nH]c4ncccc34)C(C)C2)cc1,IC50,4.91,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,NHMZZPYSOHOZKU-UHFFFAOYSA-N
CHEMBL391499,,C[C@@H]1CN(C(=O)c2csc(Br)n2)CCN1S(=O)(=O)c1c[nH]c2ncccc12,IC50,6.38,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,RMNCEFNERVTQJN-SNVBAGLBSA-N
CHEMBL399421,,COc1ncc(OC)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)C[C@H]3C)c[nH]c12,IC50,8.3,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,XGLVOQFSQKQWHL-CQSZACIVSA-N
CHEMBL4453821,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCCC4)CC3)cc2)ncc1Cl,IC50,6.7,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,KJYKPTQKFIDZFU-UHFFFAOYSA-N
CHEMBL3137331,DEFACTINIB,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1,IC50,4.99,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,FWLMVFUGMHIOAA-UHFFFAOYSA-N
CHEMBL4554455,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1C(F)(F)F,IC50,7.22,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,UXDPRPCEEZGHNQ-UHFFFAOYSA-N
CHEMBL2017974,BUPARLISIB,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,EC50,6.89,CHEMBL2020180,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in PTEN-deficient human U87MG cells after 1 hr,U-87MG ATCC,CWHUFRVAEUJCEF-UHFFFAOYSA-N
CHEMBL432537,,O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1ccccc1c2=O,IC50,7.4,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,UFMQJYHLIUACCG-UHFFFAOYSA-N
CHEMBL3884639,,CCOC(=O)c1nc2ccccc2nc1C#CC1CC1,IC50,5.21,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CMGQXFJIDHHBGP-UHFFFAOYSA-N
CHEMBL1256459,TORIN1,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,IC50,7.09,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AKCRNFFTGXBONI-UHFFFAOYSA-N
CHEMBL379300,A-443654,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,IC50,6.61,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,YWTBGJGMTBHQTM-IBGZPJMESA-N
CHEMBL27759,ENTINOSTAT,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,4.44,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,INVTYAOGFAGBOE-UHFFFAOYSA-N
CHEMBL2172631,,Cc1nc(Nc2cccnc2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,5.19,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,MQFYWBFKHIRBIQ-UHFFFAOYSA-N
CHEMBL242770,,CC(COc1ccc2c3c(oc2c1)C(=O)c1ccccc1C3=O)N(C)C,IC50,5.33,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,HTJRAEYDZNBECV-UHFFFAOYSA-N
CHEMBL388880,,c1cn(-c2ccc(OC3CCCCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,7.11,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,HGPUMTWTRGEZDO-UHFFFAOYSA-N
CHEMBL232818,,c1cn(-c2ccc(OCCN(Cc3ccc4c(c3)OCO4)Cc3ccc4c(c3)OCO4)cc2)cn1,IC50,5.82,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,WPWUABDSYBUYSZ-UHFFFAOYSA-N
CHEMBL2170087,,COc1ncc(Nc2ncc([C@H](C)N3CCN(S(C)(=O)=O)C[C@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.51,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-KGLIPLIRSA-N
CHEMBL2170085,,COc1ncc(Nc2ncc([C@H](N3CCN(S(C)(=O)=O)CC3)C(F)(F)F)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.36,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,BTHPXDNRFHNRDI-KRWDZBQOSA-N
CHEMBL3806219,,Cc1ccc(OCc2cn(CC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@@H]5[C@@H]4CC[C@]4(C)C(=O)CC[C@@H]54)C3)nn2)cc1,IC50,4.73,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,YLGXDGNAZDDRHG-AXOMYGEFSA-N
CHEMBL3805633,,C[C@]12CC[C@H](OC(=O)Cn3cc(CNc4ccc(Br)cc4)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.06,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JJMCMOFPGYOSRJ-SUAVODKESA-N
CHEMBL3805391,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cc(Cl)ccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.32,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MVQRUVBPPCEYAE-RIWGJCQISA-N
CHEMBL3805540,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cc(F)ccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.04,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BQFMWMDYXURCKR-RIWGJCQISA-N
CHEMBL4793459,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)Nc2ccccc2F)cc1,IC50,5.4,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,DSFJPTWEJDCCKX-UHFFFAOYSA-N
CHEMBL4796569,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)Nc2ccccc2Cl)cc1,IC50,5.54,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,OHHJTGRTQJGKLY-UHFFFAOYSA-N
CHEMBL5569751,,N#CC1(C(=O)NCCc2ccccc2F)CC2c3ccccc3C1c1ccccc12,IC50,4.31,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,DJZIVJNHSWIMMC-UHFFFAOYSA-N
CHEMBL2163598,,COc1cc(CN(C(C)C)S(=O)(=O)c2ccccn2)cc2c1OC(C)(C)C=C2,IC50,4.14,CHEMBL2169673,Cytotoxicity against human LN229 cells transfected with V6R incubated for 3 days under normoxic condition by SRB assay,LN-229,LREPTZOCUMWFMS-UHFFFAOYSA-N
CHEMBL1914743,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.7,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,YKIWXNATSYCOKT-UHFFFAOYSA-N
CHEMBL1914710,,O=S(=O)(Nc1cc(-c2ccc3ncccc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.42,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,LBMKYGFVNPHLPV-UHFFFAOYSA-N
CHEMBL1914728,,CN(C)c1ccc(-c2ccnc3ccc(-c4cnc(Cl)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc23)cc1,IC50,7.21,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,DCKNELOICLMUKN-UHFFFAOYSA-N
CHEMBL1914738,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCCCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.89,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,CITYVTFEGMZZGV-UHFFFAOYSA-N
CHEMBL445564,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCC#N)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,UWUBRPDSQCUZOQ-UHFFFAOYSA-N
CHEMBL4528589,,COc1cccc(N2C(=N)S/C(=C\c3ccc(-c4ccc5c(c4)C(=O)NC5=O)o3)C2=O)c1,IC50,5.0,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,HCJVVFVIICAVRF-BILQUMLASA-N
CHEMBL5431799,,COc1cccc(SC2=CC(=O)c3cccc(O)c3C2=O)c1,IC50,5.09,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,FKUQPQABTSLCJZ-UHFFFAOYSA-N
CHEMBL4853279,,Cc1nc(=O)c2c(-c3cccc(Cl)c3)c(C(=O)c3ccccc3)[nH]c2[nH]1,IC50,6.05,CHEMBL4818316,Cytotoxicity against human U87 cells by MTT assay,U-87MG ATCC,GUTOAQSFSWJYTL-UHFFFAOYSA-N
CHEMBL3301610,ABEMACICLIB,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,EC50,6.27,CHEMBL4387158,Antiproliferative activity against human T98G assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,T98G,UZWDCWONPYILKI-UHFFFAOYSA-N
CHEMBL4287065,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)c2cn(Cc3ccc(OC)c(OC)c3)nn2)cc1,IC50,6.07,CHEMBL4343250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,HPNCRJJSTODGJI-UHFFFAOYSA-N
CHEMBL1782901,,CCCCCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.21,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,JINCHVNCWHGGGU-QGWJVEIISA-N
CHEMBL5630349,,C#CCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.18,CHEMBL5621064,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,IJDJQTVSYXXWMT-UHFFFAOYSA-N
CHEMBL5436814,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)N[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,9.15,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,GFNOBLJAGYIDLB-YQCPNUQPSA-N
CHEMBL5402604,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(-c4ccccc4)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.16,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,NHMQMQATMQEBKF-UHFFFAOYSA-N
CHEMBL5408579,,C=C1C(=O)N(c2cc(OC)c(OC)c(OC)c2)[C@H]1c1ccc(OC)c(/C=C/CC(=O)NO)c1,IC50,5.67,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,LTQYHLRYCLMQNY-XYXUZSOXSA-N
CHEMBL4793994,,C=C1C(=O)N(c2cc(OC)c(OC)c(OC)c2)[C@H]1c1ccc(OC)c(O)c1,IC50,6.84,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,VQAFFPQTZLYJDR-GOSISDBHSA-N
CHEMBL5523580,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.94,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZSIDGHXLTCSENF-UHFFFAOYSA-N
CHEMBL5517720,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)COc4cccnc4)cc3)cc2)n1,IC50,5.93,CHEMBL5509853,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,KRQSJWTXUQGYKQ-KDYSTLNUSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,4.05,CHEMBL5509850,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,5.51,CHEMBL5509852,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL5620297,,CCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.8,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,NAOYDIWOTBXUJD-XIFFEERXSA-N
CHEMBL5619669,,CCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.9,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,XNIOOABZUIRVKL-BHVANESWSA-N
CHEMBL4633648,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)NCCCC)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.76,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,RMWJGKGUCUHVCC-ZDBMLTPASA-N
CHEMBL4641992,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)NC(C)C)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.26,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,LEICXSSFNVJEDD-VACPRRTESA-N
CHEMBL4643037,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1cccnc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.57,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,LDBJWVCPZNVIIN-MVNQOXTESA-N
CHEMBL5417192,,COc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.25,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,USJUPOQTPOFLDF-UHFFFAOYSA-N
CHEMBL5422395,,COCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,8.06,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,BGMYFXWMIMLVCJ-UHFFFAOYSA-N
CHEMBL5410189,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1F,IC50,7.99,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RQFGVNXBMRSDGL-UHFFFAOYSA-N
CHEMBL4093415,,CSc1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.35,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,SMUJMXAEMNIVGX-RMKNXTFCSA-N
CHEMBL5291472,,OC1CC2CC1CN2c1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,4.56,CHEMBL5250738,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay,U-87MG ATCC,ZMOMHLVVLVGMBV-UHFFFAOYSA-N
CHEMBL5433226,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc(F)ccc32)cc1,IC50,4.37,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,MIXJLSRSFQOQPD-UHFFFAOYSA-N
CHEMBL2170090,,COc1ncc(Nc2ncc(C(C)(C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.52,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,DZRQGNOLDZNGKA-UHFFFAOYSA-N
CHEMBL2170089,,COc1ncc(Nc2ncc([C@H](C)N3CCN(S(C)(=O)=O)C[C@@H]3C)cc2-c2nc(C)nc(N)n2)cc1F,IC50,8.52,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,SYUHGFRIKWMPPV-KBPBESRZSA-N
CHEMBL2170084,,COc1ncc(Nc2ncc([C@@H](N3CCN(S(C)(=O)=O)CC3)C(F)(F)F)cc2-c2nc(C)nc(N)n2)cc1F,IC50,7.75,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,BTHPXDNRFHNRDI-QGZVFWFLSA-N
CHEMBL2164698,,Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,5.7,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,LIQPIULRQPRNHC-UHFFFAOYSA-M
CHEMBL2165015,,COC(=O)N1CCN(Cc2cnc(Nc3ccc(OC)nc3)c(-c3nc(C)nc(N)n3)c2)CC1,IC50,7.21,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,AXHJCTAXCZSLFA-UHFFFAOYSA-N
CHEMBL2165029,,COc1ccc(Nc2ncc(N3CCOCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.08,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,UMNVNHUOVNNHPM-UHFFFAOYSA-N
CHEMBL3780259,,COc1cc2c(Oc3ccc(NC(=O)c4c(Cl)c5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.8,CHEMBL3782282,Cytotoxicity against human U87MG cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JNSHVPBNGLECKZ-UHFFFAOYSA-N
CHEMBL2037144,,COc1ccc(-c2c(COC(=O)NC(C)C)c(COC(=O)NC(C)C)c3sc4ccccc4n23)cc1,IC50,4.22,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,XCFLJAUWJKYJSW-UHFFFAOYSA-N
CHEMBL2165017,,COc1ccc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.8,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,RNTFRUPRTOCGJO-UHFFFAOYSA-N
CHEMBL2165009,,COc1ccc(Nc2ncc(CN3CCCCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.85,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,XDLCZYNDGPSHBI-UHFFFAOYSA-N
CHEMBL2165031,,COc1ccc(Nc2ncc(N3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.06,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,HJMSDMFCCDZFIX-UHFFFAOYSA-N
CHEMBL4476614,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCS(C)(=O)=O)CC3)cc2)ncc1Cl,IC50,6.04,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,ZOHDSYSNYVEESE-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,6.22,CHEMBL3806924,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by Z2 coulter counter method,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL5425232,,O=C1C=C(Sc2ccc(O)cc2)C(=O)c2c(O)cccc21,IC50,5.19,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,YBKODABFAUCIHI-UHFFFAOYSA-N
CHEMBL3735275,,CN1CC2C3=N/C(=C(/c4c(F)c(F)c(S[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(F)c4F)C4=N/C(=C(/c5c(F)c(F)c(F)c(F)c5F)c5ccc([nH]5)/C(c5c(F)c(F)c(S[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(F)c5F)=C5/C=CC(=N5)C3c3c(F)c(F)c(F)c(F)c3F)C=C4)C2C1,EC50,10.0,CHEMBL3737968,Photocytotoxicity against human U87 cells assessed as cell survival preincubated for 24 hrs followed by irradiation at 16 J/cm2 measured at 24 hrs by WST-8 assay,U-87MG ATCC,XLZXJTFDRJWXSX-SCIACSNLSA-N
CHEMBL3765584,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2cccc(F)c2)nn1,IC50,5.69,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,KTNZWURAXJUMHW-UHFFFAOYSA-N
CHEMBL3763753,,O=C1c2ccccc2Nc2ccccc2N1Cc1cn(Cc2ccc(F)cc2)nn1,IC50,4.42,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OQWFEEXCSSYPKS-UHFFFAOYSA-N
CHEMBL5268484,,C/C=C/Cn1cc(-c2cc(OC)c(C(=O)N3CCOCC3)cc2OC)c2cc(C)[nH]c2c1=O,IC50,5.3,CHEMBL5262594,Cytotoxicity against human LN-229 cells measured after 3 days,LN-229,FWTDDBIMDSVPTR-AATRIKPKSA-N
CHEMBL4789504,,CN(C)CCCNC(=O)c1ccc(NC(=O)Nc2ccc(Nc3nc(/C=C/c4ccccc4)nc(N4CCOCC4)n3)cc2)cc1,IC50,5.64,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,JVMVYUIDMDTZDE-GIJQJNRQSA-N
CHEMBL4791748,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1)Nc1ccc(C(=O)NCCN2CCCC2)cc1,IC50,5.84,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,DQHQFAXHHXUAPF-CAOOACKPSA-N
CHEMBL5399499,,C=C(C)C#C[C@]12O[C@H]1[C@@H]1OC(C)(C)[C@H](OC(C)=O)C[C@@]13O[C@H]3C2=O,IC50,5.17,CHEMBL5392808,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,UDLWCNHPUOUNNV-ZPUMPEKVSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,6.02,CHEMBL5680328,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by 3H-thymidine incorporation assay,U-87MG ATCC,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL213746,,CCN(CC)c1ccc2c(C#N)c(-c3nc4ccccc4[nH]3)c(=O)oc2c1,IC50,4.37,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,BCLNKBPAGCVDED-UHFFFAOYSA-N
CHEMBL374632,,CCN(CC)c1ccc2cc(-c3nc4ccccc4[nH]3)c(=O)oc2c1,IC50,4.82,CHEMBL853547,Antiproliferative activity against human U87 MG cell line,U-87MG ATCC,GOLORTLGFDVFDW-UHFFFAOYSA-N
CHEMBL5647606,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)ncc1C(F)(F)F,IC50,5.56,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,VMWRMINOTAWTRV-UHFFFAOYSA-N
CHEMBL5647080,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCN(CCO)CC3)cc2)ncc1C(F)(F)F,IC50,5.43,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,BJMQXXHLUKXBRQ-UHFFFAOYSA-N
CHEMBL5639507,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(CS(=O)(=O)N3CCOCC3)cc2)ncc1C(F)(F)F,IC50,4.72,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,REDVNZHZAIDXGJ-UHFFFAOYSA-N
CHEMBL5647372,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1C(F)(F)F,IC50,6.92,CHEMBL5635292,Inhibition of colony formation in human U-87MG cells,U-87MG ATCC,QUPSSTNMTKCKSQ-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,7.92,CHEMBL4735628,Cytotoxicity against human T98G assessed as reduction in cell viability after 72 hrs by MTS assay,T98G,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4092171,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc(C#N)cc1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,ACNMHKXKDCWNAR-UHFFFAOYSA-N
CHEMBL5220854,,COc1ccc(-c2ncccc2NCc2ccc(C)cc2)cc1OC,IC50,4.61,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,GLGSWJSMMONYGR-UHFFFAOYSA-N
CHEMBL4285631,,COc1ccc(Cn2cc(C(=O)c3cn(-c4ccccc4)nc3-c3ccc(F)cc3)nn2)cc1OC,IC50,5.42,CHEMBL4271208,Cytotoxicity in human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,BASABKRMOALIDI-UHFFFAOYSA-N
CHEMBL4796914,,Oc1c(C(c2ccc(F)cc2)N2CCCCC2)ccc2c1CCC2,IC50,4.55,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,PUJDQZLKNOZWLN-UHFFFAOYSA-N
CHEMBL1485589,,COc1ccccc1C(c1cc2c(cc1O)OCO2)N1CCOCC1,IC50,4.56,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,CSQQCASHAULUEU-UHFFFAOYSA-N
CHEMBL4750094,,COc1cccc(C(Nc2ccccn2)c2ccc3cccnc3c2O)c1,IC50,4.92,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,LRIKTDRCLNJXMA-UHFFFAOYSA-N
CHEMBL2095087,,Cc1ccnc(NC(c2ccc3cccnc3c2O)c2c(F)cccc2Cl)c1,IC50,4.69,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,CRIZOPXWFAJBPS-UHFFFAOYSA-N
CHEMBL4762974,,Cc1ccnc(NC(c2ccc3cccnc3c2O)c2c(Cl)cccc2Cl)c1,IC50,5.14,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,LNQAUBSYKUMDRN-UHFFFAOYSA-N
CHEMBL4206850,,N[C@H]1CCN(C(=O)c2coc3c(O)c4c(c(O)c23)C(=O)c2ccccc2C4=O)C1,IC50,5.28,CHEMBL4480830,Cytotoxicity against human A172 cells after 72 hrs by MTT assay,A-172,HECFNGGMVTZBKE-VIFPVBQESA-N
CHEMBL5563067,,CCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.49,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,RVTVYAMLKHQXSN-GFCCVEGCSA-N
CHEMBL5563434,,CCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.78,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,MZBKDEGDTCITBX-CQSZACIVSA-N
CHEMBL1645551,,Cc1nccc2c1[nH]c1cc(OCc3ccccn3)ccc12,IC50,4.7,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,RINQBMRYJCENBJ-UHFFFAOYSA-N
CHEMBL2164403,,Cc1c2c(cc[n+]1CCO)c1ccc(OCc3ccccc3)cc1n2Cc1ccccc1.[Br-],IC50,4.21,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,XPIFHWUFLHRFRI-UHFFFAOYSA-M
CHEMBL2164708,,Cc1nccc2c3ccc(O)cc3n(Cc3ccccc3)c12,IC50,4.09,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,SZJTUBCBHRFAAE-UHFFFAOYSA-N
CHEMBL2164705,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,6.22,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,BKJRAVOKCBMHTR-UHFFFAOYSA-M
CHEMBL2165003,,COc1ccc(Nc2ncc(CN3CCCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.19,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,ONJSIGPCPAOGNJ-UHFFFAOYSA-N
CHEMBL2165014,,COc1ccc(Nc2ncc(CN3CCN(C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.64,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,QIBHHZDVUBRFRC-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.64,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL2165030,,COc1ccc(Nc2ncc(C3=CCOCC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.33,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,IFIUXKIVTAKIHT-UHFFFAOYSA-N
CHEMBL3945818,,O=C1C=C(NCc2cn(C[Se]c3ccccc3)nn2)C(=O)c2ccccc21,IC50,6.01,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,MHCZNBSEGFJRMA-UHFFFAOYSA-N
CHEMBL3966682,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(C[Se]c2ccccc2)nn1,IC50,5.88,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,DRDCWILTIUDZCE-UHFFFAOYSA-N
CHEMBL3932274,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1n1cc(C[Se]c2ccccc2)nn1,IC50,5.58,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,GIGCBAVNNGPPQM-UHFFFAOYSA-N
CHEMBL517968,,CC1(C)OC2=C(C(=O)c3ccccc3C2=O)C1N=[N+]=[N-],IC50,5.52,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,KTBBERAINMFOJN-UHFFFAOYSA-N
CHEMBL2164693,,Cc1c2c(cc[n+]1Cc1ccccc1)c1ccc(OCc3ccc(F)cc3)cc1n2Cc1ccc(F)cc1.[Br-],IC50,6.4,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,APZJDZWUWVRLPM-UHFFFAOYSA-M
CHEMBL2164714,,CCCn1c2cc(OCc3ccccc3)ccc2c2ccnc(C)c21,IC50,4.47,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,GFKJHDTZPIORLX-UHFFFAOYSA-N
CHEMBL2164709,,Cc1nccc2c3ccc(OCc4ccccc4)cc3n(Cc3ccccc3)c12,IC50,4.44,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,RRSQKKMTIRLMGU-UHFFFAOYSA-N
CHEMBL2165027,,COCc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1,IC50,6.82,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,DLFVITASTHEQDC-UHFFFAOYSA-N
CHEMBL2165025,,COc1cnc(Nc2ccc(OC)nc2)c(-c2nc(C)nc(N)n2)c1,IC50,7.38,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,DYLZJJGYKQIVGK-UHFFFAOYSA-N
CHEMBL4074759,,c1cncc(CN2CCC(c3cnc4c(N5CCOCC5)cc(-c5ccc6[nH]ccc6c5)nn34)CC2)c1,IC50,5.29,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,VHAOWCMAMJCCDO-UHFFFAOYSA-N
CHEMBL4074775,,Cc1cnc2c(N3CCOCC3)cc(-c3ccc(NC(=O)Nc4cccnc4)cc3)nn12,IC50,4.89,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,JPPYZWTZMGTNMQ-UHFFFAOYSA-N
CHEMBL4093332,,Cc1cnc2c(N3CCOC[C@@H]3C)cc(-c3ccc(NC(=O)Nc4cccnc4)cc3)nn12,IC50,4.97,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,NSBZLJYTQXCINL-KRWDZBQOSA-N
CHEMBL5430557,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1OCCN1CCOCC1,IC50,7.86,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,YFRRKGINNPHMHR-UHFFFAOYSA-N
CHEMBL5425652,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1Cl,IC50,7.38,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,WGOFDWAXBNRPKE-UHFFFAOYSA-N
CHEMBL5423222,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1cccc(Br)c1,IC50,7.39,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,RVWHXDQOWSKLRN-UHFFFAOYSA-N
CHEMBL4103646,,CN1C/C(=C\c2cc(F)c(F)cc2F)C(=O)/C(=C/c2cc(F)c(F)cc2F)C1,IC50,5.51,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,HICMTPXFJJCCDU-TUOIWHRTSA-N
CHEMBL4070918,,O=C1/C(=C/c2ccc(F)c(F)c2)CSC/C1=C\c1ccc(F)c(F)c1,IC50,5.64,CHEMBL4045042,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GPWYCKFIDQFBEP-ACFHMISVSA-N
CHEMBL4097794,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCc4ccccc43)c(OC)c2)cc1,IC50,4.82,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,YRRPPWAVUNXBTB-RIYZIHGNSA-N
CHEMBL4062039,,COc1ccc(C(=O)/C=C/c2ccc(OCCCN3CCCc4ccccc43)c(OC)c2)cc1,IC50,4.74,CHEMBL4045084,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QVODHRCONKKYLI-MHWRWJLKSA-N
CHEMBL4527122,,CCCCCCNC(=S)NCc1ccc2c(c1)OCO2,IC50,4.06,CHEMBL4388788,Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,IKBHNADYMMDTRR-UHFFFAOYSA-N
CHEMBL4464767,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4ccc5c(c4)C(=O)NC5=O)s3)C2=O)cc1,IC50,5.0,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,SAJVLIRHXSJMQH-BILQUMLASA-N
CHEMBL4579277,,Cc1cn([C@H]2C[C@H](n3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,4.97,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,WEBCKHJLVOSNNV-ZQLWZKNSSA-N
CHEMBL4554315,,Cc1cn([C@H]2C[C@H](n3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,5.72,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,BIUUUPZSQFCVTA-ZQLWZKNSSA-N
CHEMBL4552928,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(COC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(NC(=O)OCc3ccccc3)nc2=O)C1(F)F,IC50,5.96,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,KGZWHTDZGKHYDI-BEYURWCVSA-N
CHEMBL5558630,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.48,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,LKBCVMRXHSKDPT-UHFFFAOYSA-N
CHEMBL5556281,,COc1cc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCCCOc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,IC50,6.08,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,SGMKJWDGNACVOF-UHFFFAOYSA-N
CHEMBL4284204,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3cccs3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.89,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,DAXIRJXAMMBHLE-BERMCJJASA-N
CHEMBL4288699,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(C(=O)OCc4ccc(OC)cc4)nn3)CC[C@@H]12,IC50,5.43,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,NDHUIPQPANWQBE-YSBZXDJFSA-N
CHEMBL5423304,,O=C1c2nc3ccccc3c(=O)n2C2C=CC([N+](=O)O)=CC12,IC50,7.4,CHEMBL5386659,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 14 hrs by CCK8 assay,U-87MG ATCC,VHANRRAMCXJVLJ-UHFFFAOYSA-N
CHEMBL601661,,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,IC50,7.19,CHEMBL5696731,Antiproliferative activity against human U-87MG cells assessed as cell growth inhibition incubated for 24 hrs by MTS assay,U-87MG ATCC,QLHHRYZMBGPBJG-UHFFFAOYSA-N
CHEMBL1231795,,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1,EC50,6.3,CHEMBL5675724,Antiproliferative against human LN-229 cells after 5 days by Cell-Titer Glo assay,LN-229,QOECJCJVIMVJGX-UHFFFAOYSA-N
CHEMBL1236095,,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,IC50,5.66,CHEMBL5708655,Antiproliferative activity against human SNB-75 cells assessed as inhibition of cell growth incubated for 72 hrs by celltiter-glo assay,SNB-75,JFOAJUGFHDCBJJ-UHFFFAOYSA-N
CHEMBL223142,SCHWEINFURTHIN G,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)CC[C@@]2(C)O3)cc1O,IC50,8.1,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,CGJIPMVTBQUUQL-GEDZTWKOSA-N
CHEMBL3805245,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5c(Cl)cccc54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.48,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,SOABZRUKTCYMPO-IUFQJPFESA-N
CHEMBL3805659,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5c(Cl)ccc(Cl)c54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,5.02,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,BBWPOSLPFWUEKE-GBQDJQSCSA-N
CHEMBL3805763,,C[C@]12CC[C@H](OC(=O)Cn3cc(CN4C(=O)C(=O)c5cccc(Cl)c54)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.68,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,OKJZQJSPKHBPRJ-DCCPDJSOSA-N
CHEMBL4129272,,C=Cc1ccc(OC(=O)c2ccc(O)c(NC(C)=O)c2)cc1,IC50,4.99,CHEMBL4119405,Cytotoxicity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,GIZFCCIAJXWSKK-UHFFFAOYSA-N
CHEMBL178310,,COc1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1,IC50,6.3,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,MXYYHEJTMJMGSX-UHFFFAOYSA-N
CHEMBL361956,,COc1cc(OC)cc(-c2nc(O)c3c4c(sc3n2)CCCC4)c1,IC50,4.32,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,YXZRLJZTIHFJAM-UHFFFAOYSA-N
CHEMBL4176356,,O=c1[nH]c(-c2ccc(F)cc2)nc2sc3c(c12)CCCC3,IC50,4.77,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,KAOOMLBGJNXBLA-UHFFFAOYSA-N
CHEMBL5571295,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.84,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,IHVNOGSWEFFJSN-KHEAGTJRSA-N
CHEMBL5568768,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NCCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.54,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,QTMBOQARWWEVKV-APYISGCASA-N
CHEMBL5569274,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.89,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,DHUBQULUTJZTLG-MMNKWBABSA-N
CHEMBL5567441,,N#CC1(C(=O)NCCc2cccc(Cl)c2)CC2c3ccccc3C1c1ccccc12,IC50,4.44,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,VYZHXQPBFGSXFU-UHFFFAOYSA-N
CHEMBL5574930,,N#CC1(C(=O)NCCS(=O)(=O)Nc2ccc(F)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.89,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,ZUEUGFYUZCGAOG-UHFFFAOYSA-N
CHEMBL5592097,,Cc1c(Br)c(C)n2c1C=C1C=C(Br)C(CCC(=O)NCCCCCCNC(=O)c3ccc(S(N)(=O)=O)cc3)=[N+]1[B-]2(F)F,IC50,6.52,CHEMBL5576892,Photodynamic antitumor activity against human U87 cells assessed as inhibition of cell growth incubated for 60 mins followed by compound washout and light irradiation measured after 72 hrs by MTT assay,U-87MG ATCC,ODEJCZKRNICMAE-UHFFFAOYSA-N
CHEMBL4515390,,CC[C@@H](N)CNc1ccnc(-c2cc(-c3cnn(C)c3)ccc2O)n1,IC50,6.22,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,SCJXQZZYGYLKJG-CQSZACIVSA-N
CHEMBL4790355,,COc1cc(C(Nc2ccc(C)cn2)c2ccc3cccnc3c2O)cc(OC)c1O,IC50,5.13,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,MITSWHDEOSTHCR-UHFFFAOYSA-N
CHEMBL590899,,Oc1c(C(Nc2ccccn2)c2ccc(Cl)cc2)ccc2cccnc12,IC50,4.97,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,RDIURRMJOIJGSL-UHFFFAOYSA-N
CHEMBL2094875,,Oc1c(C(Nc2ccccn2)c2ccccc2Cl)ccc2cccnc12,IC50,5.03,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,RGPCTXYEMALQFR-UHFFFAOYSA-N
CHEMBL589912,,Cc1ccnc(NC(c2ccccc2F)c2ccc3cccnc3c2O)c1,IC50,4.88,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,LLJNUTJAVMTITA-UHFFFAOYSA-N
CHEMBL576209,,CCc1ccc(C(Nc2cc(C)ccn2)c2ccc3cccnc3c2O)cc1,IC50,5.05,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,BLRVDQSWWDLAAA-UHFFFAOYSA-N
CHEMBL589706,,Cc1ccnc(NC(c2ccc([N+](=O)[O-])cc2)c2ccc3cccnc3c2O)c1,IC50,5.47,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,WRUZNTSXJKBYPR-UHFFFAOYSA-N
CHEMBL4074207,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1cccc(Cl)c1)CC(C)(C)O2,IC50,4.7,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,AWBDPWSULFCJEF-UHFFFAOYSA-N
CHEMBL4064472,,CC(C)(C)OC(=O)Nc1ccc2c(c1)C(NC(=O)Nc1ccc(Cl)cc1)CC(C)(C)O2,IC50,4.58,CHEMBL4054425,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,ORCGAZNEXCXRPF-UHFFFAOYSA-N
CHEMBL4776190,,Oc1ccc2[nH]ncc2c1C(c1ccc(F)cc1)N1CCCCC1,IC50,4.06,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,TXEWFPSKHMOWRP-UHFFFAOYSA-N
CHEMBL4099164,,CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)O,IC50,4.36,CHEMBL4047157,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,ZYPYAXPTWKNCLK-LPSCLBFBSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.58,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4750697,,C#CCOc1ccc(/C=C/C(=O)c2cccc(Br)c2)cc1OC,IC50,5.59,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,KWVYUPDEBNSUDY-VQHVLOKHSA-N
CHEMBL2165736,,CCNC(=O)Nc1ccc(S(=O)(=O)Oc2ccccc2CC)cc1,IC50,5.04,CHEMBL4723432,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by sulforhodamine B assay,SNB-75,BEQRKSLOFGBOPF-UHFFFAOYSA-N
CHEMBL4291927,,C(=C/c1ccc(OCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.44,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,ZWMRQMMBBVUDPI-JGUILPGDSA-M
CHEMBL4281382,,COc1cc(OC)c2c(=O)c(OCCCOc3ccccc3/C=C/C(=O)/C=C/c3ccccn3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.41,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,QPAZZOMARVCHOR-YXLFCKQPSA-N
CHEMBL4291595,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccc(/C=C/C(=O)/C=C/c4scnc4C)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.23,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,BGPYOJIUFHLROC-USJAFLQSSA-N
CHEMBL3804989,,C[C@]12CC[C@H](OC(=O)Cn3cc(COc4cc(=O)oc5ccccc45)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.4,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,TXOQAEYMEFQCKY-SFZGMJDZSA-N
CHEMBL3805490,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc(OC)c1OC,IC50,4.75,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,LRNGFHVVRARXBA-YPKPFQOOSA-N
CHEMBL1738758,ONVANSERTIB,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,IC50,6.64,CHEMBL5682227,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth incubated for 72 hrs by cell-titer glo assay,T98G,QHLVBNKYJGBCQJ-UHFFFAOYSA-N
CHEMBL5086293,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(F)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.34,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GAFFZCCTWJWKRW-SMRIDXHDSA-N
CHEMBL5089631,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccccc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.6,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,CKQLOINPQOUXOW-MCLIRCHUSA-N
CHEMBL5079791,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C(C)(C)C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.52,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,QLFCJGYFBTYJGC-VZHCALMGSA-N
CHEMBL5080969,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.57,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,WCCOFLBJUFCACV-BDFBTMKGSA-N
CHEMBL5086100,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CCCCC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.67,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,DBJDUIQIYKJHPB-SMRIDXHDSA-N
CHEMBL5076815,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.64,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,YSEVIHSXDAOIMX-VZHCALMGSA-N
CHEMBL4285275,,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,IC50,6.35,CHEMBL5048128,Cytotoxicity against human U-87 MG cells by sulforhodamine B assay,U-87MG ATCC,LNKLNUAMTRHBLB-CGJDGIRVSA-N
CHEMBL4211294,,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2,IC50,5.49,CHEMBL5048128,Cytotoxicity against human U-87 MG cells by sulforhodamine B assay,U-87MG ATCC,HWCVTYJVEWESOJ-XREWKEJESA-N
CHEMBL4285275,,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,IC50,5.35,CHEMBL5048137,Cytotoxicity against human U-87 MG cells using best fit nonlinear regression analysis,U-87MG ATCC,LNKLNUAMTRHBLB-CGJDGIRVSA-N
CHEMBL3805190,,COc1cc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(O)cc2)cc(OC)c1OC,IC50,5.75,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OWRSMPKWHXEMRA-YPKPFQOOSA-N
CHEMBL5092573,,Cc1ccc(CN2C(=O)[C@](O)(CC(=O)c3ccc4c(c3)OCO4)c3cc(Br)ccc32)cc1,IC50,4.81,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,RJWAPLZQOHMKPF-VWLOTQADSA-N
CHEMBL5418850,,COc1ccc2c(c1)c(Cc1cc(C)c(O)c(C)c1)cn2S(=O)(=O)c1ccc(C)cc1,IC50,4.55,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,UOBDDXCBKVNHNT-UHFFFAOYSA-N
CHEMBL5432847,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)cc(N2CCN(C(=S)SCC(=O)N3CCCC3)CC2)n1,IC50,5.7,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,WKWYSOWNDOKVBG-UHFFFAOYSA-N
CHEMBL1724189,,Nc1ccc(Cn2ccc3c4c(N)nc(N)nc4ccc32)cc1,IC50,4.68,CHEMBL5051747,Antiproliferative activity against human U-87 MG cells after 72 hrs by MTT assay,U-87MG ATCC,LNEWNMFMWDBAKM-UHFFFAOYSA-N
CHEMBL1724189,,Nc1ccc(Cn2ccc3c4c(N)nc(N)nc4ccc32)cc1,IC50,6.17,CHEMBL5051749,Antiproliferative activity against human A-172 cells after 72 hrs by MTT assay,A-172,LNEWNMFMWDBAKM-UHFFFAOYSA-N
CHEMBL1724189,,Nc1ccc(Cn2ccc3c4c(N)nc(N)nc4ccc32)cc1,IC50,4.96,CHEMBL5051750,Antiproliferative activity against human T98G cells after 72 hrs by MTT assay,T98G,LNEWNMFMWDBAKM-UHFFFAOYSA-N
CHEMBL3923330,,COc1ncc(-c2ccc3nccc(-c4ccc(CN5CCN(C(C)C)CC5)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.33,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,NVSHUXDGRVRGBX-UHFFFAOYSA-N
CHEMBL3924412,,COc1ncc(-c2ccc3nccc(-c4ccc(CN(CCO)CCO)cc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.84,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WWQGZIBPCULVTA-UHFFFAOYSA-N
CHEMBL3896400,,CCN(Cc1ccc(-c2ccnc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)cc23)cc1)C1CCCCC1,IC50,5.84,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VDKDZMNKYPRJFD-UHFFFAOYSA-N
CHEMBL3923855,,COc1ncc(-c2ccc3nccc(N4CCCC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.17,CHEMBL3867030,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SVNLAKNJHSGYGN-UHFFFAOYSA-N
CHEMBL3982619,,O=C1CS/C(=N/Nc2nncc3ccccc23)N1c1ccccc1,IC50,8.34,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,GSFCLBKGTQCVGV-HEHNFIMWSA-N
CHEMBL3938794,,O=C1CS/C(=N/Nc2nncc3ccccc23)N1,IC50,8.62,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RRPVAUYNDYHREV-UHFFFAOYSA-N
CHEMBL3896476,,S=C(NNc1nncc2ccccc12)Nc1ccc(Cl)cc1,IC50,8.08,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,PBFFTWJHTSVERV-UHFFFAOYSA-N
CHEMBL3908272,,O=S(=O)(Nc1ncccn1)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.12,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,AUAMVGQDEAESMO-UHFFFAOYSA-N
CHEMBL3899216,,Cc1cc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)no1,IC50,8.36,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RTWIUHXCAFIOQK-UHFFFAOYSA-N
CHEMBL3934506,,O=C1C2=C(C(=O)c3ccccc31)[C@H](c1ccccc1)[C@@H](n1cc(C[Se]c3ccccc3)nn1)CO2,IC50,5.25,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,FOZGPHHONSZBQI-BJKOFHAPSA-N
CHEMBL3974809,,CCCCCCc1cn(CC2CC3=C(O2)c2ccccc2C(=O)C3=O)nn1,IC50,5.57,CHEMBL3862209,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,ADVBYVIGGIGVIF-UHFFFAOYSA-N
CHEMBL5591952,,N[C@H]1CC[C@H](NC(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)CC1,IC50,5.35,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,REIKLGHKTPRJRF-JOCQHMNTSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.74,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5571420,,N#CC1(C(=O)NCCC2CCN(Cc3ccccc3)CC2)CC2c3ccccc3C1c1ccccc12,IC50,4.94,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,BFBLDTSWYZNMAD-UHFFFAOYSA-N
CHEMBL2037069,,OCc1c(CO)c2sc3ccccc3n2c1C1CC1,IC50,4.54,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,HWRJDZOMOKZHOF-UHFFFAOYSA-N
CHEMBL2037076,,CCNC(=O)OCc1c(COC(=O)NCC)c2sc3ccccc3n2c1-c1ccc(OC)cc1,IC50,4.53,CHEMBL2039002,Cytotoxicity against human U87 cells after 72 hrs by alamar blue assay,U-87MG ATCC,GKXKHQWSIYHBAH-UHFFFAOYSA-N
CHEMBL5270282,,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](NC(=O)CCCNC(=O)c2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)ccn2)C(C)(C)C)cc1,IC50,4.69,CHEMBL5239980,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,DQWLHVNWDUFZCJ-XUHBGXIGSA-N
CHEMBL5273395,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)NC5CN6CCC5CC6)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.67,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,RYQYIWQEMSPDMJ-UHFFFAOYSA-N
CHEMBL5282212,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccc6[nH]ncc6c5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.82,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,ICRBTXCCGGMHJF-UHFFFAOYSA-N
CHEMBL3884794,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccccc1C,IC50,4.5,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ISEGQTIMVBKKSL-UHFFFAOYSA-N
CHEMBL4862917,,O=C(CCCCCNC(=O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O)NO,IC50,5.26,CHEMBL5614797,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,BWMRGOQFHBXKQR-UHFFFAOYSA-N
CHEMBL2298457,,N#CC1=C(N)Oc2c(c(=O)oc3ccccc23)C12C(=O)N(CCCCBr)c1ccccc12,IC50,4.11,CHEMBL5232067,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay,U-87MG ATCC,JVTAAAJPZUCLIR-UHFFFAOYSA-N
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,5.7,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.43,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,4.88,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL288441,BOSUTINIB,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,IC50,4.48,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,UBPYILGKFZZVDX-UHFFFAOYSA-N
CHEMBL573107,,CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C,IC50,5.17,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,DTEKTGDVSARYDS-UHFFFAOYSA-N
CHEMBL379975,,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,IC50,5.34,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,DPEXRCOBPACFOO-UHFFFAOYSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,4.65,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL280986,,CC(C)=CCC[C@](C)(O)C1CC[C@]2(C)C1[C@H](O)CC1[C@@]3(C)CC[C@H](O)C(C)(C)C3CC[C@]12C,IC50,4.42,CHEMBL5233963,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation,U-87MG ATCC,PYXFVCFISTUSOO-NKYJHZBASA-N
CHEMBL5268257,,O=C(CCCCCNC(=O)C1=CC2C(=O)C3C=CC=C(O)C3C(=O)C2C(O)=C1)NO,IC50,5.26,CHEMBL5231068,Cytotoxicity against human U87 cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,ALJZJKPKINLHPS-UHFFFAOYSA-N
CHEMBL4285427,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccccc5)c4=O)cc3F)ccnc21,IC50,5.45,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RBQAQDXTXSPOKX-UHFFFAOYSA-N
CHEMBL4291079,,CC[N+](CC)(CC)CCCCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,5.75,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,CAKFDDIAFHTZIJ-WPDLWGESSA-M
CHEMBL4277852,,C(=C/c1ccc(OCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.42,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,SJAKUNBAYWZRAM-BTKVJIOYSA-M
CHEMBL4282960,,CC1(C)[C@H]2OC(=O)O[C@H]2[C@@H](O)[C@]2(C=O)[C@H]3CC[C@]4(C)[C@@H](c5ccc(=O)oc5)[C@@H](Cl)C[C@]4(O)C3=CC[C@@H]12,EC50,6.21,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,CMWNDRSEHHSODA-XBJQJAEESA-N
CHEMBL67,COMBRETASTATIN A4,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,6.32,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,HVXBOLULGPECHP-WAYWQWQTSA-N
CHEMBL9941,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,6.24,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IKMOZUDCUBMIRL-FNORWQNLSA-N
CHEMBL4648447,,O=C(O)c1cccc(-n2nnc3c2C(=O)c2ccccc2C3=O)c1,IC50,4.67,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,GSZLJYACJIRCIN-UHFFFAOYSA-N
CHEMBL4645339,,COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OC(=O)c1cccc(Cn2cc(CCOC(=O)CCC(=O)n3cc(/C=C/c4cccnc4)c4ccccc43)nn2)c1,IC50,6.19,CHEMBL4603843,Antiproliferative activity against human U87 cells assessed as reduction in cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,LJDAZCPWCZBFKM-CJQREAPYSA-N
CHEMBL5561986,,NCCN(Cc1ccc2ccccc2c1)c1nc(C(=O)Nc2ccc(O)cc2)cs1,IC50,5.24,CHEMBL5520021,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UKTIJZJOHLGMQZ-UHFFFAOYSA-N
CHEMBL5624701,,CCOc1ccc(Oc2ccc(C3=NN(C4=NC(=O)CS4)C(c4cc(O)c(O)c(Br)c4Br)C3)cc2)cc1,IC50,5.58,CHEMBL5620677,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,SSAVEPMIHHRFHV-UHFFFAOYSA-N
CHEMBL5279397,,CCCN(CCC)c1ccnc(NCc2csc(-c3ccccc3)n2)n1,IC50,4.79,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,OLEDTHPOZSTPSH-UHFFFAOYSA-N
CHEMBL5564226,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,6.07,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,SRWAGSNKUFDMAT-UHFFFAOYSA-N
CHEMBL5559947,,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,6.11,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,UNVKVCJYTQIHSW-UHFFFAOYSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.54,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,4.28,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,AHJRHEGDXFFMBM-UHFFFAOYSA-N
CHEMBL3414623,,Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12,IC50,5.71,CHEMBL5675970,Antiproliferative activity against human A-172 cells after 10 days,A-172,PNYRDVBFYVDJJI-UHFFFAOYSA-N
CHEMBL4205768,,CCOC(=O)c1c(Nc2ccccc2)sc(C(=O)c2cnc3ccc(C)cn23)c1C,IC50,4.37,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,TVKXBGHYRKKAEJ-UHFFFAOYSA-N
CHEMBL202721,,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,IC50,4.18,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,OGNYUTNQZVRGMN-UHFFFAOYSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.7,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL1760590,,COc1ccc(C[C@H]2CO[C@H](c3ccc(OC)c(OC)c3)[C@H]2CO)cc1OC,IC50,4.81,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,AYWPHVUFQNWITL-PNLZDCPESA-N
CHEMBL402653,,COc1cc([C@@H]2OC[C@@H]3[C@H]2CO[C@H]3c2cc(OC)c(O)c(OC)c2)cc(OC)c1O,IC50,5.05,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,KOWMJRJXZMEZLD-WRMVBYCNSA-N
CHEMBL460862,(-)-PINORESINOL,COc1cc([C@@H]2OC[C@H]3[C@@H]2CO[C@H]3c2ccc(O)c(OC)c2)ccc1O,IC50,4.88,CHEMBL1763720,Anticancer activity against human XF498 cells by SRB assay,XF 498,HGXBRUKMWQGOIE-FEBSWUBLSA-N
CHEMBL4062698,,Cc1nc(C)c(/C=C/C(=O)N2CCC=C(Cl)C2=O)nc1C,IC50,5.46,CHEMBL4037659,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XAZAQCSIQYKFPW-VOTSOKGWSA-N
CHEMBL4534317,,O=C(Nc1nc2ccc(F)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,4.9,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DZMFLHMZKMFRGK-UHFFFAOYSA-N
CHEMBL4079425,,CC(C)(C)c1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.49,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,HAVIMTMYFSHBCX-ZHACJKMWSA-N
CHEMBL1779544,,Cc1c2c(n3c1CCC(=O)N1CCC[C@@H]1CNc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,EC50,5.96,CHEMBL1780618,Antiproliferative activity against human U87 cells by luminescence assay,U-87MG ATCC,CQXLACSOWMIHAJ-QGZVFWFLSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.52,CHEMBL4015759,Cytotoxicity against human U87MG cells assessed as reduction in cell survival after 96 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4538916,,COc1cc(CNC(=O)Nc2ccc(Cl)cc2)ccc1O,IC50,4.03,CHEMBL4388788,Cytotoxicity against human U87 cells assessed as decrease in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,CDCCZJXLORNRAE-UHFFFAOYSA-N
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,5.41,CHEMBL5226671,Antiproliferative activity against human U87 cells,U-87MG ATCC,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CHEMBL5282240,,C/C=C/Cn1cc(-c2ccc(C(C)(C)O)cc2OC)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261760,Cytotoxicity against human AM-38 cells measured after 8 days,AM-38,GVJYOLRRZZUUOE-AATRIKPKSA-N
CHEMBL2165023,,COc1ccc(Nc2ncc(Br)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.08,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,VBYCMVGPGAGETD-UHFFFAOYSA-N
CHEMBL2165037,,Cc1nc(-c2cccnc2Nc2cccc3n[nH]cc23)c2[nH]cnc2n1,IC50,6.47,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,HMCXLHKQRBBRRQ-UHFFFAOYSA-N
CHEMBL2165269,,COc1ccc(Nc2ncccc2-c2nc(C)nc(N)n2)cn1,IC50,6.44,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,XZIRFISMMDAPDH-UHFFFAOYSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],IC50,6.3,CHEMBL4810931,Antiproliferative activity against human KNS-42 cells assessed as reduction in cell proliferation measured after 48 hrs by EdU-incorporation assay,KNS-42,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL4646493,,CCCCC#Cc1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n2ncnc(N)c12,IC50,6.0,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,JBNNQRWQYOANLE-MIGQKNRLSA-N
CHEMBL4634224,,COc1ccc(-c2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)n3ncnc(N)c23)cc1,IC50,4.39,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,LDZMHIGRWXMUOC-DZUCGIPZSA-N
CHEMBL453902,,CCCCc1ccc(N2C(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,6.02,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,FVSDHXRLSKXVSU-UHFFFAOYSA-N
CHEMBL507815,,COc1ccc(N2NC(=O)NC3(CSC4=C3C(=O)c3ncccc3C4=O)C2=O)cc1,IC50,5.42,CHEMBL957401,Antiproliferative activity against human XF498 cells after 96 hrs by MTT assay,XF 498,WSGPGBRUDKIIGH-UHFFFAOYSA-N
CHEMBL4572210,BAY-771,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1,IC50,5.21,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,LZLNIHXKWZZQLE-UHFFFAOYSA-N
CHEMBL1836101,,Cc1ccc(CN2C(=O)S/C(=C\c3c4ccccc4nc4ccccc34)C2=O)cc1,IC50,5.11,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,XEBUFDRTTQXKLP-UCQKPKSFSA-N
CHEMBL2035438,,O=C1S/C(=C\c2c3ccccc3nc3ccccc23)C(=O)N1Cc1ccc(Cl)cc1,IC50,5.24,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,GMCUOUPIWVXCTM-XKZIYDEJSA-N
CHEMBL5274651,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-],IC50,4.13,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,WIUJEGJOHIUWMY-SUPJBSOFSA-M
CHEMBL1256459,TORIN1,CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1,IC50,7.36,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,AKCRNFFTGXBONI-UHFFFAOYSA-N
CHEMBL514499,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,IC50,6.86,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,JSKUWFIZUALZLX-UHFFFAOYSA-N
CHEMBL27759,ENTINOSTAT,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,5.63,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,INVTYAOGFAGBOE-UHFFFAOYSA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,5.85,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.34,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL255863,NILOTINIB,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,IC50,4.02,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,HHZIURLSWUIHRB-UHFFFAOYSA-N
CHEMBL379975,,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,IC50,5.6,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,DPEXRCOBPACFOO-UHFFFAOYSA-N
CHEMBL3335766,,O=c1ccc(-c2cccc(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCN(CCO)CC4)c3)cn2)CCO1,IC50,5.47,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,KARZYTQDIOCJQW-SANMLTNESA-N
CHEMBL3335782,,N#Cc1cccc(-c2ccc(=O)n(C[C@@H]3CN(c4ncc(-c5ccc(OCCN6CCOCC6)cc5)cn4)CCO3)n2)c1,IC50,5.47,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,HJCJMGGMQIUHGY-LJAQVGFWSA-N
CHEMBL5437234,,CCC1=C(C)/C(=C/c2ccc(C(=O)Nc3nc4ccccc4s3)cc2)CCC1(C)C,IC50,4.64,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,VOGYFQFWXUTSHU-CAPFRKAQSA-N
CHEMBL5440659,,CCC1=C(C)/C(=C/c2ccc(C(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)CCC1(C)C,IC50,4.32,CHEMBL5323141,Anticancer activity against human LN-229 cells assessed as cell growth inhibition inhibition incubated for 3 days,LN-229,HJUVJJGIFNOFCE-CAPFRKAQSA-N
CHEMBL567015,DENDROGENIN A,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](NCCc4cnc[nH]4)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,IC50,6.13,CHEMBL1040901,Cytotoxicity against human U87 cells after 72 hrs by trypan blue exclusion assay,U-87MG ATCC,AVFNYTPENXWWCA-BULFVYHESA-N
CHEMBL1097307,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N[C@@H](C)C(=O)OCC#CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,5.29,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,KMUMKXDYUNUHJP-QNKOPLAASA-N
CHEMBL175918,,CC1(C)CC(NC(=O)NCc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.82,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,BTLAYFGMHXAALT-UHFFFAOYSA-N
CHEMBL378033,,CC1(C)CC(NC(=O)Nc2cccc(Cl)c2)c2cc(F)ccc2O1,IC50,4.35,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,WVJAISADWKHYRO-UHFFFAOYSA-N
CHEMBL213706,,CC1(C)CC(NC(=O)Nc2ccc(Cl)cc2)c2cc(Cl)ccc2O1,IC50,4.48,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,XCNTZWMMYVKZPH-UHFFFAOYSA-N
CHEMBL209643,,CC1(C)CC(NC(=O)Nc2cccc(Cl)c2)c2cc(Br)ccc2O1,IC50,4.17,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,HLXNKMOLEFMIFG-UHFFFAOYSA-N
CHEMBL425784,,CC1(C)CC(NC(=O)Nc2ccc(Cl)cc2)c2cc(Br)ccc2O1,IC50,4.57,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,CLJQJCFKFTWBEI-UHFFFAOYSA-N
CHEMBL497954,,CC1(C)CC(NC(=S)Nc2cccc(Cl)c2)c2cc(Br)ccc2O1,IC50,5.05,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,SBLLOSAMWVFIDV-UHFFFAOYSA-N
CHEMBL467766,,COc1ccc(NC(=S)NC2CC(C)(C)Oc3ccc(Br)cc32)cc1,IC50,4.48,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,BHQGZMYIJIWWDI-UHFFFAOYSA-N
CHEMBL596384,,CC1(C)CC(NC(=S)Nc2ccc(C#N)cc2)c2cc(F)ccc2O1,IC50,4.72,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,PKTSPJYSUTZTIX-UHFFFAOYSA-N
CHEMBL595765,,CC1(C)CC(NC(=S)Nc2ccc(C#N)cc2)c2cc(Cl)ccc2O1,IC50,5.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,MYSINLZROQQGJK-UHFFFAOYSA-N
CHEMBL593579,,CC1(C)CC(NC(=S)Nc2cccc([N+](=O)[O-])c2)c2cc(F)ccc2O1,IC50,5.05,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,RPZWUSCLISWIAW-UHFFFAOYSA-N
CHEMBL3416200,,COc1cc(C(N)=O)cc(-c2nc(N3CCOCC3)c3cc(OC)c(OCCN4CCCC4)cc3n2)c1,IC50,5.61,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KHSQMICBWNABRT-UHFFFAOYSA-N
CHEMBL3416183,,COc1cc2nc(-c3cc(C(N)=O)cc(C(F)(F)F)c3)nc(N3CCOCC3)c2cc1OC,IC50,5.92,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZONBDBSYIRAYPB-UHFFFAOYSA-N
CHEMBL3416006,,COc1cc(C(N)=O)cc(-c2nc(N3CCOCC3)c3cc(OC)c(OC)cc3n2)c1,IC50,6.0,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DPPWUQVKIGSRNI-UHFFFAOYSA-N
CHEMBL5093530,,Nc1nc2cc3c(cc2cc1C(=O)NCCc1c[nH]c2ccccc12)OCCO3,IC50,4.35,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,ZQIJBTBWKOLWCH-UHFFFAOYSA-N
CHEMBL2144684,,COc1cc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(N)nc2cc1OC,IC50,4.62,CHEMBL5031820,Cytotoxicity against human A 172 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,A-172,QCHLGZWWWSKMPE-UHFFFAOYSA-N
CHEMBL3805449,,O=C(/C=C\Nc1ccc(F)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,4.75,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,RHQMXZQEBQJNKG-PFONDFGASA-N
CHEMBL3805690,,O=C(/C=C\Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,4.88,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NFAMYNQBDJCOMF-PFONDFGASA-N
CHEMBL1276127,INDIRUBIN,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O,IC50,4.9,CHEMBL5151556,Cytotoxicity against human U87 cells assessed as cell growth inhibition measured after 24 hrs by MTT assay,U-87MG ATCC,CRDNMYFJWFXOCH-YPKPFQOOSA-N
CHEMBL2180739,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1ccncc1)c1cccc(F)c1,IC50,6.68,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,IMNXDWVLNJJERQ-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.65,CHEMBL3627050,Antiproliferative activity against human LN229 cells assessed as growth inhibition incubated for 48 hrs by MTT assay,LN-229,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4636438,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(OC)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.36,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,JDRUXFHAXKJOOG-FLRPPASCSA-N
CHEMBL5618555,,CCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.71,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,RZJVZXFLQUKHCG-YTTGMZPUSA-N
CHEMBL5619669,,CCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.91,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,XNIOOABZUIRVKL-BHVANESWSA-N
CHEMBL5620107,,CCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.14,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,ZWJZSZVFRGWKLP-BHVANESWSA-N
CHEMBL5632034,,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)ccc1F,IC50,6.17,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,LTAUUJCJWYELLU-HTAPYJJXSA-N
CHEMBL5633668,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3ncc4c(n3)N(C)C(=O)OC4)cc2)CC1,IC50,7.35,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,PUYKVXYHYSNEOJ-INIZCTEOSA-N
CHEMBL5632655,,C=CC(=O)N1CCC(N(C)Cc2ccc([C@H](C)Nc3ncc4c(n3)N(CC)C(=O)OC4)cc2)CC1,IC50,7.87,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,DYROKBWIUGQINH-SFHVURJKSA-N
CHEMBL5633478,,C=CC(=O)N1CCN(C(CC2CC2)c2ccc([C@H](C)Nc3nc(F)cc(N4C(=O)OCC4(C)C)n3)cc2)CC1,IC50,9.3,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,NRKYICITCPBBEB-HSTJUUNISA-N
CHEMBL4747345,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCCC3)n2)cc1,IC50,5.35,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NEZOVFDTMRGNBQ-GIDUJCDVSA-N
CHEMBL4777552,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccc(Cl)cc3)nc(N3CCOCC3)n2)cc1)Nc1cccc(F)c1,IC50,5.36,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,UETFDSDTHZGWKZ-AWNIVKPZSA-N
CHEMBL4786297,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1)Nc1ccc(C(=O)NCCN2CCOCC2)cc1,IC50,6.26,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,VULCEIDDAZGSQP-GIDUJCDVSA-N
CHEMBL4293371,,COc1cccc(/C=C/C(=O)c2ccc(OCC(=O)Nc3ccc4c(c3)COC4=O)cc2)c1,IC50,5.24,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,KHRIHMMGXZXSCD-LFYBBSHMSA-N
CHEMBL1592888,,Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@@H](CN1CCOCC1)CO3,IC50,5.09,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,HQVHOQAKMCMIIM-FQEVSTJZSA-N
CHEMBL2165026,,COc1ccc(Nc2ncc(CO)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.06,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,JJRKQAAMIWSSRQ-UHFFFAOYSA-N
CHEMBL5092199,,Cc1c(Cl)cccc1Nc1ccccc1C(=O)Nc1ccc2c(c1)OCO2,IC50,5.19,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,DWUXWNDVKZWHPM-UHFFFAOYSA-N
CHEMBL1023,BEXAROTENE,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,IC50,4.48,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,NAVMQTYZDKMPEU-UHFFFAOYSA-N
CHEMBL191384,,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,IC50,4.91,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,AVLYNJZZQYEFEA-XDJHFCHBSA-N
CHEMBL4790321,,CC(C)(CO)Cn1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21,IC50,4.28,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,CEWOYNHYISZPFC-UHFFFAOYSA-N
CHEMBL339505,,C#CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.4,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LWZDHLHMEOGKDZ-TXHRRWQRSA-N
CHEMBL4787561,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCOCCO)C(=O)C=C(NCCOCCO)C1=O)OC,IC50,4.9,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,RYXFTCJGJZSPGQ-LWOLOBPDSA-N
CHEMBL5413752,,COc1cc(COc2ccc3cc(CN(c4cc(-c5cc(OC6CCOCC6)c6ncnc(C)c6c5)cnc4OC)S(=O)(=O)c4ccc(F)cc4F)c(=O)oc3c2)c([N+](=O)[O-])cc1OC,IC50,5.49,CHEMBL5365273,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CTG assay,U-87MG ATCC,SQZMHFUFHLUQNN-UHFFFAOYSA-N
CHEMBL2348735,,Nc1cc(-c2ccccc2)c(=O)[nH]n1,IC50,5.24,CHEMBL2351701,Cytotoxicity against human SF295 cells after 48 hrs by MTT assay,SF295,YJGAKEQOUFXKBO-UHFFFAOYSA-N
CHEMBL4794124,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCC(O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.43,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,NXVPLORZKVVQMN-CFAHVTDHSA-N
CHEMBL4794663,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCC3CCC(C(=O)O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.55,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LGYRVCYOCBKGHK-ULLGIGRLSA-N
CHEMBL4777808,,C#CCCN1CCC(NC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)CC1,IC50,5.31,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WGKIKYFSLYDSHO-JBUWZVAHSA-N
CHEMBL4778032,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(Cc4ccccc4)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.96,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WBRMZSFRWYMDJR-FSGHDYEQSA-N
CHEMBL126986,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.9,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,IKFQBKKOFWMKDO-HSHPMGMFSA-N
CHEMBL4789835,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCOCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.58,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,FWFGPTQFVAHBCB-GTZYIQDLSA-N
CHEMBL4866860,,COc1ccc(C)c2c1CC1(C(=O)N(C)C(=O)N1C)C1=C2C(=O)c2[nH]cc(CCNCc3ccccc3Br)c2C1=O,IC50,5.91,CHEMBL4831830,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,NEIODWUCCZANRT-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.82,CHEMBL2019566,Cytotoxicity against human XF498 cells after 48 hrs by SRB assay,XF 498,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL2035473,,Cc1ccc2[se]n(CCCCCn3[se]c4ccc(C)cc4c3=O)c(=O)c2c1,IC50,4.91,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,XUNAXWKPYVSIFE-UHFFFAOYSA-N
CHEMBL4646929,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1cccc(C(F)(F)F)c1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.01,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ZBSWWAZKCCWCKH-WQDDGORTSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,9.42,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4169901,,O=C1c2ccccc2C(=O)c2c(-c3ccc(Br)cc3)coc21,IC50,5.46,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,FQENAOMGHQFHAS-UHFFFAOYSA-N
CHEMBL4173329,,COc1ccc(-c2coc3c2C(=O)c2ccccc2C3=O)cc1,IC50,5.3,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,DWIJEFQDVDRKED-UHFFFAOYSA-N
CHEMBL4173738,,COc1ccc(-c2coc3c2C(=O)c2ccccc2C3=O)cc1OC,IC50,5.43,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,OLEHVZCPKTVDTA-UHFFFAOYSA-N
CHEMBL4166476,,O=C1c2ccccc2C(=O)c2c(-c3cccc4ccccc34)coc21,IC50,5.35,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,CBWPQRWVKCXPAY-UHFFFAOYSA-N
CHEMBL4634483,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccc(Cl)cc3)c12,IC50,4.49,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,IJSDNULBQHJOOO-MIGQKNRLSA-N
CHEMBL4551060,,C=C(c1cc(C)nc(C)c1)c1ccc2c(ccn2C)c1,IC50,7.5,CHEMBL4331383,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,YKKUAOOAOPZZDC-UHFFFAOYSA-N
CHEMBL5439857,,COc1ccc(-c2ccc3[nH]c(=O)c4cnc(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)n4c3c2)cn1,IC50,5.39,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,GYQFVNINNLAMOS-UHFFFAOYSA-N
CHEMBL2170098,,COc1cncc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)c1,IC50,7.52,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,OHZHBEQIRGURAO-UHFFFAOYSA-N
CHEMBL2170095,,COc1ncc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.21,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,XXVQUOSJLYEXMX-UHFFFAOYSA-N
CHEMBL2170093,,Cc1ccc(Nc2ncc(CN3CCN(S(C)(=O)=O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.36,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,NRNPLKNQEHSDHU-UHFFFAOYSA-N
CHEMBL2297269,,COc1cc(OC)c2c(-n3ccnc3)cc(-c3ccccc3)nc2c1,IC50,4.26,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,TZSRESUMYOIXEO-UHFFFAOYSA-N
CHEMBL1834959,,O=C(O)c1cccc(C#Cc2ccc(S(=O)(=O)Nc3ccccn3)cc2)c1,IC50,4.12,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,FKSJWWYXAUHHOQ-UHFFFAOYSA-N
CHEMBL1614646,SUSALIMOD,Cc1cccnc1NS(=O)(=O)c1ccc(C#Cc2ccc(O)c(C(=O)O)c2)cc1,IC50,4.16,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,WJLQPSZXCOYTHS-UHFFFAOYSA-N
CHEMBL3824119,,O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,IC50,6.35,CHEMBL3826434,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,ZWERENZUADIUDM-JMIUGGIZSA-N
CHEMBL3823831,,CCCCCCCNC(C1=C(O)C(=O)c2ccccc2C1=O)c1ccccn1,IC50,6.0,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,XLIDYKIFFYGVPE-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.41,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1738758,ONVANSERTIB,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,IC50,6.0,CHEMBL5682229,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by cell-titer glo assay,U-87MG ATCC,QHLVBNKYJGBCQJ-UHFFFAOYSA-N
CHEMBL5569551,,N#CC1(C(=O)NCCc2ccc3c(c2)OCO3)CC2c3ccccc3C1c1ccccc12,IC50,4.43,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,WFJXGLXEQPSKTB-UHFFFAOYSA-N
CHEMBL5565649,,N#CC1(C(=O)NCC2CCN(Cc3ccccc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.23,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,ZMUBXGDBYBDURM-UHFFFAOYSA-N
CHEMBL4763035,,C=C(CC)C(=O)c1ccc(OCC(=O)N2CCN(S(=O)(=O)c3ccc(OC)cc3)CC2)c(Cl)c1Cl,IC50,6.68,CHEMBL4675763,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability by CellTiter Glo luminescent assay,U-87MG ATCC,DWOGIRGYIBQNND-UHFFFAOYSA-N
CHEMBL575828,GOSSYPOLONE,CC1=C(C2=C(C)C(=O)c3c(c(C=O)c(O)c(O)c3C(C)C)C2=O)C(=O)c2c(C=O)c(O)c(O)c(C(C)C)c2C1=O,IC50,4.58,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,YSPBCFMMSKAENM-UHFFFAOYSA-N
CHEMBL598841,,CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]c(=O)[nH]c34)CC2)cc1,IC50,7.89,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,CENSOIHHGQYIKW-UHFFFAOYSA-N
CHEMBL597793,,NC1(COCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,9.23,CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,U-87MG ATCC,UFBYOZWKWYKBBZ-UHFFFAOYSA-N
CHEMBL263664,,NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,9.18,CHEMBL1074388,Inhibition of PKB in human U87MG cells assessed as GSK3-beta phosphorylation by ELISA,U-87MG ATCC,RZIDZIGAXXNODG-UHFFFAOYSA-N
CHEMBL4452076,,COc1cc(/C=C/C(=O)Nc2ccc(CC(=O)NN)cc2)ccc1O,IC50,4.31,CHEMBL4315250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,QWPLWKBEPSFENZ-WEVVVXLNSA-N
CHEMBL4280638,,C#CCOc1ccc(-c2noc(-c3nnn(-c4cccc(/C(C)=N/O)c4)c3N)n2)cc1,IC50,5.34,CHEMBL5227636,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability by XTT assay,A-172,IGQKYFPXTAJJLB-DHRITJCHSA-N
CHEMBL5269634,,CO[C@@H]1CC(=O)Nc2c(O)c3cc4c2[C@H]1[C@@H](/C=C/C=C/C[C@H](OC(=O)[C@@H](C)NC(=O)C1CCCCC1)[C@H](C)[C@@H](O)/C(C)=C\CC3)O4,IC50,5.15,CHEMBL5249012,Antiproliferative activity against human U-87 MG assessed as cell growth inhibition incubated for 48 hrs by Cell Counting Kit-8 assay,U-87MG ATCC,LBJSTKXSGJVGJM-VZRUPSOZSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,8.05,CHEMBL5257547,Antiproliferative activity against human XF498 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,XF 498,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL2152477,,COc1cccc2c1C(=O)c1ccc3c(c1C2=O)C(=O)C[C@](C)(O)C3,IC50,4.77,CHEMBL3636048,Cytotoxicity against human SF295 cells after 72 hrs by MTS assay,SF295,XZLGWJORNHETKI-HXUWFJFHSA-N
CHEMBL504816,(L)-1-METHYLTRYPTOPHAN,Cn1cc(C[C@H](N)C(=O)O)c2ccccc21,IC50,4.25,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,ZADWXFSZEAPBJS-JTQLQIEISA-N
CHEMBL252316,,C=C1C(=O)[C@@]23CC[C@H]4[C@@](C)(CCC[C@]4(C)C(=O)O)[C@@H]2CC[C@@H]1C3,IC50,5.43,CHEMBL1112256,Cytotoxicity against human SF295 cells after 69 hrs by MTT assay,SF295,WQBNGXOJBVBQKP-YBDDNXDTSA-N
CHEMBL4783328,,C1=C2CNCC3=Cc4c(ccc5ccccc45)OC23Oc2ccc3ccccc3c21,IC50,5.28,CHEMBL4688126,Anti-cancer activity against human SF-295 cells assessed as cell growth inhibition measured after 48 hrs by SRB method,SF295,FKUSUQUCJVZNII-UHFFFAOYSA-N
CHEMBL4857859,,CS(=O)(=O)c1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.11,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,IGHMKCXCLCQOOD-UHFFFAOYSA-N
CHEMBL4874832,,CSc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.57,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,QUOPXRYKTOYGSC-UHFFFAOYSA-N
CHEMBL4866877,,Cc1ccc(-c2nc3ccc(C)cn3c2Sc2ccccc2)cc1,IC50,4.09,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,ZZWGYALMBMIHRB-UHFFFAOYSA-N
CHEMBL4871031,,Clc1ccc(Sc2c(-c3ccccc3)nc3ccccn23)cc1,IC50,4.2,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,KRTIFEYECZHTLC-UHFFFAOYSA-N
CHEMBL5219493,,COc1cc(OC)cc(-c2ncccc2NCc2ccc(Cl)cc2)c1,IC50,4.26,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MECMYKCKBJRKFQ-UHFFFAOYSA-N
CHEMBL5220680,,COc1cc(OC)cc(-c2ncccc2NCc2ccc(C)cc2)c1,IC50,4.44,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,IPVVCLCABITZJW-UHFFFAOYSA-N
CHEMBL5219066,,N#CCC(=O)Nc1sc(C(=O)Nc2ccccc2)c(-c2ccccc2)c1C#N,IC50,5.2,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,DNRFQOZSIMRZPZ-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.42,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL106098,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.25,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,UIJWAUWNFOKGHC-XLVZBRSZSA-N
CHEMBL4778502,,C=CC(=O)Nc1ccc(OC)c(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,5.35,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,ABGXDJDXYCHCQN-UHFFFAOYSA-N
CHEMBL478316,,Cc1ccc(CN(Cc2ccc(O)c3ncccc23)Cc2ccc(O)c3ncccc23)cc1,IC50,7.15,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,JUTVCEPDUKZIQE-UHFFFAOYSA-N
CHEMBL5646546,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(CCN3CCS(=O)(=O)CC3)cc2)ncc1C(F)(F)F,IC50,4.91,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,FBRXOXGYBUZPES-UHFFFAOYSA-N
CHEMBL575456,,Cc1cc2c(c(O)c1-c1c(C)cc3c(c1O)/C(=C/N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(=O)C(O)=C3C(C)C)/C(=C/N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(=O)C(O)=C2C(C)C,IC50,4.51,CHEMBL1037675,Anticancer activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,FVNKIYDSILCLGI-BDXXZCQXSA-N
CHEMBL322251,,Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,8.7,CHEMBL815085,Compound was tested for inhibiting HIV (ADA) entry into U-87 cells; range is 2-20 nM,U-87MG ATCC,RQDGBNLSKUOAJD-SFTDATJTSA-N
CHEMBL324884,,CN(C)c1ccnc2c1C(=O)c1c(-c3ccccc3NC(=O)C(F)(F)F)ccnc1C2=O,IC50,7.22,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,SGLCYAHRUHJFMT-UHFFFAOYSA-N
CHEMBL2011468,,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CC#CP(=O)(OCC)OCC)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,IC50,7.44,CHEMBL2015748,Antiproliferative activity against human T98G cells assessed as decrease in cell number after 72 hrs by WST assay,T98G,HXQZYSIVVPUAQB-KBNXZVMKSA-N
CHEMBL2037451,,C/C(=N/NC(=S)Nc1ccc([N+](=O)[O-])cc1)c1ccccn1,IC50,6.85,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PTOHINKLMXPSKL-YVLHZVERSA-N
CHEMBL2037449,,C/C(=N/NC(=S)Nc1ccccc1[N+](=O)[O-])c1ccccn1,IC50,8.18,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,MXWJIUNQTNDDFG-YVLHZVERSA-N
CHEMBL2037444,,C/C(=N/NC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,7.77,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,RLHHYLRHRGHQLT-ZDLGFXPLSA-N
CHEMBL2037436,,C/C(=N\NC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.92,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,VCKFVZSNSWYSKQ-VCHYOVAHSA-N
CHEMBL2037336,,CC(=NNC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.51,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,PMHTWYVKIPHSFS-UHFFFAOYSA-N
CHEMBL2037450,,C/C(=N/NC(=S)Nc1cccc([N+](=O)[O-])c1)c1ccccn1,IC50,7.16,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NPHJRKXEZJAUIL-YVLHZVERSA-N
CHEMBL1970209,,C/C(=N/NC(=S)Nc1ccccc1Cl)c1ccccn1,IC50,8.59,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,DIAIPLSVPPGTLG-ZDLGFXPLSA-N
CHEMBL1630580,,C/C(=N\NC(=S)Nc1ccc(Cl)cc1)c1ccccn1,IC50,8.77,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,KRCPOZLWYUZVBS-VCHYOVAHSA-N
CHEMBL282346,,C/C(=N\NC(=S)Nc1ccccc1)c1ccccn1,IC50,8.85,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VHVSCHSQNUUXNS-GZTJUZNOSA-N
CHEMBL2037342,,CC(=NNC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.23,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NRNNRLWHLIPYQW-UHFFFAOYSA-N
CHEMBL5176707,,CC(C)=CC[C@@H](OC(=O)CCC(=O)N1CCCC1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.58,CHEMBL5138621,Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,U-87MG ATCC,ORJHVQMCHBDMDR-LJQANCHMSA-N
CHEMBL466361,,COc1cc2cc3c(c(-c4ccc5c(c4)OCO5)c2cc1OC)C(=O)OC3,IC50,4.67,CHEMBL5258260,Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis,U-87MG ATCC,RTDRYYULUYRTAN-UHFFFAOYSA-N
CHEMBL4072698,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(C2CCCCC2)cc1,EC50,5.02,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,DSDWNTNXGNKAAP-ZRDIBKRKSA-N
CHEMBL5268015,,Cc1ccccc1NS(=O)(=O)/C=C/c1ccc(OCc2ccc(C(=O)NCCO[C@@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)cc2)cc1,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,QQUTVICRJMPQSH-ZJXIGYLBSA-N
CHEMBL5406487,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccc(NCc4ccc(C(=O)NO)cc4)cc3)CC1)C2,IC50,5.21,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,RVROQBLQPGMOBQ-UHFFFAOYSA-N
CHEMBL5410787,,O=C(C#Cc1ccccc1)Nc1cc(-c2ncc[nH]2)ccc1F,IC50,6.94,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,ZBGGIVGWYMSCND-UHFFFAOYSA-N
CHEMBL5397031,,CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.51,CHEMBL5326128,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs,U-87MG ATCC,DWMRSQUGHUXVSZ-UHFFFAOYSA-N
CHEMBL5177050,,O=C(NCc1ccccc1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.08,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,UGPZJVXEWINCSS-UHFFFAOYSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.8,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL5182819,,COc1cccc(-c2nn(-c3ccccc3)cc2-c2ccnc(NCCCNC(=O)Nc3ccc(F)cc3)c2)c1,IC50,5.14,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,BBDDFAGBJKUSTL-UHFFFAOYSA-N
CHEMBL5205920,,O=C(NCCCNc1cc(-c2cn(-c3ccccc3)nc2-c2cccc(O)c2)ccn1)Nc1cccc(C(F)(F)F)c1,IC50,6.13,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,KEZRNSQBXOWDMI-UHFFFAOYSA-N
CHEMBL4776084,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCN3CCCC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.69,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,JESPMFITLIOJOF-KCXRSMJOSA-N
CHEMBL4795779,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(C(C)=O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.95,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WYDFMOGWHOXTHB-CBKZOCRPSA-N
CHEMBL4787237,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCO)C(=O)C=C(NCCO)C1=O)OC,IC50,5.69,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,XBQQRQDTUFDEFJ-PVETWVJJSA-N
CHEMBL321336,,N#CC1=C(N)Oc2c(ccc3ccccc23)C1c1cccc([N+](=O)[O-])c1,IC50,7.17,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,KLHQWXOILCCTOX-UHFFFAOYSA-N
CHEMBL5203253,,COc1cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc(OC)c1OC(C)C,IC50,7.28,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,XROQSPRUVSWIFG-UHFFFAOYSA-N
CHEMBL837,7-ETHYL-10-HYDROXYCAMPTOTHECIN,CCc1c2c(nc3ccc(O)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,IC50,7.52,CHEMBL3795470,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by SRB assay,U-87MG ATCC,FJHBVJOVLFPMQE-QFIPXVFZSA-N
CHEMBL3659990,,O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F,IC50,5.39,CHEMBL4220066,Antiproliferative activity against human T98G cells,T98G,PVMIBRDKTVSNOE-UHFFFAOYSA-N
CHEMBL4226082,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.62,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,VAWUMMRNRUYZAS-UHFFFAOYSA-N
CHEMBL4227076,,Cc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,4.82,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,HHBBCKXNKNEFRQ-UHFFFAOYSA-N
CHEMBL4227858,,CCC(=O)Nc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)sc2n1,IC50,5.82,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,PFGIZSASYPLVGU-UHFFFAOYSA-N
CHEMBL4226683,,COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(C)(=O)=O,IC50,5.52,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,KUQHUGURFNQQJW-UHFFFAOYSA-N
CHEMBL1956945,,CC(C)(O)[C@@H]1C[C@H]2[C@](C)(CC1=O)C[C@@H]1C[C@@]12C,IC50,5.94,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,ZUTBZJSJTAUXPB-SLFYDOTPSA-N
CHEMBL917,FLOXURIDINE,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,IC50,4.98,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,ODKNJVUHOIMIIZ-RRKCRQDMSA-N
CHEMBL3793447,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccc([N+](=O)[O-])cc1,IC50,6.06,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,QCIKSNAZLKDOMN-YNEHKIRRSA-N
CHEMBL3794553,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12,IC50,5.25,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,LKSPPCNHWCHCRG-XUVXKRRUSA-N
CHEMBL3793469,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cccc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,4.58,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,KVYCFVZPOXFXOY-VTYCOLDWSA-N
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,5.06,CHEMBL3584023,Cytotoxicity against human U87MG cells assessed as cell viability after 48 hrs by Alamar Blue assay,U-87MG ATCC,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL44,GENISTEIN,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,IC50,4.26,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,TZBJGXHYKVUXJN-UHFFFAOYSA-N
CHEMBL5283175,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccncn5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.6,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,AMMUYGQQMQZGGU-UHFFFAOYSA-N
CHEMBL5570148,,Cc1ccc(-n2cncc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,4.36,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,OTIGKMXGJJEDJY-UHFFFAOYSA-N
CHEMBL1086706,,COc1ccccc1C(=O)Nc1cn(-c2ccccc2)nc1-c1ccccc1,IC50,4.09,CHEMBL1121120,Cytotoxicity against human U87MG cells after 24 hrs by MTT assay,U-87MG ATCC,CPGXMVQJYLPITP-UHFFFAOYSA-N
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,5.65,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,JWQOJVOKBAAAAR-UHFFFAOYSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,8.02,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL254129,CYCLOPAMINE,CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C,IC50,4.81,CHEMBL1105585,Cytotoxicity against human U87 cells assessed as viability in presence of beta glucuronidase,U-87MG ATCC,QASFUMOKHFSJGL-LAFRSMQTSA-N
CHEMBL591985,,O=C(Nc1nonc1NC(=O)c1c(F)c(F)c(F)c(F)c1F)c1c(F)c(F)c(F)c(F)c1F,IC50,4.59,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,PTTHCDRNSSJOMO-UHFFFAOYSA-N
CHEMBL602439,,COc1cccc(C(=O)Nc2nonc2NC(=O)c2cccc(OC)c2)c1,IC50,4.15,CHEMBL1068378,Inhibition of human U87MG cells after 48 hrs,U-87MG ATCC,CLSVEQQHELQLAY-UHFFFAOYSA-N
CHEMBL4524968,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(-c4ccc(C(C)(C)C)cc4)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.72,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,VISWQCFQPPJSKS-ZVDSPYHHSA-M
CHEMBL4875605,,COc1ccc(C)c2c1CC1(C(=O)N(C)C(=O)N1C)C1=C2C(=O)c2[nH]cc(CCNC(=O)c3ccccc3)c2C1=O,IC50,5.56,CHEMBL4831830,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,GJZPHHMDWDCERL-UHFFFAOYSA-N
CHEMBL4789753,,COc1ccccc1-c1csc2cnc(Nc3ccc(CP(=O)(OC)OC)cc3)nc12,IC50,5.77,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,JHAPGQGRXCYODV-UHFFFAOYSA-N
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,5.78,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL4784230,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3)nc12,IC50,6.19,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UKPLONCDDRXSLC-UHFFFAOYSA-N
CHEMBL4564445,,COc1cc2c(cc1OC)[C@H](O)[C@@H]1c3c(cc4c(c3-2)OCO4)CC[N+]1(C)[O-],IC50,5.8,CHEMBL4337234,Cytotoxicity against human SF295 cells assessed as inhibition of cell viability after 69 hrs by MTT assay,SF295,XKKFNYKNDDHAQC-CHEUHSMRSA-N
CHEMBL1171994,,Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,IC50,5.84,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,VOALQSCHGCHZEL-IBGZPJMESA-N
CHEMBL1171993,,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4)C3)c12,IC50,5.24,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,RFTXEPTYKFWMBQ-IBGZPJMESA-N
CHEMBL1165153,,COc1ccc(-c2nnn(CCCCCCCn3nnnc3-c3ccc(OC)c(OC)c3)n2)cc1OC,IC50,4.26,CHEMBL1169033,Anticancer activity against human T98G cells after 24 hrs by MTT assay,T98G,LYQFYRDFHDRAHI-UHFFFAOYSA-N
CHEMBL453114,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(C2(O)CCCCC2)nn1,IC50,6.37,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,KHPUEYZUOUVPQB-UHFFFAOYSA-N
CHEMBL5187816,,Cc1ccc(-c2cc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)n(-c3ccccc3)n2)cc1,IC50,5.98,CHEMBL5104528,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability by MTT assay,SF295,PHZKISDSHJPMKB-UHFFFAOYSA-N
CHEMBL5089977,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CCCCC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.59,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,XNZFUNKIEWOVAE-MCLIRCHUSA-N
CHEMBL5083112,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Br)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.63,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,ZOLXXYHLNIAOLS-MCLIRCHUSA-N
CHEMBL5078218,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.91,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,FRDGYTCJYQGQAW-GTKRWHGSSA-N
CHEMBL5091566,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.49,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,BZQJKEMXKXEHFN-WFVGHVPHSA-N
CHEMBL5081131,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.81,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,LNWNGALQBKWVHJ-WFVGHVPHSA-N
CHEMBL5079791,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C(C)(C)C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.91,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,QLFCJGYFBTYJGC-VZHCALMGSA-N
CHEMBL1087195,,OC[C@H](NC[C@H]1NC[C@H](O)[C@@H]1O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1,IC50,4.1,CHEMBL1104856,Cytotoxicity against human U87 cells after 72 hrs by colorimetric assay,U-87MG ATCC,RJPZKJUGELCBHP-YDZRNGNQSA-N
CHEMBL4785811,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C)nc12,IC50,5.9,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,IWAMHIHVZUDZJR-UHFFFAOYSA-N
CHEMBL4098250,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.06,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VZHPPMUSJZGRBR-UHFFFAOYSA-N
CHEMBL4583512,,COc1cc(/C=C/C(=O)Nc2ccccc2COc2ccc(OC3CCNCC3)cc2)ccc1O.Cl,IC50,4.85,CHEMBL4315250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,ZYTOOBSCVFGQBC-FTPOTTDRSA-N
CHEMBL4537608,,CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](OC(=O)CCN)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)OCc1ccccc1,IC50,5.62,CHEMBL4329226,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,UAMNSVVOLBKNJP-FUIGNZSISA-N
CHEMBL4518892,,CCOP(=O)(OCC)C(N(OC(C)c1cn(C)c[n+]1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,SWPSBFJFCWSDLA-UHFFFAOYSA-N
CHEMBL4518892,,CCOP(=O)(OCC)C(N(OC(C)c1cn(C)c[n+]1C)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,SWPSBFJFCWSDLA-UHFFFAOYSA-N
CHEMBL4559506,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.51,CHEMBL4316285,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,U-87MG ATCC,HWEPQWQOQSZLRC-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,6.37,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL4872337,,CC12CC3CC(C)(C1)CC(NCc1ccc(/C=C/C(=O)NO)cc1)(C3)C2,IC50,5.73,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,JIHCJWRDPIDHTK-BQYQJAHWSA-N
CHEMBL4848719,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCC(=O)NO)(C3)C2,IC50,4.79,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,TYMNJEPTNOZUMD-UHFFFAOYSA-N
CHEMBL3310804,,COc1c(NS(=O)(=O)c2ccc(F)cc2)cc(-c2ccc3nc(NC(=O)C4CC4)sc3n2)cc1C(N)=O,IC50,4.69,CHEMBL3362568,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KFJRXDCGDJWJQB-UHFFFAOYSA-N
CHEMBL5197128,,CCN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.37,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,GTYQBMHURMYYGD-UHFFFAOYSA-N
CHEMBL5178580,,COCCN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.4,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,WMQFPBIGGMHBLW-UHFFFAOYSA-N
CHEMBL5193656,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(CC3CC3)CC2)cc1)OCc1cccnc1,IC50,5.97,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,MYUNXMGJJWLYEZ-UHFFFAOYSA-N
CHEMBL5209544,,COCCN1CCN(c2cc(F)ccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.28,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,IRVYLZDWOWZXOO-UHFFFAOYSA-N
CHEMBL1650631,,Oc1ccccc1-c1nc2ccccc2o1,EC50,4.28,CHEMBL5217394,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,GHGZVWOTJDLREY-UHFFFAOYSA-N
CHEMBL4100244,,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NC(CCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]1C[C@@H](O[C@@H]2C[C@@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2c(OC)cccc2C4=O)O[C@H](C)[C@H]1O,IC50,5.3,CHEMBL4015759,Cytotoxicity against human U87MG cells assessed as reduction in cell survival after 96 hrs by MTT assay,U-87MG ATCC,QIPAJWNWNVEIHL-SFFMQNFJSA-N
CHEMBL3400561,,CCC1=CC2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccc(I)cc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,5.3,CHEMBL3404302,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs,U-87MG ATCC,VRKUVRJAEOSZFG-LUJDZOJYSA-N
CHEMBL4786229,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3C(F)(F)F)nc12,IC50,5.68,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IGPMZLFRZABUAK-UHFFFAOYSA-N
CHEMBL4742260,,COc1cccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)[nH]c(=O)c2C#N)c1,IC50,4.22,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,SEOYEEBWNFIYKE-UHFFFAOYSA-N
CHEMBL4755770,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(N)c(C#N)c(-c2ccccc2)n1,IC50,4.94,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,NZYGXGIPGFEIFS-UHFFFAOYSA-N
CHEMBL4171347,,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)C[C@H](O)[C@@]2(C)O3)cc1O,EC50,7.3,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,ZNONRWMENUEMDO-ZWAQFZTDSA-N
CHEMBL4174800,,CC(C)=CCC/C(C)=C/Cc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)[C@@H](O)C3)cc(O)c1O,EC50,6.6,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,LZMKRXSJEAADRC-QVLGIOJXSA-N
CHEMBL83286,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)/c2=N\Nc2ccccc2)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,AGFRIFGJACNPFZ-RFBIWTDZSA-N
CHEMBL3621411,,CCCCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.51,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,QTXHAQXFVJHSHE-UHFFFAOYSA-M
CHEMBL3621409,,CCCCCCCCCCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.24,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,PSSICEWKMGRSPN-UHFFFAOYSA-M
CHEMBL4169444,,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)NCC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1,IC50,6.69,CHEMBL4153991,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,LEOMYZQGJDWCFQ-UHFFFAOYSA-N
CHEMBL2035470,,Cc1ccc2[se]n(CCn3[se]c4ccc(C)cc4c3=O)c(=O)c2c1,IC50,4.75,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,XTQXKDSAJRFHNT-UHFFFAOYSA-N
CHEMBL4555219,,COc1ccc(C2CC(c3ccc4ccccc4c3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(Cl)cc43)S2)cc1,EC50,6.42,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,LLFSKETWTCGGIS-DQSJHHFOSA-N
CHEMBL4173722,,Cc1ccc(S(=O)(=O)NCCN2c3nc4ccccc4cc3Sc3cc4ccccc4nc32)cc1,IC50,5.77,CHEMBL4140037,Cytotoxicity against human SNB75 cells assessed as cell growth inhibition after 48 hrs by SRB assay,SNB-75,HMIROELUYZRDFH-UHFFFAOYSA-N
CHEMBL595878,,COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)C(C(N)=O)CC[C@@H]12,IC50,4.95,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,NOMXUKYQQHVOQD-GIVGKIPPSA-N
CHEMBL604895,,CCCC[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)c(OC)cc4[C@H]3CC[C@]12C,IC50,4.68,CHEMBL1046467,Antiproliferative activity against human U87MG cells by Brdu incorporation assay,U-87MG ATCC,WNVNGNGYHALVBP-WFHKDSDPSA-N
CHEMBL3659991,,CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1,IC50,5.58,CHEMBL4220066,Antiproliferative activity against human T98G cells,T98G,ZBBDKEHQTOTGRO-UHFFFAOYSA-N
CHEMBL1615281,SLC-0111,NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,IC50,4.24,CHEMBL5542075,Antiproliferative activity against human U-87MG cells assessed as reduction in cell growth incubated for 72 hrs in the presence of hypoxic condition by cytofluorimetric analysis,U-87MG ATCC,YJQZNWPYLCNRLP-UHFFFAOYSA-N
CHEMBL564618,,CNC(=O)OCc1c(COC(=O)NC)c(-c2ccc(OC)cc2)n2c1Cc1cc(OC)ccc1-2,IC50,4.42,CHEMBL1053149,Cytotoxicity against human U87 cells after 72 hrs by WST-1 assay,U-87MG ATCC,MQLPOOFUYWVTRF-UHFFFAOYSA-N
CHEMBL447807,BENZYLISOSELENOCYANATE,[Se]=C=NCc1ccccc1,IC50,4.37,CHEMBL1014404,Cytotoxicity against human T98G cells after 72 hrs by MTS assay,T98G,NAOAAZDDXUNOGA-UHFFFAOYSA-N
CHEMBL4291994,,COc1cc(OC)c2c(=O)c(OCCCOc3ccccc3/C=C/C(=O)/C=C/c3cccc([N+](=O)[O-])c3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.1,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WFRWRDGTFGNABL-YXLFCKQPSA-N
CHEMBL1088481,,Oc1ccc(CN(Cc2cccc(I)c2)Cc2ccc(O)c3ncccc23)c2cccnc12,IC50,6.35,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,KAEVGKLVCMVJRS-UHFFFAOYSA-N
CHEMBL1086767,,O=C(O)C1CCC(CN(Cc2ccc(O)c3ncccc23)Cc2ccc(O)c3ncccc23)CC1,IC50,5.01,CHEMBL1107605,Cytotoxicity against human T98G cells by MTT assay,T98G,BUKNSOHSQVHWSQ-UHFFFAOYSA-N
CHEMBL1170262,,N#Cc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(Cl)cc4)C3)c12,IC50,5.2,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,SUASCQMYTOBJHW-IBGZPJMESA-N
CHEMBL5087558,,CC(C)(C)NC(=O)c1ccc2cc1OCCOCCNc1ccn3ncc-2c3n1,EC50,5.04,CHEMBL5167606,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability after 1 to 7 days by resazurin dye based fluorimetric analysis,LN-229,YCFFONJEHNSECY-UHFFFAOYSA-N
CHEMBL4780040,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCC(N(C)C)CC1,IC50,5.08,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,NWFALPFTUGPTOD-UHFFFAOYSA-N
CHEMBL4788364,,C=CC(=O)Nc1cccc(Nc2cc(-n3c(CCCO)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,4.66,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,CRMFEXOOQMAPDO-UHFFFAOYSA-N
CHEMBL4092812,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(C)c(Cl)cc2OC)nnc1Cl,IC50,6.3,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,RJTWTALAEKYMLH-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,5.33,CHEMBL4187982,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4207217,,O=C(c1sc(N2CCOCC2)nc1-c1ccc(Cl)cc1)c1cnc2ccc(Br)cn12,IC50,4.12,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,FWQWDAJDROZYTA-UHFFFAOYSA-N
CHEMBL4212097,,O=C(c1sc(N2CCOCC2)nc1-c1ccc(Cl)cc1)c1cnc2ccccn12,IC50,4.09,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,UHRZOGNKLDKBRU-UHFFFAOYSA-N
CHEMBL3233842,,N#C[C@@H]1CC(F)(F)CN1C(=O)CNC(=O)c1ccnc2ccccc12,IC50,7.38,CHEMBL4624681,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate measured upto 60 mins by fluorescence based assay,U-87MG ATCC,PUOOCZVRHBHJRS-NSHDSACASA-N
CHEMBL67279,TALABOSTAT,CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O,IC50,6.65,CHEMBL4624682,Inhibition of FAP in human U87MG cells using Suc-Gly-Pro-AMC as substrate by fluorescence based assay,U-87MG ATCC,FKCMADOPPWWGNZ-YUMQZZPRSA-N
CHEMBL4797369,,CC(C)(C)OC(=O)N1CC[C@]2(C(=O)Nc3ccccc32)[C@H]1c1cccc(Nc2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.75,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,YIKYKYFYFWNCSE-PDDLMNHVSA-N
CHEMBL4777260,,C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O,IC50,5.48,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,HTADFAXGWGDWNE-UHFFFAOYSA-N
CHEMBL4750273,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C4CC4)c(=O)c3=O)cc2)ncc1Cl,IC50,5.14,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,NTYSXVNDTBLJBP-XSFVSMFZSA-N
CHEMBL4636054,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccc(F)cc3F)c12,IC50,4.36,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,XCVFQTFAGIWYAN-MIGQKNRLSA-N
CHEMBL4536640,,COc1cc(C(=O)c2cn(-c3ccc(N)cc3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.62,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,HQVMRVMGUWOSRW-UHFFFAOYSA-N
CHEMBL4451152,,CCOP(=O)(OCC)C(N(OC(C)c1ncc[nH]1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,CNDVAMMAAGJGKC-UHFFFAOYSA-N
CHEMBL4454246,,CCOP(=O)(OCC)C(N(OC(C)n1ccnc1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,VEDYZZHYDWWOEK-UHFFFAOYSA-N
CHEMBL4080000,,CN1CCN(CCOC(=O)N(c2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)CC1,IC50,5.09,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,CHHCUIHBACXKKX-UHFFFAOYSA-N
CHEMBL4090317,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,4.94,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,PHZNEXIQOLYTSB-UHFFFAOYSA-N
CHEMBL411043,,ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1,IC50,4.84,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,SEFWYTXTKMMUEF-UHFFFAOYSA-N
CHEMBL4090317,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,5.1,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,PHZNEXIQOLYTSB-UHFFFAOYSA-N
CHEMBL4060917,,CSc1nc(N(C(=O)OC(Cc2ccccc2)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.61,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,YZYCFZMIKGBFFD-UHFFFAOYSA-N
CHEMBL4069584,,CCC(CN1CCN(C)CC1)OC(=O)N(c1cccc(Br)c1)c1nc(SC)nc2c1cnn2CC(C)c1ccccc1,IC50,5.7,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,VIWJZMBDSOVKQF-UHFFFAOYSA-N
CHEMBL1836680,,CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.82,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,JSXXDWHFXXQDDJ-UHFFFAOYSA-N
CHEMBL4635291,,C#CCOc1ccc2c(c1O)C(=O)c1c3c(cc(O)c1C2=O)[C@@]12O[C@@]1([C@](C)(O)[C@@H](O)C(=O)OC)[C@H](C#C/C=C\C#C[C@H]2O)N3,EC50,8.55,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,CKFSRLNTPDHQJR-DNZMGCGRSA-N
CHEMBL4648960,,COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1c(ccc(OCC(C)=O)c1O)C4=O,EC50,8.96,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,DSBNSMOLGAFZIH-KQGFGPPRSA-N
CHEMBL1643,RIBAVIRIN,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,IC50,4.73,CHEMBL4682962,Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,SNB-75,IWUCXVSUMQZMFG-AFCXAGJDSA-N
CHEMBL4754468,,NC(=O)c1n[nH]nc1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,IC50,5.03,CHEMBL4682962,Antiproliferative activity against human SNB-75 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,SNB-75,IJUOARZYZPGODW-ZCIQCHDPSA-N
CHEMBL3343397,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(C)cc5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.66,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FKIGNRIKSXHZMX-UHFFFAOYSA-N
CHEMBL3343398,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C(F)(F)F)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.84,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FIORSHYNVPDAAK-UHFFFAOYSA-N
CHEMBL5566709,,N#CC1(C(=O)NCCCc2ccc(Br)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.61,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,YZAAPYGRXYNYPH-UHFFFAOYSA-N
CHEMBL4084557,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5[nH]ccc45)cc3)c(C)cc2=O)cc1,IC50,5.08,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WYYAFOSCVKITNK-UHFFFAOYSA-N
CHEMBL4087981,,Cc1cc(=O)n(-c2cccc(F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,IC50,5.63,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OKOMFNJHGSKAPK-UHFFFAOYSA-N
CHEMBL4448494,,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,IC50,6.68,CHEMBL4305840,Antiproliferative activity against human U87MG cells,U-87MG ATCC,KGMVZSJAPXYTKH-UHFFFAOYSA-N
CHEMBL4463991,,COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(Cl)c(Cl)c4)ncnc3s2)cc1,IC50,5.36,CHEMBL4376496,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,TWKFKWDVEWKTRX-RUDMXATFSA-N
CHEMBL4794252,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)[nH]c(=O)c2C#N)cc1,IC50,4.32,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,ITGGBHPLLQUCNS-UHFFFAOYSA-N
CHEMBL4536320,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(C)=N/OCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.18,CHEMBL4352916,Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay,U-87MG ATCC,OVQLAFDDLBGHAL-LBCQYTAVSA-N
CHEMBL4562522,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(-c4ccccn4)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.8,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,JQEUEXIZZPTVBG-JJNZMVMZSA-M
CHEMBL5281811,,CCOC(=O)[C@H]1[C@@H](NO)[C@@H]2c3ccccc3OC(C)(C)[C@H]2[C@H](O)[C@]12C(=O)Nc1ccc(Cl)cc12,IC50,4.43,CHEMBL5235657,Anticancer activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,XJVZAIYAAGLARK-XNZMQEADSA-N
CHEMBL3693786,CITARINOSTAT,O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO,IC50,5.04,CHEMBL5042627,Anti-proliferative activity against human U87G cells assessed as cell viability measured after 72 hrs by Cell-Titer assay,U-87MG ATCC,VLIUIBXPEDFJRF-UHFFFAOYSA-N
CHEMBL3086870,,O=C1c2ccccc2-n2c1nc1ccc(F)cc1c2=O,IC50,6.3,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,DRHLXNRAFXVHOY-UHFFFAOYSA-N
CHEMBL5196800,,C=C1C(=O)[C@]23[C@H](OC(=O)/C=C/c4ccncc4)[C@H]1CC[C@H]2[C@]12CCCC(C)(C)[C@H]1[C@H](O)[C@@]3(O)OC2,IC50,6.08,CHEMBL5158408,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,KOQSZWQYZSBQDS-KLSHHCPLSA-N
CHEMBL3823023,,O=C1C(O)=C(C(NCCCCl)c2ccccc2O)C(=O)c2ccccc21,IC50,4.76,CHEMBL3826202,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FXHSYGLMIOXGQO-UHFFFAOYSA-N
CHEMBL4545330,,N#Cc1cccc(/C=C/C(=O)c2ccc(O)cc2)c1,IC50,4.99,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IZCIYUNGVIXYJY-RUDMXATFSA-N
CHEMBL4443827,,COc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccccc3)sc2c1,IC50,4.39,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,LISAUXBSYRKDOU-UHFFFAOYSA-N
CHEMBL4460474,,COc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)sc2c1,IC50,4.67,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VSWARFMGPYOYCE-UHFFFAOYSA-N
CHEMBL4567644,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccccc3s2)cc1,IC50,4.94,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GTYNRXNKGRRCHY-UHFFFAOYSA-N
CHEMBL4575907,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4ccc(OC)c(F)c4)o3)C2=O)cc1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,GKVFGTSDUJDABC-YNMBWQPYSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,5.28,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.54,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL3885383,,CCOC(=O)c1nc2ccccc2nc1C#CC1CCCC1,IC50,4.94,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BWLLEPXRBLMWQW-UHFFFAOYSA-N
CHEMBL3410527,,COc1ccc(/C=C2\CS(=O)(=O)C/C(=C\c3ccc(OC)cc3)C2=O)cc1,IC50,5.45,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,NXXRLIAVYCJUJL-JYFOCSDGSA-N
CHEMBL3410535,,O=C1/C(=C/c2ccc([N+](=O)[O-])cc2)CS(=O)(=O)C/C1=C\c1ccc([N+](=O)[O-])cc1,IC50,6.11,CHEMBL3412377,Cytotoxicity against human U87MG cells after 48 hrs by resazurin assay,U-87MG ATCC,SSAMIOWVUGBIJK-KAVGSWPWSA-N
CHEMBL4750524,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1,IC50,4.28,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,AVTGLIIZLJGQBA-UHFFFAOYSA-N
CHEMBL3578215,,Cc1ccc(-c2nn(CC(Cl)c3ccccc3)c3ncnc(N)c23)cc1,IC50,6.11,CHEMBL3580215,Anticancer activity against human U87 cells assessed as cell growth inhibition after 20 to 70 hrs by Real-time RTCA iCELLgence system,U-87MG ATCC,QQYAHZXECNNZDC-UHFFFAOYSA-N
CHEMBL3805533,,O=C(/C=C\Nc1ccc(O)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,5.33,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,KPKQJAZKSIOCFD-PFONDFGASA-N
CHEMBL4564763,,Nc1ccn([C@@H]2O[C@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](O)C2(F)F)c(=O)n1,IC50,4.78,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,SGMFJEHTWHPKLD-LTYCNYMDSA-N
CHEMBL4542902,,O=C(Nc1ccn([C@@H]2O[C@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](O)C2(F)F)c(=O)n1)OCc1ccccc1,IC50,5.35,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,BUSDOHDRRNDJLF-DJAIRROUSA-N
CHEMBL4581890,,O=C(Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1)OCc1cn(C[C@H]2O[C@@H](n3ccc(NC(=O)c4ccccc4)nc3=O)C(F)(F)[C@@H]2OC(=O)c2ccccc2)nn1,IC50,5.47,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,ZKTZRHMWOIKMHZ-VNSBPBJWSA-N
CHEMBL1089635,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c4c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C4=O)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c4c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C4=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,8.22,CHEMBL1103642,Cytotoxicity against human U87MG cells after 48 hrs by [3H]thymidine incorporation assay,U-87MG ATCC,NNYUKHCUMZKJBM-DGMYVURFSA-N
CHEMBL4451049,,COc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)/C=C/C(=O)c1ccc(C)cc1)C1CCCCC1,IC50,5.85,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,GAIRAQHWWXYQQO-QURGRASLSA-N
CHEMBL4634484,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(C)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.61,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,IMZOOIBLUCCSLH-PXCOWHNISA-N
CHEMBL4634155,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)NC(C)(C)C)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.73,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,URTDCBMFULZXCB-PJWUZBAESA-N
CHEMBL4633371,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1cccc3ncccc13)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.83,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,KSQRXEXFMMPQCN-UNNJENKKSA-N
CHEMBL4437813,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(CCc5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.56,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,WPLVKGDSOQHJGK-UHFFFAOYSA-N
CHEMBL4517377,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.12,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BPPIZXAQRSWBHX-UHFFFAOYSA-N
CHEMBL4475370,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.52,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,LDENNHFIECOFKY-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.66,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,6.31,CHEMBL5241698,Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition in presence of piperlongumine,SF295,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL5265913,,C=C(C)[C@H]1CCC2(C=O)OC2C1,IC50,4.66,CHEMBL5234885,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,SF295,VOSYWBFRXUHESA-IDKOKCKLSA-N
CHEMBL5289138,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccc(Cl)cc4)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,FTTGDLXSSQOLFF-LBGRBXAQSA-N
CHEMBL5195348,,O=C(Nc1nc2ccccc2[nH]1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.35,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,GCKVDJPBBGKETN-UHFFFAOYSA-N
CHEMBL4097158,,O=C(NC12CC3CC(CC(C3)C1)C2)c1cc2ccccc2n1CCCCO,IC50,5.32,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,GKMLNDHZKRSYQX-UHFFFAOYSA-N
CHEMBL5272452,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccn[nH]5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,5.05,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,HGFWFEHZQQWXSB-UHFFFAOYSA-N
CHEMBL5192005,,O=C(NC12CC3CC(CC(C3)C1)C2)c1c[nH]c2cc(Cl)cc(Cl)c2c1=O,IC50,5.04,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,XPXLCIVJFFMFBT-UHFFFAOYSA-N
CHEMBL5198199,,O=C(NC12CC3CC(CC(C3)C1)C2)c1cc(=O)c2cc(Cl)ccc2[nH]1,IC50,5.21,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,RSRJMBPXTHZXAP-UHFFFAOYSA-N
CHEMBL4579634,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CCC(=O)[C@H](C)O,IC50,5.7,CHEMBL4374033,Antiproliferative activity against human SNB75 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SNB-75,DZUFXUWCLMAHIK-VOUBRIMZSA-N
CHEMBL413,SIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,5.0,CHEMBL5216199,Antitumor activity against human U-87 MG cells assessed as cell growth inhibition,U-87MG ATCC,QFJCIRLUMZQUOT-HPLJOQBZSA-N
CHEMBL235658,,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,EC50,6.22,CHEMBL5227811,Antiproliferative activity against human U87 cells assessed as cell growth inhibition,U-87MG ATCC,ODYAQBDIXCVKAE-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,8.1,CHEMBL4735629,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4062346,,C[C@H]1COCCN1c1cc(-c2ccc(NC(=O)Nc3cccnc3)cc2)nn2ccnc12,IC50,4.87,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,BKMXVVIHRZYVSO-INIZCTEOSA-N
CHEMBL4091820,,C[C@H]1COCCN1c1cc(-c2ccc(NC(=O)Nc3ccncc3)cc2)nn2ccnc12,IC50,5.13,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,JDBFJYXPPSRGTL-INIZCTEOSA-N
CHEMBL3290921,,COc1ccc(-n2nc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c(C)cc2=O)cc1,IC50,5.75,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YKAPPPKEWGESSK-UHFFFAOYSA-N
CHEMBL4643861,,COc1ccc2c(c1)O[C@H]1c3cc(OC)c(OC)cc3OC[C@@H]21,IC50,4.48,CHEMBL4619138,Cytotoxicity against human SF295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XCRBPIBUMBLGCZ-UGSOOPFHSA-N
CHEMBL469708,,COc1ccc2c(c1)OC1c3cc(OC)c(OC)cc3OCC21,IC50,4.86,CHEMBL4619138,Cytotoxicity against human SF295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XCRBPIBUMBLGCZ-UHFFFAOYSA-N
CHEMBL3805083,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(Cl)cc2)cc1,IC50,5.05,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,FSJUUMHKAZICMF-NXVVXOECSA-N
CHEMBL3806288,,C[C@]12CC[C@H](OC(=O)Cn3cc(COc4ccc(Br)cc4)nn3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,IC50,4.52,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,RKICRLQYXPRAQL-SUAVODKESA-N
CHEMBL3805047,,COc1ccc(NCc2cn(CC(=O)O[C@H]3CC[C@@]4(C)C(=CC[C@@H]5[C@@H]4CC[C@]4(C)C(=O)CC[C@@H]54)C3)nn2)cc1,IC50,4.01,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,IRXQYSBMUZWEMG-AXOMYGEFSA-N
CHEMBL4791977,,CNC(=O)c1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1,IC50,6.15,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,YPPUDNFZYQCHLP-UHFFFAOYSA-N
CHEMBL4780493,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)C4CCNCC4)cc3)nc12,IC50,5.97,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,LBGLUQINWPUOOC-UHFFFAOYSA-N
CHEMBL4800645,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)[C@@H]4CCCNC4)cc3)nc12,IC50,6.44,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UDPSCVKNVATZTE-MRXNPFEDSA-N
CHEMBL4871194,,CS(=O)(=O)c1ccc(-c2nc3ccccn3c2Sc2cccc3ccccc23)cc1,IC50,4.25,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,XUCNYBYWEJHTDT-UHFFFAOYSA-N
CHEMBL2172477,,CC(=O)Nc1cc(-c2c(Nc3ccn(C)n3)nc3ccc(-c4cccnc4C)cn23)nc(C)n1,IC50,6.64,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,YQTDIAJNWCPLOM-UHFFFAOYSA-N
CHEMBL2172627,,CNc1cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)nc(C)n1,IC50,6.15,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,BMRLEHIKKZUCGW-UHFFFAOYSA-N
CHEMBL4441412,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(COC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.78,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,VRIPLPUPBHVIEP-KHMDBFSKSA-M
CHEMBL5563094,,CCc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1,IC50,5.23,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,WLGXZBAICQVSRE-UHFFFAOYSA-N
CHEMBL5574178,,COc1cc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc(OC)c1Br,IC50,5.54,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,KLALLFUUYWKCCC-UHFFFAOYSA-N
CHEMBL273862,HYDROXYCAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1,IC50,5.54,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,HAWSQZCWOQZXHI-FQEVSTJZSA-N
CHEMBL5574844,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCSSCCC(=O)NC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.39,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,LKEWPEIROHRLHI-KHEAGTJRSA-N
CHEMBL5575144,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NCCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,7.08,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,QPNUMAODVVORBN-MFMXYXMPSA-N
CHEMBL5431878,,Cc1cc(Cc2c[nH]c3ccc(F)cc23)cc(C)c1O,IC50,4.26,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,GCQIAAMCCOXMDD-UHFFFAOYSA-N
CHEMBL5437494,,Cc1cc(Cc2cn(C)c3ccccc23)cc(C)c1O,IC50,5.1,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,KSICBPUDEOOBSJ-UHFFFAOYSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.07,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL4787572,,Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2CC1CCNCC1,IC50,4.09,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,GTWNYADDKACXSW-UHFFFAOYSA-N
CHEMBL5572843,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.83,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,FCJFNQFJJLCVAQ-UHFFFAOYSA-N
CHEMBL1724189,,Nc1ccc(Cn2ccc3c4c(N)nc(N)nc4ccc32)cc1,IC50,6.25,CHEMBL5051748,Antiproliferative activity against human LN-229 cells after 72 hrs by MTT assay,LN-229,LNEWNMFMWDBAKM-UHFFFAOYSA-N
CHEMBL4872595,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCCCCC(=O)NO)(C3)C2,IC50,5.02,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,BLGDOJXSHOVDCJ-UHFFFAOYSA-N
CHEMBL5191892,,C[C@H](NC(=O)c1ccc2cc1OCCOCCNc1ccn3ncc-2c3n1)c1ccncc1,EC50,5.66,CHEMBL5167606,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability after 1 to 7 days by resazurin dye based fluorimetric analysis,LN-229,FFVXISWLYSJERX-INIZCTEOSA-N
CHEMBL3781356,,CS(=O)(=O)c1ccc(-c2ccc3oc(=O)c4[nH]c(=O)n(-c5ccc(CC#N)cc5)c4c3c2)cc1,IC50,4.4,CHEMBL3783887,Growth inhibition of human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,HLDPDDVUFNMNBD-UHFFFAOYSA-N
CHEMBL3343410,,CC[P@@]1(=O)O[C@H]([C@H]2COC(C)(C)O2)[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O,Ki,7.72,CHEMBL3374643,Antimigratory activity against human SNB75 cells on matrix containing fibronectin after 24 hrs by 2-D migration assay,SNB-75,YDBHENJAGLBQMF-ZAHCLZMSSA-N
CHEMBL3343410,,CC[P@@]1(=O)O[C@H]([C@H]2COC(C)(C)O2)[C@@H]2OC(C)(C)O[C@@H]2[C@@H]1O,Ki,7.18,CHEMBL3374646,Antimigratory activity against human SNB75 cells on matrix containing vitronectin after 24 hrs by 2-D migration assay,SNB-75,YDBHENJAGLBQMF-ZAHCLZMSSA-N
CHEMBL3601925,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,6.14,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,YCMPAJXRYQKAKZ-UHFFFAOYSA-N
CHEMBL4283735,,COc1cc(OC)c2c(=O)c(OCCCOc3ccc(/C=C/C(=O)/C=C/c4scnc4C)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.39,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,WVNPKIXIDRSNFO-XVNCSPBISA-N
CHEMBL4276849,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3ccc(Cl)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.68,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,RJVSPMPKAQHNKF-JSAVKQRWSA-N
CHEMBL3621415,,CCCCCCCCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,4.82,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,RDUNXYIJQXYURN-UHFFFAOYSA-M
CHEMBL3582134,,C/C1=C\CC[C@@]2(C)O[C@H]2[C@H]2OC(=O)[C@@H](CN(C)C)[C@@H]2CC1,IC50,5.06,CHEMBL3584023,Cytotoxicity against human U87MG cells assessed as cell viability after 48 hrs by Alamar Blue assay,U-87MG ATCC,UJNSFDHVIBGEJZ-ONGJMVGKSA-N
CHEMBL3621993,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Nc1ccc(C(=O)/C=C/c2ccc([N+](=O)[O-])cc2)cc1,IC50,5.54,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,BWDWZTPOHBSIOC-CXUHLZMHSA-N
CHEMBL3621996,,COc1ccc(/C=C/C(=O)c2ccc(NC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)cc2)cc1,IC50,5.97,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,YJMOUQWVLIGKPC-LICLKQGHSA-N
CHEMBL2441129,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=C(Cl)C(=O)c3ccccc3C2=O)nn1,IC50,5.75,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,PPERCHXBOIBCRO-UHFFFAOYSA-N
CHEMBL2441128,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(CNC2=C(Br)C(=O)c3ccccc3C2=O)nn1,IC50,5.66,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,RLTXFXYHQISJCL-UHFFFAOYSA-N
CHEMBL15192,LAPACHONE,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.04,CHEMBL3624431,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,QZPQTZZNNJUOLS-UHFFFAOYSA-N
CHEMBL3092022,,COc1cc(OC)c(C(C#CCCc2ccc(O[Si](C)(C)C(C)(C)C)cc2)CC(=O)c2ccc(OC(C)=O)cc2)c(OC)c1,IC50,5.1,CHEMBL3096271,Cytotoxicity against human U87MG cells after 5 days by methylene blue staining assay,U-87MG ATCC,GMAGLVPSKNBQKR-UHFFFAOYSA-N
CHEMBL4870114,,CC12CC3CC(C)(C1)CC(NS(=O)(=O)c1ccc(/C=C/C(=O)NO)cc1)(C3)C2,IC50,5.7,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,CQPIEFONMMNTCA-VMPITWQZSA-N
CHEMBL4851084,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCCC(=O)NO)(C3)C2,IC50,4.73,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,CWIKVVHAHBDBDR-UHFFFAOYSA-N
CHEMBL4871275,,CC12CC3CC(C)(C1)CC(NC(=O)CCCCCCCC(=O)NO)(C3)C2,IC50,4.47,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,FFQIAPNNAZFJSB-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,6.6,CHEMBL5231221,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability,U-87MG ATCC,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL5200657,,COCCN1CCN(c2cccc(F)c2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.4,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,KQUOBMSIJCDOQG-UHFFFAOYSA-N
CHEMBL5277266,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccccn5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.98,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,MSAGIXUBDWCPAH-UHFFFAOYSA-N
CHEMBL4065541,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@H](Cc2ccccc2)NC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.21,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,JQTYHXXMGULJBL-GHIXNXTASA-N
CHEMBL4452167,,O=C(Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1)OCc1cn(C[C@H]2O[C@@H](n3ccc(NC(=O)OCc4ccccc4)nc3=O)C(F)(F)[C@@H]2O)nn1,IC50,5.67,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,AMCNVJZJFHUOGU-DJAIRROUSA-N
CHEMBL1257065,STILONIUM IODIDE,CC[N+](CC)(CC)CCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,5.36,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,RDTKUZXIHMTSJO-UEIGIMKUSA-M
CHEMBL4280452,,CC[N+](CC)(CC)CCCCOc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1.[I-],IC50,6.24,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,KTDBKCRZBFSZBP-CALJPSDSSA-M
CHEMBL4293646,,CC[N+](CC)(CC)CCCCCCOc1ccc(/C=C/c2ccccc2)cc1.[I-],IC50,5.41,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,FXBKAVKFPWOCQQ-CMBBICFISA-M
CHEMBL4288506,,C(=C/c1ccc(OCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.17,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,CBQLKOLDQYBDLK-QREUMGABSA-M
CHEMBL4292276,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(Cl)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.83,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BTRLTDGZLHFFRU-UVHRBFQASA-N
CHEMBL4288866,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(C)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.72,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,QHBSNJNISDFZDK-DRCGVWDTSA-N
CHEMBL4287584,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(CN(C)C)nn3)CC[C@@H]12,IC50,4.89,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,FPJJIHRGNDQZBF-XWXXQTTFSA-N
CHEMBL4285131,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccc(F)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.9,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UQSKKVZPQVVURT-DGVIHOGNSA-N
CHEMBL4291163,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCOC(C)=O)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.66,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,JZDWHRVMFVGBGO-IUGFVHJESA-N
CHEMBL810,TEMOZOLOMIDE,Cn1nnc2c(C(N)=O)ncn2c1=O,IC50,4.17,CHEMBL5031400,Cytotoxicity effect against human LN-229 cells assessed as cell growth inhibition incubated for 48 hrs by trypan blue exclusion assay,LN-229,BPEGJWRSRHCHSN-UHFFFAOYSA-N
CHEMBL5089530,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C#N)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.46,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GTGMLRAJBUWXCG-VZHCALMGSA-N
CHEMBL5078218,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.59,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,FRDGYTCJYQGQAW-GTKRWHGSSA-N
CHEMBL5082849,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.67,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,IKANBESOKWBFOM-DKAJQEPCSA-N
CHEMBL5074496,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Cl)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.05,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,JGCYYQSMCMPXED-SMRIDXHDSA-N
CHEMBL5091183,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7nccs7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.77,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,WLZOZZHOZLJSCI-RCGAJBMESA-N
CHEMBL5081131,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.59,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,LNWNGALQBKWVHJ-WFVGHVPHSA-N
CHEMBL5080560,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(F)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.61,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,NSHNVMIURYQLAG-MCLIRCHUSA-N
CHEMBL4456054,,Cc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccccc3)sc2c1,IC50,4.63,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CTWYFCWLZHLKTO-UHFFFAOYSA-N
CHEMBL4127714,,C[C@H]1[C@H](N2CCN(c3ccc(F)cc3)CC2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,4.59,CHEMBL4123814,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,CIUGTJDAPFQJON-RRXFZIEKSA-N
CHEMBL4159373,,COc1ccc(C(=C(F)F)c2cc(OC)c(OC)c(OC)c2)cc1N,IC50,9.7,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,KVUQMSRUDFEMNF-UHFFFAOYSA-N
CHEMBL3416184,,COc1cc2nc(-c3cc(OC(F)(F)F)cc(C(N)=O)c3)nc(N3CCOCC3)c2cc1OC,IC50,6.22,CHEMBL3421311,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JBVPCMMERZJZFC-UHFFFAOYSA-N
CHEMBL3339348,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(O)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.77,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MQOZCTADCBDYAG-XICOUIIWSA-N
CHEMBL3339350,,COc1cc(/C=N/NC(=O)Cc2ccc(Oc3ccnc4cc(OCCCN5CCOCC5)c(OC)cc34)c(F)c2)ccc1O,IC50,5.23,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,YMAOSZPMGYKLNN-QLQYKETESA-N
CHEMBL3339354,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.52,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,PZIBOPQOMMNWBQ-LALXJTNGSA-N
CHEMBL3339365,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.46,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,MQTYXBYTHJGYMD-GKVNEZTPSA-N
CHEMBL4513992,,N#Cc1cccc(/C=C/C(=O)c2ccc(B(O)O)cc2)c1,IC50,4.61,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,TXAAMGTWMYWEKM-RUDMXATFSA-N
CHEMBL4572589,,CCN(CC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.75,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,PVIFYSUWLTVVKK-MDWZMJQESA-N
CHEMBL4174909,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(O[C@@H]3CCOC3)c2n1,IC50,6.4,CHEMBL4150398,Cytotoxicity against human U87MG cells after 96 hrs by MTT assay,U-87MG ATCC,DVLVYFPEVHXTKT-GOSISDBHSA-N
CHEMBL4862637,,C[C@H]1[C@@H](O[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@@H](O)[C@@H]2[C@@H]3C[C@H](O)[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.16,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,JZYCDNBRXQHIMA-GGWWRNHQSA-N
CHEMBL3600438,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cn2n1,IC50,5.97,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RQCGZIMOCDOERZ-UHFFFAOYSA-N
CHEMBL3600439,,COc1ncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.0,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ORGODRQWHUVBIJ-UHFFFAOYSA-N
CHEMBL5093902,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.47,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,VDNKOXGKXPTVCH-BDFBTMKGSA-N
CHEMBL5088699,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccccc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.43,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,VHYGQIMOTUOCGE-SMRIDXHDSA-N
CHEMBL5088772,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(OC)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.38,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,JGPLYADDPRLOJV-VZHCALMGSA-N
CHEMBL5086293,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(F)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.23,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,GAFFZCCTWJWKRW-SMRIDXHDSA-N
CHEMBL5074496,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Cl)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.04,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,JGCYYQSMCMPXED-SMRIDXHDSA-N
CHEMBL5082849,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.42,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,IKANBESOKWBFOM-DKAJQEPCSA-N
CHEMBL5090018,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CCC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.82,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,BDWTWOVMVWJZNR-SUNMMQDUSA-N
CHEMBL5089977,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CCCCC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.41,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,XNZFUNKIEWOVAE-MCLIRCHUSA-N
CHEMBL5083112,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Br)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.58,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,ZOLXXYHLNIAOLS-MCLIRCHUSA-N
CHEMBL5088699,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccccc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.31,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,VHYGQIMOTUOCGE-SMRIDXHDSA-N
CHEMBL5088772,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(OC)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.36,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,JGPLYADDPRLOJV-VZHCALMGSA-N
CHEMBL5089631,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccccc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.49,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,CKQLOINPQOUXOW-MCLIRCHUSA-N
CHEMBL5079791,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C(C)(C)C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.75,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,QLFCJGYFBTYJGC-VZHCALMGSA-N
CHEMBL4565354,,Nc1nccc(N2CCCC(CCc3ccccc3)C2)n1,IC50,6.0,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,LBTBVAZVSLCXCP-UHFFFAOYSA-N
CHEMBL4856711,,Cc1ccc(Nc2ccccc2C(=O)NCCc2c[nH]c3ccccc23)cc1,IC50,4.46,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,CPGBITKHHPQFPE-UHFFFAOYSA-N
CHEMBL4861158,,COc1cc(Nc2ccccc2C(=O)NCCc2c[nH]c3ccccc23)cc(OC)c1OC,IC50,5.32,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,WPCCJSLETMQZDD-UHFFFAOYSA-N
CHEMBL5575091,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N[C@@H]1CCNC1)C3,IC50,5.24,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,PREHDGJVTUBHPV-LLVKDONJSA-N
CHEMBL5583787,,N#CC1(C(=O)NC2CCN(Cc3ccccc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.13,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,SSCLZFPVEGLVNP-UHFFFAOYSA-N
CHEMBL5289288,,Cc1ccc(F)c(NS(=O)(=O)/C=C/c2cccc(OCCOC3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)c2)c1,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,PHLBKOVEFMVWTA-IIBVODSDSA-N
CHEMBL1822937,,CCCCOc1c(OC)ccc2cc(C(=O)NCc3cn(CCF)nn3)c(=O)[nH]c12,Ki,6.21,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,MEWJSKBKQBTZIF-UHFFFAOYSA-N
CHEMBL1821796,EUPHODENDROPHANE F,CC(=O)OC/C1=C/[C@H]2[C@@H](OC(C)=O)[C@](C)(OC(C)=O)C[C@]2(OC(C)=O)C(=O)[C@H](C)/C=C/C(C)(C)[C@H](OC(=O)c2cccnc2)[C@H](OC(C)=O)[C@@H]1OC(=O)C(C)C,IC50,4.18,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,LXVCUUREWHBIOM-IICLPEKWSA-N
CHEMBL5195348,,O=C(Nc1nc2ccccc2[nH]1)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.39,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,GCKVDJPBBGKETN-UHFFFAOYSA-N
CHEMBL5176572,,CCCCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,7.33,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,VXYALBNZTFRWKJ-UHFFFAOYSA-N
CHEMBL5193363,,CN(CCCCCCCCN)Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.1,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,VELMLCUIUXYDFS-UHFFFAOYSA-N
CHEMBL4754919,,C#CCOc1ccc(/C=C/C(=O)c2cccc(OC)c2)cc1OC,IC50,5.84,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,KVRBFOWNODELCR-CSKARUKUSA-N
CHEMBL2381450,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc([N+](=O)[O-])cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,5.1,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,OGWVNIXGXAVTCX-WKZPCIAFSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,4.16,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL258844,,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,IC50,4.46,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,BIWGYFZAEWGBAL-UHFFFAOYSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,7.7,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.76,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL1801204,AZD-8055,COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO,IC50,5.99,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,KVLFRAWTRWDEDF-IRXDYDNUSA-N
CHEMBL2392964,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.83,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,USGGPNGHCXQGQY-UHFFFAOYSA-N
CHEMBL2392967,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,6.24,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MMLHZEYVLDVWPX-UHFFFAOYSA-N
CHEMBL2435962,,COc1cc2c(Oc3ccc(NC(=O)c4nccc(-c5ccc(F)cc5F)n4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.11,CHEMBL2437785,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,TUGDKOZAGJNHHL-UHFFFAOYSA-N
CHEMBL1800936,,CC[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.84,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,KFRXJKMLZFERKO-KDOFPFPSSA-N
CHEMBL4778367,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C(C)C)nc12,IC50,7.07,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,DEVYXOKAXWLJRC-UHFFFAOYSA-N
CHEMBL4784940,,CC(=O)c1c(C)c2cnc(Nc3ccc4c(n3)CCN(CCN(C)C)C4)nc2n2cc(C(C)C)nc12,IC50,6.6,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,YSOMCCRHZLRXAQ-UHFFFAOYSA-N
CHEMBL3301610,ABEMACICLIB,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,IC50,6.15,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,UZWDCWONPYILKI-UHFFFAOYSA-N
CHEMBL4788224,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCOCC3)n2)cc1,IC50,5.77,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,QOQHRNUWUVTBOE-YIXHJXPBSA-N
CHEMBL105821,,CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1,IC50,9.7,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,UCANOSVRVFBCJE-GKPLWNPISA-N
CHEMBL3577921,,COc1ncc(-c2cc3c(-c4ccncc4)ncnc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.36,CHEMBL3579772,Cytotoxicity against human U87MG cells harboring PTEN deletion mutant assessed as growth inhibition after 4 days by CellTiter-Glo luminescent cell viability assay,U-87MG ATCC,IHWMYZQUTPMTII-UHFFFAOYSA-N
CHEMBL122557,,O=C1c2c(O)ccnc2-c2nccc3c2c1nc1ccccc13,IC50,5.4,CHEMBL815875,In vitro cytotoxicity against human glioblastomas cell line U87MG.,U-87MG ATCC,MCTCVKDGNCPADW-UHFFFAOYSA-N
CHEMBL3975938,,CC1c2cc(-c3c[nH]c4cc(F)ccc34)ccc2S(=O)(=O)N1CC1(C)COC(=O)N1,IC50,7.24,CHEMBL3871117,Inhibition of TDO2 in human A172 cells assessed as kynurenine formation after overnight incubation,A-172,OZEBOPTWTROCBM-UHFFFAOYSA-N
CHEMBL5288916,,CC(C)CNc1ccnc(NCc2csc(-c3ccccc3)c2)n1,IC50,4.51,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,SPBSZKORELYQFI-UHFFFAOYSA-N
CHEMBL428676,AMONAFIDE,CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O,IC50,4.62,CHEMBL4831081,Cytotoxicity against human A 172 cells assessed as cell viability measured after 96 hrs by XTT assay,A-172,UPALIKSFLSVKIS-UHFFFAOYSA-N
CHEMBL4756418,,CC(C)(C)OC(=O)N1CC[C@]2(C(=O)Nc3ccccc32)[C@H]1c1cccc(-c2ccc(CO)c(S(C)(=O)=O)c2)c1,IC50,5.2,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,WCOXMLFEWOILDZ-PDDLMNHVSA-N
CHEMBL456237,LXR-623,Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1,IC50,5.08,CHEMBL4686887,Antiproliferative activity against human A 172 cells measured after 7 days by CCK8 assay,A-172,KYWWJENKIMRJBI-UHFFFAOYSA-N
CHEMBL4166186,,C=C(c1ccc(OC)c(N)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.05,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,PNMBGQAVCUEXEN-UHFFFAOYSA-N
CHEMBL3341777,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](Nc1ccc3ccccc3c1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,5.47,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,FWHOARIZUBCNOV-JBNHJABESA-N
CHEMBL1928606,,Cc1ccc(S(=O)(=O)N2c3ccccc3[C@H]3COc4ccccc4[C@H]32)cc1,IC50,4.5,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,ISQKBCDJGDKCMA-DENIHFKCSA-N
CHEMBL1738758,ONVANSERTIB,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,IC50,7.21,CHEMBL5682223,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by cell-titer glo assay,LN-229,QHLVBNKYJGBCQJ-UHFFFAOYSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,5.63,CHEMBL5241697,Antiproliferative activity against human SF-295 cells assessed as cell growth inhibition,SF295,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL1914735,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCCN4CCCCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.75,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,GIFGUUZRMKEHAB-UHFFFAOYSA-N
CHEMBL1914739,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4CCC(F)(F)CC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.72,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,ZVLSVNCJSAVVGW-UHFFFAOYSA-N
CHEMBL4558022,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCC(=O)OC)CC3)cc2)ncc1Cl,IC50,5.88,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,IFMLFCIKGPQUCD-UHFFFAOYSA-N
CHEMBL4440684,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4ccccc4)CC3)cc2)ncc1Cl,IC50,5.47,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,JYQCJMFJYVZDON-UHFFFAOYSA-N
CHEMBL1738719,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCOCC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.8,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,RTARVPHTCQRSDW-UHFFFAOYSA-N
CHEMBL1914732,,CN(Cc1ccccc1)c1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,6.59,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,BCKWCRGCXCOSGR-UHFFFAOYSA-N
CHEMBL4551635,BAY-069,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1Cl,IC50,6.45,CHEMBL4885538,Cellular mechanistic assay  BCAA measurement (U-87-MG cells),U-87MG ATCC,UNSHMXUHOHBLIQ-UHFFFAOYSA-N
CHEMBL4159104,,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1,IC50,6.62,CHEMBL4153991,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,SOAVEOJCKVRROO-UHFFFAOYSA-N
CHEMBL5562084,,CC(C)CNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.42,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,AVASHGQZRZLOTG-CYBMUJFWSA-N
CHEMBL4873517,,CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccc(F)cc4)c3)nc3sccn23)n1,IC50,4.81,CHEMBL4832265,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,AWCIKMLGHHTGHO-UHFFFAOYSA-N
CHEMBL1927617,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(CCO)c23)C1=O,IC50,5.37,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IUQCEFOORKUSKN-UHFFFAOYSA-N
CHEMBL1927619,,CN(C)CCCN1C(=O)c2cccc3c2c(cc2nnn(CCCN(C)C)c23)C1=O,IC50,6.52,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CDJIQIYMQMJOIQ-UHFFFAOYSA-N
CHEMBL2398336,,COc1ccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.21,CHEMBL4713866,Antiproliferative activity against human A 172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,FFIDHUYNLVXETI-UHFFFAOYSA-N
CHEMBL1801036,CYCLOVIOLACIN O13,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,IC50,5.59,CHEMBL5048137,Cytotoxicity against human U-87 MG cells using best fit nonlinear regression analysis,U-87MG ATCC,HHLPYNQQOPKSJQ-XVGLBWMNSA-N
CHEMBL5090055,,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2,IC50,5.54,CHEMBL5048137,Cytotoxicity against human U-87 MG cells using best fit nonlinear regression analysis,U-87MG ATCC,GXCNZQOZVJURKD-DXBOVLASSA-N
CHEMBL4472885,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.09,CHEMBL5114109,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,AYSPBJARTFATSL-UHFFFAOYSA-N
CHEMBL4777034,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCCCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.68,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CUAAXWZMCZCACR-OLLHKAICSA-N
CHEMBL4789807,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCC3COCCOCCOCCOCCOCCO3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,6.08,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WWJRXVJEMHEKCV-VAAXJPQESA-N
CHEMBL5278544,,N#CC1=C(N)Oc2c(c(=O)oc3ccc(Br)cc23)C12C(=O)Nc1ccccc12,IC50,4.11,CHEMBL5232067,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay,U-87MG ATCC,RKGJUGSDACTEQU-UHFFFAOYSA-N
CHEMBL4755661,,Cc1ccnc(NC(c2cccc(F)c2)c2ccc3cccnc3c2O)c1,IC50,5.04,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,OTFQEKBHSZDRLM-UHFFFAOYSA-N
CHEMBL4786723,,Cc1ccnc(NC(c2ccc(C(F)(F)F)cc2)c2ccc3cccnc3c2O)c1,IC50,5.68,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,NGAWFARRBBNJRI-UHFFFAOYSA-N
CHEMBL4797303,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCCCO)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.8,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,NXDNEVNAIVDFGW-LMZWQJSESA-N
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,6.07,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL38434,BREQUINAR,Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O,IC50,4.09,CHEMBL4723432,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by sulforhodamine B assay,SNB-75,PHEZJEYUWHETKO-UHFFFAOYSA-N
CHEMBL3290904,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c(=O)cc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.8,CHEMBL3293741,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OHOIQYVRPXKLSA-UHFFFAOYSA-N
CHEMBL5184014,,CC(Oc1ccc(-c2ccc(C=CC(=O)O)cc2)cc1C12CC3CC(CC(C3)C1)C2)C(=O)NO,IC50,6.0,CHEMBL5155487,Antiproliferative activity against human U-87 MG cells incubated for 24 hrs followed by incubating in drug-free medium for 48 hrs and measured by SRB assay,U-87MG ATCC,PIJPEZHKJKJZHS-UHFFFAOYSA-N
CHEMBL4225799,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.54,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,PZZLYBFEQUTEIT-UHFFFAOYSA-N
CHEMBL4225944,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(C)(=O)=O,IC50,5.52,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,QGAOXAMNRDEXDY-UHFFFAOYSA-N
CHEMBL3357873,,COc1ccc(Nc2ncc(C(C)(C)O)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.32,CHEMBL3379686,Inhibition of PI3K-mediated Akt S473 phosphorylation in human U87MG cells after 2 hrs by cell-based assay,U-87MG ATCC,ZZDDSJQCHASOIC-UHFFFAOYSA-N
CHEMBL4848510,,CSc1ccc(/C=C/c2cc(/C=C3\Sc4ccccc4N3CCCN3CCOCC3)c3ccccc3[n+]2C)cc1.[I-],IC50,4.01,CHEMBL4834608,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,DROUWMZEXFQPRA-JRUHLWALSA-M
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,6.72,CHEMBL3395180,Inhibition of colony formation in human U87MG cells after 2 weeks by crystal violet staining-based assay,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL4068974,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(-n2ccnc2)cc1,EC50,4.87,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,CMZRTYGMDDGILK-FNORWQNLSA-N
CHEMBL3601922,,CCCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,6.38,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AMIXYWIQKYPHQE-UHFFFAOYSA-N
CHEMBL3343413,,CC1(C)O[C@H]2[C@@H]([C@H]3COC(C)(C)O3)O[P@](=O)(c3ccccc3)[C@@H](OC(=O)c3ccccc3)[C@H]2O1,IC50,5.02,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,SFTPJRPHQMDNLY-DDNJDZIRSA-N
CHEMBL3343643,,CC1(C)O[C@@H]2[C@H](O1)[C@@H](Nc1ccccc1)[P@](=O)(c1ccccc1)O[C@@H]2[C@H]1COC(C)(C)O1,IC50,5.0,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,ZXWDPALQHPNKFF-KBSTVAECSA-N
CHEMBL3343644,,Cc1ccc(N[C@@H]2[C@H]3OC(C)(C)O[C@H]3[C@@H]([C@H]3COC(C)(C)O3)O[P@@]2(=O)c2ccccc2)cc1,IC50,5.27,CHEMBL3374069,Antiproliferative activity against human SNB75 cells after 48 to 72 hrs by MTT assay,SNB-75,IKVOFDAMYNPSSA-RSERMMFASA-N
CHEMBL3339369,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.41,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,PVHJURUEMDDUCX-BOABNOFISA-N
CHEMBL4799122,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3cccc(N4CCOC4=O)c3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.5,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,YLJXBMOGMHSNKO-UHUNBADTSA-N
CHEMBL4799459,,CCOC(=O)C1CCC(CNC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)CC1,IC50,6.21,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CJDXOEPOEHTNCA-BQTGEACFSA-N
CHEMBL4798246,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(S(C)(=O)=O)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.63,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,GWJCJNGBXYSNPJ-HCNZWEOSSA-N
CHEMBL4784511,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCCCO)C(=O)C=C(NCCCCO)C1=O)OC,IC50,5.39,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,QMEKDPSTHUHPSV-UWQVLHRZSA-N
CHEMBL4796360,,CN1CCN(c2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)n2)CC1,IC50,5.92,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,CIYCHIXAEULMGX-LHHJGKSTSA-N
CHEMBL4779191,,CC1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(Nc4nc(/C=C/c5ccccc5)nc(N5CCOCC5)n4)cc3)cc2)CC1,IC50,6.06,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,LRZBGPLGJHGCGH-FRKPEAEDSA-N
CHEMBL4785380,,O=C(Nc1ccc(Cl)cc1)Nc1cccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCOCC3)n2)c1,IC50,5.44,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,SESLUDIACMIRCO-KPKJPENVSA-N
CHEMBL4869235,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8cc[nH]c8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.49,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,RWDLNVWZZSROOD-KODZDQQCSA-N
CHEMBL388978,STAUROSPORINE,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,8.01,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,HKSZLNNOFSGOKW-FYTWVXJKSA-N
CHEMBL5634063,,CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@]4(C)C(=CC(=O)O[C@H]4c4coc(C(=O)CCl)c4)[C@]2(C)OC(=O)C[C@@H]13,IC50,5.77,CHEMBL5627877,Anticancer activity against human A-172 cells assessed as reduction in cell viability incubated for 72 hrs by Alamar Blue assay,A-172,SAWWDURHVOQNRR-ADRFUERYSA-N
CHEMBL3628032,,C/C=C(\C)C(=O)OCC1=C2/C(=C\[C@@]3(C)CC[C@](O)(O3)[C@H](C)C[C@@H]2O)OC1=O,IC50,5.02,CHEMBL3632160,Antiproliferative activity against human SF295 cells for 72 hrs by cyquant assay,SF295,CXGKQKUIHGHUEP-BFWKSYKFSA-N
CHEMBL180127,SALUBRINAL,O=C(/C=C/c1ccccc1)NC(NC(=S)Nc1cccc2cccnc12)C(Cl)(Cl)Cl,IC50,4.34,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,LCOIAYJMPKXARU-VAWYXSNFSA-N
CHEMBL3621414,,CCCCCCCCCCCCCCCCCCOc1c(OC)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Br-],IC50,4.65,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,WYKAGJLKBKZKCZ-UHFFFAOYSA-M
CHEMBL49642,INDIBULIN,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12,IC50,7.11,CHEMBL5256113,Cytotoxicity against multidrug resistance human U87 cells assessed as cell growth inhibition,U-87MG ATCC,SOLIIYNRSAWTSQ-UHFFFAOYSA-N
CHEMBL5279895,,C=C(C)[C@@H]1CC[C@]2(COC(=O)CCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.[Br-],IC50,4.66,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,NXMOMYUADRXZIB-NQZOKFLLSA-M
CHEMBL5281628,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccccc3Cl)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,BQGLNCJFOGQRDR-ROQWCOLUSA-N
CHEMBL5281508,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3c(Cl)cccc3Cl)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,AAXNPJGPQSXHPI-IBPPZMNKSA-N
CHEMBL5218737,,CO[C@@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)OC([C@H](C)C[C@@H]2C[C@@H]3C[C@H]2C[C@H]3O)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,8.66,CHEMBL5216199,Antitumor activity against human U-87 MG cells assessed as cell growth inhibition,U-87MG ATCC,PWOJHTAZPQKPPN-MCVDMIQGSA-N
CHEMBL5207505,,O=C(O)C=Cc1ccc(-c2ccc(OCC(=O)NO)c(C34CC5CC(CC(C5)C3)C4)c2)cc1,IC50,5.96,CHEMBL5155487,Antiproliferative activity against human U-87 MG cells incubated for 24 hrs followed by incubating in drug-free medium for 48 hrs and measured by SRB assay,U-87MG ATCC,YJMADWAPLKRSFA-UHFFFAOYSA-N
CHEMBL3409958,,C/C(=N\O)c1cc(-c2ccc(O)c(F)c2)ccc1O,IC50,4.16,CHEMBL3413577,Antiproliferative activity against human U87 cells assessed as reduction in cell growth after 96 hrs,U-87MG ATCC,VYJNYSBKIQUCBW-LZYBPNLTSA-N
CHEMBL5201292,,CS(=O)(=O)N1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.99,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,DGVJYSWWBMMKSB-UHFFFAOYSA-N
CHEMBL5192081,,COCCN1CCN(c2ccc(C)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.72,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YLFZSOVLOJKOPG-UHFFFAOYSA-N
CHEMBL4073794,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5cccc(Cl)c5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.01,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,VPMDLQXEBDMFMZ-UHFFFAOYSA-N
CHEMBL4062438,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(Cl)cc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.3,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DLSXFVOHVLZRTP-UHFFFAOYSA-N
CHEMBL4063742,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.99,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,QKPLOCPOKHWCDZ-UHFFFAOYSA-N
CHEMBL3426496,,C=C1C(=O)[C@H]2C[C@]1(O)CC1=C2[C@]2(C)CCCC(C)(C)[C@H]2CC1,IC50,5.57,CHEMBL3428817,Cytotoxicity against human A172 cells assessed as cell viability after 24 hrs by MTT assay,A-172,CHRNFZZARNTWCF-KQEPKPNTSA-N
CHEMBL4788576,,CCOc1cc(C(=O)NC2CCNCC2)ccc1Nc1ncc2scc(-c3ccccc3OC)c2n1,IC50,5.69,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,FEPSYSFWHWLVLS-UHFFFAOYSA-N
CHEMBL4799952,,COc1ccccc1-c1csc2cnc(Nc3cc(F)c(C(=O)NC4CCNCC4)cc3F)nc12,IC50,5.83,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IVDWLTZQEUFLDQ-UHFFFAOYSA-N
CHEMBL4583117,,COc1cc(/C=N/Nc2nc(-c3cccc(Br)c3)cs2)cc(Br)c1OC,IC50,4.06,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,SRRTVRYBFLLLEO-ZVBGSRNCSA-N
CHEMBL4453790,,Fc1ccc(/C=N/Nc2nc(-c3ccc(F)c(F)c3)cs2)cc1F,IC50,4.36,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,IAURITNYRKQDAX-QPSGOUHRSA-N
CHEMBL5088605,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CCC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.5,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,JXGWMVJAVZKEBT-YXZQVLARSA-N
CHEMBL5088699,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccccc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.19,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,VHYGQIMOTUOCGE-SMRIDXHDSA-N
CHEMBL2398340,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc4c(c3)OCO4)ccc2NS(C)(=O)=O)c1,IC50,6.92,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,PIWUCDPMEFZJLM-UHFFFAOYSA-N
CHEMBL5394592,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(Cl)cc(Cl)c3)ccc2NS(C)(=O)=O)c1,IC50,6.82,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,NKVCJWYRWCQWSL-UHFFFAOYSA-N
CHEMBL2398340,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc4c(c3)OCO4)ccc2NS(C)(=O)=O)c1,IC50,7.46,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,PIWUCDPMEFZJLM-UHFFFAOYSA-N
CHEMBL5408307,,CCOc1cccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)c1,IC50,7.42,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,GTTIKNCVGNBXMI-UHFFFAOYSA-N
CHEMBL2313556,,CCCCCCC(=O)O[C@H]1c2cc(OC)c(OC)c(OC)c2-c2c(cc3c(c2OC)OCO3)C[C@H](C)[C@]1(C)O,IC50,4.21,CHEMBL2318887,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,BDGYFNCAAHFNGL-AHFZSLFQSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,4.6,CHEMBL3758039,Antiproliferative activity against human T98G cells assessed as cell viability after 72 hrs by MTT assay,T98G,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL5285515,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3cccc(Cl)c3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,JGZUQRVSEHRGNR-DPKHVTONSA-N
CHEMBL5274557,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccc(OC(F)(F)F)cc3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,FXVRDIACCMROQQ-KFFRJZQJSA-N
CHEMBL3806129,,COc1ccc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1,IC50,5.16,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,WEJHSCQUSADJPH-NXVVXOECSA-N
CHEMBL2206905,,COc1cnc(Nc2cnc(Cl)c(NS(=O)(=O)N3CCOCC3)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.12,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,JQXMRKGWLJIJAG-UHFFFAOYSA-N
CHEMBL2206914,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)C3CC3)c2)n1,IC50,7.44,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,FOVDAQSOCPEZCB-UHFFFAOYSA-N
CHEMBL2206913,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(C)(=O)=O)c2)n1,IC50,7.7,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,MYQDIPJMQYEWIZ-UHFFFAOYSA-N
CHEMBL2164691,,Cc1c2c(cc[n+]1Cc1ccccc1F)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-],IC50,6.16,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,FZBLAUDIPVURBE-UHFFFAOYSA-M
CHEMBL2164401,,CCCCCC[n+]1ccc2c3ccc(OCc4ccccc4)cc3n(Cc3ccccc3)c2c1C.[Br-],IC50,5.51,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,KRSNLGJGHQIGRU-UHFFFAOYSA-M
CHEMBL5411474,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSCc2ccccc2CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC1=O,IC50,5.08,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,FVNGGHBJUPVYSQ-RUZHBQKASA-N
CHEMBL4798470,,CCCCOCCOCCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,5.91,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,QYRFNJFXPLGFQD-AMIPGTMGSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,5.06,CHEMBL5041371,Cytotoxicity against human T98G cells assessed as growth inhibition,T98G,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,5.0,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL4163437,,COC(=O)C1=C(C)NC(C)=C(C(C)=O)C1c1ccc(N(CCCl)CCCl)cc1,IC50,4.62,CHEMBL4153065,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 3 days by MTT assay,U-87MG ATCC,SANFHZBUPNWPLF-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,6.54,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL504859,ZYGOSPORAMIDE,CC(C)C[C@@H]1NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)OC(=O)[C@H](Cc2ccccc2)NC1=O,IC50,5.38,CHEMBL986450,Cytotoxicity against human SF295 cells,SF295,CKEAPQMIPHEQRF-LVIOGHJBSA-N
CHEMBL2165016,,COc1ccc(Nc2ncc(CN3CCN(C(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.85,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,WNLWNUNVLRWGBW-UHFFFAOYSA-N
CHEMBL2165011,,COc1ccc(Nc2ncc(CN3CCC(O)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,6.46,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,PLZWKQZPZPLCFY-UHFFFAOYSA-N
CHEMBL3354443,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,6.09,CHEMBL3376032,Cytotoxicity against human SF295 cells assessed as growth inhibition after 72 hrs by MTT assay,SF295,LVHKHLZPRPTQJG-OKFZLHBCSA-N
CHEMBL2165039,,COc1ccc(Nc2ncccc2-c2nc(C)nc3nc[nH]c23)cn1,IC50,6.55,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,YXRVSHHKBCULEI-UHFFFAOYSA-N
CHEMBL2165051,,Cc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1,IC50,8.05,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,HQPMEVMEMPHSDM-UHFFFAOYSA-N
CHEMBL4745220,,CSc1cc2c(c3c1C[C@@](C)(O)CC3=O)C(=O)c1ccc([C@H]3CC[C@H](N(C)C)[C@H](C)O3)c(O)c1C2=O,IC50,5.1,CHEMBL4670045,Cytotoxicity against human U87 cells assessed as reduction in cell viability by SRB assay,U-87MG ATCC,ZBALKLFZSLAGHI-KUXCXQJKSA-N
CHEMBL83527,PTEROSTILBENE,COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1,IC50,4.47,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,VLEUZFDZJKSGMX-ONEGZZNKSA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,6.61,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,8.55,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL314455,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(C)/c2=N\Nc2ccccn2)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,VYPKYZTWZFRBOL-PNHLSOANSA-N
CHEMBL1090771,AVAGACESTAT,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1,IC50,4.21,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,XEAOPVUAMONVLA-QGZVFWFLSA-N
CHEMBL85989,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CCCC#N)c2=O)cc1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,QCKSYPIYXKRMJG-UHFFFAOYSA-N
CHEMBL553,ERLOTINIB,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,IC50,4.4,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AAKJLRGGTJKAMG-UHFFFAOYSA-N
CHEMBL392695,S-TRITYL-L-CYSTEINE,N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O,IC50,5.59,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,DLMYFMLKORXJPO-FQEVSTJZSA-N
CHEMBL300389,,OCCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1,IC50,6.88,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,IYNDTACKOAXKBJ-UHFFFAOYSA-N
CHEMBL514499,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,IC50,7.61,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,JSKUWFIZUALZLX-UHFFFAOYSA-N
CHEMBL2035490,,CC(=O)Oc1ccc2[se]n(CCn3[se]c4ccc(OC(C)=O)cc4c3=O)c(=O)c2c1,IC50,4.68,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,SDTYCQFRHHTONZ-UHFFFAOYSA-N
CHEMBL2035463,,O=c1c2ccccc2[se]n1CCCCCn1[se]c2ccccc2c1=O,IC50,5.22,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,OKIJKVDEYDUBKL-UHFFFAOYSA-N
CHEMBL2035460,ETHASELEN,O=c1c2ccccc2[se]n1CCn1[se]c2ccccc2c1=O,IC50,5.19,CHEMBL2039585,Growth inhibition of human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,SFFSGPCYJCMDJM-UHFFFAOYSA-N
CHEMBL2035489,,COc1ccc2[se]n(CCn3[se]c4ccc(OC)cc4c3=O)c(=O)c2c1,IC50,5.7,CHEMBL2039587,Inhibition of TrxR in human U87MG cells after 12 hrs by insulin-reducing method,U-87MG ATCC,MZMQMEKKARSJNG-UHFFFAOYSA-N
CHEMBL4218338,,O=c1c(-c2c(O)cc3c(c2O)C[C@@H](O)[C@@H](c2ccc(O)c(O)c2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.49,CHEMBL4187982,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,LVGLBFQVAZMOBH-ONOMSOESSA-N
CHEMBL4092551,,O=C(/C=C/c1ccc([N+](=O)[O-])s1)c1ccc(-n2ccnc2)cc1,EC50,5.0,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,OSONMWPTENINFH-FNORWQNLSA-N
CHEMBL4778320,,Cc1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.72,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,OHUPSIYNIKCTNE-CMDGGOBGSA-N
CHEMBL5432897,,COc1ccc(OC)c(COc2cc(NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc2NS(C)(=O)=O)c1,IC50,5.58,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,OBOCKVNQRVNBRB-UHFFFAOYSA-N
CHEMBL5423780,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C#N)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.54,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,JPLZYVWUANYAPB-UHFFFAOYSA-N
CHEMBL5402604,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(-c4ccccc4)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.34,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,NHMQMQATMQEBKF-UHFFFAOYSA-N
CHEMBL5427602,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccccc3C)ccc2NS(C)(=O)=O)c1,IC50,6.51,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,XEWMFCOWYNRNJR-UHFFFAOYSA-N
CHEMBL5413645,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(N)cc3)ccc2NS(C)(=O)=O)c1,IC50,5.44,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,PXQGWUYSXHQDIU-UHFFFAOYSA-N
CHEMBL4865341,,O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCNCC4)c3c2)cnc1Cl)c1ccccc1,IC50,6.23,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,QIWKQWGDKAHMQB-UHFFFAOYSA-N
CHEMBL244599,,CN(C)CCCN(C)c1cc(Oc2ccc(-n3ccnc3)cc2)nc(Cc2ccc3c(c2)OCO3)n1,IC50,6.66,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,GQYFOXVFQHETME-UHFFFAOYSA-N
CHEMBL243978,,c1cn(-c2ccc(Oc3nccc(Oc4ccc5c(c4)OCO5)n3)cc2)cn1,IC50,7.26,CHEMBL887582,Inhibition of iNOS in human A172 cells after 18 to 24 hrs,A-172,XPXGYINSBORUMM-UHFFFAOYSA-N
CHEMBL4166144,,COc1ncc(-c2cc(OC3CCOCC3)c3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.38,CHEMBL4150401,Cytotoxicity against human T98G cells after 96 hrs by MTT assay,T98G,FEHPMLVVSQNYOF-UHFFFAOYSA-N
CHEMBL4166594,,CNc1nc(C)c2cc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4F)c3)cc(OC3CCOCC3)c2n1,IC50,6.41,CHEMBL4150401,Cytotoxicity against human T98G cells after 96 hrs by MTT assay,T98G,IEDGFXCUFJCEAP-UHFFFAOYSA-N
CHEMBL4163035,,O=C1c2ccccc2C(=O)c2c(-c3ccccc3[N+](=O)[O-])coc21,IC50,5.53,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,NXARMQFGIYKUEY-UHFFFAOYSA-N
CHEMBL1614701,SELUMETINIB,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,IC50,4.86,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,CYOHGALHFOKKQC-UHFFFAOYSA-N
CHEMBL508617,,COc1ccc(C(=C(F)F)c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,9.52,CHEMBL4143254,Antiproliferative activity against human U87 cells after 72 hrs by resazurin-based fluorescence assay,U-87MG ATCC,MBCRBMZSBBOEIB-UHFFFAOYSA-N
CHEMBL2333165,WITHAWRIGHTOLIDE,C=C1C(=O)O[C@@H]2C[C@@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]45C[C@H]4CC(=O)[C@]5(C)[C@H]3CC[C@]12C,IC50,5.82,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,RWZUJIPMFKTTKN-LWNWQIFTSA-N
CHEMBL1771376,,COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(N)c2)c(OC)c1,IC50,8.52,CHEMBL2015273,Cytotoxicity against human U87 cells after 96 hrs by trypan blue exclusion assay,U-87MG ATCC,KUTAVMCJCVADGZ-BQYQJAHWSA-N
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,5.67,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,RITAVMQDGBJQJZ-FMIVXFBMSA-N
CHEMBL379975,,O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21,IC50,4.16,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,DPEXRCOBPACFOO-UHFFFAOYSA-N
CHEMBL191334,NUTLIN-3,COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,5.57,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,BDUHCSBCVGXTJM-WUFINQPMSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.46,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL4084062,,O=C(Nc1ccncc1)Nc1ccc(-c2cc(N3CCOCC3)c3nccn3n2)cc1,IC50,4.96,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,KNESBUDRMICDEI-UHFFFAOYSA-N
CHEMBL4070976,,O=C(Nc1ccc(-c2cc(N3CC4CCC(C3)O4)c3nccn3n2)cc1)Nc1cccnc1,IC50,5.24,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,PKCKCYAOLWSNMX-UHFFFAOYSA-N
CHEMBL4081558,,COc1ccc(NC(=O)Nc2ccc(-c3cc(N4CCOC[C@@H]4C)c4nccn4n3)cc2)cc1,IC50,5.1,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,RXSGPQOOGWNRGY-KRWDZBQOSA-N
CHEMBL2172633,,Cc1nc(Nc2ccc(N3CCOCC3)nn2)cc(-c2c(Nc3cc[nH]n3)nc3cccnn23)n1,IC50,6.51,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,RWELDMOWSUFXDT-UHFFFAOYSA-N
CHEMBL259225,,COc1ccc(Cn2nnc3c2C(=O)c2cnncc2C3=O)cc1,IC50,6.93,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,ZPZNNDFWFGCXMR-UHFFFAOYSA-N
CHEMBL3884598,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccccc1OC,IC50,4.94,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FOLXSMCHLAVLAD-UHFFFAOYSA-N
CHEMBL3884559,,Cc1ccc(-c2cc3nc4ccccc4nc3c(=O)n2-c2ccccc2)cc1,IC50,4.62,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XWIGUVUPWOQXQA-UHFFFAOYSA-N
CHEMBL3885039,,CCOC(=O)c1nc2ccccc2nc1C#Cc1ccc(C)cc1,IC50,5.48,CHEMBL3875895,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CHWYXVGWFPJTPQ-UHFFFAOYSA-N
CHEMBL1812545,,Fc1ccc2c(/C=C/c3nnn[nH]3)c[nH]c2c1,IC50,6.17,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,JDBSZVDIUIRSDG-DAFODLJHSA-N
CHEMBL2088458,,CC(C)(O)c1cc2nc(N/N=C/c3cn(Cc4cccc(Cl)c4)c4ccccc34)nc(N3CCOCC3)c2s1,IC50,5.05,CHEMBL2090861,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FDAFULHOWNERPN-WCMJOSRZSA-N
CHEMBL233930,ASTRAGALIN,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,5.51,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,JPUKWEQWGBDDQB-QSOFNFLRSA-N
CHEMBL4779081,,CC(C)(C)n1nc(-c2c[nH]c3ccccc23)c2c(N)ncnc21,IC50,4.41,CHEMBL4774321,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell automated imaging analysis,LN-229,RBZLXANOQRQGTN-UHFFFAOYSA-N
CHEMBL4208931,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(Br)cc4)c3=O)cc2)ccn1,IC50,4.82,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,PCHIOMPKEXUBIZ-UHFFFAOYSA-N
CHEMBL4214315,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4F)c3=O)cc2)ccn1,IC50,5.63,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MJHSGZFYJYAKDV-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.87,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL4798199,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCCCCCO)C(=O)C=C(NCCCCCCO)C1=O)OC,IC50,4.94,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CCUXIDYESZWAMT-PHPNYCJASA-N
CHEMBL4098626,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CN)cc2)nnc1Cl,IC50,5.62,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,MUHNVADDYLCREH-UHFFFAOYSA-N
CHEMBL4097578,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)nnc1Cl,IC50,5.82,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,NVINUJFUNDNKJI-UHFFFAOYSA-N
CHEMBL5432925,,O=C(Nc1ccc(OS(=O)(=O)c2ccc(F)cc2)cc1)C12CC3CC(CC(C3)C1)C2,IC50,5.71,CHEMBL5332778,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition,SNB-75,LLXLLGJJXOHBLG-UHFFFAOYSA-N
CHEMBL5175805,,Cc1c2ccncc2c(C(=O)NCc2ccccc2)c2c1[nH]c1ccccc12,IC50,5.77,CHEMBL5127175,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,OOOWESDITGBKBN-UHFFFAOYSA-N
CHEMBL5401830,,COc1cc2c(cc1OC)C(=O)C(CC1CCN(C(=O)CCCCCC(=O)NO)CC1)C2,IC50,4.37,CHEMBL5326097,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,YCICPHILAFCEKI-UHFFFAOYSA-N
CHEMBL4228422,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)C1CC1,IC50,5.19,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,VTEMJWZRTCUZNF-UHFFFAOYSA-N
CHEMBL3092912,,C=CCCCCOc1ccccc1-c1cnc(NC(=O)CCCC=C)n1C,IC50,4.66,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,YFIUCUWRXAOMPG-UHFFFAOYSA-N
CHEMBL3092919,,C=CCCCCOc1ccccc1-c1cnc(OCCOCC=C)n1C,IC50,4.19,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CMRMWVVBROHLFE-UHFFFAOYSA-N
CHEMBL3092929,,COc1ccccc1-c1cnc(OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)n1C,IC50,4.11,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,GQWJGHLDGVKVAR-UHFFFAOYSA-N
CHEMBL3093015,,C=CCCCCOc1ccccc1-c1cnc(OCCCC=C)n1C,IC50,5.52,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,QNRREQOEGKSYOM-UHFFFAOYSA-N
CHEMBL3093022,,Cn1c2cnc1OCCCCCCCCCCCOc1ccccc1-2,IC50,4.25,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DGYHEGRMGGZWCS-UHFFFAOYSA-N
CHEMBL3093023,,Cn1c2cnc1OCCCCCCCCCCOc1ccccc1-2,IC50,4.39,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,JYDKAGFAKVIWKO-UHFFFAOYSA-N
CHEMBL4086949,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(-c4ccco4)cc3n2)C[C@H](C)O1,IC50,4.89,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,MFZWCDCACTYPKX-OKILXGFUSA-N
CHEMBL4447343,,CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CNC(=O)Nc3ccc(Cl)cc3)CCC[C@]21C,IC50,4.67,CHEMBL4415221,Cytotoxicity activity against human T98G cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,T98G,BBKLOKKZPCGLMA-DOEKTCAHSA-N
CHEMBL4226602,,COc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(Cl)s1,IC50,5.09,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,JBLPKNBKTJTXEH-UHFFFAOYSA-N
CHEMBL1160723,LEVISOPRENALINE,CC(C)NC[C@H](O)c1ccc(O)c(O)c1,IC50,10.3,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,JWZZKOKVBUJMES-NSHDSACASA-N
CHEMBL229476,,C[C@@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.21,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-GTNSWQLSSA-N
CHEMBL228417,,COc1ccc(C[C@H](C)NC[C@@H](O)c2cc(O)cc(O)c2)cc1,IC50,6.47,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-KPZWWZAWSA-N
CHEMBL155625,INDOLE-3-CARBINOL,OCc1c[nH]c2ccccc12,EC50,3.54,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,IVYPNXXAYMYVSP-UHFFFAOYSA-N
CHEMBL5412369,,O=C1C=C(Sc2ccc(F)cc2)C(=O)c2c(O)cccc21,IC50,4.76,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,BLOAEHAYJXOIAI-UHFFFAOYSA-N
CHEMBL5408166,,CC(=O)OC[C@H]1O[C@@H](SC2=C(c3ccc(O)cc3O)C(=O)c3c(O)cccc3C2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O,IC50,5.13,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,LTEBXJABOGQTMD-PLOQDKEESA-N
CHEMBL5410666,,COc1ccc([C@H]2[C@H](COC(=O)c3ccc(C(=O)NO)cc3)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,7.25,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,YONFXCGSVGYJHD-CYFREDJKSA-N
CHEMBL866,MYCOPHENOLIC ACID,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,IC50,4.97,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,HPNSFSBZBAHARI-RUDMXATFSA-N
CHEMBL4278234,,O=C(COc1ccc(C(=O)/C=C/c2c(F)cccc2F)cc1)Nc1ccc2c(c1)COC2=O,IC50,5.43,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,BDIHMOMPFWOHNY-ZHACJKMWSA-N
CHEMBL4287065,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)c2cn(Cc3ccc(OC)c(OC)c3)nn2)cc1,IC50,6.01,CHEMBL4271208,Cytotoxicity in human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,HPNCRJJSTODGJI-UHFFFAOYSA-N
CHEMBL4461409,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCC4OCCO4)CC3)cc2)ncc1Cl,IC50,5.56,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,XCMKUMJDPLUMEU-UHFFFAOYSA-N
CHEMBL4061268,,CN1CCN(c2ccc(NC(=O)Nc3ccc(-c4cc(N5CCOCC5)c5nccn5n4)cc3)cc2)CC1,IC50,5.31,CHEMBL4009784,Antiproliferative activity against human U87 cells after 72 hrs by SRB assay,U-87MG ATCC,VWMSFHKLLJFBIQ-UHFFFAOYSA-N
CHEMBL3545369,EPACADOSTAT,NS(=O)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1,IC50,6.58,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,FBKMWOJEPMPVTQ-UHFFFAOYSA-N
CHEMBL4567542,,O=C(/C=C/c1ccc(Br)cc1)c1cccc(O)c1,IC50,4.17,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,IIRXFNIZXUTCQA-RMKNXTFCSA-N
CHEMBL4567542,,O=C(/C=C/c1ccc(Br)cc1)c1cccc(O)c1,IC50,4.12,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,IIRXFNIZXUTCQA-RMKNXTFCSA-N
CHEMBL4472710,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(CO)c(Br)c2)c1,IC50,4.87,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,LFVVIVJGWWBLKR-VMPITWQZSA-N
CHEMBL4459634,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)cc2)cc1,IC50,4.82,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,RACOPDZWMOVJGX-BJMVGYQFSA-N
CHEMBL4449607,,N#Cc1cccc(/C=C/C(=O)c2ccc(O)c(F)c2)c1,IC50,4.54,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,OMUNGWCVIFBULF-GQCTYLIASA-N
CHEMBL4519381,,N#Cc1cccc(/C=C/C(=O)c2ccc(F)c(O)c2)c1,IC50,4.64,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,WHPARJMPPFCLBF-QPJJXVBHSA-N
CHEMBL4440711,,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)[O-])CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@H](n3cc(-c4ccc(-c5ccccc5)cc4)nn3)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C.[Na+],IC50,4.3,CHEMBL4316859,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,LHHMPPIBBXYZGO-IKKRBILRSA-M
CHEMBL4748252,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccc(Cl)cc4)nc3C)[nH]c(=O)c2C#N)cc1OC,IC50,4.41,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,GBCHSGFNRBCWDX-UHFFFAOYSA-N
CHEMBL4440874,,O=C(/C=C/c1ccccc1)Nc1cc2c(Nc3cc(Cl)cc(Cl)c3)ncnc2s1,IC50,5.35,CHEMBL4376496,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,GDAAOODIQQYYCC-VOTSOKGWSA-N
CHEMBL4778942,,C=CCc1cc(C(C)=O)ccc1OCC=C(C)C,IC50,4.89,CHEMBL4724747,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay,U-87MG ATCC,KOLRKUQANUTCKQ-UHFFFAOYSA-N
CHEMBL5287303,,NCCCC[C@@H](N)C(=O)N[C@H](CCCCN)C(=O)NC(Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCCN)C(N)=O,IC50,4.77,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,NEIQYEKCZHGMGF-MHJXGLRJSA-N
CHEMBL5267172,,NCCCC[C@H](NC(=O)C(NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(c1ccccc1)c1ccccc1)C(N)=O,IC50,5.18,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,GGAKLYWEFZCVIT-NIEMNNIISA-N
CHEMBL4290833,,Cc1ccc(C(=O)c2ccc3c(c2)c2ccccc2n3CC(F)(F)F)c2ccccc12,EC50,5.25,CHEMBL4268949,Cytotoxicity against human T98G cells after 72 hrs by WST-1 assay,T98G,QGCINUSCAQKZRG-UHFFFAOYSA-N
CHEMBL5283305,,CCOC(=O)/C(C(C)=O)=C1/SC=C(n2c(CC#N)nc3ccccc32)N1c1ccccc1,IC50,6.64,CHEMBL5245308,Cytotoxicity against human U-87 MG cells,U-87MG ATCC,XZZVSFBNJPKMJR-GHVJWSGMSA-N
CHEMBL4286146,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccc(C(F)(F)F)cc2Cl)c1=O,IC50,5.22,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UWVXKIKCLHNUQR-UHFFFAOYSA-N
CHEMBL4280638,,C#CCOc1ccc(-c2noc(-c3nnn(-c4cccc(/C(C)=N/O)c4)c3N)n2)cc1,IC50,5.48,CHEMBL4256905,Cytotoxicity against human U87 cells after 72 hrs by XTT assay,U-87MG ATCC,IGQKYFPXTAJJLB-DHRITJCHSA-N
CHEMBL4851018,,c1ccc(Sc2c(-c3ccccc3)nc3sc4ccccc4n23)cc1,IC50,4.2,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,AIAIWRCHFPGNSP-UHFFFAOYSA-N
CHEMBL4868424,,CCc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.21,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,CHMJSPHPRHGXBC-UHFFFAOYSA-N
CHEMBL4791605,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccc(Cl)c(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.08,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,PPUFOBOWJQAPEP-UHFFFAOYSA-N
CHEMBL4761565,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)nc(N)c2C#N)cc1,IC50,4.85,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,NPQVWIBTCGJRNL-UHFFFAOYSA-N
CHEMBL178907,,O=[N+]([O-])c1ccc(-c2nc(O)c3c4c(sc3n2)CCCC4)cc1,IC50,4.36,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,XTPPTIANZNOWLE-UHFFFAOYSA-N
CHEMBL360687,,Oc1nc(-c2ccc(Cl)cc2)nc2sc3c(c12)CCCC3,IC50,4.47,CHEMBL4132132,Antiproliferative activity against human LN229 cells after 72 hrs by MTT assay,LN-229,JANUPDZTKCXNTJ-UHFFFAOYSA-N
CHEMBL4777260,,C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O,IC50,6.89,CHEMBL4704568,Cytotoxicity against human A172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,HTADFAXGWGDWNE-UHFFFAOYSA-N
CHEMBL5421446,,CN(C)C1CCN(CC#Cc2nn(C3CCCCC3)c3nc(NC(C)(C)C)ncc23)C1,EC50,5.57,CHEMBL5330903,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by PrestoBlue reagent based fluorescence assay,U-87MG ATCC,UBZCQXOPUDLSQV-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.39,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4284568,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1ccc2ncccc2c1)c1ccccc1,IC50,5.89,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,DYQOTLNYCHIRDN-BHDDXSALSA-N
CHEMBL4286859,,CCOC(=O)C[n+]1cccc2cc(OP(=O)([O-])OC[C@H]3O[C@@H](n4cc(F)c(=O)[nH]c4=O)C[C@@H]3OC(=O)c3ccccc3)ccc21,IC50,4.89,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,PTGXRXANBUIEOI-ISJGIBHGSA-N
CHEMBL4289951,,C[N+]1(Cc2ccccc2)C2CCC1CC(OP(=O)([O-])OC[C@H]1O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]1OC(=O)c1ccccc1)C2,IC50,4.3,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,AUYPZBNHPQGOKM-ICBLKLOPSA-N
CHEMBL4286524,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3cccnc3)O2)cc1F,IC50,5.92,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,RRRLTAROEKGADT-QJPTWQEYSA-N
CHEMBL2172485,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncnc4)cn23)n1,IC50,7.03,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,VLUBDPDZETYNRC-UHFFFAOYSA-N
CHEMBL2172636,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cccnc4)cn23)n1,IC50,7.0,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,TVEHRMCNBMAAEH-UHFFFAOYSA-N
CHEMBL2172637,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccccn23)n1,IC50,7.72,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,OEQWYIZFUDGMEW-UHFFFAOYSA-N
CHEMBL4291998,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccc(/C=C/C(=O)/C=C/c4ccccn4)cc3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,5.33,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,CPTQMCWMTHOBAE-XQYSVVAESA-N
CHEMBL4286248,,COc1cc(OC)c2c(=O)c(OCCCCOc3ccccc3/C=C/C(=O)/C=C/c3ccco3)c(-c3cc(OC)c(OC)c(OC)c3)oc2c1,IC50,4.97,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,DDYCHWQCWXIEPN-JLXBFWJWSA-N
CHEMBL200215,,COc1ccc(C(=O)Nc2ccc(CNc3ccc(-c4nc5ccccc5[nH]4)cc3)cc2)cc1Br,IC50,5.57,CHEMBL4326337,Antiproliferative activity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,ZXCHHWOWYQRGIU-UHFFFAOYSA-N
CHEMBL4576477,,COc1ccc(C(=O)Nc2ccc(CNc3ccc(-c4nc5ccccc5[nH]4)cc3F)cc2)cc1Br,IC50,5.55,CHEMBL4326337,Antiproliferative activity against human U87MG cells after 3 days by SRB assay,U-87MG ATCC,WMVLPLMOADXKBC-UHFFFAOYSA-N
CHEMBL5517720,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)COc4cccnc4)cc3)cc2)n1,IC50,5.99,CHEMBL5509849,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,KRQSJWTXUQGYKQ-KDYSTLNUSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,5.98,CHEMBL5509852,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL5517720,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)COc4cccnc4)cc3)cc2)n1,IC50,5.78,CHEMBL5509852,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,KRQSJWTXUQGYKQ-KDYSTLNUSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,5.6,CHEMBL5509856,Synergistic antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs in presence of AG-120 by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,6.35,CHEMBL5509858,Synergistic antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs in presence of FK866 by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL5082180,,CCn1c(CO)cc2cc(N(C)c3nc(C)nc4ccccc34)ccc21,IC50,9.29,CHEMBL5056082,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CellTiter-Glo reagent based luminescence assay,U-87MG ATCC,FDENVCDRDMNEBW-UHFFFAOYSA-N
CHEMBL3408446,,Cc1cccc2c(=O)c3c(NCc4ccncc4)ccc(C(=O)NCCN(C)C)c3[nH]c12,IC50,5.66,CHEMBL3414073,Antiproliferative activity against human A172 cells after 48 hrs by MTT assay,A-172,XLGUMPXXUZHRQM-UHFFFAOYSA-N
CHEMBL3763377,,CCOc1ccc(/C(=C\c2cc(OC)c(OC)c(OC)c2)C(=O)N2CCC=CC2=O)cc1,IC50,5.99,CHEMBL3767864,Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay,T98G,AUFHQHMUSWKDHR-XSFVSMFZSA-N
CHEMBL3618233,,COc1ncc(Nc2nc3ccccn3c2-c2nc(C)nc(N)n2)cc1F,IC50,7.07,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,JYIYDFDRQAREDE-UHFFFAOYSA-N
CHEMBL3618237,,Cc1nc(N)nc(-c2c(Nc3cccc4[nH]ncc34)nc3ccccn23)n1,IC50,7.5,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,VJDWLNYNYCCEMY-UHFFFAOYSA-N
CHEMBL3618238,,COc1ncc(Nc2nc3ccc(N4CCNCC4)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,7.39,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,QRUFDISOBAPRHT-UHFFFAOYSA-N
CHEMBL3810134,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4cccnc4)n3)ccc21,IC50,4.83,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,ARKIBANBPWEQHQ-LPYMAVHISA-N
CHEMBL4788336,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)N/N=C/c2cccc(O)c2)cc1,IC50,4.89,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,LUSNWRGCSGDUFN-CCVNUDIWSA-N
CHEMBL4798707,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)N/N=C/c2ccccn2)cc1,IC50,4.66,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,HTRWIOXPFBBBCH-CCVNUDIWSA-N
CHEMBL4790096,,CC1=C[C@@]2(C)[C@@H]3C(=O)[C@]4(C[C@@H]2O)C[C@@](O)(Cc2ccc(cc2)O[C@H]2[C@H]3[C@@H]1[C@]1(C)C[C@H](C)C[C@H](C)[C@@H]21)NC4=O,IC50,4.91,CHEMBL4739244,Antiproliferative activity against human U-87MG cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay,U-87MG ATCC,OZCVEXIHCIYUCZ-JJTBKSGYSA-N
CHEMBL4792993,,CCOP(=O)(OCC)C(O)c1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1,IC50,5.71,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,INDQJKBAPRKZIB-UHFFFAOYSA-N
CHEMBL4786939,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(C)c3)nc12,IC50,6.34,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,ASCPVWGAFCCXHP-UHFFFAOYSA-N
CHEMBL4776781,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C(C)(C)C)nc12,IC50,7.31,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,QCXLRAYMDUWMRT-UHFFFAOYSA-N
CHEMBL4780277,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCC(N(C)C)C4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.27,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,JVMPHSVTHWBZJL-UHFFFAOYSA-N
CHEMBL4794123,,CNCCN1CCc2nc(Nc3ncc4c(C)c(C(C)=O)c5nc(C(C)C)cn5c4n3)ccc2C1,IC50,6.73,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,ZDIWOUQHEGENJG-UHFFFAOYSA-N
CHEMBL2103835,,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@@H](NC)C(C)C)C(C)C,EC50,9.7,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,DASWEROEPLKSEI-UIJRFTGLSA-N
CHEMBL4168005,,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(/C=C/c2ccc(O)c(O)c2)cc1O,EC50,7.6,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,RNBVIZOPZQHBFX-OKGMQGNASA-N
CHEMBL4159671,,C/C(=C\Cc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)[C@@H](O)C3)cc(O)c1O)CCC(O)C(C)(C)O,EC50,6.3,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,OZSHINGQPPSWDW-JADAMXTKSA-N
CHEMBL4166907,,CC(C)=CCC[C@]1(C)Oc2c(O)cc(/C=C/c3cc(O)c4c(c3)OC(C)(C)C(O)C4)cc2C[C@@H]1O,EC50,6.35,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,QJSWIQFERWNYJM-XHPROGOUSA-N
CHEMBL223142,SCHWEINFURTHIN G,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)CC[C@@]2(C)O3)cc1O,EC50,7.35,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,CGJIPMVTBQUUQL-GEDZTWKOSA-N
CHEMBL388570,,C[C@H](Cc1ccc(O)cc1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,9.85,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-DIFFPNOSSA-N
CHEMBL4099583,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,6.81,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,HNJSJKVDJXKHBF-BLMIFYICSA-N
CHEMBL4080633,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)OCCOCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.62,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,KWNJEIUCZHXCQH-HKIQETCMSA-N
CHEMBL4096223,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCNC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.24,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,FZQGJDNLXMYXQU-DZLLRAINSA-N
CHEMBL4086970,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@@H](NC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)[C@@H](C)CC)C[C@H]1C(=C)C,IC50,8.0,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,LNMLOIVELKGFHO-KODPKBOBSA-N
CHEMBL4079118,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)[C@@H]2CCCN2C(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,7.26,CHEMBL4054365,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,ZKEOIBRIAYPMIV-RRXKMURMSA-N
CHEMBL4170303,,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c(O)c(C/C=C(\C)CCC(O)C(C)(C)O)c2)cc1O,EC50,7.0,CHEMBL4134627,Antiproliferative activity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,VYHNYBOVGSSVMH-FPZVNABHSA-N
CHEMBL3357148,,C=C[C@@](C)(O)CC/C=C(\C)C(=O)OC[C@H]1O[C@@H](OC(=O)[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](CO[C@@H]7OC[C@H](O)[C@H](O)[C@H]7O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]2(C)CC3)[C@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O[C@@H]4OC[C@@H](O)[C@H](O)[C@H]4O)[C@H]3O)[C@@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,IC50,4.83,CHEMBL3385800,Inhibition of cell proliferation of human U87MG cells assessed as cell viability after 72 hrs by sulforhodamine B assay,U-87MG ATCC,PSWTYKAGISJRNR-YRGLWYEXSA-N
CHEMBL4283509,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)([O-])Oc1ccc[n+](Cc2ccccc2)c1)c1ccccc1,IC50,6.18,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,FGHKFVXFDAGVOZ-ISJGIBHGSA-N
CHEMBL422,TRIFLUOPERAZINE,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,EC50,4.87,CHEMBL4232380,Induction of intracellular Ca2+ level in human U87MG cells by Fura-2 AM dye-based assay,U-87MG ATCC,ZEWQUBUPAILYHI-UHFFFAOYSA-N
CHEMBL4536596,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccc(Cl)cc3s2)cc1,IC50,5.06,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,FPDGSJOUIPJMFW-UHFFFAOYSA-N
CHEMBL1834956,,O=C(O)c1cc(/C=C/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,IC50,4.16,CHEMBL1838227,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,U-87MG ATCC,UAHMKJJFOGZIDP-SNAWJCMRSA-N
CHEMBL1821795,EUPHODENDROPHANE E,C=C1[C@@H](OC(=O)C(C)C)[C@@H](OC(=O)c2ccccc2)[C@@H](OC(C)=O)C(C)(C)/C=C/[C@@H](C)C(=O)[C@@]2(O)C[C@H](C)[C@H](OC(=O)CC)[C@@H]2[C@H]1OC(C)=O,IC50,4.14,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,AJDFLYUZLBJRGW-FFGYUFPDSA-N
CHEMBL422,TRIFLUOPERAZINE,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,IC50,5.0,CHEMBL4232384,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 24 hrs by MTT assay,U-87MG ATCC,ZEWQUBUPAILYHI-UHFFFAOYSA-N
CHEMBL4452177,,Cc1ccc(C(=O)/C=C/C(=O)N(C2CC2)C(C(=O)NCc2ccccc2)c2ncc(C)cn2)cc1,IC50,4.82,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,ZMLWDTSYBVZHLZ-CCEZHUSRSA-N
CHEMBL4764175,,C/C(=C\CC/C(C)=C/CC[C@@H]1[C@@]2(C)CCC(=O)C(C)(C)[C@H]2CC[C@@]1(C)O)CC/C=C(\C)C(=O)OCc1cn(-c2cccc(Cl)c2)nn1,IC50,4.04,CHEMBL4682994,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,RCPXKGSMTTWSML-MJZBXAEKSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.23,CHEMBL4682994,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4284206,,COc1ccc(C(=O)Nc2ccc(CNc3ccc(-c4nc5cc(CC(=O)O)ccc5[nH]4)cc3F)cc2)cc1Br,IC50,5.55,CHEMBL4265452,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,GFYVINPXBSVXAR-UHFFFAOYSA-N
CHEMBL4284717,,C(=C/c1ccc(OCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,6.19,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,IBFRVLYRRRNWFE-XMXXDQCKSA-M
CHEMBL2392953,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.67,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AXUCCAZTQZZNLL-UHFFFAOYSA-N
CHEMBL2392961,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.94,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,GQFDQOGJNMXMEO-UHFFFAOYSA-N
CHEMBL535,SUNITINIB,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,IC50,5.51,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,WINHZLLDWRZWRT-ATVHPVEESA-N
CHEMBL217092,SARACATINIB,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,IC50,5.48,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,OUKYUETWWIPKQR-UHFFFAOYSA-N
CHEMBL3989596,LEURUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)[C@@H](N)CC(C)C)[C@H](O)[C@H](C)O1,IC50,6.22,CHEMBL4015761,Cytotoxicity against human U87MG cells treated with MJ02 assessed as reduction in cell survival after 96 hrs by MTT assay,U-87MG ATCC,HROXIDVVXKDCBD-ZUWKMVCBSA-N
CHEMBL388978,STAUROSPORINE,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,7.7,CHEMBL4618024,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth,U-87MG ATCC,HKSZLNNOFSGOKW-FYTWVXJKSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.1,CHEMBL4619138,Cytotoxicity against human SF295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL3800481,,CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,PSICWGWNIOOULV-UHFFFAOYSA-N
CHEMBL3797590,,Nc1nc2cc(-c3nn(CC4OCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,JSPBEUDGGZHEMZ-UHFFFAOYSA-N
CHEMBL4476042,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCOC)CC3)cc2)ncc1Cl,IC50,6.21,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,VHBOBXDEBONQMT-UHFFFAOYSA-N
CHEMBL4785582,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12,IC50,6.8,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,NHLMMNCVSWYEIL-UHFFFAOYSA-N
CHEMBL5283179,,CCC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,IC50,5.57,CHEMBL5445637,"Affinity Phenotypic Cellular interaction: (ProQinase broad tumor cell line profiling (CellTiterGlo assay, antiproliferative activity in brain, A172,cancer cell line)) EUB0001183a CSNK2A2",A-172,YKDZIFFKQUNVHH-UHFFFAOYSA-N
CHEMBL500508,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5cccc([N+](=O)[O-])c5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.38,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,UJTDZRSLKUKGDS-GVQBMFDGSA-N
CHEMBL500078,,COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3cc(CNc5ccc(C)cc5)nn3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.22,CHEMBL994927,Cytotoxicity against human SF295 cells by sulforhodamine B assay,SF295,ZNQZXZRYMXGUNT-ALMBTRMVSA-N
CHEMBL4639289,,CC[C@H]1CCC[C@H](OC(=O)CCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[I-],IC50,5.57,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,MZXDWPDPYCBCEL-JMIXZKEHSA-M
CHEMBL1928600,,COc1cc(C=O)cc2c1O[C@@H]1C3=C(OC[C@H]21)C(=O)c1ccccc1C3=O,IC50,5.13,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,BSPXWCBZAVVIAU-VLIAUNLRSA-N
CHEMBL235934,CLAUSINE E,COC(=O)c1cc(O)c2[nH]c3ccccc3c2c1,IC50,4.14,CHEMBL1930776,Growth inhibition human T98G cells after 48 hrs by WST-8 based CCK8 assay,T98G,ZWPODTIRGFOENJ-UHFFFAOYSA-N
CHEMBL599619,PTEROCARPANQUINONE,O=C1C2=C(C(=O)c3ccccc31)[C@H]1Oc3ccccc3[C@H]1CO2,IC50,5.44,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,BUEHOQICFGQBNY-ACJLOTCBSA-N
CHEMBL1914736,,O=S(=O)(Nc1cc(-c2ccc3ncc(NCCN4CCOCC4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,7.36,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,DDYGLALBILACTA-UHFFFAOYSA-N
CHEMBL554,LAPATINIB,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,4.93,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,BCFGMOOMADDAQU-UHFFFAOYSA-N
CHEMBL220241,GSK-269962A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,IC50,5.05,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,YOVNFNXUCOWYSG-UHFFFAOYSA-N
CHEMBL11359,CISPLATIN,,IC50,4.69,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,4.49,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,6.56,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL222102,KU-55933,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,IC50,4.06,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,XRKYMMUGXMWDAO-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,6.84,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL4125819,,C=Cc1ccc(OC(=O)c2ccc(O)c(N)c2SC[C@@H](NC(C)=O)C(=O)O)cc1,IC50,5.66,CHEMBL4119405,Cytotoxicity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,JHYFUEHJYLZHTG-OAHLLOKOSA-N
CHEMBL3927740,,CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)NCCCCCCNC(=O)c1ccc(SC2=C(/C=C/C4=[N+](CCCCS(=O)(=O)[O-])c5ccc6ccccc6c5C4(C)C)CCC/C2=C\C=C2\N(CCCCS(=O)(=O)O)c4ccc5ccccc5c4C2(C)C)cc1)[C@@H]3C,EC50,6.23,CHEMBL3867247,Phototoxicity against human U87 cells assessed as reduction in cell viability preincubated for 24 hrs with subsequent irradiation 4 J/cm2 followed by 48 hrs incubation in dark by MTT assay,U-87MG ATCC,JDJLAIIQEOSLBN-RPWWTVJQSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,5.25,CHEMBL3806952,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.86,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL259181,,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,IC50,5.21,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,DOKZLKDGUQWMSX-HKBQPEDESA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.43,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL135561,,COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1,IC50,5.25,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,GKFPROVOIQKYTO-UZLBHIALSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,9.6,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.01,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,8.72,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL255863,NILOTINIB,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,IC50,4.59,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,HHZIURLSWUIHRB-UHFFFAOYSA-N
CHEMBL1807805,,CC[C@H](N)C(=O)N1CCc2c(C)c3c(n2-c2ccc(C(N)=O)c(c2)N[C@@H](C)[C@H](C)C1)CC(C)(C)CC3=O,IC50,7.35,CHEMBL1810580,Antiproliferative activity against human U87MG cells,U-87MG ATCC,POLHEQGIVQDPGA-MMOPVJDHSA-N
CHEMBL1668099,CORNUSALTERIN F,CC(C)CCC[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C=CC(=O)[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.61,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,SRZGQWOHBSWCAT-MHNWUIROSA-N
CHEMBL1668104,CORNUSALTERIN K,CC(C)CCC[C@H](C)[C@@H]1CC[C@]2(C)[C@@H]3CC=C4C(C)(C)C(=O)C[C@@H](O)[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.92,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,FEAAYJYTVFABGY-UHNHVWPPSA-N
CHEMBL1668107,(-)-LEUCOPHYLLONE,COC(C)(C)/C=C/C[C@H](C)[C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)[C@H]3CC[C@@]12C,IC50,4.74,CHEMBL1669908,Cytotoxicity against human XF498 cells by SRB assay,XF 498,VUTMJNYAUWPTQA-ZLEOEWCPSA-N
CHEMBL5220621,,COc1cc(OC)cc(-c2ncccc2CNc2ccc(C)cc2)c1,IC50,4.7,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,PJVCDFODASFIKH-UHFFFAOYSA-N
CHEMBL4743394,,CC1=C[C@]2(C)C(=O)C[C@]34C[C@](O)(Cc5ccc(cc5)O[C@H]5[C@@H]([C@@H]1[C@]1(C)C[C@H](C)C[C@H](C)[C@@H]51)[C@H]2C3=O)NC4=O,IC50,5.97,CHEMBL4739244,Antiproliferative activity against human U-87MG cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay,U-87MG ATCC,DJXHULBSNKVOCR-DDIFOEQUSA-N
CHEMBL3765646,,COc1cc(Cn2cc(CN3C(=O)c4ccccc4Nc4ccccc43)nn2)cc(OC)c1OC,IC50,5.75,CHEMBL3768108,Cytotoxicity against human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FTKQQUWXZIHXIO-UHFFFAOYSA-N
CHEMBL3600443,,COc1ncc(-c2ccc3nc(NC(=O)N4CCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.77,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BXDIIOOGLWXHIE-UHFFFAOYSA-N
CHEMBL3601921,,CNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,6.19,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MAJONJHMOFHAJV-UHFFFAOYSA-N
CHEMBL3601927,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCN(C)CC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,6.12,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ITSUIVIXCNLTDI-UHFFFAOYSA-N
CHEMBL3601928,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.95,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KZBQWFCDLBEVOS-UHFFFAOYSA-N
CHEMBL3601929,,COc1ncc(-c2ccc3nc(NC(=O)NCCN4CCCCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.97,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MZVYOYMCEXRORF-UHFFFAOYSA-N
CHEMBL3600436,,CCN(CC)CCNC(=O)Nc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2n1,IC50,6.12,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DHJDUPOSBIQOLR-UHFFFAOYSA-N
CHEMBL419735,,CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1,IC50,8.85,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,DLDMOIDCLHDMPT-URGPHPNLSA-N
CHEMBL5093864,,COc1ccc(Cn2cc(CNC(=O)[C@]3(C)CC[C@]4(C)CC[C@]5(C)C6=CC=C7C(=CC(=O)C(O)=C7C)[C@]6(C)CC[C@@]5(C)[C@@H]4C3)nn2)cc1,IC50,5.5,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,VYZSZIMIQTZEEB-MPOPNXFASA-N
CHEMBL5093902,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.7,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,VDNKOXGKXPTVCH-BDFBTMKGSA-N
CHEMBL5093864,,COc1ccc(Cn2cc(CNC(=O)[C@]3(C)CC[C@]4(C)CC[C@]5(C)C6=CC=C7C(=CC(=O)C(O)=C7C)[C@]6(C)CC[C@@]5(C)[C@@H]4C3)nn2)cc1,IC50,5.84,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,VYZSZIMIQTZEEB-MPOPNXFASA-N
CHEMBL5076793,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Br)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.38,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ZWTPPPFBFCVMIN-SMRIDXHDSA-N
CHEMBL4226926,,COc1ncc(-c2nc3c(C)nc(N)nc3n(C)c2=O)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.2,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,VABHZMQJUZDGNK-UHFFFAOYSA-N
CHEMBL4294765,,C[N+](C)(C)CCOP(=O)([O-])OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1OC(=O)c1ccccc1,IC50,4.61,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,WBJKHKYBIKTDKR-RCCFBDPRSA-N
CHEMBL4289951,,C[N+]1(Cc2ccccc2)C2CCC1CC(OP(=O)([O-])OC[C@H]1O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]1OC(=O)c1ccccc1)C2,IC50,4.44,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,AUYPZBNHPQGOKM-ICBLKLOPSA-N
CHEMBL4538710,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCC#N)CC3)cc2)ncc1Cl,IC50,5.76,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,AKGPHMOJVOKNTN-UHFFFAOYSA-N
CHEMBL4445960,,CCOC(=O)CSC(=S)N1CCN(C(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)CC1,IC50,5.12,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,WWBCEBIYRDVNAY-UHFFFAOYSA-N
CHEMBL4437276,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCOCC4)CC3)cc2)ncc1Cl,IC50,6.33,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,HDKDGZQXCIWANT-UHFFFAOYSA-N
CHEMBL3805804,,COc1ccc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)cc1,IC50,5.6,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,CHIVYXWZAIGRIN-NXVVXOECSA-N
CHEMBL3805926,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)/C=C\Nc2ccc(O)cc2)cc1,IC50,5.43,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,RONBAJUFIMRMAK-NXVVXOECSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,5.44,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL4174791,,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccc(OCCN(CCCl)CCCl)cc1,IC50,4.62,CHEMBL4153065,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 3 days by MTT assay,U-87MG ATCC,MHFKYSJXUZHRBE-UHFFFAOYSA-N
CHEMBL4463158,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCO)CC3)cc2)ncc1Cl,IC50,6.15,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,MFQXRBCDXYFWMG-UHFFFAOYSA-N
CHEMBL4476367,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4ccncc4)CC3)cc2)ncc1Cl,IC50,5.77,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,CLAVOBNQCPZLLN-UHFFFAOYSA-N
CHEMBL4525498,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCc4cccnc4)CC3)cc2)ncc1Cl,IC50,5.82,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,ZNEWWRLRHOQSJO-UHFFFAOYSA-N
CHEMBL4453262,,CNC(=O)c1ccccc1Nc1ccnc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)n1,IC50,5.55,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,KQBOVKMESRRNOP-UHFFFAOYSA-N
CHEMBL4279256,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(COc3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.53,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,RHTQHLXGXSNSRP-XMVQVYPASA-N
CHEMBL72165,,O=C1c2cc(Br)ccc2-n2c1nc1ccccc1c2=O,IC50,7.27,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,INPHXCCBDRGBRF-UHFFFAOYSA-N
CHEMBL1276265,,O=C1c2ccc(Cl)cc2-n2c1nc1ccccc1c2=O,IC50,6.02,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,KHONZILMMZKIQL-UHFFFAOYSA-N
CHEMBL4444886,,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,9.13,CHEMBL4309336,Antiproliferative activity against human U87MG cells transfected with IDH1 R132H mutant,U-87MG ATCC,KICQCOSIQLKQBA-OZXSUGGESA-N
CHEMBL52226,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2CCl)OCCO3,IC50,7.27,CHEMBL624721,Compound was evaluated for in vitro antiproliferative activity against A172 human CNS cancer cell line,A-172,WJHZRWBKASGXFE-UHFFFAOYSA-N
CHEMBL4536640,,COc1cc(C(=O)c2cn(-c3ccc(N)cc3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.32,CHEMBL4316285,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,U-87MG ATCC,HQVMRVMGUWOSRW-UHFFFAOYSA-N
CHEMBL4559506,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.44,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,HWEPQWQOQSZLRC-UHFFFAOYSA-N
CHEMBL111477,,CN(C)c1ccnc2c1-c1nc3ccccc3c3ccnc(c13)C2=O,IC50,7.3,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,UYBWDRPVFJJAOX-UHFFFAOYSA-N
CHEMBL4287819,,COc1ccc(/C=C/C(=O)c2ccc(OCC(=O)Nc3ccc4c(c3)COC4=O)cc2)cc1,IC50,5.31,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,ASZAWGVSVIPAKR-YIXHJXPBSA-N
CHEMBL110742,,O=C1c2ncccc2C(=O)c2c(-c3ccccc3NC(=O)C(F)(F)F)ccnc21,IC50,9.05,CHEMBL878023,In vitro inhibition of U-87 MG (human glioblastoma) cell growth.,U-87MG ATCC,MNBDHAXJFRIQPS-UHFFFAOYSA-N
CHEMBL4281312,,C(=C/c1ccc(OCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1)\c1ccccc1.[I-],IC50,7.16,CHEMBL4265358,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,XXXQFBDSNLMKFH-RXQWRGDBSA-M
CHEMBL4280635,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(-c3ccc(F)cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.55,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CYDQIRZQIOCDIS-UVHRBFQASA-N
CHEMBL4294821,,C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/Cn3cc(Cc4ccccc4)nn3)CC[C@@H]12,IC50,4.88,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CLZIQMRGNCTWQV-SBUPNFJNSA-N
CHEMBL4280764,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(N3C(=O)c4ccccc4C3=O)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.91,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,GPIWVZDXLBSFNC-HCFHHERYSA-N
CHEMBL4293071,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CNC(=O)c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.03,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CIGUJYYNCWVQDY-KVUZRMRJSA-N
CHEMBL4278041,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(C(=O)OCc3ccc([N+](=O)[O-])cc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.7,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,UROQQMHVVMNRRL-UTBWARILSA-N
CHEMBL4293259,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(C(F)(F)F)cc5Cl)c4=O)cc3)ccnc21,IC50,4.9,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BPQOIWPXRJBFFE-UHFFFAOYSA-N
CHEMBL4281371,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)c(Cl)c5)c4=O)cc3)ccnc21,IC50,5.63,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,DQQVYTMOPDGVEX-UHFFFAOYSA-N
CHEMBL4293054,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3)ccnc21,IC50,5.67,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MZFRNRYVIPHDJN-UHFFFAOYSA-N
CHEMBL4287907,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccc(Cl)cc2)c1=O,IC50,5.47,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WKHQVCCQVAGYFZ-UHFFFAOYSA-N
CHEMBL5619323,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccc(C(F)(F)F)cc12)c1c[nH]c2ccc(C(F)(F)F)cc12,IC50,5.11,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,HHNHRKMSQZHDMP-NDEPHWFRSA-N
CHEMBL3911801,,Cc1ccc(S(=O)(=O)O)cc1.Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1,IC50,4.56,CHEMBL3881188,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation after 72 hrs by Alamar Blue assay,U-87MG ATCC,HDYUXDNMHBQKAU-UHFFFAOYSA-N
CHEMBL1098875,,O=C1c2cc(F)ccc2-n2c1nc1ccccc1c2=O,IC50,5.92,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,UXBGZQXHNVNPFT-UHFFFAOYSA-N
CHEMBL388177,,C[C@H](Cc1cccc2ccccc12)NC[C@@H](O)c1cc(O)cc(O)c1,IC50,7.83,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,QGUPDXLZKDANGO-SPLOXXLWSA-N
CHEMBL3415683,,CCCn1c2cc(OCCC(C)C)ccc2c2cc[n+](CC)c(C)c21.[Br-],IC50,6.05,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,JSZFYCAAEFGXHB-UHFFFAOYSA-M
CHEMBL3415681,,CCCn1c2cc(OCc3ccccc3)ccc2c2cc[n+](CCC(C)C)c(C)c21.[Br-],IC50,5.82,CHEMBL3417898,Cytotoxicity against human T98G cells by MTT assay,T98G,ABRKHCCTKBQBCO-UHFFFAOYSA-M
CHEMBL4862917,,O=C(CCCCCNC(=O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O)NO,IC50,5.26,CHEMBL4819317,Antiproliferative activity against human T98G cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,T98G,BWMRGOQFHBXKQR-UHFFFAOYSA-N
CHEMBL4778059,,COc1ccc(-c2nc(SCC(=O)c3sc(-c4ccccc4)nc3C)[nH]c(=O)c2C#N)cc1OC,IC50,4.81,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,QIGTZJZYCIYETC-UHFFFAOYSA-N
CHEMBL4799717,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(Cl)c(Cl)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.16,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,VAUNCIHMHCCKTR-UHFFFAOYSA-N
CHEMBL4791890,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccccc2)c(C#N)c(=O)[nH]1,IC50,4.56,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,IJSLANCLTAKFPA-UHFFFAOYSA-N
CHEMBL4747829,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2cccc(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.4,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,QNPNVJJIHWFAPD-UHFFFAOYSA-N
CHEMBL4793286,,Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CSc1nc(-c2ccc3c(c2)OCO3)c(C#N)c(=O)[nH]1,IC50,4.25,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,OZGPGYPHRFNYMT-UHFFFAOYSA-N
CHEMBL4765150,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(N)c(C#N)c(-c4ccc(Cl)cc4)n3)s2)cc1,IC50,5.34,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,XUVNDESQVQOWQX-UHFFFAOYSA-N
CHEMBL4748991,,CC(=O)O[C@@H]1C[C@H](O)[C@@]23COC(O)[C@]1(C)[C@@H]2C[C@@H](O)[C@@]1(C)[C@@H]2C(=O)C[C@@H](c4ccoc4)[C@]2(C)[C@@H](O)C(=O)[C@@H]13,IC50,5.42,CHEMBL4712389,Cytotoxicity against human XF498 cells by SRB staining assay,XF 498,JOQZKEFBHIMDMX-JIOZLIPLSA-N
CHEMBL92,DOCETAXEL ANHYDROUS,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,IC50,8.7,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,ZDZOTLJHXYCWBA-VCVYQWHSSA-N
CHEMBL4641965,,CCCC#Cc1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n2ncnc(N)c12,IC50,7.4,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,ODOGHCIPJNPLNR-NGFQHRJXSA-N
CHEMBL4644331,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(C#Cc3ccccc3)c12,IC50,4.06,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,XCRZMSZGJGMUNI-DDBAPUKQSA-N
CHEMBL4642282,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccoc3)c12,IC50,6.0,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,DNVDVLAZRSLHRN-ZRJCITRHSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.04,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL3818299,,CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)C(=O)c1c(-c2ccccc2)[nH]c2ccccc12,IC50,8.37,CHEMBL3820275,Binding affinity to MDM2 in human U87MG cells assessed as inhibition of MDM2/p53 protein interaction after 10 mins by quantitative sandwich immuno assay,U-87MG ATCC,QXHBVJGLCMIHJL-UIOOFZCWSA-N
CHEMBL211045,,COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1,IC50,5.19,CHEMBL3820289,Antiproliferative activity against human U87MG cells expressing wild type p53 after 48 hrs by MTS assay,U-87MG ATCC,BDUHCSBCVGXTJM-UHFFFAOYSA-N
CHEMBL4226543,,COc1ncc(-c2cc3c(C)nc(NC(=O)C4CC4)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.19,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,BUCASPXHFMVOBK-UHFFFAOYSA-N
CHEMBL5289048,,COc1ccc(/C(C)=C/CN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1,IC50,4.56,CHEMBL5225163,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,PTGWAAKNSYOHMB-WOJGMQOQSA-N
CHEMBL5289048,,COc1ccc(/C(C)=C/CN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1,IC50,4.62,CHEMBL5225164,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,PTGWAAKNSYOHMB-WOJGMQOQSA-N
CHEMBL5191412,,CCCCN(CC)Cc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2,IC50,4.23,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,KZQKDZDBFPECEU-UHFFFAOYSA-N
CHEMBL5266738,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CCC(=O)CCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,8.7,CHEMBL5228642,Cytotoxicity against human U87 cells,U-87MG ATCC,BGXDEQSJLXURBE-RHSVSJCASA-N
CHEMBL3301909,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N(C)C)[C@H](O)[C@H](C)O1,IC50,7.23,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,DJEFXYVVRUAFEB-KYZOVJJKSA-N
CHEMBL4762068,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3CCC(=O)[C@H](C)O3)[C@H](C)O2)[C@H](C)O1,IC50,5.66,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,VEYVSXCINGFXMS-ILPMSGFSSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,5.62,CHEMBL4343250,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL4451152,,CCOP(=O)(OCC)C(N(OC(C)c1ncc[nH]1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,CNDVAMMAAGJGKC-UHFFFAOYSA-N
CHEMBL4450150,,CCOP(=O)(OCC)C(N(OC(C)c1c[nH]cn1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,RNDBBVMDROJPJH-UHFFFAOYSA-N
CHEMBL5564744,,N#CC1(C(=O)NCCSc2ccccc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.84,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,IWIGGGFCALSMIX-UHFFFAOYSA-N
CHEMBL3897723,,COc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccc(Cl)cc2)cc1,IC50,9.85,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,YFBBPYBKOLENKT-JNAKGCJYSA-N
CHEMBL3900264,,Clc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccccc2)cc1,IC50,9.38,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,WFLJBHIMLGVBCP-AGFWYPDZSA-N
CHEMBL3966129,,Clc1ccc(C(/C=C/c2ccccc2)=N\Nc2nncc3ccccc23)cc1,IC50,9.28,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,IFAAYTNDJIPJBZ-ANPOLSPOSA-N
CHEMBL3903713,,C(=C/c1ccccc1)\C(=N\Nc1nncc2ccccc12)c1ccccc1,IC50,9.48,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,IUZQUGLOCXBWCX-QCGZKTFGSA-N
CHEMBL3979610,,Fc1ccc(Nc2nncc3ccccc23)cc1,IC50,9.37,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,LOCGWCWPUSRMSW-UHFFFAOYSA-N
CHEMBL3950630,,Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)n1,IC50,9.25,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,RXVARTZYPOQZBI-UHFFFAOYSA-N
CHEMBL3926223,,NS(=O)(=O)c1ccc(Nc2nncc3ccccc23)cc1,IC50,8.28,CHEMBL3870497,Antiproliferative activity against human SF295 cells after 72 hrs by Sulforhodamine B-stain assay,SF295,DIVNHQLVPJIYEC-UHFFFAOYSA-N
CHEMBL4761582,,CO[C@@]1(C)N(/C=C/c2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,5.35,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,KQGIOFULIYUITH-XXFRDUSWSA-N
CHEMBL1928402,,CC(=O)c1nc(C(=O)NCCc2ccccc2)cc2c1[nH]c1ccccc12,IC50,4.89,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,QPUYCBSQXKSFOO-UHFFFAOYSA-N
CHEMBL3339357,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4ccc(Cl)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.4,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,VXFKXGMEBXBHBS-QLQYKETESA-N
CHEMBL3339363,,COc1cc2c(Oc3ccc(CC(=O)N/N=C/c4cccs4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.94,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,APUQOERXRBJYOF-FMFFXOCNSA-N
CHEMBL3339367,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(O)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.94,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,LCHQLVMHOJANLQ-ICUTVXMZSA-N
CHEMBL4645881,,Cc1c(C(=O)N/N=C\c2ccc(O)cc2O)oc2cccc(O)c12,IC50,5.36,CHEMBL4618024,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth,U-87MG ATCC,PUQINIYVPDTKEP-LSCVHKIXSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,5.77,CHEMBL5509855,Synergistic antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs in presence of FK866 by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL4632430,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CC3)cc2)n1,IC50,4.36,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GFJVQOGPGWADQB-UHFFFAOYSA-N
CHEMBL4639855,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CCCC3)cc2)n1,IC50,4.24,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,NCFQFVDGGRBEDT-UHFFFAOYSA-N
CHEMBL4642258,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccc(Cl)cc4)cc3)n2)cn1,IC50,4.45,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,GVBXGRYWKSAQLW-UHFFFAOYSA-N
CHEMBL4649095,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cccc(Cl)n4)cc3)n2)cn1,IC50,4.26,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,HVHJKHDMLQCSHC-UHFFFAOYSA-N
CHEMBL4752934,,C/C(=C\CC/C(C)=C/CC[C@@H]1[C@@]2(C)CCC(=O)C(C)(C)[C@H]2CC[C@@]1(C)O)CC/C=C(\C)C(=O)OCc1cn(C[C@@H]2O[C@H](n3ccc(=O)[nH]c3=O)C[C@H]2O)nn1,IC50,4.12,CHEMBL4682994,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,YTODEFJNERGMCA-SFPLGXOVSA-N
CHEMBL1927612,,CN(C)CCN1C(=O)c2cccc3c2c(cc2nnn(CCO)c23)C1=O,IC50,5.91,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IZMMYUJCJGTURE-UHFFFAOYSA-N
CHEMBL3109414,,CC(=O)O[C@@]1(C)CCC(=O)[C@H](C)CCC[C@]2(C)O[C@H]2C(=O)C(=C(C)C)CC1,IC50,4.5,CHEMBL3112362,Cytotoxicity against human A172 cells cells after 24 hrs by MTT assay,A-172,VLTIKKJYNDMBON-OUWXYEHJSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.96,CHEMBL895813,Cytotoxicity against human U87MG cells,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL515,CHLORAMBUCIL,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,IC50,4.73,CHEMBL4153065,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 3 days by MTT assay,U-87MG ATCC,JCKYGMPEJWAADB-UHFFFAOYSA-N
CHEMBL4215067,,O=c1c(-c2c(O)cc3c(c2O)C[C@H](O)[C@H](c2ccc(O)c(O)c2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.05,CHEMBL4187982,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,LVGLBFQVAZMOBH-LGGPFLRQSA-N
CHEMBL260577,,NC(c1ccc(Cl)cc1)C1CCN(c2ccnc3[nH]ccc23)CC1,IC50,6.23,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,PRPNDHHOYWARPB-UHFFFAOYSA-N
CHEMBL405384,,NC(c1ccc(Cl)cc1)C1CCN(c2ncnc3[nH]ccc23)CC1,IC50,6.23,CHEMBL932639,Inhibition of GSK3-beta in human U87MG cells by ELISA,U-87MG ATCC,CUQIEUIMKDNKMI-UHFFFAOYSA-N
CHEMBL4642396,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(F)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.22,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ITURVIGXXSTVPJ-QCOVWQHTSA-N
CHEMBL4638757,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(N)=S)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.64,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,FKTGRRSUPMAQPN-MUUWPGBXSA-N
CHEMBL477923,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.24,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,KTEXNACQROZXEV-QLIGOWBFSA-N
CHEMBL561183,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C=O)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.13,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,TZIPSCRSSJQDML-OOCKOLEWSA-N
CHEMBL261341,,CC(C)Cn1nnc2c1C(=O)c1cnncc1C2=O,IC50,6.85,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,QOVAUBWYDGPSKT-UHFFFAOYSA-N
CHEMBL261330,,CCCn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,7.75,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,UGVODSLSZYPSHI-UHFFFAOYSA-N
CHEMBL259989,,Cn1nc2c(n1)C(=O)c1cnncc1C2=O,IC50,8.4,CHEMBL923236,Cytotoxicity against human XF498 cells after 3 days by SRB assay,XF 498,NPDJZPQYKSWUBJ-UHFFFAOYSA-N
CHEMBL4870888,,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1C(F)(F)F,IC50,4.05,CHEMBL4810781,Neurotoxicity in human U87 MG cells assessed as cell viability for 24 hrs by MTT assay,U-87MG ATCC,PGJNUZLHOQESIJ-FCXRPNKRSA-N
CHEMBL5220783,,COc1ccc(CNc2cccnc2-c2cc(OC)cc(OC)c2)cc1,IC50,5.62,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,HBEMOPXGFXWWGC-UHFFFAOYSA-N
CHEMBL4776452,,CCC(=O)Oc1cccc2ccc(/C=C/c3ccccc3[N+](=O)[O-])nc12,EC50,4.98,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,GDKCQKXZEFPKQP-ZRDIBKRKSA-N
CHEMBL4102608,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1cccc(Br)c1,EC50,5.17,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,VVMBNIZQCAZRDO-GQCTYLIASA-N
CHEMBL5268257,,O=C(CCCCCNC(=O)C1=CC2C(=O)C3C=CC=C(O)C3C(=O)C2C(O)=C1)NO,IC50,5.26,CHEMBL5231067,Cytotoxicity against human T98G cells assessed as inhibition of cell growth by MTT assay,T98G,ALJZJKPKINLHPS-UHFFFAOYSA-N
CHEMBL5275745,,CC[C@]1(OC(=O)OCc2cc(/C=C/C3=[N+](CCCS(=O)(=O)[O-])c4ccccc4C3)cc(/C=C/C3=[N+](CCCS(=O)(=O)[O-])c4ccccc4C3)c2OCc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)Cc2cc3n(c(=O)c2OC1=O)Cc1cc2ccccc2nc1-3,IC50,7.7,CHEMBL5231221,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability,U-87MG ATCC,BVNSZDGKOZIVLM-WIBDCOBLSA-N
CHEMBL3087009,,O=C1c2cc(F)ccc2-n2c1nc1ccc(F)cc1c2=O,IC50,5.09,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,PNIGSYVPVQBQOJ-UHFFFAOYSA-N
CHEMBL4161974,,O=C1c2ccccc2C(=O)c2c(-c3ccc(F)cc3)coc21,IC50,5.2,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,RFAKFRFVHNUKKX-UHFFFAOYSA-N
CHEMBL4165413,,CSc1ccc(-c2coc3c2C(=O)c2ccccc2C3=O)cc1,IC50,5.46,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,KPYPFYOXKVMRGM-UHFFFAOYSA-N
CHEMBL4177099,,O=C1c2ccccc2C(=O)c2c(-c3cccs3)coc21,IC50,5.3,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,XMJAULWIBAYPCF-UHFFFAOYSA-N
CHEMBL4170019,,CCOC(=O)Cc1oc2c(c1-c1cc(OC)c(OC)c(OC)c1)C(=O)c1ccccc1C2=O,IC50,4.99,CHEMBL4153503,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,SBUILDHSGAVMRE-UHFFFAOYSA-N
CHEMBL1956944,,CC(C)(O)[C@@H]1C[C@H]2[C@@](C)(C[C@@H]3C[C@@]32C)C[C@@H]1O,IC50,5.95,CHEMBL1960358,Cytotoxicity against human U87MG cells after 24 hrs by MTS assay,U-87MG ATCC,QRDWGAFJTAQHKE-QIWTVSAUSA-N
CHEMBL352557,,CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CCN1CCOCC1,IC50,4.09,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,TYZMMQCZNRBREP-UHFFFAOYSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,4.61,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL513,CARMUSTINE,O=NN(CCCl)C(=O)NCCCl,IC50,4.26,CHEMBL3879643,Cytotoxicity against AGT-deficient human SF126 cells assessed as reduction in cell viability pretreated with O6-BG for 2 hrs followed by addition of compound measured after 24 hrs by CCK8 assay,SF126,DLGOEMSEDOSKAD-UHFFFAOYSA-N
CHEMBL38957,,CC(=O)Nc1ccc2[nH]c(C(=O)Nc3ccc4[nH]c(C(=O)N5CC(CCl)c6c5cc(O)c5ccccc65)cc4c3)cc2c1,IC50,9.29,CHEMBL801643,"Cytotoxicity against NCI tumor panel, SNB-75 CNS cancer cell line",SNB-75,BIIZHPQOVMNVIQ-UHFFFAOYSA-N
CHEMBL254129,CYCLOPAMINE,CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C,IC50,4.65,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,QASFUMOKHFSJGL-LAFRSMQTSA-N
CHEMBL4092812,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(C)c(Cl)cc2OC)nnc1Cl,IC50,5.04,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,RJTWTALAEKYMLH-UHFFFAOYSA-N
CHEMBL4065141,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)nnc1Cl,IC50,5.0,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,SBVLCTFHZGZENM-UHFFFAOYSA-N
CHEMBL4065141,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)nnc1Cl,IC50,6.16,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,SBVLCTFHZGZENM-UHFFFAOYSA-N
CHEMBL4644711,,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)CCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1.[Br-],IC50,5.89,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,OATZKDGKJULOEE-SJMAVRMZSA-M
CHEMBL5575251,,Nc1nc(-c2ccccc2)cc(-c2ccc(S(N)(=O)=O)cc2)n1,IC50,4.47,CHEMBL5542075,Antiproliferative activity against human U-87MG cells assessed as reduction in cell growth incubated for 72 hrs in the presence of hypoxic condition by cytofluorimetric analysis,U-87MG ATCC,UXUNOXZFVHSUQD-UHFFFAOYSA-N
CHEMBL2402943,,CC(C)=CCC[C@]1(C)C=Cc2c(c(C)cc3c2[nH]c2ccccc23)O1,IC50,4.6,CHEMBL2405051,Cytotoxicity against human U87MG cells assessed as growth inhibition after 48 hrs by MTT assay,U-87MG ATCC,HTNVFUBCWIYPJN-HSZRJFAPSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,6.17,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL591429,PAC-1,C=CCc1cccc(/C=N/NC(=O)CN2CCN(Cc3ccccc3)CC2)c1O,IC50,4.31,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,YQNRVGJCPCNMKT-LFVJCYFKSA-N
CHEMBL228043,,C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br,IC50,4.19,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,UVSVTDVJQAJIFG-VURMDHGXSA-N
CHEMBL11359,CISPLATIN,,IC50,4.1,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.45,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL2392965,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C(F)(F)F)cc5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.0,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CASORRYOKCLYHM-UHFFFAOYSA-N
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,5.59,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,PQAPVTKIEGUPRN-UHFFFAOYSA-N
CHEMBL5618867,,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(/C=C/C(=O)NO)cc2)ccc1O,IC50,5.56,CHEMBL5623095,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,VNSNXSBINKRROS-KZHHGSSRSA-N
CHEMBL259181,,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,IC50,4.28,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,DOKZLKDGUQWMSX-HKBQPEDESA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,4.89,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL412142,LADUVIGLUSIB,Cc1cnc(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)[nH]1,IC50,4.5,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,AQGNHMOJWBZFQQ-UHFFFAOYSA-N
CHEMBL2313790,,COc1cc(Sc2c(-n3ccnc3)[nH]c3ccccc23)cc(OC)c1OC,IC50,7.07,CHEMBL2321142,Cytotoxicity against human U87MG cells assessed as cell survival after 24 hrs by MTS conversion assay,U-87MG ATCC,AVBIIULMFIIGCG-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.6,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5282388,,COc1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,5.05,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,WTEBNBAKSFFCPW-UHFFFAOYSA-N
CHEMBL5278825,,c1ccc(-n2c(SCCc3c[nH]c4ccccc34)nnc2-c2ccncc2)cc1,IC50,4.57,CHEMBL5258492,Antiproliferative activity against human A-172 cells assessed as inhibition of cell growth incubated for 24 hrs by MTT assay,A-172,PIKYRJSSRILQPF-UHFFFAOYSA-N
CHEMBL3262868,,COc1ccc(OC)c(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)c1,IC50,5.19,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BYDDZSQPFPOZNA-OKCVXOCRSA-N
CHEMBL3263124,,CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3c[nH]c4ccccc34)cc2F)ccn1,IC50,6.16,CHEMBL3271571,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,INHLNWGLDZHSOV-WCMJOSRZSA-N
CHEMBL5571278,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CCNCC1)C3,IC50,5.85,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,FXNCQKVCGAATHN-UHFFFAOYSA-N
CHEMBL2381454,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7cccc(CO)c7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.28,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,ZOPCSEXIYNWPNP-BJMSDPACSA-N
CHEMBL5273890,,Cc1ccccc1NS(=O)(=O)/C=C/c1cccc(OCCO[C@@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)c1,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,HEGZCFUAQVLBQV-KKJLATHWSA-N
CHEMBL3115966,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4cc(Cl)c(Cl)cc4Cl)nn3)[C@@H]2CC1,IC50,4.77,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,HJWIIMDENOAEFK-ORRPWZRNSA-N
CHEMBL3115971,,CC1=C2C[C@H]3O[C@@]3(C)[C@@H]2[C@H]2OC(=O)[C@@H](CNCc3cn(-c4ccc(Br)cc4)nn3)[C@@H]2CC1,IC50,4.28,CHEMBL3119053,Cytotoxicity against human T98G cells assessed as growth inhibition by colorimetric sulphorhodamine B assay,T98G,TZKODUIENJFEBB-VMAZJTETSA-N
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.73,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,SUDAHWBOROXANE-SECBINFHSA-N
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.45,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,RAHBGWKEPAQNFF-UHFFFAOYSA-N
CHEMBL4552836,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(CNc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(NC(=O)OCc3ccccc3)nc2=O)C1(F)F,IC50,5.42,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,LKZZHMMCAAPJJW-BEYURWCVSA-N
CHEMBL4524657,,Cc1cn([C@H]2C[C@H](OC(=O)OC(C)(C)C)[C@@H](Cn3cc(COC(=O)Nc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)c(=O)[nH]c1=O,IC50,5.01,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,OSOCTTLUFUAUDA-KXHDOTFISA-N
CHEMBL4280053,,COc1cc(Sc2c[nH]c3c(-c4cccs4)cccc23)cc(OC)c1OC,IC50,7.02,CHEMBL4271598,Growth inhibition of human U87MG cells after 48 hrs by MTS assay,U-87MG ATCC,HHIQFCHFPXQBND-UHFFFAOYSA-N
CHEMBL4285411,,CCCCCCCCCCCC[N+]1(C)CCN(CC(=O)O[C@H]2CCC[C@H](CC)OC(=O)C[C@@H]3C(=C[C@@H]4[C@H]3C=C[C@@H]3C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]43)C(=O)[C@@H]2C)CC1.[I-],IC50,5.12,CHEMBL4267508,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,ZOLGSVKCRDIUOJ-NCHIOQGESA-M
CHEMBL4513331,,COc1ccc(N2C(=N)S/C(=C\c3ccc(-c4cccnc4)o3)C2=O)cc1,IC50,4.6,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,SHLANBXRIPRBCH-RYBWPTGJSA-N
CHEMBL3936933,,[N-]=[N+]=NCC1CC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.41,CHEMBL3865945,Cytotoxicity against human SF295 cells overexpressing NQO1 assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,RWRRUAODLXTKEG-UHFFFAOYSA-N
CHEMBL4786625,,Cc1ccc(C(=O)/C=C/C(=O)OCCN(C)C(C(=O)NC2CCCCC2)c2ccc(F)cc2)cc1,IC50,5.23,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,KLJFMKGGTCMJKN-WUKNDPDISA-N
CHEMBL4745896,,Cc1ccc(C(C(=O)NC(C)(C)C)N(C)CCOC(=O)/C=C/C(=O)c2ccc(F)cc2)cc1,IC50,5.16,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,JPLCIQRNFUEDHY-CCEZHUSRSA-N
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.46,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,SUDAHWBOROXANE-SECBINFHSA-N
CHEMBL2134202,,CCc1cncnc1N1CCN(Cc2nc3cc(C(F)(F)F)ccc3[nH]2)CC1,IC50,4.2,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,FBLPQCAQRNSVHB-UHFFFAOYSA-N
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,5.13,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,CEGSUKYESLWKJP-UHFFFAOYSA-N
CHEMBL399530,,CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,IC50,4.98,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,OWPMENVYXDJDOW-UHFFFAOYSA-N
CHEMBL2417555,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.7,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,AZPBOWXQOORSRH-UHFFFAOYSA-N
CHEMBL2417834,,COc1ncc(-c2ccc3nc(NC(C)=O)nn3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.68,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,BLXIBDATVDFOEA-UHFFFAOYSA-N
CHEMBL83527,PTEROSTILBENE,COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1,IC50,4.85,CHEMBL4185546,Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay,LN-229,VLEUZFDZJKSGMX-ONEGZZNKSA-N
CHEMBL165,RESVERATROL,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,IC50,4.96,CHEMBL4185546,Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay,LN-229,LUKBXSAWLPMMSZ-OWOJBTEDSA-N
CHEMBL209857,,CC1(C)CC(NC(=O)Nc2ccccc2Cl)c2cc(Br)ccc2O1,IC50,4.96,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,GZJQSNLEMHHIIP-UHFFFAOYSA-N
CHEMBL610773,,CC1(C)CC(NC(=S)Nc2cccc(C#N)c2)c2cc(Cl)ccc2O1,IC50,5.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,MPACSKWCHWTFLA-UHFFFAOYSA-N
CHEMBL611936,,CC1(C)CC(NC(=S)Nc2ccc(C#N)cc2)c2cc(Br)ccc2O1,IC50,4.62,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,NSCMHWQEWCQUKL-UHFFFAOYSA-N
CHEMBL595242,,CC1(C)CC(NC(=S)Nc2ccc([N+](=O)[O-])cc2)c2cc(F)ccc2O1,IC50,5.3,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YWZWRTAQMFMTSJ-UHFFFAOYSA-N
CHEMBL2041936,,COc1ccc(Cl)cc1CNC(=S)Nc1ccc([N+](=O)[O-])cc1,IC50,4.46,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,FSPOCHCSOXLMBF-UHFFFAOYSA-N
CHEMBL4543075,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccccc2[N+](=O)[O-])cc(OC)c1OC,IC50,7.52,CHEMBL4316285,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,U-87MG ATCC,RTVPWMWCWOVESQ-UHFFFAOYSA-N
CHEMBL4586068,,COc1cc(C(=O)c2cn(-c3ccc(F)cc3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.34,CHEMBL4316285,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,U-87MG ATCC,ANSTTWYVEJBPTF-UHFFFAOYSA-N
CHEMBL4444616,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccccc2F)cc(OC)c1OC,IC50,7.27,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,AOPYZCNEKFOSTL-UHFFFAOYSA-N
CHEMBL4586068,,COc1cc(C(=O)c2cn(-c3ccc(F)cc3)cc2-c2ccc(N)cc2)cc(OC)c1OC,IC50,7.66,CHEMBL4316286,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,T98G,ANSTTWYVEJBPTF-UHFFFAOYSA-N
CHEMBL392695,S-TRITYL-L-CYSTEINE,N[C@@H](CSC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O,IC50,5.52,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,DLMYFMLKORXJPO-FQEVSTJZSA-N
CHEMBL5567673,,CC(C)NC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.43,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,LRLQSCGBFVRVPC-GFCCVEGCSA-N
CHEMBL4857714,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc(Cl)cc7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.17,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,WMFPXSAAFKGDEW-JKSHRDJASA-N
CHEMBL5619004,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCc1ccco1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.34,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,OZENKSHIKBNFBN-YTTGMZPUSA-N
CHEMBL5618510,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OCC1CCOCC1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.53,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,LKLFFCBTMAGYQY-XIFFEERXSA-N
CHEMBL5284130,,c1cn2cc(-c3ccc4ncn(C5CCCCC5)c4c3)nc(-c3ccc4ncn(C5CCCCC5)c4c3)c2n1,IC50,6.09,CHEMBL5625479,Growth inhibition of human SF-295 cells,SF295,XEFFCFLZLHGTDK-UHFFFAOYSA-N
CHEMBL4636420,,COc1ccc2c(c1O)C(=O)c1c3c(cc(O)c1C2=O)[C@@]12O[C@@]1([C@@H](C)O)[C@H](C#C/C=C\C#C[C@H]2O)N3,EC50,9.35,CHEMBL4621655,Cytotoxicity against human SF295 cells assessed as reduction in cell viability measured after 72 hrs by CellTiter 96 aqueous one solution assay,SF295,DJOMZYYFFHCVSQ-UBZKRVARSA-N
CHEMBL4755220,,O=C(Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1)Nc1ccc(C(=O)NCCN2CCCCC2)cc1,IC50,5.96,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,JZNRJZMZSVXVRD-GIJQJNRQSA-N
CHEMBL5081131,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC5CC5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.58,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,LNWNGALQBKWVHJ-WFVGHVPHSA-N
CHEMBL5093902,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.58,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,VDNKOXGKXPTVCH-BDFBTMKGSA-N
CHEMBL5074496,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Cl)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.02,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,JGCYYQSMCMPXED-SMRIDXHDSA-N
CHEMBL5076793,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Br)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.19,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,ZWTPPPFBFCVMIN-SMRIDXHDSA-N
CHEMBL4799550,,CCCCc1ccc(C(=O)/C=C/c2ccco2)cc1,EC50,4.91,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,DBSVGRDPWNJUBN-VAWYXSNFSA-N
CHEMBL5075135,,O=C(NO)c1ccc(CN(Cc2cccnc2)S(=O)(=O)c2cc(F)c(F)c(F)c2F)cc1,IC50,5.7,CHEMBL5042627,Anti-proliferative activity against human U87G cells assessed as cell viability measured after 72 hrs by Cell-Titer assay,U-87MG ATCC,HBOMISXRZUHCSH-UHFFFAOYSA-N
CHEMBL2398336,,COc1ccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.7,CHEMBL4713864,Antiproliferative activity against human T98G cells overexpressing AR assessed as reduction in cell viability incubated for 48 hrs by MTT assay,T98G,FFIDHUYNLVXETI-UHFFFAOYSA-N
CHEMBL2398336,,COc1ccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.32,CHEMBL4713867,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,FFIDHUYNLVXETI-UHFFFAOYSA-N
CHEMBL2398330,,COc1ccc(C(=O)Nc2ccc(N(C)S(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.52,CHEMBL4713867,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,LNDXEXUTQMQCLA-UHFFFAOYSA-N
CHEMBL5189034,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccc(F)cc1)O2,IC50,6.68,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,DXFZJLAGWYZJCJ-UHFFFAOYSA-N
CHEMBL509219,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1N=[N+]=[N-],IC50,5.92,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,OURJDSNLCDZIHT-UHFFFAOYSA-N
CHEMBL4447630,,CC1(C)O[C@@H]2O[C@@H](COC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)[C@H]3OC(C)(C)O[C@H]3[C@@H]2O1,IC50,6.8,CHEMBL5104528,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability by MTT assay,SF295,GYARFLWMYFKNBZ-ADFNPOGKSA-N
CHEMBL2348734,,CC(=O)Nc1cc(-c2ccccc2)c(=O)[nH]n1,IC50,5.12,CHEMBL2351701,Cytotoxicity against human SF295 cells after 48 hrs by MTT assay,SF295,YLTAJJJPAWSRTK-UHFFFAOYSA-N
CHEMBL4211294,,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2,IC50,5.1,CHEMBL5048136,Cytotoxicity against human U-87 MG cells assessed as cell viability using raw interpretation method,U-87MG ATCC,HWCVTYJVEWESOJ-XREWKEJESA-N
CHEMBL5278357,,COc1ccc(-c2cc3c(C)nc(N)nc3n(C3CCC(OCCO)CC3)c2=O)cn1,IC50,6.75,CHEMBL5347390,Antiproliferative activity against human U87 cells incubated for 3 hrs by resazurin dye based assay,U-87MG ATCC,XDLYKKIQACFMJG-UHFFFAOYSA-N
CHEMBL3805698,,O=C(/C=C\Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc(F)cc1,IC50,5.05,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,IDZHBQXXPRSFKI-PFONDFGASA-N
CHEMBL3805065,,COc1cc(N/C=C\C(=O)c2cn(-c3ccccc3)nc2-c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,IC50,5.29,CHEMBL3808074,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,JFUCGYAMBXSBPL-SEYXRHQNSA-N
CHEMBL3618239,,COc1ccc(Nc2nc3ccc(N4CCNCC4)cn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.16,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,YBQVCLWCRGNXIX-UHFFFAOYSA-N
CHEMBL4450150,,CCOP(=O)(OCC)C(N(OC(C)c1c[nH]cn1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,RNDBBVMDROJPJH-UHFFFAOYSA-N
CHEMBL4437294,,CCOP(=O)(OCC)C(N(OC(C)c1cn(C)cn1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,JPGPKRXXXWYEON-UHFFFAOYSA-N
CHEMBL4792743,,CCOP(=O)(Cc1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1)N1CCOCC1,IC50,5.91,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UGYFXTRYBRHBRT-UHFFFAOYSA-N
CHEMBL4785079,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CC5(CCOCC5)C4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.27,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,UQTOSACIYYZMNE-UHFFFAOYSA-N
CHEMBL4792101,,CC(=O)c1c(C)c2cnc(Nc3ccc(CN4CCNCC4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.78,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,KSHZWPCJWQWIST-UHFFFAOYSA-N
CHEMBL4786967,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3C)nc12,IC50,6.6,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,XUKLMBGZXHMYHP-UHFFFAOYSA-N
CHEMBL4454246,,CCOP(=O)(OCC)C(N(OC(C)n1ccnc1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,VEDYZZHYDWWOEK-UHFFFAOYSA-N
CHEMBL4467693,,CCOP(=O)(OCC)C(N(OC(C)n1cc[n+](C)c1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,BEBGZMBAAKJZSE-UHFFFAOYSA-N
CHEMBL4437294,,CCOP(=O)(OCC)C(N(OC(C)c1cn(C)cn1)C(C)(C)C)C(C)(C)C,IC50,4.6,CHEMBL4339956,Cytotoxicity against human U87MG cells assessed as reduction in cell survival measured after 72 hrs by MTT assay,U-87MG ATCC,JPGPKRXXXWYEON-UHFFFAOYSA-N
CHEMBL4550214,,O=C(NO)c1ccc(Cn2c(=O)n(CCc3ccccc3)c(=O)c3ccccc32)cc1,IC50,5.81,CHEMBL5141029,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JBJIKUXUKSADFV-UHFFFAOYSA-N
CHEMBL5202357,,COCCN1CCN(c2ccc(OC)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.46,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,SIKDOWIWMSTJIV-UHFFFAOYSA-N
CHEMBL5431398,,Nc1ncnc2c1ccn2[C@@H]1O[C@H]([C@@H]2OCCc3cc(Cl)ccc32)[C@@H](O)[C@H]1O,IC50,8.59,CHEMBL5350332,Anti-proliferative activity against human U-87 MG cells assessed as cell growth inhibition incubated for 3 days by CCK-8 assay,U-87MG ATCC,MURBFVDKWOUNSQ-IPXJXJKCSA-N
CHEMBL5416410,DASATINIB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O,IC50,7.35,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,XHXFZZNHDVTMLI-UHFFFAOYSA-N
CHEMBL27759,ENTINOSTAT,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,IC50,4.47,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,INVTYAOGFAGBOE-UHFFFAOYSA-N
CHEMBL220241,GSK-269962A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,IC50,5.09,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,YOVNFNXUCOWYSG-UHFFFAOYSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,6.54,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,6.25,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.95,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL472940,,Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12,IC50,4.31,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,RFAXLXKIAKIUDT-UHFFFAOYSA-N
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,5.19,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,GFMMXOIFOQCCGU-UHFFFAOYSA-N
CHEMBL3262727,,O=C(/C=C/c1cccc(S(=O)(=O)n2ccc3cccnc32)c1)NO,IC50,5.73,CHEMBL5614538,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,OXPJGPURVBXIAP-VOTSOKGWSA-N
CHEMBL4556764,,C[C@H]1C[C@@](C)(O)C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1=O,IC50,6.66,CHEMBL4416282,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 72 hrs by SRB assay,U-87MG ATCC,NFDQYBUVHVRNNY-VATFKXGISA-N
CHEMBL4752642,,C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O,IC50,5.66,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,UTSSJQUIRGMHJS-UHFFFAOYSA-N
CHEMBL4783568,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C(C)C)c(=O)c3=O)cc2)ncc1Cl,IC50,5.15,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,HKMFURWCSXCSMM-XSFVSMFZSA-N
CHEMBL4750273,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C4CC4)c(=O)c3=O)cc2)ncc1Cl,IC50,6.05,CHEMBL4704568,Cytotoxicity against human A172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,NTYSXVNDTBLJBP-XSFVSMFZSA-N
CHEMBL4640462,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(C#CC3CC3)c12,IC50,7.52,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,KZXJVSCNNXNJSX-NGFQHRJXSA-N
CHEMBL4638439,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccccc3)c12,IC50,4.12,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,JSZDOJWBOJQLPQ-MIGQKNRLSA-N
CHEMBL388978,STAUROSPORINE,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,8.52,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,HKSZLNNOFSGOKW-FYTWVXJKSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,5.15,CHEMBL4364468,Cytotoxicity against human U87MG Cells 48 hrs by MTS assay,U-87MG ATCC,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL4749576,,Oc1c(C(c2ccc(F)cc2)N2CCCCC2)ccc2cccnc12,IC50,4.43,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,HOKPJBCDXUEGDO-UHFFFAOYSA-N
CHEMBL4776896,,Oc1c(C(c2ccc3c(c2)OC(F)(F)O3)N2CCCCC2)ccc2ccoc12,IC50,5.05,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,YWTCGWLCGFLFTK-UHFFFAOYSA-N
CHEMBL4783594,,CN(C)c1nc(/C=C/c2cccc([N+](=O)[O-])c2)nc(Nc2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)n1,IC50,5.29,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,DLQATWWNPBJVMI-GIDUJCDVSA-N
CHEMBL4784902,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3ccc(Cl)cc3)nc(N3CCOCC3)n2)cc1,IC50,5.6,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NYYWQGPXVXSKKR-LZWSPWQCSA-N
CHEMBL4789421,,CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(Nc4nc(/C=C/c5ccccc5)nc(N5CCOCC5)n4)cc3)cc2)CC1,IC50,6.64,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,FOXFJTSNPCDILE-FRKPEAEDSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.5,CHEMBL4309539,Growth inhibition of human SNB75 cells incubated for 48 hrs by sulforhodamine B assay,SNB-75,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL4786042,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C3CCCCC3)nc12,IC50,6.91,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,SSQHDFZENWGTNQ-UHFFFAOYSA-N
CHEMBL2165033,,COc1ccc(Nc2ncc(-c3cnn(C)c3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.47,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,KRSNHRXVUCZIHY-UHFFFAOYSA-N
CHEMBL5076062,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Cl)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.18,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,AWKSMQZRGODOHH-MCLIRCHUSA-N
CHEMBL5080088,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5nccs5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.32,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,GJQSIGCKFMWMGG-VZTVURHLSA-N
CHEMBL5076062,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Cl)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.08,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,AWKSMQZRGODOHH-MCLIRCHUSA-N
CHEMBL5275650,,c1ccc(-c2nc(CNc3nccc(NC4CC4)n3)cs2)cc1,IC50,4.14,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,KUTNRROCOWVKIM-UHFFFAOYSA-N
CHEMBL5269859,,CC(C)CNc1ccnc(NCc2csc(-c3ccc(Cl)cc3)n2)n1,IC50,4.78,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,KUONEDFEQUGOFF-UHFFFAOYSA-N
CHEMBL5271397,,CC(C)CNc1ccnc(NCc2csc(-c3ccc(C(F)(F)F)cc3)n2)n1,IC50,4.7,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,BPNDTEKFFIXTAK-UHFFFAOYSA-N
CHEMBL5288870,,CC(C)CNc1ccnc(NC(=O)c2csc(-c3ccccc3)n2)n1,IC50,4.23,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,WZXXDPKTYAQIAG-UHFFFAOYSA-N
CHEMBL4783539,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n2cc(C(C)C)nc12,IC50,6.54,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,JAJXESNKQGDUIJ-UHFFFAOYSA-N
CHEMBL3809774,,Cn1cc(/C=C2/C(=O)Nc3ccccc32)c2cc(Nc3nccc(-c4ccc(O)cc4)n3)ccc21,IC50,4.88,CHEMBL3813411,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,QIDFHLVCKQCNOZ-OEAKJJBVSA-N
CHEMBL5279358,,CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(COC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)OC(=O)CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-].[Br-],IC50,4.29,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,CEXFQWGSZICLHN-JFHYDWJLSA-L
CHEMBL233030,,c1cn(-c2ccc(O[C@H]3CCN(Cc4ccc5c(c4)OCO5)C3)cc2)cn1,IC50,5.8,CHEMBL893544,Inhibition of nitric oxide formation in human A172 cells,A-172,WZGVPRAMPUCENN-IBGZPJMESA-N
CHEMBL2042556,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1ccc(N(C)C)c2ccccc12,IC50,8.13,CHEMBL2044176,Antiproliferative activity against human A172 cells after 5 days by MTT assay,A-172,XWCSZMDVKNZVMD-UHFFFAOYSA-N
CHEMBL4453906,,COC(C)(C)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)C=C(O)C(=O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.68,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,QQAHLBORSCNRPX-QBVDEUJGSA-N
CHEMBL4548558,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1CNC(=O)[C@H](C)O,IC50,5.7,CHEMBL4374036,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SF295,XZYKRDKKCJVLNQ-SPJFXFQZSA-N
CHEMBL4207018,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1,IC50,5.54,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CJTFWXXRGSFAFF-UHFFFAOYSA-N
CHEMBL4218367,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(Br)cc4F)c3=O)cc2)ccn1,IC50,4.99,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UJCIPXGVLWQAMH-UHFFFAOYSA-N
CHEMBL4214300,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(C(F)(F)F)cc4Cl)c3=O)cc2)ccn1,IC50,4.96,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,APGHTOISOKBSEA-UHFFFAOYSA-N
CHEMBL4298697,,C=C1C(=O)O[C@@H]2C3O[C@]3(C)CC/C=C(\C)CC[C@@H]12,IC50,5.36,CHEMBL4381714,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,KTEXNACQROZXEV-JADZJFIVSA-N
CHEMBL4203396,,Cc1ccc(Nc2nc(C)c(C(=O)c3cnc4ccc(Br)cn34)s2)cc1,IC50,4.28,CHEMBL4181987,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 46 hrs by MTT assay,U-87MG ATCC,MATXBQCYJIHSDO-UHFFFAOYSA-N
CHEMBL514499,GW843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC,IC50,4.26,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,JSKUWFIZUALZLX-UHFFFAOYSA-N
CHEMBL325041,BORTEZOMIB,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,IC50,7.05,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,GXJABQQUPOEUTA-RDJZCZTQSA-N
CHEMBL220241,GSK-269962A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,IC50,5.14,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,YOVNFNXUCOWYSG-UHFFFAOYSA-N
CHEMBL2363137,,Cc1cc([N+](=O)[O-])ccc1NS(=O)(=O)c1cc(Cl)ccc1Cl,IC50,4.72,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,AXNUEXXEQGQWPA-UHFFFAOYSA-N
CHEMBL509032,TAE-684,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,IC50,5.95,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,QQWUGDVOUVUTOY-UHFFFAOYSA-N
CHEMBL603469,LESTAURTINIB,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,IC50,5.83,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,UIARLYUEJFELEN-LROUJFHJSA-N
CHEMBL258844,,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,IC50,4.37,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,BIWGYFZAEWGBAL-UHFFFAOYSA-N
CHEMBL5439741,,CC1(C)CCc2c(O)cc(CCc3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](O)CC[C@@]3(C)O4)cc2O1,IC50,7.11,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,VJWKPCYKFHMZSX-ITLAICGJSA-N
CHEMBL5414636,,COc1cc(CCc2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,5.42,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,XZCWUPSHHPDPSM-VOKYQHOCSA-N
CHEMBL5399392,,CC1(C)CCc2c(O)cc(/C=C/c3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](OC=O)CC[C@@]3(C)O4)cc2O1,IC50,7.91,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,GKACSTTYVBTVFY-JCZAHQRISA-N
CHEMBL3335765,,O=c1ccc(-c2cccc(F)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.31,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,KWBSFQPATIAOSN-DEOSSOPVSA-N
CHEMBL5427602,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccccc3C)ccc2NS(C)(=O)=O)c1,IC50,5.92,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,XEWMFCOWYNRNJR-UHFFFAOYSA-N
CHEMBL2398338,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(I)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.32,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,UZYGIQDDFAEAQN-UHFFFAOYSA-N
CHEMBL2398337,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(OC)c(OC)c3)ccc2NS(C)(=O)=O)c1,IC50,7.05,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,ROOGRPRNWIQQDK-UHFFFAOYSA-N
CHEMBL5398001,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.11,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,VHLKUFIUVFOKSP-UHFFFAOYSA-N
CHEMBL5436907,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C#N)c3)ccc2NS(C)(=O)=O)c1,IC50,5.3,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,MMKJHFJHDJJWCS-UHFFFAOYSA-N
CHEMBL5413649,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(Br)c3)ccc2NS(C)(=O)=O)c1,IC50,5.57,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,HIOFAGZBNFHBTQ-UHFFFAOYSA-N
CHEMBL5418601,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccs3)ccc2NS(C)(=O)=O)c1,IC50,5.46,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,LKMLRQDOTROMLW-UHFFFAOYSA-N
CHEMBL4797378,,Cc1ccc(C)c(C(Nc2ccccn2)c2ccc3cccnc3c2O)c1,IC50,4.86,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,SMVGLVQESZULKI-UHFFFAOYSA-N
CHEMBL4799197,,Cc1ccnc(NC(c2ccc(OCc3ccccc3)cc2)c2ccc3cccnc3c2O)c1,IC50,5.03,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,DNOYNFNXZASMBC-UHFFFAOYSA-N
CHEMBL4788798,,CCS(=O)(=O)N(C)c1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,8.24,CHEMBL4713864,Antiproliferative activity against human T98G cells overexpressing AR assessed as reduction in cell viability incubated for 48 hrs by MTT assay,T98G,FIQDGCIYCNETRN-UHFFFAOYSA-N
CHEMBL3343379,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5C)c4C)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.62,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FTNYLEQWPAHOGD-UHFFFAOYSA-N
CHEMBL3343396,,COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccccc5Cl)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.91,CHEMBL3381423,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JLCOBIOZIRCTOF-UHFFFAOYSA-N
CHEMBL306946,TRYPTANTHRIN,O=C1c2ccccc2-n2c1nc1ccccc1c2=O,IC50,6.71,CHEMBL4383518,Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs,U-87MG ATCC,VQQVWGVXDIPORV-UHFFFAOYSA-N
CHEMBL3623535,,CN(C)CCn1c2c(c3c4ccccc4c(O)cc31)C(=O)c1ccccc1C2=O,IC50,6.77,CHEMBL3626442,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation by MTT assay,U-87MG ATCC,BNGCHTGHSNZIMQ-UHFFFAOYSA-N
CHEMBL3623536,,CN(C)CCCn1c2c(c3c4ccccc4c(O)cc31)C(=O)c1ccccc1C2=O,IC50,6.49,CHEMBL3626442,Cytotoxicity against human U87MG cells assessed as inhibition of cell proliferation by MTT assay,U-87MG ATCC,DBMXTOFHRZLJSW-UHFFFAOYSA-N
CHEMBL1023,BEXAROTENE,C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C,IC50,4.18,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,NAVMQTYZDKMPEU-UHFFFAOYSA-N
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,5.0,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,PLHJCIYEEKOWNM-HHHXNRCGSA-N
CHEMBL5566435,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1ccc(C(C)C)cc1,IC50,5.37,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,PTQSQMGZFHNZJA-UHFFFAOYSA-N
CHEMBL4204238,,CNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4F)c3=O)cc2)ccn1,IC50,5.47,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,IKAFRBGBNHGPLF-UHFFFAOYSA-N
CHEMBL4213745,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4)c3=O)cc2)ccn1,IC50,5.58,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ASDPCMCMYGUYRD-UHFFFAOYSA-N
CHEMBL5418635,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.47,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,WCFCCDOJPGJVBQ-XDQLDVNZSA-N
CHEMBL2297267,,CCCNc1cc(-c2ccccc2)nc2cc(OC)cc(OC)c12,IC50,5.74,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,BJLGSPWOVYBXPO-UHFFFAOYSA-N
CHEMBL5417824,,Cc1cc(Cc2c[nH]c3ccc([N+](=O)[O-])cc23)cc(C)c1O,IC50,4.13,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WLWADVZEPFXBBL-UHFFFAOYSA-N
CHEMBL1234354,PF-04691502,COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1,IC50,6.47,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,XDLYKKIQACFMJG-WKILWMFISA-N
CHEMBL4227319,,Cc1nc(N)nc2sc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc12,IC50,5.24,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,UBCWTPNRACWDAI-UHFFFAOYSA-N
CHEMBL4228112,,Cc1ncc(-c2cc3c(C)nc(N)nc3s2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,5.06,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,WJUJPSLJDDCZAM-UHFFFAOYSA-N
CHEMBL4225483,,COc1ncc(-c2cc3c(C)nc(NC(C)=O)nc3s2)cc1NS(=O)(=O)c1ccc(Cl)s1,IC50,6.16,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,AUQPVAKLJJBNFN-UHFFFAOYSA-N
CHEMBL5590802,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)N1CCNCC1)C3,IC50,5.3,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,PIZLVEIDCBQEAF-UHFFFAOYSA-N
CHEMBL601719,CRIZOTINIB,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,IC50,5.14,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,KTEIFNKAUNYNJU-GFCCVEGCSA-N
CHEMBL3339368,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.43,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,QWZRHATYSBQMPY-BOABNOFISA-N
CHEMBL3339370,,COc1cc2c(Oc3ccc(CC(=O)N/N=C(/C)c4ccc(C(F)(F)F)cc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.23,CHEMBL3385126,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth after 72 hrs by MTT assay,U-87MG ATCC,OAZGFRFNDUWGJE-PTZDRTPLSA-N
CHEMBL4572210,BAY-771,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1,IC50,5.21,CHEMBL4885538,Cellular mechanistic assay  BCAA measurement (U-87-MG cells),U-87MG ATCC,LZLNIHXKWZZQLE-UHFFFAOYSA-N
CHEMBL297453,EPIGALOCATECHIN GALLATE,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,IC50,4.75,CHEMBL4185545,Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay,U-87MG ATCC,WMBWREPUVVBILR-WIYYLYMNSA-N
CHEMBL1822928,,CCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc(F)cc3)c(=O)[nH]c12,Ki,8.55,CHEMBL1825306,Displacement of [3H]CP-55940 from human CB2 receptor expressed in human U87 cells after 1 hr by scintillation counting,U-87MG ATCC,JQYZYQKWXGNSIW-UHFFFAOYSA-N
CHEMBL1774420,CASEARUPESTRIN D,C=CC(=C)CC[C@]1(C)[C@H](C)[C@@H](OC(=O)/C=C\C=C\CCCCC)[C@H](OC(C)=O)[C@@]23C(=C[C@H](O)C[C@@H]12)[C@@H](OC(C)=O)O[C@@H]3OC(C)=O,IC50,6.37,CHEMBL1776150,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,KAIWHFAEAXEXOF-PDNIMGFCSA-N
CHEMBL4476032,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.19,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CTERTLMYSCTHRG-UHFFFAOYSA-N
CHEMBL4589156,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.78,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DIQRSOSRXNCKNT-UHFFFAOYSA-N
CHEMBL4543837,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.25,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,CMAXWGUPESWTSJ-UHFFFAOYSA-N
CHEMBL4436126,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(C5CCCC5)c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.28,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,XUNMGCAUOVQOGB-UHFFFAOYSA-N
CHEMBL4450512,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](n2cc(C[Se]c3ccc(F)cc3)nn2)[C@H]1Br,IC50,5.83,CHEMBL4423109,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,OAOAYCGZHNXPAB-WMZHIEFXSA-N
CHEMBL4452420,,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)O,IC50,4.7,CHEMBL4417156,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,FOPNWILAJGHOCW-FFJZLYMMSA-N
CHEMBL2205662,,Cc1ccc(N(CCn2nnc3c(C(N)=O)ncn3c2=O)CCn2nnc3c(C(N)=O)ncn3c2=O)cc1,IC50,4.85,CHEMBL4423099,Antiproliferative activity against human U87MG cells after 5 days by CyQuantGR dye-based fluorescence assay,U-87MG ATCC,SRFTZNAYQBILPX-UHFFFAOYSA-N
CHEMBL2397805,,Clc1ccccc1CNc1ncnc2c1cnn2CC(Cl)c1ccc(Br)cc1,IC50,4.9,CHEMBL4423084,Antiproliferative activity against human T98G cells after 72 hrs by MTS assay,T98G,PYGLWXFBTJNWSQ-UHFFFAOYSA-N
CHEMBL4580296,,O=C(CCCc1ccc(-c2cc3ccccc3cn2)cc1)Nc1ccc(O)cc1,EC50,6.22,CHEMBL4423119,Cytotoxicity against human U87 cells after 72 hrs by AlamarBlue assay,U-87MG ATCC,AMOLMRUARSNWSM-UHFFFAOYSA-N
CHEMBL2165018,,COc1ccc(Nc2ncc(CN3CCN(S(=O)(=O)N(C)C)CC3)cc2-c2nc(C)nc(N)n2)cn1,IC50,7.64,CHEMBL2169663,Inhibition of Phosphatidylinositol 3-kinase pathway in PTEN-deficient human U87MG cells assessed as inhibition of phosphorylation of AKTat Ser473 after 2 hrs by AlphaScreen assay,U-87MG ATCC,NRFWIMBKAYHJFY-UHFFFAOYSA-N
CHEMBL4447316,,O=C(Nc1nc2ccccc2s1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.05,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,YNPVEFLXALYKQO-UHFFFAOYSA-N
CHEMBL4445854,,O=C(Nc1nc2ccc(Cl)cc2s1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.3,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,PUGCWXBHZFBSAI-UHFFFAOYSA-N
CHEMBL2164400,,Cc1c2c(cc[n+]1CCc1ccccc1)c1ccc(OCC3CCCCC3)cc1n2CC1CCCCC1.[Br-],IC50,6.58,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,TZYCRYUQSNOYGP-UHFFFAOYSA-M
CHEMBL4457290,,COc1cc(/C=N/Nc2nc(-c3ccc(F)c(F)c3)cs2)cc(Br)c1OC,IC50,4.58,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,NVUFJWMQODHBNK-GZIVZEMBSA-N
CHEMBL1683545,,C=C(C)CN1CCO[C@@H](C[C@H]2O[C@H]3C[C@H]4O[C@@H](CC[C@@H]5O[C@@H](CC[C@@]67C[C@H]8O[C@H]9[C@@H](O6)[C@H]6O[C@H](CC[C@@H]6O[C@H]9[C@H]8O7)CC(=O)C[C@@H]3[C@H]2OC)CC5=C)C[C@@H](C)C4=C)C1,IC50,9.59,CHEMBL1687617,Antiproliferative activity against human SF295 cells,SF295,JBFLNPIQVUSWKG-BVBWJHDNSA-N
CHEMBL4436746,,COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1,IC50,6.48,CHEMBL4309536,Growth inhibition of human SF295 cells incubated for 48 hrs by sulforhodamine B assay,SF295,JNRBIZYBWZXQKC-UHFFFAOYSA-N
CHEMBL4436746,,COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1,IC50,6.07,CHEMBL4309539,Growth inhibition of human SNB75 cells incubated for 48 hrs by sulforhodamine B assay,SNB-75,JNRBIZYBWZXQKC-UHFFFAOYSA-N
CHEMBL4215210,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(OC)cc4)c3=O)cc2)ccn1,IC50,5.14,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SWANNODYZURKDJ-UHFFFAOYSA-N
CHEMBL4126209,,COc1cc2cc3c(N)n[nH]c3nc2cc1OC,IC50,4.58,CHEMBL4124283,Antiproliferative activity against human LN229 cells by MTT assay,LN-229,PWFMGWOLIUNSRG-UHFFFAOYSA-N
CHEMBL5427579,,COc1cccc2c1nc(C(F)F)n2-c1nc(N2CCOCC2)nc(N2CCN(C(=S)SCC(=O)N3CCN(C)CC3)CC2)n1,IC50,5.78,CHEMBL5369157,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 96 hrs by MTT assay,U-87MG ATCC,CFBNFHFRAZDQNM-UHFFFAOYSA-N
CHEMBL2424939,,N#Cc1c(-c2cc(OCc3ccccc3)cc(OCc3ccccc3)c2)cc(-c2cc(Cl)ccc2O)[nH]c1=O,IC50,4.51,CHEMBL5379452,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition,LN-229,NZRBRJQYGLEINZ-UHFFFAOYSA-N
CHEMBL3092913,,C=CCCCCOc1ccccc1-c1cnc(S(=O)(=O)c2ccccc2)n1C,IC50,4.15,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,DKDHTSRRZSXYPT-UHFFFAOYSA-N
CHEMBL2203622,,Cn1c2cnc1OCC/C=C\CCCCOc1ccccc1-2,IC50,4.0,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,AGLKQNJMUAORON-HYXAFXHYSA-N
CHEMBL3092930,,C#CCCCCOc1ncc(-c2ccccc2OC)n1C,IC50,4.46,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,JXZDXRISBRZIAA-UHFFFAOYSA-N
CHEMBL3093018,,C=CCCCCOc1ccc(F)cc1-c1cnc(OCCC=C)n1C,IC50,4.06,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,CSIJDNPARFEYCV-UHFFFAOYSA-N
CHEMBL3093027,,Cn1c2cnc1OCCCCCCCCOc1ccc(F)cc1-2,IC50,4.11,CHEMBL3097572,Cytotoxicity against apoptotic-resistant human T98G cells assessed as growth inhibition after 72 hrs by MTT-based colorimetric assay,T98G,IGAPMBZCWRQXDN-UHFFFAOYSA-N
CHEMBL3659991,,CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1,IC50,5.57,CHEMBL4220076,Antiproliferative activity against human U87 cells,U-87MG ATCC,ZBBDKEHQTOTGRO-UHFFFAOYSA-N
CHEMBL85048,,COc1cccc2cc(-c3ccccc3)c(O)nc12,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,WKUIEDQCNTVPIR-UHFFFAOYSA-N
CHEMBL85048,,COc1cccc2cc(-c3ccccc3)c(O)nc12,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,WKUIEDQCNTVPIR-UHFFFAOYSA-N
CHEMBL4437779,,COc1ccc(C2CC(c3ccc4ccccc4c3)=NN2C2=NC(=O)/C(=C3/C(=O)Nc4ccc(C)cc43)S2)cc1,EC50,6.64,CHEMBL4340129,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,RXWBUUZJSGAQNO-ZIADKAODSA-N
CHEMBL4289446,,C[N+](C)(CCOP(=O)([O-])OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1OC(=O)c1ccccc1)Cc1ccccc1,IC50,5.7,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,OWFIZODXJXOTEE-RBZQAINGSA-N
CHEMBL4282076,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3ccccc3)O2)cc1F,IC50,4.49,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,SNJLCEROIWROPY-YNEHKIRRSA-N
CHEMBL4278613,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)Oc3ccc4ncccc4c3)O2)cc1F,IC50,5.72,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,GEUOSZWLJLGCAR-ARFHVFGLSA-N
CHEMBL1927611,,CCCCn1nnc2cc3c4c(cccc4c21)C(=O)N(CCN(C)C)C3=O,IC50,5.84,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WGNOVGWSADFUFQ-UHFFFAOYSA-N
CHEMBL5413649,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(Br)c3)ccc2NS(C)(=O)=O)c1,IC50,6.28,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,HIOFAGZBNFHBTQ-UHFFFAOYSA-N
CHEMBL5426295,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,5.69,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,OMRMOMGAFQHZAC-UHFFFAOYSA-N
CHEMBL4210516,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)O[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,8.7,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,SALXJHIWNUWMJC-RKHHLZPHSA-N
CHEMBL1914717,,O=S(=O)(Nc1cc(-c2ccc3nnccc3c2)cnc1Cl)c1ccc(F)cc1,IC50,5.72,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,VCBPUBKXIUCCIO-UHFFFAOYSA-N
CHEMBL1914720,,O=S(=O)(Nc1cc(-c2ccc3nccc(N4CCCCC4)c3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.3,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,ZCCGGRQYWABCQX-UHFFFAOYSA-N
CHEMBL1914737,,CN(C)c1cnc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cc2n1,IC50,7.36,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,SFNZMGFKQRJYOV-UHFFFAOYSA-N
CHEMBL1914740,,O=S(=O)(Nc1cc(-c2ccc3ncc(N4C[C@H]5CC[C@H](CC5)C4)nc3c2)cnc1Cl)c1ccc(F)cc1,IC50,6.61,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,YMALNMKYJXDZRH-HDICACEKSA-N
CHEMBL1928602,,Cc1ccc(S(=O)(=O)N2c3ccccc3[C@H]3COC4=C(C(=O)c5ccccc5C4=O)[C@H]32)cc1,IC50,5.41,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,NYYWIMCKZBTYCE-OFNKIYASSA-N
CHEMBL599620,,O=C1C2=C(C(=O)c3ccccc31)[C@H]1Oc3ccc([N+](=O)[O-])cc3[C@H]1CO2,IC50,5.05,CHEMBL1932170,Antineoplastic activity against human SF295 cells after 72 hrs by MTT assay,SF295,HKGUYNZPILAARL-ACJLOTCBSA-N
CHEMBL3112718,,COc1ncc(-c2cnc3nc(N)nc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,6.2,CHEMBL4220371,Antiproliferative activity against human U87MG cells after 4 days by Celltiter-Glo luminescence cell viability assay,U-87MG ATCC,PXMBVEZQNFLFAI-UHFFFAOYSA-N
CHEMBL5417439,,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@@]1(C)[C@H](C2)C(C)(C)[C@H](O)C[C@@H]1O,IC50,6.29,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,QSGMDCONBUKXFI-ZLSLZSISSA-N
CHEMBL5416867,,C#CCOc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.54,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,OCLGZGCWFAWRSR-UQWWERDESA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.46,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,7.4,CHEMBL891734,Cytotoxicity against human XF498 cells by SRB assay,XF 498,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4741608,,O=C(Nc1ccc(Cl)cc1)Nc1cccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)c1,IC50,6.0,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,NIXLRJFSGVRJDB-NTEUORMPSA-N
CHEMBL260000,,NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1,IC50,5.37,CHEMBL932640,Growth inhibition of human U87MG cells by SRB assay,U-87MG ATCC,KCWPSUKJCKZEAO-UHFFFAOYSA-N
CHEMBL4440344,,CCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC,IC50,5.72,CHEMBL4417156,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,LUTSMTMYLLRKGQ-BHUDLXTMSA-N
CHEMBL4781277,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(-c3ccccc3)nc12,IC50,6.38,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,DXMKHNHIGFRRCN-UHFFFAOYSA-N
CHEMBL189963,PALBOCICLIB,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,IC50,6.46,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,AHJRHEGDXFFMBM-UHFFFAOYSA-N
CHEMBL4209066,,CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(Br)cc4)c3=O)cc2)ccn1,IC50,5.29,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,LXOUSUKBGVWKHI-UHFFFAOYSA-N
CHEMBL4868381,,CC12CC3CC(C)(C1)CC(NCc1cccc(NC(=O)CCCCCCC(=O)NO)c1)(C3)C2,IC50,5.85,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,HVRZKHZWMPYXIF-UHFFFAOYSA-N
CHEMBL4860287,,CC12CC3CC(C)(C1)CC(NCc1ccc(NCc4ccc(C(=O)NO)cc4)cc1)(C3)C2,IC50,5.62,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,OYYLVIRWYJWNIM-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,7.81,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL483847,,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,IC50,4.5,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,WEVYNIUIFUYDGI-UHFFFAOYSA-N
CHEMBL36,PYRIMETHAMINE,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,IC50,4.69,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,WKSAUQYGYAYLPV-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.05,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL449158,BRYOSTATIN 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3,IC50,6.31,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,MJQUEDHRCUIRLF-TVIXENOKSA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,6.62,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,4.45,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,4.05,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,CEGSUKYESLWKJP-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.87,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,4.42,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,CTESJDQKVOEUOY-UHFFFAOYSA-N
CHEMBL258844,,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,IC50,4.54,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,BIWGYFZAEWGBAL-UHFFFAOYSA-N
CHEMBL558642,GSK-650394,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,IC50,4.12,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,WVSBGSNVCDAMCF-UHFFFAOYSA-N
CHEMBL1091644,LINSITINIB,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,IC50,4.18,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,PKCDDUHJAFVJJB-VLZXCDOPSA-N
CHEMBL105784,,CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1,IC50,9.22,CHEMBL815091,Concentration required to inhibit the entry of HIV-1 reporter virus (ADA) into U-87 cells by 50%,U-87MG ATCC,KHXJCLMSOWKPMR-BGABXYSRSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.4,CHEMBL4262752,Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,7.29,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL553025,VINORELBINE,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,7.92,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,GBABOYUKABKIAF-IELIFDKJSA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,6.57,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL221137,EMBELIN,CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O,IC50,5.76,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,IRSFLDGTOHBADP-UHFFFAOYSA-N
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.76,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL289228,TIPIFARNIB,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,IC50,5.67,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,PLHJCIYEEKOWNM-HHHXNRCGSA-N
CHEMBL288441,BOSUTINIB,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,IC50,5.56,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,UBPYILGKFZZVDX-UHFFFAOYSA-N
CHEMBL210618,,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,IC50,4.49,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,KQMPRSZTUSSXND-UHFFFAOYSA-N
CHEMBL393929,,O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1,IC50,4.38,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,XOLMRFUGOINFDQ-YBEGLDIGSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,7.72,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL1614701,SELUMETINIB,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,IC50,4.31,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,CYOHGALHFOKKQC-UHFFFAOYSA-N
CHEMBL1173055,RUCAPARIB,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.49,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,HMABYWSNWIZPAG-UHFFFAOYSA-N
CHEMBL810,TEMOZOLOMIDE,Cn1nnc2c(C(N)=O)ncn2c1=O,IC50,4.27,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,BPEGJWRSRHCHSN-UHFFFAOYSA-N
CHEMBL4462577,,COc1ccc(-c2cc(OCCN(C)c3ncc(C(=O)NO)cn3)c3ncnc(C)c3c2)cn1,IC50,6.47,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,GVPYBTYCSMGVJF-UHFFFAOYSA-N
CHEMBL2407685,,CCC1=C[C@@H]2CN(C1)/C(C(=O)NC(C)C)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.46,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,OOZUTWKHVKEHJA-HAIPHDKGSA-N
CHEMBL2407575,,CCC1=C[C@@H]2CN(C1)/C(C(=O)OC)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,6.16,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,WOCJLYOUBCFBGS-OUEVRHDASA-N
CHEMBL2407572,,CCC1=C[C@@H]2CN(/C=C(/C(=O)OC)Cc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,6.16,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,IRMFYALZOGMPTP-WPHLDODYSA-N
CHEMBL415960,,O=c1[nH]c(=O)n([C@H]2S[C@@H](CO)[C@H](O)[C@@H]2O)cc1F,IC50,4.38,CHEMBL691299,In vitro cytotoxicity against HTB14 human glioma cell line,U-87MG ATCC,FLAHATSCJQFZKB-TYQACLPBSA-N
CHEMBL443747,,Cc1ccc2c(N3CCN(C)CC3)nc(-c3ccccc3C)cc2c1,IC50,5.18,CHEMBL822902,In vitro cytotoxicity against XF498 (human CNS) tumor cell line.,XF 498,CQNQPKDGOOMWLD-UHFFFAOYSA-N
CHEMBL4459634,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)cc2)cc1,IC50,4.7,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,RACOPDZWMOVJGX-BJMVGYQFSA-N
CHEMBL4472807,,O=C(/C=C/c1ccc(-n2cnc3ccccc32)cc1)c1cccc(O)c1,IC50,4.97,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,OFWLIONWWZAJBY-JLHYYAGUSA-N
CHEMBL3335762,,O=c1ccc(-c2cccc(Cl)c2)nn1C[C@@H]1CN(c2ncc(-c3cnn(C4CCNCC4)c3)cn2)CCO1,IC50,5.0,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,ZNHGQRICZRXNDO-DEOSSOPVSA-N
CHEMBL3335783,,N#Cc1cccc(-c2ccc(=O)n(C[C@@H]3CN(c4ncc(-c5ccc(OCCN6CCOCC6)c(Cl)c5)cn4)CCO3)n2)c1,IC50,5.85,CHEMBL3389848,Cytotoxicity against human U87MG cells after 72 hrs by WST8 assay,U-87MG ATCC,YYJDVXLJGBXQRF-MHZLTWQESA-N
CHEMBL4520670,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(O)c(C(F)(F)F)c2)c1,IC50,4.46,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,IRTWUJOEIWQCHP-FNORWQNLSA-N
CHEMBL4520508,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(O)cc2)c1,IC50,4.49,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,ZZCQHDGFTSZZOY-BJMVGYQFSA-N
CHEMBL4550951,,N#Cc1ccc(/C=C/C(=O)c2ccc(O)c(F)c2)cc1,IC50,4.55,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,KWEGBFABGINGLE-FNORWQNLSA-N
CHEMBL4447323,,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.46,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,KMNSOGVLHRWNCE-MDWZMJQESA-N
CHEMBL4520508,,COC(=O)c1cccc(/C=C/C(=O)c2ccc(O)cc2)c1,IC50,4.54,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,ZZCQHDGFTSZZOY-BJMVGYQFSA-N
CHEMBL4447323,,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.59,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,KMNSOGVLHRWNCE-MDWZMJQESA-N
CHEMBL2385199,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cc(C(F)(F)F)ccc5Cl)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.85,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,JYQLVVOBTMGKEW-UHFFFAOYSA-N
CHEMBL539855,,CN1CCOc2cccc3nc(O)c(nc23)-c2cccc3c(=O)n(sc23)CC1.Cl,IC50,7.89,CHEMBL910891,Inhibition of E2F transcription activity in T98G cells expressing CDC6 promoter gene,T98G,UAWACQSTQPYGJL-UHFFFAOYSA-N
CHEMBL3618231,,COc1ccc(Nc2nc3ccccn3c2-c2nc(C)nc(N)n2)cn1,IC50,7.4,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,GMDFBJKMPHZUTJ-UHFFFAOYSA-N
CHEMBL3618240,,COc1ncc(Nc2nc3ccc(N4CCN(C(C)C)CC4)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,6.53,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,OWFAMDTUROKDJB-UHFFFAOYSA-N
CHEMBL3618245,,COc1ncc(Nc2nc3ccc(C(C)(C)O)cn3c2-c2nc(C)nc(N)n2)cc1F,IC50,8.35,CHEMBL3620382,Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by alpha screen assay,U-87MG ATCC,IYNZEXDVRAZUPW-UHFFFAOYSA-N
CHEMBL5281433,,c1ccc(-c2nc(CNc3nccc(NC4CCCCC4)n3)cs2)cc1,IC50,4.93,CHEMBL5250714,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,ROALZJVDIFVDHW-UHFFFAOYSA-N
CHEMBL3715519,,O=C(/C=C/c1ccc2cccc(O)c2n1)c1ccncc1,IC50,5.78,CHEMBL3720731,Inhibition of cell proliferation of human U87MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,DROJYBGOPVMSMV-VOTSOKGWSA-N
CHEMBL5618400,,CCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.97,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,ZSGFENIVWPHHNA-DHUJRADRSA-N
CHEMBL5620079,,CCCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,5.14,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,WMHNKAPHRPPRMJ-QNGWXLTQSA-N
CHEMBL5620269,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.43,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,LSCFMIBDVFNSCU-NDEPHWFRSA-N
CHEMBL5618865,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2c(F)cccc12)c1c[nH]c2c(F)cccc12,IC50,5.26,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,GVYYFFSSLUXDQY-SANMLTNESA-N
CHEMBL5618668,,CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.63,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,BXPIBHVYDBWEDU-NDEPHWFRSA-N
CHEMBL5619638,,CCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.98,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,IORSARDCFLNDGU-UMSFTDKQSA-N
CHEMBL572881,MOTESANIB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,IC50,4.25,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,RAHBGWKEPAQNFF-UHFFFAOYSA-N
CHEMBL1972860,ELESCLOMOL,CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1,IC50,7.68,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,BKJIXTWSNXCKJH-UHFFFAOYSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,5.35,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL393929,,O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1,IC50,5.23,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,XOLMRFUGOINFDQ-YBEGLDIGSA-N
CHEMBL255342,,O=C1/C(=C/c2cccs2)CC/C1=C\c1cccs1,IC50,4.46,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,KPFZCKDPBMGECB-WGDLNXRISA-N
CHEMBL315586,,COc1cc(OC)c2cc(-c3ccc(OC(C)=O)cc3)c(=O)n(C)c2c1,IC50,5.0,CHEMBL815080,Cytotoxicity against U-87 MG glioblastomas using MTT colorimetric assay,U-87MG ATCC,DPKRAOIUIBYOGG-UHFFFAOYSA-N
CHEMBL315586,,COc1cc(OC)c2cc(-c3ccc(OC(C)=O)cc3)c(=O)n(C)c2c1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,DPKRAOIUIBYOGG-UHFFFAOYSA-N
CHEMBL5185523,,O=C(NC1CCCCC1)c1[nH]cnc1-c1nc2ccccc2[nH]1,IC50,4.21,CHEMBL5117724,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay,LN-229,JABMGIWPHDQZBN-UHFFFAOYSA-N
CHEMBL5191048,,CN1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.9,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,VMBGOURPMZPQKK-UHFFFAOYSA-N
CHEMBL5202758,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(C3CC3)CC2)cc1)OCc1cccnc1,IC50,5.98,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YIZPEFOMDBKNLH-UHFFFAOYSA-N
CHEMBL5198901,,COCCN1CCN(c2ccc(N)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.25,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,YNEHDLYTCXJMDF-UHFFFAOYSA-N
CHEMBL5195459,,COCCN1CCN(c2ccc(Br)cc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,5.58,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,DNCCJXQJWBFRJN-UHFFFAOYSA-N
CHEMBL5170843,,COCCN1CCN(c2c(C)cccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.0,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,XZKSUYJOLGVZJU-UHFFFAOYSA-N
CHEMBL64925,MG-132,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,IC50,5.44,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,TZYWCYJVHRLUCT-VABKMULXSA-N
CHEMBL258844,,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,IC50,5.11,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,BIWGYFZAEWGBAL-UHFFFAOYSA-N
CHEMBL5282240,,C/C=C/Cn1cc(-c2ccc(C(C)(C)O)cc2OC)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261885,Cytotoxicity against human T98G cells measured after 8 days,T98G,GVJYOLRRZZUUOE-AATRIKPKSA-N
CHEMBL5630349,,C#CCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,4.79,CHEMBL5621070,"Antiproliferative activity against human U87 cells incubated for 48 hrs in presence of (2S,4R)-1-((S)-2-(5-azidopentanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide by MTT assay",U-87MG ATCC,IJDJQTVSYXXWMT-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,5.09,CHEMBL2091818,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by MTT assay,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4277691,,COc1ccc(Cn2cc(C(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)nn2)cc1OC,IC50,6.07,CHEMBL4423095,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,FSJLTXIAYGJAJT-UHFFFAOYSA-N
CHEMBL325041,BORTEZOMIB,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,IC50,5.11,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,GXJABQQUPOEUTA-RDJZCZTQSA-N
CHEMBL5290555,,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(N)=O,IC50,4.73,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,NEIQYEKCZHGMGF-OZUVFQIFSA-N
CHEMBL4520892,,Fc1ccc(/C=N/Nc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1F,IC50,4.52,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,XDKIXIWBMYDGIV-LIMNOBDPSA-N
CHEMBL413,SIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,6.92,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,QFJCIRLUMZQUOT-HPLJOQBZSA-N
CHEMBL217092,SARACATINIB,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,IC50,5.57,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,OUKYUETWWIPKQR-UHFFFAOYSA-N
CHEMBL1242367,,CCNc1cc(N[C@H]2CC[C@@H](O)CC2)nc(Nc2ccc3c(ccn3Cc3ccccc3)c2)n1,IC50,4.86,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,YVXCDLCJCIDFHE-DKXQDJALSA-N
CHEMBL554,LAPATINIB,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,IC50,4.34,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,BCFGMOOMADDAQU-UHFFFAOYSA-N
CHEMBL4090941,,C=C[C@]1(C)CC[C@@H](C(=C)COC(=O)CNC(=O)CCC(=O)OCCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)C[C@H]1C(=C)C,IC50,8.7,CHEMBL5228642,Cytotoxicity against human U87 cells,U-87MG ATCC,IGHHYVSLRSHUME-SZZCUWPLSA-N
CHEMBL3600441,,COc1ncc(-c2ccc3nc(NC(=O)NCC(=O)N4CCOCC4)nn3c2)cc1NS(=O)(=O)c1ccc(F)cc1,IC50,5.49,CHEMBL3602198,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BQXGFTKZRMUKEA-UHFFFAOYSA-N
CHEMBL3588937,,CC[C@H](C)C(=O)Oc1ccc(/C=C/COC(C)=O)cc1OC,IC50,6.32,CHEMBL3592118,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,OGNZVIKZDOKDLK-SYTKJHMZSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.7,CHEMBL4480830,Cytotoxicity against human A172 cells after 72 hrs by MTT assay,A-172,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5086100,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CCCCC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.52,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,DBJDUIQIYKJHPB-SMRIDXHDSA-N
CHEMBL5076815,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.53,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,YSEVIHSXDAOIMX-VZHCALMGSA-N
CHEMBL5082185,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.45,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,MZYJAIGPHMIGGJ-MPOPNXFASA-N
CHEMBL5089530,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C#N)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.57,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,GTGMLRAJBUWXCG-VZHCALMGSA-N
CHEMBL5091566,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.48,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,BZQJKEMXKXEHFN-WFVGHVPHSA-N
CHEMBL4875135,,COc1ccc(C)c2c1CC1(C(=O)N(C)C(=O)N1C)C1=C2C(=O)c2[nH]cc(CCNC(=O)c3ccco3)c2C1=O,IC50,5.59,CHEMBL4831830,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,LLOJEEJKHZKUMN-UHFFFAOYSA-N
CHEMBL4848269,,COc1ccc2[nH]cc(CCn3nnc4c3C(C)(C)[C@@H]3CC[C@]5(C)[C@H](CC=C6[C@@H]7CC(C)(C)CC[C@]7(C(=O)O)CC[C@]65C)[C@@]3(C)C4)c2c1,IC50,4.36,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,MVMWIJMMJOGXPC-CXAHALKTSA-N
CHEMBL3792832,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1ccc(Cl)cc1,IC50,6.17,CHEMBL3795432,Antiproliferative activity against human T98G cells assessed as cell viability after 48 hrs by MTT assay,T98G,KWNHGHKHLZMRLZ-YNEHKIRRSA-N
CHEMBL3793820,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1CO)c1cc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)cc(C(=O)O[C@H]2C[C@H](n3cc(F)c(=O)[nH]c3=O)O[C@@H]2CO)c1,IC50,4.98,CHEMBL3795434,Antiproliferative activity against human U87MG cells assessed as cell viability after 48 hrs by MTT assay,U-87MG ATCC,YRYZCLZPZKWTEP-PWRNOJCPSA-N
CHEMBL4854240,,C[C@H]1[C@@H](O[C@@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@H](O)[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]43)C2)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.54,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,RNWIIGNOXMOPCU-HFXUAUAYSA-N
CHEMBL2042472,,CN(C)c1ccc2c(c1)OC(N)=C(C#N)C2c1cccc2c(F)cccc12,IC50,7.2,CHEMBL2044174,Antiproliferative activity against human U87 cells after 5 days by MTT assay,U-87MG ATCC,YKVMJQBXOMKRHY-UHFFFAOYSA-N
CHEMBL810,TEMOZOLOMIDE,Cn1nnc2c(C(N)=O)ncn2c1=O,IC50,4.19,CHEMBL2044176,Antiproliferative activity against human A172 cells after 5 days by MTT assay,A-172,BPEGJWRSRHCHSN-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.8,CHEMBL4416282,Antiproliferative activity against human U87MG cells assessed as reduction in cell viability after 72 hrs by SRB assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1236095,,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,IC50,5.54,CHEMBL5708690,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by celltiter-glo assay,SF295,JFOAJUGFHDCBJJ-UHFFFAOYSA-N
CHEMBL1236095,,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,IC50,6.69,CHEMBL5708692,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth incubated for 72 hrs by celltiter-glo assay,T98G,JFOAJUGFHDCBJJ-UHFFFAOYSA-N
CHEMBL5631831,,C#CCO[C@H]1C=C(C(C)C)[C@]2(CCCC(=O)O2)[C@H]2CC[C@]3(C)C(=CC(=O)O[C@H]3c3ccoc3)[C@]12C,IC50,6.11,CHEMBL5627877,Anticancer activity against human A-172 cells assessed as reduction in cell viability incubated for 72 hrs by Alamar Blue assay,A-172,ZEXXLMFXMQNCPC-UQJYIFJESA-N
CHEMBL5618668,,CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.33,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,BXPIBHVYDBWEDU-NDEPHWFRSA-N
CHEMBL5618247,,CCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.9,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,LJBFWTUMACMVTG-XIFFEERXSA-N
CHEMBL4206033,BAY1436032,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,IC50,7.82,CHEMBL5625292,Antiproliferative activity against human LN-229 cells assessed as reduction in cell growth incubated for 5 days by Celltiter-Glo assay,LN-229,RNMAUIMMNAHKQR-QFBILLFUSA-N
CHEMBL5631626,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3ncc(F)c(N4C(=O)OCC4(C)C)n3)cc2)CC1,IC50,7.73,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,FUDYXUKVOLBVPN-KRWDZBQOSA-N
CHEMBL1800934,,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,IC50,8.36,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,MLQLUFQBFMFXJO-QKKBWIMNSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,7.21,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL601719,CRIZOTINIB,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,IC50,4.05,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,KTEIFNKAUNYNJU-GFCCVEGCSA-N
CHEMBL513909,BI-2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,IC50,6.59,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,XQVVPGYIWAGRNI-JOCHJYFZSA-N
CHEMBL4859606,,CN(C)c1ccc(/C=C/c2cc(/C=C3\Sc4ccccc4N3CCCN3CCOCC3)c3ccccc3[n+]2C)cc1.[I-],IC50,4.82,CHEMBL4834608,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,GWKIKXZINVGPPC-UHFFFAOYSA-M
CHEMBL1173655,AFATINIB,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,IC50,4.3,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,ULXXDDBFHOBEHA-CWDCEQMOSA-N
CHEMBL1090090,VX-702,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F,IC50,4.01,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,FYSRKRZDBHOFAY-UHFFFAOYSA-N
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,4.88,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,CEGSUKYESLWKJP-UHFFFAOYSA-N
CHEMBL399530,,CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,IC50,5.13,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,OWPMENVYXDJDOW-UHFFFAOYSA-N
CHEMBL5567846,,COc1ccc(N(Cc2cn(S(=O)(=O)c3ccc(C)cc3)nn2)C2=CC(=O)c3ccccc3C2=O)cc1,IC50,6.38,CHEMBL5514115,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,SF295,YYCWDXYXDBGOSK-UHFFFAOYSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,5.89,CHEMBL5621064,Antiproliferative activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL5573795,,N#CC1=C(N)Oc2c(ccc3cccnc23)C1c1ccc(Cl)c(Cl)c1,IC50,5.21,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,RHAXVWDHVALGPB-UHFFFAOYSA-N
CHEMBL5572022,,N#CC1=C(N)Oc2c(cc(Cl)c3cccnc23)C1c1ccccc1,IC50,5.36,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,GOOCOOVJUWBXFS-UHFFFAOYSA-N
CHEMBL5568956,,COc1ccc(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)c(OC)c1OC,IC50,5.28,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,WAEKICOBONBQNO-UHFFFAOYSA-N
CHEMBL5575261,,COc1cc(OC)c(C2C(C#N)=C(N)Oc3c2ccc2ccc(C)nc32)cc1OC,IC50,5.33,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,GVXBTRKMBKAEMP-UHFFFAOYSA-N
CHEMBL5283179,,CCC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C,IC50,5.57,CHEMBL5445497,"Affinity Phenotypic Cellular interaction: (ProQinase broad tumor cell line profiling (CellTiterGlo assay, antiproliferative activity in brain, A172,cancer cell line)) EUB0001183a CSNK2A1",A-172,YKDZIFFKQUNVHH-UHFFFAOYSA-N
CHEMBL2398338,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(I)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.34,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,UZYGIQDDFAEAQN-UHFFFAOYSA-N
CHEMBL4789623,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)Nc2ccc(F)cc2)cc1,IC50,5.47,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,NLPAQCHZGISERZ-UHFFFAOYSA-N
CHEMBL2144684,,COc1cc2cc(C(=O)NCCc3c[nH]c4ccccc34)c(N)nc2cc1OC,IC50,4.36,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,QCHLGZWWWSKMPE-UHFFFAOYSA-N
CHEMBL5572679,,N#CC1(C(=O)Nc2ccc([N+](=O)[O-])cc2)CC2c3ccccc3C1c1ccccc12,IC50,4.71,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,QKMWZJJOEMMGRF-UHFFFAOYSA-N
CHEMBL5594023,,N#CC1(C(=O)NCCc2ccc(Cl)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.11,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,SYLBGAKAQUBPER-UHFFFAOYSA-N
CHEMBL2398330,,COc1ccc(C(=O)Nc2ccc(N(C)S(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,8.73,CHEMBL4713864,Antiproliferative activity against human T98G cells overexpressing AR assessed as reduction in cell viability incubated for 48 hrs by MTT assay,T98G,LNDXEXUTQMQCLA-UHFFFAOYSA-N
CHEMBL4778389,,C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)[C@H]3O[C@H]3[C@]3(C[C@@H]([C@H](C)O)C(=O)O3)[C@]1(C)[C@@H]2OC(=O)CCCCCCCCCCC,IC50,6.16,CHEMBL4703288,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by CellTiter Glo assay,U-87MG ATCC,DQJKVVGTJNBSOS-FNWZZRCQSA-N
CHEMBL5569152,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCCC(=O)NC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.54,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,GVMAIWHRYQNXBM-ODVYPAPQSA-N
CHEMBL498271,,C=C(c1ccc(OC)c(O)c1)c1cc(OC)c(OC)c(OC)c1,IC50,8.08,CHEMBL5056082,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CellTiter-Glo reagent based luminescence assay,U-87MG ATCC,CNGKIRSNRQSORA-UHFFFAOYSA-N
CHEMBL4636205,,COc1ccc2c(c1)O[C@@H]1c3cc(OC)c(OC)cc3OC[C@H]21,IC50,5.44,CHEMBL4619138,Cytotoxicity against human SF295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XCRBPIBUMBLGCZ-FZKQIMNGSA-N
CHEMBL3797933,,Nc1nc2cc(-c3nn(CC4CCCC4)c4ncnc(N)c34)ccc2o1,EC50,7.89,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,GUFVTKTWKYLOQP-UHFFFAOYSA-N
CHEMBL3797834,,Nc1nc2cc(-c3nn(CC4CCCO4)c4ncnc(N)c34)ccc2o1,EC50,7.0,CHEMBL4610640,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by Prestoblue reagent based assay,U-87MG ATCC,NIIYHUNRXQLMBG-UHFFFAOYSA-N
CHEMBL4209984,,CCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccccc4F)c3=O)cc2)ccn1,IC50,5.49,CHEMBL4185091,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,UDAGYKCSEKUJCJ-UHFFFAOYSA-N
CHEMBL4094401,,C=C(c1ccc(OC)cc1)c1nc(C)cc2ccccc12,IC50,6.52,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,ACIGFOPJVNVVEM-UHFFFAOYSA-N
CHEMBL4104557,,C=C(c1ccc(OC)cc1)c1cc(C(N)=O)nc2ccccc12,IC50,6.62,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,GRCGUFRAVOMYDW-UHFFFAOYSA-N
CHEMBL1821794,EUPHODENDROPHANE D,C=C1[C@@H](OC(C)=O)[C@@H](OC(=O)c2ccccc2)[C@@H](OC(C)=O)C(C)(C)/C=C/[C@@H](C)C(=O)[C@@]2(O)C[C@H](C)[C@H](OC(=O)C(C)C)[C@@H]2[C@H]1OC(C)=O,IC50,4.28,CHEMBL1827319,Anticancer activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,ZDNXSCUQPPKQFI-GIDYPEMCSA-N
CHEMBL4076617,,Cc1cc(=O)n(-c2cccc(C(F)(F)F)c2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)c(F)c1,IC50,5.64,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KLBRHXOKSPCITH-UHFFFAOYSA-N
CHEMBL2385203,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5cccc(F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,5.61,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,LGOXXSVEWLLEKB-UHFFFAOYSA-N
CHEMBL2385189,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5Br)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.67,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,MSITUNSZTDTYHG-UHFFFAOYSA-N
CHEMBL4777512,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3cccc(CS(=O)(=O)N(C(C)C)C(C)C)c3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.62,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,GPZJQNHHEUXZBK-LJRMQGSKSA-N
CHEMBL102809,,O=C1c2cccnc2C(=O)c2ncc(CBr)cc21,IC50,6.3,CHEMBL801363,In vitro cytotoxic activity against SF-295 (CNS carcinoma) cell lines by using SRB assay,SF295,BURDIDMYOSZEKU-UHFFFAOYSA-N
CHEMBL1782894,,CCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(OC)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.75,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,XFTYNIHRCPHPLE-QQJYNPJZSA-N
CHEMBL1782908,,CCCCCCCc1cn([C@@H]2c3cc4c(cc3[C@@H](c3cc(OC)c(O)c(OC)c3)[C@H]3C(=O)OC[C@@H]32)OCO4)nn1,IC50,5.0,CHEMBL1785372,Cytotoxicity against human SF295 cells after 48 hrs by sulforhodamine B assay,SF295,ZWDSPRLENGPJSS-GVQBMFDGSA-N
CHEMBL4100154,,CCCCc1ccc(C(=O)/C=C/c2ccc([N+](=O)[O-])o2)cc1,EC50,5.24,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,GZGDJNZTNKYESX-PKNBQFBNSA-N
CHEMBL185,FLUOROURACIL,O=c1[nH]cc(F)c(=O)[nH]1,IC50,5.31,CHEMBL5527512,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by SRB assay,U-87MG ATCC,GHASVSINZRGABV-UHFFFAOYSA-N
CHEMBL2170092,,Cc1nc(N)nc(-c2cc(CN3CCN(S(C)(=O)=O)CC3)cnc2Nc2ccc(Cl)nc2)n1,IC50,7.46,CHEMBL2173752,Inhibition of PI3K-mediated AKT Ser473 phosphorylation in human U87MG cells after 2 hrs,U-87MG ATCC,DDOGMZTWQKWDBQ-UHFFFAOYSA-N
CHEMBL2164699,,Cc1c2c(cc[n+]1CCO)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-],IC50,5.54,CHEMBL2166484,Growth inhibition of human T98G cells after 3 days by MTT assay,T98G,WQWPESUTDGGMLK-UHFFFAOYSA-M
CHEMBL1778208,,Cc1c2c(n3c1CCCNC(=O)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.38,CHEMBL1781357,Antiproliferative activity against human T98G cells,T98G,SRLFTYLZJAKYNU-AWEZNQCLSA-N
CHEMBL1778208,,Cc1c2c(n3c1CCCNC(=O)[C@H](C)Nc1cc-3ccc1C(N)=O)CC(C)(C)CC2=O,IC50,7.1,CHEMBL1781358,Antiproliferative activity against human U87MG cells,U-87MG ATCC,SRLFTYLZJAKYNU-AWEZNQCLSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,5.59,CHEMBL5509850,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL5562174,,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccc(NC(=O)COc3cccnc3)cc2)cc1,IC50,6.05,CHEMBL5509852,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,NGXVQQDDOXHWSX-CUVVAGTFSA-N
CHEMBL5562495,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCNCc1ccc(-c2cccc(-c3ccccc3)c2C)nc1OC,IC50,5.97,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,VVLHCHPQYBPEER-UHFFFAOYSA-N
CHEMBL5072935,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.4,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,CUINUPNRWNLOJW-VZTVURHLSA-N
CHEMBL5091183,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7nccs7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.57,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,WLZOZZHOZLJSCI-RCGAJBMESA-N
CHEMBL5081089,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C#N)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.33,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,HVZRIWTYRLQBBL-MPOPNXFASA-N
CHEMBL5072935,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.57,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,CUINUPNRWNLOJW-VZTVURHLSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.77,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5076062,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Cl)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.28,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,AWKSMQZRGODOHH-MCLIRCHUSA-N
CHEMBL5081089,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C#N)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.61,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,HVZRIWTYRLQBBL-MPOPNXFASA-N
CHEMBL5072935,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.43,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,CUINUPNRWNLOJW-VZTVURHLSA-N
CHEMBL5082849,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(C(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.6,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,IKANBESOKWBFOM-DKAJQEPCSA-N
CHEMBL5086100,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC7CCCCC7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.51,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,DBJDUIQIYKJHPB-SMRIDXHDSA-N
CHEMBL5560744,,O=C(CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O)NCc1ccccc1,IC50,4.75,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,DPMNMEXKPODRQY-MRXNPFEDSA-N
CHEMBL5561001,,CNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.54,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,KLVWGRQAXNOKKU-LLVKDONJSA-N
CHEMBL5568088,,Cc1ccc(S(=O)(=O)N[C@H](CCC(=O)NCC(C)C)C(=O)O)cc1,IC50,4.58,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,FPNCESYOAUSRJV-CQSZACIVSA-N
CHEMBL5558526,,CCCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)O,IC50,4.48,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,PIUOPAFPGCAJPW-OAHLLOKOSA-N
CHEMBL5078850,,Cc1ccc(NC(=O)C[C@H]2SC(NC(c3ccc(F)cc3)c3c(O)[nH]c(=O)[nH]c3=O)=NC2=O)cc1C,IC50,4.33,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,IOCQRHYFRXFFQW-VTBWFHPJSA-N
CHEMBL1558546,,COc1ccc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)C(C)C)cc2)cc1,IC50,4.25,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,UQCKAVVYNFPENZ-UHFFFAOYSA-N
CHEMBL5284601,,CCN(CC)c1ccc2cc(-c3nc4cc(C5=NCCN5)ccc4[nH]3)c(=O)oc2c1.Cl,IC50,5.85,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,UIOIAAZYDYFLLF-UHFFFAOYSA-N
CHEMBL9514,NOCODAZOLE,COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1,IC50,7.0,CHEMBL5260656,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by CellTiter96 Aqueous One Solution cell proliferation assay,LN-229,KYRVNWMVYQXFEU-UHFFFAOYSA-N
CHEMBL5423568,,C#CCN(C)CCCOc1ccc(N(C)C(=O)c2cc(C(C)C)c(O)cc2O)cc1Cl,IC50,6.34,CHEMBL5371254,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth measured after 72 hrs by CCK8 method,T98G,JHKZNXCXUMFEOS-UHFFFAOYSA-N
CHEMBL4449607,,N#Cc1cccc(/C=C/C(=O)c2ccc(O)c(F)c2)c1,IC50,4.66,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,OMUNGWCVIFBULF-GQCTYLIASA-N
CHEMBL4792276,,CCOP(=O)(Cc1ccc(Nc2ncc3scc(-c4ccccc4OC)c3n2)cc1)NC,IC50,5.89,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,JHGVHNNCSQFDDF-UHFFFAOYSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.82,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,4.5,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,GFMMXOIFOQCCGU-UHFFFAOYSA-N
CHEMBL5618867,,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(/C=C/C(=O)NO)cc2)ccc1O,IC50,5.27,CHEMBL5614770,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,LN-229,VNSNXSBINKRROS-KZHHGSSRSA-N
CHEMBL4444616,,COc1cc(C(=O)c2cn(-c3cccc(N)c3)cc2-c2ccccc2F)cc(OC)c1OC,IC50,7.21,CHEMBL4316285,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay,U-87MG ATCC,AOPYZCNEKFOSTL-UHFFFAOYSA-N
CHEMBL4454458,,COc1cc(-c2ccc(O)c(O)c2)c(OC)c(O)c1-c1ccc(OCC=C(C)C)c(O)c1,IC50,4.86,CHEMBL4344200,Cytotoxicity against human U87 cells after 24 hrs by SRB method,U-87MG ATCC,BAJXGZAFNOHQFY-UHFFFAOYSA-N
CHEMBL1230609,FORETINIB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,6.02,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CXQHYVUVSFXTMY-UHFFFAOYSA-N
CHEMBL4072042,,COC(=O)[C@H](NC(=O)COCCOCCOCCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1)C(C)C,IC50,6.96,CHEMBL4041767,Antiproliferative activity against human U87MG cells after 72 hrs by SRB assay,U-87MG ATCC,MVGCPIGVTXRNLD-UUWRZZSWSA-N
CHEMBL888,GEMCITABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,IC50,6.13,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,SDUQYLNIPVEERB-QPPQHZFASA-N
CHEMBL1171837,PONATINIB,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12,IC50,5.73,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,PHXJVRSECIGDHY-UHFFFAOYSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,4.64,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.73,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL3349342,,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(CC(O)CO)CC1,IC50,4.42,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,RDSACQWTXKSHJT-UHFFFAOYSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,4.29,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL4577957,,COc1ccc(C(C(=O)NC(C)(C)C)N(C(=O)/C=C/C(=O)c2ccc(C)cc2)C(C)C)cc1,IC50,6.34,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,QTNSHHDKLYQCRG-WUKNDPDISA-N
CHEMBL4589636,,COc1cc(C(C(=O)NC(C)(C)C)N(CCC(C)C)C(=O)/C=C/C(=O)c2ccc(F)cc2)cc(OC)c1OC,IC50,5.54,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,JUDLAZMMKWRKDD-BUHFOSPRSA-N
CHEMBL2407901,,COCCOc1ccc2cc1OCC(=O)N(C)CCCN(C)Cc1c[nH]c3ncnc(c13)N2,IC50,8.3,CHEMBL5513260,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 72 hrs by AlamarBlue assay,U-87MG ATCC,HGGMHYCPDXPSRF-UHFFFAOYSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,5.99,CHEMBL5509853,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL5517720,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)COc4cccnc4)cc3)cc2)n1,IC50,6.24,CHEMBL5509854,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,KRQSJWTXUQGYKQ-KDYSTLNUSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,6.25,CHEMBL5509858,Synergistic antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs in presence of FK866 by CCK8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL4580864,,C/C=C(\C)C(=O)O[C@H]1C=CC(=O)O[C@H]1COC(=O)[C@H](C)O,IC50,4.8,CHEMBL4374033,Antiproliferative activity against human SNB75 cells assessed as reduction in cell viability after 48 hrs by SRB assay,SNB-75,FKBITCOIJAFLNT-SPJFXFQZSA-N
CHEMBL2397988,,COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(O)c2)c(OC)c1,IC50,7.58,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,GZAXTJIYUCUXDY-BQYQJAHWSA-N
CHEMBL2397992,,COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(N)c2)c(OC)c1,IC50,8.05,CHEMBL2400497,Cytotoxicity against human U87 cells after 96 hrs by sulforhodamine B assay,U-87MG ATCC,OLRRWEXEHIWZJV-BQYQJAHWSA-N
CHEMBL5270178,,C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)cc2)c2cc[nH]c2c1=O,IC50,4.7,CHEMBL5261760,Cytotoxicity against human AM-38 cells measured after 8 days,AM-38,JGOZUFGBTSAWEI-NSCUHMNNSA-N
CHEMBL4446068,,O=C(Nc1nc2ccc(F)cc2s1)c1cn(-c2ccccc2)nc1-c1ccccc1,IC50,5.25,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BCGLFSYECNRIGQ-UHFFFAOYSA-N
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,4.66,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RITAVMQDGBJQJZ-FMIVXFBMSA-N
CHEMBL2402943,,CC(C)=CCC[C@]1(C)C=Cc2c(c(C)cc3c2[nH]c2ccccc23)O1,IC50,4.6,CHEMBL2405052,Cytotoxicity against human LN229 cells assessed as growth inhibition after 48 hrs by MTT assay,LN-229,HTNVFUBCWIYPJN-HSZRJFAPSA-N
CHEMBL5570163,,Cc1ccc2ccc3c(c2n1)OC(N)=C(C#N)C3c1cccc(Cl)c1Cl,IC50,5.43,CHEMBL5544541,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth inhibition incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,NUPVGXXBPQRNFR-UHFFFAOYSA-N
CHEMBL5559617,,N#Cc1ccc2nc(NC(=O)Nc3cccc(Cl)c3)sc2c1,IC50,6.07,CHEMBL5506204,Antiproliferative activity against human LN-229 cells assessed as cell growth inhibition measured after 6 days by RealTime-Glow MT cell viability assay,LN-229,URCZUKFRZQNQSQ-UHFFFAOYSA-N
CHEMBL5398001,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(Cl)cc3)ccc2NS(C)(=O)=O)c1,IC50,6.68,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,VHLKUFIUVFOKSP-UHFFFAOYSA-N
CHEMBL2417823,,CCOCCNc1nc2ccc(-c3cnc(OC)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1,IC50,5.09,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,WOVOBVDLACIZOX-UHFFFAOYSA-N
CHEMBL2417819,,COc1ncc(-c2ccc3nc(N)nn3c2)cc1NS(=O)(=O)c1ccc(Cl)cc1,IC50,5.51,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,HDBBMQFYARREDI-UHFFFAOYSA-N
CHEMBL5193900,,CC(C)N1CCN(c2ccccc2C(=O)Nc2ccc(CNC(=O)OCc3cccnc3)cc2)CC1,IC50,6.6,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,ZDWBQZIZWCJTMO-UHFFFAOYSA-N
CHEMBL5203979,,O=C(NCc1ccc(NC(=O)c2ccccc2N2CCN(CCO)CC2)cc1)OCc1cccnc1,IC50,6.19,CHEMBL5132186,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 assay,U-87MG ATCC,WYOGQUUJNMLBBR-UHFFFAOYSA-N
CHEMBL4561563,,COc1ccc(-c2cc3c([nH]c(=O)n3-c3cc(OC)c(OC)c(OC)c3)c(C(N)=O)n2)cc1O,IC50,6.25,CHEMBL5526621,Antiproliferative activity against human U-87 MG assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,WUZIEGHVPAZRFN-UHFFFAOYSA-N
CHEMBL5560224,,COc1cc(-n2cnc3ccc(-c4ccc(C)c(N)c4)nc32)cc(OC)c1OC,IC50,7.82,CHEMBL5526621,Antiproliferative activity against human U-87 MG assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,WAGLVYSVXYGSOH-UHFFFAOYSA-N
CHEMBL4850400,,O=S(=O)(Nc1cc(-c2ccc3nncc(N4CCOCC4)c3c2)cnc1Cl)c1ccccc1,IC50,5.7,CHEMBL4825007,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,LXWMLQCBWUVOFP-UHFFFAOYSA-N
CHEMBL2333591,WITHAMETELIN O,C=C1C(=O)O[C@@H]2C[C@]1(C)OC[C@H]2[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]4(O)CC=CC(=O)[C@]4(C)[C@H]3CC[C@]12C,IC50,5.96,CHEMBL2344179,Cytotoxicity against human U87 cells after 72 hrs by MTS assay,U-87MG ATCC,QDXNBCJROMNCKV-YAZLIRBPSA-N
CHEMBL389390,,C[C@@H](Cc1ccc(O)cc1)NC[C@@H](O)c1cc(O)cc(O)c1,IC50,6.74,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LSLYOANBFKQKPT-APPDUMDISA-N
CHEMBL5277464,,C/C(=C\CN1CCN(C(=O)C2CCCC2)CC1)c1ccccc1,IC50,4.41,CHEMBL5225163,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,NRJLQONGQFSUJQ-GZTJUZNOSA-N
CHEMBL5591538,,Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCCCCCNC(=O)c3ccc(S(N)(=O)=O)cc3)=[N+]1[B-]2(F)F,IC50,4.72,CHEMBL5576892,Photodynamic antitumor activity against human U87 cells assessed as inhibition of cell growth incubated for 60 mins followed by compound washout and light irradiation measured after 72 hrs by MTT assay,U-87MG ATCC,ABRYOLABXRIXQY-UHFFFAOYSA-N
CHEMBL5427204,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CSCc2ccccc2CSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,5.2,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,SUXHRWAZLZFIAB-ZBLPZKBESA-N
CHEMBL5400289,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CSCc2cccc(c2)CSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC1=O,IC50,4.97,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,HVBFVEAXTBQINV-RUZHBQKASA-N
CHEMBL5180831,,CC(C)=CCC(OC(=O)CCC(=O)Nc1ccc(Oc2ccccc2)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.42,CHEMBL5098102,Cytotoxicity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,MIBZPPSVQUCRDI-UHFFFAOYSA-N
CHEMBL27,PROPRANOLOL,CC(C)NCC(O)COc1cccc2ccccc12,IC50,4.12,CHEMBL5033045,Antiproliferation activity against human T98G cells measured after 72 hrs by crystal violet staining based assay,T98G,AQHHHDLHHXJYJD-UHFFFAOYSA-N
CHEMBL5279871,,Nc1c([N+](=O)[O-])cnc(NC2CCCCC2)c1[N+](=O)[O-],IC50,5.5,CHEMBL5230754,Cytotoxicity against human U87 cells assessed cell growth inhibition incubated for 2 days by MTT assay,U-87MG ATCC,YGFOLYFTLSRURR-UHFFFAOYSA-N
CHEMBL5179749,,O=C(CCl)n1c(-c2cc3ccccc3oc2=O)nc2ccccc21,IC50,6.47,CHEMBL5126907,Anticancer activity against human U-87 MG cells assessed as cell growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,NPBMRKAPXAXYOK-UHFFFAOYSA-N
CHEMBL5084521,,CCC1(CCCc2ccccc2)CCN(c2cc(N)nc(N)n2)CC1,IC50,5.6,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,NZZRGWCFVCHLMJ-UHFFFAOYSA-N
CHEMBL2029363,,COc1ccc(/C=C/C(=O)c2cccc(I)c2)cc1,EC50,4.87,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,KGQYENFXOZQJMC-JXMROGBWSA-N
CHEMBL2237320,,O=C(O)/C(=C\c1cccc(O)c1O)c1ccccc1,IC50,4.01,CHEMBL3063161,Cytotoxicity against Homo sapiens (human) SF295 cells after 48 hr by SRB assay,SF295,HVWOBICWAVJFIV-XFXZXTDPSA-N
CHEMBL5618805,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC[C@@H]1CCCO1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.63,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,MJHSFRDACBYUCG-UDNBHOFDSA-N
CHEMBL5404116,,O=C(Nc1ccc(OS(=O)(=O)c2ccccc2)cc1)C12CC3CC(CC(C3)C1)C2,IC50,5.14,CHEMBL5332778,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition,SNB-75,NYTJZFKTUQYXEN-UHFFFAOYSA-N
CHEMBL5404116,,O=C(Nc1ccc(OS(=O)(=O)c2ccccc2)cc1)C12CC3CC(CC(C3)C1)C2,IC50,5.08,CHEMBL5332775,Cytotoxicity against human SF-295 cells assessed as cell growth inhibition,SF295,NYTJZFKTUQYXEN-UHFFFAOYSA-N
CHEMBL432537,,O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1ccccc1c2=O,IC50,6.35,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,UFMQJYHLIUACCG-UHFFFAOYSA-N
CHEMBL1276265,,O=C1c2ccc(Cl)cc2-n2c1nc1ccccc1c2=O,IC50,4.74,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,KHONZILMMZKIQL-UHFFFAOYSA-N
CHEMBL3086870,,O=C1c2ccccc2-n2c1nc1ccc(F)cc1c2=O,IC50,4.42,CHEMBL3872639,Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry,U-87MG ATCC,DRHLXNRAFXVHOY-UHFFFAOYSA-N
CHEMBL4764865,,CCCCCCCCCC(=O)O[C@@H]1[C@@H]2OC(=O)[C@@H]([C@@H]2C(C)C)[C@]2(O)[C@H]3O[C@H]3[C@]3(C[C@](O)([C@H](C)OC)C(=O)O3)[C@]12C,IC50,6.16,CHEMBL4703288,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by CellTiter Glo assay,U-87MG ATCC,JATXQDKTIIOOJF-LGLGYDADSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,4.0,CHEMBL4703288,Antiproliferative activity against human U87 cells assessed as reduction in cell viability after 72 hrs by CellTiter Glo assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.72,CHEMBL5527512,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by SRB assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL5556585,,N[C@@H]1CCN(C(=O)C2Cc3c(O)c4c(c(O)c3C2)C(=O)c2ccccc2C4=O)C1,IC50,5.7,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,DKTKUPGWANWPSS-LLVKDONJSA-N
CHEMBL5571085,,O=C1c2ccccc2C(=O)c2c(O)c3c(c(O)c21)CC(C(=O)NC1CN2CCC1CC2)C3,IC50,5.72,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,CFPMIAZXFUSXFT-UHFFFAOYSA-N
CHEMBL5590332,,NCCNC(=O)C1Cc2c(O)c3c(c(O)c2C1)C(=O)c1ccccc1C3=O,IC50,5.58,CHEMBL5529312,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,LN-229,UAFZPRBWBJJMKI-UHFFFAOYSA-N
CHEMBL2172488,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cncn4C)cn23)n1,IC50,7.64,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,CTXUPZKYBBQLJM-UHFFFAOYSA-N
CHEMBL2172637,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccccn23)n1,IC50,7.16,CHEMBL2175548,Inhibition of mTORC1-mediated pS6 Ser240/244-phosphorylation in human U87MG cells,U-87MG ATCC,OEQWYIZFUDGMEW-UHFFFAOYSA-N
CHEMBL5618084,,O=C(NO)c1c(Cl)cc2c(c1Cl)CCN(C(=O)c1cc3ccccc3[nH]1)C2,IC50,5.51,CHEMBL5614661,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,CSPSXNPSWROICV-UHFFFAOYSA-N
CHEMBL101506,PINOSYLVIN,Oc1cc(O)cc(/C=C/c2ccccc2)c1,IC50,4.05,CHEMBL5614823,Antitumor activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,YCVPRTHEGLPYPB-VOTSOKGWSA-N
CHEMBL359744,DOXORUBICIN HYDROCHLORIDE,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,IC50,6.96,CHEMBL4275993,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,MWWSFMDVAYGXBV-RUELKSSGSA-N
CHEMBL4560404,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccc(Nc3ccccn3)c3nsnc23)nn1,IC50,6.32,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,ZLFDIBARBTYWTJ-UHFFFAOYSA-N
CHEMBL5191451,,O=C(NCCc1ccc2c(c1)OCO2)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.63,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,GJWCCGFDLGWEPL-UHFFFAOYSA-N
CHEMBL4796767,,O=C(Nc1ccc(Cl)cc1)Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1,IC50,5.32,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,WYWRHENCLIRCQN-GIDUJCDVSA-N
CHEMBL98,VORINOSTAT,O=C(CCCCCCC(=O)Nc1ccccc1)NO,IC50,4.8,CHEMBL4817318,Antiproliferation activity against human U-87 MG cells assessed as growth inhibition measured after 1 hr by MTT assay,U-87MG ATCC,WAEXFXRVDQXREF-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.89,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL5088605,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CCC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.59,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,JXGWMVJAVZKEBT-YXZQVLARSA-N
CHEMBL5080969,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.45,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,WCCOFLBJUFCACV-BDFBTMKGSA-N
CHEMBL5088605,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CCC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.41,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,JXGWMVJAVZKEBT-YXZQVLARSA-N
CHEMBL5083112,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(Br)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.64,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ZOLXXYHLNIAOLS-MCLIRCHUSA-N
CHEMBL1963047,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccccc21,IC50,4.57,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,MUEMGQSGNZKFJI-UHFFFAOYSA-O
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,5.08,CHEMBL4704568,Cytotoxicity against human A172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL5185656,,CCN(Cc1cc2c(cc1-c1cc3ccc4c(c3cn1)OCO4)OCO2)C(C)C,IC50,4.04,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,DKIPQTQYFUGDIF-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.29,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL4789700,,CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1CC=C1C(=O)OC[C@@]12O,IC50,4.98,CHEMBL4739244,Antiproliferative activity against human U-87MG cells assessed as reduction in cell viability incubated for 72 hrs by sulforhodamine B assay,U-87MG ATCC,VKALAWOSHGRQLE-UOVKNHIHSA-N
CHEMBL4790976,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NNC3=NCCN3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.68,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,MISLLMBLUFYMSV-HSHPMGMFSA-N
CHEMBL4794792,,CO[C@@H](/C=C/C=C(/C)C(N)=O)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@@H](O)[C@H](C[C@H](C)CC1=C(NCCCN2CCCC2)C(=O)C=C(NCCCN2CCCC2)C1=O)OC,IC50,5.07,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,HVIZDCKOTOTUSS-VIWRZIFASA-N
CHEMBL4795680,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccccc3F)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.98,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CFCPSPSXDXPSNF-TVYXGFEUSA-N
CHEMBL4777420,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCc3ccc(CS(N)(=O)=O)cc3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.56,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,BQRHZZRVKLDJPT-COPNASJUSA-N
CHEMBL4799181,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCN3CCCC3=O)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.75,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WXJOUBTZJSXXHL-YFBAPNSQSA-N
CHEMBL3622533,FIMEPINOSTAT,COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1,IC50,8.15,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,JOWXJLIFIIOYMS-UHFFFAOYSA-N
CHEMBL4576273,,CNC(=S)NC[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3CC[C@@H]12,IC50,4.13,CHEMBL4415221,Cytotoxicity activity against human T98G cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,T98G,KOTBLJFSPQDYRP-ILWGZMRPSA-N
CHEMBL4455327,,Oc1ccccc1-c1ccc2ccccc2c1,EC50,4.32,CHEMBL4369488,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,DYXBPOGHFMDEDL-UHFFFAOYSA-N
CHEMBL1448,NICLOSAMIDE,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,IC50,6.52,CHEMBL4423123,Antiproliferative activity against human T98G cells after 5 days by AlamarBlue assay,T98G,RJMUSRYZPJIFPJ-UHFFFAOYSA-N
CHEMBL4580296,,O=C(CCCc1ccc(-c2cc3ccccc3cn2)cc1)Nc1ccc(O)cc1,EC50,6.22,CHEMBL4423120,Cytotoxicity against human U87 cells expressing EGFRvIII after 72 hrs by AlamarBlue assay,U-87MG ATCC,AMOLMRUARSNWSM-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,6.13,CHEMBL4187983,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,T98G,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4215067,,O=c1c(-c2c(O)cc3c(c2O)C[C@H](O)[C@H](c2ccc(O)c(O)c2)O3)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,IC50,4.08,CHEMBL4187983,Cytotoxicity against human T98G cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,T98G,LVGLBFQVAZMOBH-LGGPFLRQSA-N
CHEMBL4065200,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5Cl)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.82,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,SIYNNPMXYLMWRK-UHFFFAOYSA-N
CHEMBL189584,PD-173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,IC50,4.35,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,DXCUKNQANPLTEJ-UHFFFAOYSA-N
CHEMBL1079175,MK-2206,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,IC50,5.18,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,ULDXWLCXEDXJGE-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,7.27,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL220241,GSK-269962A,CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21,IC50,4.93,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,YOVNFNXUCOWYSG-UHFFFAOYSA-N
CHEMBL1190711,,COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC,IC50,4.65,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,JWQOJVOKBAAAAR-UHFFFAOYSA-N
CHEMBL96926,THAPSIGARGIN,C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@H]([C@@H]1OC(=O)CCCCCCC)[C@@](C)(OC(C)=O)C[C@H](OC(=O)CCC)[C@@]1(O)[C@H]2OC(=O)[C@@]1(C)O,IC50,7.42,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,IXFPJGBNCFXKPI-FSIHEZPISA-N
CHEMBL159,VINBLASTINE,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,IC50,7.66,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,JXLYSJRDGCGARV-CFWMRBGOSA-N
CHEMBL443684,NAVITOCLAX,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,IC50,5.05,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,JLYAXFNOILIKPP-KXQOOQHDSA-N
CHEMBL105442,CI-1040,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,IC50,4.71,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,GFMMXOIFOQCCGU-UHFFFAOYSA-N
CHEMBL1289926,AXITINIB,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,IC50,5.48,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,RITAVMQDGBJQJZ-FMIVXFBMSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.64,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.97,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL4084900,,OCCc1c(-c2ccccc2)[nH]c2ccccc12,EC50,3.96,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,BUHQDNJEIACSBT-UHFFFAOYSA-N
CHEMBL226545,TRYPTOPHOL,OCCc1c[nH]c2ccccc12,EC50,3.24,CHEMBL4007133,Cytotoxicity against human U87 cells assessed as decrease in cell proliferation after 72 hrs by SRB assay,U-87MG ATCC,MBBOMCVGYCRMEA-UHFFFAOYSA-N
CHEMBL4438521,,C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)OCCOCCOCCOCCOCCOC(=O)/C1=C/CC[C@@]3(C)O[C@H]3[C@H]3OC(=O)C(=C)[C@@H]3CC1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.68,CHEMBL4381716,Antiproliferative activity against human SF126 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF126,WTILQCQZUFSWFT-ZIGMMIRASA-N
CHEMBL1669125,,COC(C)(C)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.71,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,VKANVHXFBJQXLP-OWIQXKKRSA-N
CHEMBL5090055,,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2,IC50,5.42,CHEMBL5048136,Cytotoxicity against human U-87 MG cells assessed as cell viability using raw interpretation method,U-87MG ATCC,GXCNZQOZVJURKD-DXBOVLASSA-N
CHEMBL4211294,,CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2,IC50,5.1,CHEMBL5048137,Cytotoxicity against human U-87 MG cells using best fit nonlinear regression analysis,U-87MG ATCC,HWCVTYJVEWESOJ-XREWKEJESA-N
CHEMBL1836680,,CSc1nc(Nc2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.64,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,JSXXDWHFXXQDDJ-UHFFFAOYSA-N
CHEMBL4080000,,CN1CCN(CCOC(=O)N(c2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)CC1,IC50,5.7,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,CHHCUIHBACXKKX-UHFFFAOYSA-N
CHEMBL411043,,ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1,IC50,5.54,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,SEFWYTXTKMMUEF-UHFFFAOYSA-N
CHEMBL400211,,CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1,IC50,4.9,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,ZSKSRKTYCCBGOO-UHFFFAOYSA-N
CHEMBL5198581,,c1c(CN2CCCCC2)c(-c2cc3ccc4c(c3cn2)OCO4)cc2c1OCO2,IC50,4.19,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,USYQRHGGZWJHHN-UHFFFAOYSA-N
CHEMBL5405131,,CCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,7.62,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,JWEWUMAOGAJRFE-UHFFFAOYSA-N
CHEMBL5412755,,CC(C)Oc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccccc1,IC50,6.83,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,JZKJUGGOUQDPMN-UHFFFAOYSA-N
CHEMBL5423916,,C#CCOCCOc1ccc(-c2ncc[nH]2)cc1NC(=O)C#Cc1ccc(Cl)cc1,IC50,7.25,CHEMBL5326123,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer-glo luminescent assay,U-87MG ATCC,FZIXQPIRVNNTOM-UHFFFAOYSA-N
CHEMBL5219304,,N#Cc1c(N)sc(C(=O)Nc2ccc(Cl)cc2)c1-c1ccccc1,IC50,6.23,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,SCOWIOYWMUWXIE-UHFFFAOYSA-N
CHEMBL5280637,,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)C(NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(c1ccccc1)c1ccccc1)C(N)=O,IC50,4.76,CHEMBL5257408,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 4 hrs by MTS assay,U-87MG ATCC,LTYNXVKTWDPHFB-NIEMNNIISA-N
CHEMBL5397397,,COc1ccc([C@H]2[C@H](COC(=O)c3ccc(C(=O)O)cc3)C(=O)N2c2cc(OC)c(OC)c(OC)c2)cc1O,IC50,6.37,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,XUANTVDRXBBKKU-CYFREDJKSA-N
CHEMBL512504,,N#Cc1c(O)c2c(-c3ccc(-c4ccccc4O)cc3)csc2[nH]c1=O,IC50,4.37,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,CTESJDQKVOEUOY-UHFFFAOYSA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,6.54,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL2107358,OBATOCLAX MESYLATE,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O,IC50,6.05,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,ZFKXDVMHNXPEIY-PEZBNFGJSA-N
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.4,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL5394069,,O=C1c2nc3ccccc3c(=O)n2C2C=CC(F)=CC12,IC50,7.22,CHEMBL5386675,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,UCPXJPWNFMCNGL-UHFFFAOYSA-N
CHEMBL1448,NICLOSAMIDE,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,IC50,6.52,CHEMBL4423124,Antiproliferative activity against human U87 cells after 5 days by AlamarBlue assay,U-87MG ATCC,RJMUSRYZPJIFPJ-UHFFFAOYSA-N
CHEMBL1448,NICLOSAMIDE,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,IC50,6.52,CHEMBL4423122,Antiproliferative activity against human LN229 cells after 5 days by AlamarBlue assay,LN-229,RJMUSRYZPJIFPJ-UHFFFAOYSA-N
CHEMBL2398337,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(OC)c(OC)c3)ccc2NS(C)(=O)=O)c1,IC50,6.66,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,ROOGRPRNWIQQDK-UHFFFAOYSA-N
CHEMBL5422599,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(SC)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.54,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,JVKAPVVHNMBGTI-UHFFFAOYSA-N
CHEMBL5406903,,COc1cccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)c1,IC50,6.66,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,RCRFQZPPCAAFGM-UHFFFAOYSA-N
CHEMBL5574889,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2c3ccccc3C1c1ccccc12,IC50,4.49,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,AVLMGGDRKCUXNX-UHFFFAOYSA-N
CHEMBL5565419,,N#CC1(C(=O)NCCc2cccc(F)c2)CC2c3ccccc3C1c1ccccc12,IC50,4.48,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,MINIVHBJXIKTDA-UHFFFAOYSA-N
CHEMBL5570552,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2(CCl)c3ccccc3C1c1ccccc12,IC50,4.22,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,HJZLJCJZFZIGQD-UHFFFAOYSA-N
CHEMBL5589895,,CC12CC(C#N)(C(=O)NCCc3ccc(F)cc3)C(c3ccccc31)c1ccccc12,IC50,4.54,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,BMAULUQSRDFIMN-UHFFFAOYSA-N
CHEMBL5569947,,O=C(NCCC1CCN(Cc2ccccc2)CC1)C1(Cl)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.91,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,GRPGOWYCBMOEDP-UHFFFAOYSA-N
CHEMBL5568864,,N#CC1(C(=O)NCCc2ccc(Br)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.01,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,CBORGTCUMVCDNJ-UHFFFAOYSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,4.57,CHEMBL5258260,Cytotoxicity against human U87 cells incubated for 24 hrs by AlamarBlue staining based analysis,U-87MG ATCC,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL5566352,,CC(C)c1cc(-c2cncn2C2CC2)c(O)cc1O,EC50,4.09,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,CDVWSEQXFMRSLI-UHFFFAOYSA-N
CHEMBL572878,TOZASERTIB,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,IC50,4.24,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,GCIKSSRWRFVXBI-UHFFFAOYSA-N
CHEMBL325041,BORTEZOMIB,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,IC50,7.78,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,GXJABQQUPOEUTA-RDJZCZTQSA-N
CHEMBL105,MITOMYCIN,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,IC50,5.89,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,NWIBSHFKIJFRCO-WUDYKRTCSA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,5.57,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL585951,,Fc1cc(-c2cc[nH]/c(=N/c3ccc(-n4cnc(N5CCOCC5)n4)cc3)n2)cc(N2CCOCC2)c1,IC50,5.56,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,AHMHIFXJPSHHPH-UHFFFAOYSA-N
CHEMBL5084833,,O=C(NCCc1ccccc1)c1ccc(N2C[C@@H]3C[C@H](C2)c2cccc(=O)n2C3)c(NS(=O)(=O)c2cccc(Cl)c2)c1,IC50,4.25,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,IBUZEKDFVKRIMO-UKILVPOCSA-N
CHEMBL5091451,,COc1ccc(Cn2c(SCC(=O)n3c4c(c5ccccc53)CCCC4)nc3ccccc32)cc1,IC50,4.05,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,OROYCXKEWCOECY-UHFFFAOYSA-N
CHEMBL5071699,,O=C(C1=C(O)C(=O)N(CCc2c[nH]c3ccccc23)[C@@H]1c1cccc(O)c1)c1ccc(Cl)cc1,IC50,4.26,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,VAJYWPOLVMLRQQ-XMMPIXPASA-N
CHEMBL3797512,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(=O)/C=C/C=C(C)\C=C\[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,7.2,CHEMBL4430445,Antiproliferative activity against human SF295 cells assessed as reduction in cell viability by Alamar blue assay,SF295,AIIZZRMMCAVMCU-GXNNERPOSA-N
CHEMBL5201426,,CC(C)=CC[C@@H](OC(=O)CCC(=O)Nc1ccc(Oc2ccccc2)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.42,CHEMBL5138627,Anticancer activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,MIBZPPSVQUCRDI-HHHXNRCGSA-N
CHEMBL608533,MIDOSTAURIN,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,IC50,6.72,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,BMGQWWVMWDBQGC-IIFHNQTCSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,4.79,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL252164,LUMINESPIB,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1,IC50,7.13,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,NDAZATDQFDPQBD-UHFFFAOYSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,7.57,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,4.89,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL255863,NILOTINIB,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,IC50,5.52,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,HHZIURLSWUIHRB-UHFFFAOYSA-N
CHEMBL1201182,TEMSIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,7.58,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,CBPNZQVSJQDFBE-FUXHJELOSA-N
CHEMBL188678,,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,IC50,4.06,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,JAMULYFATHSZJM-UHFFFAOYSA-N
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.14,CHEMBL2363703,SANGER: Inhibition of human T98G cell growth in a cell viability assay.,T98G,SUDAHWBOROXANE-SECBINFHSA-N
CHEMBL1169610,,N[C@]1(CNC(=O)c2ccc(F)cc2)CCN(c2ncnc3[nH]cc(Cl)c23)C1,IC50,6.44,CHEMBL1176555,Inhibition of AKT1-mediated GSK3alpha phosphorylation in human U87 cells after 1 hr by ELISA,U-87MG ATCC,CIUDTEMUAJXOJA-SFHVURJKSA-N
CHEMBL1970209,,C/C(=N/NC(=S)Nc1ccccc1Cl)c1ccccn1,IC50,8.96,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,DIAIPLSVPPGTLG-ZDLGFXPLSA-N
CHEMBL2037437,,C/C(=N\NC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,7.77,CHEMBL2038605,Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay,T98G,RLHHYLRHRGHQLT-VCHYOVAHSA-N
CHEMBL2037448,,C/C(=N/NC(=S)Nc1ccc(I)cc1)c1ccccn1,IC50,7.23,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,NRNNRLWHLIPYQW-ZDLGFXPLSA-N
CHEMBL2037443,,C/C(=N/NC(=S)Nc1cccc(F)c1)c1ccccn1,IC50,7.75,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,VCKFVZSNSWYSKQ-ZDLGFXPLSA-N
CHEMBL2037442,,C/C(=N/NC(=S)Nc1ccccc1F)c1ccccn1,IC50,8.3,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,PMHTWYVKIPHSFS-ZDLGFXPLSA-N
CHEMBL1630582,,C/C(=N\NC(=S)Nc1cccc(Cl)c1)c1ccccn1,IC50,7.51,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,QJEQNMXYYQUOAY-VCHYOVAHSA-N
CHEMBL2037340,,CC(=NNC(=S)Nc1ccccc1I)c1ccccn1,IC50,8.21,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,JJPHEFXBDVUGNK-UHFFFAOYSA-N
CHEMBL2037338,,CC(=NNC(=S)Nc1ccc(F)cc1)c1ccccn1,IC50,8.0,CHEMBL2038604,Cytotoxicity against human U87 cells expressing wild-type p53 after 48 hrs by MTT assay,U-87MG ATCC,RLHHYLRHRGHQLT-UHFFFAOYSA-N
CHEMBL2137530,SERDEMETAN,c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1,IC50,4.51,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,CEGSUKYESLWKJP-UHFFFAOYSA-N
CHEMBL399530,,CCc1cc(-c2[nH]nc(C)c2-c2ccc3c(c2)OCCO3)c(O)cc1O,IC50,4.23,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,OWPMENVYXDJDOW-UHFFFAOYSA-N
CHEMBL5085058,,Nc1cc(N2CCCC(CO)(CCCc3ccccc3)C2)ncn1,IC50,4.7,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,ZOTMPAOQJWQQTF-UHFFFAOYSA-N
CHEMBL598013,,NC1(Cc2ccc(Cl)cc2)CCN(c2ccnc3[nH]ncc23)CC1,IC50,7.8,CHEMBL1074387,Antiproliferative activity against human U87MG cells after 96 hrs by SRB assay,U-87MG ATCC,ZFVMFXQNRBEZFM-UHFFFAOYSA-N
CHEMBL2407570,,C=CCNC(=O)[C@@H]1[C@H](C(=O)OC)Cc2c([nH]c3ccccc23)[C@@](C(=O)OC)(c2cc3c(cc2OC)N(C)[C@H]2[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]32[C@@H]54)C[C@@H]2C=C(CC)CN1C2,IC50,8.0,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,BKGZSICZXAUIEC-AIURUJAXSA-N
CHEMBL4457896,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(Cc5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,5.76,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,DXBRPGIDDDERSJ-UHFFFAOYSA-N
CHEMBL4465102,,COc1ccc(CCn2c(=O)c(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCOCC6)c(OC)cc45)c(F)c3)nc3ccccc32)cc1,IC50,4.89,CHEMBL4409746,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,SLMKYOATISOBCY-UHFFFAOYSA-N
CHEMBL2407576,,CCC1=C[C@@H]2CN(C1)/C(C(=O)NCc1ccccc1)=C(/C(=O)OC)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,IC50,8.0,CHEMBL2412721,Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay,U-87MG ATCC,JYNSQZYXYMMRCR-KCAACJCTSA-N
CHEMBL4862657,,Clc1ccc(-c2nc3ccccn3c2Sc2ccccc2)cc1,IC50,4.52,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,OPJWIMGLGACYQU-UHFFFAOYSA-N
CHEMBL4859618,,c1ccc(Sc2c(-c3ccsc3)nc3ccccn23)cc1,IC50,4.23,CHEMBL4825111,Anticancer activity against human U-87 MG cells assessed as growth inhibition incubated for 48 hrs by MTT assay,U-87MG ATCC,JAKCVTVOHLWYMB-UHFFFAOYSA-N
CHEMBL117427,,COc1cnc2c3c(nccc13)-c1cccnc1C2=O,IC50,7.3,CHEMBL815879,In vitro antitumor effects against human U87MG cell lines.,U-87MG ATCC,ULSFNUQXUHMWNZ-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.01,CHEMBL4611999,Cytotoxicity against human U87MG cells assessed as reduction in cell viability after 48 hrs under hypoxia condition by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL221264,,Cc1cc(N2CCCCC2CC(=O)NCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1,IC50,8.39,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,SAKNCIOIYNBASO-UHFFFAOYSA-N
CHEMBL220771,,Cc1cc(N2CCN(C(=O)C(C)C)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,8.72,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,BNKGEZQUYVVMBA-UHFFFAOYSA-N
CHEMBL424756,,Cc1cc(N2CCN(S(C)(=O)=O)C(CC(=O)NCc3ccc4c(c3)OCO4)C2)nc(-n2ccnc2)n1,IC50,7.92,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,DKDAINNDAVRQIB-UHFFFAOYSA-N
CHEMBL5579660,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCSSCCC(=O)NCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.61,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,WJHAJXOQPHTYDU-MFMXYXMPSA-N
CHEMBL4776995,,COCCOCCOCCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,6.1,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,CLEROOQKZZNPCB-OHNMWDNLSA-N
CHEMBL4788059,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NC3CCN(C(=O)OC(C)(C)C)CC3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,7.08,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,VXJBHECSURPXCH-AJRNXTKXSA-N
CHEMBL5219349,,Cc1ccccc1Oc1cc(-n2c(=O)cc(C(F)(F)F)[nH]c2=O)c2ccccc2c1C#N,IC50,5.57,CHEMBL5217600,Upregulation of BCAA expression in human U-87 MG cells,U-87MG ATCC,JBKRLZPXWNTYBD-UHFFFAOYSA-N
CHEMBL468384,,CC1(C)CC(NC(=S)Nc2ccccc2)c2cc(Cl)ccc2O1,IC50,4.43,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,UHBQMDJDZKZNBH-UHFFFAOYSA-N
CHEMBL468570,,COc1ccccc1NC(=S)NC1CC(C)(C)Oc2ccc(Br)cc21,IC50,4.38,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,YOBAVTGWSRCIHE-UHFFFAOYSA-N
CHEMBL609853,,CC1(C)CC(NC(=S)Nc2cccc([N+](=O)[O-])c2)c2cc(Br)ccc2O1,IC50,5.4,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,ZIJLARUXEXUTGH-UHFFFAOYSA-N
CHEMBL2041939,,O=[N+]([O-])c1cccc(NC(=S)NC2CCOc3ccc(Cl)cc32)c1,IC50,5.0,CHEMBL2045874,Growth inhibition of human T98G cells after 72 hrs by MTT assay,T98G,KTZDWMQYTLYXRJ-UHFFFAOYSA-N
CHEMBL2380760,,NS(=O)(=O)c1cccc2c1C(=O)c1cccc(O)c1C2=O,IC50,6.68,CHEMBL4423131,Antiproliferative activity against human U87 cells,U-87MG ATCC,CQBHSRLUQDYPBU-UHFFFAOYSA-N
CHEMBL4459344,,O=C(O)CNC1=CC(=O)c2ccccc2C1=O,IC50,5.62,CHEMBL4423116,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,JBLAYIBZIRMMIJ-UHFFFAOYSA-N
CHEMBL4463379,,CC(C)=CCC1=C(NCCCCN(CN)CCCc2ccccc2)C(=O)c2ccccc2C1=O,IC50,5.37,CHEMBL4423115,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,KCCDBBFLENUYEW-UHFFFAOYSA-N
CHEMBL3109730,,O=C1C=C(O)C(=O)C(CC2CCC3CCCCC3C2)=C1O,IC50,4.63,CHEMBL4423115,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,ZYJWXCFHIXLPHN-UHFFFAOYSA-N
CHEMBL373881,,CS(=O)(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.15,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,KPPHWLDGUOOBEH-UHFFFAOYSA-N
CHEMBL290548,,COC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NCc2ccc3c(c2)OCO3)C1,IC50,9.42,CHEMBL920402,Inhibition of cytokine-induced iNOS expressed in human A172 cells assessed as inhibition of NO formation,A-172,NVYMEDQKBQMAKF-UHFFFAOYSA-N
CHEMBL23293,SALIRASIB,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O,IC50,4.3,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,WUILNKCFCLNXOK-CFBAGHHKSA-N
CHEMBL497600,,COCOC(=O)c1ccccc1SC/C=C(\C)CC/C=C(\C)CCC=C(C)C,IC50,5.0,CHEMBL959912,Cytotoxicity against human U87 cells after 5 to 7 days,U-87MG ATCC,WPYKJACQQNTKNZ-FJNYLYSMSA-N
CHEMBL4287953,,CCCCCCCCCC[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,6.17,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,CEVBXTPFVCEMSL-UPRLRBBYSA-N
CHEMBL4294765,,C[N+](C)(C)CCOP(=O)([O-])OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1OC(=O)c1ccccc1,IC50,5.75,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,WBJKHKYBIKTDKR-RCCFBDPRSA-N
CHEMBL4078390,,C[C@@H]1CN(c2nc(N3CCOCC3)c3sc(CO)cc3n2)C[C@H](C)O1,IC50,5.18,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,PNVPFJFQLFNCRW-TXEJJXNPSA-N
CHEMBL4076699,,Cc1c(-c2ccn[nH]2)sc2c(N3CCOCC3)nc(N3C[C@@H](C)O[C@@H](C)C3)nc12,IC50,5.06,CHEMBL4051861,Antiproliferative activity against PTEN deficient human U87MG cells after 72 hrs by CCK-8 assay,U-87MG ATCC,XDZQUDSFDVBLAQ-BETUJISGSA-N
CHEMBL2417817,,O=C(Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)cn2n1)C1CC1,IC50,4.96,CHEMBL2421640,Antiproliferative activity against human U87MG cells after 48 hrs by MTT assay,U-87MG ATCC,NPRACIZSBGXOJC-UHFFFAOYSA-N
CHEMBL1631907,,O=C1[C@@H]2CS[C@]3(C(=O)Nc4ccccc43)N2C(=O)N1Cc1ccc(Cl)cc1,IC50,5.6,CHEMBL4423096,Antiproliferative activity against human U87MG cells after 48 hrs by MTS assay,U-87MG ATCC,POVQHLNFAUGINO-HNAYVOBHSA-N
CHEMBL2419658,,COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(Cl)cc4)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,7.62,CHEMBL2421440,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,OISVKZQFIIKGRN-QLQYKETESA-N
CHEMBL4591450,,Nc1c(-c2cccnc2)ncc2c1C(=O)c1c(-c3ccccn3)nn(-c3ccc(F)cc3F)c1C2=O,IC50,5.6,CHEMBL4423108,Antiproliferative activity against human U87MG cells after 72 hrs by coulter counting analysis,U-87MG ATCC,IOIRIAXEZBQMFS-UHFFFAOYSA-N
CHEMBL4741412,,Cc1nn(C)c(Oc2cccc(Cl)c2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.07,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,YRHOSPRJJFQXQC-LJUMEUDFSA-N
CHEMBL4789652,,Cc1nn(C)c(Oc2ccc(I)cc2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,4.78,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,WTFHVKBAPQTCPD-LJUMEUDFSA-N
CHEMBL2035436,,CCOC(=O)/C(C#N)=C/c1c2ccccc2nc2ccccc12,IC50,4.26,CHEMBL2039143,Antiproliferative activity against human SF295 cells after 72 hrs by MTT assay,SF295,DQRHRTFTKBWRQW-ACCUITESSA-N
CHEMBL4440446,,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)cc1F,IC50,4.09,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,WATIGWMSDNNQOX-HOINCJJXSA-N
CHEMBL4475212,,Cc1cn([C@H]2C[C@H](OC(=O)OC(C)(C)C)[C@@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)O2)c(=O)[nH]c1=O,IC50,5.16,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,AYRRJYFNWXNEKO-KXHDOTFISA-N
CHEMBL4550927,,O=C(Nc1ccn([C@@H]2O[C@H](Cn3cc(CNc4ccn([C@@H]5O[C@H](CO)[C@@H](O)C5(F)F)c(=O)n4)nn3)[C@@H](OC(=O)c3ccccc3)C2(F)F)c(=O)n1)c1ccccc1,IC50,5.26,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,MLUVLOZVYSIBBN-VNSBPBJWSA-N
CHEMBL4561418,,CC(C)(C)OC(=O)O[C@@H]1[C@@H](Cn2cc(COC(=O)Nc3ccn([C@@H]4O[C@H](CO)[C@@H](O)C4(F)F)c(=O)n3)nn2)O[C@@H](n2ccc(N)nc2=O)C1(F)F,IC50,5.66,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,BJQYGWHXZWDCFZ-YFYJLLRASA-N
CHEMBL129,ZIDOVUDINE,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,IC50,4.92,CHEMBL4387665,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay,U-87MG ATCC,HBOMLICNUCNMMY-XLPZGREQSA-N
CHEMBL4444594,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCC(C)O)CC3)cc2)ncc1Cl,IC50,6.06,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,HPSJXDROBGLIOR-UHFFFAOYSA-N
CHEMBL4469292,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN(C)C)CC3)cc2)ncc1Cl,IC50,6.7,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,QGKIOGPLCLIXGN-UHFFFAOYSA-N
CHEMBL4514099,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)N3CCN(C(=S)SCCN4CCN(C)CC4)CC3)cc2)ncc1Cl,IC50,6.21,CHEMBL4353491,Antiproliferative activity against human U87MG cells overexpressing FAK assessed as reduction in cell viability after 72 hrs by MTS assay,U-87MG ATCC,KGHJJSWYKYIAGJ-UHFFFAOYSA-N
CHEMBL2381453,,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OCc6cn(-c7ccc(OC)cc7)nn6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,IC50,4.36,CHEMBL2383735,Cytotoxicity against human SF295 cells after 48 hrs by SRB assay,SF295,JHLMREYJLSMARD-BJMSDPACSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,7.25,CHEMBL4053635,Antiproliferative activity against human SF295 cells after 72 hrs by CellTiter96 AQueous nonradioactive cell proliferation assay,SF295,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL4098626,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CN)cc2)nnc1Cl,IC50,7.85,CHEMBL4010922,Inhibition of colony formation in human U87MG cells,U-87MG ATCC,MUHNVADDYLCREH-UHFFFAOYSA-N
CHEMBL4080590,,CNC(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)nnc1Cl,IC50,4.77,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,BJYZYCDBIWVFEN-UHFFFAOYSA-N
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,5.89,CHEMBL4010920,Cytotoxicity against human U87MG cells assessed as reduction in cell viability by WST1 assay,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL5078956,,Nc1nccc(N2CCCC(CO)(CCCc3ccccc3)C2)n1,IC50,5.05,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,DTYLCARBXSKICY-UHFFFAOYSA-N
CHEMBL5086648,,Nc1cc(N2CCCC(CCCc3ccccc3)(C(=O)O)C2)nc(N)n1,IC50,4.41,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,LJIWGZSNRNUHTR-UHFFFAOYSA-N
CHEMBL4097507,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.76,CHEMBL4057887,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HWSVUGUCKRCZGU-UHFFFAOYSA-N
CHEMBL303697,LIGUSTRAZINE,Cc1nc(C)c(C)nc1C,IC50,4.79,CHEMBL4037667,Antiproliferative activity against human U87MG cells after 72 hrs in presence of piperlongumine by MTT assay,U-87MG ATCC,FINHMKGKINIASC-UHFFFAOYSA-N
CHEMBL4104881,,Cc1cc(=O)n(-c2ccccc2)nc1C(=O)Nc1ccc(Oc2ccnc3c2ccn3C)cc1,IC50,5.36,CHEMBL4034160,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,MOGJDMGFFLJPOL-UHFFFAOYSA-N
CHEMBL5088772,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(OC)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.16,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,JGPLYADDPRLOJV-VZHCALMGSA-N
CHEMBL5091306,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C(C)(C)C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.56,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,RVEWODMIOUUZJR-CHFKRMNXSA-N
CHEMBL301982,CELASTROL,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C,IC50,5.5,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,KQJSQWZMSAGSHN-JJWQIEBTSA-N
CHEMBL5089530,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C#N)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.36,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,GTGMLRAJBUWXCG-VZHCALMGSA-N
CHEMBL5091183,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7nccs7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.86,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,WLZOZZHOZLJSCI-RCGAJBMESA-N
CHEMBL7064,,O=C1c2ccccc2-c2n[nH]c3cccc1c23,IC50,4.65,CHEMBL5116965,Antiproliferative activity against human SF-295 cells measured after 48 hrs by SRB assay,SF295,ACPOUJIDANTYHO-UHFFFAOYSA-N
CHEMBL5179338,,O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)N1CCN(c2cc(-c3cn(-c4ccccc4)nc3-c3cccc(O)c3)ccn2)CC1,IC50,6.2,CHEMBL5116968,Antiproliferative activity against human SNB-75 cells measured after 48 hrs by SRB assay,SNB-75,XJAJDOWMQVDEOT-UHFFFAOYSA-N
CHEMBL4545456,,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,EC50,6.77,CHEMBL4387155,Antiproliferative activity against human U87MG assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,U-87MG ATCC,KMRYRPPWJDYHAL-QGZVFWFLSA-N
CHEMBL3301610,ABEMACICLIB,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,EC50,6.7,CHEMBL4387157,Antiproliferative activity against human A172 assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,A-172,UZWDCWONPYILKI-UHFFFAOYSA-N
CHEMBL4440980,,C[C@@H]1CCCCn2ncc(-c3nc(Nc4ccc(N5CCN(C)CC5)cn4)ncc3F)c21,EC50,5.84,CHEMBL4387158,Antiproliferative activity against human T98G assessed as reduction in cell viability incubated for 5 days by CyQuantGR dye-based fluorescence assay,T98G,UHCMUGYUWQCODZ-MRXNPFEDSA-N
CHEMBL4289873,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc21,IC50,5.88,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,XUCISSARDQCVDI-UHFFFAOYSA-N
CHEMBL4278984,,Cn1ccc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccccc5)c4=O)cc3)ccnc21,IC50,5.3,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,HEXNNTWGHZWZTQ-UHFFFAOYSA-N
CHEMBL4288088,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(Br)cc2)c1=O,IC50,5.82,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,FVZDXCVIWBCBLL-UHFFFAOYSA-N
CHEMBL4282597,,O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)cc1)c1cc2cccnc2n(-c2ccccc2)c1=O,IC50,5.8,CHEMBL4252885,Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RVDUZURNNZCDII-UHFFFAOYSA-N
CHEMBL4278554,,COc1cc(Sc2c[nH]c3cc(-c4ccsc4)ccc23)cc(OC)c1OC,IC50,7.8,CHEMBL4271598,Growth inhibition of human U87MG cells after 48 hrs by MTS assay,U-87MG ATCC,YIPMYOQVBMPGMW-UHFFFAOYSA-N
CHEMBL2172490,,Cc1cc(-c2ccc3nc(Nc4cc[nH]n4)c(-c4nc(C)nc(N)n4)n3c2)on1,IC50,7.14,CHEMBL2175549,Inhibition of mTORC1-mediated 4EBP1-phosphorylation in human U87 cells,U-87MG ATCC,INKMULYTOXUNTN-UHFFFAOYSA-N
CHEMBL5428849,,NCCCCNCCCNC(=O)c1csc(-c2csc(CCN)n2)n1,IC50,4.43,CHEMBL5351368,Antiproliferative activity against human U87 cells incubated for 72 hrs by WST-1 assay,U-87MG ATCC,UIHHDALTZVAFSF-UHFFFAOYSA-N
CHEMBL4575344,,CN(CCNCc1ccccn1)CCNCc1ccccn1,IC50,5.17,CHEMBL4381289,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 48 hrs by cell titer-glo assay,LN-229,CHFNQDVXSWSOSP-UHFFFAOYSA-N
CHEMBL4527563,,COc1ncc(-c2cc(OC3CCOCC3)c3ncnc(C)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F,IC50,7.3,CHEMBL5365273,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CTG assay,U-87MG ATCC,HLTLYKPFSSMNIF-UHFFFAOYSA-N
CHEMBL5413752,,COc1cc(COc2ccc3cc(CN(c4cc(-c5cc(OC6CCOCC6)c6ncnc(C)c6c5)cnc4OC)S(=O)(=O)c4ccc(F)cc4F)c(=O)oc3c2)c([N+](=O)[O-])cc1OC,IC50,7.28,CHEMBL5365279,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth pre-treated with compound followed by UV irradiation for 5 mins measured after 72 hrs by CTG assay,U-87MG ATCC,SQZMHFUFHLUQNN-UHFFFAOYSA-N
CHEMBL237858,,CC1CN(C(=O)c2ccccc2)CCN1S(=O)(=O)c1c[nH]c2c(-c3cccnc3)nccc12,IC50,6.19,CHEMBL902989,Antiviral activity against HIV1 pseudovirus in U87 cells expressing CD4 and CCR5 after 72 hrs by M33 pseudotyped assay,U-87MG ATCC,SRBILTJOWAUJHB-UHFFFAOYSA-N
CHEMBL4280638,,C#CCOc1ccc(-c2noc(-c3nnn(-c4cccc(/C(C)=N/O)c4)c3N)n2)cc1,IC50,5.34,CHEMBL4256904,Cytotoxicity against human A172 cells after 72 hrs by XTT assay,A-172,IGQKYFPXTAJJLB-DHRITJCHSA-N
CHEMBL4084427,,CSc1nc(N(C(=O)OC(C)CN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.13,CHEMBL4013504,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs by trypan blue assay,U-87MG ATCC,DAIZESMIDQCQRX-UHFFFAOYSA-N
CHEMBL4068211,,CN1CCN(CCOC(=O)N(Cc2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccccc2)CC1,IC50,4.82,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,ONIFAJAFWHMUOA-UHFFFAOYSA-N
CHEMBL4080000,,CN1CCN(CCOC(=O)N(c2ccccc2)c2ncnc3c2cnn3CC(Cl)c2ccc(Br)cc2)CC1,IC50,5.29,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,CHHCUIHBACXKKX-UHFFFAOYSA-N
CHEMBL2407628,,CSc1nc(N(C(=O)OCCN2CCN(C)CC2)c2cccc(Br)c2)c2cnn(CC(C)c3ccccc3)c2n1,IC50,5.66,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,MVGQVUFEKIVQTO-UHFFFAOYSA-N
CHEMBL4069584,,CCC(CN1CCN(C)CC1)OC(=O)N(c1cccc(Br)c1)c1nc(SC)nc2c1cnn2CC(C)c1ccccc1,IC50,5.19,CHEMBL4013505,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 48 hrs by trypan blue assay,U-87MG ATCC,VIWJZMBDSOVKQF-UHFFFAOYSA-N
CHEMBL3394092,,ClC(Cn1ncc2c(Nc3cccc(Br)c3)nc(SCCN3CCOCC3)nc21)c1ccccc1,IC50,5.72,CHEMBL4013506,Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by trypan blue assay,U-87MG ATCC,TWWILBWAYDXBCM-UHFFFAOYSA-N
CHEMBL3785796,,COc1cc(/C=C/C(=O)OCCCc2cc(OC)c3c(c2)[C@@H](CO)[C@H](c2cc(OC)c(O[C@H](CO)[C@H](O)c4ccc(O)c(OC)c4)c(OC)c2)O3)ccc1O,IC50,4.74,CHEMBL3792217,Cytotoxicity against human XF498 cells by SRB assay,XF 498,TXCVWSBILJVFSH-XWRZMSEUSA-N
CHEMBL5184582,,C[C@@H]1C2CCCC3CC[C@]4(C)OO[C@]32[C@H](O[C@@H]1OCCCN=C=S)O4,IC50,5.13,CHEMBL5141030,Antiproliferative activity against human U-87 MG cells assessed as inhibitionof cell growth incubated for 24 to 72 hrs by MTT assay,U-87MG ATCC,BWVBJFMFARXZSB-FHRQGKHISA-N
CHEMBL5619479,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2cccc(F)c12)c1c[nH]c2cccc(F)c12,IC50,4.66,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,NCEYYCYQKDMNMV-SANMLTNESA-N
CHEMBL5619198,,CCCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.7,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,OAHWQNOGENVZIW-QNGWXLTQSA-N
CHEMBL5620245,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2c(Br)cccc12)c1c[nH]c2c(Br)cccc12,IC50,5.06,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,FNKHUIDOILEMJD-SANMLTNESA-N
CHEMBL5619004,,CC(C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCc1ccco1)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.75,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,OZENKSHIKBNFBN-YTTGMZPUSA-N
CHEMBL1592888,,Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@@H](CN1CCOCC1)CO3,IC50,5.1,CHEMBL5108105,Cytotoxicity against human KNS-42 cells assessed as reduction in cell viability incubated for 72 hrs by PrestoBlue reagent based cell viability assay,KNS-42,HQVHOQAKMCMIIM-FQEVSTJZSA-N
CHEMBL5191451,,O=C(NCCc1ccc2c(c1)OCO2)c1cc2c(F)cc(F)cc2[nH]1,IC50,5.54,CHEMBL5108106,Antiproliferative activity against human KNS-42 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,KNS-42,GJWCCGFDLGWEPL-UHFFFAOYSA-N
CHEMBL244424,,CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)Cc1cc2c(cc1[N+](=O)[O-])OCO2)C(N)=O,IC50,4.5,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,AKKCHMMHCPYTQV-ZDUSSCGKSA-N
CHEMBL244422,,CC(C)C[C@H](NC(=O)Cc1cc2c(cc1[N+](=O)[O-])OCO2)C(N)=O,IC50,4.72,CHEMBL906315,Cytotoxicity against SF295 cells,SF295,DXIGNJWPGZGXNB-JTQLQIEISA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.24,CHEMBL5138627,Anticancer activity against human U87 cells incubated for 48 hrs by MTT assay,U-87MG ATCC,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1173055,RUCAPARIB,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.7,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,HMABYWSNWIZPAG-UHFFFAOYSA-N
CHEMBL5273431,,Cn1ccc(NC(=O)Nc2ccc(-c3nc(-c4ccc(CN5CCN(S(C)(=O)=O)CC5)s4)nc(N4CCOCC4)n3)cc2)n1,IC50,6.62,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,CFZSBYXRCFGDLU-UHFFFAOYSA-N
CHEMBL1801036,CYCLOVIOLACIN O13,CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CO)C(=O)N4)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N2,IC50,5.47,CHEMBL5048136,Cytotoxicity against human U-87 MG cells assessed as cell viability using raw interpretation method,U-87MG ATCC,HHLPYNQQOPKSJQ-XVGLBWMNSA-N
CHEMBL325041,BORTEZOMIB,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,IC50,9.59,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,GXJABQQUPOEUTA-RDJZCZTQSA-N
CHEMBL413,SIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,6.23,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,QFJCIRLUMZQUOT-HPLJOQBZSA-N
CHEMBL2144069,,Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1,IC50,4.24,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,ZGBGPEDJXCYQPH-UHFFFAOYSA-N
CHEMBL513909,BI-2536,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,IC50,7.09,CHEMBL2363341,SANGER: Inhibition of human KNS-42 cell growth in a cell viability assay.,KNS-42,XQVVPGYIWAGRNI-JOCHJYFZSA-N
CHEMBL2392821,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,IC50,5.7,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JPILOKCQOSEJCY-UHFFFAOYSA-N
CHEMBL2392956,,COc1ccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCCCC6)c(OC)cc45)c(F)c3)c3ccccc3n2)cc1,IC50,5.87,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,AINVSYIOEHAUFN-UHFFFAOYSA-N
CHEMBL2392954,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCOCC1,IC50,5.97,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,CBQVYYAOAXGPTL-UHFFFAOYSA-N
CHEMBL2392822,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccccc5)nc5ccc(F)cc45)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.02,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,JOVWHEAGFGXIPE-UHFFFAOYSA-N
CHEMBL2392820,,COc1cccc(-c2cc(C(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)c3cc(F)ccc3n2)c1,IC50,6.08,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,BGNDGDOLSKHSRL-UHFFFAOYSA-N
CHEMBL2392959,,COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5cccc(Cl)c5)nc5ccccc45)cc3F)ccnc2cc1OCCCN1CCCCC1,IC50,6.82,CHEMBL2395923,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,RLOWINIQUHNWJO-UHFFFAOYSA-N
CHEMBL5184353,,CCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,7.97,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,MFWGVEDLBIPFGB-UHFFFAOYSA-N
CHEMBL5198083,,C=CCOc1c(OC)cc(C2C(C#N)=C(N)Oc3c2ccc2ccccc32)cc1OC,IC50,8.24,CHEMBL5131359,Cytotoxicity against human U-87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,LOSDQHCJIMFLOV-UHFFFAOYSA-N
CHEMBL501411,SPINOSYN A,CC[C@H]1CCC[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1,IC50,4.01,CHEMBL4628637,Antiproliferative activity against human U87MG cells incubated for 48 hrs,U-87MG ATCC,SRJQTHAZUNRMPR-UYQKXTDMSA-N
CHEMBL2206906,,COCCOc1cnc(Nc2cnc(Cl)c(NS(C)(=O)=O)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.11,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,LPQNHUUMWHCKNU-UHFFFAOYSA-N
CHEMBL2206903,,COc1cnc(Nc2cnc(Cl)c(NS(C)(=O)=O)c2)c(-c2nc(C)nc(N)n2)c1,IC50,8.41,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,FMNSKWKSXFWJNP-UHFFFAOYSA-N
CHEMBL2206902,,Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N3CCOCC3)c2)n1,IC50,6.61,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,OMAOPVVDUUYSAR-UHFFFAOYSA-N
CHEMBL2206901,,COCCN(C)S(=O)(=O)Nc1cc(Nc2ncc(Cl)cc2-c2nc(C)nc(N)n2)cnc1Cl,IC50,7.28,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,GLCIVEQBDOXJQU-UHFFFAOYSA-N
CHEMBL2206917,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)N3CCOCC3)c2)n1,IC50,7.07,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,AZUIZZBFQBKTCG-UHFFFAOYSA-N
CHEMBL2206916,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C(C)C)c2)n1,IC50,6.39,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,KRDRDADGCWRDPV-UHFFFAOYSA-N
CHEMBL2206915,,Cc1nc(N)nc(-c2cccnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1,IC50,7.6,CHEMBL2214063,Inhibition of PI3K in human U87MG cells assessed as inhibition of Akt phosphorylation,U-87MG ATCC,BRCRBCBCOVSRKR-UHFFFAOYSA-N
CHEMBL4868061,,Cc1cccc(Nc2ccccc2C(=O)NCCc2c[nH]c3ccccc23)c1,IC50,4.63,CHEMBL4826561,Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay,U-87MG ATCC,XYBCHHOMYORUSX-UHFFFAOYSA-N
CHEMBL4778600,,Oc1c(C(c2ccc(F)cc2)N2CCCCC2)ccc2cncnc12,IC50,4.5,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,IFAUDODREFDNNI-UHFFFAOYSA-N
CHEMBL4757693,,Oc1c(C(c2ccc(F)cc2)N2CCNCC2)ccc2cncnc12,IC50,4.36,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,PSTLKJQTFBBOPN-UHFFFAOYSA-N
CHEMBL4785968,,Oc1cc2c(cc1C(c1ccc(F)cc1)N1CCCCC1)OCCO2,IC50,6.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GVIIALXPLGHLMC-UHFFFAOYSA-N
CHEMBL4791006,,COc1cccc(C(c2cc3c(cc2O)OC(F)(F)O3)N2CCOCC2)c1OC,IC50,4.4,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,ZLRIEFNTOOLHMU-UHFFFAOYSA-N
CHEMBL4776561,,Oc1cc2c(cc1C(c1ccc(F)cc1)N1CCCCC1)CCC2,IC50,4.89,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,NUDOUHHYOQUTRX-UHFFFAOYSA-N
CHEMBL4798777,,Oc1ccc2scnc2c1C(c1ccc(F)cc1)N1CCCCC1,IC50,6.0,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,YNJFTLBKDAEMQY-UHFFFAOYSA-N
CHEMBL2180729,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccc2ccccc21)c1cccc(F)c1,IC50,6.43,CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,U-87MG ATCC,SKKKGQUKKUZJRL-UHFFFAOYSA-N
CHEMBL2297273,,COc1cc(OC)c2c(NC3CCCCC3)cc(-c3ccccc3)nc2c1,IC50,5.22,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,YPHABYOXTFGEGV-UHFFFAOYSA-N
CHEMBL2297270,,COc1cc(OC)c2c(N3CCCCC3)cc(-c3ccccc3)nc2c1,IC50,4.18,CHEMBL3070030,Antitumor activity against Homo sapiens (human) LN229 cells assessed as inhibition of cell viability after 72 hr by MTT assay,LN-229,FEDOBZBQUWXHKG-UHFFFAOYSA-N
CHEMBL2172483,,COc1ncccc1-c1ccc2nc(Nc3cc[nH]n3)c(-c3nc(C)nc(N)n3)n2c1,IC50,6.86,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,OEYUWZFJYRUVIQ-UHFFFAOYSA-N
CHEMBL2172482,,Cc1nc(N)nc(-c2c(Nc3cc[nH]n3)nc3ccc(-c4cnccc4C)cn23)n1,IC50,7.89,CHEMBL2175550,Inhibition of mTORC2-mediated AKT Ser473-phosphorylation in human U87 cells,U-87MG ATCC,NECBLBSHQGQKDS-UHFFFAOYSA-N
CHEMBL1615183,,Cc1nc(N)nc(-n2c(Nc3cc[nH]n3)nc3ccccc32)n1,IC50,6.78,CHEMBL2175548,Inhibition of mTORC1-mediated pS6 Ser240/244-phosphorylation in human U87MG cells,U-87MG ATCC,DMMFPXAFVNDPCA-UHFFFAOYSA-N
CHEMBL5597580,,O=C(O)[C@@H]1[C@H](C(=O)n2ccc3ccccc32)[C@H]2CC[C@@H]1O2,IC50,4.15,CHEMBL5587080,Cytotoxicity against human U-87 MG cells incubated for 48 hrs by CCK8 assay,U-87MG ATCC,KZVHQCVKMCBKRP-RQJABVFESA-N
CHEMBL3594269,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1Sc1ccccc1,IC50,6.05,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,XTAGJHBSEWJYBQ-UHFFFAOYSA-N
CHEMBL221644,,CC1(C)CCC2=C(O1)c1ccccc1/C(=N/O)C2=O,IC50,5.46,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,ZYGJOALPFNIQHK-VBKFSLOCSA-N
CHEMBL5185867,,O=C1C(=O)c2c(O)cccc2C2=C1CCC(c1ccc(Cl)cc1)O2,IC50,6.77,CHEMBL5104518,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,OLSKPZUKOJUJHV-UHFFFAOYSA-N
CHEMBL2430036,,C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)[C@H]5CC=C6[C@@H]7[C@H](O)C(C)(C)CC[C@]7(C(=O)O)CC[C@@]6(C)[C@]5(C)CC[C@H]4C3(C)C)OC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O,IC50,4.24,CHEMBL2433427,Cytotoxicity against human U87MG cells assessed as cell viability after 72 hrs by MTT assay,U-87MG ATCC,YYNGQYRUWXEJIJ-ZNTOFBKISA-N
CHEMBL477772,PAZOPANIB,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,5.18,CHEMBL2363664,SANGER: Inhibition of human SNB75 cell growth in a cell viability assay.,SNB-75,CUIHSIWYWATEQL-UHFFFAOYSA-N
CHEMBL5181773,,CN(Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1)C(=O)CCCCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCCCCC(=O)O)c4ccccc4C3(C)C)=C2Cl)C(C)(C)c2ccccc21,IC50,4.82,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,RGFTYPLHNYSHCT-UHFFFAOYSA-O
CHEMBL4594201,,CC1(C)O[C@H]2O[C@H](COC3C4=C(OC3(C)C)c3ccccc3C(=O)C4=O)[C@@H](OCc3ccccc3)[C@H]2O1,IC50,6.47,CHEMBL4407644,Anticancer activity against human SF295 cells by MTT assay,SF295,LIRLLGKTZVCTNS-XTNHUWDISA-N
CHEMBL4560404,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)C1n1cc(-c2ccc(Nc3ccccn3)c3nsnc23)nn1,IC50,6.13,CHEMBL4407616,Cytotoxicity against human SF295 cells assessed as reduction in cell viability after 72 hrs by MTT assay,SF295,ZLFDIBARBTYWTJ-UHFFFAOYSA-N
CHEMBL217354,,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,IC50,6.08,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,PQAPVTKIEGUPRN-UHFFFAOYSA-N
CHEMBL1173055,RUCAPARIB,CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,IC50,4.13,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,HMABYWSNWIZPAG-UHFFFAOYSA-N
CHEMBL4749385,,CC(C)(C)OC(=O)N1CCC2(C(=O)Nc3ccccc32)C1c1cccc(-c2cc(F)c(CO)c(S(C)(=O)=O)c2)c1,IC50,5.07,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,HYQGRYRHNUHTJF-UHFFFAOYSA-N
CHEMBL1800961,,C[C@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,8.72,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LGUXLVJQUKRZBO-SZNDQCEHSA-N
CHEMBL1800963,,COc1ccc(C[C@@H](C)NC[C@H](O)c2cc(O)cc(O)c2)c2ccccc12,IC50,8.4,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,MLQLUFQBFMFXJO-SZNDQCEHSA-N
CHEMBL5624772,,O=C(CBr)N1CCN(Cc2ccccc2)C12COC2,IC50,4.84,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,IJUVLJPFJOOTMB-UHFFFAOYSA-N
CHEMBL5629911,,COc1ccc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)c(OC)c1OC,IC50,5.7,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,YJIUFCQCXZCPCY-WYMLVPIESA-N
CHEMBL5630884,,COc1cc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)cc(OC)c1OC,IC50,5.66,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,KXLZHAYSAFHCAT-OUKQBFOZSA-N
CHEMBL5630623,,O=C(/C=C/c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)o1)c1ccncc1,IC50,4.98,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,VROPXIBVQDNQDY-SOFGYWHQSA-N
CHEMBL5630621,,O=C(/C=C/c1ccncc1)c1ccc(C(=O)N2CCN(Cc3ccccc3)C23COC3)cc1,IC50,5.52,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,HWKVFCNTYRXRDC-IZZDOVSWSA-N
CHEMBL5426265,,COc1ncc(-c2cc(OC3CCOCC3)c3ncnc(C)c3c2)cc1N(Cc1cc2ccc(O)cc2oc1=O)S(=O)(=O)c1ccc(F)cc1F,IC50,7.96,CHEMBL5365273,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CTG assay,U-87MG ATCC,FMBOZAUZAYJAQV-UHFFFAOYSA-N
CHEMBL2385195,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,6.46,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,FDCKDXZISZRERO-UHFFFAOYSA-N
CHEMBL376007,SCHWEINFURTHIN F,COc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,7.01,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,BUFNPAYKUGAAAO-HLULBIOLSA-N
CHEMBL5409120,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](OC=O)C(C)(C)[C@H]1C2,IC50,6.42,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,OPHLMZMHCHXHFP-QODMNUCZSA-N
CHEMBL5433829,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)C[C@@H](OC=O)[C@@H](OC=O)C(C)(C)[C@H]1C2,IC50,6.3,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,FIHDOLOFALIBNB-XDOKPFJCSA-N
CHEMBL4641079,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(-c3ccsc3)c12,IC50,4.24,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,NJZNRDNBXVDDEO-ZRJCITRHSA-N
CHEMBL4640055,,Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccccc3)cc2)n1,IC50,4.58,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,LOZVEFLIYFPCMV-UHFFFAOYSA-N
CHEMBL4635455,,Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ncccc4Cl)cc3)n2)cn1,IC50,4.42,CHEMBL4623065,Antiproliferative activity against human U87 cells assessed as cell growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,ADAPNHDAVCDSDS-UHFFFAOYSA-N
CHEMBL1336,SORAFENIB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,IC50,4.9,CHEMBL5239980,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,MLDQJTXFUGDVEO-UHFFFAOYSA-N
CHEMBL4859691,,C[C@H]1[C@@H](O[C@@H]2CC[C@@]3(C)[C@@H](C2)C[C@H](O)[C@@H]2[C@@H]3CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]23)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,6.38,CHEMBL4830288,Anticancer activity against human U-87 MG cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK8 reagent assay,U-87MG ATCC,ZTPKCMSHVVATOJ-JHWQQEMVSA-N
CHEMBL4792320,,N#Cc1c(N2CCOCC2)sc(-c2nc[nH]n2)c1-c1ccc(NC(=O)N/N=C/c2ccco2)cc1,IC50,4.91,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,LWCWWDARQBRUKC-LGJNPRDNSA-N
CHEMBL4291607,,O=C(O[C@H]1C[C@H](n2cc(F)c(=O)[nH]c2=O)O[C@@H]1COP(=O)(O)Oc1ccccc1)c1ccccc1,IC50,6.09,CHEMBL4254533,Cytostatic activity against human T98G cells assessed as reduction in cell viability after 48 hrs by MTT assay,T98G,TVSGTBVPVITRGR-IPMKNSEASA-N
CHEMBL4291354,,CCOC(=O)C[n+]1cccc(OP(=O)([O-])OC[C@H]2O[C@@H](n3cc(F)c(=O)[nH]c3=O)C[C@@H]2OC(=O)c2ccccc2)c1,IC50,6.24,CHEMBL4254537,Cytostatic activity against human U87MG cells assessed as reduction in cell viability after 48 hrs by MTT assay,U-87MG ATCC,WHXVUFUYVAMPKN-PWRODBHTSA-N
CHEMBL4286444,,Cc1cc(=O)c(O)c(C(c2ccc(CCc3ccccc3)cc2)c2oc(C)cc(=O)c2O)o1,IC50,4.57,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,UEJPIJRIQVWZCA-UHFFFAOYSA-N
CHEMBL2180727,,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,IC50,4.7,CHEMBL4258445,Antiproliferative activity against human U87 cells by MTT assay,U-87MG ATCC,FNYGWXSATBUBER-UHFFFAOYSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,4.81,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL44657,ETOPOSIDE,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,IC50,5.44,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CHEMBL472940,,Oc1ccc2ccccc2c1SSc1c(O)ccc2ccccc12,IC50,4.66,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,RFAXLXKIAKIUDT-UHFFFAOYSA-N
CHEMBL3545252,DOCETAXEL,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,IC50,7.99,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,XCDIRYDKECHIPE-QHEQPUDQSA-N
CHEMBL34259,METHOTREXATE,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,IC50,6.22,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,FBOZXECLQNJBKD-ZDUSSCGKSA-N
CHEMBL176544,,Cn1cc(/C=C2\C(=O)Nc3cccnc32)c2ccccc21,IC50,4.3,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,NXNQLECPAXXYTR-LCYFTJDESA-N
CHEMBL240954,,CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](O)[C@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)O[C@H]1C,IC50,4.22,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,SXOZSDJHGMAEGZ-IGKKHSBFSA-N
CHEMBL507361,MIRDAMETINIB,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,IC50,5.85,CHEMBL2363740,SANGER: Inhibition of human AM-38 cell growth in a cell viability assay.,AM-38,SUDAHWBOROXANE-SECBINFHSA-N
CHEMBL5440334,,C=C1C(=O)N(c2cc(OC)c(OC)c(OC)c2)[C@H]1c1ccc(OC)c(/C=C/C(=O)NO)c1,IC50,7.14,CHEMBL5328891,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,PVWHETLDZLZCTN-WFNSPDMASA-N
CHEMBL413,SIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,7.52,CHEMBL2363630,SANGER: Inhibition of human SF126 cell growth in a cell viability assay.,SF126,QFJCIRLUMZQUOT-HPLJOQBZSA-N
CHEMBL4293082,,CC1(C)[C@@H](OC(N)=O)[C@H]2O[C@H]2[C@]2(C=O)[C@H]3CC[C@]4(C)[C@@H](c5ccc(=O)oc5)[C@@H](Cl)C[C@]4(O)C3=CC[C@@H]12,EC50,8.19,CHEMBL4269852,Cytotoxicity against human U87MG cells assessed as decrease in cell viability after 72 hrs by MTS assay,U-87MG ATCC,PRWPKNOLVLDXSO-OYFNOYEBSA-N
CHEMBL4280528,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CCOC(=O)c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.82,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,RCXHJQPQDDODGW-AMERCFFHSA-N
CHEMBL4282461,,C=C1C(=O)O[C@H]2[C@H]1CC/C(Cn1cc(CNC(=O)/C=C/c3ccccc3)nn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.53,CHEMBL4272593,Antiproliferative activity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,SOAATGVSBYXULL-SLJYEFRKSA-N
CHEMBL4798940,,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,IC50,6.35,CHEMBL4687828,Cytotoxicity in human U87 cells assessed as reduction in cell viability incubated for 2 hrs by Cell-titer-blue assay,U-87MG ATCC,DNZPQXXGAMXDHH-FCNQEGBTSA-N
CHEMBL4465942,,O=C(Nc1nc2ccccc2s1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,4.94,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VPZGTTFECODUMR-UHFFFAOYSA-N
CHEMBL4446129,,O=C(Nc1nc2ccc(Cl)cc2s1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1,IC50,5.23,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,XDGFOYZEECLHHR-UHFFFAOYSA-N
CHEMBL458997,,CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,IC50,5.54,CHEMBL4704567,Cytotoxicity against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,UYJNQQDJUOUFQJ-UHFFFAOYSA-N
CHEMBL4752642,,C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O,IC50,6.19,CHEMBL4704568,Cytotoxicity against human A172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,UTSSJQUIRGMHJS-UHFFFAOYSA-N
CHEMBL4789041,,COc1ccc2cc1Oc1ccc(cc1)Cc1nccc3c4c(c(OC)c(c13)Oc1c3c(cc(OC)c1OC)[C@H](C2)N(C)CC3)OCO4,IC50,6.42,CHEMBL4688075,Anticancer activity against human T98G cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay,T98G,PCEQWUUFUJWIBW-NDEPHWFRSA-N
CHEMBL4459518,,CN(CCOC(=O)/C=C/C(=O)c1ccc(F)cc1)C(C(=O)NC(C)(C)C)c1ccc(F)cc1,IC50,5.05,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RJGWWNVHLMPYEN-BUHFOSPRSA-N
CHEMBL5266584,,CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)OCC(O)COC(=O)CCCC[P+](c3ccccc3)(c3ccccc3)c3ccccc3)[C@H]2CC1.[Br-],IC50,5.01,CHEMBL5256161,Cytotoxicity against human T98G cells assessed as number of viable cells measured after 48 hrs by MTT based colorimetric assay,T98G,QDQPHTVQELYRSR-QJYNUPQVSA-M
CHEMBL5413573,,NCCCCNCCCNC(=O)c1csc(-c2csc(CCNCc3ccc4scnc4c3)n2)n1,IC50,4.78,CHEMBL5351368,Antiproliferative activity against human U87 cells incubated for 72 hrs by WST-1 assay,U-87MG ATCC,FXQZOIBTCCOGNX-UHFFFAOYSA-N
CHEMBL5573821,,Cc1ccc(CCNC(=O)C2(C#N)CC3c4ccccc4C2c2ccccc23)cc1,IC50,4.22,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,LUCOEIXBNKKXSK-UHFFFAOYSA-N
CHEMBL5570551,,N#CC1(C(=O)NCCc2ccc([N+](=O)[O-])cc2)CC2c3ccccc3C1c1ccccc12,IC50,4.62,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,GTSYFCWIXPZHOK-UHFFFAOYSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],IC50,6.71,CHEMBL4810922,Antiproliferative activity against human U-87MG cells assessed as reduction in cell proliferation measured after 48 hrs in presence of TMZ by EdU-incorporation assay,U-87MG ATCC,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],EC50,6.97,CHEMBL4810930,Cytotoxicity against human KNS-42 cells assessed as reduction in total cell count measured after 96 hrs in presence of TMZ by Hoechst staining based analysis,KNS-42,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],IC50,6.71,CHEMBL4810932,Antiproliferative activity against human KNS-42 cells assessed as reduction in cell proliferation measured after 48 hrs in presence of TMZ by EdU-incorporation assay,KNS-42,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL4792680,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccccc2)c(C#N)c(=O)[nH]1,IC50,4.25,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,DCNGLUBPOAYJPH-UHFFFAOYSA-N
CHEMBL4751240,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2cccc(Cl)c2)c(C#N)c(=O)[nH]1,IC50,4.55,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,QNMGQJMYIJEWAV-UHFFFAOYSA-N
CHEMBL4096826,,C=C(c1ccc(OC)cc1)c1cc(C(=O)OC)nc2ccccc12,IC50,8.64,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,SICDWJZZXUDUED-UHFFFAOYSA-N
CHEMBL4077156,,C=C(c1ccc(OC)cc1)c1cc(C(F)(F)F)nc2ccccc12,IC50,7.66,CHEMBL4006122,Cytotoxicity against human U87 cells assessed as decrease in cell growth after 72 hrs by resazurin dye-based fluorimetric method,U-87MG ATCC,UYUDQATZMGXFQX-UHFFFAOYSA-N
CHEMBL4740296,,CO[C@@]1(C)N(CCc2ccccc2)C(=O)c2cc3c4ccccc4n(C)c3c(=O)n21,IC50,5.05,CHEMBL4670186,Antiproliferative activities against human U-87 MG cells by SRB assay,U-87MG ATCC,HJEQLHSAFDJJPU-DEOSSOPVSA-N
CHEMBL5185523,,O=C(NC1CCCCC1)c1[nH]cnc1-c1nc2ccccc2[nH]1,IC50,4.81,CHEMBL5117722,Antiproliferative activity against human U87 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay,U-87MG ATCC,JABMGIWPHDQZBN-UHFFFAOYSA-N
CHEMBL1625188,,COc1ccc(CCNCc2ccc(OCc3ccc(Cl)nc3)c(OC)c2)cc1OC,EC50,5.3,CHEMBL5129769,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 72 hrs,LN-229,XNPRQBVQOJZMMA-UHFFFAOYSA-N
CHEMBL4797411,,COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)cc3F)nc12,IC50,5.62,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,LWYQSQHYOQZLGD-UHFFFAOYSA-N
CHEMBL4789212,,COc1cc(C(=O)NC2CCNCC2)c(F)cc1Nc1ncc2scc(-c3ccccc3OC)c2n1,IC50,5.45,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,RRSINXKFGITOLR-UHFFFAOYSA-N
CHEMBL1873475,IBRUTINIB,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,IC50,5.5,CHEMBL4832265,Antiproliferative activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB assay,SNB-75,XYFPWWZEPKGCCK-GOSISDBHSA-N
CHEMBL15192,LAPACHONE,CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O,IC50,6.02,CHEMBL3611293,Cytotoxicity against human SF295 cells assessed as cell viability after 72 hrs by MTT assay,SF295,QZPQTZZNNJUOLS-UHFFFAOYSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.65,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL553,ERLOTINIB,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,IC50,4.22,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,AAKJLRGGTJKAMG-UHFFFAOYSA-N
CHEMBL4783479,,C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCN(C2CCN(C)CC2)CC1,IC50,5.19,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,LPFKPANEFAADFV-UHFFFAOYSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],EC50,6.41,CHEMBL4810929,Cytotoxicity against human KNS-42 cells assessed as reduction in total cell count measured after 96 hrs by Hoechst staining analysis,KNS-42,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL5080969,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(CC(C)C)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.45,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,WCCOFLBJUFCACV-BDFBTMKGSA-N
CHEMBL5081089,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C#N)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.61,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,HVZRIWTYRLQBBL-MPOPNXFASA-N
CHEMBL1963047,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccccc21,IC50,4.72,CHEMBL5038359,Dark toxicity against human U-87 MG cells incubated for 48 hrs by Alamar blue assay,U-87MG ATCC,MUEMGQSGNZKFJI-UHFFFAOYSA-O
CHEMBL5089437,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccc(I)cc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccc(I)cc21,IC50,4.94,CHEMBL5038359,Dark toxicity against human U-87 MG cells incubated for 48 hrs by Alamar blue assay,U-87MG ATCC,FZNGVYVJSVCUNB-UHFFFAOYSA-O
CHEMBL5087179,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccc(I)cc4C3(C)C)C[N+](C)(C)C2)=[N+](CCCCCC(=O)O)c2ccc(I)cc21,IC50,4.21,CHEMBL5038359,Dark toxicity against human U-87 MG cells incubated for 48 hrs by Alamar blue assay,U-87MG ATCC,PBMRAVBJOHZYEY-UHFFFAOYSA-P
CHEMBL4584988,,CCCCN(CCCC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(C#N)c2)cc1,IC50,4.77,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,PZRIKWNOAQZQDI-XNTDXEJSSA-N
CHEMBL4545330,,N#Cc1cccc(/C=C/C(=O)c2ccc(O)cc2)c1,IC50,4.78,CHEMBL4390741,Cytotoxicity against human A172 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,A-172,IZCIYUNGVIXYJY-RUDMXATFSA-N
CHEMBL4438947,,O=C(/C=C/c1ccc(B(O)O)cc1)c1ccccc1,IC50,4.51,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,GJEUTIGMSWDODK-DHZHZOJOSA-N
CHEMBL4577143,,CCN(CC)S(=O)(=O)c1ccc(C(=O)/C=C/c2cccc(O)c2)cc1,IC50,4.39,CHEMBL4390740,Cytotoxicity against human U87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,WQJDLXODDONTGE-MDWZMJQESA-N
CHEMBL5275748,,Nc1nc(-c2cccc(OCCCN3CCCC3)c2)nc2c1c(=O)oc1cc(OCCCN3CCCC3)ccc12,IC50,4.41,CHEMBL5232067,Antiproliferative activity against human U87 cells assessed as reduction in cell viability by MTT assay,U-87MG ATCC,PZZLXYMMLWEFMZ-UHFFFAOYSA-N
CHEMBL5276542,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5nc[nH]n5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.74,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,OUYPCXLZQOCROY-UHFFFAOYSA-N
CHEMBL5417697,,O=C(Nc1cccc(Cl)c1)Sc1nnc(-c2ccc(Cl)cc2)n1-c1ccccc1,IC50,5.38,CHEMBL5333090,Antiproliferative activity against human U87 cells assessed as inhibition of cell growth,U-87MG ATCC,LUMVYWFMNQMBOU-UHFFFAOYSA-N
CHEMBL5287987,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5cncnc5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.83,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,DLYWBQVCKWSDMK-UHFFFAOYSA-N
CHEMBL4748209,,C=CC(=O)Nc1cccc(Nc2cc(-n3c(C)nnc3-c3ccc(F)cc3)ccn2)c1,IC50,4.29,CHEMBL4707743,Antiproliferative activity against human U-87MG cells harboring wild type EGFR assessed as inhibition of cell growth by MTT assay,U-87MG ATCC,RWTHYPRQARXLCM-UHFFFAOYSA-N
CHEMBL5397139,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(-c3ccccc3)cc2)C(=O)N(C)[C@H](C)C(=O)N[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](COC)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](COC)C(=O)N1C,IC50,10.1,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,MKLAVULUNKJJPK-FYOBYPTESA-N
CHEMBL5422790,,CN(C)c1ccc(/N=N/c2ccc(S(=O)(=O)NCCc3nc(-c4nc(C(=O)NCCCNCCCCN)cs4)cs3)cc2)cc1,IC50,4.34,CHEMBL5351368,Antiproliferative activity against human U87 cells incubated for 72 hrs by WST-1 assay,U-87MG ATCC,OZYDGNJHIKBMTD-HEFFKOSUSA-N
CHEMBL5079362,,O=C1c2cc(I)ccc2N(c2cccc(F)c2)C2c3[nH]c4ccccc4c3CCN12,IC50,5.13,CHEMBL5339028,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by MTT assay,U-87MG ATCC,JACXJNXOIHUXIX-UHFFFAOYSA-N
CHEMBL1927614,,CN(C)CCCn1nnc2cc3c4c(cccc4c21)C(=O)N(CCN(C)C)C3=O,IC50,6.85,CHEMBL1929814,Cytotoxicity against human U87MG cells after 72 hrs by MTT assay,U-87MG ATCC,WXUHPAUCHCAIPF-UHFFFAOYSA-N
CHEMBL5280123,,O=C1c2cccc3cccc(c23)C(=O)N1CCCCOc1ccc(-c2nc3ccc(N4CCOCC4)cc3[nH]2)cc1,IC50,6.96,CHEMBL5245068,Cytotoxicity against human SNB-75 cells assessed as cell growth inhibition incubated for 48 hrs by sulforhodamine B reagent assay,SNB-75,QGKRJVRREBVWCS-UHFFFAOYSA-N
CHEMBL1949932,,C=C1CC[C@H](OC)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,IC50,4.27,CHEMBL1953622,Antiproliferative activity against human U87MG cells after 72 hrs by MTS assay,U-87MG ATCC,URIJSEIPUOYEFF-YELRADRNSA-N
CHEMBL375563,,CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.43,CHEMBL1955142,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,PYXFVCFISTUSOO-HKUCOEKDSA-N
CHEMBL1669124,,CC(C)(O)CCC[C@@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C,IC50,4.6,CHEMBL4369210,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 48 hrs by MTT assay,U-87MG ATCC,VKYVIIIEJKSVBR-XHJPDDKBSA-N
CHEMBL3621412,,CCCCCCCCCCc1c2[n+](cc3c(OC)c(OC)ccc13)CCc1cc3c(cc1-2)OCO3.[I-],IC50,5.44,CHEMBL3625192,Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 24 hrs by MTT assay,U-87MG ATCC,JKASRMSRXGFEGS-UHFFFAOYSA-M
CHEMBL5573925,,N#CC1(C(=O)NCCC2CCN(Cc3ccc(F)cc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.73,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,BJHOYNGWJMVXPJ-UHFFFAOYSA-N
CHEMBL5575796,,N#CC1(C(=O)NCCS(=O)(=O)Nc2ccccc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.58,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,XJSVJCMJVXZLEQ-UHFFFAOYSA-N
CHEMBL4856308,,O=C(/C=C/c1ccccc1)O[C@H](c1ccccc1)[C@@H]1O[C@@H]2CC(=O)O[C@@H]2[C@@H]1O,IC50,4.49,CHEMBL4836842,Antiproliferative activity against human U87 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,GDYNBHXFRSGEGM-FXLLVQDUSA-N
CHEMBL5397075,,C=CCOc1cc(/C=C/c2cc(O)c(CC=C(C)C)c(O)c2)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.38,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,FCIXCOAOQBTADC-UQWWERDESA-N
CHEMBL5396667,,CC1(C)CCc2c(O)cc(CCc3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](OC=O)CC[C@@]3(C)O4)cc2O1,IC50,7.17,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,CFKFSLXHHGZHHP-VOKYQHOCSA-N
CHEMBL5402401,,CC1(C)CCc2c(O)cc(/C=C/c3cc(O)c4c(c3)C[C@@H]3C(C)(C)[C@H](O)CC[C@@]3(C)O4)cc2O1,IC50,8.03,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,ZDNJECQLZCXDFY-WQRMQLLLSA-N
CHEMBL5433096,,COc1cc(/C=C/c2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](O)C(C)(C)[C@H]1C2,IC50,6.32,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,WNLPKXXIDNGVIL-SQMHIVSLSA-N
CHEMBL5620207,,C#CCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.44,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,SPCWHTKAHOLBOD-PMERELPUSA-N
CHEMBL5619479,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2cccc(F)c12)c1c[nH]c2cccc(F)c12,IC50,4.97,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,NCEYYCYQKDMNMV-SANMLTNESA-N
CHEMBL5620207,,C#CCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.76,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,SPCWHTKAHOLBOD-PMERELPUSA-N
CHEMBL5618644,,CCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.97,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,LWAKRXJTSPCTEM-UMSFTDKQSA-N
CHEMBL5619198,,CCCCCCCCCCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.88,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,OAHWQNOGENVZIW-QNGWXLTQSA-N
CHEMBL4571722,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2)CC1,IC50,7.82,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,NZIKKCSMHNBNPK-WAOWUJCRSA-N
CHEMBL5632259,,C=CC(=O)N1CCN(C(CC)c2ccc([C@H](C)Nc3nccc(N4CCOC4=O)n3)cc2)CC1,IC50,8.66,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,VLZWVMXOKOOBSV-YMXDCFFPSA-N
CHEMBL223046,VEDELIANIN,CC(C)=CCc1c(O)cc(/C=C/c2cc(O)c3c(c2)C[C@@H]2C(C)(C)[C@H](O)[C@H](O)C[C@@]2(C)O3)cc1O,IC50,7.82,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,OYMAGMAEFPAAGU-HKYLTJPLSA-N
CHEMBL3220808,,C[C@H]1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)OCC[N+](C)(C)Cc4ccccc4)[C@@H]2CC[C@]1(Cl)C3.[Br-],IC50,4.2,CHEMBL4689358,Cytotoxicity against human T98G cells assessed as reduction in cell viability by DAPI staining based assay,T98G,VVEZDYZVKNBPHF-PRQQZGLHSA-M
CHEMBL5281732,,COc1cc(Nc2ccc3nnc(-c4cccs4)n3c2)cc(OC)c1OC,IC50,4.69,CHEMBL5224863,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth,T98G,NEUWAHWZAYQREP-UHFFFAOYSA-N
CHEMBL5620052,,COc1ccc(-c2ccc(C(=O)N3CCc4c(cc(Cl)c(C(=O)NO)c4Cl)C3)cc2)cc1,IC50,5.4,CHEMBL5614661,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,RDTQMQMGGPHOHV-UHFFFAOYSA-N
CHEMBL1173154,,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)cc2)ccc1O,IC50,5.26,CHEMBL4838616,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,NMRUIRRIQNAQEB-VEAXOGKZSA-N
CHEMBL4877449,,CC(C)OC(=O)[C@H](N)Cc1cn(C)c2ccccc12.Cl,IC50,6.07,CHEMBL4838616,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,SNYZUMLXSTYVPU-BTQNPOSSSA-N
CHEMBL558642,GSK-650394,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,IC50,4.6,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,WVSBGSNVCDAMCF-UHFFFAOYSA-N
CHEMBL575448,BMS-754807,C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1,IC50,5.82,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,LQVXSNNAFNGRAH-QHCPKHFHSA-N
CHEMBL477772,PAZOPANIB,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,IC50,5.43,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,CUIHSIWYWATEQL-UHFFFAOYSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,5.34,CHEMBL2363720,SANGER: Inhibition of human A172 cell growth in a cell viability assay.,A-172,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL803,CYTARABINE,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,IC50,5.76,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
CHEMBL413,SIROLIMUS,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,IC50,5.29,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,QFJCIRLUMZQUOT-HPLJOQBZSA-N
CHEMBL428647,PACLITAXEL,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,IC50,5.38,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,RCINICONZNJXQF-MZXODVADSA-N
CHEMBL577784,BX-795,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,IC50,4.96,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,VAVXGGRQQJZYBL-UHFFFAOYSA-N
CHEMBL1879463,DACTOLISIB,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,IC50,6.52,CHEMBL2363811,SANGER: Inhibition of human U-87-MG cell growth in a cell viability assay.,U-87MG ATCC,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
CHEMBL5218785,,CCOC(=O)c1c(N)sc(C(=O)Nc2ccc(Cl)cc2)c1-c1ccccc1,IC50,6.41,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,DSJIPZTZCBUSIZ-UHFFFAOYSA-N
CHEMBL5219322,,N#Cc1c(N)sc(C(=O)Nc2ccccc2)c1-c1ccccc1,IC50,5.05,CHEMBL5216302,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition by MTT assay,U-87MG ATCC,VJVXZLADENLGMU-UHFFFAOYSA-N
CHEMBL5275244,,C/C(=C\CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1)c1ccccc1,IC50,4.65,CHEMBL5225163,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,CCEWBVIQKCUYJV-WOJGMQOQSA-N
CHEMBL5289048,,COc1ccc(/C(C)=C/CN2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)cc1,IC50,4.62,CHEMBL5225163,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay,U-87MG ATCC,PTGWAAKNSYOHMB-WOJGMQOQSA-N
CHEMBL5277464,,C/C(=C\CN1CCN(C(=O)C2CCCC2)CC1)c1ccccc1,IC50,4.41,CHEMBL5225164,Anti-proliferative against human U-87 MG cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,NRJLQONGQFSUJQ-GZTJUZNOSA-N
CHEMBL5207176,,c1c(CN2CCCCCC2)c(-c2cc3ccc4c(c3cn2)OCO4)cc2c1OCO2,IC50,4.26,CHEMBL5122968,Antiproliferative activity against human U87 cells measured after 72 hrs by MTT assay,U-87MG ATCC,KGYHKHZROFSQOS-UHFFFAOYSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],EC50,6.97,CHEMBL4810920,Cytotoxicity against human U-87MG cells assessed as reduction in total cell count measured after 96 hrs in presence of TMZ by Hoechst staining analysis,U-87MG ATCC,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL4864756,,COc1cc(C(=O)NC2CCCN(C(=O)CCCCCN3/C(=C/C=C4\CCCC(/C=C/C5=[N+](CCCCCC(=O)N6CCCC(NC(=O)c7cc(OC)c(OC)c(OC)c7)C6)c6ccccc6C5(C)C)=C4Cl)C(C)(C)c4ccccc43)C2)cc(OC)c1OC.[Br-],IC50,6.3,CHEMBL4810921,Antiproliferative activity against human U-87MG cells assessed as reduction in cell proliferation measured after 48 hrs by EdU-incorporation assay,U-87MG ATCC,QTRZVIIDNJPRSU-UHFFFAOYSA-N
CHEMBL259181,,OC[C@H](Cc1ccccc1)Nc1nc(Oc2ccc3c(c2)CCC3)nc2c1ncn2Cc1ccc(-c2ccccc2)cc1,IC50,5.49,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,DOKZLKDGUQWMSX-HKBQPEDESA-N
CHEMBL558642,GSK-650394,O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1,IC50,5.12,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,WVSBGSNVCDAMCF-UHFFFAOYSA-N
CHEMBL94657,PATUPILONE,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1,IC50,8.72,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,QXRSDHAAWVKZLJ-PVYNADRNSA-N
CHEMBL191384,,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,IC50,5.52,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,AVLYNJZZQYEFEA-XDJHFCHBSA-N
CHEMBL65,CAMPTOTHECIN,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,IC50,8.1,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,VSJKWCGYPAHWDS-FQEVSTJZSA-N
CHEMBL939,GEFITINIB,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,IC50,4.96,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,XGALLCVXEZPNRQ-UHFFFAOYSA-N
CHEMBL443684,NAVITOCLAX,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1,IC50,4.97,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,JLYAXFNOILIKPP-KXQOOQHDSA-N
CHEMBL109480,TANESPIMYCIN,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O,IC50,7.19,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,AYUNIORJHRXIBJ-TXHRRWQRSA-N
CHEMBL222102,KU-55933,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,IC50,4.0,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,XRKYMMUGXMWDAO-UHFFFAOYSA-N
CHEMBL1079175,MK-2206,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,IC50,5.24,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,ULDXWLCXEDXJGE-UHFFFAOYSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.63,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL2165191,AZD-6482,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,IC50,4.62,CHEMBL2363632,SANGER: Inhibition of human SF295 cell growth in a cell viability assay.,SF295,IRTDIKMSKMREGO-OAHLLOKOSA-N
CHEMBL169372,,CCCN(CCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC)C(=O)OCc1ccccc1,IC50,5.63,CHEMBL618617,Cytotoxicity against A-172 human tumor cell lines,A-172,YAYJCWOTIVMBGB-UHFFFAOYSA-N
CHEMBL4874975,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(CCc7c[nH]c8ccccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.46,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,CZTODLSQKDVKCS-CYOJNKNFSA-N
CHEMBL5091306,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(C(C)(C)C)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.35,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,RVEWODMIOUUZJR-CHFKRMNXSA-N
CHEMBL5080560,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(F)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.57,CHEMBL5044225,Antiproliferative activity against human A-172 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,A-172,NSHNVMIURYQLAG-MCLIRCHUSA-N
CHEMBL5090018,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(CCC(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.76,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,BDWTWOVMVWJZNR-SUNMMQDUSA-N
CHEMBL5080088,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5nccs5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.48,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,GJQSIGCKFMWMGG-VZTVURHLSA-N
CHEMBL5082185,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.49,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,MZYJAIGPHMIGGJ-MPOPNXFASA-N
CHEMBL2146196,"cis-Dichloro[(2S,3R,4S)-2-aminomethyl-3,4-(O-isopropylidene)dihydrxypyrrolidine]platinum (II)",,IC50,5.21,CHEMBL822894,In vitro cytotoxicity against CNS cancer XF 498 cell lines,XF 498,
CHEMBL4854989,,C[C@@]1(C(=O)CO)CC[C@@H]2C(=C[C@H]3OC(=O)[C@]4(C)[C@H]3[C@]23CC[C@@]4(O)OC3)C1,IC50,5.66,CHEMBL4842430,Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,SF295,YKOCFEFYIFARIO-BIVJBNGQSA-N
CHEMBL4759979,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3ccccc3)nc(N3CCOCC3)n2)cc1,IC50,5.32,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,VCCVHWUDWBSEKU-GIDUJCDVSA-N
CHEMBL1554780,,COc1cc(C(c2cc3c(cc2O)OCO3)N2CCOCC2)ccc1O,IC50,4.57,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,RADCFXRBORYSKP-UHFFFAOYSA-N
CHEMBL228996,,COc1ccc(C[C@H](C)NC[C@H](O)c2cc(O)cc(O)c2)cc1,IC50,8.7,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,WHAUNCTVVNUUIP-SGTLLEGYSA-N
CHEMBL1800962,,C[C@@H](Cc1ccc2ccccc2c1)NC[C@H](O)c1cc(O)cc(O)c1,IC50,7.14,CHEMBL3887982,"Mitogenesis inhibition method: To measure beta2-AR mediated inhibition of mitogenesis, HEK-beta2-AR, 1321N1 or U87MG cells were seeded in a 96-well plate at approximately 5,000 cells/well. After 48 hours, the wells were rinsed twice and the medium was replaced with fresh medium containing 10 uL of drug in sterile water. After another 24 hours of incubation at 37 C., 0.25 uCi of [3H]-thymidine was added to each well. The cells were incubated for an additional 2 hours at 37 C., at which point 10 uL of 10x trypsin was added, and the resuspended cells were harvested using a Tomtec 96 harvester through glass fiber filters.",U-87MG ATCC,LGUXLVJQUKRZBO-QKKBWIMNSA-N
CHEMBL3113716,,Clc1cccc(/C=N/Nc2cnc3ccccc3n2)c1Cl,IC50,5.21,CHEMBL3118174,Cytotoxicity against human SF295 cells assessed as growth inhibition by MTT assay,SF295,ALKVARZYBSMXMJ-UFWORHAWSA-N
CHEMBL5087242,,COc1cc(NC(=O)c2ccccc2Nc2cccc(Cl)c2C)cc(OC)c1OC,IC50,4.26,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,JQJLSDCXRGCLNB-UHFFFAOYSA-N
CHEMBL5094553,,COc1cc(NC(=O)c2ccccc2Nc2cccc(C(F)(F)F)c2)cc(OC)c1OC,IC50,4.28,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,SEDIPHJTXQZFDO-UHFFFAOYSA-N
CHEMBL5090197,,O=C(Nc1ccc2c(c1)OCO2)c1ccccc1Nc1cccc(C(F)(F)F)c1,IC50,4.58,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,JATYNCWXASKYNI-UHFFFAOYSA-N
CHEMBL5090568,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(C(F)(F)F)c2)cc1OC,IC50,4.14,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,MQILAKUASHKEQM-UHFFFAOYSA-N
CHEMBL4750331,,Cc1nc(-c2ccccc2)sc1C(=O)CSc1nc(-c2ccc(Cl)cc2)c(C#N)c(=O)[nH]1,IC50,4.36,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,TXCLIWYZLLCKOE-UHFFFAOYSA-N
CHEMBL4750598,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4ccc(OC)cc4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.6,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,KLNAFXRJSQSCRM-UHFFFAOYSA-N
CHEMBL4790098,,COc1ccc(-c2nc(C)c(C(=O)CSc3nc(-c4cccc(Cl)c4)c(C#N)c(=O)[nH]3)s2)cc1,IC50,4.1,CHEMBL4713097,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell viability measured after 24 to 48 hrs by MTT assay,U-87MG ATCC,JSXTVTWUTBNLHE-UHFFFAOYSA-N
CHEMBL5421266,,CNc1ncc2c(C#CCN3CCC(N(C)C)CC3)nn(CC3CCCC3)c2n1,EC50,4.8,CHEMBL5330903,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 5 days by PrestoBlue reagent based fluorescence assay,U-87MG ATCC,FCZCQCJUJGYANI-UHFFFAOYSA-N
CHEMBL5084269,,O=C(C[C@@]1(O)C(=O)N(Cc2cccc(Cl)c2)c2ccccc21)c1ccccn1,IC50,4.56,CHEMBL5029875,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay,U-87MG ATCC,JJOIKBZRLCEZOR-QFIPXVFZSA-N
CHEMBL4783328,,C1=C2CNCC3=Cc4c(ccc5ccccc45)OC23Oc2ccc3ccccc3c21,IC50,5.3,CHEMBL4688129,Anti-cancer activity against human SNB-75 cells assessed as cell growth inhibition measured after 48 hrs by SRB method,SNB-75,FKUSUQUCJVZNII-UHFFFAOYSA-N
CHEMBL5267044,,Cc1c(Cl)ccc2c(/C=C3\NC(=O)N(Cc4ccc(F)c(F)c4)C3=O)c[nH]c12,IC50,5.85,CHEMBL5582679,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by MTS assay,U-87MG ATCC,OEXMEVPQEPHTAQ-IDUWFGFVSA-N
CHEMBL4793298,,C[N+](=O)c1ccc(/C=C/C(=O)c2ccc(N3CCOCC3)cc2)o1,EC50,5.01,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,ILLFPXCUYAQGTM-SOFGYWHQSA-N
CHEMBL4073310,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(I)cc1,EC50,5.28,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,KYRLMIXZFNCBMW-FNORWQNLSA-N
CHEMBL4070585,,O=C(/C=C/c1ccc([N+](=O)[O-])o1)c1ccc(N2CCNCC2)cc1,EC50,5.31,CHEMBL4767683,Antiproliferative activity against human U87MG cells assessed as cell growth inhibition measured after 72 hrs by SRB assay,U-87MG ATCC,ZZXWVWNECFVHBY-FNORWQNLSA-N
CHEMBL5089333,,Nc1nc2cc3c(cc2cc1C(=O)NCc1ccccc1)OCO3,IC50,4.12,CHEMBL5031814,Cytotoxicity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,GFOKSVKZSHIVQO-UHFFFAOYSA-N
CHEMBL2385197,,COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)c(F)c5)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,IC50,5.97,CHEMBL2390322,Cytotoxicity against c-Met-dependent human U87MG cells assessed as growth inhibition after 72 hrs by MTT assay,U-87MG ATCC,QDZNZFNADWFZJG-UHFFFAOYSA-N
CHEMBL5280867,,CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)NN5CCOCC5)cc4)nc(N4CCOCC4)n3)s2)CC1,IC50,4.57,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,PBSBZNYTIWLPAF-UHFFFAOYSA-N
CHEMBL521851,PICTILISIB,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,IC50,5.5,CHEMBL5240755,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay,U-87MG ATCC,LHNIIDJUOCFXAP-UHFFFAOYSA-N
CHEMBL5283948,,Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCNC(=O)c2cc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)ccn2)C(C)(C)C)cc1,IC50,4.91,CHEMBL5239980,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,U-87MG ATCC,DQWLHVNWDUFZCJ-JGTDPZFESA-N
CHEMBL465843,PIPLARTINE,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,IC50,5.0,CHEMBL5241672,Antiproliferative activity against human U87 cells assessed as cell growth inhibition,U-87MG ATCC,VABYUUZNAVQNPG-BQYQJAHWSA-N
CHEMBL5271581,,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)/C=C/c4ccc(F)cc4Cl)C(N)=O)C(=O)O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C,IC50,7.79,CHEMBL5254512,Antiproliferative activity against human SF-295 cells assessed inhibition of cell growth incubated for 72 hrs by SRB assay,SF295,ZMDKGABGPBZBQT-QUFZNYFDSA-N
CHEMBL5275603,,C[C@H]1[C@H](OCCNC(=O)c2ccc(COc3ccc(/C=C/S(=O)(=O)Nc4ccccc4Cl)cc3)cc2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.05,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,JMDVEJHAKIXHJA-VHPJKMJMSA-N
CHEMBL5275306,,C[C@H]1[C@H](OCCOc2cccc(/C=C/S(=O)(=O)Nc3ccccc3)c2)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,7.3,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,MYBTYUMEQPJCTQ-AMYPSBKZSA-N
CHEMBL307261,ARTENIMOL,C[C@H]1[C@@H](O)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3,IC50,5.28,CHEMBL5245427,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,BJDCWCLMFKKGEE-ISOSDAIHSA-N
CHEMBL5397623,,COc1cc(CCc2cc(O)c3c(c2)OC(C)(C)CC3)cc2c1O[C@]1(C)CC[C@@H](OC=O)C(C)(C)[C@H]1C2,IC50,5.83,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,IQJLHDQHDSJGOX-MMXANPLTSA-N
CHEMBL5414661,,Cc1ccc(S(=O)(=O)n2cc(Cc3cc(C)c(O)c(C)c3)c3cc(C#N)ccc32)cc1,IC50,4.52,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,WXVURXPNUZJFDV-UHFFFAOYSA-N
CHEMBL5419481,,CCC(=O)n1cc(Cc2cc(C)c(O)c(C)c2)c2ccccc21,IC50,4.0,CHEMBL5374305,Anti-proliferative activity against human U-87 MG cells assessed as cell viability incubated for 2 hrs by CCK8 assay,U-87MG ATCC,COVOZZAUNPLIGT-UHFFFAOYSA-N
CHEMBL1097310,,CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)N1CCC[C@H]1C(=O)OCC#CCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,IC50,4.87,CHEMBL1111152,Cytotoxicity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,NJNRIENLQRRMHI-JGFHVXTRSA-N
CHEMBL4793784,,Cc1cccc(C(C(=O)NC(C)(C)C)N(C)CCOC(=O)/C=C/C(=O)c2ccc(F)cc2)c1,IC50,5.1,CHEMBL4685245,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AAOVMOLAQUMBGX-BUHFOSPRSA-N
CHEMBL5401329,,CC(C)=CCc1c(O)cc(/C=C/c2cc3c(c4c2C=CCO4)O[C@]2(C)CC[C@@H](O)C(C)(C)[C@H]2C3)cc1O,IC50,6.32,CHEMBL5373035,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation incubated for 72 hrs by CellTiter-Glo luminescent assay,U-87MG ATCC,GEOMYVWLNBJOIW-MGWHEABOSA-N
CHEMBL5089770,,Nc1cc(N2CCCC(CO)(CCCc3ccccc3)C2)nc(N)n1,IC50,5.0,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,LZETYUWTRRRBAK-UHFFFAOYSA-N
CHEMBL5090697,,Nc1nccc(N2CCC(CO)(CCCc3ccccc3)CC2)n1,IC50,5.4,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,XWMNSXWGSICEJS-UHFFFAOYSA-N
CHEMBL5079071,,Cc1cc(N2CCCC(CO)(CCCc3ccccc3)C2)nc(N)n1,IC50,5.1,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,CILSBPSVDVVHIX-UHFFFAOYSA-N
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,6.32,CHEMBL1055840,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL1565145,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCOCC2)cc1OC,IC50,4.74,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,POUGOEFZYGQTHG-UHFFFAOYSA-N
CHEMBL1490147,,COc1ccc(C(c2cc3c(cc2O)OCO3)N2CCCCC2)cc1,IC50,4.55,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,VXUBMVYKZKUFMX-UHFFFAOYSA-N
CHEMBL4747596,,COc1cccc(C(c2ccc3cccnc3c2O)N2CCOCC2)c1OC,IC50,4.48,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,QPHWILHOQHBVES-UHFFFAOYSA-N
CHEMBL4785141,,Oc1c(C(c2ccc3c(c2)CCC3)N2CCCCC2)ccc2ccoc12,IC50,5.3,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,GWLMNYOYFMJDOR-UHFFFAOYSA-N
CHEMBL4753733,,Oc1c(C(c2ccc(C(F)(F)F)cc2)N2CCCCC2)ccc2ccoc12,IC50,5.3,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,UQOORHXLHLDATJ-UHFFFAOYSA-N
CHEMBL1436701,,COc1cccc(C(c2cc3c(cc2O)OCO3)N2CCOCC2)c1OC,IC50,4.5,CHEMBL4729814,Cytotoxicity against human U-87 MG cells assessed as growth inhibition measured after 72 hrs by MTT assay,U-87MG ATCC,PKUPFNJHQHKECO-UHFFFAOYSA-N
CHEMBL4641440,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=S)Nc1ccc(Cl)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.83,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,ZVXBWXYPCFNKFC-QCOVWQHTSA-N
CHEMBL4645051,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccccn1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.52,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,APTONZVHMGOTJT-AICKGTJASA-N
CHEMBL4649423,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)Nc1ccc(OC)cc1)=C\CC[C@@]1(C)O[C@@H]21,IC50,5.5,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,AUKMHLNKGDLNTB-FLRPPASCSA-N
CHEMBL4637814,,C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)NC(C)(C)C)=C\CC[C@@]1(C)O[C@@H]21,IC50,4.85,CHEMBL4624828,Antiproliferation activity against human U87MG cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,NGPVINHTBKPBRU-PJWUZBAESA-N
CHEMBL4748501,,Cc1nn(C)c(Oc2cccc(Br)c2)c1/C=N\CCCCCCOc1cc2oc(=O)cc(C)c2cc1Cl,IC50,5.44,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,FWLTXPAKINLDFB-LJUMEUDFSA-N
CHEMBL4753177,,Cc1ccc(Oc2c(/C=N\CCCCCCOc3cc4oc(=O)cc(C)c4cc3Cl)c(C)nn2C)cc1,IC50,4.63,CHEMBL4666153,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,BKQITERMTHMMCT-MNBJERMJSA-N
CHEMBL1652062,,CC(C)CC1=C(O)C(=O)c2ccccc2C1=O,IC50,4.66,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,UASBUFXONXNWEH-UHFFFAOYSA-N
CHEMBL220648,,CC(C)CCC1=C(O)C(=O)C2=C(CCCC2)C1=O,IC50,4.7,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,UUEPXKOCNLABHE-UHFFFAOYSA-N
CHEMBL1652068,,C=CCC1=C(OC2(CC=C)C(=O)C(=O)c3ccccc3C2=O)C(=O)c2ccccc2C1=O,IC50,4.93,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,GVZVMKCRPIVYCI-UHFFFAOYSA-N
CHEMBL603842,,O=C1c2ccccc2C(=O)c2c1ccc1nc(-c3ccccc3)[nH]c21,IC50,4.81,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,DONDWNNDTIOAET-UHFFFAOYSA-N
CHEMBL5084279,,Cc1nccc(N2CCCC(CO)(CCCc3ccccc3)C2)n1,IC50,4.72,CHEMBL5050993,Antiproliferative activity against human U87 cells,U-87MG ATCC,GDBWRIBFQMJODQ-UHFFFAOYSA-N
CHEMBL113436,,Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1,IC50,9.3,CHEMBL815092,Inhibition of the entry of HIV-1 reporter virus (ADA) into U-87 cells,U-87MG ATCC,DTKUANPECHGGBY-UNMCSNQZSA-N
CHEMBL593976,,COc1cc(-c2nc3ccc4c(c3[nH]2)C(=O)c2ccccc2C4=O)ccc1O,IC50,4.87,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,FJEOIDUPEMASKE-UHFFFAOYSA-N
CHEMBL1095219,,CC1(C)OC2=C(C(=O)C(=O)c3ccccc32)[C@H](N=[N+]=[N-])[C@H]1Br,IC50,5.71,CHEMBL1664369,Cytotoxicity against human SF295 cells after 72 hrs by MTT assay,SF295,SEEHGZFDYGBTEN-IINYFYTJSA-N
CHEMBL1668699,,CN1CCN(c2ccc3nc(-c4ccc5nc(-c6ccc(Cl)cc6Cl)[nH]c5c4)[nH]c3c2)CC1,IC50,5.82,CHEMBL1671231,Cytotoxicity against human U87 cells after 72 hrs by MTT assay,U-87MG ATCC,CCDYEPLUHUIFGS-UHFFFAOYSA-N
CHEMBL601661,,CNC(=O)Nc1ccc(-c2nc(N3CC4CCC(C3)O4)c3cnn(C4CCC5(CC4)OCCO5)c3n2)cc1,IC50,7.19,CHEMBL5445968,Affinity Phenotypic Cellular interaction: (Cell growth assay (inhibition of cell proliferation in U87MG(glioma) cancer cells)) EUB0000607a MTOR,U-87MG ATCC,QLHHRYZMBGPBJG-UHFFFAOYSA-N
CHEMBL5181750,,CN(Cc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1)C(=O)CCCCCCCNC(=O)CCCCCN1/C(=C/C=C2\CCCC(/C=C/C3=[N+](CCCCCC(=O)O)c4ccccc4C3(C)C)=C2Cl)C(C)(C)c2ccccc21,IC50,4.92,CHEMBL5136479,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay,U-87MG ATCC,POMJEGFKIONNNS-UHFFFAOYSA-O
CHEMBL1963047,,CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCCCCC(=O)O)c4ccccc4C3(C)C)CCC2)=[N+](CCCCCC(=O)O)c2ccccc21,IC50,4.55,CHEMBL5136484,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs in presence of rAOC-Rib by alamar blue assay,U-87MG ATCC,MUEMGQSGNZKFJI-UHFFFAOYSA-O
CHEMBL5086293,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(F)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.59,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,GAFFZCCTWJWKRW-SMRIDXHDSA-N
CHEMBL5076793,,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(OCC(=O)NCc6cn(Cc7ccc(Br)cc7)nn6)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,IC50,5.48,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,ZWTPPPFBFCVMIN-SMRIDXHDSA-N
CHEMBL5090187,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.56,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,GAKKQBFYSNJTAZ-CDKFMWKUSA-N
CHEMBL5078218,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C(C)C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.67,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,FRDGYTCJYQGQAW-GTKRWHGSSA-N
CHEMBL5082185,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5ccc(C)cc5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.52,CHEMBL5044226,Antiproliferative activity against human LN-229 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,LN-229,MZYJAIGPHMIGGJ-MPOPNXFASA-N
CHEMBL5090187,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(C)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.86,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,GAKKQBFYSNJTAZ-CDKFMWKUSA-N
CHEMBL5093864,,COc1ccc(Cn2cc(CNC(=O)[C@]3(C)CC[C@]4(C)CC[C@]5(C)C6=CC=C7C(=CC(=O)C(O)=C7C)[C@]6(C)CC[C@@]5(C)[C@@H]4C3)nn2)cc1,IC50,5.87,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,VYZSZIMIQTZEEB-MPOPNXFASA-N
CHEMBL5080088,,CC1=C(O)C(=O)C=C2C1=CC=C1[C@@]2(C)CC[C@@]2(C)[C@@H]3C[C@](C)(C(=O)NCc4cn(Cc5nccs5)nn4)CC[C@]3(C)CC[C@]12C,IC50,5.55,CHEMBL5044228,Antiproliferative activity against human U87 cells assessed as reduction in cell viability incubated for 96 hrs by MTT assay,U-87MG ATCC,GJQSIGCKFMWMGG-VZTVURHLSA-N
CHEMBL5629866,,O=C(/C=C/c1ccccc1C(=O)N1CCN(Cc2ccccc2)C12COC2)c1ccccc1,IC50,4.98,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,RTFCGOREHPBMFR-FOCLMDBBSA-N
CHEMBL5624537,,COc1ccc(C(=O)/C=C/c2cccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)c2)cc1,IC50,5.58,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,QMNNVZYERQICFT-XNTDXEJSSA-N
CHEMBL5630858,,COc1cc(/C=C/C(=O)c2ccc(C(=O)N3CCN(Cc4ccccc4)C34COC4)s2)cc(OC)c1OC,IC50,5.7,CHEMBL5622705,Antiproliferative activity against human U87 cells assessed as cell viability measured after 72 hrs by MTT assay,U-87MG ATCC,ZTMYZDBKIVWJIQ-MDZDMXLPSA-N
CHEMBL107,COLCHICINE,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,IC50,7.44,CHEMBL5526621,Antiproliferative activity against human U-87 MG assessed as inhibition of cell growth measured after 48 hrs by MTT assay,U-87MG ATCC,IAKHMKGGTNLKSZ-INIZCTEOSA-N
CHEMBL5559415,,NC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.58,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,JKZNUSZFORUEAM-SECBINFHSA-N
CHEMBL5561148,,CCCCNC(=O)CC[C@@H](NS(=O)(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O,IC50,4.54,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ULRBAUVMGRJVES-CYBMUJFWSA-N
CHEMBL4776893,,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCC3COCCOCCOCCOCCO3)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O,IC50,5.52,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,LCZSGCOURDNTLM-UDKUWUAKSA-N
CHEMBL4796409,,CCOC(=O)N1CCC(NC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)CC1,IC50,5.96,CHEMBL4772199,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth incubated for 72 hrs by SRB assay,U-87MG ATCC,WKJCZMVINQHESV-ZJPQFJDJSA-N
CHEMBL1650631,,Oc1ccccc1-c1nc2ccccc2o1,EC50,4.28,CHEMBL4369488,Antiproliferative activity against human U87MG cells after 72 hrs by sulforhodamine B assay,U-87MG ATCC,GHGZVWOTJDLREY-UHFFFAOYSA-N
CHEMBL5639323,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(OCCN3CCOCC3)cc2)ncc1C(F)(F)F,IC50,4.92,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,SRTJLCPCKWMLHV-UHFFFAOYSA-N
CHEMBL5639819,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1Cl,IC50,5.37,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,LESGNHDGUUOEIU-UHFFFAOYSA-N
CHEMBL5641802,,CNC(=O)c1ccsc1Nc1nc(Nc2ccc(N3CCC(N4CCOCC4)CC3)cc2)ncc1C,IC50,4.94,CHEMBL5635291,Antiproliferative activity against human U-87 MG cells incubated for 48 hrs by MTT assay,U-87MG ATCC,YODZWPFTBUADGX-UHFFFAOYSA-N
CHEMBL5186348,,O=C1c2cc(-c3cccnc3)ncc2C(=O)c2c1c(-c1ccccn1)nn2-c1ccc(F)cc1F,IC50,5.6,CHEMBL5141022,Cytotoxicity against human U-87 MG cells,U-87MG ATCC,SPPMCRAMSPCJPH-UHFFFAOYSA-N
CHEMBL5618297,,Cc1ccc(CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(c2c[nH]c3ccccc23)c2c[nH]c3ccccc23)cc1,IC50,4.38,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,ODALRGSBKLSMHT-DHUJRADRSA-N
CHEMBL5619209,,CC(C)CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.76,CHEMBL5616776,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,U-87MG ATCC,PWLTUGNQRLCODH-YTTGMZPUSA-N
CHEMBL5619323,,COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccc(C(F)(F)F)cc12)c1c[nH]c2ccc(C(F)(F)F)cc12,IC50,5.26,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,HHNHRKMSQZHDMP-NDEPHWFRSA-N
CHEMBL5620297,,CCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.59,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,NAOYDIWOTBXUJD-XIFFEERXSA-N
CHEMBL5618638,,CCCCCCCCCCCCNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(C)(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,IC50,4.97,CHEMBL5616777,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth incubated for 68 hrs by CCK-8 assay,LN-229,CHENBVQGLCJZOL-KDXMTYKHSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,7.72,CHEMBL5625304,Antiproliferative activity against human U-87 MG cells assessed as reduction in cell growth by CCK-8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL5631386,,C=CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3ncc4c(n3)N(C(C)C)C(=O)OC4)cc2)CC1,IC50,8.59,CHEMBL5625326,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant measured after 72 hrs by MTT assay,U-87MG ATCC,AZWXCHCQFFUQCW-SFHVURJKSA-N
CHEMBL5284130,,c1cn2cc(-c3ccc4ncn(C5CCCCC5)c4c3)nc(-c3ccc4ncn(C5CCCCC5)c4c3)c2n1,IC50,6.09,CHEMBL5625481,Growth inhibition against human SNB-75 cells,SNB-75,XEFFCFLZLHGTDK-UHFFFAOYSA-N
CHEMBL314863,,COc1ccc(-c2cc3c(OC)cc(OC)cc3n(CC#N)c2=O)cc1,IC50,5.0,CHEMBL620413,Cytotoxicity against A-172 glioblastomas using MTT colorimetric assay,A-172,FLSXZIXQFOPKOC-UHFFFAOYSA-N
CHEMBL3797512,,CC(=O)N[C@H](C)[C@@H](O)[C@@H](C)[C@@H]1OC(=O)/C=C/C=C(C)\C=C\[C@]2(C)CCC=C[C@@H]2/C=C(C)/C=C/[C@H]1C,IC50,7.2,CHEMBL5365701,Antiproliferative activity against human SF-295 cells by Alamar Blue assay,SF295,AIIZZRMMCAVMCU-GXNNERPOSA-N
CHEMBL4754687,,CCS(=O)(=O)Nc1ccc(NC(=O)c2ccc(OC)cc2)cc1OCc1cc(OC)ccc1OC,IC50,7.92,CHEMBL4713866,Antiproliferative activity against human A 172 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay,A-172,FBNFIWKETUMPPR-UHFFFAOYSA-N
CHEMBL4777368,,Cc1c(C#N)c2nc(C(C)C)cn2c2nc(Nc3ccc(N4CCNCC4)cc3)ncc12,IC50,6.23,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,DJZJBAJKDQXEMV-UHFFFAOYSA-N
CHEMBL4781009,,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n2cc(C3CCCC3)nc12,IC50,7.19,CHEMBL4768586,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition measured after 4 to 6 days by celltiter-glo luminescent cell viability assay,U-87MG ATCC,HWCSIGMWDASGSX-UHFFFAOYSA-N
CHEMBL5569309,,Cc1ccc(-c2snnc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,6.96,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,QYHRZIQZKYOZPD-UHFFFAOYSA-N
CHEMBL5436907,,COc1ccc(OC)c(COc2cc(NC(=O)c3cccc(C#N)c3)ccc2NS(C)(=O)=O)c1,IC50,5.72,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,MMKJHFJHDJJWCS-UHFFFAOYSA-N
CHEMBL5422876,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C(F)(F)F)cc3C(F)(F)F)ccc2NS(C)(=O)=O)c1,IC50,5.77,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,QEXIPIGGYWEZII-UHFFFAOYSA-N
CHEMBL5398502,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C)cc3)ccc2NS(C)(=O)=O)c1,IC50,7.04,CHEMBL5384555,Growth inhibition of AR-overexpressing human U87 cells measured after 48 hrs by MTT assay,U-87MG ATCC,FVBRYQGAGKRSGL-UHFFFAOYSA-N
CHEMBL5420233,,CCc1ccc(C(=O)Nc2ccc(NS(C)(=O)=O)c(OCc3cc(OC)ccc3OC)c2)cc1,IC50,5.42,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,SONNMBQXZLPXFI-UHFFFAOYSA-N
CHEMBL5406623,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccc(C)c([N+](=O)[O-])c3)ccc2NS(C)(=O)=O)c1,IC50,5.43,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,MQOCVRWDRMZBHE-UHFFFAOYSA-N
CHEMBL5401077,,COc1ccc(OC)c(COc2cc(NC(=O)c3ccno3)ccc2NS(C)(=O)=O)c1,IC50,5.4,CHEMBL5384556,Growth inhibition of AR-overexpressing human T98G cells measured after 48 hrs by MTT assay,T98G,YLAGZOCVAGVUET-UHFFFAOYSA-N
CHEMBL2171777,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(O)cc34)[C@H]21,IC50,6.86,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,PLPWVVCBUWODOH-SFHVURJKSA-N
CHEMBL1914715,,O=S(=O)(Nc1cc(-c2ccc3nccnc3c2)cnc1Cl)c1ccc(F)cc1,IC50,5.84,CHEMBL1921660,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,U-87MG ATCC,TZARJJVXWKVJIK-UHFFFAOYSA-N
CHEMBL5170880,,CC(C)=CC[C@@H](OC(=O)CCC(=O)NCc1ccc(Br)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,IC50,5.46,CHEMBL5138621,Anticancer activity against human U87 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay,U-87MG ATCC,CUAXQQAJPYAQMF-JOCHJYFZSA-N
CHEMBL4862917,,O=C(CCCCCNC(=O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O)NO,IC50,5.26,CHEMBL5614796,Antiproliferative activity against human T98G cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay,T98G,BWMRGOQFHBXKQR-UHFFFAOYSA-N
CHEMBL4753289,,O=C(Nc1ccc(F)cc1)Nc1ccc(Nc2nc(/C=C/c3cccc([N+](=O)[O-])c3)nc(N3CCOCC3)n2)cc1,IC50,5.96,CHEMBL4737465,Antiproliferative activity against human U87 cells assessed as reduction in cell growth incubated for 4 days by cell-titer glo assay,U-87MG ATCC,UDVSQIRATZQDHW-YIXHJXPBSA-N
CHEMBL5174779,,CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H]2CCC(=O)N2)[C@H](C(C)C)c2ccc3c4c([nH]c3c2)-n2cnc(c2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C4)NC(=O)[C@H](C(C)C)NC1=O,IC50,5.02,CHEMBL5126223,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,UCSHFBQCLZMAJY-QFMFBHDYSA-N
CHEMBL4874754,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8[nH]ccc8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.42,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,DALIFNQGETXUAC-JDMHCBMBSA-N
CHEMBL4849422,,CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8cc[nH]c8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,IC50,4.35,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,ZBIKZWWARRAAKU-JDMHCBMBSA-N
CHEMBL4867655,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7cccc8[nH]ccc78)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.2,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,OZXMJUSGUUBKJM-KODZDQQCSA-N
CHEMBL4847529,,C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6nnn(Cc7ccc8[nH]ccc8c7)c6C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,IC50,4.48,CHEMBL4829684,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell viability measured after 72 hrs by colorimetric MTS viability assay,LN-229,ZMHNXSIWQBGZLF-KODZDQQCSA-N
CHEMBL2313487,,COc1cc(Cc2c(-c3ccn(S(=O)(=O)c4ccccc4)c3)[nH]c3ccccc23)cc(OC)c1OC,IC50,5.85,CHEMBL5223969,Anticancer activity against U-87 MG assessed as inhibition of cell proliferation incubated for 72 hrs by MTS assay,U-87MG ATCC,KTTHUXOEXYKHFJ-UHFFFAOYSA-N
CHEMBL5218612,,COc1ccc(-c2ncccc2NCc2ccc(Cl)cc2)cc1OC,IC50,4.67,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,BFORWLHSAYRUPV-UHFFFAOYSA-N
CHEMBL5219155,,COc1cc(OC)cc(-c2ncccc2CNc2ccc(Cl)cc2)c1,IC50,4.55,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,MRAYMFLAQBLFKS-UHFFFAOYSA-N
CHEMBL5220864,,COc1cc(-c2ncccc2CNc2ccc(Cl)cc2)cc(OC)c1OC,IC50,4.58,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,NQICJPRQGKQXMO-UHFFFAOYSA-N
CHEMBL140,CURCUMIN,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,IC50,4.74,CHEMBL4810781,Neurotoxicity in human U87 MG cells assessed as cell viability for 24 hrs by MTT assay,U-87MG ATCC,VFLDPWHFBUODDF-FCXRPNKRSA-N
CHEMBL5080484,,COc1ccc(NC(=O)c2ccccc2Nc2cccc(Cl)c2C)cc1OC,IC50,4.0,CHEMBL5033582,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,U-87MG ATCC,FIRSADZWNMOOCD-UHFFFAOYSA-N
CHEMBL4779569,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)[C@H]4CCCNC4)cc3)nc12,IC50,6.52,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,UDPSCVKNVATZTE-INIZCTEOSA-N
CHEMBL4797985,,COc1ccccc1-c1csc2cnc(Nc3ccc(NC(=O)CN)cc3)nc12,IC50,6.68,CHEMBL4767591,Antiproliferative activity against human U-87MG cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay,U-87MG ATCC,YSSRLUNVDUOKSW-UHFFFAOYSA-N
CHEMBL4082724,,COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,IC50,6.18,CHEMBL5114109,Antiproliferative activity against human U-87 MG cells,U-87MG ATCC,QODZCSPDZVDCSD-UHFFFAOYSA-N
CHEMBL5171079,,C=C[C@]1(C)CC[C@@H]2C[C@H]1C(=C)CN1CC(C1)C(=O)NCCCCCC(=O)N1CCN(CC1)CC2=C,IC50,4.46,CHEMBL5099146,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay relative to control,U-87MG ATCC,VTFHDQRAUJFACR-DOBADDLBSA-N
CHEMBL2017654,,N#Cc1ccc(-c2c(-c3ncn[nH]3)sc(N3CCOCC3)c2C#N)c(F)c1,IC50,5.64,CHEMBL4769548,Antiproliferative activity against human U87MG cells harboring PTEN deletion assessed as reduction in cell viability after 3 days by CellTiter-Glo luminescence assay,U-87MG ATCC,MUENOTXSRZEFJV-UHFFFAOYSA-N
CHEMBL59030,,O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1,IC50,5.44,CHEMBL4686885,Antiproliferative activity against human U87 cells overexpressing EGFR variant III measured after 7 days by CCK8 assay,U-87MG ATCC,NAXSRXHZFIBFMI-UHFFFAOYSA-N
CHEMBL4520989,,N=C1S/C(=C\c2ccc(-c3ccc4c(c3)C(=O)NC4=O)o2)C(=O)N1c1ccc(F)cc1,IC50,4.7,CHEMBL4387643,Activation of TRAIL receptor in human T98G cells assessed as reduction in cel viability by Cell-titer-Glo luminescent cell viability assay,T98G,JXEQVHSNFMQGEZ-NLDKGBHCSA-N
CHEMBL5438210,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)/C=C/[C@H](C)[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.89,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,NLLURLYURZLKHG-ZVOQMXLTSA-N
CHEMBL5422756,,CC[C@H](C)[C@H]1C(=O)N[C@@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccc(OC)cc2)C(=O)N(C)[C@H](C)C(=O)NC[C@H](N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](OC(=O)[C@H](C(C)C)N(C)C)C(C)C)C(=O)N(C)[C@@H](C)C(=O)N1C,IC50,7.52,CHEMBL5370496,Antiproliferative activity against human U-87 MG cells expressing GLuc assessed as as inhibition of GLuc secretion incubated for 18 hrs by CellTiter-Glo Luminescent Cell Viability Assay,U-87MG ATCC,YLGDVHWMOAKENB-JYRFQQDJSA-N
CHEMBL5218538,,COc1cc(-c2ncccc2NCc2cccc(N)c2)cc(OC)c1OC,IC50,4.31,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,RCVKUIIKFRQFBK-UHFFFAOYSA-N
CHEMBL2313487,,COc1cc(Cc2c(-c3ccn(S(=O)(=O)c4ccccc4)c3)[nH]c3ccccc23)cc(OC)c1OC,IC50,5.85,CHEMBL5164637,Antiproliferative activity against human U-87 MG cells assessed as cell growth inhibition incubated for 72 hrs followed by replacement with fresh medium by MTS assay,U-87MG ATCC,KTTHUXOEXYKHFJ-UHFFFAOYSA-N
CHEMBL5562891,,COc1ccc(Cn2cncc2-c2cc(C(C)C)c(O)cc2O)cc1,EC50,4.42,CHEMBL5552311,Antiproliferative activity against human U87 cells incubated for 72 hrs by alamar blue staining based analysis,U-87MG ATCC,KXIIWOMODNECDD-UHFFFAOYSA-N
CHEMBL3220804,,C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)OCC[N+](C)(C)CCCCCCCCCCCC[N+](C)(C)CCOC(=O)[C@]3(C)CCC[C@@]4(C)[C@@H]5CC[C@@]6(C)C[C@]5(CC[C@@H]43)CC6=O)(CC1=O)C2.[Br-].[Br-],IC50,4.4,CHEMBL4689358,Cytotoxicity against human T98G cells assessed as reduction in cell viability by DAPI staining based assay,T98G,XMBQLZUGOZTXPX-UTZVVGESSA-L
CHEMBL53463,DOXORUBICIN,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,IC50,5.16,CHEMBL4689358,Cytotoxicity against human T98G cells assessed as reduction in cell viability by DAPI staining based assay,T98G,AOJJSUZBOXZQNB-TZSSRYMLSA-N
CHEMBL4562297,,CC(C)(C)NC(=O)C(c1ccc(F)cc1)N(C(=O)/C=C/C(=O)c1ccc(F)cc1)C1CC1,IC50,6.1,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,RSPCURGJZZDUBD-CCEZHUSRSA-N
CHEMBL465843,PIPLARTINE,COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC,IC50,5.14,CHEMBL4362340,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,VABYUUZNAVQNPG-BQYQJAHWSA-N
CHEMBL4452505,,COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2nc3ccc(OC)cc3s2)cc1,IC50,5.23,CHEMBL4363060,Cytotoxicity against human U87MG cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,U-87MG ATCC,AEALTSKEFAKWGA-UHFFFAOYSA-N
CHEMBL4440660,,COc1cc(/C=N/Nc2nc(-c3ccccc3)cs2)cc(Br)c1OC,IC50,4.13,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,DOMXUSJBUFQIGN-KEBDBYFISA-N
CHEMBL4474520,,COc1cc(/C=N/Nc2nc(-c3ccccc3)cs2)c(Br)c(Br)c1OC,IC50,4.7,CHEMBL4396326,Antiproliferative activity against human U87MG cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,U-87MG ATCC,JKKQMALDUFGQOD-ZVBGSRNCSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,6.36,CHEMBL5509853,Antiproliferative activity against human U-87 MG cells harboring IDH1 R132H mutant assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL5417673,,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CSCc2ccc(cc2)CSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(N)=O,IC50,4.81,CHEMBL5391015,Anti-cancer activity against human U-87 MG assessed as cell viability incubated for 48 hrs by CCK-8 assay,U-87MG ATCC,ULBGHKPEHFWLSO-ZBLPZKBESA-N
CHEMBL5562174,,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccc(NC(=O)COc3cccnc3)cc2)cc1,IC50,5.9,CHEMBL5509849,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 24 hrs by CCK8 assay,U-87MG ATCC,NGXVQQDDOXHWSX-CUVVAGTFSA-N
CHEMBL3947537,,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,IC50,5.12,CHEMBL5509850,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,DCGDPJCUIKLTDU-SUNYJGFJSA-N
CHEMBL5523524,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)c4ccc5nccn5c4)cc3)cc2)n1,IC50,5.92,CHEMBL5509850,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 48 hrs by CCK8 assay,U-87MG ATCC,HENWOYNKEJWJFG-KDYSTLNUSA-N
CHEMBL3989958,IVOSIDENIB,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,IC50,4.17,CHEMBL5509851,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,WIJZXSAJMHAVGX-DHLKQENFSA-N
CHEMBL566757,DAPORINAD,O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,IC50,5.79,CHEMBL5509851,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,KPBNHDGDUADAGP-VAWYXSNFSA-N
CHEMBL5517720,,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccc(NC(=O)COc4cccnc4)cc3)cc2)n1,IC50,6.27,CHEMBL5509851,Antiproliferative activity against human U-87 MG cells harboring wildtype IDH1 assessed as inhibition of cell growth incubated for 72 hrs by CCK8 assay,U-87MG ATCC,KRQSJWTXUQGYKQ-KDYSTLNUSA-N
CHEMBL5557636,,Cc1ccc(S(=O)(=O)N[C@H](CCC(=O)NCc2ccccc2)C(=O)O)cc1,IC50,4.76,CHEMBL5525323,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,YJZSRDUHGUXYJX-QGZVFWFLSA-N
CHEMBL5172767,,COc1ccc(-c2ccc3[nH]c(=O)c4nnn(-c5ccc(N6CCNCC6)c(C(F)(F)F)c5)c4c3c2)cn1,IC50,5.78,CHEMBL5330114,Antiproliferative activity against human U-87 MG cells assessed as inhibition of cell proliferation by CCK8 assay,U-87MG ATCC,RGHLRMNPUGUZEY-UHFFFAOYSA-N
CHEMBL5565225,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CCSSCCC(=O)NCCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,6.34,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,HDDMOGVZHHEKBP-MJUOCMCKSA-N
CHEMBL5569667,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,7.28,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,HWVVCICHVKNWIN-ODVYPAPQSA-N
CHEMBL5565980,,CN1c2ccc(F)cc2C(=O)N2CCc3c([nH]c4ccc(OC(=O)CSCC(=O)NCCC[C@@H]5NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC5=O)cc34)C21,IC50,7.52,CHEMBL5552325,Cytotoxicity against human U87 cells measured after 72 hrs by CCK8 assay,U-87MG ATCC,HZGSFNWDPQBDQH-KHEAGTJRSA-N
CHEMBL5219713,,COc1ccc(CNc2cccnc2-c2ccc(OC)c(OC)c2)cc1,IC50,4.33,CHEMBL5216828,Antiproliferative activity against human U-87 MG cells measured after 48 hrs by MTT assay,U-87MG ATCC,PFIILSKISYJSFI-UHFFFAOYSA-N
CHEMBL5423893,,O=C1C=C(c2ccc(O)cc2O)C(=O)c2c(O)cccc21,IC50,5.29,CHEMBL5389193,Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin assay,U-87MG ATCC,LWCAHETWUAFCPC-UHFFFAOYSA-N
CHEMBL5399499,,C=C(C)C#C[C@]12O[C@H]1[C@@H]1OC(C)(C)[C@H](OC(C)=O)C[C@@]13O[C@H]3C2=O,IC50,4.89,CHEMBL5392809,Antiproliferative activity against human T98G cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay,T98G,UDLWCNHPUOUNNV-ZPUMPEKVSA-N
CHEMBL4287207,,O=C(/C=C/c1ccc(Oc2cc(=O)oc3ccccc23)cc1)/C=C/c1ccccn1,IC50,4.29,CHEMBL4273127,Antiproliferative activity against human U87 cells after 48 hrs by MTT assay,U-87MG ATCC,PWVODMRQWPRDJJ-UHSWXSRBSA-N
CHEMBL2017974,BUPARLISIB,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,IC50,5.32,CHEMBL4312312,Antiproliferative activity against human U87 cells after 96 hrs by MTT assay,U-87MG ATCC,CWHUFRVAEUJCEF-UHFFFAOYSA-N
CHEMBL4649297,,Nc1ncnn2c([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)cc(/C=C/c3ccccc3)c12,IC50,5.41,CHEMBL4627083,Antiproliferative activity against human LN229 cells assessed as reduction in cell viability incubated for 72 hrs by IncuCyte live-cell imaging assay,LN-229,SLEURXSVSUEDBN-LKKVPXNQSA-N
CHEMBL5595426,,N#CC1(C(=O)NCCCc2ccccc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,4.7,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,UAFFOKVVUMXPMA-UHFFFAOYSA-N
CHEMBL5571773,,N#CC1(C(=O)NCCc2ccc(F)cc2)CC2(CO)c3ccccc3C1c1ccccc12,IC50,4.82,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,UVKBAIRBMCIXFU-UHFFFAOYSA-N
CHEMBL5590378,,N#CC1(C(=O)NCCS(=O)(=O)c2ccc(Cl)cc2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.04,CHEMBL5530935,Antiproliferative activity against human LN-229 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay,LN-229,UJRAACISRFBVIZ-UHFFFAOYSA-N
CHEMBL5566563,,N#CC1(C(=O)NCCC2CCN(Cc3ccccc3)CC2)CC2(Br)c3ccccc3C1c1ccccc12,IC50,5.91,CHEMBL5530950,Inhibition of sphere formation in human LN-229 cells incubated for 168 hrs by microscopic analysis,LN-229,RZJZAWPSUBSTEJ-UHFFFAOYSA-N
CHEMBL5565987,,O=C(Nc1ncc([N+](=O)[O-])s1)c1cccc(-c2ccccn2)n1,IC50,5.94,CHEMBL5527512,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by SRB assay,U-87MG ATCC,UQIHIFJLHVPGPK-UHFFFAOYSA-N
CHEMBL1738758,ONVANSERTIB,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,IC50,6.41,CHEMBL5682228,Antiproliferative activity against human SF-295 cells assessed as inhibition of cell growth incubated for 72 hrs by cell-titer glo assay,SF295,QHLVBNKYJGBCQJ-UHFFFAOYSA-N
CHEMBL3414623,,Cc1cn(CCN2CCN(c3ccccc3-c3cc(C#N)cc(C(=O)NCCCN4CCCC4)c3)CC2)c2ccccc12,IC50,5.54,CHEMBL5676197,Antiproliferative activity against human U-87MG cells after 10 days,U-87MG ATCC,PNYRDVBFYVDJJI-UHFFFAOYSA-N
CHEMBL5558740,,COc1cc(OCc2cccc(-c3ccccc3)c2C)ccc1CNCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,IC50,5.58,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZJEUDIZHIOQKSL-UHFFFAOYSA-N
CHEMBL5562753,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCNCc1c(OC)cc(OCc2cccc(-c3ccccc3)c2C)cc1OC,IC50,5.54,CHEMBL5511079,Antiproliferative activity against human U-87 MG cells incubated for 72 hrs by MTT assay,U-87MG ATCC,ZJSVPMISCNDWRC-UHFFFAOYSA-N
